Citrus Sinensis ID: 008431
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 565 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGR9 | 676 | Probable LRR receptor-lik | yes | no | 0.985 | 0.823 | 0.521 | 1e-164 | |
| C0LGU0 | 662 | Probable LRR receptor-lik | no | no | 0.982 | 0.838 | 0.511 | 1e-156 | |
| Q9LPT1 | 686 | Probably inactive leucine | no | no | 0.982 | 0.809 | 0.468 | 1e-139 | |
| Q3E991 | 659 | Probable inactive leucine | no | no | 0.936 | 0.802 | 0.367 | 2e-98 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.907 | 0.784 | 0.356 | 7e-85 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.950 | 0.816 | 0.377 | 3e-84 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.911 | 0.804 | 0.354 | 2e-82 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.870 | 0.734 | 0.365 | 9e-81 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.929 | 0.811 | 0.353 | 1e-79 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.916 | 0.809 | 0.344 | 2e-79 |
| >sp|C0LGR9|Y4312_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g31250 OS=Arabidopsis thaliana GN=At4g31250 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 580 bits (1495), Expect = e-164, Method: Compositional matrix adjust.
Identities = 307/589 (52%), Positives = 388/589 (65%), Gaps = 32/589 (5%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV--GKLTLRALYLSLNKFTGEIPSDA 58
M+L G +DV L + GL+S+SF+ N F+G +P G ++L LYL+ N+FTGEI D
Sbjct: 84 MSLSGELDVQALGSIRGLKSISFMRNHFEGKIPRGIDGLVSLAHLYLAHNQFTGEIDGDL 143
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSY 118
F+GM L KVHL N FSG+IP+SL L KL +LNLE N F GKIP F +L ++++
Sbjct: 144 FSGMKALLKVHLEGNRFSGEIPESLGKLPKLTELNLEDNMFTGKIPAFKQKNLVTVNVAN 203
Query: 119 NQLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSISK-KTILIICTVAGATLALAAIV 177
NQL GRIP TL + T F GNKGLCG PL C+ + T+ ++ A + L +
Sbjct: 204 NQLEGRIPLTLGLMNITFFSGNKGLCGAPLLPCRYTRPPFFTVFLLALTILAVVVLITVF 263
Query: 178 AFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCY--FVNS--QND 233
C + I N + YG + Q S Y N Q D
Sbjct: 264 LSVCILSRRQGKGQDQIQNHGVGHFHGQVYGQPEQQQHSEKSSQDSKVYRKLANETVQRD 323
Query: 234 EIS---------------------KLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKA 272
+ KLHFV ND+E F L D+LRASAEVLGSG FGSSYKA
Sbjct: 324 STATSGAISVGGLSPDEDKRGDQRKLHFVRNDQERFTLQDMLRASAEVLGSGGFGSSYKA 383
Query: 273 VLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332
L +G A+VVKRFR MSN+G+E+F++HM ++G LSHPNLLPLIAFYYRKEEKLLV++++
Sbjct: 384 ALSSGRAVVVKRFRFMSNIGREEFYDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYIS 443
Query: 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD 392
NGSLANLLH R PGQ LDWPIRLKI++GV +GLAYLY+ FP + LPHGHLKSSNVLLD
Sbjct: 444 NGSLANLLHANRTPGQVVLDWPIRLKIVRGVTRGLAYLYRVFPDLNLPHGHLKSSNVLLD 503
Query: 393 NAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKF 452
+EPLLTDYALVP+VN++ +Q MVAYK+PEF Q D +R++DVWSLGILILE+LTGKF
Sbjct: 504 PNFEPLLTDYALVPVVNRDQSQQFMVAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKF 563
Query: 453 PANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWN 512
PANYL QGKGA+ +LA WV SV R EWT +VFDK+M+ K E +MLKLLKIG+ CC+W+
Sbjct: 564 PANYLRQGKGADDELAAWVESVARTEWTADVFDKEMKAGKEHEAQMLKLLKIGLRCCDWD 623
Query: 513 AERRWDLREAVEKIMELKERDNDNED--YSSY--ASEDYVYSSRAMTDE 557
E+R +L EAV++I E+ ++ SSY AS+ SSRAMT+E
Sbjct: 624 IEKRIELHEAVDRIEEVDRDAGGGQESVRSSYVTASDGDHRSSRAMTEE 672
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGU0|RLK_ARATH Probable LRR receptor-like serine/threonine-protein kinase RLK OS=Arabidopsis thaliana GN=RLK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 551 bits (1419), Expect = e-156, Method: Compositional matrix adjust.
Identities = 300/587 (51%), Positives = 388/587 (66%), Gaps = 32/587 (5%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ L G ID++ LS L LR+LSF+NN F+GP P KL L++LYLS N+F G+IP DAF
Sbjct: 83 LELSGSIDIEALSGLTSLRTLSFMNNKFEGPFPDFKKLAALKSLYLSNNQFGGDIPGDAF 142
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
GM LKKVHLA+N F+GQIP S+A L KLL+L L+GN F G+IP+F L LL+LS N
Sbjct: 143 EGMGWLKKVHLAQNKFTGQIPSSVAKLPKLLELRLDGNQFTGEIPEFE-HQLHLLNLSNN 201
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEA-CKS--------------SISKKTILIIC 164
L G IP++LS D F+GNKGL GKPLE C S S S+ ++I
Sbjct: 202 ALTGPIPESLSMTDPKVFEGNKGLYGKPLETECDSPYIEHPPQSEARPKSSSRGPLVITA 261
Query: 165 TVAGATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSD 224
VA T+ + V F R + K +P + ET + KK G D + + + +D
Sbjct: 262 IVAALTILIILGVIFLLNR--SYKNKKPRLAVETGPSSLQKKTGIREA-DQSRRDRKKAD 318
Query: 225 CYFVNSQND--------EISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLT 276
+ E +KL F+ DRE F+L DLL+ASAE+LGSG FG+SYKAVL +
Sbjct: 319 HRKGSGTTKRMGAAAGVENTKLSFLREDREKFDLQDLLKASAEILGSGCFGASYKAVLSS 378
Query: 277 GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336
G MVVKRF+QM+N G+++F EHM RLG L H NLL ++A+YYRKEEKLLV DF GSL
Sbjct: 379 GQMMVVKRFKQMNNAGRDEFQEHMKRLGRLMHHNLLSIVAYYYRKEEKLLVCDFAERGSL 438
Query: 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE 396
A LH ++ G+P LDWP RLKI+KGVAKGL YL+++ P + PHGHLKSSNVLL +E
Sbjct: 439 AINLHSNQSLGKPSLDWPTRLKIVKGVAKGLFYLHQDLPSLMAPHGHLKSSNVLLTKTFE 498
Query: 397 PLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANY 456
PLLTDY L+P++N+E AQ+HM AY+SPE+ Q +T+KTDVW LGILILE+LTGKFPAN+
Sbjct: 499 PLLTDYGLIPLINQEKAQMHMAAYRSPEYLQHRRITKKTDVWGLGILILEILTGKFPANF 558
Query: 457 LAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR 516
+ + DLA+WVNS W +FDK M T EG++LKLL IG+ CCE + E+R
Sbjct: 559 ---SQSSEEDLASWVNSGFHGVWAPSLFDKGMGKTSHCEGQILKLLTIGLNCCEPDVEKR 615
Query: 517 WDLREAVEKIMELKERDNDNED-YSSYASEDYVYSSRAMTDEDFSFS 562
D+ +AVEKI ELKER+ D++D YS+Y SE SS+ + E SF+
Sbjct: 616 LDIGQAVEKIEELKEREGDDDDFYSTYVSETDGRSSKGESCESISFA 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPT1|Y1061_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At1g50610 OS=Arabidopsis thaliana GN=At1g50610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 496 bits (1276), Expect = e-139, Method: Compositional matrix adjust.
Identities = 279/595 (46%), Positives = 385/595 (64%), Gaps = 40/595 (6%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
M L G +++D L + LR++SF+NN+F+GPMP V + T L++LYLS N+F+GEIP+DAF
Sbjct: 98 MGLTGKLNLDPLVPMKNLRTISFMNNNFNGPMPQVKRFTSLKSLYLSNNRFSGEIPADAF 157
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
GM LKK+ LA N F G IP SLA L LL+L L GN FQG+IP F L L N
Sbjct: 158 LGMPLLKKILLANNAFRGTIPSSLASLPMLLELRLNGNQFQGQIPSFQQKDLKLASFENN 217
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCG--------------------------KPLEACKS 153
L G IP++L N D SF GNKGLC P K+
Sbjct: 218 DLDGPIPESLRNMDPGSFAGNKGLCDAPLSPCSSSSPGVPVVPVSPVDPKSTSPPTGKKA 277
Query: 154 SISKKTILIICTVAGATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYH 213
+I+ + + +A + F +R N ++ P + + ++ Y +
Sbjct: 278 GSFYTLAIILIVIGIILVIIALVFCFVQSRRRNFLSAYP----SSAGKERIESYNYHQST 333
Query: 214 DMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAV 273
+ +S + S D +L FV +D + F+L DLLRASAEVLGSG+FG+SYKA
Sbjct: 334 NKNNKPAESVNHTRRGSMPDPGGRLLFVRDDIQRFDLQDLLRASAEVLGSGTFGASYKAA 393
Query: 274 LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333
+ +G +VVKR++ M+NVG+++FHEHM RLG L+HPN+LPL+A+YYR+EEKLLV++F+PN
Sbjct: 394 ISSGQTLVVKRYKHMNNVGRDEFHEHMRRLGRLNHPNILPLVAYYYRREEKLLVTEFMPN 453
Query: 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN 393
SLA+ LH A GLDW RLKIIKGVAKGL+YL+ E P +T+PHGH+KSSN++LD+
Sbjct: 454 SSLASHLH---ANNSAGLDWITRLKIIKGVAKGLSYLFDELPTLTIPHGHMKSSNIVLDD 510
Query: 394 AYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDG--VTRKTDVWSLGILILELLTGK 451
++EPLLTDYAL P+++ EHA M AYKSPE+ + G +T+KTDVW G+LILE+LTG+
Sbjct: 511 SFEPLLTDYALRPMMSSEHAHNFMTAYKSPEYRPSKGQIITKKTDVWCFGVLILEVLTGR 570
Query: 452 FPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEW 511
FP NYL QG +N L TWVN +V+E+ TG+VFDK+M+G K+ + EM+ LLKIG+ CCE
Sbjct: 571 FPENYLTQGYDSNMSLVTWVNDMVKEKKTGDVFDKEMKGKKNCKAEMINLLKIGLRCCEE 630
Query: 512 NAERRWDLREAVEKIMELKERDNDNEDYSSY---ASEDYVYSSRAMTDEDFSFSV 563
ERR D+RE VE + L+E +++ +D+ S + + VYSS + D+DF FS+
Sbjct: 631 EEERRMDMREVVEMVEMLREGESE-DDFGSMDHRGTHNNVYSSMLLDDDDFGFSM 684
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q3E991|Y5269_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At5g20690 OS=Arabidopsis thaliana GN=At5g20690 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 360 bits (924), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 213/579 (36%), Positives = 320/579 (55%), Gaps = 50/579 (8%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ L G I VD L LP L+++ NN GP+P KL L++L LS N F+GEI D F
Sbjct: 81 LGLSGTITVDDLKDLPNLKTIRLDNNLLSGPLPHFFKLRGLKSLMLSNNSFSGEIRDDFF 140
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIP-DF-PLAHLTLLDLS 117
M +LK++ L N F G IP S+ L +L +L+++ N+ G+IP +F + +L +LDLS
Sbjct: 141 KDMSKLKRLFLDHNKFEGSIPSSITQLPQLEELHMQSNNLTGEIPPEFGSMKNLKVLDLS 200
Query: 118 YNQLVGRIPDTLSNFD--ATSFQGNKGLCGKPLEACKSSI-------------------- 155
N L G +P ++++ A + N+ LCG ++ +I
Sbjct: 201 TNSLDGIVPQSIADKKNLAVNLTENEYLCGPVVDVGCENIELNDPQEGQPPSKPSSSVPE 260
Query: 156 -SKKTILIICTVAGATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHD 214
S K + V+ + L L I+ R N K + ++ +E ++ + +
Sbjct: 261 TSNKAAINAIMVSISLLLLFFIIVGVIKRRNKKKNPDFRMLANNRENDVVEVRISESSST 320
Query: 215 MGQNEIQSSDCYFVNSQNDEISK-----------------------LHFVNNDREMFELN 251
+ SS +S + K + VN D+ F L
Sbjct: 321 TAKRSTDSSRKRGGHSDDGSTKKGVSNIGKGGNGGGGGALGGGMGDIIMVNTDKGSFGLP 380
Query: 252 DLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL 311
DL++A+AEVLG+GS GS+YKAV+ TG ++VVKR R M+ + +E F M R G L HPN+
Sbjct: 381 DLMKAAAEVLGNGSLGSAYKAVMTTGLSVVVKRIRDMNQLAREPFDVEMRRFGKLRHPNI 440
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
L +A++YR+EEKL+VS+++P SL +LH R L W RLKII+GVA G+ +L+
Sbjct: 441 LTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGIYHSELTWATRLKIIQGVAHGMKFLH 500
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGV 431
+EF LPHG+LKSSNVLL YEPL++DYA +P++ +A + A+K+PEF QT V
Sbjct: 501 EEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPSNASQALFAFKTPEFAQTQQV 560
Query: 432 TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491
+ K+DV+ LGI+ILE+LTGKFP+ YL GKG D+ WV S V E+ E+ D ++
Sbjct: 561 SHKSDVYCLGIIILEILTGKFPSQYLNNGKGG-TDIVQWVQSSVAEQKEEELIDPEIVNN 619
Query: 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530
+M++LL++G C N + R D+REAV +I ++K
Sbjct: 620 TESMRQMVELLRVGAACIASNPDERLDMREAVRRIEQVK 658
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (806), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 204/573 (35%), Positives = 306/573 (53%), Gaps = 60/573 (10%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDA 58
+ L+G I +TL +L LR LS +N G +P + L +L +YL N F+GE+PS
Sbjct: 97 IGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPS-- 154
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSY 118
F QL + L+ N F+G+IP + L++L L+L+ N G +P+ L L+LS
Sbjct: 155 FVSR-QLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLNLSN 213
Query: 119 NQLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSS------------------------ 154
N L G IP L F ++SF GN LCG PL+ C +S
Sbjct: 214 NHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHKEGS 273
Query: 155 ---ISKKTILIICTVAGATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANN 211
+ TI+ I A L L ++ C K + I+ +T KA +++G+
Sbjct: 274 KRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKTLTEKAKQEFGS-- 331
Query: 212 YHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYK 271
Q E +KL F N F+L DLLRASAEVLG GS+G++YK
Sbjct: 332 -----------------GVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYK 374
Query: 272 AVLLTGPAMVVKRFRQMSNVGKEDFHEHM---TRLGSLSHPNLLPLIAFYYRKEEKLLVS 328
AVL +VVKR ++++ GK +F + M +R+G +HP+++PL A+YY K+EKL+V
Sbjct: 375 AVLEESTTVVVKRLKEVA-AGKREFEQQMEIISRVG--NHPSVVPLRAYYYSKDEKLMVC 431
Query: 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSN 388
D+ P G+L++LLH R + LDW R+KI AKG+A+L+ G HG++KSSN
Sbjct: 432 DYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAG-GPKFSHGNIKSSN 490
Query: 389 VLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELL 448
V++ + ++D+ L P++ A + Y++PE +T T K+DV+S G+LILE+L
Sbjct: 491 VIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEML 550
Query: 449 TGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCC 508
TGK P + + DL WV SVVREEWT EVFD ++ ++ E EM+++L+I M C
Sbjct: 551 TGKSPVQ--SPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMAC 608
Query: 509 CEWNAERRWDLREAVEKIMELKERDNDNEDYSS 541
E R + + V I E++ D++ SS
Sbjct: 609 VAQVPEVRPTMDDVVRMIEEIRVSDSETTRPSS 641
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 220/583 (37%), Positives = 312/583 (53%), Gaps = 46/583 (7%)
Query: 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKLT-LRALYLSLNKFTGEIPSDAFA 60
L+G I +L RL LR LS +N G +PS LT LR+LYL N+F+GE P+ +F
Sbjct: 78 LVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPT-SFT 136
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQ 120
++ L ++ ++ N+F+G IP S+ L L L L N F G +P L L ++S N
Sbjct: 137 QLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLG-LVDFNVSNNN 195
Query: 121 LVGRIPDTLSNFDATSFQGNKGLCGKPLEACKS---SISKKTILIICT----VAGATLAL 173
L G IP +LS F A SF GN LCG PL+ CKS S S LI + + L+
Sbjct: 196 LNGSIPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSK 255
Query: 174 AAIVAFSCT--------------------RGNN-SKTSEPIIVNETQETKALKKYGANNY 212
AAIVA RG+N ++T +P L +++
Sbjct: 256 AAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSS- 314
Query: 213 HDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKA 272
+ E+ + E +KL F F+L DLLRASAEVLG GS G+SYKA
Sbjct: 315 ----KEEVTGTSSGM--GGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKA 368
Query: 273 VLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332
VL G +VVKR + + K++F M +G + HPN++PL A+YY K+EKLLV DF+P
Sbjct: 369 VLEEGTTVVVKRLKDVM-ASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMP 427
Query: 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD 392
GSL+ LLH R G+ LDW R++I A+GLA+L+ L HG++K+SN+LL
Sbjct: 428 TGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVS---AKLVHGNIKASNILLH 484
Query: 393 NAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKF 452
+ ++DY L + + + Y +PE +T VT K+DV+S G+L+LELLTGK
Sbjct: 485 PNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKS 544
Query: 453 PANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWN 512
P N + G+ DL WV SVVREEWT EVFD ++ + E EM++LL+I M C
Sbjct: 545 P-NQASLGE-EGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTV 602
Query: 513 AERRWDLREAVEKIMELKERDNDNEDYSSYASEDYVYSSRAMT 555
++R ++E V +++E R +D +S+D S T
Sbjct: 603 PDQRPVMQE-VLRMIEDVNRSETTDDGLRQSSDDPSKGSEGQT 644
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (786), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 200/564 (35%), Positives = 296/564 (52%), Gaps = 49/564 (8%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS--VGKLTLRALYLSLNKFTGEIPSDA 58
+ L G I TL +L L+ LS +NS G +PS + +L LYL N F+GE+ +++
Sbjct: 83 VGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHNNFSGELTTNS 142
Query: 59 FAGMD-QLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLS 117
+ QL + L+ N SG IP L L ++ L L+ NSF G I L + +++LS
Sbjct: 143 LPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSLDLPSVKVVNLS 202
Query: 118 YNQLVGRIPDTLSNFDATSFQGNKGLCGKPLEACK-SSISKKTIL--------------- 161
YN L G IP+ L SF GN LCG PL AC +IS + L
Sbjct: 203 YNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNLPRPLTENLHPVRRRQ 262
Query: 162 ----IICTVAGATLAL--AAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDM 215
II V G ++A+ IV C ++TK + G M
Sbjct: 263 SKAYIIAIVVGCSVAVLFLGIVFLVCL---------------VKKTKKEEGGGEGVRTQM 307
Query: 216 GQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLL 275
G + + Q+ E +KL F F+L DLL+ASAEVLG GSFG++YKAVL
Sbjct: 308 GGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLE 367
Query: 276 TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNG 334
A+VVKR R++ K++F + M +G ++ H N +PL+A+YY K+EKLLV ++ G
Sbjct: 368 DTTAVVVKRLREVV-ASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKG 426
Query: 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA 394
SL ++H R G G+DW R+KI G +K ++YL+ + HG +KSSN+LL
Sbjct: 427 SLFGIMHGNR--GDRGVDWETRMKIATGTSKAISYLH----SLKFVHGDIKSSNILLTED 480
Query: 395 YEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPA 454
EP L+D +LV + N + Y +PE +T V++++DV+S G++ILE+LTGK P
Sbjct: 481 LEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPL 540
Query: 455 NYLA-QGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNA 513
+ + DL WV SVVREEWT EVFD ++ ++ E EM+++L++ + C N
Sbjct: 541 TQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNP 600
Query: 514 ERRWDLREAVEKIMELKERDNDNE 537
E R + E I +++ D +
Sbjct: 601 ESRPKMEEVARMIEDVRRLDQSQQ 624
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (771), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 206/564 (36%), Positives = 298/564 (52%), Gaps = 72/564 (12%)
Query: 19 RSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSG 77
R LS +N+ GP+P++ LT L+ L+LS N+F+G P+ + + +L ++ L+ N+FSG
Sbjct: 94 RVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPT-SITSLTRLYRLDLSFNNFSG 152
Query: 78 QIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFDATSF 137
QIP L L LL L LE N F G+IP+ L+ L ++S N G+IP++LS F + F
Sbjct: 153 QIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNSLSQFPESVF 212
Query: 138 QGNKGLCGKPLEAC--------------------------------------KSSISKK- 158
N LCG PL C KS+ + +
Sbjct: 213 TQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDKSNNTSRI 272
Query: 159 -TILIICTVAG--ATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDM 215
TI +I + G L+ +++ + C VN+ + +K L+
Sbjct: 273 STISLIAIILGDFIILSFVSLLLYYCFW-------RQYAVNKKKHSKILE---------- 315
Query: 216 GQNEIQSSDCYFVNSQND--------EISKLHFVNNDREMFELNDLLRASAEVLGSGSFG 267
G+ + SS+ Y ++QN+ + K+ F R FEL DLLRASAE+LG G FG
Sbjct: 316 GEKIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRR-FELEDLLRASAEMLGKGGFG 374
Query: 268 SSYKAVLLTGPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLL 326
++YKAVL G + VKR + V GK++F + M LG L H NL+ L A+Y+ +EEKLL
Sbjct: 375 TAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLL 434
Query: 327 VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKS 386
V D++PNGSL LLH R PG+ LDW RLKI G A+GLA+++ + L HG +KS
Sbjct: 435 VYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKS 494
Query: 387 SNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILE 446
+NVLLD + ++D+ L I Y++PE T+K+DV+S G+L+LE
Sbjct: 495 TNVLLDRSGNARVSDFGL-SIFAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLE 553
Query: 447 LLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGM 506
+LTGK P G DL WV SVVREEWT EVFD ++ K E EM+ LL+I M
Sbjct: 554 ILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAM 613
Query: 507 CCCEWNAERRWDLREAVEKIMELK 530
C A+ R + V+ I +++
Sbjct: 614 ACTAVAADHRPKMGHVVKLIEDIR 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (762), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 202/571 (35%), Positives = 305/571 (53%), Gaps = 46/571 (8%)
Query: 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFA 60
L G I L LR+LS N G +P +G + LR LYL N+F+GEIP F+
Sbjct: 82 LSGHIPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFS 141
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQ 120
+ L +++LA N FSG+I L +L L LE N G + D L+ ++S N
Sbjct: 142 -LSNLVRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQF-NVSNNL 199
Query: 121 LVGRIPDTLSNFDATSFQGNKGLCGKPLEAC----------------------------K 152
L G IP +L FD+ SF G LCGKPL C +
Sbjct: 200 LNGSIPKSLQKFDSDSFVGTS-LCGKPLVVCSNEGTVPSQPISVGNIPGTVEGSEEKKKR 258
Query: 153 SSISKKTI--LIICTVAGATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGAN 210
+S I ++I V G +L + ++ +GN + + + E + + A
Sbjct: 259 KKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATIKHHEVEIPGEKAAV 318
Query: 211 NYHDMGQ--NEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGS 268
+ NE S V + + KL F N ++F+L DLLRASAEVLG G+FG+
Sbjct: 319 EAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGT 378
Query: 269 SYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVS 328
+YKAVL + VKR + ++ +E F E + +G++ H NL+PL A+YY +EKLLV
Sbjct: 379 AYKAVLDAVTLVAVKRLKDVTMADRE-FKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVY 437
Query: 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSN 388
DF+P GSL+ LLH + G+P L+W +R I G A+GL YL+ + P + HG++KSSN
Sbjct: 438 DFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSS--HGNVKSSN 495
Query: 389 VLLDNAYEPLLTDYALVPIVNKEHAQLH-MVAYKSPEFNQTDGVTRKTDVWSLGILILEL 447
+LL N+++ ++D+ L +V+ + Y++PE V++K DV+S G+++LEL
Sbjct: 496 ILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLEL 555
Query: 448 LTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK---SGEGEMLKLLKI 504
LTGK P+N + +G DLA WV+SV REEW EVFD ++ + S E EM ++L++
Sbjct: 556 LTGKAPSNSVMNEEG--MDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQL 613
Query: 505 GMCCCEWNAERRWDLREAVEKIMELKERDND 535
G+ C E + ++R + E V +I EL++ D
Sbjct: 614 GIDCTEQHPDKRPVMVEVVRRIQELRQSGAD 644
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (759), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 203/589 (34%), Positives = 304/589 (51%), Gaps = 71/589 (12%)
Query: 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTL---RALYLSLNKFTGEIPSDAF 59
L G + T +L LR +S +N G +PSV L+L R+LY N F+G IP
Sbjct: 79 LYGPLPEKTFEKLDALRIISLRSNHLQGNIPSV-ILSLPFIRSLYFHENNFSGTIPP--- 134
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
+L + L+ N SG IP SL L +L L+L+ NS G IP+ P L L+LS+N
Sbjct: 135 VLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLP-PRLKYLNLSFN 193
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSIS----------------------- 156
L G +P ++ +F A+SFQGN LCG PL C + +
Sbjct: 194 NLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPTEGPGTTNIGRGTA 253
Query: 157 KKTI----LIICTVAGATL--ALAAIVAFSCTR---GNNSKTSEPIIVNETQETKALKKY 207
KK + ++ V G+ L + AI+ C + G T+ P KA
Sbjct: 254 KKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVP---------KAKPGR 304
Query: 208 GANNYHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFG 267
N + G Q E +KL F F+L DLLRASAEVLG GS+G
Sbjct: 305 SDNKAEEFGSG-----------VQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYG 353
Query: 268 SSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLL 326
++YKA+L G +VVKR ++++ GK +F + M +G +S H N+ PL A+Y+ K+EKLL
Sbjct: 354 TTYKAILEEGTTVVVKRLKEVA-AGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLL 412
Query: 327 VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKS 386
V D+ G+ + LLH G+ LDW RL+I A+G+++++ G L HG++KS
Sbjct: 413 VYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSA-SGAKLLHGNIKS 471
Query: 387 SNVLLDNAYEPLLTDYALVPIVNKEHAQL---HMVAYKSPEFNQTDGVTRKTDVWSLGIL 443
NVLL ++D+ + P+++ H L + Y++PE +T T+K+DV+S G+L
Sbjct: 472 PNVLLTQELHVCVSDFGIAPLMS--HHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVL 529
Query: 444 ILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM-RGTKSGEGEMLKLL 502
+LE+LTGK A G DL WV SVVREEWTGEVFD ++ + + E EM+++L
Sbjct: 530 LLEMLTGK--AAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQML 587
Query: 503 KIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDYSSYASEDYVYSS 551
+I M C + + R + E V + E++ + + +S + + SS
Sbjct: 588 QIAMACVSKHPDSRPSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSS 636
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 565 | ||||||
| 224115632 | 639 | predicted protein [Populus trichocarpa] | 0.973 | 0.860 | 0.670 | 0.0 | |
| 224121240 | 622 | predicted protein [Populus trichocarpa] | 0.973 | 0.884 | 0.638 | 0.0 | |
| 296081800 | 677 | unnamed protein product [Vitis vinifera] | 0.950 | 0.793 | 0.632 | 0.0 | |
| 255574167 | 629 | leucine-rich repeat transmembrane protei | 0.964 | 0.866 | 0.598 | 1e-180 | |
| 356554450 | 645 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.849 | 0.561 | 1e-170 | |
| 255581127 | 666 | leucine-rich repeat transmembrane protei | 0.975 | 0.827 | 0.565 | 1e-169 | |
| 357436695 | 658 | Receptor-like protein kinase [Medicago t | 0.969 | 0.832 | 0.557 | 1e-168 | |
| 359484945 | 633 | PREDICTED: probable LRR receptor-like se | 0.971 | 0.867 | 0.542 | 1e-167 | |
| 147866686 | 633 | hypothetical protein VITISV_017867 [Viti | 0.971 | 0.867 | 0.542 | 1e-167 | |
| 224118616 | 671 | predicted protein [Populus trichocarpa] | 0.985 | 0.830 | 0.554 | 1e-166 |
| >gi|224115632|ref|XP_002332104.1| predicted protein [Populus trichocarpa] gi|222874924|gb|EEF12055.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/567 (67%), Positives = 449/567 (79%), Gaps = 17/567 (2%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
M L G ID+D L +LP LR+LSF+NNSF+GPMP V KL+ LR LYLS N F+G+I DAF
Sbjct: 88 MGLKGTIDIDILMQLPTLRTLSFMNNSFEGPMPEVKKLSSLRNLYLSNNNFSGKIDKDAF 147
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
GM LK+V+LA N F+G+IP+SL +QKL +L+LEGN F G +PDFP +LT+ + + N
Sbjct: 148 DGMSSLKEVYLAHNEFTGEIPRSLVLVQKLTKLSLEGNQFDGNLPDFPQENLTVFNAAGN 207
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSISKKTILIICTVAGATLALAAIVAF 179
G+IP +L++F +SF GN+GLCGKPL ACKSS KKT++II V + +AL+AIV F
Sbjct: 208 NFKGQIPTSLADFSPSSFAGNQGLCGKPLPACKSS-RKKTVVIIVVVVVSVVALSAIVVF 266
Query: 180 SCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKLH 239
+C R +KT + ++TK KK+G + + E QSSD + D LH
Sbjct: 267 ACIRSRQNKTLK------FKDTK--KKFGDD------KKEAQSSDQFGDGKMGDSGQNLH 312
Query: 240 FVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEH 299
FV DR F+L DLLRASAEVLGSG+FGSSYKAVLL GPAMVVKRFR MSNVGKE FHEH
Sbjct: 313 FVRYDRNRFDLQDLLRASAEVLGSGTFGSSYKAVLLDGPAMVVKRFRHMSNVGKEGFHEH 372
Query: 300 MTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKI 359
M +LG+LSHPNLLPL+A+YYRKEEKLLVSDFV NGSLA+ LH +R+PG+P +DWP RL+I
Sbjct: 373 MRKLGTLSHPNLLPLVAYYYRKEEKLLVSDFVGNGSLASHLHGKRSPGKPWIDWPTRLRI 432
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA 419
IKGVAKGLAYLYKEFP + LPHGHLKSSNVLLD+ +EPLLTDYALVP+VNK+H+Q MVA
Sbjct: 433 IKGVAKGLAYLYKEFPTLALPHGHLKSSNVLLDDTFEPLLTDYALVPVVNKDHSQQVMVA 492
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479
YKSPE +Q+D RKTDVWSLGILILE+LTGKFP NYL QGKG +ADLATWVNSVVREEW
Sbjct: 493 YKSPECSQSDRPNRKTDVWSLGILILEILTGKFPENYLTQGKGGDADLATWVNSVVREEW 552
Query: 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDY 539
TGEVFD DM TK+ EGEMLKLLKIGMCCCEWN ERRWDL+ AV KI ELKERDNDN+D+
Sbjct: 553 TGEVFDMDMMRTKNCEGEMLKLLKIGMCCCEWNLERRWDLKVAVAKIEELKERDNDNDDF 612
Query: 540 S-SYASEDYVYSSRAMTDEDFSFSVAG 565
S SYASE VYSSRA+TD+DFSFSV G
Sbjct: 613 SNSYASEGEVYSSRAVTDDDFSFSVNG 639
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121240|ref|XP_002330778.1| predicted protein [Populus trichocarpa] gi|222872580|gb|EEF09711.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1812), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/567 (63%), Positives = 439/567 (77%), Gaps = 17/567 (2%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAF 59
M L G I++D L++L LR+LSF+NNS +G MP V KL L+ L+LS N F+G+I DAF
Sbjct: 71 MGLTGTINIDILTQLSKLRTLSFMNNSLEGSMPQVKKLGPLKNLFLSNNSFSGKIAEDAF 130
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
GM+ L++VHLA N F+G IP+SL QKL +L+LEGN GK+P FP +LT+ + + N
Sbjct: 131 DGMNSLREVHLAHNEFTGGIPRSLVSAQKLTKLSLEGNQLDGKLPGFPQENLTVFNAADN 190
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSISKKTILIICTVAGATLALAAIVAF 179
G+IP +L++F +SF GNKGLCGKPL ACKSS KK ++II A +AL+AIVAF
Sbjct: 191 NFEGQIPASLAHFSPSSFTGNKGLCGKPLPACKSS-KKKIMMIIVVTVVAVVALSAIVAF 249
Query: 180 SCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKLH 239
SC +KT + N +++ A+ + +G+ EIQSSD F +++ + +LH
Sbjct: 250 SCICCRTAKTPK---FNYSKKKIAM--------NGVGKKEIQSSD-QFGDAKTVDNGQLH 297
Query: 240 FVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEH 299
FV DR F+L DLL+ASAEVLGSG+ GSSYK VL GP+MVVKRFR MSNVG E+FHEH
Sbjct: 298 FVRYDRGRFDLQDLLKASAEVLGSGTLGSSYKTVLSDGPSMVVKRFRHMSNVGNEEFHEH 357
Query: 300 MTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKI 359
M +LG+LSHPNLLPL+A+YYRKEEKLLVSD + NGSLA+ LH +RAPG+P LDWP RLKI
Sbjct: 358 MRKLGTLSHPNLLPLVAYYYRKEEKLLVSDLIENGSLASRLHAKRAPGKPWLDWPTRLKI 417
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA 419
+KGVA+GL YLYKEFP + LPHGHLKSSNVLLD+ +EPLLTDYALVP+VN++HAQ MVA
Sbjct: 418 VKGVARGLVYLYKEFPTLALPHGHLKSSNVLLDDTFEPLLTDYALVPLVNRDHAQQVMVA 477
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479
YKSPEF +D TRKTDVWSLGILILE+LTGKFP NYL QG+G ADLATWVNSVVREEW
Sbjct: 478 YKSPEFTHSDRTTRKTDVWSLGILILEILTGKFPENYLMQGRGGGADLATWVNSVVREEW 537
Query: 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDY 539
TGEVFD D+ TK+ E EMLKLLK GMCCCEWN E RWDL+EAV KI +LKERDNDN+D+
Sbjct: 538 TGEVFDMDIMRTKNCEKEMLKLLKTGMCCCEWNMENRWDLKEAVAKIEDLKERDNDNDDF 597
Query: 540 S-SYASEDYVYSSRAMTDEDFSFSVAG 565
S SYASE VYSSRAMTD+DFSFSV G
Sbjct: 598 SNSYASE--VYSSRAMTDDDFSFSVNG 622
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081800|emb|CBI20805.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/566 (63%), Positives = 429/566 (75%), Gaps = 29/566 (5%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
M L G ID+++L L LR++S + NSF GPMP+ +L L++LYLS N+F+GE+P DAF
Sbjct: 59 MGLAGQIDIESLKELQMLRTISIMGNSFGGPMPAFKRLAALKSLYLSNNRFSGELPHDAF 118
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
A M+ LKKVHLA+N F+G+IPKSLA L +LL++ LE N+F+GKIP FP L ++++S N
Sbjct: 119 AHMNWLKKVHLAQNEFTGKIPKSLAKLPRLLEVLLENNNFEGKIPKFPQNELQMVNMSNN 178
Query: 120 QLVGRIPDTLSNFDATSFQGN--KGLCGKPLEACKSSISKKTILIICTVAGATLALAAIV 177
L GRIP +LS D +SF GN LC S++S I A + + +
Sbjct: 179 ALEGRIPASLSKMDRSSFIGNLWSSLC--------SALSYIYISSTQLFAAQDVVIGFDL 230
Query: 178 AFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISK 237
+FS + + K S II E +A K E+ S+ Y + E +
Sbjct: 231 SFSPCK-ESKKPSILIIALEAAVYEAEHK------------EVGSTGVY----KKGEQGQ 273
Query: 238 LHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFH 297
L+FV NDRE FEL DLLRASAEVLGSGSFGSSYKAVLL+GPAMVVKRF+QM+ +G DFH
Sbjct: 274 LYFVRNDRERFELQDLLRASAEVLGSGSFGSSYKAVLLSGPAMVVKRFKQMNRLGSGDFH 333
Query: 298 EHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL 357
EHM RLG LSHPNLL L+AFYY+KEEKLLVSDFVPNGSLA+ LH +RAPGQPGLDWPIRL
Sbjct: 334 EHMRRLGRLSHPNLLSLVAFYYKKEEKLLVSDFVPNGSLASHLHSKRAPGQPGLDWPIRL 393
Query: 358 KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM 417
KII+ VA LAYLYKE +TLPHGHLKSSNVLLD+ +EP+L+DYALVP +N+EHAQ M
Sbjct: 394 KIIQKVAHALAYLYKELSDLTLPHGHLKSSNVLLDDKFEPVLSDYALVPAINREHAQQIM 453
Query: 418 VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477
VAYKSPEF Q D TRKTDVWSLGILILE+LTGKFPANYL QGKGAN+DL +WVNSVVRE
Sbjct: 454 VAYKSPEFMQYDRTTRKTDVWSLGILILEMLTGKFPANYLKQGKGANSDLLSWVNSVVRE 513
Query: 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNE 537
EWTGEVFDKDM+GT++GEGEMLKLLKIGM CCEWN E+RWDL+EAV++I ELKERD+D E
Sbjct: 514 EWTGEVFDKDMKGTRNGEGEMLKLLKIGMSCCEWNMEKRWDLKEAVKRIEELKERDSD-E 572
Query: 538 DYSSYASEDYVYSSRAMTDEDFSFSV 563
D SSYASE +YSSRAMTD+DFSFSV
Sbjct: 573 DNSSYASEGDIYSSRAMTDDDFSFSV 598
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574167|ref|XP_002527999.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] gi|223532625|gb|EEF34411.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1648), Expect = e-180, Method: Compositional matrix adjust.
Identities = 339/566 (59%), Positives = 413/566 (72%), Gaps = 21/566 (3%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDA 58
M L G ID D+L+ LP LR+LSF NNSF GP P + KL +L+ LYLS N+F+G IP DA
Sbjct: 80 MGLSGKIDFDSLALLPQLRALSFKNNSFQGPFPDHLNKLRSLKTLYLSFNEFSGVIPDDA 139
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSY 118
F GM+ L ++HL N FSG IP SL L KL++L+LE N F G+IPDF H + ++S
Sbjct: 140 FYGMNSLAQLHLGHNVFSGPIPSSLVPLTKLVRLSLEDNQFDGQIPDFQ-RHFSFFNVSN 198
Query: 119 NQLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSISKKTILIICTVAGATLALAAIVA 178
N L G IP +L++ + F GN GLCGKPL +CKSS KT++II V + +ALAAI+A
Sbjct: 199 NHLTGHIPASLADISPSLFAGNDGLCGKPLPSCKSS-KNKTLIIIVVVVASVVALAAILA 257
Query: 179 FSCTRGNNSKTSEPIIVN-ETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISK 237
F+ R +KT + + + Q T+A ++ M E S + K
Sbjct: 258 FAYFRRGRTKTPQLSLKQLQVQGTEAHAQFAI-----MAPKE----------SPDGNKGK 302
Query: 238 LHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFH 297
L FV NDRE FEL LLRASAE+LGS FG SYKAV+ G AMVVKRFR+MS+ K +F+
Sbjct: 303 LEFVRNDRERFELQGLLRASAEILGSSDFGPSYKAVIADGSAMVVKRFREMSDAPKSEFY 362
Query: 298 EHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL 357
+H+TRLG+LSH NLLPL+AFYYR +EKLL+SD+V NGSLA LH + + G LDWP RL
Sbjct: 363 DHITRLGTLSHRNLLPLVAFYYRNDEKLLISDYVENGSLATHLHGKHSSGGKKLDWPTRL 422
Query: 358 KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM 417
KIIKGVA+GLAYL+KE P +TLPHGHLKSSNVL+D+ +EPLLTDYAL P+VNK HAQ HM
Sbjct: 423 KIIKGVARGLAYLHKELPSLTLPHGHLKSSNVLVDHTFEPLLTDYALAPLVNKGHAQQHM 482
Query: 418 VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477
AYKSPEF Q RKTDVWSLGILILE+LTGKFPANY QG + DLA WVNSVVRE
Sbjct: 483 AAYKSPEFTQYARTIRKTDVWSLGILILEMLTGKFPANYERQG-SSKGDLARWVNSVVRE 541
Query: 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNE 537
EWTGEVFD +M GTK+GEGEMLKLLKIGMCCCEW ERRWDLR+AV++I ELKER+ + +
Sbjct: 542 EWTGEVFDVEMSGTKNGEGEMLKLLKIGMCCCEWKVERRWDLRKAVDRIEELKERERECD 601
Query: 538 DYSSYASEDYVYSSRAMTDEDFSFSV 563
++SS ASE +YSSRAMTD+DFSFS+
Sbjct: 602 EFSSNASEADIYSSRAMTDDDFSFSI 627
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554450|ref|XP_003545559.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-170, Method: Compositional matrix adjust.
Identities = 328/584 (56%), Positives = 410/584 (70%), Gaps = 36/584 (6%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
M+L G IDVDTL LP L S S +NN+F+GPMP KL LRAL+LS NKF+G+IP DAF
Sbjct: 77 MSLGGKIDVDTLLELPTLTSFSVMNNTFEGPMPEFKKLVRLRALFLSNNKFSGDIPDDAF 136
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
GM +LK+V LA N F+G IPKSLA L +L L+L GNSF G IP+F + +LS+N
Sbjct: 137 EGMTKLKRVFLAENGFTGHIPKSLANLPRLWDLDLRGNSFGGSIPEFQQKDFRMFNLSHN 196
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEAC--------KSSI----------SKKTIL 161
QL G IP++LSN D +SF GNKGLCGKP+ C +S I +K IL
Sbjct: 197 QLEGSIPESLSNKDPSSFAGNKGLCGKPMSPCNEIGGNESRSEIPYPDSSQRKGNKYRIL 256
Query: 162 IICTVAGATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQ 221
I + + +A+IVA R + K +P+I+++ + +K + + D+ + +
Sbjct: 257 ITVIIVIVVVVVASIVALLFIRNHWRKRLQPLILSKQENSKNSVDFRESQSIDVTSDFKK 316
Query: 222 SSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMV 281
D L+FV D+ F+L DLLRASA VLGSGSFGS+YKA++L GP +V
Sbjct: 317 GGD-----------GALNFVREDKGGFDLQDLLRASAVVLGSGSFGSTYKAMILNGPTVV 365
Query: 282 VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLH 341
VKRFR M+N GK++F EHM RLGSL+HPNLLPL AFYYRKE+K LV D+ NGSLA+ LH
Sbjct: 366 VKRFRHMNNAGKQEFIEHMKRLGSLTHPNLLPLDAFYYRKEDKFLVYDYAENGSLASHLH 425
Query: 342 VRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTD 401
R L+W RLKI+KGVA+GLAYLY+ FPG LPHGHLKSSNV+LD+++EP LT+
Sbjct: 426 DRNGSV---LNWSTRLKIVKGVARGLAYLYESFPGQNLPHGHLKSSNVVLDHSFEPHLTE 482
Query: 402 YALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGK 461
Y LVP++ K HAQ M AYK+PE NQ K+DVW LGILILELLTGKFPANYL GK
Sbjct: 483 YGLVPVMTKSHAQRFMAAYKAPEVNQFGRPNVKSDVWCLGILILELLTGKFPANYLRHGK 542
Query: 462 GA-NADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLR 520
G N+DLATWV+SVVREEWTGEVFDKD+ GT++GEGEMLKLL+IGM CC+W+ E RWD R
Sbjct: 543 GGNNSDLATWVDSVVREEWTGEVFDKDIMGTRNGEGEMLKLLRIGMFCCKWSVESRWDWR 602
Query: 521 EAVEKIMELKERDNDNEDYSSYASEDYVYSSRAMTDEDFSFSVA 564
EA+ KI ELKE+D+D E+YSSY SE +Y SR MT+++FSFSV
Sbjct: 603 EALAKIEELKEKDSD-EEYSSYVSEGDLY-SRTMTEDEFSFSVT 644
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255581127|ref|XP_002531377.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] gi|223529007|gb|EEF30997.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1550), Expect = e-169, Method: Compositional matrix adjust.
Identities = 327/578 (56%), Positives = 403/578 (69%), Gaps = 27/578 (4%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAF 59
M L G ID L P LR++SF+NNSFDGP+P + KL LR++YLS N F+GEIP +AF
Sbjct: 100 MGLTGKIDFQILESFPELRTISFMNNSFDGPLPEIKKLGALRSIYLSNNHFSGEIPDNAF 159
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
G+ +LKKV LA N F G IP SLA L KLL L LEGN F GK+P+F L++S N
Sbjct: 160 EGLLKLKKVFLAHNGFEGAIPSSLANLPKLLDLRLEGNKFSGKLPNFK-EKFASLNVSNN 218
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEAC----KSSISKKTILI-------ICTVAG 168
+L G IP++LS FD TSF GNKGLCG PL C SSISKK L + VA
Sbjct: 219 ELGGPIPESLSKFDLTSFSGNKGLCGWPLSQCDGSNSSSISKKPPLASIVVVAIVVAVAI 278
Query: 169 ATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHD---MGQNEIQSSDC 225
A + AA + F+ R SKT E + KK G N+ G +E S D
Sbjct: 279 AAIVGAAFILFT-RRKRTSKTIETPPPPPPSNLQ--KKTGINDVEQGLQAGSSEQSSHD- 334
Query: 226 YFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRF 285
+ EI+KL FV +DRE F+L+DLL+ASAE+LGSG FGSSYKA L TGP MVVKRF
Sbjct: 335 -----KKTEITKLSFVRDDRERFDLHDLLKASAEILGSGCFGSSYKAALSTGPTMVVKRF 389
Query: 286 RQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRA 345
+QM+NVGKE+F EHM RLG L HPNLLPL+A+YYRKEEKLLV+D+V GSLA LH +A
Sbjct: 390 KQMNNVGKEEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVTDYVEKGSLAVHLHGHQA 449
Query: 346 PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405
GQP +DW IRLK+ KG+ KGL YL+KE P + HGHLKSSNVL+D EPLLTDY LV
Sbjct: 450 LGQPNMDWSIRLKVAKGIGKGLVYLHKELPSIIAAHGHLKSSNVLIDECNEPLLTDYGLV 509
Query: 406 PIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKG-AN 464
P++N+E+AQ MVAY+SPE+ Q +T+KTDVW+LGILILELLTGKFP N+L QGKG
Sbjct: 510 PVINQENAQELMVAYRSPEYLQLSRITKKTDVWNLGILILELLTGKFPTNFLPQGKGNEE 569
Query: 465 ADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
DLA+WVNS+ EEW +VFDK+++ +KS E EM KLLKIG+ CCE + E+R DLREAVE
Sbjct: 570 EDLASWVNSIPEEEWMSKVFDKEIKASKSNESEMKKLLKIGLSCCEGDVEKRLDLREAVE 629
Query: 525 KIMELKERDNDNEDYSSYASEDYVYSSRAMTDEDFSFS 562
+I ++KE+D+D++ +SS ASE SSR ++D DF FS
Sbjct: 630 RINQVKEKDSDDDLFSSCASEVDTKSSRGISD-DFVFS 666
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357436695|ref|XP_003588623.1| Receptor-like protein kinase [Medicago truncatula] gi|355477671|gb|AES58874.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1538), Expect = e-168, Method: Compositional matrix adjust.
Identities = 328/588 (55%), Positives = 396/588 (67%), Gaps = 40/588 (6%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
M L G IDVDTL L L S S NN+F+GPMP KL LR L+LS NKF+GEI D+F
Sbjct: 75 MGLGGKIDVDTLVELTDLVSFSVNNNTFEGPMPEFKKLVKLRGLFLSNNKFSGEISDDSF 134
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
GM LK+V LA N F+G IP SLA L +LL L+L GNSF G IP+F + DLS N
Sbjct: 135 EGMGNLKRVFLAGNGFNGHIPLSLAKLPRLLDLDLHGNSFGGNIPEFQQNGFRVFDLSNN 194
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSISKKTILIICTVAGA---------- 169
QL G IP++LSN +TSF NKGLCGKPL + K+I+ +V
Sbjct: 195 QLEGPIPNSLSNEPSTSFSANKGLCGKPLNNPCNIPPTKSIVQTNSVFSTQGNGKKNKKI 254
Query: 170 ---------TLALAAIVAFSCTRGNNSKTSE---PII-VNETQETKALKKYGANNYHDMG 216
+ LA+I+A + + SE PII + E+ D+
Sbjct: 255 LIVVIVVVSMVVLASILALLFIQSRQRRRSEQDQPIIGLQLNSESNPSPSVKVTKSIDLA 314
Query: 217 QNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLT 276
+ F +N E L+FV D+ FEL DLLRASAEVLGSGSFGS+YKA++L
Sbjct: 315 GD--------FSKGENGE---LNFVREDKGGFELQDLLRASAEVLGSGSFGSTYKAIVLN 363
Query: 277 GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336
GP +VVKRFR M+NVGK++F EHM +LGSL+HPNLLPLIAFYY+KEEK LV DF NGSL
Sbjct: 364 GPTVVVKRFRHMNNVGKQEFFEHMKKLGSLTHPNLLPLIAFYYKKEEKFLVYDFGENGSL 423
Query: 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE 396
A+ LH R + L W RLKIIKGVA+GLA+LYKEFP LPHGHLKSSNV+L+ ++E
Sbjct: 424 ASHLHGRNSIV---LTWSTRLKIIKGVARGLAHLYKEFPKQNLPHGHLKSSNVMLNISFE 480
Query: 397 PLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANY 456
PLLT+Y LVPI NK HAQ M +YKSPE D KTD+W LGILILELLTGKFPANY
Sbjct: 481 PLLTEYGLVPITNKNHAQQFMASYKSPEVTHFDRPNEKTDIWCLGILILELLTGKFPANY 540
Query: 457 LAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR 516
L GKG N+DLATWVNSVVREEWTGEVFDK++ GT++GEGEMLKLL+IGM CCEW+ ERR
Sbjct: 541 LRHGKGENSDLATWVNSVVREEWTGEVFDKNIMGTRNGEGEMLKLLRIGMYCCEWSVERR 600
Query: 517 WDLREAVEKIMELKERDNDNEDYSSYASEDYVYSSRAMTDEDFSFSVA 564
WD +EA++KI ELKE D ++E + SY SE +Y SR T+++FSFSV
Sbjct: 601 WDWKEALDKIEELKENDGEDESF-SYVSEGDLY-SRGATEDEFSFSVT 646
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484945|ref|XP_002266187.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Vitis vinifera] gi|297736026|emb|CBI24064.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1535), Expect = e-167, Method: Compositional matrix adjust.
Identities = 306/564 (54%), Positives = 403/564 (71%), Gaps = 15/564 (2%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
M LMG ID+DTL++LP LR +SF+NN FDG +P + KL+ L++++LS N+F+GEI DAF
Sbjct: 83 MGLMGTIDMDTLAKLPHLRGISFMNNHFDGAIPKIKKLSALKSVFLSNNQFSGEIEDDAF 142
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
+GM LKKVHLA N FSG +P+SLA L ++L+L LEGN F+G+IP+F L ++S N
Sbjct: 143 SGMVSLKKVHLAHNKFSGGVPESLALLPRILELRLEGNHFKGQIPEFRATQLQSFNISNN 202
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSISKKTILIICTVAGATLALAAI-VA 178
L G IP++L + TSF GNK LCG PL +C T++++ LAL+AI VA
Sbjct: 203 NLEGPIPESLRKMELTSFSGNKNLCGAPLGSCPRPKKPTTLMMVVVGIVVALALSAIIVA 262
Query: 179 FSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKL 238
F R + +T+ ++ ET +K ++ + ++Q S+ + + E KL
Sbjct: 263 FILLRCSKCQTT--LVQVETPPSKV-------TCRELDKVKLQESNTE--SGKKVEQGKL 311
Query: 239 HFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHE 298
+++ ND +L DLL+ASAE+LGSG FGSSYKAVL+ G ++VVKRFR M+NVGKE+F E
Sbjct: 312 YYLRNDENKCDLKDLLKASAEILGSGYFGSSYKAVLVNGSSVVVKRFRHMNNVGKEEFQE 371
Query: 299 HMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
HM RLG L+HPNLLP +A+YYR+EEKLLV+DF+ NGSLA LH A QP LDW RLK
Sbjct: 372 HMRRLGRLNHPNLLPFVAYYYREEEKLLVTDFIDNGSLAIHLHGNHARDQPRLDWATRLK 431
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV 418
IIKG+AKGLAYLY E P + PH HLKSSNVLL ++ PLLTDY LVP++N+E AQ MV
Sbjct: 432 IIKGIAKGLAYLYTELPTLIAPHSHLKSSNVLLSKSFTPLLTDYGLVPLINQEIAQALMV 491
Query: 419 AYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478
AYKSPE+ Q +T+KTDVWS G LILE+LTGKFP L QG+ ++ DLA+WVNSV +EE
Sbjct: 492 AYKSPEYKQHGRITKKTDVWSFGTLILEILTGKFPTQNLQQGQASDTDLASWVNSVSQEE 551
Query: 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNED 538
W EVFDK+M GT + + EM+KLLKIG+ CCE + +RWD++EAVEKI ELKE+D++++
Sbjct: 552 WEDEVFDKEMGGTTNSKWEMVKLLKIGLACCEGDVGKRWDMKEAVEKIEELKEKDSEDDF 611
Query: 539 YSSYASEDYVYSSRAMTDEDFSFS 562
YSSYASE SR ++DE SFS
Sbjct: 612 YSSYASE-MESPSRQLSDEP-SFS 633
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147866686|emb|CAN83670.1| hypothetical protein VITISV_017867 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 594 bits (1531), Expect = e-167, Method: Compositional matrix adjust.
Identities = 306/564 (54%), Positives = 402/564 (71%), Gaps = 15/564 (2%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
M LMG ID+DTL++LP LR +SF+NN FDG +P + KL+ L++++LS N+F+GEI DAF
Sbjct: 83 MGLMGTIDMDTLAKLPHLRGISFMNNHFDGAIPKIKKLSALKSVFLSNNQFSGEIEDDAF 142
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
+GM LKKVHLA N FSG +P+SLA L ++L+L LEGN F+G+IP+F L ++S N
Sbjct: 143 SGMVSLKKVHLAHNKFSGGVPESLALLPRILELRLEGNHFKGQIPEFRATQLQSFNISNN 202
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSISKKTILIICTVAGATLALAAI-VA 178
L G IP++L + TSF GNK LCG PL +C T++++ LAL+AI VA
Sbjct: 203 NLEGPIPESLRKMELTSFSGNKNLCGAPLGSCPRPKKPTTLMMVVVGIVVALALSAIIVA 262
Query: 179 FSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKL 238
F R + +T+ ++ ET +K ++ + ++Q S+ + + E KL
Sbjct: 263 FILLRCSKCQTT--LVQVETPPSKV-------TCRELDKVKLQESNTE--SGKKVEQGKL 311
Query: 239 HFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHE 298
+++ ND +L DLL+ASAE+LGSG FGSSYKAVL+ G ++VVKRFR M+NVGKE+F E
Sbjct: 312 YYLRNDENKCDLKDLLKASAEILGSGYFGSSYKAVLVNGSSVVVKRFRHMNNVGKEEFQE 371
Query: 299 HMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
HM RLG L+HPNLLP +A+YYR+EEKLLV+DF+ NGSLA LH A QP LDW RLK
Sbjct: 372 HMRRLGRLNHPNLLPFVAYYYREEEKLLVTDFIDNGSLAIHLHGNHARDQPRLDWATRLK 431
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV 418
IIKG+AKGLAYLY E P + PH HLKSSNVLL ++ PLLTDY LVP++N+E AQ MV
Sbjct: 432 IIKGIAKGLAYLYTELPTLIAPHSHLKSSNVLLSXSFTPLLTDYGLVPLINQEIAQALMV 491
Query: 419 AYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478
AYKSPE+ Q +T+KTDVWS G LILE+LTGKFP L QG+ ++ DLA+WVNSV +EE
Sbjct: 492 AYKSPEYKQHGRITKKTDVWSFGTLILEILTGKFPTQNLQQGQASDTDLASWVNSVSQEE 551
Query: 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNED 538
W EVFDK+M GT + + EM+KLLKIG+ CCE + +RWD++EAVEKI ELKE D++++
Sbjct: 552 WEDEVFDKEMGGTTNSKWEMVKLLKIGLACCEGDVGKRWDMKEAVEKIEELKEXDSEDDF 611
Query: 539 YSSYASEDYVYSSRAMTDEDFSFS 562
YSSYASE SR ++DE SFS
Sbjct: 612 YSSYASE-MESPSRQLSDEP-SFS 633
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118616|ref|XP_002331406.1| predicted protein [Populus trichocarpa] gi|222873620|gb|EEF10751.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 321/579 (55%), Positives = 398/579 (68%), Gaps = 22/579 (3%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAF 59
M L G IDV+ L LP L++ S +NN+FDGPMP K+ TLR++YLS N F+G IP DAF
Sbjct: 98 MGLAGKIDVEILKSLPDLKTFSIMNNNFDGPMPEFKKMVTLRSIYLSNNHFSGVIPPDAF 157
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
G+ +LKKV+LA+N F+G IP SL L KLL L LEGN F GK+PDF +L +S N
Sbjct: 158 DGILKLKKVYLAQNEFTGAIPSSLVALPKLLVLRLEGNQFTGKLPDF-THNLQSFSVSNN 216
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKS-------SISKKT--ILIICTVAGAT 170
L G IP LS D +SF GNKGLCG PL C + S SKKT +LI+ A
Sbjct: 217 ALEGPIPTGLSKMDLSSFSGNKGLCGPPLNECNTTDNDGHDSDSKKTPVLLIVILAAAVG 276
Query: 171 LALAAIVA-FSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVN 229
L + AIVA F R + S I LKK + + Q+ S D + V
Sbjct: 277 LLIGAIVAAFLFLRRRQRQASGSIEAPPPPIPSNLKK--KTGFKEENQSPSSSPD-HSVG 333
Query: 230 SQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS 289
S+ E KL FV +DRE F+L DLL+ASAE+LGSG FGSSYKA L +G MVVKRF+QM+
Sbjct: 334 SRKGEGPKLSFVRDDREKFDLPDLLKASAEILGSGCFGSSYKAALSSGTMMVVKRFKQMN 393
Query: 290 NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQP 349
NVGKE+F EHM RLG L H NLLPL+A+YYRKEEKLL++DFV GSLA LH +A GQP
Sbjct: 394 NVGKEEFQEHMRRLGRLKHSNLLPLVAYYYRKEEKLLITDFVEKGSLAAHLHGHQALGQP 453
Query: 350 GLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409
L WP RLKI+KGVA+GLAYLYK+ P + HGHLKSSNVLL + EP+LTDY LVP++N
Sbjct: 454 SLGWPSRLKIVKGVARGLAYLYKDLPNIIAAHGHLKSSNVLLTQSNEPMLTDYGLVPVIN 513
Query: 410 KEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA-NADLA 468
+E+AQ MVAYKSPE+ +T+KTDVWSLGILI+E+LTGK PAN++ QGKG+ DLA
Sbjct: 514 QENAQELMVAYKSPEYLHHGRITKKTDVWSLGILIVEILTGKLPANFVPQGKGSEQQDLA 573
Query: 469 TWVNSVVREEWTGEVFDKDMRGTKS-----GEGEMLKLLKIGMCCCEWNAERRWDLREAV 523
+WVNSV EEW V DKDM + GE E++KLLKIG+ CCE + E+R DL+EAV
Sbjct: 574 SWVNSVPYEEWINVVLDKDMTNVSTKPNGGGESEVMKLLKIGLSCCEADVEKRLDLKEAV 633
Query: 524 EKIMELKERDNDNEDYSSYASEDYVYSSRAMTDEDFSFS 562
E+I E+KE+D+D++ +SSYASE + SSR +DE F+FS
Sbjct: 634 ERIEEIKEKDSDDDFFSSYASEGDMKSSRGKSDE-FTFS 671
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 565 | ||||||
| TAIR|locus:2128156 | 676 | AT4G31250 [Arabidopsis thalian | 0.569 | 0.476 | 0.665 | 9.8e-146 | |
| TAIR|locus:2087595 | 679 | PRK4 "pollen receptor like kin | 0.575 | 0.478 | 0.588 | 7.2e-139 | |
| TAIR|locus:2008061 | 686 | PRK5 "pollen receptor like kin | 0.584 | 0.481 | 0.563 | 2.5e-136 | |
| TAIR|locus:2063621 | 647 | PRK2A "AT2G07040" [Arabidopsis | 0.987 | 0.862 | 0.455 | 1.3e-125 | |
| TAIR|locus:2180409 | 659 | PRK6 "pollen receptor like kin | 0.511 | 0.438 | 0.479 | 2.4e-91 | |
| TAIR|locus:2078546 | 633 | PRK3 "AT3G42880" [Arabidopsis | 0.504 | 0.450 | 0.454 | 7.1e-90 | |
| TAIR|locus:2193942 | 644 | AT1G72460 [Arabidopsis thalian | 0.527 | 0.462 | 0.385 | 1.3e-84 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.573 | 0.483 | 0.423 | 1.7e-82 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.557 | 0.478 | 0.422 | 1.5e-81 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.553 | 0.483 | 0.409 | 5.2e-79 |
| TAIR|locus:2128156 AT4G31250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1124 (400.7 bits), Expect = 9.8e-146, Sum P(2) = 9.8e-146
Identities = 219/329 (66%), Positives = 266/329 (80%)
Query: 237 KLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDF 296
KLHFV ND+E F L D+LRASAEVLGSG FGSSYKA L +G A+VVKRFR MSN+G+E+F
Sbjct: 348 KLHFVRNDQERFTLQDMLRASAEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIGREEF 407
Query: 297 HEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR 356
++HM ++G LSHPNLLPLIAFYYRKEEKLLV++++ NGSLANLLH R PGQ LDWPIR
Sbjct: 408 YDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTPGQVVLDWPIR 467
Query: 357 LKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH 416
LKI++GV +GLAYLY+ FP + LPHGHLKSSNVLLD +EPLLTDYALVP+VN++ +Q
Sbjct: 468 LKIVRGVTRGLAYLYRVFPDLNLPHGHLKSSNVLLDPNFEPLLTDYALVPVVNRDQSQQF 527
Query: 417 MVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476
MVAYK+PEF Q D +R++DVWSLGILILE+LTGKFPANYL QGKGA+ +LA WV SV R
Sbjct: 528 MVAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQGKGADDELAAWVESVAR 587
Query: 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD--N 534
EWT +VFDK+M+ K E +MLKLLKIG+ CC+W+ E+R +L EAV++I E+ +RD
Sbjct: 588 TEWTADVFDKEMKAGKEHEAQMLKLLKIGLRCCDWDIEKRIELHEAVDRIEEV-DRDAGG 646
Query: 535 DNEDY-SSY--ASEDYVYSSRAMTDEDFS 560
E SSY AS+ SSRAMT+E FS
Sbjct: 647 GQESVRSSYVTASDGDHRSSRAMTEE-FS 674
|
|
| TAIR|locus:2087595 PRK4 "pollen receptor like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 7.2e-139, Sum P(2) = 7.2e-139
Identities = 193/328 (58%), Positives = 259/328 (78%)
Query: 236 SKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKED 295
+KL F+ +D + F+L DLLRASAEVLGSGSFGSSYK + +G +VVKR++ M+NVG+++
Sbjct: 353 NKLLFLQDDIQRFDLQDLLRASAEVLGSGSFGSSYKTGINSGQMLVVKRYKHMNNVGRDE 412
Query: 296 FHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPI 355
FHEHM RLG L HPNLLP++A+YYR+EEKLL+++F+PN SLA+ LH + QPGLDWP
Sbjct: 413 FHEHMRRLGRLKHPNLLPIVAYYYRREEKLLIAEFMPNRSLASHLHANHSVDQPGLDWPT 472
Query: 356 RLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL 415
RLKII+GVAKGL YL+ E +T+PHGHLKSSNV+LD ++EPLLTDYAL P++N E +
Sbjct: 473 RLKIIQGVAKGLGYLFNELTTLTIPHGHLKSSNVVLDESFEPLLTDYALRPVMNSEQSHN 532
Query: 416 HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV 475
M++YKSPE++ +T+KTDVW LG+LILELLTG+FP NYL+QG AN L TWV+++V
Sbjct: 533 LMISYKSPEYSLKGHLTKKTDVWCLGVLILELLTGRFPENYLSQGYDANMSLVTWVSNMV 592
Query: 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535
+E+ TG+VFDK+M G K+ + EML LLKIG+ CCE + ERR ++R+AVEKI LKE + D
Sbjct: 593 KEKKTGDVFDKEMTGKKNCKAEMLNLLKIGLSCCEEDEERRMEMRDAVEKIERLKEGEFD 652
Query: 536 NEDYSSYASEDYVYSSRAMTDEDFSFSV 563
N D++S V++SR + D+DF F++
Sbjct: 653 N-DFASTTHN--VFASRLIDDDDFGFAM 677
|
|
| TAIR|locus:2008061 PRK5 "pollen receptor like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 2.5e-136, Sum P(2) = 2.5e-136
Identities = 191/339 (56%), Positives = 259/339 (76%)
Query: 230 SQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS 289
S D +L FV +D + F+L DLLRASAEVLGSG+FG+SYKA + +G +VVKR++ M+
Sbjct: 350 SMPDPGGRLLFVRDDIQRFDLQDLLRASAEVLGSGTFGASYKAAISSGQTLVVKRYKHMN 409
Query: 290 NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQP 349
NVG+++FHEHM RLG L+HPN+LPL+A+YYR+EEKLLV++F+PN SLA+ LH A
Sbjct: 410 NVGRDEFHEHMRRLGRLNHPNILPLVAYYYRREEKLLVTEFMPNSSLASHLH---ANNSA 466
Query: 350 GLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409
GLDW RLKIIKGVAKGL+YL+ E P +T+PHGH+KSSN++LD+++EPLLTDYAL P+++
Sbjct: 467 GLDWITRLKIIKGVAKGLSYLFDELPTLTIPHGHMKSSNIVLDDSFEPLLTDYALRPMMS 526
Query: 410 KEHAQLHMVAYKSPEFNQTDG--VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADL 467
EHA M AYKSPE+ + G +T+KTDVW G+LILE+LTG+FP NYL QG +N L
Sbjct: 527 SEHAHNFMTAYKSPEYRPSKGQIITKKTDVWCFGVLILEVLTGRFPENYLTQGYDSNMSL 586
Query: 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527
TWVN +V+E+ TG+VFDK+M+G K+ + EM+ LLKIG+ CCE ERR D+RE VE +
Sbjct: 587 VTWVNDMVKEKKTGDVFDKEMKGKKNCKAEMINLLKIGLRCCEEEEERRMDMREVVEMVE 646
Query: 528 ELKERDNDNEDYSSY---ASEDYVYSSRAMTDEDFSFSV 563
L+E +++ +D+ S + + VYSS + D+DF FS+
Sbjct: 647 MLREGESE-DDFGSMDHRGTHNNVYSSMLLDDDDFGFSM 684
|
|
| TAIR|locus:2063621 PRK2A "AT2G07040" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1234 (439.4 bits), Expect = 1.3e-125, P = 1.3e-125
Identities = 264/579 (45%), Positives = 352/579 (60%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ L G ID++ L L LRSLSFINN F GP P KL L++LYLS N+F EIP DAF
Sbjct: 73 LELSGSIDIEALMGLNSLRSLSFINNKFKGPFPEFKKLVALKSLYLSNNQFDLEIPKDAF 132
Query: 60 AGMDQLKKVHLARNHFSGQIPKSXXXXXXXXXXXXXXXSFQGKIPDFPLAHLTLLDLSYN 119
GM LKK+HL +N+F G+IP S F G+IP+F H +L+LS N
Sbjct: 133 DGMGWLKKLHLEQNNFIGEIPTSLVKSPKLIELRLDGNRFTGQIPEFR-HHPNMLNLSNN 191
Query: 120 QLVGRIPDTLSNFDATSFQGNKGLCGKPLEA-CXX----XXXXXXXXXXCXXXXXXXXXX 174
L G+IP++ S D F+GNKGLCGKPL+ C
Sbjct: 192 ALAGQIPNSFSTMDPKLFEGNKGLCGKPLDTKCSSPYNHSSEPKSSTKKTSSKFLYIVAA 251
Query: 175 XXXXFSCTR---G------NNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDC 225
+ + G K +P++ E + + G + GQ S +
Sbjct: 252 AVAALAASLIIIGVVIFLIRRRKKKQPLLSAEPGPSSLQMRAGIQE-SERGQGSYHSQNR 310
Query: 226 YFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRF 285
+ +KL F+ +D+ FEL DLL+ASAE+LGSG FG+SYK +L G MVVKRF
Sbjct: 311 --AAKKMIHTTKLSFLRDDKGKFELQDLLKASAEILGSGCFGASYKTLLSNGSVMVVKRF 368
Query: 286 RQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRA 345
+ M++ G ++F EHM RLG L+H NLLP++A+YY+KEEKL VSDFV NGSLA LH ++
Sbjct: 369 KHMNSAGIDEFQEHMKRLGRLNHENLLPIVAYYYKKEEKLFVSDFVANGSLAAHLHGHKS 428
Query: 346 PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405
GQP LDWP R I+KGV +GL YL+K P + PHGHLKSSNVLL +EPLL DY L+
Sbjct: 429 LGQPSLDWPTRFNIVKGVGRGLLYLHKNLPSLMAPHGHLKSSNVLLSEKFEPLLMDYGLI 488
Query: 406 PIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANA 465
P++N+E AQ MVAYKSPE+ + VT+KTDVW LG+LILE+LTGK ++ K +
Sbjct: 489 PMINEESAQELMVAYKSPEYVKQSRVTKKTDVWGLGVLILEILTGKLLESFSQVDKESEE 548
Query: 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525
DLA+WV S + EWT E+FD++M T + E +L L++IG+ CCE + E+R D+REAVEK
Sbjct: 549 DLASWVRSSFKGEWTQELFDQEMGKTSNCEAHILNLMRIGLSCCEVDVEKRLDIREAVEK 608
Query: 526 IMEL-KERDNDNED-YSSYASEDYVYSSRAMTDEDFSFS 562
+ +L KER+ ++D YS+YASE SSR ++ E + S
Sbjct: 609 MEDLMKEREQGDDDFYSTYASEADGRSSRGLSSEGINLS 647
|
|
| TAIR|locus:2180409 PRK6 "pollen receptor like kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 2.4e-91, Sum P(2) = 2.4e-91
Identities = 139/290 (47%), Positives = 197/290 (67%)
Query: 241 VNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHM 300
VN D+ F L DL++A+AEVLG+GS GS+YKAV+ TG ++VVKR R M+ + +E F M
Sbjct: 370 VNTDKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMTTGLSVVVKRIRDMNQLAREPFDVEM 429
Query: 301 TRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKII 360
R G L HPN+L +A++YR+EEKL+VS+++P SL +LH R L W RLKII
Sbjct: 430 RRFGKLRHPNILTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGIYHSELTWATRLKII 489
Query: 361 KGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAY 420
+GVA G+ +L++EF LPHG+LKSSNVLL YEPL++DYA +P++ +A + A+
Sbjct: 490 QGVAHGMKFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPSNASQALFAF 549
Query: 421 KSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480
K+PEF QT V+ K+DV+ LGI+ILE+LTGKFP+ YL GKG D+ WV S V E+
Sbjct: 550 KTPEFAQTQQVSHKSDVYCLGIIILEILTGKFPSQYLNNGKGGT-DIVQWVQSSVAEQKE 608
Query: 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530
E+ D ++ +M++LL++G C N + R D+REAV +I ++K
Sbjct: 609 EELIDPEIVNNTESMRQMVELLRVGAACIASNPDERLDMREAVRRIEQVK 658
|
|
| TAIR|locus:2078546 PRK3 "AT3G42880" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 673 (242.0 bits), Expect = 7.1e-90, Sum P(2) = 7.1e-90
Identities = 130/286 (45%), Positives = 191/286 (66%)
Query: 241 VNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHM 300
VN+++ F L DL++A+AEVLG+GS GS+YKAV+ G ++VVKR R M+ + +E F M
Sbjct: 344 VNSEKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMANGLSVVVKRIRDMNKLAREAFDTEM 403
Query: 301 TRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKII 360
R G L HPN+L +A++YR+EEKL+VS+++P SL +LH R L W RLKII
Sbjct: 404 QRFGKLRHPNVLTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGVYHSELTWATRLKII 463
Query: 361 KGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAY 420
+GVA+G+ +L++EF LPHG+LKSSNVLL YEPL++DYA +P++ +A + A+
Sbjct: 464 QGVARGMDFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPNNASQALFAF 523
Query: 421 KSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480
KSPEF Q V+ K+DV+ LGI++LE++TGKFP+ YL GKG D+ WV S + +
Sbjct: 524 KSPEFVQNQQVSPKSDVYCLGIIVLEVMTGKFPSQYLNTGKGGT-DIVEWVQSSIAQHKE 582
Query: 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526
E+ D ++ +M++LL+IG C N R +++E V +I
Sbjct: 583 EELIDPEIASNTDSIKQMVELLRIGAACIASNPNERQNMKEIVRRI 628
|
|
| TAIR|locus:2193942 AT1G72460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 544 (196.6 bits), Expect = 1.3e-84, Sum P(2) = 1.3e-84
Identities = 123/319 (38%), Positives = 195/319 (61%)
Query: 236 SKLHFVNNDREMFELNDLLRASAEVLG-----------SGSFGSSYKAVLLTGPAMVVKR 284
S L VN ++ +F L+DL++A+A VLG SG GS+YKAVL G +VVKR
Sbjct: 327 SDLVMVNKEKGVFRLSDLMKAAAHVLGNPGGGSNRPRSSGGVGSAYKAVLSNGVTVVVKR 386
Query: 285 FRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRR 344
M+ V + F + + +LGSL H N+L +A+++R++EKLLV +FVPN +L + LH
Sbjct: 387 VTVMNQVSVDVFDKEIRKLGSLQHKNVLTPLAYHFRQDEKLLVFEFVPNLNLLHRLHGDH 446
Query: 345 APGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404
Q LDWP RLKII+G+A+G+ YL++E + LPHG+LKSSN+ L EPL++++ L
Sbjct: 447 EEFQ--LDWPSRLKIIQGIARGMWYLHRELGFLNLPHGNLKSSNIFLAEDGEPLISEFGL 504
Query: 405 VPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGAN 464
++N + +VA+KSPE ++ V+ K+DV+S G+++LE+LTGKFP+ Y +
Sbjct: 505 QKLINPDAQSQSLVAFKSPEADRDGTVSAKSDVFSFGVVVLEILTGKFPSQYAGLNRAGG 564
Query: 465 ADLATWVNSVVREE-WTGEVFDKDMRGT---KSGEGEMLKLLKIGMCCCEWNAERRWDLR 520
A+L W+ S + + W + + K E E+ +L+IG+ C + ++R ++
Sbjct: 565 ANLVEWLGSALEQGGWMDLLHPMVVTAAAEDKIMEEEIENVLRIGVRCTREDPDQRPNMT 624
Query: 521 EAVEKIMELKERDNDNEDY 539
E V+ EL D+ N+D+
Sbjct: 625 EVVD---ELTIEDS-NDDF 639
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 1.7e-82, Sum P(2) = 1.7e-82
Identities = 146/345 (42%), Positives = 200/345 (57%)
Query: 195 VNETQETKALKK----YGANNYHDMGQNEIQSSDCYFVNSQNDEIS---KLHFVNNDREM 247
VN+ + +K L+ Y +N Y QN N+QN ++ K+ F R
Sbjct: 305 VNKKKHSKILEGEKIVYSSNPYPTSTQNN---------NNQNQQVGDKGKMVFFEGTRR- 354
Query: 248 FELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV-GKEDFHEHMTRLGSL 306
FEL DLLRASAE+LG G FG++YKAVL G + VKR + V GK++F + M LG L
Sbjct: 355 FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRL 414
Query: 307 SHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKG 366
H NL+ L A+Y+ +EEKLLV D++PNGSL LLH R PG+ LDW RLKI G A+G
Sbjct: 415 RHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARG 474
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFN 426
LA+++ + L HG +KS+NVLLD + ++D+ L I Y++PE
Sbjct: 475 LAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGL-SIFAPSQTVAKSNGYRAPELI 533
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFPANYLAQG-KGANADLATWVNSVVREEWTGEVFD 485
T+K+DV+S G+L+LE+LTGK P N + G G DL WV SVVREEWT EVFD
Sbjct: 534 DGRKHTQKSDVYSFGVLLLEILTGKCP-NMVETGHSGGAVDLPRWVQSVVREEWTAEVFD 592
Query: 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530
++ K E EM+ LL+I M C A+ R + V+ I +++
Sbjct: 593 LELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIR 637
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 597 (215.2 bits), Expect = 1.5e-81, Sum P(2) = 1.5e-81
Identities = 136/322 (42%), Positives = 192/322 (59%)
Query: 234 EISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGK 293
E +KL F F+L DLLRASAEVLG GS G+SYKAVL G +VVKR + + K
Sbjct: 330 ERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVM-ASK 388
Query: 294 EDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDW 353
++F M +G + HPN++PL A+YY K+EKLLV DF+P GSL+ LLH R G+ LDW
Sbjct: 389 KEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDW 448
Query: 354 PIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413
R++I A+GLA+L+ L HG++K+SN+LL + ++DY L + +
Sbjct: 449 DNRMRIAITAARGLAHLHVS---AKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSP 505
Query: 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNS 473
+ Y +PE +T VT K+DV+S G+L+LELLTGK P N + G+ DL WV S
Sbjct: 506 PNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSP-NQASLGE-EGIDLPRWVLS 563
Query: 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533
VVREEWT EVFD ++ + E EM++LL+I M C ++R ++E + I ++ R
Sbjct: 564 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVN-RS 622
Query: 534 NDNEDYSSYASEDYVYSSRAMT 555
+D +S+D S T
Sbjct: 623 ETTDDGLRQSSDDPSKGSEGQT 644
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 5.2e-79, Sum P(2) = 5.2e-79
Identities = 132/322 (40%), Positives = 200/322 (62%)
Query: 218 NEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTG 277
NE S V + + KL F N ++F+L DLLRASAEVLG G+FG++YKAVL
Sbjct: 328 NEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAV 387
Query: 278 PAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337
+ VKR + ++ +E F E + +G++ H NL+PL A+YY +EKLLV DF+P GSL+
Sbjct: 388 TLVAVKRLKDVTMADRE-FKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLS 446
Query: 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEP 397
LLH + G+P L+W +R I G A+GL YL+ + P HG++KSSN+LL N+++
Sbjct: 447 ALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDP--LSSHGNVKSSNILLTNSHDA 504
Query: 398 LLTDYALVPIVNKEHAQLHMVA-YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANY 456
++D+ L +V+ + Y++PE V++K DV+S G+++LELLTGK P+N
Sbjct: 505 RVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNS 564
Query: 457 LAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK---SGEGEMLKLLKIGMCCCEWNA 513
+ +G DLA WV+SV REEW EVFD ++ + S E EM ++L++G+ C E +
Sbjct: 565 VMNEEGM--DLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHP 622
Query: 514 ERRWDLREAVEKIMELKERDND 535
++R + E V +I EL++ D
Sbjct: 623 DKRPVMVEVVRRIQELRQSGAD 644
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGR9 | Y4312_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5212 | 0.9858 | 0.8239 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01930039 | hypothetical protein (639 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 565 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-32 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.001 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.001 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.002 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.002 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.003 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.003 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.004 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.004 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.004 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.004 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.004 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 9e-42
Identities = 137/524 (26%), Positives = 223/524 (42%), Gaps = 101/524 (19%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLTLRALYLSLNKFTGEIPSDAFA 60
NL G I+ +P L+ LS N F G +P S G L L LS N+F+G +P
Sbjct: 439 NLQGRIN-SRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPR-KLG 496
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIP----DFPLAHLTLLDL 116
+ +L ++ L+ N SG+IP L+ +KL+ L+L N G+IP + P+ L+ LDL
Sbjct: 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV--LSQLDL 554
Query: 117 SYNQLVGRIPDTLSN--------------------------FDATSFQGNKGLCG----K 146
S NQL G IP L N +A++ GN LCG
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS 614
Query: 147 PLEACKSSISKKTILIICTVAGATLALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKK 206
L CK + T + A+VAF + + LK+
Sbjct: 615 GLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFG------------FVFIRGRNNLELKR 662
Query: 207 YGANNYHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAE--VLGSG 264
++ G E+Q D S +ND+L + E V+ G
Sbjct: 663 V----ENEDGTWELQFFDSKVSKS-----------------ITINDILSSLKEENVISRG 701
Query: 265 SFGSSYKA-VLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE 323
G+SYK + G VVK ++++ + + +G L HPN++ LI ++
Sbjct: 702 KKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKG 757
Query: 324 KLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY-KEFPGVTLPHG 382
L+ +++ +L+ +L L W R KI G+AK L +L+ + P V + G
Sbjct: 758 AYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVV--G 807
Query: 383 HLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGI 442
+L +++D EP L +L ++ + AY +PE +T +T K+D++ G+
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGL 866
Query: 443 LILELLTGKFPANYLAQGKG----------ANADLATWVNSVVR 476
+++ELLTGK PA+ G ++ L W++ +R
Sbjct: 867 ILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 77/276 (27%), Positives = 113/276 (40%), Gaps = 34/276 (12%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
LGSGSFG+ YKA +V VK ++ S K + R L LSHPN++
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE--KSKKDQTARREIRILRRLSHPNIVR 62
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
LI + K+ LV ++ G L + L L KI + +GL YL+
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHSN 117
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQT- 428
G+ H LK N+LLD + D+ L + K + L Y +PE
Sbjct: 118 --GII--HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 429 DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488
+G K DVWSLG+++ ELLTGK P G+ L + ++ +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQL-IRRILGPPLEFDEPKWS- 227
Query: 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
SG E L+K C + +R E ++
Sbjct: 228 ----SGSEEAKDLIK---KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
LG G FG+ Y A TG + +K + + S+ E+ + L L+HPN++ L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+ LV ++ GSL +LL L L+I+ + +GL YL+ G+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSN--GII 114
Query: 379 LPHGHLKSSNVLLDNA-YEPLLTDYALVPIVNKEHAQLH-MV---AYKSPE-FNQTDGVT 432
H LK N+LLD+ + L D+ L ++ + + L +V AY +PE +
Sbjct: 115 --HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 433 RKTDVWSLGILILEL 447
K+D+WSLG+++ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 259 EVLGSGSFGSSYKA-VLLTGPAMVVKRFRQMSNVGKEDFHEH---MTRLGSLSHPNLLPL 314
E +G G FG YKA TG + +K + KE + + L HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKV---IKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
Y +K+E +V +F GSL +LL L + K + KGL YL+
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT----LTESQIAYVCKELLKGLEYLHSN- 117
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV---AYKSPEFNQTDGV 431
G+ H +K++N+LL + E L D+ L ++ A+ MV + +PE
Sbjct: 118 -GII--HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 432 TRKTDVWSLGILILELLTGKFP 453
K D+WSLGI +EL GK P
Sbjct: 175 DYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGK-----EDFHEHMTRLGSLSHPNLL 312
+++G G+FG YK + L TG + +K Q+S + + + L +L HPN++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIK---QISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
I + ++ ++ NGSL ++ G + + V +GLAYL++
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIK---KFG--PFPESLVAVYVYQVLQGLAYLHE 117
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQT 428
+ GV H +K++N+L L D+ + +N V + +PE +
Sbjct: 118 Q--GVI--HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 429 DGVTRKTDVWSLGILILELLTGKFPANYLAQ 459
G + +D+WSLG ++ELLTG P L
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNP 204
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV----VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLP 313
+ LG G+FG YK L VK ++ S ++DF + + L HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRR----APGQPGLDWPIRLKIIKGVAKGLAY 369
L+ +E LV +++ G L + L R +P + L L +AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL-------VPIVNKEHAQLHMVAYKS 422
L H L + N L+ ++D+ L K +L + + +
Sbjct: 121 L--ASKKFV--HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP-IRWMA 175
Query: 423 PE-FNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
PE DG+ T K+DVWS G+L+ E+ T G P
Sbjct: 176 PESLK--DGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 1e-21
Identities = 66/280 (23%), Positives = 103/280 (36%), Gaps = 48/280 (17%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
E LG GSFG Y A TG + +K + + E + R L L HPN++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKV---IKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L + +++ LV ++ G L +LL R L ++ + L YL
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYL--- 113
Query: 374 FPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV---AYKSPE 424
H LK N+LLD L D+ L ++ V Y +PE
Sbjct: 114 -------HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484
G + D+WSLG+++ ELLTGK P + L + + + F
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFP-------GDDQLLELFKKIGKPKPP---F 216
Query: 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
E L++ + E+R EA++
Sbjct: 217 PPPEWDISP---EAKDLIR---KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLL 312
+ LG G+FG YK L VK ++ S +E+F E + + LSHPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L+ + E +V++++P G L + L L L++ +AKG+ YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK----LTLKDLLQMALQIAKGMEYLES 120
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPEFN 426
H L + N L+ ++D+ L + ++ + + +PE
Sbjct: 121 ----KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 427 QTDGVTRKTDVWSLGILILELLT-GKFP 453
+ T K+DVWS G+L+ E+ T G+ P
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR-------LGSLSHPN 310
E+LG GSFGS Y A+ TG M VK D E + L SL HPN
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE-----LSGDSEEELEALEREIRILSSLQHPN 60
Query: 311 LLPLIAFYY--RKEEK---LLVSDFVPNGSLANLLHVRRAPGQPGLDWP-IRLKIIKGVA 364
+ + +Y R EEK + ++V GSL++LL L P IR K + +
Sbjct: 61 I---VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-----KFGKLPEPVIR-KYTRQIL 111
Query: 365 KGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL---VPIVNKEHAQLHMV--- 418
+GLAYL+ G+ H +K +N+L+D+ L D+ + + +
Sbjct: 112 EGLAYLHSN--GIV--HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 419 AYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ +PE + + R D+WSLG ++E+ TGK P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 66/239 (27%), Positives = 113/239 (47%), Gaps = 22/239 (9%)
Query: 260 VLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPL 314
VLG GS G YK TG +K+ + G E+F + + R L S P ++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI-HV--DGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+Y++ E +V +++ GSLA+LL ++ P P+ I + + KGL YL+ +
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPE---PVLAYIARQILKGLDYLHTKR 119
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDY----ALVPIVNKEHAQLHMVAYKSPEFNQTDG 430
+ H +K SN+L+++ E + D+ L +++ + + V Y SPE Q +
Sbjct: 120 HII---HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 431 VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489
+ D+WSLG+ +LE GKFP +L G+ + +L + E F + R
Sbjct: 177 YSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLL 312
+ LG G+FG YK L VK ++ ++ E+F + L HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L+ +E ++V +++P G L + L R L L +A+G+ YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 373 EFPGVTLPHGH--LKSSNVLLDNAYEPLLTDYALVPIVNKE---HAQLHMVAYK--SPEF 425
H L + N L+ ++D+ L + + + + + +PE
Sbjct: 122 ------KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 426 NQTDGVTRKTDVWSLGILILELLT-GKFP 453
+ T K+DVWS G+L+ E+ T G+ P
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 62/161 (38%), Positives = 84/161 (52%), Gaps = 11/161 (6%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAF 59
NL G I +L L L+ L N GP+P S+ L L +L LS N +GEIP +
Sbjct: 247 NLTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP-ELV 304
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAH--LTLLDLS 117
+ L+ +HL N+F+G+IP +L L +L L L N F G+IP H LT+LDLS
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 118 YNQLVGRIPDTLSN----FDATSFQGN-KGLCGKPLEACKS 153
N L G IP+ L + F F + +G K L AC+S
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 30/212 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLL 312
+ LG G+FG YK L VK ++ ++ E+F + L HPN++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L+ +E +V +++ G L + L R P L L +A+G+ YL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR----PKLSLSDLLSFALQIARGMEYLES 120
Query: 373 EFPGVTLPHGH--LKSSNVLLDNAYEPLLTDYAL------VPIVNKEHAQLHMVAYK--S 422
H L + N L+ ++D+ L K + + +
Sbjct: 121 ------KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG---KLPIRWMA 171
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
PE + T K+DVWS G+L+ E+ T G+ P
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 80.6 bits (197), Expect = 3e-16
Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 28/214 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHP-NLLP 313
LG GSFG Y A + +K + K E R L SL+HP N++
Sbjct: 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVK 62
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L F+ + LV ++V GSL +LL G L L I+ + L YL+ +
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP--LSESEALFILAQILSALEYLHSK 120
Query: 374 FPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVNKEHAQLHM----------VAYKS 422
+ H +K N+LLD + L D+ L ++ + + Y +
Sbjct: 121 ----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 423 PE---FNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE + +D+WSLGI + ELLTG P
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 260 VLGSGSFGSSYKAVLLTGP-------AMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNL 311
VLGSG+FG+ YK V + P + +K R+ ++ ++ + + S+ HP++
Sbjct: 14 VLGSGAFGTVYKGVWI--PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG----LDWPIRLKIIKGVAKGL 367
+ L+ + L++ +P G L L +VR G L+W ++ +AKG+
Sbjct: 72 VRLLGICL-SSQVQLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQ------IAKGM 122
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSP---- 423
+YL + L H L + NVL+ +TD+ L +++ + + H K P
Sbjct: 123 SYLEE----KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 424 --EFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
E T K+DVWS G+ + EL+T G P
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 260 VLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS-NVGKEDFHEHM--------TRLGSLSHP 309
++GSGSFGS Y + +G M VK+ S + +D M L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 310 NLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
N++ + + + ++VP GS+A LL+ A + + ++ + KGL Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-----FEETLVRNFVRQILKGLNY 121
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV---------NKEHAQLH-MVA 419
L+ + H +K +N+L+DN ++D+ + + N L V
Sbjct: 122 LHNR----GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ +PE + TRK D+WSLG L++E+LTGK P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 27/209 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGK-----EDFHEHMTRLGSLSHPNLL 312
E+LGSGSFGS Y+ + L G VK + + + + L L HPN
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN-- 63
Query: 313 PLIAFYY---RKEEKLLVS-DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLA 368
I Y R+E+ L + + VP GSLA LL + P+ + + GL
Sbjct: 64 --IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS-----FPEPVIRLYTRQILLGLE 116
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---YKSPE- 424
YL+ H +K +N+L+D L D+ + V + + +PE
Sbjct: 117 YLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP 453
Q G D+WSLG +LE+ TGK P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 64/250 (25%), Positives = 108/250 (43%), Gaps = 27/250 (10%)
Query: 251 NDLLRASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHP 309
+DL LG+G+ G K + TG M VK R + + + + L L
Sbjct: 1 DDLEYLG--ELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKC 56
Query: 310 NLLPLIAFY---YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKG 366
N ++ FY Y + + +++ GSL +L + G+ I KI V KG
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPER--ILGKIAVAVLKG 112
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA----LVPIVNKEHAQLHMVAYKS 422
L YL+++ + H +K SN+L+++ + L D+ LV + K Y +
Sbjct: 113 LTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS--YMA 167
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE---W 479
PE Q + + K+D+WSLG+ ++EL TG+FP Y + + + +V E
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFP--YPPENDPPDGIFEL-LQYIVNEPPPRL 224
Query: 480 TGEVFDKDMR 489
F D +
Sbjct: 225 PSGKFSPDFQ 234
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 259 EVLGSGSFGSSYKAVL-LTGPAMVVKR--FRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+G GSFG +K V +K+ +M+ +E+ + L L ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQP---GLDWPIRLKIIKGVAKGLAYLYK 372
+ K + +V ++ NG L LL ++R G+P W ++I+ G LA+L+
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLG----LAHLHS 119
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--AQLHMVA---YKSPEFNQ 427
+ + H +KS N+ LD + D + +++ A +V Y SPE +
Sbjct: 120 K----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCE 174
Query: 428 TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA 463
K+DVW+LG+++ E TGK P + A +GA
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHP--FDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 50/133 (37%), Positives = 68/133 (51%), Gaps = 9/133 (6%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP---SVGKLTLRALYLSLNKFTGEIPSDA 58
N+ G I RLP +++++ NN GP+P +LR L LS N FTG IP +
Sbjct: 80 NISGKISSAIF-RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS 138
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDL 116
++ L L+ N SG+IP + L L+L GN GKIP+ L L L L
Sbjct: 139 IPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 117 SYNQLVGRIPDTL 129
+ NQLVG+IP L
Sbjct: 196 ASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 60/168 (35%), Positives = 82/168 (48%), Gaps = 11/168 (6%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAF 59
NL G I + + L L L + N+ GP+P S+G L L+ L+L NK +G IP F
Sbjct: 223 NLSGEIPYE-IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLS 117
+ +L + L+ N SG+IP+ + LQ L L+L N+F GKIP L L +L L
Sbjct: 282 -SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340
Query: 118 YNQLVGRIPDTL---SNFDATSFQGNKGLCGK-PLEACKSSISKKTIL 161
N+ G IP L +N N L G+ P C S K IL
Sbjct: 341 SNKFSGEIPKNLGKHNNLTVLDLSTNN-LTGEIPEGLCSSGNLFKLIL 387
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 47/126 (37%), Positives = 68/126 (53%), Gaps = 8/126 (6%)
Query: 13 SRLPGLRSLSFIN---NSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L ++SL +I N+ G +P +G LT L L L N TG IPS + + L+
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS-SLGNLKNLQY 264
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRI 125
+ L +N SG IP S+ LQKL+ L+L NS G+IP+ L +L +L L N G+I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 126 PDTLSN 131
P L++
Sbjct: 325 PVALTS 330
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 53/156 (33%), Positives = 64/156 (41%), Gaps = 27/156 (17%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAG 61
L G I D + LR L+ NN+F G +P L L LS N +GEIP+D
Sbjct: 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPND-IGS 162
Query: 62 MDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIP----------------- 104
LK + L N G+IP SL L L L L N G+IP
Sbjct: 163 FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN 222
Query: 105 ----DFP-----LAHLTLLDLSYNQLVGRIPDTLSN 131
+ P L L LDL YN L G IP +L N
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 50/213 (23%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGK------EDFHEHMTRLGSLSHPNL 311
+ LG+G+F S Y+A + TG M VK+ + N E + + + L+HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ ++ L +++ GS+++LL + + + + + + +GL+YL+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEA----VIINYTEQLLRGLSYLH 120
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKE-------HAQ-LHMVAYKS 422
+ + H +K +N+L+D+ + L + D+ + + Q L +A+ +
Sbjct: 121 EN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455
PE + + R DVWS+G +I+E+ T K P N
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGK--EDFHEHMTRLGSLSHPNLLPLIAF 317
+G G+FG Y AV L TG M VK R N K ++ + M L L HPNL+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+E+ + ++ G+L LL R LD + + +GLAYL+ G+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRI-----LDEHVIRVYTLQLLEGLAYLHSH--GI 120
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL------HMV---AYKSPEF--- 425
H +K +N+ LD+ L D+ + K + + AY +PE
Sbjct: 121 V--HRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ G R D+WSLG ++LE+ TGK P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 245 REMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLG 304
RE F L LGSG FG ++ + + +K + + ++DF + + L
Sbjct: 5 REEFTL-------ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALK 57
Query: 305 SLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVA 364
L H +L+ L A E ++++ + G +LL R+P L + + VA
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKG---SLLAFLRSPEGQVLPVASLIDMACQVA 114
Query: 365 KGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL---HMVAYK 421
+G+AYL ++ H L + N+L+ + D+ L ++ KE L + YK
Sbjct: 115 EGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYK 169
Query: 422 --SPEFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
+PE + K+DVWS GIL+ E+ T G+ P
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 25/205 (12%)
Query: 261 LGSGSFGSSYKAVLL-----TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPL 314
LG G FG TG + VK + DF + L +L H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 315 IAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
+ + L+ +++P+GSL + L +R + ++ L + KG+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRH--RDQINLKRLLLFSSQICKGMDYLGS 127
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN--------KEHAQLHMVAYKSPE 424
+ H L + N+L+++ ++D+ L ++ KE + + Y +PE
Sbjct: 128 Q----RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 425 FNQTDGVTRKTDVWSLGILILELLT 449
+T + +DVWS G+ + EL T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 31/234 (13%)
Query: 231 QNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFR--- 286
++ EI++L F + ++F DL +G GSFG+ Y A + T + +K+
Sbjct: 10 KDPEIAELFFKEDPEKLF--TDLRE-----IGHGSFGAVYFARDVRTNEVVAIKKMSYSG 62
Query: 287 QMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAP 346
+ SN +D + + L + HPN + Y R+ LV ++ GS ++LL V + P
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP 121
Query: 347 GQPGLDWPIRLK-IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405
Q + + I G +GLAYL+ + H +K+ N+LL + L D+
Sbjct: 122 LQE-----VEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSA 172
Query: 406 PIVNKEHAQLHMVAYKSPEF------NQTDGVTRKTDVWSLGILILELLTGKFP 453
I + ++ + + +PE Q DG K DVWSLGI +EL K P
Sbjct: 173 SIASPANSFVGTPYWMAPEVILAMDEGQYDG---KVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 19/201 (9%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+GSG FG + L + +K R+ MS +EDF E + LSHP L+ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+ LV +F+ +G L++ L +R L + V +G+AYL
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLESS----N 120
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIV-----NKEHAQLHMVAYKSPEFNQTDGVTR 433
+ H L + N L+ ++D+ + V V + SPE +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 434 KTDVWSLGILILELLT-GKFP 453
K+DVWS G+L+ E+ + GK P
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 15/148 (10%)
Query: 354 PIRL----KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409
PI + KI V +GL YLY + H +K SN+L+++ + L D+ + +
Sbjct: 99 PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155
Query: 410 KEHAQLHM--VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP---ANYLAQGKGAN 464
A + Y SPE Q T K+DVWSLGI I+EL GKFP +N G+
Sbjct: 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215
Query: 465 ADLATWVNSVVREE---WTGEVFDKDMR 489
+ + +V+E F +D+R
Sbjct: 216 MGILDLLQQIVQEPPPRLPSSDFPEDLR 243
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (165), Expect = 2e-12
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKR--FRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+ +G GSFG Y G V+K MS +ED + L L+HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQP-----GLDWPIRLKIIKGVAKGLAYL 370
+ K + +V ++ G L+ + ++ G+P LDW ++L L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYL 119
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN--KEHAQLHMV---AYKSPEF 425
+ + H +K N+ L + L D+ + +++ + A+ +V Y SPE
Sbjct: 120 HSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPEL 174
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
Q K+D+WSLG ++ EL T K P
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAM----VVKRFRQMSNVGK-EDFHEHMTRLGSLSHPNLLP 313
V+G G FG Y L+ VK +++++ + E F + + SHPN+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 314 LIAFYYRKE-EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-Y 371
L+ E L+V ++ +G L N +R P + I + VAKG+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNF--IRSETHNPTVKDLIGFGL--QVAKGMEYLAS 116
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV-PIVNKEHAQLHM-------VAYKSP 423
K+F H L + N +LD ++ + D+ L I +KE+ +H V + +
Sbjct: 117 KKFV-----HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 424 EFNQTDGVTRKTDVWSLGILILELLTGKFP----------ANYLAQGK 461
E QT T K+DVWS G+L+ EL+T P YL QG+
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR 219
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 33/209 (15%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAM----VVKRFRQMSNVGKEDFHE---HMTRLGSLSHPN 310
++LGSG FG+ +K + + G ++ +K + S G++ F E HM +GSL H
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAY 70
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPG----QPGLDWPIRLKIIKGVAKG 366
++ L+ +L V+ P GSL L HVR+ Q L+W ++ +AKG
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQ------IAKG 121
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSP--- 423
+ YL + + H +L + N+LL + + D+ + ++ + + +K+P
Sbjct: 122 MYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 424 ---EFNQTDGVTRKTDVWSLGILILELLT 449
E T ++DVWS G+ + E+++
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 14/199 (7%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LG+G FG + + VK + + E F + + L H L+ L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLP 380
+E +V++++ GSL + L ++ L P + + +A+G+AYL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESR----NYI 125
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----VAYKSPEFNQTDGVTRKT 435
H L + N+L+ + D+ L ++ + + + +PE T K+
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 436 DVWSLGILILELLT-GKFP 453
DVWS GIL+ E++T G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 234 EISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGK 293
++++L F ++ ++F + +G GSFG+ Y A + +V ++MS GK
Sbjct: 3 DVAELFFKDDPEKLF-------SDLREIGHGSFGAVYFARDVRNSEVVA--IKKMSYSGK 53
Query: 294 E------DFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPG 347
+ D + + L L HPN + Y R+ LV ++ GS ++LL V + P
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPL 112
Query: 348 QPGLDWPIRLK-IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406
Q + + + G +GLAYL+ + H +K+ N+LL L D+
Sbjct: 113 QE-----VEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSAS 163
Query: 407 IVNKEHAQLHMVAYKSPEF------NQTDGVTRKTDVWSLGILILELLTGKFP 453
I+ + + + +PE Q DG K DVWSLGI +EL K P
Sbjct: 164 IMAPANXFVGTPYWMAPEVILAMDEGQYDG---KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 49/200 (24%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LG+G FG + + VK + + + F E + +L H L+ L A +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLP 380
+E ++++++ GSL + L ++ + P + +A+G+AY+ ++
Sbjct: 73 EEPIYIITEYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYI 125
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVN------KEHAQLHMVAYKSPEFNQTDGVTRK 434
H L+++NVL+ + + D+ L ++ +E A+ + + +PE T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIK 184
Query: 435 TDVWSLGILILELLT-GKFP 453
+DVWS GIL+ E++T GK P
Sbjct: 185 SDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LG+G FG ++ + + VK + + + +DF + L HP L+ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLP 380
+E +V++ + GSL L A L P + + VA G+AYL +
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQ-GGAGRA--LKLPQLIDMAAQVASGMAYLEAQ----NYI 125
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----VAYKSPEFNQTDGVTRKT 435
H L + NVL+ + D+ L ++ ++ + + + +PE + + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 436 DVWSLGILILELLT-GKFP 453
DVWS GIL+ E++T G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 42/218 (19%)
Query: 261 LGSGSFGSSYKAVLLTGPAMV-VKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLI 315
+G G++G YKA +V +K+ R M N KE F R L L HPN++ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-MEN-EKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 316 AFYYRKEEK--LLVSDFVPNGSLANLLH---VRRAPGQPGLDWPIRLKIIKGVAK----G 366
K + +V +++ + L LL V+ Q IK K G
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ-----------IKCYMKQLLEG 112
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL---HMVA--YK 421
L YL+ G+ H +K SN+L++N L D+ L K ++ ++ Y+
Sbjct: 113 LQYLHSN--GIL--HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168
Query: 422 SPE--FNQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
PE T + D+WS+G ++ EL GK F +
Sbjct: 169 PPELLLGATR-YGPEVDMWSVGCILAELFLGKPIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
EV+G G+ Y A+ L V +KR + ++ + + + +HPN++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+ +E LV ++ GSL ++ ++ + + GLD I ++K V KGL YL+
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDI--MKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---- 120
Query: 377 VTLPHGH----LKSSNVLLDNAYEPLLTDY----ALVPIVNKEHAQLHMVA----YKSPE 424
+G +K+ N+LL + D+ +L ++ + +PE
Sbjct: 121 ----NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 425 -FNQTDGVTRKTDVWSLGILILELLTGKFP 453
Q G K D+WS GI +EL TG P
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEH--MTRLGSLSHPNLLPLIA 316
+G G FG G + VK + S + E MT L HPNL+ L+
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL---RHPNLVQLLG 67
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFP 375
+ +V++++ GSL + L R+ G+ + +L V +G+ YL K F
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEKNF- 123
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-VAYKSPEFNQTDGVTRK 434
H L + NVL+ ++D+ L ++ + V + +PE + + K
Sbjct: 124 ----VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 435 TDVWSLGILILELLT-GKFP 453
+DVWS GIL+ E+ + G+ P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 40/222 (18%)
Query: 246 EMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHE---HMT 301
E+F++ E LG GS+GS YKA+ TG + +K +ED E ++
Sbjct: 3 EVFDIL-------EKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEIS 50
Query: 302 RLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK--- 358
L P ++ Y++ + +V ++ GS+++++ + L
Sbjct: 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN----------KTLTEEE 100
Query: 359 ---IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL 415
I+ KGL YL+ H +K+ N+LL+ + L D+ + + A+
Sbjct: 101 IAAILYQTLKGLEYLHS----NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156
Query: 416 HMVA----YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ V + +PE Q G K D+WSLGI +E+ GK P
Sbjct: 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 32/216 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF------------RQMSNVGKEDFHEHMTRLGS 305
E++G G++G Y A+ + TG M VK+ RQ V + + L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMV--KALRSEIETLKD 64
Query: 306 LSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365
L H N++ + F +E + ++VP GS+ + L R G+ + + + V +
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGR--FEEQLVRFFTEQVLE 119
Query: 366 GLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI---VNKEHAQLHM---VA 419
GLAYL+ + + H LK+ N+L+D ++D+ + + + M V
Sbjct: 120 GLAYLHSK----GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 420 YKSPEFNQTD--GVTRKTDVWSLGILILELLTGKFP 453
+ +PE + G + K D+WSLG ++LE+ G+ P
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 35/236 (14%)
Query: 231 QNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN 290
++ EI+ L + ++ E+F +G GSFG+ Y A +V ++MS
Sbjct: 6 KDPEIADLFYKDDPEEIF-------VGLHEIGHGSFGAVYFATNSHTNEVVA--VKKMSY 56
Query: 291 VGKE------DFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRR 344
GK+ D + + L L HPN + Y ++ LV ++ GS ++LL V +
Sbjct: 57 SGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK 115
Query: 345 APGQPGLDWPIRLK-IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA 403
P Q + + I G +GLAYL+ + H +K+ N+LL + L D+
Sbjct: 116 KPLQE-----VEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFG 166
Query: 404 LVPIVNKEHAQLHMVAYKSPEF------NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ ++ + + +PE Q DG K DVWSLGI +EL K P
Sbjct: 167 SASKSSPANSFVGTPYWMAPEVILAMDEGQYDG---KVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LGSG FG + + +K + + + +EDF E + LSHP L+ L +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLP 380
++ +V++F+ NG L N L R+ G+ D + L + + V +G+ YL + +
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQ--GKLSKD--MLLSMCQDVCEGMEYLERN----SFI 122
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-----AQLHMVAYKSPEFNQTDGVTRKT 435
H L + N L+ + ++D+ + V + V + PE + K+
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 436 DVWSLGILILELLT-GKFP 453
DVWS G+L+ E+ T GK P
Sbjct: 183 DVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR-QMSNVGK-----EDFHEHMTRLGSLSHPNLL 312
EVLG G++G+ Y + G + VK+ SNV E E + L SL H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
+ + +FVP GS++++L+ R P L P+ K K + G+AYL+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGP----LPEPVFCKYTKQILDGVAYLHN 120
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV-----NKEHAQL----HMVAY-KS 422
+ H +K +NV+L L D+ + + H+ + H Y +
Sbjct: 121 N----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE G RK+D+WS+G + E+ TGK P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LG+G FG + A + VK + S + E F + +L H L+ L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLP 380
E ++++F+ GSL + L QP P + +A+G+A++ +
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIAEGMAFIEQR----NYI 124
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVN------KEHAQLHMVAYKSPEFNQTDGVTRK 434
H L+++N+L+ + + D+ L ++ +E A+ + + +PE T K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIK 183
Query: 435 TDVWSLGILILELLT-GKFP 453
+DVWS GIL++E++T G+ P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 46/202 (22%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 259 EVLGSGSFGSSYKAVL-LTGPAMV---VKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLP 313
+V+G G FG + L L G + +K + S+ + DF + +G HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L + +++++++ NGSL L R G+ + +++G+A G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL--RENDGK--FTVGQLVGMLRGIASGMKYLSE- 124
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPEFNQ 427
+ H L + N+L+++ ++D+ L + A + + +PE
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 428 TDGVTRKTDVWSLGILILELLT 449
T +DVWS GI++ E+++
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 261 LGSGSFGSSYKAVLLTGP---AMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
LG GS+GS YK L+ A+ MS +ED + L S++HPN+ I++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISY 64
Query: 318 YYRKEEKLL------VSDFVPNGSLANLLHVRRAPGQP---GLDWPIRLKIIKGVAKGLA 368
KE L V ++ P G L+ + R+ + W I +++ +GL
Sbjct: 65 ---KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRGLQ 117
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA--QLHMVAYKSPEFN 426
L+++ + H LKS+N+LL + D + ++ K A Q+ Y +PE
Sbjct: 118 ALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVW 173
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFPAN 455
+ + K+D+WSLG L+ E+ T P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQMSN--VGKEDFHEHMTRLGSLSHPNL 311
+VLGSG+FG+ YK + + V +K R+ ++ KE E + S+ +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-MASVDNPHV 71
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLL--HVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
L+ +L ++ +P G L + + H Q L+W ++ +AKG+ Y
Sbjct: 72 CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNY 124
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSP------ 423
L + L H L + NVL+ +TD+ L ++ + + H K P
Sbjct: 125 LEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 424 EFNQTDGVTRKTDVWSLGILILELLT 449
E T ++DVWS G+ + EL+T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 24/163 (14%)
Query: 21 LSFINNSFDGPMPS-VGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ 78
L N G +P+ + KL L+++ LS N G IP + + L+ + L+ N F+G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPP-SLGSITSLEVLDLSYNSFNGS 481
Query: 79 IPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQ 138
IP+SL L L LNL GNS G++P L L S+N F
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPA-ALGGRLLHRASFN-----------------FT 523
Query: 139 GNKGLCGKP-LEACKSSISKKTILIICTVAGATLALAAIVAFS 180
N GLCG P L AC +S + I G ++A +V +
Sbjct: 524 DNAGLCGIPGLRACGPHLSVGAKIGI--AFGVSVAFLFLVICA 564
|
Length = 623 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 21/202 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G G+FG YK VL + VK R + K F + L HPN++ LI
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+K+ +V + VP GSL L +R+ + L L++ A G+ YL +
Sbjct: 61 CVQKQPIYIVMELVPGGSL--LTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESK---- 112
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---------YKSPEFNQT 428
H L + N L+ ++D+ + +E ++ V+ + +PE
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGM---SREEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 429 DGVTRKTDVWSLGILILELLTG 450
T ++DVWS GIL+ E +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 44/227 (19%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRF--RQMSNVGKEDF----HEHMTRLGSLSHPNL 311
+++G GSF + A T +K RQ+ K + E +TRL HP +
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--GHPGI 64
Query: 312 LPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
+ L + ++ EE L V ++ PNG L + + LD + L YL
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYL 118
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA--------LVPIVNKEHAQLHMVA--- 419
+ + G+ H LK N+LLD +TD+ P NK A
Sbjct: 119 HSK--GII--HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 420 -------------YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y SPE + +D+W+LG +I ++LTGK P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 36/211 (17%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFR----QMSNVGKEDFHEHMTRLGSLSHPNLLP 313
E +G G+ G YKA TG + +K+ R + E + + HPN++
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINE-----ILIMKDCKHPNIVD 79
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDW-PIRLK------IIKGVAKG 366
Y +E +V +++ GSL +++ +R+ + + V +G
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDII-----------TQNFVRMNEPQIAYVCREVLQG 128
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH-MV---AYKS 422
L YL+ + V H +KS N+LL L D+ + KE ++ + +V + +
Sbjct: 129 LEYLHSQ--NVI--HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMA 184
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE + K D+WSLGI+ +E+ G+ P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 245 REMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHE---HM 300
+E +EL + +GSG++G YKA + TG + +K + +DF +
Sbjct: 2 QEDYEL-------IQRIGSGTYGDVYKARDIATGELVAIK---VIKLEPGDDFEIIQQEI 51
Query: 301 TRLGSLSHPNLLPLIAFY--YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL 357
+ L HPN+ +A++ Y + +KL +V ++ GSL ++ V R P L
Sbjct: 52 SMLKECRHPNI---VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP----LSELQIA 104
Query: 358 KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL-H 416
+ + KGLAYL++ H +K +N+LL + L D+ + AQL
Sbjct: 105 YVCRETLKGLAYLHETG----KIHRDIKGANILLTEDGDVKLADFGVS-------AQLTA 153
Query: 417 MVA----------YKSPEF---NQTDGVTRKTDVWSLGILILELLTGKFP 453
+A + +PE + G K D+W+LGI +EL + P
Sbjct: 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 33/164 (20%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKLT-LRALYLSLNKFTGEIP---- 55
N G I V L+ LP L+ L +N F G +P +GK L L LS N TGEIP
Sbjct: 319 NFTGKIPV-ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 56 -----------SDAFAGM--------DQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEG 96
S++ G L++V L N FSG++P L + L++
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 97 NSFQGKIPD--FPLAHLTLLDLSYNQLVGRIPDT-----LSNFD 133
N+ QG+I + + L +L L+ N+ G +PD+ L N D
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLD 481
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGP-------AMVVKRFRQMSNVG-KEDFHEHMTRLGSLSHPN 310
E LG G+FG YK L TGP ++ +K ++ + +++F + + L HPN
Sbjct: 11 EELGEGAFGKVYKGEL-TGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAP------------GQPGLDWPIRLK 358
++ L+ +++ ++ +++ +G L L VR +P + LD L
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFL-VRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV------NKEH 412
I +A G+ YL H L + N L+ ++D+ L + +
Sbjct: 129 IAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILEL 447
L V + PE T ++D+WS G+++ E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+ LG+G FG + + +K +Q S + E F + L HP L+ L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+E ++++++ NGSL + L + P L + + +A+G+A++ ++
Sbjct: 71 -TQEPIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAFIERK----N 122
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVN------KEHAQLHMVAYKSPEFNQTDGVT 432
H L+++N+L+ + D+ L ++ +E A+ + + +PE T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFT 181
Query: 433 RKTDVWSLGILILELLT-GKFP 453
K+DVWS GIL+ E++T G+ P
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLL 312
+VLGSG+FG+ YK + + V +K + + +F + + S+ HP+L+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRR--APGQPGLDWPIRLKIIKGVAKGLAYL 370
L+ +L V+ +P+G L + +H + Q L+W ++ +AKG+ YL
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSP------E 424
+ L H L + NVL+ + +TD+ L ++ + + + K P E
Sbjct: 126 EER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 425 FNQTDGVTRKTDVWSLGILILELLT 449
T ++DVWS G+ I EL+T
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKE--DFHEHMTRLGSLSHPNLLPLIA 316
E +G GSFG +K + +V + + E D + +T L P +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG-LDWPIRLKIIKGVAKGLAYLYKEFP 375
Y + + ++ +++ GS +LL +PG LD I++ + KGL YL+ E
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHSE-- 120
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGV 431
H +K++NVLL E L D+ + + + + + +PE +
Sbjct: 121 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 432 TRKTDVWSLGILILELLTGKFPANYL 457
K D+WSLGI +EL G+ P + L
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 44/195 (22%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 261 LGSGSFGSSYKAVLLT-GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYY 319
LG G +G Y+ V + VK ++ + E+F + + + HPNL+ L+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 320 RKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTL 379
R+ ++++F+ G NLL R + ++ + L + ++ + YL K+
Sbjct: 73 REPPFYIITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NF 125
Query: 380 PHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA-----YKSPEFNQTDGVTRK 434
H L + N L+ + + D+ L ++ + H A + +PE + + K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 435 TDVWSLGILILELLT 449
+DVW+ G+L+ E+ T
Sbjct: 186 SDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 40/178 (22%), Positives = 76/178 (42%), Gaps = 15/178 (8%)
Query: 283 KRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKL----LVSDFVPNGSLAN 338
K+F + V + + L + N+L + F + L L+ ++ G L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 339 LLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL 398
+L + L + +L + KGL LYK P+ +L S + L+ Y+
Sbjct: 112 VLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKY---TNKPYKNLTSVSFLVTENYKLK 163
Query: 399 LTDYALVPIV-NKEHAQLHMVAYKSPEF--NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ + L I+ + ++ + Y S + + T K D++SLG+++ E+ TGK P
Sbjct: 164 IICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 36/101 (35%), Positives = 60/101 (59%), Gaps = 6/101 (5%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK-SLAGLQKLLQLNLEGNS 98
++ + LS N+ +G IP D F L+ ++L+ N+F+G IP+ S+ L+ L+L N
Sbjct: 95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLET---LDLSNNM 151
Query: 99 FQGKIPD--FPLAHLTLLDLSYNQLVGRIPDTLSNFDATSF 137
G+IP+ + L +LDL N LVG+IP++L+N + F
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192
|
Length = 968 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 59/216 (27%), Positives = 88/216 (40%), Gaps = 22/216 (10%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKR--FRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
E +G GSFG+ K G +V K + M+ K+ + L L HPN I
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN----I 61
Query: 316 AFYY-----RKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
YY R + L +V ++ G LA L+ + + ++ +I+ + L
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYE 120
Query: 370 L-YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPE 424
+ PG T+ H LK +N+ LD L D+ L I+ + + Y SPE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP---ANYL 457
K+D+WSLG LI EL P N L
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 31/207 (14%)
Query: 260 VLGSGSFGSSYKAVLLTGP-------AMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLL 312
VLGSG+FG+ YK + + A+ V R KE E G + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG-VGSPYVC 72
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG----LDWPIRLKIIKGVAKGLA 368
L+ +L V+ +P G L L +VR + G L+W ++ +AKG++
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQ------IAKGMS 123
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSP----- 423
YL + V L H L + NVL+ + +TD+ L +++ + + H K P
Sbjct: 124 YLEE----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 424 -EFNQTDGVTRKTDVWSLGILILELLT 449
E T ++DVWS G+ + EL+T
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LG+G FG + + VK + + E F E + L H L+ L A
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLP 380
E +V++++ GSL + L + G+ L P + + VA G+AY+ + +
Sbjct: 73 -EPIYIVTEYMSKGSLLDFL--KDGEGR-ALKLPNLVDMAAQVAAGMAYIER----MNYI 124
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----VAYKSPEFNQTDGVTRKT 435
H L+S+N+L+ + + D+ L ++ + + +PE T K+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 436 DVWSLGILILELLT-GKFP 453
DVWS GIL+ EL+T G+ P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 35/235 (14%)
Query: 232 NDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN 290
+ EI++L ++ ++F DL +G GSFG+ Y A + T + +K+ MS
Sbjct: 1 DPEIAELFSKDDPEKLFT--DLRE-----IGHGSFGAVYFARDVRTNEVVAIKK---MSY 50
Query: 291 VGKE------DFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRR 344
GK+ D + + L L HPN + Y R+ LV ++ GS +++L V +
Sbjct: 51 SGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK 109
Query: 345 APGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404
P Q + I I G +GLAYL+ H +K+ N+LL L D+
Sbjct: 110 KPLQ---EVEIA-AICHGALQGLAYLHS----HERIHRDIKAGNILLTEPGTVKLADFGS 161
Query: 405 VPIVNKEHAQLHMVAYKSPEF------NQTDGVTRKTDVWSLGILILELLTGKFP 453
+V+ ++ + + +PE Q DG K DVWSLGI +EL K P
Sbjct: 162 ASLVSPANSFVGTPYWMAPEVILAMDEGQYDG---KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 3e-09
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 261 LGSGSFGSSYKA-VLLTGP--AMVVKRFRQMSNVGKEDFHEHMTR--LGSLSHPNLLPLI 315
LG GSFG TG AM V + +++ + + H R L ++HP ++ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE-HTLTERNILSRINHPFIVKLH 59
Query: 316 AFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK--------G 366
+ ++ EEKL LV ++ P G L + L + + A+
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLS-------------KEGRFSEERARFYAAEIVLA 105
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKS 422
L YL+ G+ + LK N+LLD LTD+ L ++ E ++ + Y +
Sbjct: 106 LEYLHSL--GII--YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLA 161
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE G + D WSLG+L+ E+LTGK P
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LG G FG + G V + + + E F + + L H L+PL A
Sbjct: 14 LGQGCFGEVWMGTW-NGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLP 380
+E +V++F+ GSL + L + G+ L P + + +A G+AY+ + +
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL--KEGDGK-YLKLPQLVDMAAQIADGMAYIER----MNYI 124
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----VAYKSPEFNQTDGVTRKT 435
H L+++N+L+ + + D+ L ++ + + +PE T K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 436 DVWSLGILILELLT-GKFP 453
DVWS GIL+ EL+T G+ P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKE--DFHEHMTRLGSLSHPNLLPLIA 316
E +G GSFG YK + +V + + E D + +T L P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG-LDWPIRLKIIKGVAKGLAYLYKEFP 375
Y + + ++ +++ GS +LL +PG L+ I++ + KGL YL+ E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-------KPGPLEETYIATILREILKGLDYLHSE-- 120
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGV 431
H +K++NVLL + L D+ + + + + + +PE +
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 432 TRKTDVWSLGILILELLTGKFP 453
K D+WSLGI +EL G+ P
Sbjct: 179 DFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 259 EVLGSGSFGSSYKA-VLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E+LG G+ G+ YKA LLT + VK ++ E + M+ L L + +I F
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 318 Y--YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
Y + E ++ + ++F+ GSL R+ P + +I V KGL YL+
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY---RKIPE------HVLGRIAVAVVKGLTYLW--- 112
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYA----LVPIVNKEHAQLHMVAYKSPEFNQTDG 430
+ + H +K SN+L++ + L D+ LV + K + + AY +PE +
Sbjct: 113 -SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTN--AYMAPERISGEQ 169
Query: 431 VTRKTDVWSLGILILELLTGKFP 453
+DVWSLGI +EL G+FP
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 30/232 (12%)
Query: 264 GSFGSSYKA-VLLTGPAMVVKRFR--------QMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
G+FGS Y A TG +K + Q++NV E + P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES----PYVAKL 62
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ K+ LV +++ G A+L+ G DW + + I V G+ L++
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTL---GGLPEDW-AK-QYIAEVVLGVEDLHQR- 116
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRK 434
G+ H +K N+L+D LTD+ L + + Y +PE G +
Sbjct: 117 -GII--HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKM 173
Query: 435 TDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-EWTGEVFD 485
+D WSLG +I E L G P + A A + N + R W EV +
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFH-------AETPDAVFDNILSRRINWPEEVKE 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMT-----RLGSLSHPNLLPL 314
+G G++G YKA LTG + +K+ + + + L L+HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ + K + LV +F+ +L + + Q GL + + + +GLA+ +
Sbjct: 64 LDVFRHKGDLYLVFEFM----DTDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL-HMVA---YKSPEFNQTDG 430
G+ H LK N+L++ L D+ L H V Y++PE D
Sbjct: 118 -GIL--HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 431 V-TRKTDVWSLGILILELLTGK--FPA-NYLAQ 459
+ D+WS+G + ELL+ + FP + + Q
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 44/204 (21%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTG----PAMVVKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLP 313
+V+G+G FG ++ +L A+ +K + + ++DF + +G SH N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL-KIIKGVAKGLAYLYK 372
L + + +++++++ NG+L L R G+ +L +++G+A G+ YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYL--RDHDGEFS---SYQLVGMLRGIAAGMKYLSD 125
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-------VAYKSPEF 425
+ H L + N+L+++ E ++D+ L ++ + + + + +PE
Sbjct: 126 ----MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 426 NQTDGVTRKTDVWSLGILILELLT 449
T +DVWS GI++ E+++
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYY 319
LG G+FG YKA TG K + S EDF + L HPN++ L Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 320 RKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTL 379
+ + ++ +F G+L +++ L P + + + + L +L+ +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG----LTEPQIRYVCRQMLEALNFLHSHK----V 124
Query: 380 PHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSP----------EFNQTD 429
H LK+ N+LL + L D+ V NK Q +P E + +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFG-VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 430 GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADL 467
K D+WSLGI ++E LAQ + + +L
Sbjct: 184 PYDYKADIWSLGITLIE----------LAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 259 EVLGSGSFGSSYKA-VLLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
V+G G++G K TG + +K+F++ + ED + R L L H N++
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHV-RRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L + RK LV ++V LL + +PG GL I + + +AY +
Sbjct: 65 LKEAFRRKGRLYLVFEYVER----TLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHS 118
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV--NKEHAQLHMVA---YKSPEFNQ 427
+ H +K N+L+ + L D+ + VA Y++PE
Sbjct: 119 H----NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 428 TDGVTRK-TDVWSLGILILELLTGK--FP 453
D K DVW++G ++ ELL G+ FP
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G G+ G+ Y A+ + TG + +K+ KE + + HPN++ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
Y +E +V +++ GSL +++ + +D + + + L +L+
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN---- 134
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH-MVAYKSPEFNQTDGVTRK-- 434
+ H +KS N+LL LTD+ + E ++ MV +P + + VTRK
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAY 192
Query: 435 ---TDVWSLGILILELLTGKFP 453
D+WSLGI+ +E++ G+ P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
E++G G FG+ + TG + VK + +V + F E + L H NL+ L+
Sbjct: 12 EIIGEGEFGAVLQGEY-TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+V + + G+L N L R G+ + L+ VA+G+ YL +
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESK----K 120
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDV 437
L H L + N+L+ ++D+ L + + V + +PE + + K+DV
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDV 180
Query: 438 WSLGILILELLT-GKFP 453
WS G+L+ E+ + G+ P
Sbjct: 181 WSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LG+G FG + +K ++ S + +++F E + LSH L+ L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPGVTL 379
+ +V++++ NG L N L L++ K V +G+AYL K+F
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLR----EHGKRFQPSQLLEMCKDVCEGMAYLESKQF----- 121
Query: 380 PHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----VAYKSPEFNQTDGVTRK 434
H L + N L+D+ ++D+ L V + + V + PE + K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 435 TDVWSLGILILELLT-GKFP 453
+DVW+ G+L+ E+ + GK P
Sbjct: 182 SDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 46/211 (21%), Positives = 82/211 (38%), Gaps = 25/211 (11%)
Query: 259 EVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMSNVGK---EDFHEHMTRLGSLSHPNLL 312
++LG G FGS + L V + ++ E+F + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 313 PLIAFYYRKEEK------LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR--LKIIKGVA 364
LI + +++ F+ +G L + L R G P P++ LK + +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP-EKLPLQTLLKFMVDIA 123
Query: 365 KGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--HAQLHM----V 418
G+ YL H L + N +L + D+ L + + Q + V
Sbjct: 124 LGMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 419 AYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
+ + E T K+DVW+ G+ + E+ T
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYY 319
LG G+FG YKA TG K S ED+ + L + +HP ++ L+ +Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 320 RKEEKLLVSDFVPNGSL-ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+ ++ +F P G++ A +L + R GL P I + + + L YL+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM----K 130
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYAL----VPIVNKEHAQLHMVAYKSPEFNQTDGVTR- 433
+ H LK+ NVLL + L D+ + V + + + + + +PE + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 434 ----KTDVWSLGILILEL 447
K D+WSLGI ++E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LG G FG + G V + + + E F + + L H L+ L A
Sbjct: 14 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 71
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPG--LDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+E +V++++ GSL + L G+ G L P + + +A G+AY+ + +
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLK-----GEMGKYLRLPQLVDMAAQIASGMAYVER----MN 122
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----VAYKSPEFNQTDGVTR 433
H L+++N+L+ + D+ L ++ + + +PE T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 434 KTDVWSLGILILELLT-GKFP 453
K+DVWS GIL+ EL T G+ P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320
LGSG FG + + +K R+ + + ++DF E + LSHPNL+ L +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLP 380
+ +V++++ NG L N L R+ L + V + + YL E G
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTE----WLLDMCSDVCEAMEYL--ESNGFI-- 122
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIV------NKEHAQLHMVAYKSPEFNQTDGVTRK 434
H L + N L+ ++D+ L V + + + V + PE + K
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP-VKWAPPEVFDYSRFSSK 181
Query: 435 TDVWSLGILILELLT-GKFP 453
+DVWS G+L+ E+ + GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 261 LGSGSFGSSYKAVLL------TGPAMV-VKRFRQMSNVG-KEDFHEHMTRLGSLSHPNLL 312
LGSG+FG Y+ +GP V VK R+ + K++F + + + +HPN++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRA--PGQPGLDWPIRLKIIKGVAKGLAYL 370
L+ E + ++ + + G L + L R G P L L I VAKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 371 YKEFPGVTLPHGHLKSSNVLL-----DNAYEPLLTDYALVPIV------NKEHAQLHMVA 419
+ + H L + N L+ D + D+ L + KE L V
Sbjct: 123 EQ----MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 420 YKSPEFNQTDGV-TRKTDVWSLGILILELLT 449
+ +PE + DG T ++DVWS G+L+ E+LT
Sbjct: 179 WMAPE-SLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKE--DFHEHMTRLGSLSHPNLLPLIA 316
E +G GSFG +K + +V + + E D + +T L P +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
Y + + ++ +++ GS +LL R P D ++K + KGL YL+ E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--RAGP----FDEFQIATMLKEILKGLDYLHSE--- 120
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVT 432
H +K++NVLL + L D+ + + + + + +PE Q
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 433 RKTDVWSLGILILELLTGKFP 453
K D+WSLGI +EL G+ P
Sbjct: 180 SKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 6e-08
Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 20/152 (13%)
Query: 308 HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL 367
+PN + L + +L+ D++ +G L +LL L KII+ + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-----LSEAEVKKIIRQLVEAL 122
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHMVAYKSPE-- 424
L+K + H +K NVL D A + + L DY L I+ + Y SPE
Sbjct: 123 NDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKI 178
Query: 425 ---FNQTDGVTRKTDVWSLGILILELLTGKFP 453
D W++G+L ELLTGK P
Sbjct: 179 KGHNYD-----VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 36/222 (16%)
Query: 260 VLGSGSFGSSYKAVL--LTGPA----MVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLL 312
LG G FG KA L G A + VK ++ ++ D L ++HP+++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRR-------------------APGQPGLDW 353
L + LL+ ++ GSL + L R P + L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 354 PIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413
+ +++G+ YL + + L H L + NVL+ + ++D+ L V +E +
Sbjct: 127 GDLISFAWQISRGMQYLAE----MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 414 QLHM------VAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
+ V + + E T ++DVWS G+L+ E++T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 8e-08
Identities = 44/200 (22%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G G+ G+ + A+ + TG + +K+ KE + + L +PN++ +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+ +E +V +++ GSL +++ + +D + + + L +L+
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHAN---- 134
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVTR 433
+ H +KS NVLL LTD+ + E ++ + + +PE
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 434 KTDVWSLGILILELLTGKFP 453
K D+WSLGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 42/130 (32%), Positives = 62/130 (47%), Gaps = 8/130 (6%)
Query: 45 LSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGL-QKLLQLNLEGNSFQGKI 103
LS +G+I S F + ++ ++L+ N SG IP + L LNL N+F G I
Sbjct: 76 LSGKNISGKISSAIF-RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI 134
Query: 104 PDFPLAHLTLLDLSYNQLVGRIPDTLSNFDATSF--QGNKGLCGKPLEACKSSISKKTIL 161
P + +L LDLS N L G IP+ + +F + G L GK +S++ T L
Sbjct: 135 PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK----IPNSLTNLTSL 190
Query: 162 IICTVAGATL 171
T+A L
Sbjct: 191 EFLTLASNQL 200
|
Length = 968 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 303 LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG 362
L ++HPN++ + E ++ +F+ GSL + L + +
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG----THIADEQFLA-----DVARQ 176
Query: 363 VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----HAQLHMV 418
+ G+AYL++ + H +K SN+L+++A + D+ + I+ + ++ + +
Sbjct: 177 ILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232
Query: 419 AYKSPEFNQTDGVTRK-----TDVWSLGILILELLTGKFPANYLAQGKGA 463
AY SPE TD D+WSLG+ ILE G+FP QG A
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA 282
|
Length = 353 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDF------HEHMTRLGSLSH--- 308
E++G G++G+ Y+ + TG + +K + N+ D E + L L
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALK----IINLDTPDDDVSDIQRE-VALLSQLRQSQP 61
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK----IIKGVA 364
PN+ Y + ++ ++ GS+ L+ + G PI K II+ V
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-------KAG---PIAEKYISVIIREVL 111
Query: 365 KGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY---ALVPIVNKEHAQLHMVAY- 420
L Y++K V + H +K++N+L+ N L D+ AL+ + + + Y
Sbjct: 112 VALKYIHK----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYW 167
Query: 421 KSPEFNQTDGVT--RKTDVWSLGILILELLTGKFP 453
+PE T+G K D+WSLGI I E+ TG P
Sbjct: 168 MAPEV-ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 252 DLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHE-----HMTRLGSL 306
+LL + K T + VK+ + + KED +R L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQ--L 56
Query: 307 SHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKG 366
HPN+LP + + E +VS + GS +LL G P L I I+K V
Sbjct: 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL--AIAF-ILKDVLNA 113
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA-LVPIVN--KEHAQLH------- 416
L Y++ + H +K+S++LL + +L+ V ++ K +H
Sbjct: 114 LDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 417 -MVAYKSPEFNQTD--GVTRKTDVWSLGILILELLTGKFP 453
+ + SPE Q + G K+D++S+GI EL G P
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 259 EVLGSGSFGSSYKAVLLTGP----AMVVKRFRQMSNVGKEDFHEHM-TRLGSLSHPNLLP 313
+VLG+G++G + +TG +K ++ + V K EH T L H P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 314 -LIAFYY--RKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLA 368
L+ +Y + E KL L+ D+V G + L+ R + ++ G + L
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED------EVRFYSGEIILALE 119
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP-IVNKEHAQLH----MVAYKSP 423
+L+K + + + +K N+LLD+ +LTD+ L +++E + + + Y +P
Sbjct: 120 HLHK----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 424 EFNQTD-GVTRKTDVWSLGILILELLTGKFP 453
E + G + D WSLGILI ELLTG P
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 261 LGSGSFGSSYKAVLL----TGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
+G GSFG KA+L+ G V+K +MS +E+ + + L ++ HPN++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRA---PGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ +V D+ G L ++ +R P LDW +++ + L +++
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVH 118
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK--EHAQ--LHMVAYKSPEFNQ 427
+ H +KS N+ L L D+ + ++N E A+ + Y SPE +
Sbjct: 119 DR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174
Query: 428 TDGVTRKTDVWSLGILILELLTGK 451
K+D+W+LG ++ E+ T K
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 47/206 (22%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM----SNVGKEDFHEHMTRLGSLSHPNLLP 313
EV+G+G FG + L L G + + + + + DF + +G HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL-KIIKGVAKGLAYLYK 372
L + +++++F+ NG+L + L R+ GQ I+L +++G+A G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFT---VIQLVGMLRGIAAGMKYLSE 124
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM---------VAYKSP 423
+ H L + N+L+++ ++D+ L + + + + + +P
Sbjct: 125 ----MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 424 EFNQTDGVTRKTDVWSLGILILELLT 449
E T +DVWS GI++ E+++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 261 LGSGSFGSSYKAV-LLTGP--AMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLI 315
+ G++G + A TG A+ V + M N + E L P + +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI-LSQAQSPYV---V 56
Query: 316 AFYY--RKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
YY + ++ L LV +++P G LA+LL + LD + I + L YL+
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVLALEYLHS 111
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL--VPIVNKEHAQLHMVA----------Y 420
G+ H LK N+L+D+ LTD+ L V +V ++ Y
Sbjct: 112 N--GII--HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 421 KSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455
+PE G ++ D WSLG ++ E L G P +
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
E +G GSFG YKA+ T + +K + + ED + + L P I
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY----IT 62
Query: 317 FYYR---KEEKL-LVSDFVPNGSLANLLHVRRAPGQPG-LDWPIRLKIIKGVAKGLAYLY 371
YY K KL ++ ++ GS +LL +PG LD I++ V GL YL+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL-------KPGKLDETYIAFILREVLLGLEYLH 115
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK---------- 421
+E H +K++N+LL + L D+ + QL K
Sbjct: 116 EE----GKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFW 164
Query: 422 -SPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE + G K D+WSLGI +EL G+ P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 261 LGSGSFGSSYKAVLLTG--PAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPL 314
LG+GSFG A P + +KRF + S + K+ +H+ L ++HP + L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEK-SKIIKQKQVDHVFSERKILNYINHPFCVNL 96
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHV-RRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+ + LV +FV G L +R P G + ++ +I + L +Y++
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN-KEHAQLHMVAYKSPEFNQTDGVT 432
LK N+LLD +TD+ +V+ + + Y +PE G
Sbjct: 157 ----------LKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHG 206
Query: 433 RKTDVWSLGILILELLTGKFP 453
+ D W+LGI I E+L G P
Sbjct: 207 KAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFR---QMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
E +G G++G YKA LTG + +K+ R + V E ++ L L+HPN++ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE-ISLLKELNHPNIVKL 64
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ + + + LV +F+ + L + G I L +IK +YL++
Sbjct: 65 LDVIHTENKLYLVFEFL-HQDLKKFMDASPLSG-------IPLPLIK------SYLFQLL 110
Query: 375 PGVTLPHGH------LKSSNVLLDNAYEPLLTDYAL-----VPIVNKEHAQLHMVAYKSP 423
G+ H H LK N+L++ L D+ L VP+ H ++ + Y++P
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-EVVTLWYRAP 169
Query: 424 E-FNQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
E + D+WSLG + E++T + FP +
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G G+ G+ Y A+ + TG + +K+ KE + + +PN++ +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
Y +E +V +++ GSL +++ + +D + + + L +L+
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHSN---- 134
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVTR 433
+ H +KS N+LL LTD+ + E ++ + + +PE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 434 KTDVWSLGILILELLTGKFP 453
K D+WSLGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 52/206 (25%), Positives = 81/206 (39%), Gaps = 21/206 (10%)
Query: 261 LGSGSFGSSYKAVLLTGPA---MVVKRFRQMSNVGKED-FHEHMTRLGSLSHPNLLPLIA 316
+G+G FG G + +VVK R + ++ F + + L+HPN+L +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
LLV +F P G L N L R + ++ VA GL +L++
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---- 118
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH----AQLHMVAYK--SPEFNQTDG 430
H L N L + DY L E H V + +PE + G
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 431 -------VTRKTDVWSLGILILELLT 449
T+K+++WSLG+ + EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 39/165 (23%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 293 KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLD 352
+ DF + +G HPN++ L + + ++V++++ NGSL L R+ GQ +
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTV- 105
Query: 353 WPIRL-KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411
I+L +++G+A G+ YL + H L + N+L+++ ++D+ L ++ +
Sbjct: 106 --IQLVGMLRGIASGMKYL----SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159
Query: 412 HAQLHM-------VAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
+ + + +PE T +DVWS GI++ E+++
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 17/216 (7%)
Query: 248 FELNDLLRASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL 306
F DL +G G+FG+ K + +G M VKR R S V +++ + L +
Sbjct: 1 FTAEDLK--DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR--STVDEKEQKRLLMDLDVV 56
Query: 307 SHPNLLPLIAFYYR---KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGV 363
+ P I +Y +E + + + SL + + I KI
Sbjct: 57 MRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVAT 116
Query: 364 AKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---Y 420
K L YL +E + + H +K SN+LLD L D+ + + A+ Y
Sbjct: 117 VKALNYLKEE---LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY 173
Query: 421 KSPEF---NQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE + DG ++DVWSLGI + E+ TGKFP
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 45/200 (22%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G G+ G+ Y A+ + TG + +++ KE + + +PN++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
Y +E +V +++ GSL +++ + +D + + + L +L+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN---- 135
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL-HMVA---YKSPEFNQTDGVTR 433
+ H +KS N+LL LTD+ + E ++ MV + +PE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 434 KTDVWSLGILILELLTGKFP 453
K D+WSLGI+ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 261 LGSGSFGSSYKAVLL---------TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL 311
LG G+FGS V L TG + VK+ + + DF + L SL H N+
Sbjct: 12 LGKGNFGS----VELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 312 LPLIAFYY---RKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLA 368
+ Y R+ +L V +++P GSL + L R LD L + KG+
Sbjct: 68 VKYKGVCYSAGRRNLRL-VMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGME 122
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV--NKEHAQLHM-----VAYK 421
YL H L + N+L+++ + D+ L ++ +KE+ ++ + +
Sbjct: 123 YL----GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 422 SPEFNQTDGVTRKTDVWSLGILILELLT 449
+PE + +DVWS G+++ EL T
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 46/199 (23%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 260 VLGSGSFGSSYKAVLLTGPAMVVKR---FRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
V+G G+FG + +V+ + QM+ + L LSHPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+ + ++V ++ P G+LA + R LD L + L +++ +
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTK--- 120
Query: 377 VTLPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHMVA---YKSPEFNQTDGVT 432
+ H LK+ N+LLD + + D+ + I++ + +V Y SPE +
Sbjct: 121 -LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 433 RKTDVWSLGILILELLTGK 451
+K+D+W+LG ++ EL + K
Sbjct: 180 QKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 261 LGSGSFGSSYKAVLLTGPA----------MVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN 310
LG G+F + YK VL VV + + F E + + LSH +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
L+ L R +E ++V ++V G L LH R L W +L + K +A L YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLH--REKNNVSLHW--KLDVAKQLASALHYL 117
Query: 371 YKEFPGVTLPHGHLKSSNVLL-----DNAYEPL--LTDYAL-VPIVNKEHAQLHMVAYKS 422
+ L HG++ N+L+ + Y P L+D + + ++++E + + +
Sbjct: 118 EDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER-IPWIA 172
Query: 423 PEF--NQTDGVTRKTDVWSLGILILEL 447
PE N +T D WS G +LE+
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 259 EVLGSGSFGSSYKAVLLTGP------AMVVKRFRQMSNVGKEDFHEHMTR--LGSLSHPN 310
+VLG GSFG + +TGP AM K ++ + ++ M R L ++HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAM--KVLKKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 311 LLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
++ L + ++ E KL L+ DF+ G L L K + + + +
Sbjct: 60 IVKL-HYAFQTEGKLYLILDFLRGGDLFTRLS----------------KEVMFTEEDVKF 102
Query: 370 LYKEFPGVTLPHGH--------LKSSNVLLDNAYEPLLTDYAL----VPIVNKEHAQLHM 417
E + L H H LK N+LLD LTD+ L + K ++
Sbjct: 103 YLAEL-ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 161
Query: 418 VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGK 461
V Y +PE G T+ D WS G+L+ E+LTG P QGK
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGK 201
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 13/195 (6%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKR---FRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
+G G F YKA+ LL G + +K+ F M ++D + + L L HPN++ +A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+ E +V + G L+ ++ + + + K + L +++ +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLCSALEHMHSK--- 125
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVT 432
+ H +K +NV + L D L + + H + Y SPE +G
Sbjct: 126 -RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 433 RKTDVWSLGILILEL 447
K+D+WSLG L+ E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 261 LGSGSFGSSYKA-VLLTGPAMVVKRFRQMSNVGKEDFHEHMT-R----LGSLSHPNLLPL 314
+G G+ G +KA TG + +K+ ++ E + R L + HP ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKK---VALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ + +LV +++P L+ +L P ++ ++ + KG+AY++
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQ---VK-SYMRMLLKGVAYMHAN- 118
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL--HMVA---YKSPE--FNQ 427
G+ H LK +N+L+ + D+ L + ++E +L H VA Y++PE +
Sbjct: 119 -GIM--HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 428 ---TDGVTRKTDVWSLGILILELLTGK--FP 453
GV D+W++G + ELL G FP
Sbjct: 176 RKYDPGV----DLWAVGCIFAELLNGSPLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKR---FRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+ +G GSFG Y A + V + +M KE + + L + HPN++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRA---PGQPGLDWPIRLKIIKGVAKGLAYLYK 372
A + +V ++ G L ++ +R L W ++ ++ GL +++
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIHD 119
Query: 373 EFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVNK--EHAQ--LHMVAYKSPEFNQ 427
+ H +KS N+ L N L D+ + +N E A + Y SPE Q
Sbjct: 120 R----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP 453
KTD+WSLG ++ EL T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 259 EVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+ +G G FG V+L G + VK + ++ + F + + L H NL+ L+
Sbjct: 12 QTIGKGEFGD----VMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 316 AFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
++ L +V++++ GSL + L R+ G+ L LK V + + YL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---- 118
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN--KEHAQLHMVAYKSPEFNQTDGVT 432
H L + NVL+ ++D+ L + ++ +L V + +PE + +
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKFS 177
Query: 433 RKTDVWSLGILILELLT-GKFP 453
K+DVWS GIL+ E+ + G+ P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 47/223 (21%), Positives = 79/223 (35%), Gaps = 37/223 (16%)
Query: 259 EVLGSGSFGSSYKAVLLTGPA------MVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNL 311
LG G+FG + + VK ++ SN ++DF L + H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLL-----HVRRAPGQPGLDWPIR----LKIIKG 362
+ + ++V +++ +G L L + L+I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 363 VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-----------EPLLTDYALVPIVNKE 411
+A G+ YL H L + N L+ + TDY V
Sbjct: 131 IASGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV----GG 182
Query: 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
H L + + PE T ++DVWS G+++ E+ T GK P
Sbjct: 183 HTMLP-IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI-AFY 318
LG G+FG YKA TG K S ED+ + L S HPN++ L+ AFY
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 319 YRKEEKLLVSDFVPNGSL-ANLLHVRRAPGQPGLDWPIRLKII-KGVAKGLAYLYKEFPG 376
Y +L+ +F G++ A +L + R +P +++++ K + L YL++
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELERPLTEP------QIRVVCKQTLEALNYLHEN--- 122
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYAL----VPIVNKEHAQLHMVAYKSPEF-----NQ 427
+ H LK+ N+L + L D+ + + + + + + +PE ++
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 428 TDGVTRKTDVWSLGILILEL 447
K DVWSLGI ++E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 1e-06
Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 1/60 (1%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
L++L LS N+ T IP AF G+ LK + L+ N+ + P++ +GL L L+L GN+
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 16/199 (8%)
Query: 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV--GKEDFHEHMTR--LGSLSHPNLLPLIA 316
+G+G+FG + + + V K++ H H + L +SHP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLH-VRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
+ + ++ ++VP G L + L R GL + + L YL+
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE------IVCALEYLH---- 118
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVP-IVNKEHAQLHMVAYKSPEFNQTDGVTRK 434
+ + LK N+LLD LTD+ + ++ Y +PE Q+ G +
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKA 178
Query: 435 TDVWSLGILILELLTGKFP 453
D W+LGILI E+L G P
Sbjct: 179 VDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 58/228 (25%), Positives = 91/228 (39%), Gaps = 52/228 (22%)
Query: 253 LLRASAEVLGSGSFGSSYKAVLLTGP------AMVVKRFRQMSNVGKE-DFHEHMTRLGS 305
LLRA LG G+FG Y+ + + VK + + E DF +
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 306 LSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLL-HVRRAPGQPG-LDWPIRLKIIKGV 363
+H N++ LI + + + ++ + + G L + L R P +P L L + V
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 364 AKGLAYLYKEFPGVTLPHGHLKSSNVLLDN--------------AYEPLLTDY------A 403
AKG YL +E + H + + N LL A + Y A
Sbjct: 126 AKGCKYL-EENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 404 LVPIVNKEHAQLHMVAYKSPE-FNQTDGV-TRKTDVWSLGILILELLT 449
++PI + PE F DG+ T KTDVWS G+L+ E+ +
Sbjct: 182 MLPI-----------KWMPPEAF--LDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 43/183 (23%), Positives = 83/183 (45%), Gaps = 16/183 (8%)
Query: 276 TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335
TG + VK+ +E + + H N++ + Y +E +V +F+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 336 LANLL-HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA 394
L +++ H R Q + V + L+YL+ + GV H +KS ++LL +
Sbjct: 106 LTDIVTHTRMNEEQIA-------TVCLSVLRALSYLHNQ--GVI--HRDIKSDSILLTSD 154
Query: 395 YEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVTRKTDVWSLGILILELLTG 450
L+D+ V+KE + + + +PE + D+WSLGI+++E++ G
Sbjct: 155 GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
Query: 451 KFP 453
+ P
Sbjct: 215 EPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 243 NDREMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDF---HE 298
N +E FEL + +GSG++G YKA + TG +K + EDF +
Sbjct: 6 NPQEDFEL-------IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQ 55
Query: 299 HMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
+ + H N++ Y R+++ + +F GSL ++ HV + + + R
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL-DNAYEPLLTDYA----LVPIVNKEHA 413
+ +GL YL+ + H +K +N+LL DN + L D+ + + K +
Sbjct: 116 L-----QGLYYLHSK----GKMHRDIKGANILLTDNGHVK-LADFGVSAQITATIAKRKS 165
Query: 414 QLHMVAYKSPEFNQTD---GVTRKTDVWSLGILILEL 447
+ + +PE + G + D+W++GI +EL
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 33/221 (14%)
Query: 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFR---QMSNVGKE--DFHEHMTRLGSLSHPNL 311
++LG G+FG Y + TG + K+ + + KE + L +L H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 312 LPLIAFYYRKEEKLLV--SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
+ + EK L +++P GS+ + L A L + K + + +G++Y
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-----LTESVTRKYTRQILEGMSY 121
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---------- 419
L+ + H +K +N+L D+A L D+ +K + M
Sbjct: 122 LH----SNMIVHRDIKGANILRDSAGNVKLGDFG----ASKRLQTICMSGTGIRSVTGTP 173
Query: 420 -YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP-ANYLA 458
+ SPE +G RK DVWSLG ++E+LT K P A Y A
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV----VKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLL 312
+ LG GSFG + T V VK + ++S++ +DF + + SL H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLI 59
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG---LDWPIRLKIIKGVAKGLAY 369
L + V++ P GSL + L D+ ++ +A G+ Y
Sbjct: 60 RLYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRY 112
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL---VPIVNKEHAQLHM-----VAYK 421
L + H L + N+LL + + + D+ L +P N++H + A+
Sbjct: 113 LESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ-NEDHYVMEEHLKVPFAWC 167
Query: 422 SPEFNQTDGVTRKTDVWSLGILILELLT 449
+PE +T + +DVW G+ + E+ T
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLL-HVRRAPGQPGLDWPIRLKIIKGVAKGL 367
P ++ +Y E + + + GSL +L +R P + I K+ V +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE------ILGKVSIAVLRGL 116
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP--IVNKEHAQLHMVAYKSPEF 425
AYL ++ + H +K SN+L+++ E L D+ + I + ++ + +Y SPE
Sbjct: 117 AYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER 173
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
Q + ++D+WS+G+ ++EL G++P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 47/224 (20%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVG--KEDFHEHMTRLGSLS-HPNLLPL 314
EV+G G++G YKA TG + +K M + +E+ E L S HPN +
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYSNHPN---I 65
Query: 315 IAFY--YRK------EEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365
FY + K +++L LV + GS+ +L+ R G+ L I++ +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR-LKEEWIAYILRETLR 124
Query: 366 GLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK---- 421
GLAYL++ + H +K N+LL E L D+ + AQL +
Sbjct: 125 GLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGV-------SAQLDSTLGRRNTF 173
Query: 422 -------SPEF---NQTDGVT--RKTDVWSLGILILELLTGKFP 453
+PE ++ + ++DVWSLGI +EL GK P
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 30/228 (13%)
Query: 241 VNNDREMFELNDLLRASAEVLGSGSFGSSYKA-VLLTGPAMVVKRFRQMSNVGKEDFHEH 299
++ + +LNDL +GSG+ G YK TG M VK+ R+ N KE+
Sbjct: 5 IDGQKYPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRI 60
Query: 300 MTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF-------VPNGSLANLLHVRRAPGQPGLD 352
+ L + + P I Y ++D + + L LL +R Q +
Sbjct: 61 LMDLDVVLKSHDCPYIVKCY----GYFITDSDVFICMELMSTCLDKLL--KRI--QGPIP 112
Query: 353 WPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP--IVNK 410
I K+ + K L YL KE GV H +K SN+LLD + L D+ + + +K
Sbjct: 113 EDILGKMTVAIVKALHYL-KEKHGVI--HRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169
Query: 411 EHA-QLHMVAYKSPEF----NQTDGVTRKTDVWSLGILILELLTGKFP 453
AY +PE + + DVWSLGI ++EL TG+FP
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/210 (25%), Positives = 83/210 (39%), Gaps = 30/210 (14%)
Query: 259 EVLGSGSFGS----------SYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH 308
+V+G GSFG AV + +V+ R Q K E L ++ H
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ-----KHIMAERNVLLKNVKH 55
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKI-IKGVAKGL 367
P L+ L + E+ V DFV G L L R+ +P R + +A L
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP------RARFYAAEIASAL 109
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL----VPIVNKEHAQLHMVAYKSP 423
YL+ + + + LK N+LLD+ +LTD+ L + + Y +P
Sbjct: 110 GYLHS----INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
Query: 424 EFNQTDGVTRKTDVWSLGILILELLTGKFP 453
E + D W LG ++ E+L G P
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 42/241 (17%)
Query: 260 VLGSGSFGSSYKAVLL----TGPAMVVKR--FRQMSNVGKEDFHEHMTRLGSLSHPNLLP 313
VLG G+FG A L +V K ++S + D + L L HPN+
Sbjct: 7 VLGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI-- 61
Query: 314 LIAFY--YRKEEKLLVS-DFVPNGSLANLLHVRRAPGQPGLDWPIRLKI--IKGVAKGLA 368
IA+Y + + LL+ ++ G+L + + VR Q G + + + + + ++
Sbjct: 62 -IAYYNHFMDDNTLLIEMEYANGGTLYDKI-VR----QKGQLFEEEMVLWYLFQIVSAVS 115
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPE 424
Y++K + H +K+ N+ L A L D+ + I+ E++ V Y SPE
Sbjct: 116 YIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE 171
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGK--FPANYLAQGKGANADLATWVNSVVREEWTGE 482
Q K+D+W+LG ++ ELLT K F A + V +V+ +T
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT----------NPLNLVVKIVQGNYTPV 221
Query: 483 V 483
V
Sbjct: 222 V 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 12/108 (11%)
Query: 354 PIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA----LVPIVN 409
I KI + K L YL+ + +++ H +K SNVL++ + L D+ LV V
Sbjct: 103 DILGKIAVSIVKALEYLHSK---LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159
Query: 410 KEH---AQLHMVAYK-SPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
K + +M + +PE NQ G K+DVWSLGI ++EL TG+FP
Sbjct: 160 KTIDAGCKPYMAPERINPELNQK-GYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 34/209 (16%)
Query: 261 LGSGSFGSSYKA-VLLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLI 315
LG G FG V +K ++ ++ + EH+ L +HP ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK-RHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGL--DWPIRLKIIKGVAKGLAYL--- 370
+ K+ ++ ++ G L +L R GL ++ R I V YL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR------GLFDEYTARF-YIACVVLAFEYLHNR 112
Query: 371 ---YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV---NKEHAQLHMVAYKSPE 424
Y++ LK N+LLD+ L D+ + K Y +PE
Sbjct: 113 GIIYRD----------LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE 162
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP 453
G D WSLGIL+ ELLTG+ P
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 27/215 (12%)
Query: 261 LGSGSFGSSYKAVLLT------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
LG G+FG + A + VK + S+ ++DFH L +L H +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLH------VRRAPGQP--GLDWPIRLKIIKGVAKG 366
+ ++V +++ +G L L V A G L L I + +A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-------HAQLHMVA 419
+ YL + H L + N L+ + D+ + V H L +
Sbjct: 133 MVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-IR 187
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
+ PE T ++DVWSLG+++ E+ T GK P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRF---RQMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
++G GS+G K TG + +K+F V K E + L L H NL+ L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE-IRMLKQLRHENLVNL 65
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
I + RK+ LV +FV + L +L + P GLD K + + +G+ + +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDL---EKYPN--GLDESRVRKYLFQILRGIEFCHSH- 119
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQLHMVA---YKSPEFNQTD- 429
+ H +K N+L+ + L D+ + VA Y++PE D
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 430 GVTRKTDVWSLGILILELLTGK--FPAN 455
R D+W++G L+ E+LTG+ FP +
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 5e-06
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 67/231 (29%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ-MSNVG------KEDFHEHMTRLGSLSHPN 310
E LG G++G YKA TG + +K+ R G +E ++ L L HPN
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE-----ISLLKELKHPN 59
Query: 311 LLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVA----K 365
++ L+ + E KL LV ++ L L R P + +IK + +
Sbjct: 60 IVKLLDVIH-TERKLYLVFEYCDM-DLKKYLDKRPGP--------LSPNLIKSIMYQLLR 109
Query: 366 GLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYAL-----VPIVNKEHAQ 414
GLAY H H LK N+L++ L D+ L +P+
Sbjct: 110 GLAYC----------HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----RTY 155
Query: 415 LHMVA---YKSPE-----FNQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
H V Y++PE + + V D+WS+G + E++TGK FP +
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 36/211 (17%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVK--------RFRQMSNVGKEDFHEHMTRLGSLSHP 309
E LG+GSFG A TG +K + +Q+ +V +E + L LSHP
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEK-----SILMELSHP 78
Query: 310 NLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKG--- 366
++ ++ + + + +FV G L H+R+A P VAK
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFP-----------NDVAKFYHA 125
Query: 367 ---LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL-HMVAYKS 422
LA+ Y + + LK N+LLDN +TD+ V L Y +
Sbjct: 126 ELVLAFEYLHSKDII--YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLA 183
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE Q+ G + D W++G+L+ E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 261 LGSGSFGSSYKAVLL-TGPAMVVKRF---RQMSNVGKE--DFHEHMTRLGSLSHPNLLPL 314
LG G+FG Y + TG + VK+ KE + L +L H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER---- 65
Query: 315 IAFYY---RKEEKLLV-SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
I YY R +E L + +++P GS+ + L +A G L + K + + +G+ YL
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQL---KAYG--ALTETVTRKYTRQILEGVEYL 120
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA-------YKSP 423
+ + H +K +N+L D+A L D+ + + + + SP
Sbjct: 121 HSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 424 EFNQTDGVTRKTDVWSLGILILELLTGKFP-ANYLA 458
E +G RK DVWS+G ++E+LT K P A + A
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 46/216 (21%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAM------VVKRFRQMSNVGK-EDFHEHMTRLGSLSHPNL 311
E LG +FG YK L P M +K + ++N + +F + + + L HPN+
Sbjct: 11 EELGECAFGKIYKGHLYL-PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG------------LDWPIRLKI 359
+ L+ +++ ++ +++ G L L +R G LD L I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV-PIVNKEHAQLHM- 417
+A G+ YL F H L + N+L+ ++D L I + ++ ++
Sbjct: 130 AIQIAAGMEYLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 418 ----VAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
+ + PE + +D+WS G+++ E+ +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 261 LGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLI-A 316
LG G+ GS K L TG +K N + K+ E + S P ++ A
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRE-LEINKSCKSPYIVKYYGA 67
Query: 317 FYYRKEEKL-LVSDFVPNGSLANLL-HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
F + + ++ GSL ++ V++ G+ G + + KI + V KGL+YL+
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG-EKVL-GKIAESVLKGLSYLHSR- 124
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALV-PIVNKEHAQLHMVA-YKSPEFNQTDGVT 432
+ H +K SN+LL + L D+ + +VN + Y +PE Q +
Sbjct: 125 ---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYS 181
Query: 433 RKTDVWSLGILILELLTGKFP 453
+DVWSLG+ +LE+ +FP
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 14/197 (7%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E+LG G+FG +K L + VK ++ + K F L HPN++ LI
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+++ +V + VP G + L R+ + ++ + A G+AYL +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFAL--DAAAGMAYLESK---- 112
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVP-----IVNKEHAQLHMVAYKSPEFNQTDGVT 432
H L + N L+ ++D+ + I + + + + +PE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 433 RKTDVWSLGILILELLT 449
++DVWS GIL+ E +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 40/217 (18%)
Query: 259 EVLGSGSFGSSY--------------KAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLG 304
E LGSG+FG Y K + + PA + + ++G D +T +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG--DIVSEVTIIK 63
Query: 305 -SLSHPNLLPLIAFYYR---KEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLD---WPIR 356
L HPN I YY+ + ++L +V D + L + + Q + W I
Sbjct: 64 EQLRHPN----IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 357 LKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH 416
++++ L YL+KE V H L +N++L + +TD+ L E ++L
Sbjct: 120 VQMVLA----LRYLHKEKRIV---HRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLT 171
Query: 417 MVA----YKSPEFNQTDGVTRKTDVWSLGILILELLT 449
V Y PE + + K DVW+ G ++ ++ T
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 1e-05
Identities = 20/60 (33%), Positives = 27/60 (45%), Gaps = 2/60 (3%)
Query: 64 QLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQL 121
LK + L+ N + + GL L L+L GN+ P+ L L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 47/199 (23%), Positives = 88/199 (44%), Gaps = 17/199 (8%)
Query: 261 LGSGSFG-SSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYY 319
+G GS G V +G + VK+ +E + + H N++ + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 320 RKEEKLLVSDFVPNGSLANLL-HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+E +V +F+ G+L +++ H R Q + V K L+ L+ + GV
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLHAQ--GVI 138
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVTRK 434
H +KS ++LL + L+D+ V+KE + + + +PE +
Sbjct: 139 --HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 435 TDVWSLGILILELLTGKFP 453
D+WSLGI+++E++ G+ P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 24/217 (11%)
Query: 260 VLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
VLG G++G Y A L T + +K + + + HE + L H N++ +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+ + VP GSL+ LL + P + I K + +GL YL+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT--KQILEGLKYLHDN----Q 128
Query: 379 LPHGHLKSSNVLLDNAYEPLL--TDYALVPIVNKEHAQLHMVA--------YKSPEF--N 426
+ H +K NVL+ N Y ++ +D+ +K A ++ Y +PE
Sbjct: 129 IVHRDIKGDNVLV-NTYSGVVKISDFG----TSKRLAGINPCTETFTGTLQYMAPEVIDK 183
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA 463
G D+WSLG I+E+ TGK P L + + A
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 29/213 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFH-------EHMTRLGSLSHPNL 311
+V+G G+FG KA + + ++M +D H E + +LG HPN+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 70
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRA-PGQPGLDWPIR----------LKII 360
+ L+ + L ++ P+G+L + L R P L
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 361 KGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP----IVNKEHAQLH 416
VA+G+ YL ++ H L + N+L+ Y + D+ L V K +L
Sbjct: 131 ADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186
Query: 417 MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
V + + E T +DVWS G+L+ E+++
Sbjct: 187 -VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 45/206 (21%), Positives = 83/206 (40%), Gaps = 23/206 (11%)
Query: 261 LGSGSFGSSYKAVLLTGPAMV----VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
+G G F Y+A L V V+ F M ++D + + L L+HPN++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 317 FYYRKEEKLLVSDFVPNGSLANLL-----HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ E +V + G L+ ++ R P + + ++L + +++
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL------CSAVEHMH 123
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQ 427
+ H +K +NV + L D L + + H + Y SPE
Sbjct: 124 SR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP 453
+G K+D+WSLG L+ E+ + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 19/105 (18%)
Query: 358 KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH- 416
KI V +GL YL ++ + H +K SN+L+++ E L D+ + QL
Sbjct: 103 KISIAVLRGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGV-------SGQLID 152
Query: 417 -MV-------AYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
M +Y SPE Q T ++D+WSLG+ ++E+ G++P
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 52/242 (21%), Positives = 102/242 (42%), Gaps = 34/242 (14%)
Query: 227 FVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGS----SYKAVLLTGPAMVV 282
F+N D I+K+ + E +E+ +V+G G+FG +K+ ++
Sbjct: 24 FLNRYKDTINKIRDLRMKAEDYEV-------VKVIGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 283 KRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLL--VSDFVPNGSLANLL 340
+F + F E + + P ++ L FY ++++ L V +++P G L NL+
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLM 134
Query: 341 HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400
P + + + + + +++++ +K N+LLD + L
Sbjct: 135 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD----------VKPDNMLLDKSGHLKLA 184
Query: 401 DYALVPIVNKE-----HAQLHMVAYKSPEFNQTDG----VTRKTDVWSLGILILELLTGK 451
D+ +NKE + Y SPE ++ G R+ D WS+G+ + E+L G
Sbjct: 185 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244
Query: 452 FP 453
P
Sbjct: 245 TP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 21/205 (10%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKR---FRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
+G G F Y+A LL G + +K+ F M + D + + L L+HPN++ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 317 FYYRKEEKLLVSDFVPNGSLANLL-HVRRAPGQPGLDWPIRLKIIKGVAKGLAYL---YK 372
+ E +V + G L+ ++ H ++ RL K V K L +
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQK---------RLIPEKTVWKYFVQLCSALE 120
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQT 428
+ H +K +NV + L D L + + H + Y SPE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 429 DGVTRKTDVWSLGILILELLTGKFP 453
+G K+D+WSLG L+ E+ + P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 259 EVLGSGSFGSSYKAVLL-TGP-----AMVVKRFRQMSNVG-KEDF-HEHMTRLGSLSHPN 310
E LG FG YK L T P A+ +K + + +E+F HE M R L HPN
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR-SRLQHPN 69
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPG------------QPGLDWPIRLK 358
++ L+ +++ ++ + + L L V R+P + L+ +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFL-VMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM- 417
I+ +A G+ +L + H L + NVL+ + ++D L V M
Sbjct: 129 IVTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 418 -----VAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
+ + SPE + +D+WS G+++ E+ +
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 17/167 (10%)
Query: 296 FHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPI 355
F E + + +SH +++ L R E ++V +FV G L +H + L P
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV----LTTPW 106
Query: 356 RLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL-----DNAYEPL--LTDYALVPIV 408
+ K+ K +A L+YL + L HG++ + N+LL D P L+D + V
Sbjct: 107 KFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162
Query: 409 NKEHAQLHMVAYKSPE-FNQTDGVTRKTDVWSLGILILEL-LTGKFP 453
+ + + +PE + ++ D WS G + E+ G+ P
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY- 318
LG G++GS YK + TG M +K R + K F++ + L L ++ FY
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK--FNQIIMELDILHKAVSPYIVDFYG 66
Query: 319 --YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+ + + +++ GSL L A G+ + +I V KGL +L +E
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATE--GIPEDVLRRITYAVVKGLKFLKEEH-- 122
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM--VAYKSPE------FNQT 428
+ H +K +NVL++ + L D+ + + A+ ++ +Y +PE NQ
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 429 DGVTRKTDVWSLGILILELLTGKFP 453
T ++DVWSLG+ ILE+ G++P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 21/200 (10%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIA 316
+G GS+G +K TG + +K+F + + K E + L L HPNL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE-IRMLKQLKHPNLVNLIE 67
Query: 317 FYYRKEEKLLVSDFVPNGSLANL-LHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
+ RK + LV ++ + L L + R G+ + KII + + + +K
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH-- 119
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN-KEHAQLHMVA---YKSPEFNQTDGV 431
H +K N+L+ + L D+ I+ VA Y++PE D
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 432 -TRKTDVWSLGILILELLTG 450
DVW++G + ELLTG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 65/289 (22%), Positives = 122/289 (42%), Gaps = 48/289 (16%)
Query: 186 NSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDR 245
+ E I + E + KA K + + + + + N+ DE D
Sbjct: 3 DWPIDEDINIYEEKNHKANKGG-SGKFEMNDKKLDEEERSHNNNAGEDE---------DE 52
Query: 246 EMFELNDLLRASAE------VLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHE 298
E ND+ R+ + ++G+GSFG Y+A+ + T + +K+ Q +
Sbjct: 53 EKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE--- 109
Query: 299 HMTRLGSLSHPNLLPLIAFYY----RKEEKLL----VSDFVPNGSLANLLHVRRAPGQPG 350
+ + +L+H N++ L +YY +K EK + V +F+P + H R
Sbjct: 110 -LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN----- 163
Query: 351 LDWPIRLKIIK----GVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALV 405
+ + L ++K + + LAY++ +F + H LK N+L+D N + L D+
Sbjct: 164 -NHALPLFLVKLYSYQLCRALAYIHSKF----ICHRDLKPQNLLIDPNTHTLKLCDFGSA 218
Query: 406 PIVNKEHAQLHMVA---YKSPEFN-QTDGVTRKTDVWSLGILILELLTG 450
+ + + Y++PE T D+WSLG +I E++ G
Sbjct: 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 49/220 (22%)
Query: 260 VLGSGSFGSSYKAVLLTGP------AMVVKRFRQMSNVGKEDFHEHMTR--LGSLSHPNL 311
VLG G +G ++ +TG AM V + + K+ H R L ++ HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 312 LPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGV-AKGLAY 369
+ LI + ++ KL L+ +++ G L +H+ R +G+ + A
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGEL--FMHLER----------------EGIFMEDTAC 103
Query: 370 LYKEFPGVTLPHGH--------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA-- 419
Y + L H H LK N+LLD LTD+ L KE V
Sbjct: 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC----KESIHEGTVTHT 159
Query: 420 ------YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE G + D WSLG L+ ++LTG P
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 32/233 (13%)
Query: 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQM-----SNVGKEDFHEHMTRLGSLSHPN 310
A + LG G FGS + L +++ + M + EDF + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 311 LLPLIAFYYRKEEK------LLVSDFVPNGSLANLLHVRRAPGQPG-LDWPIRLKIIKGV 363
++ LI + E +++ F+ +G L + L R P L + +K + +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 364 AKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP-IVNKEHAQLHMVAYKS 422
A G+ YL + + H L + N +L+ + D+ L I N ++ + +A
Sbjct: 122 ASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 423 PEFNQTDGV-----TRKTDVWSLGILILELLT-GKFP---------ANYLAQG 460
++ + + T K+DVWS G+ + E+ T G+ P +YL QG
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG 230
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 43/223 (19%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVG----KEDFHEH-----------MTRL 303
+ LG G+FG KA + + S V K+D E M +
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNP-----NETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 304 GSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQ---PGLDWPIRLKII 360
G H N++ L+ ++ +V ++ +G+L + L RR PG+ P P +
Sbjct: 73 GK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 361 K--------GVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN--- 409
+ VA+G+ +L + H L + NVL+ + + D+ L ++
Sbjct: 131 QKDLVSFAYQVARGMEFLASK----KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 410 --KEHAQLHM-VAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
++ + V + +PE T ++DVWS G+L+ E+ T
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 50/215 (23%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHP 309
+ LG+GSFG V+L +G +K + + + K EH+ L S+ HP
Sbjct: 7 KTLGTGSFGR----VMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 310 NLLPLIAFYYRKEEKLL--VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK-- 365
L+ L + +++ L V ++VP G L + L +P VA+
Sbjct: 62 FLVNLYGSF--QDDSNLYLVMEYVPGGELFSHLRKSGRFPEP-------------VARFY 106
Query: 366 ------GLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA 419
L YL+ + + LK N+LLD+ +TD+ V K + +
Sbjct: 107 AAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRT--YTLC 159
Query: 420 ----YKSPEFNQTDGVTRKTDVWSLGILILELLTG 450
Y +PE + G + D W+LGILI E+L G
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 260 VLGSGSFGSSY----KAVLLTGPAMVV--KRFRQMS-NVGKEDFHEHMTRLGSLSHPNLL 312
LG G FG + K + G +V K ++ + +F + LSH N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPI----RLKIIKGVAKGLA 368
L+ E ++ ++ G L L ++ + P+ ++ + +A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV-NKE---HAQLHM-VAYKSP 423
+L H L + N L+ + E ++ +L V N E + + + +P
Sbjct: 132 HLSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 424 EFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
E Q D + K+DVWS G+L+ E+ T G+ P
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 58/231 (25%)
Query: 260 VLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPL 314
+G G++G YKA TG + +K+ R + N KE F R L L+H N++ L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR-LDN-EKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 315 ----------IAFYYRKEEKLLVSDFVPNGSLANLL----------HVRRAPGQPGLDWP 354
+ F K LV +++ + L LL H++
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIK----------- 119
Query: 355 IRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQ 414
+K + +GL Y +K+ H +K SN+LL+N + L D+ L + N E ++
Sbjct: 120 ---SFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 415 LH-----MVAYKSPEFNQTDGVTRKT---DVWSLGILILELLTGK--FPAN 455
+ + Y+ PE G R DVWS G ++ EL T K F AN
Sbjct: 173 PYTNKVITLWYRPPEL--LLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 29/209 (13%)
Query: 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
AE LG G+ + VL+ VK R ++ + DF + + + L +PN++ L+
Sbjct: 30 AEFLGEGAPEFDGQPVLVA-----VKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQ-------PGLDWPIRLKIIKGVAKGLAY 369
+ ++++++ NG L L R P + L + +A G+ Y
Sbjct: 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKY 144
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL---------VPIVNKEHAQLHMVAY 420
L + H L + N L+ N Y + D+ + I + + +A+
Sbjct: 145 L----ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW 200
Query: 421 KSPEFNQTDGVTRKTDVWSLGILILELLT 449
+S + T +DVW+ G+ + E+ T
Sbjct: 201 ESILLGK---FTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 38/151 (25%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 308 HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLL-HVRRAPGQPGLDWPIRLKIIKGVAKG 366
HPN++ + + Y +E +V +F+ G+L +++ H R ++ + V K
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-------MNEEQIATVCLAVLKA 127
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKS 422
L++L+ + GV H +KS ++LL + L+D+ V+KE + + + +
Sbjct: 128 LSFLHAQ--GVI--HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE + D+WSLGI+++E++ G+ P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLH-VRRAPGQPGLDWPIRLKIIKGVAKGL 367
P ++ +Y E + + + GSL +L R P Q I K+ V KGL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ------ILGKVSIAVIKGL 116
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP--IVNKEHAQLHMVAYKSPEF 425
YL ++ + H +K SN+L+++ E L D+ + I + ++ + +Y SPE
Sbjct: 117 TYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER 173
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
Q + ++D+WS+G+ ++E+ G++P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 45/220 (20%)
Query: 260 VLGSGSFGSSYKAVLLTGP------AMVVKRFRQMSNVGKEDFHEH-MTRLGSLSHPNLL 312
VLG+G++G + + G AM K ++ + V K EH T L
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAM--KVLKKATIVQKAKTAEHTRTERQVLEAVRRC 64
Query: 313 P-LIAFYY--RKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLA 368
P L+ +Y + + KL L+ D+V G L L+ R + + +R+ I + V
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIV----- 115
Query: 369 YLYKEFPGVTLPHGH--------LKSSNVLLDNAYEPLLTDYAL-----VPIVNKEHAQL 415
+ L H H +K N+LLD+ +LTD+ L + ++
Sbjct: 116 --------LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC 167
Query: 416 HMVAYKSPEF--NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ Y +PE + G + D WSLG+L ELLTG P
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRF-----RQMSNVGKEDFHEHMTRLGSLSHPNL 311
++LG G+FG Y TG + VK+ Q ++ + L +L H +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 312 LPLIAFYYRKEEKLL--VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
+ EEK L +++P GS+ + L +A G L + + + + +G++Y
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYG--ALTENVTRRYTRQILQGVSY 121
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---------- 419
L+ + H +K +N+L D+A L D+ +K + M
Sbjct: 122 LH----SNMIVHRDIKGANILRDSAGNVKLGDFG----ASKRIQTICMSGTGIKSVTGTP 173
Query: 420 -YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ SPE +G RK DVWS+ ++E+LT K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 40/215 (18%)
Query: 259 EVLGSGSFG----------SSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH 308
+V+G GSFG S+ AV + ++K+ Q E L +L H
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ-----NHIMAERNVLLKNLKH 55
Query: 309 PNLLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKG 366
P L+ L + ++ EKL V D+V G L L R +P R + VA
Sbjct: 56 PFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP------RARFYAAEVASA 108
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA------- 419
+ YL+ + + + LK N+LLD+ +LTD+ L KE +
Sbjct: 109 IGYLHS----LNIIYRDLKPENILLDSQGHVVLTDFGLC----KEGVEPEETTSTFCGTP 160
Query: 420 -YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE + + R D W LG ++ E+L G P
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 259 EVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVGKEDFHEHM-TRLGSLSHPNLLP 313
+VLG+G++G + + +G +K ++ + V K EH T L H P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 314 LIA---FYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLA 368
+ + ++ + KL L+ D++ G L L R + ++I G + L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ------EVQIYSGEIVLALE 119
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL-----VPIVNKEHAQLHMVAYKSP 423
+L+K + + + +K N+LLD+ +LTD+ L V + ++ + Y +P
Sbjct: 120 HLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 424 EF--NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ G + D WS+G+L+ ELLTG P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 51/232 (21%), Positives = 90/232 (38%), Gaps = 64/232 (27%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFH----EHMTRLGSLSHPNLLPLI 315
LG G+FG YKA + TG + +K+ + + K+ F + L L HPN++PLI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 316 AFYYRKEEKL-------------LVSDFVPNGSLANLLH---VRRAPGQPGLDWPIRLKI 359
+ +K + D L+ LL V+ Q I+
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHD------LSGLLENPSVKLTESQ------IKC-Y 120
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV------------PI 407
+ + +G+ YL++ + H +K++N+L+DN + D+ L
Sbjct: 121 MLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 408 VNKEHAQLHMVA---YKSPEF-----NQTDGVTRKTDVWSLGILILELLTGK 451
++V Y+ PE T V D+W +G + E+ T +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 24/211 (11%)
Query: 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFR---QMSNVGKE--DFHEHMTRLGSLSHPNL 311
++LG G+FG Y TG + VK+ + + KE + L +L H +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 312 LPLIAFYYRKEEKLL--VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
+ E+ L + +P GS+ + L A L + K + + +G++Y
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-----LTENVTRKYTRQILEGVSY 121
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA----LVPIVNKEHAQLHMVA---YKS 422
L+ + H +K +N+L D+ L D+ L I + + S
Sbjct: 122 LHSNM----IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE +G RK D+WS+G ++E+LT K P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 44/195 (22%), Positives = 85/195 (43%), Gaps = 17/195 (8%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYY 319
+GSG++G YKA L TG VK + + + + H N++ Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 320 RKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTL 379
+E+ + ++ GSL ++ HV + + + R + +GLAYL+ +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK----GK 127
Query: 380 PHGHLKSSNVLLDNAYEPLLTDYA----LVPIVNKEHAQLHMVAYKSPE---FNQTDGVT 432
H +K +N+LL + + L D+ + + K + + + +PE + G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 433 RKTDVWSLGILILEL 447
+ D+W++GI +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G G++G YK G VK +S+V +E E+ +HPN++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 318 YYRKEEKL-----LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
+Y+ ++ + LV + GS+ L+ GQ LD + I+ G GL +L+
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA----LVPIVNKEHAQLHMVAYKSPEF--- 425
+ H +K +N+LL L D+ L + + + + +PE
Sbjct: 147 N----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202
Query: 426 -NQTD-GVTRKTDVWSLGILILELLTGKFP 453
Q D + DVWSLGI +EL G P
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 35/150 (23%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 308 HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL 367
H N++ + Y EE ++ +F+ G+L +++ R L+ + + V + L
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQAL 130
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSP 423
YL+ + GV H +KS ++LL L+D+ ++K+ + + + +P
Sbjct: 131 CYLHSQ--GVI--HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 424 EFNQTDGVTRKTDVWSLGILILELLTGKFP 453
E + D+WSLGI+++E++ G+ P
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 303 LGSLSHPNLLPLIAFYYRKEEKLLVSDFVP--NGSLANLLHVRRAPGQPGLDWPIRLKII 360
L +++HP+++ + +V +P + L L R P L L I
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRP----LPIDQALIIE 163
Query: 361 KGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY--ALVPIVNKEHAQLH-M 417
K + +GL YL+ + H +K+ N+ +++ + + D A P+V L
Sbjct: 164 KQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219
Query: 418 VAYKSPEFNQTDGVTRKTDVWSLGILILELL 448
V +PE D K D+WS GI++ E+L
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 25/209 (11%)
Query: 259 EVLGSGSFGSSYKAVL--------LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN 310
E LG G+F +K + L +++K + E F E + + LSH +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
L+ +E ++V ++V GSL ++++ + W + VAK LA+
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLD--TYLKKNKNLINISWKLE------VAKQLAWA 112
Query: 371 YKEFPGVTLPHGHLKSSNVLL------DNAYEPL--LTDYALVPIVNKEHAQLHMVAYKS 422
L HG++ + NVLL P L+D + V + L + +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVP 172
Query: 423 PE-FNQTDGVTRKTDVWSLGILILELLTG 450
PE ++ D WS G + E+ +G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 24/207 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTR-----LGSLSHPNLLP 313
+V+G GSFG A + Q + K+ +H+ L ++ HP L+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 314 LIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLAYLY 371
L F ++ +KL V D++ G L L R +P R + +A L YL+
Sbjct: 61 L-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASALGYLH 113
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV-----AYKSPEFN 426
+ + + LK N+LLD+ +LTD+ L N EH Y +PE
Sbjct: 114 S----LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
R D W LG ++ E+L G P
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
EV+G+G++G YK + + + ++ +E+ + L SH IA Y
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRN---IATY 78
Query: 319 Y----------RKEEKLLVSDFVPNGSLANLLHVRRAPGQP-GLDWPIRLKIIKGVAKGL 367
Y ++ LV +F GS+ +L V+ G DW I + + +GL
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL--VKNTKGNALKEDWIAY--ICREILRGL 134
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA----LVPIVNKEHAQLHMVAYKSP 423
A+L+ + H +K NVLL E L D+ L V + + + + +P
Sbjct: 135 AHLHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
Query: 424 EF-----NQTDGVTRKTDVWSLGILILELLTGKFP 453
E N ++D+WSLGI +E+ G P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G G++G +K + G VK + ++ +E E+ HPN++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 318 YYRKEEK-----LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
YY+K+ K LV + GS+ +L+ G+ ++ PI I+ GL +L+
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEALMGLQHLHV 142
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL-VPIVNKEHAQLHMVA---YKSPEF--- 425
H +K +N+LL L D+ + + + + V + +PE
Sbjct: 143 N----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 426 -NQTDGV-TRKTDVWSLGILILELLTGKFP 453
Q D + DVWSLGI +EL G P
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH-PNLLPLIAF 317
E++G+G++G YK + + + ++ +E+ + + L SH N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 318 YYRK------EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ +K ++ LV +F GS+ +L ++ G + I I + + +GL++L+
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAY-ICREILRGLSHLH 128
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA----LVPIVNKEHAQLHMVAYKSPEF-- 425
+ + H +K NVLL E L D+ L V + + + + +PE
Sbjct: 129 QH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 426 ---NQTDGVTRKTDVWSLGILILELLTGKFP 453
N K+D+WSLGI +E+ G P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 31/129 (24%)
Query: 351 LDWPIR---------LKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL---DNAYEPL 398
LDW ++ +II L Y + E + L H LK N+L+ D +P+
Sbjct: 219 LDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE---LHLMHTDLKPENILMETSDTVVDPV 275
Query: 399 LTDYALVP------------IVNKEHAQLHMVA---YKSPEFNQTDGVTRKTDVWSLGIL 443
T+ AL P ++ H++ +V+ Y+SPE G TD+WS+G +
Sbjct: 276 -TNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334
Query: 444 ILELLTGKF 452
I EL TGK
Sbjct: 335 IYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 261 LGSGSFGSSYKA----VLLTGPAMVV--KRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
LG G+FG + A +L M+V K ++ S ++DF L L H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVR------------RAPGQPGLDWPIRLKIIKG 362
L+V +++ +G L L APGQ L L I
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL--GQMLAIASQ 130
Query: 363 VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV-PIVNKEHAQ-----LH 416
+A G+ YL + H L + N L+ + D+ + I + ++ + +
Sbjct: 131 IASGMVYL----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 417 MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
+ + PE T ++D+WS G+++ E+ T GK P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 26/110 (23%), Positives = 47/110 (42%), Gaps = 7/110 (6%)
Query: 347 GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL-- 404
G+PG + + GL +L++ + + LK NVLLD+ ++D L
Sbjct: 88 GEPGFPEARAIFYAAQIICGLEHLHQRR----IVYRDLKPENVLLDDHGNVRISDLGLAV 143
Query: 405 -VPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ K + Y +PE Q + D ++LG + E++ G+ P
Sbjct: 144 ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 47/222 (21%), Positives = 87/222 (39%), Gaps = 40/222 (18%)
Query: 261 LGSGSFGSSYKAVLLTGPAMV---------VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPN 310
+G G+FG ++A P ++ VK ++ S + DF + HPN
Sbjct: 13 IGQGAFGRVFQA---RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVR---------------RAPGQPGLDW-- 353
++ L+ + L+ +++ G L L R R G L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 354 PIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV-PIVNKEH 412
+L I K VA G+AYL + H L + N L+ + D+ L I + ++
Sbjct: 130 TEQLCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 413 AQLHM-----VAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
+ + + PE + T ++DVW+ G+++ E+ +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 259 EVLGSGSFGSSYKAVLL--------TGPAMVVKRF-RQMSNVGKEDFHEHMTRLGSLSHP 309
VLG G FG K L TG + VK R+ + + + L +L H
Sbjct: 10 RVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 310 NLLPLIAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL 367
N++ + K L+ ++VP GSL + L + L+ L + + +G+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGM 120
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-------VAY 420
AYL+ + H L + NVLLDN + D+ L V + H + V +
Sbjct: 121 AYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 421 KSPEFNQTDGVTRKTDVWSLGILILELLT 449
+ E + + + +DVWS G+ + ELLT
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 51/201 (25%), Positives = 82/201 (40%), Gaps = 14/201 (6%)
Query: 260 VLGSGSFGSSYKA-VLLTGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
VLG G FG V TG K+ +++ E + R+ + + +A
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 317 FYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
+ Y ++ L LV + G L H+ G PG D + + GL L +E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLK--FHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYAL---VPIVNKEHAQLHMVAYKSPEFNQTDGVT 432
+ + LK N+LLD+ ++D L +P ++ V Y +PE + T
Sbjct: 122 --RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 433 RKTDVWSLGILILELLTGKFP 453
D W LG LI E++ G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 260 VLGSGSFGSSYKAVLL----TGPAM--VVKRFRQMSNVG-KEDFHEH---MTRLGSLSHP 309
LG+G+FG +A + M VK + ++ +E M+ LG+ H
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HE 99
Query: 310 NLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
N++ L+ L+++++ G L N L +R + L L VAKG+A+
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAF 156
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV-------PIVNKEHAQLHMVAYKS 422
L + H L + NVLL + + D+ L V K +A+L V + +
Sbjct: 157 LASK----NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP-VKWMA 211
Query: 423 PEFNQTDGV-TRKTDVWSLGILILELLT 449
PE + + V T ++DVWS GIL+ E+ +
Sbjct: 212 PE-SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 53/229 (23%)
Query: 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQ--MSNV-GKEDFHE-----HMTRLGSLSHP 309
+GSG++G A TG + +K+ + S + K + E HM H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM------DHE 74
Query: 310 NLLPLIAFYYRKEEK------LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGV 363
N++ L+ + LV+ + L N++ ++ D I+ ++ +
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLS-----DDHIQF-LVYQI 127
Query: 364 AKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---Y 420
+GL Y++ + H LK SN+ ++ E + D+ L + E VA Y
Sbjct: 128 LRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG--YVATRWY 181
Query: 421 KSPE-------FNQTDGVTRKTDVWSLGILILELLTGK--FPA-NYLAQ 459
++PE +NQT D+WS+G ++ ELLTGK FP +++ Q
Sbjct: 182 RAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGKTLFPGSDHIDQ 224
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 315 IAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+A+ Y ++ L LV + G L H+ G+ G + + + GL L++E
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLK--FHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL---VPIVNKEHAQLHMVAYKSPEFNQTDG 430
+ + LK N+LLD+ ++D L VP ++ V Y +PE + +
Sbjct: 122 ----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 177
Query: 431 VTRKTDVWSLGILILELLTGKFP 453
T D W+LG L+ E++ G+ P
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 26/105 (24%), Positives = 48/105 (45%), Gaps = 10/105 (9%)
Query: 353 WPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV-----PI 407
R I+K + + Y++ + L H +K N+ L+ + +L D+
Sbjct: 267 KQTR-AIMKQLLCAVEYIHDKK----LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 408 VNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKF 452
++ + VA SPE DG TD+WS G+++L++L+ F
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 55/235 (23%), Positives = 91/235 (38%), Gaps = 58/235 (24%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFR--QMSNVGKEDFHE------HMTRLGSL----- 306
LG G++G KA LTG + +K+ + ++SN +D H T L L
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 307 -SHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK------I 359
H N++ L+ Y + LV D + L ++ + IRL I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK-----------IRLTESQVKCI 124
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV------PIVNKEHA 413
+ + GL L+K + H L +N+ +++ + D+ L P +
Sbjct: 125 LLQILNGLNVLHKWY----FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 414 QLHM------------VAYKSPEF-NQTDGVTRKTDVWSLGILILELLTGK--FP 453
M + Y++PE + D+WS+G + ELLTGK FP
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235
|
Length = 335 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 14/201 (6%)
Query: 260 VLGSGSFGSSYKA-VLLTGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
VLG G FG V TG KR +++ E + ++ + + +A
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 317 FYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
+ Y ++ L LV + G L H+ G PG + L + GL L++E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLK--FHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYAL---VPIVNKEHAQLHMVAYKSPEFNQTDGVT 432
+ LK N+LLD+ ++D L +P ++ V Y +PE T
Sbjct: 122 --NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 433 RKTDVWSLGILILELLTGKFP 453
D W LG LI E++ G+ P
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 25/207 (12%)
Query: 261 LGSGSFGSSYKAVLLTG--PA-MVVKRFRQMSNVGKE-DFHEHMTRLGSLSHPNLLPLIA 316
+G+G FG + +G PA +VVK R ++V ++ F E SL H NLL +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
LLV +F P G L L R D ++ +A GL +L+K
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-----AQLHM-VAYKSPEFNQTDG 430
H L N LL + DY L KE QL + + + +PE D
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL--VDE 176
Query: 431 V---------TRKTDVWSLGILILELL 448
V T++++VWSLG+ I EL
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPL 314
E +G G++G YK TG + +K+ R S V E ++ L L HPN++ L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE-ISLLKELQHPNIVCL 64
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
++ L+ +F+ S+ ++ P +D +K +YLY+
Sbjct: 65 QDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMD-AELVK---------SYLYQIL 111
Query: 375 PGVTLPHGH------LKSSNVLLDNAYEPLLTDYAL-----VPIVNKEHAQLHMVAYKSP 423
G+ H LK N+L+DN L D+ L +P+ H ++ + Y++P
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-EVVTLWYRAP 170
Query: 424 EFNQTDGVTRKT---DVWSLGILILELLTGK 451
E G R + D+WS+G + E+ T K
Sbjct: 171 EV--LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 34/220 (15%)
Query: 261 LGSGSFGSSYKA----VLLTGPAMVV--KRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
LG G+FG + A + T M+V K + + ++DF L +L H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHV-------------RRAPGQPGLDWPIRLKIIK 361
+ ++V +++ +G L L R+A G+ GL L I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ--MLHIAS 130
Query: 362 GVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-------HAQ 414
+A G+ YL + H L + N L+ + D+ + V H
Sbjct: 131 QIASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 415 LHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
L + + PE T ++DVWS G+++ E+ T GK P
Sbjct: 187 LP-IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 31/196 (15%)
Query: 276 TGPAMVVKRFRQMSNVGKED---FHEHMTRLGSLSHPNLLPLIAFYYRKEEKLL-VSDFV 331
TG + +K R + + F L HPN++ L+ L V ++V
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 332 PNGSLANLLHVRRA--PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNV 389
P +L +L A G+ G +++ V LA + + G+ H LK N+
Sbjct: 62 PGRTLREVLAADGALPAGETG-------RLMLQVLDALACAHNQ--GIV--HRDLKPQNI 110
Query: 390 ------------LLDNAYEPLLTDY--ALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKT 435
+LD LL A V + + L Y +PE + + VT +
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS 170
Query: 436 DVWSLGILILELLTGK 451
D+++ G++ LE LTG+
Sbjct: 171 DLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 260 VLGSGSFGSSYKAVL----LTGPAMVVKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
V+G GSFG +A+L + +K R S+ ED + L + HPN++
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRA---PGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ +V ++ G L + ++R P L W +++ + G+ +++
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA----QLHMVAYKSPEFNQ 427
++ + H +KS N+ L + L D+ ++ A + Y PE +
Sbjct: 118 EK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP 453
K+D+WSLG ++ EL T K P
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 32/212 (15%)
Query: 260 VLGSGSFGSSYK----------AVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHP 309
V+G G+FG A+ V++ + NV E L L+HP
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK-GSVRNVLNE-----RRILQELNHP 60
Query: 310 NLLPLIAFY-YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL 367
L+ L +Y ++ EE + LV D + G L H+ + + ++ I + L
Sbjct: 61 FLVNL--WYSFQDEENMYLVVDLLLGGDLR--YHLSQ--KVKFSEEQVKF-WICEIVLAL 113
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV---AYKSPE 424
YL+ + G+ H +K N+LLD +TD+ + V + Y +PE
Sbjct: 114 EYLHSK--GII--HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFPANY 456
G + D WSLG+ E L GK P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 25/207 (12%)
Query: 259 EVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVGKEDFHEHMTR---LGSLSHPNL 311
++LG G+FG K +L+ +G +K ++ + K++ +T L + HP L
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLAYL 370
L + K+ V ++V G L L R + R + + L YL
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED------RTRFYGAEIVSALDYL 111
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFN 426
+ + + LK N++LD +TD+ L + A + Y +PE
Sbjct: 112 HSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
+ + R D W LG+++ E++ G+ P
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 259 EVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVGKEDFHEHMTR---LGSLSHPNL 311
++LG G+FG K +L+ TG +K ++ V K++ +T L + HP L
Sbjct: 1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLAYL 370
L + + V ++ G L L R + R + + L YL
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALDYL 111
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFN 426
+ E V + LK N++LD +TD+ L K+ A + Y +PE
Sbjct: 112 HSEKNVV---YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 168
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
+ + R D W LG+++ E++ G+ P
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 43/170 (25%), Positives = 80/170 (47%), Gaps = 26/170 (15%)
Query: 299 HMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
H+++L +HPN++P A + E +V+ F+ GS +L+ G L
Sbjct: 51 HVSKL--FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY--- 105
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY-ALVPIVNKEHAQ--- 414
I++GV K L Y++ + H +K+S++L+ + L+ + + ++N H Q
Sbjct: 106 ILQGVLKALDYIHH----MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN--HGQRLR 159
Query: 415 ---------LHMVAYKSPEFNQTD--GVTRKTDVWSLGILILELLTGKFP 453
+ ++ + SPE Q + G K+D++S+GI EL G P
Sbjct: 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 303 LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG 362
LG H N++ L R ++V++++ NG+L + L R+ GQ L + ++ G
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQ--LVAGQLMGMLPG 115
Query: 363 VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM----- 417
+A G+ YL + + H L + VL+++ ++ + + E M
Sbjct: 116 LASGMKYLSE----MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171
Query: 418 VAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
V + +PE Q + +DVWS GI++ E+++
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 31/214 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFH-------EHMTRLGSLSHPNL 311
+V+G G+FG +A++ + + + E+ H E + +LG HPN+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH--HPNI 65
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRA-PGQPG----------LDWPIRLKII 360
+ L+ + + ++ P G+L + L R P L L+
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 361 KGVAKGLAYLY-KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP----IVNKEHAQL 415
VA G+ YL K+F H L + NVL+ + D+ L V K +L
Sbjct: 126 SDVATGMQYLSEKQFI-----HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 416 HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
V + + E T K+DVWS G+L+ E+++
Sbjct: 181 P-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 53/235 (22%), Positives = 88/235 (37%), Gaps = 38/235 (16%)
Query: 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN 310
+++L G+FG + +L+ V S + + L LSH N
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGV------A 364
+LP++ E V P + NL + + P L + V A
Sbjct: 70 ILPILHVCIEDGEPPFV--LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 365 KGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL----VPIVNKEHA----QLH 416
G++YL+K + H + + N ++D + +TD AL P H +
Sbjct: 128 CGMSYLHKR----GVIHKDIAARNCVIDEELQVKITDNALSRDLFP--MDYHCLGDNENR 181
Query: 417 MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFP---------ANYLAQGK 461
V + + E + +DVWS G+L+ EL+T G+ P A YL G
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 24/107 (22%), Positives = 46/107 (42%), Gaps = 11/107 (10%)
Query: 358 KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP--IVNKEHAQL 415
K+IK + K + + + HG +K N+++D + DY + I++ +H +
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185
Query: 416 H---------MVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ Y + + VTR+ D+ SLG +L+ K P
Sbjct: 186 SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 261 LGSGSFGSSY----KAVLLTGPA--MVVKRFRQMSNVGKE-DFHEHMTRLGSLSHPNLLP 313
LG GSFG Y K V+ P + +K + +++ + +F + + + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRA--PGQPGLDWPIRLKIIK---GVAKGLA 368
L+ + + L++ + + G L + L R P P K+I+ +A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV------NKEHAQLHMVAYKS 422
YL H L + N ++ + + D+ + + K L V + S
Sbjct: 134 YLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 423 PEFNQTDGV-TRKTDVWSLGILILELLT 449
PE + DGV T +DVWS G+++ E+ T
Sbjct: 190 PE-SLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 260 VLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPL 314
V+G GSFG A G VK ++ + + K++ M L ++ HP L+ L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 315 IAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLAYLYK 372
+ ++ +KL V D+V G L H++R P R + +A L YL+
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP----EPRARFYAAEIASALGYLH- 113
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA--------YKSPE 424
+ + + LK N+LLD+ +LTD+ L KE + Y +PE
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLC----KEGIEHSKTTSTFCGTPEYLAPE 166
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ R D W LG ++ E+L G P
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 30/164 (18%)
Query: 308 HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL 367
HPN++ + ++S F+ GS +LL + G+ + I+ G +GL
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL---KTYFPEGMSEALIGNILFGALRGL 114
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDN----AYEPLLTDYALVPIVNKEHAQLHMVAYKSP 423
YL++ H ++K+S++L+ + L Y+LV + Q V Y P
Sbjct: 115 NYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLV-----RNGQKAKVVYDFP 165
Query: 424 EFNQT--------------DGVTRKTDVWSLGILILELLTGKFP 453
+F+ + G K+D++S+GI EL TG+ P
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 18/197 (9%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
E +G G+FG + L V VK R+ + K F + L SHPN++ LI
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+K+ +V + V G L R G P L +++++ A G+ YL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL---RTEG-PRLKVKELIQMVENAAAGMEYLESK--- 113
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYAL-------VPIVNKEHAQLHMVAYKSPEFNQTD 429
H L + N L+ ++D+ + V Q+ V + +PE
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP-VKWTAPEALNYG 171
Query: 430 GVTRKTDVWSLGILILE 446
+ ++DVWS GIL+ E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 26/74 (35%), Positives = 36/74 (48%), Gaps = 2/74 (2%)
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVP-IVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWS 439
H LK N L+D + LTD+ L IV ++ + Y +PE + G D WS
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWS 183
Query: 440 LGILILELLTGKFP 453
LG ++ E L G FP
Sbjct: 184 LGCMLYEFLCG-FP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQ---MSNVGKEDFHEHMTRLGSLSHPNLLPLI- 315
+G G+FG A LTG + +K+ + + K + E + L L H N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-LKLLKHLRHENIISLSD 76
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
F E+ V++ + L LL R Q + + +GL Y++
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQ------FIQYFLYQILRGLKYVHS--A 127
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---YKSPEFNQT-DGV 431
GV H LK SN+L++ + + D+ L I ++ V+ Y++PE T
Sbjct: 128 GVV--HRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 432 TRKTDVWSLGILILELLTGK--FP 453
+ D+WS G + E+L GK FP
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFP 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFH----EHMTRLGSLSHPNLLPL- 314
+G G++G Y+A +G + +K+ R M N ++ +T L +L HPN++ L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR-MDNE-RDGIPISSLREITLLLNLRHPNIVELK 72
Query: 315 -IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+ + LV ++ LA+LL P ++ + +GL YL++
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP----FSESQVKCLMLQLLRGLQYLHEN 127
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA------YKSPEF-- 425
F + H LK SN+LL + + D+ L M Y++PE
Sbjct: 128 F----IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 426 ---NQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
T + D+W++G ++ ELL K P
Sbjct: 182 GCTTYTTAI----DMWAVGCILAELLAHKPLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 26/208 (12%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMT--RLGSL--SHPNLLP 313
VLG GSFG A L +G VK ++ + +D MT R+ SL +HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L + + V +FV G L + H++++ D + L +L+ +
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRR---FDEARARFYAAEITSALMFLHDK 115
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA--------YKSPEF 425
G+ + LK NVLLD+ L D+ + KE Y +PE
Sbjct: 116 --GII--YRDLKLDNVLLDHEGHCKLADFGMC----KEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
Q D W++G+L+ E+L G P
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 25/100 (25%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 357 LKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY--ALVPI---VNKE 411
L I + V + + YL++ + H +K+ N+ +++ + L D+ A P+ NK
Sbjct: 185 LAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGK 451
+ +A +PE D D+WS GI++ E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 384 LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVTRKTDVWS 439
LK N+LLD L D+ L + K+ + + Y +PE G T+ D W+
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178
Query: 440 LGILILELLTGKFP 453
LG+L+ E+LTG P
Sbjct: 179 LGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 59/216 (27%), Positives = 88/216 (40%), Gaps = 44/216 (20%)
Query: 260 VLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMT--RLGSLS--HPN 310
VLG GSFG VLL T VK ++ + +D MT R+ +L+ HP
Sbjct: 2 VLGKGSFGK----VLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
L L + + K+ V ++V G L + H++R D P + GL +L
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQR---SGRFDEPRARFYAAEIVLGLQFL 112
Query: 371 YKEFPGVTLPHG----HLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA------- 419
++ G LK NVLLD+ + D+ + KE L V
Sbjct: 113 HE--------RGIIYRDLKLDNVLLDSEGHIKIADFGMC----KE-GILGGVTTSTFCGT 159
Query: 420 --YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE D W+LG+L+ E+L G+ P
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM----VA---YKSPEFNQT-DGVT 432
H LK SN+LL+ + + D+ L I + EH VA Y++PE G T
Sbjct: 129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYT 188
Query: 433 RKTDVWSLGILILELLTGK--FPAN-YLAQ 459
+ D+WS+G ++ E+L+ + FP YL Q
Sbjct: 189 KAIDIWSVGCILAEMLSNRPLFPGKDYLHQ 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 51/228 (22%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+GSG++GS A + VK+ + S + + + L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK-----------IIKGVAKG 366
F P S+ N V G D +K +I + +G
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---YKSP 423
L Y++ + H LK SNV ++ E + D+ L + E VA Y++P
Sbjct: 131 LKYIHS----AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG--YVATRWYRAP 184
Query: 424 E-------FNQTDGVTRKTDVWSLGILILELLTGK--FPAN-YLAQGK 461
E +NQT D+WS+G ++ ELL GK FP N Y+ Q K
Sbjct: 185 EIMLNWMHYNQT------VDIWSVGCIMAELLKGKALFPGNDYIDQLK 226
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 24/214 (11%)
Query: 260 VLGSGSFGSSYKAVLL----TGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLP 313
+LG G FGS +A L + + VK + S+ E+F + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 314 LIAFYYRKEEK------LLVSDFVPNGSLANLLHVRRAPGQP-GLDWPIRLKIIKGVAKG 366
LI R K +++ F+ +G L L + R +P L ++ + +A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSP--- 423
+ YL + H L + N +L+ + D+ L + A K P
Sbjct: 126 MEYLSSK----NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 424 ---EFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
E + T +DVW+ G+ + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 34/110 (30%), Positives = 51/110 (46%), Gaps = 7/110 (6%)
Query: 347 GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL-V 405
G PG D + + GL L++E + + LK N+LLD+ ++D L V
Sbjct: 95 GNPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAV 150
Query: 406 PIVNKE--HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
I E ++ V Y +PE + + T D W LG LI E++ GK P
Sbjct: 151 EIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 42/208 (20%), Positives = 81/208 (38%), Gaps = 23/208 (11%)
Query: 259 EVLGSGSFGS----SYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
+V+G G+FG +K+ ++ +F + F E + + P ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ + +V +++P G L NL+ ++ + K K +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMS----------NYDVPEKWAKFYTAEVVLALDAI 158
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-----HAQLHMVAYKSPEFNQTD 429
+ L H +K N+LLD L D+ +++ + Y SPE ++
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 430 G----VTRKTDVWSLGILILELLTGKFP 453
G R+ D WS+G+ + E+L G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 29/213 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFH-------EHMTRLGSLSHPNL 311
+V+G G+FG KA + + ++M +D H E + +LG HPN+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 58
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLH-----------VRRAPGQPGLDWPIRLKII 360
+ L+ + L ++ P+G+L + L L L
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 361 KGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP----IVNKEHAQLH 416
VA+G+ YL ++ H L + N+L+ Y + D+ L V K +L
Sbjct: 119 ADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 417 MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449
V + + E T +DVWS G+L+ E+++
Sbjct: 175 -VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 27/110 (24%), Positives = 47/110 (42%), Gaps = 14/110 (12%)
Query: 354 PIRLK----IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV---- 405
P+ L+ I + + + LAYL+ G + H +K+ N+ LD +L D+
Sbjct: 181 PLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 406 --PIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
P + + + SPE D KTD+WS G+++ E+
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.004
Identities = 31/106 (29%), Positives = 41/106 (38%), Gaps = 50/106 (47%)
Query: 381 HGHLKSSNVLLD---------------------NAYEPLLTDYALVPIVNKEHAQLHMVA 419
H LK SN+LL+ N P+LTDY VA
Sbjct: 130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY---------------VA 174
Query: 420 ---YKSPEF-----NQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
Y++PE T GV D+WS+G ++ E+L GK FP
Sbjct: 175 TRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGKPLFPGT 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 565 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.23 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.21 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.21 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.11 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.83 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.78 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.76 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.76 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.74 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.72 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.34 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.3 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.3 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.2 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.19 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.16 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.16 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.16 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.04 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.96 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.96 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.95 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.91 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.85 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-61 Score=563.07 Aligned_cols=466 Identities=27% Similarity=0.488 Sum_probs=329.6
Q ss_pred CCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEE
Q 008431 15 LPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQL 92 (565)
Q Consensus 15 l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 92 (565)
+++|+.|+|++|++++.+|. +..+ +|+.|+|++|+++|.+|.. |.++++|++|+|++|.++|.+|..|+++++|+.|
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 552 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE-LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL 552 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChH-HcCccCCCEEECCCCcccccCChhHhCcccCCEE
Confidence 34555555555555555552 2222 5777888888887777754 7788888888888888888888888888888888
Q ss_pred eccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCcc--ccCCCCCcccCCCCCCCCCC----ccccccccccceeeee
Q 008431 93 NLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDT--LSNFDATSFQGNKGLCGKPL----EACKSSISKKTILIIC 164 (565)
Q Consensus 93 ~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~n~~~cg~p~----~~c~~~~~~~~~~~v~ 164 (565)
+|++|+++|.+|.. .+.+|+.|++++|+++|.+|.. +..+...++.||+.+|+.+. ++|........+.+++
T Consensus 553 ~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~ 632 (968)
T PLN00113 553 DLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYI 632 (968)
T ss_pred ECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeeh
Confidence 88888888888764 5778888888888888888853 55667778999999998542 3564321222222222
Q ss_pred e-hhhHHHHHHHh-hheeeecCCCCCCCCCccccccchhhhhhhcCCCCcccCCCCcccCCcccccCcccccccceeEec
Q 008431 165 T-VAGATLALAAI-VAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKLHFVN 242 (565)
Q Consensus 165 ~-~~~~~~~l~~i-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (565)
+ +++++++++++ +++++.++++..+...... . .. ... . . .+..
T Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~---------~~~-----~----~-------------~~~~ 677 (968)
T PLN00113 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN---E-DG---------TWE-----L----Q-------------FFDS 677 (968)
T ss_pred hHHHHHHHHHHHHHHHHHHHHhhhccccccccc---c-cc---------ccc-----c----c-------------cccc
Confidence 2 22222222222 2222222221111110000 0 00 000 0 0 0000
Q ss_pred CCccccchhHHHhh--ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEE
Q 008431 243 NDREMFELNDLLRA--SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYY 319 (565)
Q Consensus 243 ~~~~~~~~~~~~~~--~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 319 (565)
.....++.+++... ..++||+|+||.||+|.. .++..||||++...... ..+|++.+++++|||||+++|+|.
T Consensus 678 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~ 753 (968)
T PLN00113 678 KVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR 753 (968)
T ss_pred ccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE
Confidence 00112233333322 346899999999999995 58899999998643222 234688999999999999999999
Q ss_pred ecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEE
Q 008431 320 RKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL 399 (565)
Q Consensus 320 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl 399 (565)
+.+..|+||||+++|+|.++++. ++|..+.+++.|+|+||+|||+.+.+ +|+||||||+||+++.++.+++
T Consensus 754 ~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~ 824 (968)
T PLN00113 754 SEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHL 824 (968)
T ss_pred cCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEE
Confidence 99999999999999999999952 89999999999999999999965433 7999999999999999998887
Q ss_pred eccCCcccccccccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 400 TDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 400 ~DfGla~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
. ||............++..|+|||++.+..++.++|||||||++|||+||+.||+... +....+.+|++.......
T Consensus 825 ~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~ 900 (968)
T PLN00113 825 R-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCH 900 (968)
T ss_pred E-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccc
Confidence 6 776655444445577899999999999999999999999999999999999986322 223567788876655544
Q ss_pred cCccccccccCC-CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 480 TGEVFDKDMRGT-KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 480 ~~~~~d~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
....+|+.+... ....++..++.+++.+||+.||++||||.||++.|+++....
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 555667666443 234567778999999999999999999999999999987644
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-56 Score=455.50 Aligned_cols=283 Identities=31% Similarity=0.582 Sum_probs=245.9
Q ss_pred CccccchhHHHhhc-----cceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEE
Q 008431 244 DREMFELNDLLRAS-----AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318 (565)
Q Consensus 244 ~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 318 (565)
....|+++++..++ .++||+|+||.||+|.+.+|..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35678889988886 3689999999999999999999999988754332145699999999999999999999999
Q ss_pred EecC-ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCc
Q 008431 319 YRKE-EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEP 397 (565)
Q Consensus 319 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~ 397 (565)
.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.+++ +||||||||+|||||+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCE
Confidence 9998 599999999999999999875542 589999999999999999999998876 69999999999999999999
Q ss_pred EEeccCCcccccc-ccc---c-cccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHH
Q 008431 398 LLTDYALVPIVNK-EHA---Q-LHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVN 472 (565)
Q Consensus 398 kl~DfGla~~~~~-~~~---~-~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 472 (565)
||+|||+|+.... ... . .||.+|+|||+...+..+.|+|||||||+|+||+||+.|.+.... .....+..|+.
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHH
Confidence 9999999977654 322 1 789999999999999999999999999999999999998874331 22345899999
Q ss_pred HHhhhcccCccccccccCCCCCH-HHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 473 SVVREEWTGEVFDKDMRGTKSGE-GEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 473 ~~~~~~~~~~~~d~~~~~~~~~~-~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+......+++|+.+....... .++.++..+|.+|++.+|.+||+|.||+++|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999889999999997444443 7889999999999999999999999999999766544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=397.98 Aligned_cols=252 Identities=28% Similarity=0.397 Sum_probs=207.2
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCcc--CHHHHHHHHHHHhcCCCCCccceEEEEEecC-ceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV--GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-EKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~E~~~~g 334 (565)
.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999865555999999754322 2568999999999999999999999999887 799999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC-CccCCCCCCCEEEcCCC-CcEEeccCCcccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT-LPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNK-- 410 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~-- 410 (565)
+|.++++... ...+++..++.++.|||+||.|||+. + ||||||||+|||++.++ ++||+|||+++....
T Consensus 126 sL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 126 SLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred cHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999998741 12499999999999999999999998 6 99999999999999997 999999999987653
Q ss_pred -c-ccccccccccCCCccC--CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 411 -E-HAQLHMVAYKSPEFNQ--TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 411 -~-~~~~~t~~y~aPE~~~--~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
. ....||+.|||||++. ...|+.|+|||||||++|||+||+.||.... ..+.+...........
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~--------~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA--------PVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCCCCC----
Confidence 2 2357899999999999 5699999999999999999999999997422 1222222222221111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCC
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDN 534 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 534 (565)
+ +......+..++.+||..||+.||++.|++..|+.+.....
T Consensus 267 -~-----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 267 -I-----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred -C-----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1 11133478888889999999999999999999998877543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=381.34 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=210.5
Q ss_pred cchhHHHhhccceecccCceeEEEEEE-eCCCeeEEEEeec-cCccCHHHHHHHHHHHhcCCCCCccceEEEEEecC-ce
Q 008431 248 FELNDLLRASAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-EK 324 (565)
Q Consensus 248 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~ 324 (565)
++..|+. ....||+|..|+|||+++ .+++.+|+|.+.. ......+++.+|++++++++||+||+++|.|+.+. ..
T Consensus 76 i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLE--RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhh--hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 4445554 347899999999999995 4788999999953 33455678999999999999999999999999998 59
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
.++||||++|||++++...+ .+++...-.|+.+|++||.|||+.. +||||||||+|||++..|++||||||.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence 99999999999999998653 3899999999999999999999631 899999999999999999999999999
Q ss_pred ccccccc--ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 405 VPIVNKE--HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 405 a~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
++.+... .+.+||..|||||.+.+..|+.++||||||++++|+++|+.||.... ....+..+.+...+.+.
T Consensus 226 S~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~p---- 298 (364)
T KOG0581|consen 226 SGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEP---- 298 (364)
T ss_pred cHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCC----
Confidence 9887654 56789999999999999999999999999999999999999987431 11233444444444332
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.|.+... ....++..++..||+.||.+|||++|+++.
T Consensus 299 --pP~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 --PPRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --CCCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222221 234578888999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=375.49 Aligned_cols=188 Identities=24% Similarity=0.396 Sum_probs=172.7
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
+.||+|+||+||+|+ ..++..||||.+... .....+-...|+.+|++++|||||++++++..++..|||||||.|||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 459999999999999 457899999999765 44556778999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC------CCcEEeccCCccccc
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA------YEPLLTDYALVPIVN 409 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~------~~~kl~DfGla~~~~ 409 (565)
|.+|++.++. +++..+..++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.+.
T Consensus 96 Ls~yi~~~~~-----l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 96 LSDYIRRRGR-----LPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred HHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999997653 99999999999999999999999 99999999999999765 458999999999987
Q ss_pred cc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 410 KE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 410 ~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.. .+.+|++.|||||++..++|+.|+|+||.|+|+||+++|++||+
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 65 45689999999999999999999999999999999999999997
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=385.47 Aligned_cols=258 Identities=22% Similarity=0.370 Sum_probs=212.9
Q ss_pred chhHHHhhccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEE
Q 008431 249 ELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 249 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 328 (565)
+++.-.....+.||+|.||+||.|.+.....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++.+||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3333334456889999999999999988889999999865 344678999999999999999999999999988999999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
|||+.|+|.++|+...+ ..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+..
T Consensus 281 E~m~~GsLl~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EecccCcHHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEccccccccc
Confidence 99999999999987322 3488899999999999999999999 9999999999999999999999999999965
Q ss_pred ccccc--cc---ccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 409 NKEHA--QL---HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 409 ~~~~~--~~---~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
..+.. .. -...|.|||.+..++++.|||||||||+||||+| |+.||.. ....+.+... ..+..
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------msn~ev~~~l-e~GyR-- 422 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------MSNEEVLELL-ERGYR-- 422 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------CCHHHHHHHH-hccCc--
Confidence 54422 12 2367999999999999999999999999999999 9999862 2333333222 22211
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.+.+..+...+.+++..||..+|++|||.+.+...|+++....
T Consensus 423 --------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 423 --------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred --------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 1223344557888999999999999999999999998886544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=384.74 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=204.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeec---cCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQ---MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|||+.||.++. .+|..||+|++.+ ......+...+||++.+.|+|||||+++++|.+.+..|||.|+|+
T Consensus 22 ~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 22 RGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence 457899999999999995 8999999999975 234556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|..+++.++ .+++.+++.+++||+.||.|||+. +|+|||||..|++|++++++||+|||||..+..+
T Consensus 102 ~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 102 RGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred CccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999998544 399999999999999999999999 9999999999999999999999999999887633
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+.+||+.|.|||++....++..+||||+||+||.|+.|++||+. ..+.+-...+... +..-|
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet--------k~vkety~~Ik~~----~Y~~P-- 238 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET--------KTVKETYNKIKLN----EYSMP-- 238 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc--------chHHHHHHHHHhc----Ccccc--
Confidence 466899999999999999999999999999999999999999972 1222222211111 11111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
........+|+.+.|+.||.+|||+++|+..
T Consensus 239 ------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 ------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222367788889999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=353.31 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=205.5
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeec--cCccCHHHHHHHHHHHhcCCCCCccceEE-EEEecCc-eEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLIA-FYYRKEE-KLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~E~~ 331 (565)
..++||+|+||+|||+. ..+|..+|.|++.- .+...+.....|+.+|++|+|||||++++ .+.++.+ ++||||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 34789999999999999 67999999999872 33444567899999999999999999998 4444444 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
.+|||.+.++..+.. ...+++..+++++.|++.||..+|...+..-|+||||||.||+|+.+|.+|++|||+++.+...
T Consensus 103 ~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~ 181 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK 181 (375)
T ss_pred cccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence 999999999876543 2359999999999999999999999665434999999999999999999999999999988655
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.+.+||+.||+||.+...+|+.||||||+||++|||+.-++||. +..+.+..+.+...+ . |.
T Consensus 182 ~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~--------g~n~~~L~~KI~qgd-~-----~~ 247 (375)
T KOG0591|consen 182 TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY--------GDNLLSLCKKIEQGD-Y-----PP 247 (375)
T ss_pred hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc--------cccHHHHHHHHHcCC-C-----CC
Confidence 45689999999999999999999999999999999999999997 223433333332221 1 11
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
+. .+.....+..++..|+..||+.||+....+..++.
T Consensus 248 ~p----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LP----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred Cc----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 13344578889999999999999986555555543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=367.30 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=197.0
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCcc-------CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNV-------GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||.|-+|. ..+|+.||||.+.+.... ......+|+++|++++|||||+++++|...+..|+||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 46889999999999999 678999999999742211 1223569999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC---CCcEEeccCCc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA---YEPLLTDYALV 405 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGla 405 (565)
||++||+|.+.+-..+. +.+.....+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+|
T Consensus 256 E~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999976553 77788889999999999999999 99999999999999765 78999999999
Q ss_pred cccccc---ccccccccccCCCccCCCCC---CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTDGV---TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~~~---~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
+..... .+.+||+.|.|||++.+..+ ..|+|+||+||+||-+++|.+||...... ..+ ...+..+.
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~sl----~eQI~~G~ 398 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PSL----KEQILKGR 398 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----ccH----HHHHhcCc
Confidence 988644 46789999999999877643 34889999999999999999999743211 111 11111111
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. .. +.....+-..+.++++.++|..||++|||+.|+++.
T Consensus 399 y-~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 399 Y-AF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred c-cc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0 00 011123344578899999999999999999999764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=388.30 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=212.0
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|+.. +...||||.++..... ...+|.+|+++++.++|||||+|+|.|..++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 3467999999999999843 3457999999876544 67899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 330 FVPNGSLANLLHVRRAPG---------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
||..|||.++|+.+.... .+.|+..+.+.||.|||.||.||-++ .+|||||..+|+|+.++..+||+
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhceeccceEEEec
Confidence 999999999998764432 22388999999999999999999988 89999999999999999999999
Q ss_pred ccCCccccccc-cc-----ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHH
Q 008431 401 DYALVPIVNKE-HA-----QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNS 473 (565)
Q Consensus 401 DfGla~~~~~~-~~-----~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 473 (565)
|||+++..... .. ..-.++|||||.+..++||++||||||||+|||++| |+.||.... .+.|..
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---------n~EVIe 716 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---------NQEVIE 716 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---------hHHHHH
Confidence 99999865433 22 222478999999999999999999999999999999 999986332 223333
Q ss_pred HhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 474 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.++.+.. .+.++.+..++.+|+..||+.+|++||+.+||-.+|+......
T Consensus 717 ~i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 717 CIRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 4444322 1223456678999999999999999999999999999886543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=341.10 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=195.4
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..++|+|+||+||||+ ..+|+.||||++.... ..-++-.++||++|++++|||+|.++++|..+...+||+|||+..
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 3579999999999999 5689999999997543 334566889999999999999999999999999999999999874
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
-|. -|.... .+++.....+++.|++.|+.|+|++ ++|||||||+|||++.++.+|+||||+|+.+...
T Consensus 87 vL~-eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 87 VLH-ELERYP----NGVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred HHH-HHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 444 444333 2489999999999999999999999 9999999999999999999999999999988743
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHH--H-----------HHHhh
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATW--V-----------NSVVR 476 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--~-----------~~~~~ 476 (565)
+..+.|.+|+|||.+.+ -+|+..+||||.||++.||++|.+-|... .++.+. + ...+.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~-------SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR-------SDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc-------chHHHHHHHHHHHcccCHHHHHHhc
Confidence 24567899999998776 68999999999999999999999988632 122221 1 11111
Q ss_pred hc-ccCccccccccCCCCC----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 477 EE-WTGEVFDKDMRGTKSG----EGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 477 ~~-~~~~~~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. ....+.-|.....+.. +....-+++++..|++.||++|++.+|++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 1112222222111110 122336789999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.27 Aligned_cols=233 Identities=23% Similarity=0.308 Sum_probs=197.3
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||+||.++ .++++.+|+|++++.. ....+....|..+|.+++||.||+++-.|++.+.+|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 45799999999999999 5678999999997543 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
||.|+.+|...+. +++..+..++.+|+.||.|||+. +||||||||+|||||.+|+++|+|||+++..-..
T Consensus 109 GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 109 GGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred CccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999986553 99999999999999999999999 9999999999999999999999999999864332
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+.+||+.|||||++....|+..+|.||+||++|||++|.+||. ..+...+.....+.... ..+.
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~--------~~~~~~~~~~I~~~k~~---~~p~- 247 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY--------AEDVKKMYDKILKGKLP---LPPG- 247 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc--------CccHHHHHHHHhcCcCC---CCCc-
Confidence 34589999999999999999999999999999999999999997 34555666555554300 0011
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCC
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRW 517 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 517 (565)
.-.....+++.+.|..||++|.
T Consensus 248 -------~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 -------YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -------cCCHHHHHHHHHHhccCHHHhc
Confidence 1123566777799999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.55 Aligned_cols=254 Identities=19% Similarity=0.272 Sum_probs=199.5
Q ss_pred hccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHH-HHHHHHHHHhcCC-CCCccceEEEEEecC-ceEEEEecc
Q 008431 256 ASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKE-DFHEHMTRLGSLS-HPNLLPLIAFYYRKE-EKLLVSDFV 331 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~lv~E~~ 331 (565)
...++||.|+||.||+|+ ..+|..||||++++.-....+ -=++|+..|++++ |||||++++.+.+.+ .+|+|||||
T Consensus 13 ~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M 92 (538)
T KOG0661|consen 13 TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM 92 (538)
T ss_pred HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh
Confidence 356789999999999999 678999999999864333222 2468999999999 999999999999888 899999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
+. +|+++++.++. .|++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.....
T Consensus 93 d~-NLYqLmK~R~r----~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 93 DC-NLYQLMKDRNR----LFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred hh-hHHHHHhhcCC----cCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccccccC
Confidence 75 99999987744 499999999999999999999999 9999999999999999999999999999987654
Q ss_pred ---ccccccccccCCCcc-CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHH--HHHhh----hcccC
Q 008431 412 ---HAQLHMVAYKSPEFN-QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWV--NSVVR----EEWTG 481 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~-~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~ 481 (565)
+..+.|..|+|||++ ....|+.+.||||+|||++|+.+-++-|.... .+.+.. ...+. +.|..
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-------E~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-------EIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-------HHHHHHHHHHHhCCCccccchh
Confidence 456789999999965 56779999999999999999999998886321 111111 11111 11110
Q ss_pred --------ccccccccCCCC---CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 482 --------EVFDKDMRGTKS---GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 482 --------~~~d~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+--|...+..- ......++++++.+|++|||++|||+.|+++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 011111111110 11245678899999999999999999998765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=352.35 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=198.5
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecC--ceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE--EKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~E~~~~ 333 (565)
..+.||+|+||+||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|.....+ .+++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 4578999999999999954 58999999987543333667899999999999999999999865555 58999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCcccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVNK-- 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~-- 410 (565)
|+|.+++...+. .|++..+..+.+||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 101 GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 101 GSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999987653 399999999999999999999998 9999999999999999 79999999999886652
Q ss_pred -----cccccccccccCCCccCCCC-CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 411 -----EHAQLHMVAYKSPEFNQTDG-VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 411 -----~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
.....||+.|||||++..+. ...++||||+||++.||+||++||... .....++........
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~----- 240 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDS----- 240 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCC-----
Confidence 23467899999999988532 335999999999999999999999732 122333333322221
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
-|.+.. .......+++.+|++.||++||||.|+++..--.
T Consensus 241 ~P~ip~-----~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 241 LPEIPD-----SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred CCCCCc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 122211 1223567778899999999999999998875543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=350.49 Aligned_cols=256 Identities=19% Similarity=0.329 Sum_probs=205.0
Q ss_pred cchhHHHhhccceecccCceeEEEEEEeCCCeeEEEEeeccCccC---HHHHHHHHHHHhcCCCCCccceEEEEEe----
Q 008431 248 FELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVG---KEDFHEHMTRLGSLSHPNLLPLIAFYYR---- 320 (565)
Q Consensus 248 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~---- 320 (565)
++.+++.......||+|++|.||+|.. +|+.||||+++...... .+.|.+|+.+|++++|||||+++|++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~ 93 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence 445555555557899999999999997 78899999997543332 4678899999999999999999999977
Q ss_pred cCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 321 KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 321 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
....++||||+++|+|.+++.... .++|.....++.|++.||.|||+.. +++||||||+|||+++++.+||+
T Consensus 94 ~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 94 LPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred CCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEc
Confidence 346789999999999999997543 3889999999999999999999742 67899999999999999999999
Q ss_pred ccCCccccccc-ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 401 DYALVPIVNKE-HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 401 DfGla~~~~~~-~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
|||+++..... ....++..|+|||++.. ..++.++|||||||++|||+||+.||... ...+........
T Consensus 166 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--------~~~~~~~~i~~~ 237 (283)
T PHA02988 166 CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--------TTKEIYDLIINK 237 (283)
T ss_pred ccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhc
Confidence 99998865433 34567889999999865 67999999999999999999999999732 222222222222
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
... +.+. ......+.+++.+||+.||++|||+.|+++.|+.++
T Consensus 238 ~~~-----~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 238 NNS-----LKLP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCC-----CCCC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111 1111 112346788899999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=342.19 Aligned_cols=254 Identities=19% Similarity=0.281 Sum_probs=201.5
Q ss_pred hhccceecccCceeEEEEE-EeCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 255 RASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
+...++||.|..++||+|+ .+.++.||||++.-. .....+.+.+|++.|+.++||||++++..|..+..+|+||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 3456789999999999999 668899999999732 23346889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|++.++++..-.. ++++..+..|.+++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+...
T Consensus 108 ~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred CCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999876544 499999999999999999999999 9999999999999999999999999986544322
Q ss_pred -------ccccccccccCCCccC--CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 412 -------HAQLHMVAYKSPEFNQ--TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 412 -------~~~~~t~~y~aPE~~~--~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
....||+.|||||++. ...|+.|+|||||||+..||++|..||....+. +.+-..+......-
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------kvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------KVLLLTLQNDPPTL 252 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------HHHHHHhcCCCCCc
Confidence 3447899999999843 357999999999999999999999999743321 22222222211100
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.-..+ .........+.+.+++..||+.||++|||++++++.
T Consensus 253 -~t~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 -LTSGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -ccccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00000 000011223478889999999999999999998653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=349.11 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=194.9
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~~ 332 (565)
.++||+|.||.||||+ ..+|+.||+|+++... .....-..+||.+|++|+||||++|.+...+. ..+|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 4689999999999999 6789999999998543 33445678999999999999999999999877 68999999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
. ||.-++..... .|+..++..++.|++.||.|+|++ +|+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 202 h-DL~GLl~~p~v----kft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 202 H-DLSGLLSSPGV----KFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred c-hhhhhhcCCCc----ccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 7 99888865433 499999999999999999999999 99999999999999999999999999999876553
Q ss_pred -----cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh----hcccC-
Q 008431 413 -----AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR----EEWTG- 481 (565)
Q Consensus 413 -----~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~- 481 (565)
..+.|..|+|||++.+ ..|+.++|+||.||||.||++|++.|..-.. ..-...+...+- .-|..
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-----veQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-----VEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-----HHHHHHHHHHhCCCChhccccc
Confidence 3456899999997766 5799999999999999999999999863111 111111111111 11110
Q ss_pred -----ccc------cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 -----EVF------DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 -----~~~------d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+ .+.+.+. ........++|+..+|..||++|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~--~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRET--FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHH--hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000 0011000 0111245778888999999999999999865
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=320.94 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=199.4
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..++||+|.||+||+|+ ..+|+.||||+++.... .-.....+||+.|+.++|+||+.++++|-+.+..-||+|||+.
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence 45789999999999999 67899999999985422 2345689999999999999999999999999999999999986
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
||...++.... .++...+..++.++.+||+|+|.+ .|+||||||.|+|+++++.+||+|||+|+......
T Consensus 86 -dLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 86 -DLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred -cHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99999987554 489999999999999999999999 89999999999999999999999999999876542
Q ss_pred ---cccccccccCCCccC-CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 413 ---AQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 413 ---~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
..+.|..|+|||.+. ...|+..+||||.|||+.||+-|.+-|.. ..++.+...-.-.-+....-..|.+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-------~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-------DSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-------CchHHHHHHHHHHcCCCCcccCccc
Confidence 235688999999655 46799999999999999999999877652 1233332221111111111111111
Q ss_pred cC---------------CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RG---------------TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~---------------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. ..--..+....++++..++..||.+|+|+.|++++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 00112334567899999999999999999999765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=357.21 Aligned_cols=253 Identities=20% Similarity=0.307 Sum_probs=197.5
Q ss_pred ccceecccCceeEEEEEE------eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecC-ceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL------LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKE-EKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lv 327 (565)
..++||+|+||.||+|.. .++..||+|+++... ....+.+.+|+.+++++ +|||||+++++|...+ ..++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 457899999999999974 235689999987432 22345789999999999 8999999999987644 57999
Q ss_pred EeccCCCCHHHHHhhcCCC---------------------------------------------------------CCCC
Q 008431 328 SDFVPNGSLANLLHVRRAP---------------------------------------------------------GQPG 350 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~ 350 (565)
|||+++|+|.+++...... ....
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 9999999999999753210 0124
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc------ccccccccccCCC
Q 008431 351 LDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE------HAQLHMVAYKSPE 424 (565)
Q Consensus 351 l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE 424 (565)
+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....++..|+|||
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 78889999999999999999998 9999999999999999999999999999765322 1223457899999
Q ss_pred ccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHH
Q 008431 425 FNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLK 503 (565)
Q Consensus 425 ~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 503 (565)
++.+..++.++|||||||++|||++ |..||.... ....+......+... .. +......+.+
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~~~~~-----~~-----~~~~~~~l~~ 308 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ--------INEEFCQRLKDGTRM-----RA-----PENATPEIYR 308 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC--------ccHHHHHHHhcCCCC-----CC-----CCCCCHHHHH
Confidence 9988899999999999999999997 999986321 111111111111110 00 1112246788
Q ss_pred HHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 504 IGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 504 l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
++.+||+.||++|||+.|+++.|+++..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=355.40 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=203.5
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
-.+||+|+.|.||.|. ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.|...+++|+|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 3679999999999999 668899999999877677777899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
.+.+... .+++.++..|++++++||+|||.. +|+|||||.+|||++.++.+||+|||++..+... .
T Consensus 358 TDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 358 TDVVTKT------RMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred hhhhhcc------cccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 9998653 389999999999999999999999 9999999999999999999999999998776544 4
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
+.+||++|||||+.....|++|+||||||++++||+-|++||-. ....+-+..+...+ .|.++.
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--------E~PlrAlyLIa~ng------~P~lk~-- 491 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--------ENPLRALYLIATNG------TPKLKN-- 491 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--------CChHHHHHHHhhcC------CCCcCC--
Confidence 56899999999999999999999999999999999999999862 11122222222221 122222
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+.....+.++..+||+.||++||++.|+++.
T Consensus 492 -~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 -PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 22333467777789999999999999999764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=355.48 Aligned_cols=239 Identities=22% Similarity=0.370 Sum_probs=198.1
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHHH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLAN 338 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 338 (565)
+-||+|+.|.||+|++ .++.||||+++... ..+|+.|++|+||||+.+.|+|.....+|||||||+.|-|..
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 4589999999999997 57789999987542 246889999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---cccc
Q 008431 339 LLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---HAQL 415 (565)
Q Consensus 339 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---~~~~ 415 (565)
+|+..+. +.......+..+||.|+.|||.+ .|||||||.-||||..+..+||+|||.++..... .+..
T Consensus 202 VLka~~~-----itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 202 VLKAGRP-----ITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHhccCc-----cCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence 9986543 77788899999999999999998 8999999999999999999999999999876554 3567
Q ss_pred ccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCH
Q 008431 416 HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGE 495 (565)
Q Consensus 416 ~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 495 (565)
||+.|||||++.....+.|+||||||||||||+||..||....... +-|- +. ...+ ..+-+.
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwG---VG----sNsL-----~LpvPs 334 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWG---VG----SNSL-----HLPVPS 334 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEe---cc----CCcc-----cccCcc
Confidence 8999999999999999999999999999999999999997432211 0010 00 0000 111223
Q ss_pred HHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 496 GEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 496 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.+...+.-|++.||+..|..||+..+++..|+-..+.
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 4445677788899999999999999999999865544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=381.06 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=211.5
Q ss_pred ccceecccCceeEEEEEEeC--CC----eeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLT--GP----AMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||.|...+ |. .||||++++. +.....+|++|..+|++++|||||+++|+|.+....++++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 45789999999999999653 33 4999999864 34556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 330 FVPNGSLANLLHVRRAP--GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
||++|||..+|++.+.. ....+...+.+.++.|||+|+.||+++ ++|||||..+|+||+....+||+|||+|+.
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 99999999999976322 123588999999999999999999999 899999999999999999999999999994
Q ss_pred c-cccccc-----cccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 408 V-NKEHAQ-----LHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 408 ~-~~~~~~-----~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
+ ..+... .-...|||||.+..+.++.|+|||||||+|||++| |..||.. .+-.+.+....+.+.
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~--------~~n~~v~~~~~~ggR- 922 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS--------RSNFEVLLDVLEGGR- 922 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC--------cchHHHHHHHHhCCc-
Confidence 3 322211 22368999999999999999999999999999999 9999863 122222222333331
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCCCCCc
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDY 539 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~~~~ 539 (565)
+ ..+..+..++.+++..||+.+|++||+...+++++..+..........
T Consensus 923 -------L---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~ 971 (1025)
T KOG1095|consen 923 -------L---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYG 971 (1025)
T ss_pred -------c---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccc
Confidence 1 122344557889999999999999999999999999998776555444
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=356.92 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=203.9
Q ss_pred cceecccCceeEEEEEEeCC----Ce-eEEEEeec---cCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAVLLTG----PA-MVVKRFRQ---MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~----~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
.++||+|+||.||+|.+... .. ||||..+. .......+|++|+++|+.++|||||+++|++..+..+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 38999999999999996532 23 89999875 234456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
+|.||+|.++|+..+. .++..++..++.+.|.||+|||++ ++|||||..+|||++.++.+||+|||+++...
T Consensus 242 l~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred ecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999987654 399999999999999999999999 99999999999999999999999999987654
Q ss_pred ccc----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 410 KEH----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 410 ~~~----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
.-. ...-...|+|||.+....|+.++|||||||++||+++ |..||... ...+........+.....
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--------~~~~v~~kI~~~~~r~~~- 384 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--------KNYEVKAKIVKNGYRMPI- 384 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--------CHHHHHHHHHhcCccCCC-
Confidence 211 1123468999999999999999999999999999999 88898732 222222222222221111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
+......+..+..+||..+|++||||.+|.+.|+.+......
T Consensus 385 ---------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 ---------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 112233566677799999999999999999999999877543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.62 Aligned_cols=239 Identities=23% Similarity=0.328 Sum_probs=197.5
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeecc----Cc-cCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM----SN-VGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+|+.|. ..++..||+|.+... .. ...+.+.+|+.+++.++ ||||+++++++......|+|||
T Consensus 21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE 100 (370)
T KOG0583|consen 21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME 100 (370)
T ss_pred eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence 35789999999999998 557899999966542 11 23446678999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-CCcEEeccCCcccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-YEPLLTDYALVPIV 408 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~ 408 (565)
|+.+|+|.+++...+ .+.+..+..+++|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||++...
T Consensus 101 y~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 101 YCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred ecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999998733 388899999999999999999999 99999999999999999 99999999999877
Q ss_pred c-c---cccccccccccCCCccCCCC-CC-cchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 409 N-K---EHAQLHMVAYKSPEFNQTDG-VT-RKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 409 ~-~---~~~~~~t~~y~aPE~~~~~~-~~-~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
. . ..+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+. ..............
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--------~~~~~l~~ki~~~~---- 239 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--------SNVPNLYRKIRKGE---- 239 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------ccHHHHHHHHhcCC----
Confidence 2 2 25678999999999999877 86 789999999999999999999983 22233222222111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAV 523 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 523 (565)
..-|.... ...+..++.+|+..||.+|+|+.||+
T Consensus 240 ~~~p~~~~-------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 FKIPSYLL-------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ccCCCCcC-------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11111100 34788899999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=349.51 Aligned_cols=237 Identities=20% Similarity=0.320 Sum_probs=202.6
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||.||||+ ..+.+.||+|.+.+... .+.+.+.+|++++++++|||||.++++|....+.|+|.||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 4679999999999999 45788999999875433 3456789999999999999999999999999999999999976
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
+|+.+|.... .++++.+..|+.++..||.|||+. +|+|||+||.|||++..+.+|+||||+|+.+....
T Consensus 86 ~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 86 DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9999998654 399999999999999999999999 99999999999999999999999999999876543
Q ss_pred --cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 --AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 --~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
+..||+.|||||+..+..|+..+|.||+|||+||+++|++||. ...+.+.++.+..+...
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--------a~si~~Lv~~I~~d~v~---------- 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--------ARSITQLVKSILKDPVK---------- 218 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--------HHHHHHHHHHHhcCCCC----------
Confidence 4468999999999999999999999999999999999999996 24455666655554311
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+......+..+....|..||.+|.|-.+++.
T Consensus 219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11233346777888999999999999888754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=346.75 Aligned_cols=239 Identities=20% Similarity=0.283 Sum_probs=195.4
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
+.+.||+|+|++||+|+ ..+++.+|||++.+.- ....+-..+|-..|.+| .||.||+|+-.|.+...+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 46789999999999999 6689999999986421 12223456788888888 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.++|+..+. |++..++.++.+|+.||+|||+. |||||||||+|||||++|++||+|||.|+.+...
T Consensus 157 ~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 157 PNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred CCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999997754 99999999999999999999999 9999999999999999999999999999876432
Q ss_pred -----------------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHH
Q 008431 412 -----------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSV 474 (565)
Q Consensus 412 -----------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 474 (565)
.+.+||..|.+||++.....++.+|+|+||||||+|+.|++||.... .. -.++++
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N------ey--liFqkI 299 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN------EY--LIFQKI 299 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc------HH--HHHHHH
Confidence 22468899999999999999999999999999999999999997211 11 111222
Q ss_pred hhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 475 VREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 475 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+.-. . ..++.....+.+|+.+.|..||++|+|.+++-+
T Consensus 300 ~~l~---------y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 300 QALD---------Y---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHhc---------c---cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1111 1 111122246778888999999999999977743
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=347.36 Aligned_cols=254 Identities=19% Similarity=0.318 Sum_probs=208.0
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccC-HHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVG-KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..++||+|-||.|..|....+..||||+++...... ..+|.+|+++|.+++|||||+++|+|..++.+++|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 458899999999999998888999999999765444 5899999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccccc--
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA-- 413 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~-- 413 (565)
|.+++..+..+ .+.-...++|+.|||.||+||.+. ++|||||.++|||+|.++++||+|||+++-+.....
T Consensus 622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999876543 245566778999999999999998 999999999999999999999999999986543321
Q ss_pred ----ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc--CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 414 ----QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT--GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 414 ----~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.+-...|||||.+.-+++++++|||+|||++||+++ ...||....+ ..+++-....++......++ +
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~~~l-~- 767 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQVVL-S- 767 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCcceec-c-
Confidence 123478999999999999999999999999999876 7789874432 22333333344333222111 1
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.+..+...+.+++++||..|-++|||.+++...|++.
T Consensus 768 -----~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 -----RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1223445788999999999999999999999988864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=343.26 Aligned_cols=240 Identities=25% Similarity=0.362 Sum_probs=200.6
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||+|+||.||||. ..+++.||+|.+.-. .....+++.+|+.++..++++||.++++.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 3689999999999999 568899999999743 34456789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
+.+.+.... .+++..+..|++++..||.|||.+ +.+|||||+.|||+..+|.+|++|||++..+...
T Consensus 98 v~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 98 VLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hhhhhccCC-----CCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999997543 247778888999999999999999 8999999999999999999999999998766533
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
.+.+||+.|||||++....|+.|+||||+|++.+||++|.+|+....+..- + -.+.+-..|.+.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----l----------flIpk~~PP~L~~- 233 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----L----------FLIPKSAPPRLDG- 233 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----E----------EeccCCCCCcccc-
Confidence 567899999999999988999999999999999999999999874332100 0 0112223344433
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....+.+++..||+.||+.|||+.++++.
T Consensus 234 ----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 ----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 222468888889999999999999988653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.78 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=200.7
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|++. ..||||++.... ....+.|.+|+.++++-+|.||+-+.|||..... .||+.+|+|-
T Consensus 396 l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 5688999999999999973 359999998543 3346789999999999999999999999987776 9999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|+.+++..+. .|+....+.|++|||+|+.|||.+ +|||||||..||++.+++++||.|||++..-...
T Consensus 473 SLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 473 SLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999998764 489999999999999999999999 9999999999999999999999999998543221
Q ss_pred ---ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 ---HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....+...|||||++.. ..|+..+|||||||++|||+||..||. .... +-.-|+ -+ .....
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~-----dqIifm-----VG--rG~l~ 611 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR-----DQIIFM-----VG--RGYLM 611 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh-----hheEEE-----ec--ccccC
Confidence 23346678999998653 579999999999999999999999997 2211 111111 00 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
+++... ...+.+++.+|+..||..+|++||+..+++..|+++...
T Consensus 612 pd~s~~--~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 PDLSKI--RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccchhh--hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111111 124456788888899999999999999999999988763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=359.71 Aligned_cols=250 Identities=20% Similarity=0.381 Sum_probs=211.6
Q ss_pred ccceecccCceeEEEEEEe----CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..++||.|.||.||+|+++ ....||||.++... ...+.+|+.|+.+|.++.||||++|.|+.......+||.|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 4689999999999999964 23579999998643 455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|+.+|+.+.+ .+.+.+...++++||.|+.||-+. ++|||||.++|||++.+..+||+|||+++.+..+
T Consensus 713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999987764 399999999999999999999988 9999999999999999999999999999988655
Q ss_pred c-cccc------cccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 H-AQLH------MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ~-~~~~------t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
. .... ...|.|||.+..+++|.++|||||||+|||.++ |..||-+... +-|.+.++++.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---------QdVIkaIe~gy---- 851 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------QDVIKAIEQGY---- 851 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---------HHHHHHHHhcc----
Confidence 3 2111 267999999999999999999999999999887 9999863321 12223333321
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+.+.+.++...+.+|++.||+.|-.+||+..+++..|.++....
T Consensus 852 ------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 852 ------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 12234566678999999999999999999999999999997764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=339.18 Aligned_cols=256 Identities=18% Similarity=0.317 Sum_probs=196.2
Q ss_pred ccceecccCceeEEEEEEeC-----------------CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLT-----------------GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 318 (565)
..+.||+|+||.||+|...+ +..||+|.+.... .....+|.+|+.++.+++||||+++++++
T Consensus 9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 45789999999999997532 3369999887532 23345799999999999999999999999
Q ss_pred EecCceEEEEeccCCCCHHHHHhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCC
Q 008431 319 YRKEEKLLVSDFVPNGSLANLLHVRRAP--------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHL 384 (565)
Q Consensus 319 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDl 384 (565)
.+.+..++||||+++|+|.+++...... ....++|..+..++.|++.||.|||+. +|+||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~ivH~dl 164 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NFVHRDL 164 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----CccccCc
Confidence 9999999999999999999999754211 112478899999999999999999998 9999999
Q ss_pred CCCCEEEcCCCCcEEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc--CCCCccc
Q 008431 385 KSSNVLLDNAYEPLLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT--GKFPANY 456 (565)
Q Consensus 385 kp~NILl~~~~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t--g~~p~~~ 456 (565)
||+|||++.++.+||+|||+++...... ...++..|+|||++....++.++|||||||++|||++ +..||..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 9999999999999999999987653221 2234678999999888889999999999999999987 5567653
Q ss_pred cccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 457 LAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
.. .......+......... ..... .+......+.+++.+||+.||++||||.||.+.|++
T Consensus 245 ~~-----~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 245 LT-----DEQVIENAGEFFRDQGR-QVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CC-----HHHHHHHHHHHhhhccc-ccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 21 11222222222222110 00000 011223468899999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=348.94 Aligned_cols=242 Identities=22% Similarity=0.330 Sum_probs=204.6
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+-|.|-.|+ ..+|+.+|||.+.+.. ......+.+||.+|+-+.|||++++++++.++.++|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 35679999999999999 6799999999997542 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|.|++++..++. +++.++.+++.||..|+.|+|+. +|+||||||+|+|||..+++||+|||+|.+...+
T Consensus 96 gGELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 96 GGELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred CchhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999987653 89999999999999999999998 9999999999999999999999999999876554
Q ss_pred --ccccccccccCCCccCCCCCC-cchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVT-RKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+.+|++.|.|||++.+..|. .++||||+|||||.|+||+.||++ .++...+....+..+ ++ |
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--------dNir~LLlKV~~G~f--~M--P-- 232 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--------DNIRVLLLKVQRGVF--EM--P-- 232 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--------ccHHHHHHHHHcCcc--cC--C--
Confidence 577999999999999999885 799999999999999999999982 334444433333221 11 1
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
..-..++.+|+.+++..||+.|.|++||++.--
T Consensus 233 ------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 233 ------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ------CcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 112236777888999999999999999988643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=331.21 Aligned_cols=246 Identities=19% Similarity=0.325 Sum_probs=196.8
Q ss_pred ccceecccCceeEEEEEEe----CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+..+++++||||+++++++...+..++||||+
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence 4578999999999999853 35689999987542 233457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .++|..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+......
T Consensus 89 ~~~~L~~~l~~~~~----~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 89 SNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999975432 489999999999999999999998 9999999999999999999999999987654222
Q ss_pred c-----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 H-----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ~-----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
. ...++..|+|||.+.+..++.++|||||||++||+++ |+.||.... ....... ..+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--------~~~~~~~-~~~~~~----- 226 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--------GQDVIKA-VEDGFR----- 226 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHH-HHCCCC-----
Confidence 1 1234568999999988999999999999999999775 999986321 1111211 111110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
... +......+.+++.+||+.+|++|||+.|+.+.|.++
T Consensus 227 ~~~-----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPA-----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCC-----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 112234688899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.06 Aligned_cols=237 Identities=20% Similarity=0.237 Sum_probs=192.9
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
++||+|+||.||+|.. .+|+.||+|.++... ......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 578899999987532 223456889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 9999987543 389999999999999999999998 9999999999999999999999999998753221
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||... +............ ..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--------~~~~~~~~~~~~~-------~~~p- 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILMEE-------IRFP- 215 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC--------CHHHHHHHHHcCC-------CCCC-
Confidence 2346889999999999889999999999999999999999999621 1111111111111 0111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
......+.+++.+||+.||++|| ++.|+++
T Consensus 216 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 ----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11223677888899999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=347.83 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=197.1
Q ss_pred ccceecccCceeEEEEEE------eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL------LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||+||+|.. .++..||||+++... ....+.+.+|+.+++.+ +|||||+++++|...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 458899999999999973 245689999987432 23456789999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCC--------------------------------------------------------------
Q 008431 329 DFVPNGSLANLLHVRRAP-------------------------------------------------------------- 346 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 346 (565)
||+++|+|.+++......
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999999753210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc------
Q 008431 347 --------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH------ 412 (565)
Q Consensus 347 --------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~------ 412 (565)
....++|..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 012478999999999999999999998 99999999999999999999999999987654321
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
...++..|+|||++....++.++|||||||++|||++ |..||..... ..-....+..+... ..+
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~--~~~----- 339 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--------DSKFYKMIKEGYRM--LSP----- 339 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--------hHHHHHHHHhCccC--CCC-----
Confidence 1223467999999998899999999999999999998 8889863211 11111112221110 000
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
......+.+++.+||+.||++|||+.||++.|++.
T Consensus 340 ---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01123678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=337.61 Aligned_cols=240 Identities=20% Similarity=0.255 Sum_probs=192.4
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
...+||+|+||.||+|+ ..+|..+|+|++++... ...+..+.|-.+|...++|+||+|+-.|.+.+.+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 45789999999999999 66899999999986543 334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc--
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK-- 410 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~-- 410 (565)
|||+..+|.... .|++..+..++.+++.|+.-+|+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 225 GGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 225 GGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred CccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999998655 399999999999999999999999 999999999999999999999999999742110
Q ss_pred -----------------------c--------------------------ccccccccccCCCccCCCCCCcchhHHHHH
Q 008431 411 -----------------------E--------------------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLG 441 (565)
Q Consensus 411 -----------------------~--------------------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~G 441 (565)
. .+.+|||-|||||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 012578999999999999999999999999
Q ss_pred HHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCC---
Q 008431 442 ILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWD--- 518 (565)
Q Consensus 442 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs--- 518 (565)
||+|||+.|.+||....+.. ....+..|-.... -|. ......+..+++.+|+. ||++|--
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr~~l~---------fP~------~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQE-TYRKIVNWRETLK---------FPE------EVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHH-HHHHHHHHhhhcc---------CCC------cCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 99999999999997322110 0111222211110 000 01112477888999999 9999974
Q ss_pred HHHH
Q 008431 519 LREA 522 (565)
Q Consensus 519 ~~ev 522 (565)
++||
T Consensus 439 ~~EI 442 (550)
T KOG0605|consen 439 AEEI 442 (550)
T ss_pred HHHH
Confidence 5555
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=333.99 Aligned_cols=244 Identities=23% Similarity=0.270 Sum_probs=194.0
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46899999999999994 578999999986432 12234678999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 85 g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 85 GDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999988865332 2489999999999999999999998 9999999999999999999999999998765332
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ......+........ . ..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~--~----~~-- 224 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE-----RVKREEVDRRVKEDQ--E----EY-- 224 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc-----chhHHHHHHHhhccc--c----cC--
Confidence 234678999999999999999999999999999999999999973211 111111111111110 0 00
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 524 (565)
+......+.+++.+||+.||++||+ ++|+++
T Consensus 225 ---~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 ---SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1112236778899999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=324.29 Aligned_cols=241 Identities=24% Similarity=0.392 Sum_probs=196.6
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
.+.||+|+||.||++...++..+|+|.+... ....++|.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 4679999999999999888888999987643 334568999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-----
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH----- 412 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~----- 412 (565)
++++.... .++|..+..++.|++.||.|||+. +|+||||||+||++++++.+|++|||+++......
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 88 NYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99975432 389999999999999999999998 99999999999999999999999999987653221
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
...++..|+|||++....++.++|||||||++|||++ |+.||... ...+.+........ ...+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--------~~~~~~~~i~~~~~---~~~~~---- 224 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--------SNYEVVEMISRGFR---LYRPK---- 224 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHCCCC---CCCCC----
Confidence 1233467999999988889999999999999999999 99998621 12222222222111 11111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
.....+.+++.+||+.+|++|||+.|+++.|
T Consensus 225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1123678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.97 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=198.0
Q ss_pred hhccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEE
Q 008431 255 RASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 326 (565)
+...+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.+++.+ +|||||+++++|...+..++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 345688999999999998832 23579999997532 22345788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCC-------------------------------------------------------------
Q 008431 327 VSDFVPNGSLANLLHVRRA------------------------------------------------------------- 345 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~------------------------------------------------------------- 345 (565)
||||+++|+|.+++.....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 9999999999999864321
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc------ccc
Q 008431 346 ----PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH------AQL 415 (565)
Q Consensus 346 ----~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~------~~~ 415 (565)
.....+++..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 0012478899999999999999999998 99999999999999999999999999987653321 122
Q ss_pred ccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCC
Q 008431 416 HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSG 494 (565)
Q Consensus 416 ~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 494 (565)
++..|||||++....++.++|||||||++|||++ |+.||..... ..-......... .+....
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--------~~~~~~~~~~~~-----~~~~~~---- 338 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--------NSKFYKMVKRGY-----QMSRPD---- 338 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--------cHHHHHHHHccc-----CccCCC----
Confidence 3467999999988899999999999999999997 9999863211 111111111111 000000
Q ss_pred HHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 495 EGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 495 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
.....+.+++.+||+.||++|||+.||+++|+++.
T Consensus 339 -~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 -FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11246788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=340.94 Aligned_cols=235 Identities=23% Similarity=0.290 Sum_probs=191.1
Q ss_pred ecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 261 LGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 261 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999954 6889999998743 233346788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 99997543 389999999999999999999998 9999999999999999999999999998754322 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
...||+.|+|||++.+..++.++|||||||++|||+||+.||.. ............... .+.
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~--------~~~~~~~~~~~~~~~-------~~~--- 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD--------ENVNEMYRKILQEPL-------RFP--- 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC--------CCHHHHHHHHHcCCC-------CCC---
Confidence 34588999999999998999999999999999999999999962 223333333222210 010
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCC---HHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWD---LREAVE 524 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~evl~ 524 (565)
......+.+++.+||+.||++||+ +.|++.
T Consensus 214 --~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 --DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111235778888999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.27 Aligned_cols=240 Identities=21% Similarity=0.347 Sum_probs=204.4
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|.||.|-+|. +..|+.||||.+++.. ..+.-.+.+||++|+.|+||||+.++++|...+...|||||..
T Consensus 57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS 136 (668)
T KOG0611|consen 57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS 136 (668)
T ss_pred HHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence 34679999999999999 6889999999998643 3334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|.|++|+..++. |++..+..+++||.+|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+...
T Consensus 137 ~GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 137 GGELYDYISERGS-----LSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred CccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999987654 99999999999999999999998 9999999999999999999999999999887665
Q ss_pred --ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+.+|++-|.+||++.+..| ++.+|.||+||+||.|+.|..||+ +.+....++.+-+... ..|
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD--------G~Dhk~lvrQIs~GaY----rEP-- 273 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD--------GRDHKRLVRQISRGAY----REP-- 273 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC--------CchHHHHHHHhhcccc----cCC--
Confidence 46789999999999999888 478999999999999999999998 3444444443333221 111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
+......-++.++|..+|++|.|+.+|....
T Consensus 274 -------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 -------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1222556688899999999999999997764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.18 Aligned_cols=237 Identities=20% Similarity=0.244 Sum_probs=192.1
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
+.||+|+||.||++.. .+|..||+|.++... ......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999994 578999999997532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 9999887543 389999999999999999999998 9999999999999999999999999998753221
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... +............. .+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--------~~~~~~~~~~~~~~-------~~p- 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILMEEI-------RFP- 215 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHhcCCC-------CCC-
Confidence 2345789999999999889999999999999999999999998621 11111111111110 011
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 ----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11123677888899999999998 8888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=329.85 Aligned_cols=243 Identities=28% Similarity=0.478 Sum_probs=190.2
Q ss_pred cceecccCceeEEEEEEe-----CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999976 35679999996532 233678999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.++|..... ..+++..+..++.||+.||+|||+. +++|+||+++||++++++.+||+|||+++.....
T Consensus 84 ~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 84 PGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccc
Confidence 99999999987622 2499999999999999999999998 8999999999999999999999999998776221
Q ss_pred ------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 412 ------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 412 ------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
........|+|||.+....++.++||||||+++||++| |+.||.. ....++.... ........
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~--------~~~~~~~~~~-~~~~~~~~- 226 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD--------YDNEEIIEKL-KQGQRLPI- 226 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT--------SCHHHHHHHH-HTTEETTS-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccc-ccccccee-
Confidence 22345678999999888889999999999999999999 7888762 2233333333 22211110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
+......+.+++.+||+.||++|||+.|+++.|
T Consensus 227 ---------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ---------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011223677899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.42 Aligned_cols=191 Identities=24% Similarity=0.360 Sum_probs=168.0
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 4578999999999999954 6788999988743 2233467999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--c
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--H 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--~ 412 (565)
+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 160 (331)
T cd06649 89 SLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160 (331)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCcccccccccccc
Confidence 9999997543 3889999999999999999999851 5999999999999999999999999998765332 3
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
...++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 4467899999999998899999999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=335.78 Aligned_cols=240 Identities=20% Similarity=0.236 Sum_probs=194.8
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 3478999999999999954 78899999986422 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 85 GGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999997643 388999999999999999999998 9999999999999999999999999998766443
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....|++.|+|||++.+..++.++|||||||++|||++|+.||... ............. . .+.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~-~------~~~-- 218 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD--------NPFGIYEKILAGK-L------EFP-- 218 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-c------CCC--
Confidence 2446889999999998888999999999999999999999998621 1222222222111 0 010
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 525 (565)
......+.+++.+||+.||.+||+ ++|+++.
T Consensus 219 ---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 ---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111235778899999999999995 7776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=312.45 Aligned_cols=197 Identities=26% Similarity=0.384 Sum_probs=176.8
Q ss_pred cchhHHHhhccceecccCceeEEEEE-EeCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCc
Q 008431 248 FELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE 323 (565)
Q Consensus 248 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 323 (565)
+.++++. ..+.||.|+||.|.+++ ..+|..+|+|.+....- ...+...+|..+|+.+.||.+++|.+.|.+.+.
T Consensus 41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 3444443 45789999999999999 45788999999975432 334567889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccC
Q 008431 324 KLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA 403 (565)
Q Consensus 324 ~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 403 (565)
+|+||||++||.|+.+++..+. +++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999999987654 99999999999999999999998 99999999999999999999999999
Q ss_pred Cccccccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 404 LVPIVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 404 la~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
+|+.+... .+.+||+.|+|||++....|..++|.|||||++|||+.|.+||.
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 99987655 46689999999999999999999999999999999999999997
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.59 Aligned_cols=238 Identities=19% Similarity=0.239 Sum_probs=193.4
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
++||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999994 578999999997532 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 9999886543 389999999999999999999998 9999999999999999999999999998753221
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... +............ ..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~--------~~~~~~~~~~~~~-------~~~p- 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILMED-------IKFP- 215 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC--------CHHHHHHHhccCC-------ccCC-
Confidence 2345889999999998889999999999999999999999999621 1222222211111 0111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 525 (565)
......+.+++.+||+.||++|| ++.|+++.
T Consensus 216 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 ----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11123577888899999999997 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=324.38 Aligned_cols=261 Identities=21% Similarity=0.275 Sum_probs=193.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecC-----ceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-----EKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~E~ 330 (565)
..+++|.|+||.||+|.. .+++.||||++...... -.+|+++|++++|||||+|.-+|.... ...+||||
T Consensus 28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 347899999999999994 56799999999754332 246899999999999999999887532 24589999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-CCcEEeccCCccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-YEPLLTDYALVPIVN 409 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~ 409 (565)
||. +|.++++..... ...++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ +.+||||||-|+.+.
T Consensus 104 mP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred chH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 986 999999853221 12377777888999999999999997 99999999999999976 999999999999876
Q ss_pred cc---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc------
Q 008431 410 KE---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW------ 479 (565)
Q Consensus 410 ~~---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 479 (565)
.. .+...|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|... .....++. +...+....
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~----s~~dQL~e-Iik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD----SSVDQLVE-IIKVLGTPTREDIKS 252 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC----CHHHHHHH-HHHHhCCCCHHHHhh
Confidence 54 35567899999997655 57999999999999999999999988631 11111111 111111110
Q ss_pred ----cCccccccccCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhhcc
Q 008431 480 ----TGEVFDKDMRGTK----SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELKER 532 (565)
Q Consensus 480 ----~~~~~d~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~ 532 (565)
..+.-.|.+.... .......+.++++.++++++|.+|.++.|++.. .+++++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0111122222211 112334578899999999999999999998754 4555444
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=306.74 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=206.2
Q ss_pred hccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEec-----CceEEEEe
Q 008431 256 ASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-----EEKLLVSD 329 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~E 329 (565)
...+.||+|||+-||.++ ..++..+|+|++......+.+..++|++..++++|||++++++++..+ ...||+++
T Consensus 24 ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 24 RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred EEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEee
Confidence 355789999999999999 778999999999877677788899999999999999999999987643 34899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|...|+|.+.+......+ ..+++.+.+.|+.+|++||.+||+..+ +++||||||.|||+.+.+.+++.|||-++...
T Consensus 104 yy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred hhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceEEEeccCccccc
Confidence 999999999998766543 349999999999999999999999855 58999999999999999999999999876542
Q ss_pred cc-------------ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHH
Q 008431 410 KE-------------HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNS 473 (565)
Q Consensus 410 ~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 473 (565)
-. .....|..|+|||.+.. ...++++|||||||+||+|+.|..||+...+..+ ++.
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg---Sla----- 252 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG---SLA----- 252 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC---eEE-----
Confidence 11 12345788999997654 4568999999999999999999999986544211 111
Q ss_pred HhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 474 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
-.+..+.+.-... ......+.+++.+|++.||.+||++.|++..++.+.
T Consensus 253 -------LAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 -------LAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -------EeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111222211110 113347889999999999999999999999998764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.30 Aligned_cols=240 Identities=19% Similarity=0.242 Sum_probs=194.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..|+||||++
T Consensus 22 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 4578999999999999954 68899999987432 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 102 GGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred CChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999997543 388899999999999999999998 9999999999999999999999999999766443
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||... .......... .+.. .+..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~i~-~~~~------~~p~- 236 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--------TPFRIYEKIL-AGRL------KFPN- 236 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC--------CHHHHHHHHh-cCCc------CCCC-
Confidence 3456889999999999999999999999999999999999998621 1112222211 1110 0000
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 525 (565)
.....+.+++.+||+.||++||+ +.|+++.
T Consensus 237 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 ----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11135778899999999999996 5776543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=323.61 Aligned_cols=246 Identities=21% Similarity=0.392 Sum_probs=199.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|.. .++..||+|.+... ....+++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred EeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 457899999999999995 46888999988643 3345679999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--- 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 412 (565)
|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 89 L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 89 LLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred HHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999975432 2489999999999999999999998 99999999999999999999999999987654332
Q ss_pred --cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 --AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 --~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....+..|+|||++.+..++.++|||||||++|||+| |..||.. ....+..... ..... +..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~--------~~~~~~~~~~-~~~~~-----~~~- 226 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQVYELL-EKGYR-----MER- 226 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHH-HCCCC-----CCC-
Confidence 1123467999999988899999999999999999998 9999862 1222222221 11110 011
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 227 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 ----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111224688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=328.50 Aligned_cols=254 Identities=20% Similarity=0.342 Sum_probs=202.8
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 4578999999999999842 3456899988765555566899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 331 VPNGSLANLLHVRRA--------PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
+++|+|.+++..... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEeccC
Confidence 999999999975432 1122489999999999999999999998 9999999999999999999999999
Q ss_pred CCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHh
Q 008431 403 ALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVV 475 (565)
Q Consensus 403 Gla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 475 (565)
|+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.... ........
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--------~~~~~~~i- 235 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVIECI- 235 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-
Confidence 998755322 12234568999999988889999999999999999999 999986321 11111111
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..+... ... ......+.+++.+||+.||.+|||+.||++.|+++....
T Consensus 236 ~~~~~~-----~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 236 TQGRVL-----QRP-----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HcCCcC-----CCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 111110 000 112236889999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=327.17 Aligned_cols=249 Identities=20% Similarity=0.359 Sum_probs=197.9
Q ss_pred cceecccCceeEEEEEEeCC------CeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAVLLTG------PAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
.+.||+|+||.||+|..... ..||+|.+.... ......|.+|+..+++++||||+++++++...+..+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 46899999999999985432 578999886432 23346789999999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhcCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEE
Q 008431 331 VPNGSLANLLHVRRAPGQ-----------PGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL 399 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl 399 (565)
+++|+|.+++........ ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCCCcEEE
Confidence 999999999976432111 3588999999999999999999998 9999999999999999999999
Q ss_pred eccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHH
Q 008431 400 TDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVN 472 (565)
Q Consensus 400 ~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 472 (565)
+|||+++..... ....+++.|+|||++....++.++|||||||++|||+| |..||.... ..+...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--------~~~~~~ 237 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--------NQEVIE 237 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH
Confidence 999998754322 12345678999999888889999999999999999998 999986321 111111
Q ss_pred HHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 473 SVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 473 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.+....... . +......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 238 -~i~~~~~~~-----~-----~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 -MIRSRQLLP-----C-----PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHcCCcCC-----C-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111111110 0 112235788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=332.96 Aligned_cols=249 Identities=21% Similarity=0.371 Sum_probs=197.7
Q ss_pred ccceecccCceeEEEEEEe-CCC----eeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGP----AMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|.+. ++. .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..++|+||
T Consensus 11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 4578999999999999854 444 38999986432 23456799999999999999999999998764 57899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 90 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999986432 388999999999999999999998 999999999999999999999999999987643
Q ss_pred ccc------ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 EHA------QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~~~------~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
... ...+..|+|||++....++.++|||||||++|||++ |+.||... ...++ ......... .
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--------~~~~~-~~~~~~~~~--~ 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEI-SSILEKGER--L 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------CHHHH-HHHHhCCCC--C
Confidence 321 223567999999988899999999999999999998 99998621 11121 111111110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.. +......+.+++.+||+.+|++|||+.+++..|..+....
T Consensus 231 ~~--------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 PQ--------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00 0112236788999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=322.91 Aligned_cols=246 Identities=23% Similarity=0.391 Sum_probs=199.2
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++||||+++++++...+..+++|||+++|+|
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred EeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 45789999999999999888889999987643 23467899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.++++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 89 LDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 999975432 2488999999999999999999998 89999999999999999999999999997654321
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||+.....++.++|||||||++|||+| |+.||.... ..... ......... +..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--------~~~~~-~~~~~~~~~----~~~-- 226 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--------NSDVM-SALQRGYRM----PRM-- 226 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--------HHHHH-HHHHcCCCC----CCC--
Confidence 2234567999999888889999999999999999999 999986211 11111 111111110 100
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
......+.+++.+|++.+|++|||++++.+.|+++
T Consensus 227 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.66 Aligned_cols=248 Identities=18% Similarity=0.158 Sum_probs=197.5
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++...+..|+||||++
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 3578999999999999964 68899999997432 2234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~ 155 (333)
T cd05600 85 GGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA 155 (333)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccccc
Confidence 999999997543 388999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+......... .....+.....
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~--~~~~~~~~~~~ 225 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------TPNETWENLKYWK--ETLQRPVYDDP 225 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC--------CHHHHHHHHHhcc--ccccCCCCCcc
Confidence 3456899999999999889999999999999999999999999631 1111111111110 00001111000
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+.+++.+||..+|++|||+.|+++.
T Consensus 226 --~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 --RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01122367788889999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.62 Aligned_cols=246 Identities=19% Similarity=0.265 Sum_probs=194.1
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||.||+|.. .++..||+|.++... ....+.+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999995 478899999997532 22345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc---
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK--- 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~--- 410 (565)
|+|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 99999886543 389999999999999999999998 999999999999999999999999999865321
Q ss_pred -cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 411 -EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 411 -~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+..............+.......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC
Confidence 1234678999999999999999999999999999999999999974322211111222333333222211 011
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCC------HHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWD------LREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs------~~evl~ 524 (565)
......+.+++.+||+.||++||| +.|+++
T Consensus 226 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 -----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111236788889999999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=312.97 Aligned_cols=252 Identities=16% Similarity=0.181 Sum_probs=193.7
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCcc--CHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNV--GKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E~~~ 332 (565)
.+.|++|+||.||+|+ ..+++.||.|+++..... -.-..++||.+|.+++|||||.+..+... -+..|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 4789999999999999 567899999999854322 23356899999999999999999998864 357999999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
. ||..++...+. .+...++..++.|+++|++|||++ .|+||||||+|+|+...|.+||+|||+|+.+...
T Consensus 161 h-DLksl~d~m~q----~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 161 H-DLKSLMETMKQ----PFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred h-hHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 6 99999987663 388999999999999999999999 8999999999999999999999999999988765
Q ss_pred ---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
+..+-|..|+|||.+.+ ..|++..|+||+|||+.||+++++-|... + .+.+.-+-...-+...+-+.|.
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~----s---E~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK----S---EIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC----c---hHHHHHHHHHHhCCCccccCCC
Confidence 23456899999997665 57999999999999999999999988631 1 1221111111111122222221
Q ss_pred ccCC---------CCCH----------HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGT---------KSGE----------GEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~---------~~~~----------~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+... ..+. .....-.++....+.+||.+|.|+.|.++.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1110 0000 011345677788999999999999998754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=336.78 Aligned_cols=258 Identities=20% Similarity=0.365 Sum_probs=213.9
Q ss_pred ccchhHHHhhccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceE
Q 008431 247 MFELNDLLRASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKL 325 (565)
Q Consensus 247 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 325 (565)
.++++.-......+||-|.||.||.|.|+ ..-.||||.++.. .-..++|++|..+|+.++|||+|+|+|+|..+..+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 34444444445689999999999999965 4678999999865 345789999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
||+|||..|+|.+||+..... .++.-..+.++.||+.|+.||..+ ++|||||..+|+|+.++..+||+|||++
T Consensus 340 IiTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred EEEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999865432 366677889999999999999998 8999999999999999999999999999
Q ss_pred ccccccccc--cc---cccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 406 PIVNKEHAQ--LH---MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 406 ~~~~~~~~~--~~---t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
+++..+... .| .+.|.|||-+....++.|+|||+|||+|||+.| |..||.. .++.+ +...++.+.
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG--------idlSq-VY~LLEkgy 483 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQ-VYGLLEKGY 483 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC--------ccHHH-HHHHHhccc
Confidence 999876432 22 367999999999999999999999999999998 9999862 33333 333333332
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
. ...++.+..++.+|+..||+|+|.+||+..|+-+.++.+..
T Consensus 484 R----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 484 R----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred c----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1 12234556689999999999999999999999999887654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=352.29 Aligned_cols=244 Identities=16% Similarity=0.149 Sum_probs=195.9
Q ss_pred ccceecccCceeEEEEEEe-C-CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-T-GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|... + +..||+|++..........+.+|+.+++.++|||||+++++|...+..|+||||+++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 4578999999999999843 3 5678888775444444556888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.++++..... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 151 DLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999988653221 22488999999999999999999998 9999999999999999999999999999865432
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.. ......+........ ++ .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~--------~~~~~~~~~~~~~~~-----~~-~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG--------PSQREIMQQVLYGKY-----DP-F 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCC-----CC-C
Confidence 234588999999999989999999999999999999999999862 122222222222110 00 0
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+......+.+++.+||+.||++|||+.+++.
T Consensus 292 -----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 -----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111236788899999999999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.21 Aligned_cols=241 Identities=19% Similarity=0.262 Sum_probs=190.0
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 467899999997532 22344577888888776 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc---
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK--- 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~--- 410 (565)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99999886543 389999999999999999999998 999999999999999999999999999875322
Q ss_pred -cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 411 -EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 411 -~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...............++......... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~- 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI- 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC-
Confidence 1234678999999999999999999999999999999999999963222111112223333332222111 01
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
+......+.+++.+||+.||++|||+
T Consensus 225 ----p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 ----PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11122367788999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=342.15 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=198.7
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 328 (565)
..++||+|+||.||+|... .+..||||+++... ....+.|.+|+++++++. |||||+++++|...+..|+||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 4578999999999999842 23469999997432 233567999999999996 999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCC--------------------------------------------------------------
Q 008431 329 DFVPNGSLANLLHVRRAP-------------------------------------------------------------- 346 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 346 (565)
|||++|+|.++++.....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999998753210
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCc
Q 008431 347 -----------------------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEP 397 (565)
Q Consensus 347 -----------------------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~ 397 (565)
....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHhEEEeCCCEE
Confidence 012478899999999999999999998 99999999999999999999
Q ss_pred EEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHH
Q 008431 398 LLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATW 470 (565)
Q Consensus 398 kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 470 (565)
||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++ |..||.... ....
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~--------~~~~ 348 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI--------VDST 348 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc--------hhHH
Confidence 99999998765322 12235578999999988889999999999999999997 999986321 1111
Q ss_pred HHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 471 VNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 471 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
.......+... . .+......+.+++.+||+.||++|||+.+|.+.|+++..
T Consensus 349 ~~~~~~~~~~~-----~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYNKIKSGYRM-----A-----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHhcCCCC-----C-----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11112221100 0 011223468889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=303.12 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=205.1
Q ss_pred cccchhHHHhhccceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEec
Q 008431 246 EMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK 321 (565)
Q Consensus 246 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 321 (565)
..++++++. ..+.||+|.||.||.|+ ..++-.||+|++.+.. .....++.+|+++-+.|+||||.+++++|.+.
T Consensus 17 ~~~~l~dfe--igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTLDDFE--IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccchhhcc--ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 344555543 46889999999999999 5677899999986532 23346799999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEec
Q 008431 322 EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTD 401 (565)
Q Consensus 322 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 401 (565)
...||++||.++|+++..|+..+. ..+++.....++.|+|.||.|+|.. +||||||||+|+|++..+..|++|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccC
Confidence 999999999999999999985443 2488888999999999999999998 999999999999999999999999
Q ss_pred cCCccccc--ccccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 402 YALVPIVN--KEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 402 fGla~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
||.+-... ...+.+||.-|.|||+..+..++.++|+|++||+.||++.|.+||.... -.+-.+++.
T Consensus 168 fGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~---- 235 (281)
T KOG0580|consen 168 FGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIR---- 235 (281)
T ss_pred CCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHH----
Confidence 99976543 2356689999999999999999999999999999999999999997322 111111111
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..++.+| ......+.+++.+|+..+|.+|.+..||+..
T Consensus 236 k~~~~~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 KVDLKFP--------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HccccCC--------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1122222 1222367889999999999999999999865
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.29 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=199.5
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05068 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88 (261)
T ss_pred eEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence 457899999999999998778889999987532 3467799999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--cc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--AQ 414 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--~~ 414 (565)
.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 89 LEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred HHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 99997543 12489999999999999999999998 89999999999999999999999999987654321 11
Q ss_pred cc---cccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 415 LH---MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 415 ~~---t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
.+ +..|+|||+.....++.++|||||||++|||+| |+.||... ...... .........
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~-~~~~~~~~~--------- 223 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM--------TNAEVL-QQVDQGYRM--------- 223 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--------CHHHHH-HHHHcCCCC---------
Confidence 22 357999999988899999999999999999999 99998621 111111 111111100
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
..+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00112234788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=337.43 Aligned_cols=240 Identities=21% Similarity=0.257 Sum_probs=193.9
Q ss_pred ccceecccCceeEEEEEEeC--CCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLLT--GPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.+++.++|||||++++++.+.+..|+||||+
T Consensus 34 ~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCC
Confidence 45789999999999998543 3589999986422 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 114 IGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999997543 388999999999999999999998 9999999999999999999999999999876433
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... +............ . .+.+
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--------~~~~~~~~i~~~~-~--~~p~---- 249 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN--------EPLLIYQKILEGI-I--YFPK---- 249 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC--------CHHHHHHHHhcCC-C--CCCC----
Confidence 3456889999999998888999999999999999999999999631 1111111111111 0 0011
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 525 (565)
.....+.+++.+|++.||++|+ |++|+++.
T Consensus 250 -----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 -----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1113567888899999999995 88888654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.56 Aligned_cols=249 Identities=21% Similarity=0.355 Sum_probs=203.4
Q ss_pred hhccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 255 RASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
+...+.||+|+||.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 33457899999999999998889999999988665555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 88 ~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 88 SLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred CHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999976432 2489999999999999999999998 8999999999999999999999999998765432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....++..|+|||......++.++|||||||++|||++ |+.||.... ......... .... +..
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~-----~~~- 225 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQIT-AGYR-----MPC- 225 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHH-hCCc-----CCC-
Confidence 12234568999999888889999999999999999998 899986321 111111111 1100 000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
+......+.+++.+|++.||++|||+.++++.|+.+
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 ----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 112224678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=327.26 Aligned_cols=251 Identities=17% Similarity=0.237 Sum_probs=191.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|.. .++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||++ |
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (288)
T cd07871 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-S 87 (288)
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-c
Confidence 347899999999999995 478899999987432 2334568899999999999999999999999889999999997 4
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 88 DLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99998865432 378899999999999999999998 9999999999999999999999999998754322
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh---h----cc---
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR---E----EW--- 479 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~----~~--- 479 (565)
....+++.|+|||++.+ ..++.++||||+||++|||+||++||.... ..+.+..... . .+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST--------VKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCCCChHHhhcc
Confidence 23456889999998765 568999999999999999999999996321 1111111111 0 00
Q ss_pred -----cCccccccccCCCC---CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 -----TGEVFDKDMRGTKS---GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 -----~~~~~d~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+....... .......+.+++.+||++||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111100000 0011235778999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.68 Aligned_cols=192 Identities=23% Similarity=0.362 Sum_probs=167.6
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
...+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||++++++|...+..++||||+++
T Consensus 8 ~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (333)
T cd06650 8 EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (333)
T ss_pred heeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCC
Confidence 34578999999999999965 6788888887643 223346799999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 88 GSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence 99999997543 3888999999999999999999741 6999999999999999999999999998755332
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
....++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 33467889999999988889999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=334.09 Aligned_cols=237 Identities=21% Similarity=0.283 Sum_probs=191.3
Q ss_pred ceecccCceeEEEEEE----eCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 259 EVLGSGSFGSSYKAVL----LTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
+.||+|+||.||+++. .+++.||+|.++... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357889999987421 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++.... .+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999997543 378888999999999999999998 999999999999999999999999999864322
Q ss_pred c----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 411 E----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 411 ~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||... .....+....... .
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~--------~~~~~~~~~~~~~-~------ 217 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE--------NRKKTIDKILKGK-L------ 217 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC-C------
Confidence 1 2345789999999998888999999999999999999999999631 1222222222111 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
.+. ......+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLP-----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCC-----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 010 11123677889999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.73 Aligned_cols=243 Identities=21% Similarity=0.330 Sum_probs=193.9
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
+.||+|+||.||+|.. .+++.+|+|.+.... ......|.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999995 478899999876432 23346799999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccccc---
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA--- 413 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~--- 413 (565)
.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++........
T Consensus 81 ~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTEGP----RLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 999975432 388999999999999999999998 999999999999999999999999999875432211
Q ss_pred ---ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 414 ---QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 414 ---~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...+..|+|||.+....++.++|||||||++|||++ |..||..... ............. ..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---------~~~~~~~~~~~~~-----~~- 217 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---------QQTREAIEQGVRL-----PC- 217 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---------HHHHHHHHcCCCC-----CC-
Confidence 112356999999988889999999999999999998 8888863211 1111111111000 00
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 218 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 ----PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 11123468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.11 Aligned_cols=248 Identities=19% Similarity=0.338 Sum_probs=198.4
Q ss_pred ccceecccCceeEEEEEEeC------CCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLT------GPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|...+ +..||+|.++..... ..+.|.+|++++++++||||+++++++......++|||
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence 34789999999999998533 478999998754333 35689999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 330 FVPNGSLANLLHVRRA---------PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
|+++|+|.+++..... .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCCeEEEC
Confidence 9999999999976432 1223488999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHH
Q 008431 401 DYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNS 473 (565)
Q Consensus 401 DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 473 (565)
|||+++..... ....+++.|+|||++....++.++|||||||++|||++ |+.||... .....+..
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~--------~~~~~~~~ 236 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL--------SNEEVIEC 236 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHH
Confidence 99998754221 22334678999999999999999999999999999999 99998621 11122221
Q ss_pred HhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 474 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
.. .+..... +......+.+++.+||+.||++|||+.||++.|+
T Consensus 237 ~~-~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 IT-QGRLLQR----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH-cCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 1111000 0112246888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=319.30 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=196.7
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCC-ccceEEEEEecC------ceEEEE
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPN-LLPLIAFYYRKE------EKLLVS 328 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------~~~lv~ 328 (565)
++||+|+||+||+|+ ..+|+.||+|+++-... .......+|+.++++++|+| ||++++++...+ ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 569999999999999 66889999999985432 23456789999999999999 999999998877 789999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||++. +|.+++....... .+++...+..+++|++.||+|||++ +|+||||||.|||+++++.+||+|||+|+..
T Consensus 97 e~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred Eeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 99975 9999998765422 3477789999999999999999999 9999999999999999999999999999866
Q ss_pred ccc----ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh----hcc
Q 008431 409 NKE----HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR----EEW 479 (565)
Q Consensus 409 ~~~----~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~ 479 (565)
.-. ...++|..|+|||++.+. .|++..||||+|||++||+++++-|..... .+....+-+.+. +.|
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcCCCCccCC
Confidence 522 344678899999987766 799999999999999999999988863221 111111111111 223
Q ss_pred cCcccccccc----CCCCC---HH----HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 TGEVFDKDMR----GTKSG---EG----EMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 ~~~~~d~~~~----~~~~~---~~----~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....-+... ....+ .. ......+++.+|++.+|.+|.|++.++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 2222111111 00000 00 01367889999999999999999998775
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.43 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=196.4
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|...++..+|+|.+... ....++|.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred EeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 34689999999999999877778999988743 33457799999999999999999999999988899999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 87 ~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 87 LNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999975432 389999999999999999999998 99999999999999999999999999987653321
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||+..+..++.++|||||||++|||+| |+.||.... .............. ..+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~---~~~---- 223 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--------NSETVEKVSQGLRL---YRP---- 223 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHhcCCCC---CCC----
Confidence 1234567999999988889999999999999999999 999986321 11112212111110 000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
......+.+++.+||+.+|++|||+.++++.|+
T Consensus 224 ----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111247888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=337.39 Aligned_cols=238 Identities=20% Similarity=0.241 Sum_probs=191.9
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
+.||+|+||.||++.. .++..||+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999984 578999999997432 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-hCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK-EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~----~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9999886543 38999999999999999999997 5 8999999999999999999999999998753221
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||... ............. ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~--------~~~~~~~~i~~~~-------~~~p 216 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILMEE-------IRFP 216 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC--------CHHHHHHHHhcCC-------CCCC
Confidence 2345889999999998889999999999999999999999999621 1122222111111 0011
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 525 (565)
......+.+++.+||+.||++|+ ++.++++.
T Consensus 217 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 -----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11123577888899999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.08 Aligned_cols=249 Identities=19% Similarity=0.314 Sum_probs=195.8
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... ++..||+|++.... .....+|.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 4578999999999999753 34679999886432 2334578999999999999999999999998899999999
Q ss_pred ccCCCCHHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRAP-----GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
|+++|+|.+++...+.. ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEEECCCCC
Confidence 99999999999764321 112368889999999999999999998 899999999999999999999999999
Q ss_pred ccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++..... ....++..|+|||++....++.++|||||||++|||++ |..||... ............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--------~~~~~~~~~~~~ 237 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--------SNEQVLRFVMEG 237 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHcC
Confidence 8754322 12234678999999988889999999999999999999 78888621 111222211111
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
. ... . +......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 238 ~-~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 G-LLD-----K-----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred C-cCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 100 0 01122468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.90 Aligned_cols=238 Identities=19% Similarity=0.311 Sum_probs=186.8
Q ss_pred eecccCceeEEEEEEeC-------------------------CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccce
Q 008431 260 VLGSGSFGSSYKAVLLT-------------------------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPL 314 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 314 (565)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998421 12578888865433345678899999999999999999
Q ss_pred EEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC
Q 008431 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA 394 (565)
Q Consensus 315 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~ 394 (565)
+++|.+....++||||+++|+|..++..... .+++..+..++.|+++||+|||+. +|+||||||+|||++..
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEecc
Confidence 9999999999999999999999999865332 388999999999999999999998 99999999999999764
Q ss_pred C-------CcEEeccCCcccccccccccccccccCCCccCC-CCCCcchhHHHHHHHHHHH-HcCCCCccccccCCCCCc
Q 008431 395 Y-------EPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILEL-LTGKFPANYLAQGKGANA 465 (565)
Q Consensus 395 ~-------~~kl~DfGla~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el-~tg~~p~~~~~~~~~~~~ 465 (565)
+ .+|++|||++..........++..|+|||.+.. ..++.++|||||||++||+ ++|+.||..... .
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~ 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-----S 228 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-----H
Confidence 3 379999999865544444567788999998765 5689999999999999999 479999863211 0
Q ss_pred chHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
.... ...... .... .....+.+++.+||+.+|++|||+.+|++.|
T Consensus 229 ~~~~----~~~~~~-------~~~~-----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 EKER----FYEKKH-------RLPE-----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHH----HHHhcc-------CCCC-----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111 111110 0000 1113678899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=319.47 Aligned_cols=246 Identities=20% Similarity=0.368 Sum_probs=197.9
Q ss_pred ccceecccCceeEEEEEEeC----CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLLT----GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|.+.. ...||||.++... .....+|.+|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 45789999999999998642 3578999886432 333567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++.....
T Consensus 88 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 88 ENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred CCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999975432 489999999999999999999998 9999999999999999999999999999876421
Q ss_pred c------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 412 H------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 412 ~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
. ...++..|+|||......++.++|||||||++|||++ |..||.... ..... .........
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~-~~~~~~~~~--- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVI-KAVEDGYRL--- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHH-HHHHcCCCC---
Confidence 1 1223467999999988899999999999999999998 999985321 11111 111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
+. +......+.+++.+|++.+|++||++.||++.|+++
T Consensus 228 -~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -PP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 111234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.33 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=190.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||++ +
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 3478999999999999954 78899999987432 2234567899999999999999999999999999999999996 6
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 88 DLCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 88888865432 388899999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh---h----cccC-
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR---E----EWTG- 481 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~- 481 (565)
....+++.|+|||++.+ ..++.++||||+||++|||+||+.||.... +....+..... . .+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK-------DIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc-------cHHHHHHHHHHHhCCCChhhccch
Confidence 23457889999998755 458899999999999999999999996321 12121211111 0 0000
Q ss_pred ---cccccc-ccC-CCCC-H------HHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 ---EVFDKD-MRG-TKSG-E------GEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ---~~~d~~-~~~-~~~~-~------~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...++. ... .... . .....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 000 0000 0 01235678999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=324.32 Aligned_cols=252 Identities=20% Similarity=0.334 Sum_probs=201.4
Q ss_pred cceecccCceeEEEEEEe------CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.+.||+|+||.||+|... ++..+++|.+........+.+.+|++.+++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 468999999999999842 34568888887554444567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 332 PNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
++++|.+++...... ....++|..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEEC
Confidence 999999999764321 112489999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHH
Q 008431 401 DYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNS 473 (565)
Q Consensus 401 DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 473 (565)
|||+++..... ....++..|+|||++....++.++|||||||++|||+| |+.||... .....+..
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------~~~~~~~~ 237 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--------SNTEVIEC 237 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH
Confidence 99998754322 12334678999999988899999999999999999999 99998631 11111111
Q ss_pred HhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 474 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
...+..... .......+.+++.+||+.+|++|||+.+|++.|+++...
T Consensus 238 -~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 -ITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111111100 011234688999999999999999999999999999543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=333.17 Aligned_cols=232 Identities=23% Similarity=0.256 Sum_probs=187.6
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||+||+|+. .+++.||+|.+... .....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 46889999998742 223345678888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99999987543 388999999999999999999998 9999999999999999999999999998753211
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .............. ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~--------~~~~~~~~~i~~~~----~~~~--- 216 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA--------ENEDDLFEAILNDE----VVYP--- 216 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHhcCC----CCCC---
Confidence 234578999999999888999999999999999999999999962 12222222222111 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
......+.+++.+||+.||++||++
T Consensus 217 -----~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 -----TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -----CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0112367788899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.31 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=196.9
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEec-CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRK-EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lv 327 (565)
..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||++++++|... ...+++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 4578999999999999732 34789999987432 22235688899999999 899999999988754 568899
Q ss_pred EeccCCCCHHHHHhhcCCC--------------------------------------------------------CCCCC
Q 008431 328 SDFVPNGSLANLLHVRRAP--------------------------------------------------------GQPGL 351 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l 351 (565)
|||+++|+|.+++...... ....+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999999653210 01248
Q ss_pred CHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc------cccccccccCCCc
Q 008431 352 DWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH------AQLHMVAYKSPEF 425 (565)
Q Consensus 352 ~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~ 425 (565)
+|..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.... ...++..|+|||+
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 9999999999999999999998 99999999999999999999999999997653321 2234567999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHH
Q 008431 426 NQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKI 504 (565)
Q Consensus 426 ~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l 504 (565)
+.+..++.++|||||||++|||++ |+.||.... ..+............ . . +......+.++
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~-~-~--------~~~~~~~~~~l 308 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ--------IDEEFCRRLKEGTRM-R-A--------PEYATPEIYSI 308 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC--------ccHHHHHHHhccCCC-C-C--------CccCCHHHHHH
Confidence 999999999999999999999998 999986311 111111122111110 0 0 11223468899
Q ss_pred HhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 505 GMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 505 ~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
+.+||+.+|++||++.|+++.|.++..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.21 Aligned_cols=259 Identities=18% Similarity=0.188 Sum_probs=192.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 3568999999999999964 67889999987432 23356788999999999999999999999999999999999998
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
+.+..+... . ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~l~~~~~~-~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 85 NMLELLEEM-P----NGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CHHHHHHhc-C----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 777655432 2 2388999999999999999999998 9999999999999999999999999998765432
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCC-------CcchHHHHHHHhhhcccC
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA-------NADLATWVNSVVREEWTG 481 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 481 (565)
....+++.|+|||++.+..++.++|||||||++|||++|++||......... ......+...........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 1235788999999998888999999999999999999999999632110000 000000011000000000
Q ss_pred ccccccccCCCC-----CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 EVFDKDMRGTKS-----GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....+....... .......+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000011100000 0012245889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.46 Aligned_cols=239 Identities=22% Similarity=0.340 Sum_probs=189.2
Q ss_pred ceecccCceeEEEEEEeC-------------CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceE
Q 008431 259 EVLGSGSFGSSYKAVLLT-------------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKL 325 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 325 (565)
+.||+|+||.||+|.+.+ ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2257888876544444567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC-------cE
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE-------PL 398 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~-------~k 398 (565)
+||||+++|+|..++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeE
Confidence 99999999999998865432 389999999999999999999998 9999999999999987654 89
Q ss_pred EeccCCcccccccccccccccccCCCccC-CCCCCcchhHHHHHHHHHHHH-cCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 399 LTDYALVPIVNKEHAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELL-TGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 399 l~DfGla~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
++|||++..........++..|+|||++. ...++.++|||||||++|||+ +|+.|+... ..... .....
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--------~~~~~-~~~~~ 223 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK--------TLAEK-ERFYE 223 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc--------chhHH-HHHHh
Confidence 99999987765555566788999999876 467899999999999999997 588887521 11111 11111
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
.. ... . ......+.+++.+||+.||++||++.|+++.+
T Consensus 224 ~~--~~~-------~---~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQ--CML-------V---TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cC--ccC-------C---CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 10 000 0 01123678899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=347.06 Aligned_cols=262 Identities=22% Similarity=0.245 Sum_probs=210.6
Q ss_pred hHHHhhccceecccCceeEEEEEEeCC-CeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEE-EEe---c---
Q 008431 251 NDLLRASAEVLGSGSFGSSYKAVLLTG-PAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAF-YYR---K--- 321 (565)
Q Consensus 251 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~---~--- 321 (565)
........++|.+|||+.||.|....+ ..+|+|++-..+....+...+||++|+.|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 333334568999999999999996655 999999987666677788999999999997 9999999993 322 1
Q ss_pred CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEec
Q 008431 322 EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTD 401 (565)
Q Consensus 322 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 401 (565)
-+.+|.||||.||.|-+++..+... .|++.++++|+.|+|+|+++||..-+ +|||||||-+||||+.++..||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~p--PiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLKP--PIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCCC--ccchhhhhhhheEEcCCCCEEeCc
Confidence 2578999999999999999876543 49999999999999999999998633 699999999999999999999999
Q ss_pred cCCccccccc-------------ccccccccccCCCcc---CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCc
Q 008431 402 YALVPIVNKE-------------HAQLHMVAYKSPEFN---QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANA 465 (565)
Q Consensus 402 fGla~~~~~~-------------~~~~~t~~y~aPE~~---~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~ 465 (565)
||-+.-.... -....|+.|+|||++ .+..+++|+|||++||+||-|+....||+...
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------- 262 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------- 262 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence 9987532211 122458899999964 56789999999999999999999999997321
Q ss_pred chHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCCCCCc
Q 008431 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDY 539 (565)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~~~~ 539 (565)
...+++....-.. .......+.+||..||+.||++||++-+|+..+.++........+-
T Consensus 263 --------------~laIlng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 263 --------------KLAILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred --------------ceeEEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 1123333222111 1355668999999999999999999999999999998876655544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=317.17 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=193.2
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeec--cCccCHHHHHHHHHHHhcCCCCCccceEEEEEe-----cCceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-----KEEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~~lv~E 329 (565)
.+.||+|+||.|.+|. ..+|+.||||++.. ......++-.+|+.+|+.++|+||+.+++.+.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 4679999999999999 56899999999973 345556788999999999999999999999875 246899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
+|+ .||.+.++... .|+...+..++.|+++||.|+|+. +|+||||||+|+|++.++..||+|||+|+...
T Consensus 107 lMe-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HHh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccccceeecc
Confidence 995 59999998654 288899999999999999999999 99999999999999999999999999999885
Q ss_pred cc------ccccccccccCCCcc-CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh-------
Q 008431 410 KE------HAQLHMVAYKSPEFN-QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV------- 475 (565)
Q Consensus 410 ~~------~~~~~t~~y~aPE~~-~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 475 (565)
.. +..+.|..|+|||++ ....|+...||||.|||+.||++|++-|..... .+-.+.+...+
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-----v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-----VHQLQLILELLGTPSEED 251 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-----HHHHHHHHHhcCCCCHHH
Confidence 31 345678999999965 556899999999999999999999998863110 00011111111
Q ss_pred ----hhcccCcccc--ccccCCCC---CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 476 ----REEWTGEVFD--KDMRGTKS---GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 476 ----~~~~~~~~~d--~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
........+. |.....+. -.......+++..++|..||.+|+|++|+++.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000 00101000 01222467888889999999999999999765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=332.55 Aligned_cols=243 Identities=21% Similarity=0.273 Sum_probs=206.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc-eEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE-KLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~E~~~ 332 (565)
..+++|+|+||.++..++ .++..+|+|++.-. +...++...+|+.++++++|||||.+.+.|..++. .+|||+||+
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence 347899999999999984 46789999998743 34445578899999999999999999999999888 999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
||++.+.+...+. ..+++..+..++.|++.|+.|||++ +|+|||||+.||++..+..+||.|||+|+.+...
T Consensus 88 Gg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 88 GGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred CCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999987763 2489999999999999999999988 8999999999999999999999999999998765
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+..||+.||.||.+.+..|..|+||||+||++|||++-+++|. ..+....+.+..+.. ++|-
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~--------a~~m~~Li~ki~~~~-----~~Pl- 226 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK--------ASNMSELILKINRGL-----YSPL- 226 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC--------ccchHHHHHHHhhcc-----CCCC-
Confidence 35679999999999999999999999999999999999999997 234444444444332 1111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+.....++..++..||+.+|+.||++.+++.+
T Consensus 227 -----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 -----PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12333478888899999999999999999887
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=333.26 Aligned_cols=238 Identities=22% Similarity=0.254 Sum_probs=191.2
Q ss_pred ceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999954 67899999987531 23345677889888865 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|..++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99999987543 388999999999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++....++.++|||||||++|||+||+.||... ............. ...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~--------~~~~~~~~i~~~~----~~~p~-- 217 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD--------NEDDLFESILHDD----VLYPV-- 217 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC----CCCCC--
Confidence 2345789999999998889999999999999999999999999631 1222222222211 11111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCC-------CHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRW-------DLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-------s~~evl~~ 525 (565)
.....+.+++.+||+.||++|| ++.++++.
T Consensus 218 ------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 ------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1123677888999999999999 77777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=317.77 Aligned_cols=253 Identities=19% Similarity=0.278 Sum_probs=202.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence 346899999999999994 578999999886422 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 86 ~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 86 AGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99999998653321 22478899999999999999999998 9999999999999999999999999998765432
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....++..|+|||.+.+..++.++|||||||++|||++|+.||... ......+........ .+..
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~------~~~~~~~~~~~~~~~------~~~~ 228 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLFSLCQKIEQCD------YPPL 228 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc------cccHHHHHHHHhcCC------CCCC
Confidence 2345778899999988888999999999999999999999998521 112222222211111 1111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
. .......+.+++.+||+.+|++|||+.||++.|++++
T Consensus 229 ~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 P----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 1122346888999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.30 Aligned_cols=243 Identities=18% Similarity=0.211 Sum_probs=190.6
Q ss_pred ecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 261 LGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 261 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
||+|+||+||++.. .+++.||+|++..... ...+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999984 4788999999864321 2235678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
..++..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 988864322 123489999999999999999999998 9999999999999999999999999998765432 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... .....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~---------~~~~~--- 219 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRIL---------NDSVT--- 219 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhc---------ccCCC---
Confidence 336788999999999999999999999999999999999999632110 01111111111 00000
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
.+......+.+++.+||+.||++|| |++|+++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0111224677888999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=317.22 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=195.6
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|...++..+|+|.+... .....+|.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 45789999999999999877788999988643 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... .++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 87 ~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 87 LNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred HHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999975432 389999999999999999999998 89999999999999999999999999987654321
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||++....++.++|||||||++|||+| |+.||.... ..+.... ..... ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~-----~~~~-- 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--------NSEVVES-VSAGY-----RLYR-- 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--------HHHHHHH-HHcCC-----cCCC--
Confidence 1123357999999988899999999999999999999 899986321 1111111 11110 0000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
+......+.+++.+||..+|++|||+.|+++.|
T Consensus 223 ---~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 ---PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.92 Aligned_cols=240 Identities=23% Similarity=0.400 Sum_probs=187.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 347899999999999995 478999999986432 233467899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+.. ...+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 986432 256778889999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCCCccCC-----CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 -HAQLHMVAYKSPEFNQT-----DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....||..|+|||++.. ...+.++|||||||++|||++|+.||.... .......+....... .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~------~ 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-----QGDWASLMCAICMSQ------P 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhccC------C
Confidence 34568899999998643 234568999999999999999999996211 111111111111100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 294 ~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEA-----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCC-----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 11122467889999999999999999999875
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=324.27 Aligned_cols=260 Identities=21% Similarity=0.302 Sum_probs=203.8
Q ss_pred hHHHhhccceecccCceeEEEEEEe--------CCCeeEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 008431 251 NDLLRASAEVLGSGSFGSSYKAVLL--------TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYR 320 (565)
Q Consensus 251 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 320 (565)
....+...+.||+|+||.||+|... ++..||+|.+... ......++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3333445688999999999999742 2347899988643 233456789999999999 89999999999999
Q ss_pred cCceEEEEeccCCCCHHHHHhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCE
Q 008431 321 KEEKLLVSDFVPNGSLANLLHVRRAPG-----------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNV 389 (565)
Q Consensus 321 ~~~~~lv~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NI 389 (565)
....++||||+++|+|.+++......+ ...++|..+..++.|++.||+|||+. +|+||||||+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Ni 168 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAARNV 168 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----CeeecccccceE
Confidence 999999999999999999998653211 12488999999999999999999998 999999999999
Q ss_pred EEcCCCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCC
Q 008431 390 LLDNAYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKG 462 (565)
Q Consensus 390 Ll~~~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~ 462 (565)
+++.++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~------ 242 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG------ 242 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc------
Confidence 9999999999999998765432 12234567999999988889999999999999999998 7888752
Q ss_pred CCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 463 ANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
....++.... ....... .+......+.+++.+||+.+|++||||.|+++.|+++....
T Consensus 243 --~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 243 --IPVEELFKLL-KEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --CCHHHHHHHH-HcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 2222333222 2111100 01122346788899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.28 Aligned_cols=236 Identities=22% Similarity=0.255 Sum_probs=186.4
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhc-CCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGS-LSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||+||+|.. .+++.||+|.++... ....+.+..|..++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 467889999987431 2234456667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|..++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 99999987543 388999999999999999999998 9999999999999999999999999998754221
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+......... +.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~-------~~~~ 216 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE--------DEDELFDSILNDR-------PHFP 216 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCC-------CCCC
Confidence 2346789999999998889999999999999999999999999621 1122222211110 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLR-EAV 523 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl 523 (565)
......+.+++.+||+.||++||++. +++
T Consensus 217 -----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 -----RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11123567888899999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=319.26 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=193.6
Q ss_pred cceecccCceeEEEEEEeCCC---eeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEE
Q 008431 258 AEVLGSGSFGSSYKAVLLTGP---AMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLL 326 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 326 (565)
.+.||+|+||.||+|...... .+|+|.++.. .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 468999999999999965433 5889987643 233356789999999999999999999987542 24689
Q ss_pred EEeccCCCCHHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 327 VSDFVPNGSLANLLHVRRAP-GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+|||+++|+|.+++...+.. ....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988543221 123489999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 406 PIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 406 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
+...... ...+++.|+|||+.....++.++|||||||++|||++ |+.||... ...+.. .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~-~~~~~~ 230 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--------ENSEIY-DYLRQG 230 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHH-HHHHcC
Confidence 8654321 1234567999999988899999999999999999999 88998631 111111 112221
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.... ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 231 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1100 0111223678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=324.06 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=196.0
Q ss_pred ccceecccCceeEEEEEEe-----CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 329 (565)
..+.||+|+||.||+|... ++..||+|++........+.|.+|++++++++||||+++++++... ...++|||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 4578999999999999743 5789999998765555567899999999999999999999987643 46899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++...+. .++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 88 ~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 88 YLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ecCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999975432 389999999999999999999998 99999999999999999999999999988654
Q ss_pred cccc-------ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCC----CCC---cchHHHHHHHh
Q 008431 410 KEHA-------QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGK----GAN---ADLATWVNSVV 475 (565)
Q Consensus 410 ~~~~-------~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~----~~~---~~~~~~~~~~~ 475 (565)
.... ..++..|+|||+..+..++.++|||||||++|||++|..|+....... +.. ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 112346999999988889999999999999999999887753211000 000 00000111111
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
... .. ..........+.+++.+||+.+|++||||.||++.|+.++
T Consensus 240 ~~~---------~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 240 KNN---------GR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hcC---------Cc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 110 00 0001122346888999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=318.39 Aligned_cols=249 Identities=25% Similarity=0.295 Sum_probs=189.1
Q ss_pred eecccCceeEEEEEEeC---CCeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 260 VLGSGSFGSSYKAVLLT---GPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.||+|+||.||+|...+ +..+|+|+++.... .....|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 45789998875432 234578999999999999999999999998889999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--- 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 412 (565)
|.+++...........++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999765433233467888889999999999999998 99999999999999999999999999986543221
Q ss_pred ---cccccccccCCCccCCC-------CCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 413 ---AQLHMVAYKSPEFNQTD-------GVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 413 ---~~~~t~~y~aPE~~~~~-------~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
...++..|+|||++... .++.++|||||||++|||++ |+.||..... .+....... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--------EQVLTYTVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHhh-cccC
Confidence 22356789999987532 35789999999999999996 9999963211 111111111 1112
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
...++.+... ....+.+++.+|+ .+|++|||++||++.|+
T Consensus 229 ~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLP-----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCC-----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222222211 1124666778898 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=323.54 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=196.3
Q ss_pred ccceecccCceeEEEEEE-----eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-----LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 328 (565)
..+.||+|+||+||++.. .++..||+|.++... ....+.|.+|++++++++||||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 347899999999988653 367789999987532 23456789999999999999999999998754 3578999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999643 389999999999999999999998 9999999999999999999999999998765
Q ss_pred cccc-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 409 NKEH-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 409 ~~~~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
.... ...++..|+|||+.....++.++|||||||++|||+||+.|+....... .....+...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF---EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh---hhhhcccccccchhhhh
Confidence 4321 1234567999999888889999999999999999999999975322110 00000000000000000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
+..+..... ..+......+.+++.+||+.+|++|||++++++.|+++.
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111110 011123357888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.09 Aligned_cols=236 Identities=22% Similarity=0.272 Sum_probs=188.0
Q ss_pred ceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhc-CCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGS-LSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||+||+|... +++.||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999954 67899999987531 2334556778888876 5899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc---
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK--- 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~--- 410 (565)
|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99999997543 388999999999999999999998 999999999999999999999999999865321
Q ss_pred -cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 411 -EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 411 -~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
.....||..|+|||++.+..++.++|||||||++|||++|+.||... ......... ... .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--------~~~~~~~~i-~~~------~~~~~ 216 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--------DEEELFQSI-RMD------NPCYP 216 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC--------CHHHHHHHH-HhC------CCCCC
Confidence 12345789999999998889999999999999999999999999621 112222211 111 01111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLR-EAV 523 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl 523 (565)
. .....+.+++.+||+.||++||++. ++.
T Consensus 217 ~-----~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 R-----WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred c-----cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1 1123577888999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=314.68 Aligned_cols=242 Identities=22% Similarity=0.349 Sum_probs=195.5
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
++||+|+||.||+|...++..+|+|.+.... ......|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999986533 233457899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-----
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH----- 412 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~----- 412 (565)
+++..... .+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+|++|||++.......
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 81 SFLRKKKD----ELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99865432 388999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
...++..|+|||+.....++.++|||||||++||+++ |..||... .... ............ .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~--------~~~~-~~~~~~~~~~~~-----~--- 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM--------TNQQ-AREQVEKGYRMS-----C--- 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC--------CHHH-HHHHHHcCCCCC-----C---
Confidence 1223467999999988889999999999999999998 99998621 1111 111111111100 0
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
+......+.+++.+|++.+|++|||+.|+++.|.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 --PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1122347889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.59 Aligned_cols=184 Identities=19% Similarity=0.262 Sum_probs=162.1
Q ss_pred hccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
...+.||+|+||.||+|.. .+++.||+|+.. ...+.+|++++++++|||||++++++......++|+||+. +
T Consensus 95 ~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred EEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 3457899999999999994 578899999753 3457899999999999999999999999999999999995 6
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 168 ~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 168 DLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9998886543 388999999999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
....||+.|+|||++....++.++|||||||++|||+||+.||.
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 23468999999999988899999999999999999999998864
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.76 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=198.9
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeeccCccC---HHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVG---KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
+.||.|+||.||.|+ ..+...||||++.-..... -.++++|+..|++++|||+|.+.|+|..+...|||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 579999999999999 5678899999997433333 3578999999999999999999999999999999999995 5
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQ 414 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 414 (565)
+-.+++...+. ++.+..+..|..+.+.||+|||++ +.||||||..|||+.+.+.+|++|||-|.+..+..+.
T Consensus 111 SAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF 182 (948)
T KOG0577|consen 111 SASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF 182 (948)
T ss_pred cHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCchhcc
Confidence 88888887665 388999999999999999999999 8999999999999999999999999999999999999
Q ss_pred cccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 415 LHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 415 ~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
+||++|||||++. .+.|+-|+||||+||++.||.-.++|+..+ +-..-+..+.... .|.+..
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--------NAMSALYHIAQNe------sPtLqs- 247 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNE------SPTLQS- 247 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--------hHHHHHHHHHhcC------CCCCCC-
Confidence 9999999999864 468999999999999999999999996522 2222222222221 233321
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+-...+..++..||+.-|.+|||..++++
T Consensus 248 ---~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 248 ---NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 122346778888999999999999988754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.31 Aligned_cols=254 Identities=17% Similarity=0.263 Sum_probs=188.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecC-----ceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-----EKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~ 328 (565)
..+.||+|+||.||+|.. .++..||||++... .......+.+|+.++++++||||+++++++...+ ..|+||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 357899999999999994 47899999998742 2233456889999999999999999999886432 479999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 84 ELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9995 69999886543 389999999999999999999998 9999999999999999999999999998754
Q ss_pred ccc-------ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh---
Q 008431 409 NKE-------HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR--- 476 (565)
Q Consensus 409 ~~~-------~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 476 (565)
... ....+|..|+|||++.+ ..++.++|||||||++|||+||++||..... ......+.....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~ 228 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTPS 228 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 321 23457889999998765 6789999999999999999999999963110 001111111000
Q ss_pred --------hcccCccccccccCCCCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 477 --------EEWTGEVFDKDMRGTKSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 477 --------~~~~~~~~d~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+..-....... ......+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000 0112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.84 Aligned_cols=254 Identities=21% Similarity=0.321 Sum_probs=199.5
Q ss_pred hhccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEE
Q 008431 255 RASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 326 (565)
....++||+|+||.||+|++. .+..||+|+++... ....+.+.+|+.++.++. |||||+++++|...+..++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 335689999999999999853 34579999997532 222457899999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCC-------------------------------------------------------------
Q 008431 327 VSDFVPNGSLANLLHVRRA------------------------------------------------------------- 345 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~------------------------------------------------------------- 345 (565)
||||+++|+|.++++..+.
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 9999999999999975421
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC
Q 008431 346 --------------------------------PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN 393 (565)
Q Consensus 346 --------------------------------~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~ 393 (565)
.....++|...+.++.|++.||+|||+. +|+||||||+|||+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCcceEEEeC
Confidence 0112478888999999999999999988 9999999999999999
Q ss_pred CCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcc
Q 008431 394 AYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANAD 466 (565)
Q Consensus 394 ~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~ 466 (565)
++.+||+|||+++..... ....++..|+|||++....++.++|||||||++|||++ |..||....
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~-------- 346 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP-------- 346 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC--------
Confidence 999999999998764321 12345678999999988889999999999999999998 899986321
Q ss_pred hHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 467 LATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
...........+... .. +......+.+++.+||..+|++||+++|+++.|+++.
T Consensus 347 ~~~~~~~~~~~~~~~-----~~-----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNEQFYNAIKRGYRM-----AK-----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chHHHHHHHHcCCCC-----CC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111211111100 00 1112246888899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.21 Aligned_cols=245 Identities=18% Similarity=0.215 Sum_probs=191.7
Q ss_pred ecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 261 LGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 261 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
||+|+||.||++.. .+|+.+|+|++.... ......+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999984 568999999986422 12234566799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---cc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---HA 413 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---~~ 413 (565)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 988865432 2488999999999999999999998 9999999999999999999999999998765432 23
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||++.+..++.++||||+||++|||++|+.||..... ............... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~-----~~~~~----- 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTLEDE-----VKFEH----- 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhhccc-----ccccc-----
Confidence 4578899999999888899999999999999999999999863211 011111111111111 00000
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
......+.+++.+||+.||++||++.|+++.+.
T Consensus 220 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 220 -QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred -ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 011235788999999999999999988764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.94 Aligned_cols=239 Identities=21% Similarity=0.353 Sum_probs=189.5
Q ss_pred ceecccCceeEEEEEEe-C-------CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 259 EVLGSGSFGSSYKAVLL-T-------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
+.||+|+||.||+|... . ...+|+|.+........+++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36899999999999853 2 234788887654444456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC--------cEEecc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--------PLLTDY 402 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~--------~kl~Df 402 (565)
+++|+|.+++...+. .+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +|++||
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999975443 389999999999999999999998 9999999999999987765 599999
Q ss_pred CCcccccccccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCC-CCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 403 ALVPIVNKEHAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGK-FPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 403 Gla~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
|++..........++..|+|||++.. ..++.++|||||||++|||++|. .|+.... ...... .....
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--------~~~~~~-~~~~~-- 221 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--------SQKKLQ-FYEDR-- 221 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--------HHHHHH-HHHcc--
Confidence 99876655555667889999998876 45799999999999999999985 5554211 111111 11110
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
..+. .....++.+++.+||+.||++|||++|+++.|
T Consensus 222 -----~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 -----HQLP-----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----ccCC-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111 11124678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=322.10 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=198.9
Q ss_pred ccceecccCceeEEEEEEe-CCC--eeEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGP--AMVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..++||+|+||.||+|... ++. .+++|.++.. .....+.|.+|+.++.++ +||||+++++++...+..++||||+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (297)
T cd05089 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA 85 (297)
T ss_pred eeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEec
Confidence 3468999999999999864 333 4688887642 223346789999999999 7999999999999989999999999
Q ss_pred CCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 332 PNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCeEEEC
Confidence 999999999754311 112488999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhh
Q 008431 401 DYALVPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 401 DfGla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
|||++...... .....+..|+|||+.....++.++|||||||++|||+| |..||... ...........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~--------~~~~~~~~~~~ 233 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM--------TCAELYEKLPQ 233 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHhc
Confidence 99998643221 11222457999999988889999999999999999998 99998621 12222222111
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
. . .+... ......+.+++.+|++.+|.+|||+.++++.|.++......
T Consensus 234 ~-~-----~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 234 G-Y-----RMEKP-----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred C-C-----CCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1 0 00010 11224678899999999999999999999999999876533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=329.19 Aligned_cols=237 Identities=24% Similarity=0.262 Sum_probs=190.8
Q ss_pred ceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||+||+|... ++..||+|.++... ......+.+|..+++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999954 67899999997532 23345677888998887 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|..++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99999887543 389999999999999999999998 9999999999999999999999999998653211
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....+++.|+|||++.+..++.++|||||||++|||++|+.||... +............ . ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~--------~~~~~~~~i~~~~----~---~~- 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD--------DEDELFQSILEDE----V---RY- 215 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC--------CHHHHHHHHHcCC----C---CC-
Confidence 2345789999999999999999999999999999999999999621 1122222221111 0 00
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDL-----REAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~ 524 (565)
+......+.+++.+||+.||++|||+ .++++
T Consensus 216 ----~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 ----PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ----CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 01112367888999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=322.71 Aligned_cols=251 Identities=21% Similarity=0.339 Sum_probs=198.4
Q ss_pred ccceecccCceeEEEEEEeC------CCeeEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLT------GPAMVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||.||++.... ...+|+|.+... ......++.+|+.++.++ +||||+++++++...+..+++|
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 45789999999999998542 357899988743 223345688999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCc
Q 008431 329 DFVPNGSLANLLHVRRA-----------PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEP 397 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~ 397 (565)
||+++|+|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeEEEcCCCeE
Confidence 99999999999975421 1123589999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHH
Q 008431 398 LLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATW 470 (565)
Q Consensus 398 kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 470 (565)
|++|||+++...... ...++..|+|||+.....++.++|||||||++|||++ |..||... ...+.
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~ 243 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--------PVEEL 243 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC--------CHHHH
Confidence 999999987654321 1223567999999888889999999999999999998 99998521 11111
Q ss_pred HHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 471 VNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 471 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
.. ........ ..+......+.+++.+|++.||++||||.|+++.|+++.
T Consensus 244 ~~-~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FK-LLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH-HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 11111100 001122347889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=315.97 Aligned_cols=241 Identities=19% Similarity=0.305 Sum_probs=191.8
Q ss_pred eecccCceeEEEEEE---eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 260 VLGSGSFGSSYKAVL---LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.||+|+||.||+|.+ .++..+|+|.++... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999886432 223567899999999999999999999875 45678999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999997543 388999999999999999999998 99999999999999999999999999987654321
Q ss_pred -----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 413 -----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 413 -----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
...++..|+|||.+....++.++|||||||++|||+| |+.||... ....+... ...+...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~-i~~~~~~----- 217 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--------KGNEVTQM-IESGERM----- 217 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH-HHCCCCC-----
Confidence 1123468999999888889999999999999999998 99998632 11122221 2221110
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
... ......+.+++.+||+.||++||++.+|++.|++.
T Consensus 218 ~~~-----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCC-----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111 11224677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=329.16 Aligned_cols=237 Identities=25% Similarity=0.291 Sum_probs=187.5
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHH---hcCCCCCccceEEEEEecCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRL---GSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
.+.||+|+||.||+|.. .+++.||||.++... ....+.+.+|++++ +.++||||+++++++...+..|+||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 46899999999999985 478999999997432 22334566676554 567899999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|..+++.. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999887532 389999999999999999999998 999999999999999999999999999865322
Q ss_pred c----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 411 E----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 411 ~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||... ..............
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~--------~~~~~~~~i~~~~~------- 218 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD--------DEEEVFDSIVNDEV------- 218 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCC-------
Confidence 1 2345789999999999889999999999999999999999999621 12222222221110
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
... ......+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYP-----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC-----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 000 11123577889999999999999 4566554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=315.38 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=191.1
Q ss_pred ceecccCceeEEEEEEeC----CCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEe-cCceEEEEeccC
Q 008431 259 EVLGSGSFGSSYKAVLLT----GPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-KEEKLLVSDFVP 332 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E~~~ 332 (565)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998542 347899988543 22345678899999999999999999998764 456899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999975432 367888899999999999999998 9999999999999999999999999998754321
Q ss_pred -------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcC-CCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 -------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTG-KFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 -------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
....++..|+|||+.....++.++|||||||++|||++| .+||.. ...............
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~--------~~~~~~~~~~~~~~~---- 220 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--------VDSFDITVYLLQGRR---- 220 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHhcCCC----
Confidence 122345679999998888899999999999999999995 556642 112222222211110
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
+.. +......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 221 --~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 --LLQ-----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CCC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000 01112367889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=317.84 Aligned_cols=249 Identities=20% Similarity=0.308 Sum_probs=196.2
Q ss_pred cceecccCceeEEEEEEeC----CCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc------eE
Q 008431 258 AEVLGSGSFGSSYKAVLLT----GPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE------KL 325 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~ 325 (565)
.+.||+|+||.||+|.... +..||+|+++... ....+.+.+|+..++.++||||+++++++...+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4689999999999998542 3679999987432 2334678999999999999999999999876554 79
Q ss_pred EEEeccCCCCHHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 326 LVSDFVPNGSLANLLHVRRAP-GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
++|||+++|+|..++...... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECCccc
Confidence 999999999999998654321 123589999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++...... ....+..|+|||+.....++.++|||||||++|||++ |..||.... -.+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--------NHEIYDYLRHG 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcC
Confidence 87654321 1223567999999988889999999999999999999 889986321 11222211111
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
. .. .. +......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 ~-~~-----~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N-RL-----KQ-----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-CC-----CC-----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 10 01 112234788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=302.97 Aligned_cols=243 Identities=20% Similarity=0.307 Sum_probs=198.0
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccC----ccC----HHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEE
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS----NVG----KEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~----~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 327 (565)
.++||.|..++|-++. ..+|..+|+|++.... ... .++-.+|+.+|+++ .||+|+++.++|..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 4689999999999987 5688999999986321 111 24456899999997 599999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+|.|+.|.|+++|...- .++++...+|++|+..|+.|||.. +||||||||+|||+|++.++||+|||+++.
T Consensus 102 Fdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999997654 399999999999999999999999 999999999999999999999999999998
Q ss_pred ccccc---cccccccccCCCccCC------CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 408 VNKEH---AQLHMVAYKSPEFNQT------DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 408 ~~~~~---~~~~t~~y~aPE~~~~------~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
+.... ..+||++|+|||.+.. ..|+..+|+||+|||+|.|+.|.+||..-. . -.+.+.+.++
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------Q-mlMLR~ImeG 243 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------Q-MLMLRMIMEG 243 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------H-HHHHHHHHhc
Confidence 87653 5689999999997654 368899999999999999999999986211 0 1122222232
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..+.-.|.+. +......+++.+||+.||.+|.|++|+++.
T Consensus 244 -kyqF~speWa------dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 -KYQFRSPEWA------DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -ccccCCcchh------hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1233333332 333467889999999999999999999864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.32 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=196.1
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|...+...||+|+++.. ....++|.+|++++++++||||+++++++. .+..++||||+++|+|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (262)
T cd05071 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (262)
T ss_pred EeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcH
Confidence 45789999999999999777778999998753 234567999999999999999999999874 4568999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... ..+++..+..++.|++.||+|+|+. +|+||||||+||++++++.+||+|||.++......
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 88 LDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred HHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999975322 2488999999999999999999998 89999999999999999999999999987654322
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||+.....++.++|||||||++|||+| |+.||.... ............. .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---------~~~~~~~~~~~~~-----~---- 222 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYR-----M---- 222 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------hHHHHHHHhcCCC-----C----
Confidence 2234567999999888889999999999999999999 888886211 1111111111100 0
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.........+.+++.+|++.+|++|||+.++++.|++.
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00122335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.40 Aligned_cols=244 Identities=19% Similarity=0.233 Sum_probs=189.1
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+ ..+++.||+|++.... ......+.+|+.++++++|||||++++++.+.+..|+||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 34689999999999998 4578899999997532 2234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc--
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK-- 410 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~-- 410 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 85 GGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999997543 388899999999999999999998 999999999999999999999999999753210
Q ss_pred -------------------------------------------------cccccccccccCCCccCCCCCCcchhHHHHH
Q 008431 411 -------------------------------------------------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLG 441 (565)
Q Consensus 411 -------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~G 441 (565)
.....||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0123588999999999888899999999999
Q ss_pred HHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhh--ccccCcCCCCCH
Q 008431 442 ILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMC--CCEWNAERRWDL 519 (565)
Q Consensus 442 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~--Cl~~~P~~RPs~ 519 (565)
|++|||+||+.||.... ............ ... ...... .....+.+++.+ |+..+|..||++
T Consensus 236 ~il~elltG~~Pf~~~~--------~~~~~~~i~~~~--~~~---~~~~~~---~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 236 VILFEMLVGQPPFLAPT--------PTETQLKVINWE--NTL---HIPPQV---KLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hHHHHHHhCCCCCcCCC--------HHHHHHHHHccc--ccc---CCCCCC---CCCHHHHHHHHHHccCcccccCCCCH
Confidence 99999999999996311 111111111100 000 000000 011245555555 677778889999
Q ss_pred HHHHHH
Q 008431 520 REAVEK 525 (565)
Q Consensus 520 ~evl~~ 525 (565)
.|+++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.73 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=193.5
Q ss_pred ccceecccCceeEEEEEEe-CCC----eeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGP----AMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|.+. ++. .+++|.+.... .....++..|+..+++++||||+++++++. ....++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 3478999999999999953 454 36677765322 222356788888999999999999999875 4567899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .++|..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 90 SPLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred CCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999976443 389999999999999999999998 899999999999999999999999999976533
Q ss_pred cc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 EH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
.. ...++..|+|||++....++.++|||||||++||++| |+.||.... . ......+..+.. .
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~-~~~~~~~~~~~~--~ 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--------P-HEVPDLLEKGER--L 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--------H-HHHHHHHHCCCc--C
Confidence 21 2234568999999988889999999999999999998 999986321 1 111112221110 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..+. .....+.+++.+|+..||++|||+.|+++.|..+....
T Consensus 231 ~~~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 231 AQPQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1111 11235677888999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.64 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=194.6
Q ss_pred ceecccCceeEEEEEEe-CCC--eeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL-TGP--AMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||.||+|... ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999964 343 46888876432 33456789999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 334 GSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 334 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
|+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 9999999764321 112488999999999999999999998 9999999999999999999999999
Q ss_pred CCccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 403 ALVPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 403 Gla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
|++...... .....+..|+|||++....++.++|||||||++|||+| |..||... .......... ..
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~--------~~~~~~~~~~-~~ 227 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELYEKLP-QG 227 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc--------CHHHHHHHHh-CC
Confidence 998543211 11223467999999988889999999999999999997 99998621 1122222111 11
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
... + . .......+.+++.+|++.+|.+|||+.|+++.|.++.
T Consensus 228 ~~~---~--~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL---E--K-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---C--C-----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 0 0 0112236789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.76 Aligned_cols=233 Identities=22% Similarity=0.291 Sum_probs=186.1
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHH-HHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMT-RLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||+||+|+. .+|+.||+|.+.... .....++.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999995 478999999987432 122344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|..++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999987543 388999999999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~~-------~~~ 216 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RDTAEMYDNILNKPL-------RLK 216 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC--------CCHHHHHHHHHcCCC-------CCC
Confidence 234578999999999998999999999999999999999999962 222232222222110 011
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLR 520 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 520 (565)
. .....+.+++.+|++.||++||++.
T Consensus 217 ~-----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 P-----NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C-----CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 1123677888899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.34 Aligned_cols=245 Identities=23% Similarity=0.384 Sum_probs=196.3
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
...+.||+|+||.||+|...++..+|+|.+.... ...+.|.+|+.++++++|||++++++++. .+..+++|||+++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 9 QLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred hhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 3457899999999999998888889999987532 34567999999999999999999999874 556899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--- 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 412 (565)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 87 L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 87 LLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 9999975332 2489999999999999999999998 89999999999999999999999999987654321
Q ss_pred --cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 --AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 --~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||+.....++.++|||||||++|||++ |+.||... ...+...... .... +..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~-----~~~- 224 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--------NNREVLEQVE-RGYR-----MPC- 224 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHH-cCCC-----CCC-
Confidence 1223467999999888889999999999999999999 89998631 1111121111 1100 001
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223468899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.80 Aligned_cols=245 Identities=20% Similarity=0.218 Sum_probs=196.0
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecC--------ceE
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE--------EKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~ 325 (565)
..+.||+|+||+||+|+ ..+++.||||.+... .......+.+|+..+..++|+||+++++.+...+ ..+
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 45789999999999998 457899999998643 2333456889999999999999999988775432 268
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+||||+++|+|.++++..... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 999999999999999764332 23489999999999999999999998 9999999999999999999999999998
Q ss_pred cccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 406 PIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 406 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
+..... ....||+.|+|||++....++.++|||||||++|||++|+.||.. ......+........
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~--------~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG--------ENMEEVMHKTLAGRY 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHhcCCC
Confidence 765322 234688999999999999999999999999999999999999962 223333333222110
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
++ + +......+.+++.+||+.||++|||+.++++.
T Consensus 263 -----~~-~-----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 -----DP-L-----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----CC-C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 1 11122467889999999999999999999764
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=323.34 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=201.2
Q ss_pred hhccceecccCceeEEEEEEe--------CCCeeEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCce
Q 008431 255 RASAEVLGSGSFGSSYKAVLL--------TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEK 324 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 324 (565)
+...+.||+|+||.||++... +...+|+|.+... ......++.+|+.+++++ +||||+++++++...+..
T Consensus 20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 345688999999999999742 2346999998743 223345788999999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPG-----------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN 393 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~ 393 (565)
|+||||+++|+|.+++...+..+ ...++|..++.++.|++.||+|||+. +++||||||+||+++.
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nill~~ 175 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTE 175 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHHheEEcC
Confidence 99999999999999998653211 12489999999999999999999998 9999999999999999
Q ss_pred CCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcc
Q 008431 394 AYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANAD 466 (565)
Q Consensus 394 ~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~ 466 (565)
++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.. ..
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~--------~~ 247 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VP 247 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc--------CC
Confidence 999999999998755321 11123467999999988889999999999999999998 8888852 12
Q ss_pred hHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 467 LATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..+.... ........ .+......+.+++.+|+..+|++||||.||++.|+++....
T Consensus 248 ~~~~~~~-~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 248 VEELFKL-LKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHH-HHcCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 2222221 22211100 01122347778999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=314.90 Aligned_cols=237 Identities=24% Similarity=0.384 Sum_probs=189.8
Q ss_pred ceecccCceeEEEEEEeCCC-----------eeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEE
Q 008431 259 EVLGSGSFGSSYKAVLLTGP-----------AMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 327 (565)
+.||+|+||.||+|...... .+++|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999965433 4677776543322 6789999999999999999999999988 788999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-------CcEEe
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-------EPLLT 400 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-------~~kl~ 400 (565)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999976442 389999999999999999999998 999999999999999887 79999
Q ss_pred ccCCcccccccccccccccccCCCccCCC--CCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 401 DYALVPIVNKEHAQLHMVAYKSPEFNQTD--GVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 401 DfGla~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
|||++..........++..|+|||++... .++.++|||||||++|||++ |..||.... ...+..... .
T Consensus 151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--------~~~~~~~~~-~ 221 (259)
T cd05037 151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--------SSEKERFYQ-D 221 (259)
T ss_pred CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--------chhHHHHHh-c
Confidence 99999876554455667789999998776 78999999999999999999 577775321 111111111 1
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
.. . . ... ....+.+++.+|++.+|++|||+.||++.|
T Consensus 222 ~~--~-----~-~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 QH--R-----L-PMP----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CC--C-----C-CCC----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 0 0 000 114788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=316.37 Aligned_cols=246 Identities=20% Similarity=0.397 Sum_probs=197.0
Q ss_pred ccceecccCceeEEEEEEe-CCC---eeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGP---AMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|... ++. .+|+|+++.. .....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 4578999999999999964 333 6899988643 2334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++......
T Consensus 89 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 89 ENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999975432 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred cc-------ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 HA-------QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ~~-------~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
.. ...+..|+|||++....++.++|||||||++|||++ |+.||... ....+..... ...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~--------~~~~~~~~i~-~~~---- 227 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM--------SNHEVMKAIN-DGF---- 227 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC--------CHHHHHHHHh-cCC----
Confidence 11 112346999999988889999999999999999998 99998621 1122222221 110
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
..+ ........+.+++.+|++.+|++||++.+|++.|.++
T Consensus 228 ~~~------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RLP------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 0112234688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=328.11 Aligned_cols=236 Identities=23% Similarity=0.240 Sum_probs=187.9
Q ss_pred ceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhc-CCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGS-LSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||.||+|+.. +|..||+|.++... ....+.+..|..++.. .+||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999954 68899999997531 2334556778888775 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc---
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK--- 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~--- 410 (565)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99999987543 388999999999999999999998 999999999999999999999999999864321
Q ss_pred -cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 411 -EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 411 -~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||... +........ ... .+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~--------~~~~~~~~~-~~~------~~~~~ 216 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--------DEDELFESI-RVD------TPHYP 216 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHH-HhC------CCCCC
Confidence 13346789999999999989999999999999999999999999621 112222211 111 01111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLR-EAV 523 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl 523 (565)
. .....+.+++.+||+.||++||++. ++.
T Consensus 217 ~-----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 R-----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C-----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 1123577888899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=315.42 Aligned_cols=242 Identities=20% Similarity=0.323 Sum_probs=191.5
Q ss_pred eecccCceeEEEEEEe---CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 260 VLGSGSFGSSYKAVLL---TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.||+|+||.||+|.+. ++..||+|.+.... ....+.|.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999854 34568999886543 233467999999999999999999999875 457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccccc--
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA-- 413 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~-- 413 (565)
|.+++..... .+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 81 L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999975432 489999999999999999999998 999999999999999999999999999875433211
Q ss_pred -----ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 414 -----QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 414 -----~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
..++..|+|||++....++.++|||||||++||+++ |+.||.... ..++. ..+..+... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~-~~~~~~~~~-----~ 218 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--------GPEVM-SFIEQGKRL-----D 218 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--------HHHHH-HHHHCCCCC-----C
Confidence 122467999999888889999999999999999996 999986321 11222 111111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
. +......+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 219 ~-----~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 C-----PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1 112234777899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.69 Aligned_cols=190 Identities=23% Similarity=0.318 Sum_probs=167.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|.. .+++.||+|+++... ......+.+|+.++.+++||||+++++.+.+.+..|+||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 347899999999999984 468899999997532 2233568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 85 GGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999997543 389999999999999999999998 9999999999999999999999999998754211
Q ss_pred --------------------------------------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 008431 412 --------------------------------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453 (565)
Q Consensus 412 --------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p 453 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 123688999999999888999999999999999999999999
Q ss_pred cc
Q 008431 454 AN 455 (565)
Q Consensus 454 ~~ 455 (565)
|.
T Consensus 236 f~ 237 (363)
T cd05628 236 FC 237 (363)
T ss_pred CC
Confidence 96
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=319.34 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=195.0
Q ss_pred cceecccCceeEEEEEE-----eCCCeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVL-----LTGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.+.||+|+||+||+|.. .++..+|+|.+..... .....|.+|+.++++++||||+++++++...+..|+||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 47899999999999984 2457899999874332 23357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEE
Q 008431 332 PNGSLANLLHVRRAP------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL 399 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl 399 (565)
++|+|.+++...... ....+++...+.++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCCCcEEe
Confidence 999999999643210 112478899999999999999999998 8999999999999999999999
Q ss_pred eccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHH
Q 008431 400 TDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVN 472 (565)
Q Consensus 400 ~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 472 (565)
+|||+++..... ....++..|+|||+..+..++.++|||||||++|||++ |..||... ... .+.
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~--------~~~-~~~ 236 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--------SNQ-EVI 236 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------CHH-HHH
Confidence 999998765322 12234567999999988889999999999999999999 99998521 111 111
Q ss_pred HHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 473 SVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 473 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
......... .. +......+.+++.+|++.||++||++.+|.+.|..
T Consensus 237 ~~~~~~~~~-----~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQLL-----PC-----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcC-----CC-----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111110 00 01122467888899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.99 Aligned_cols=245 Identities=24% Similarity=0.412 Sum_probs=199.6
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 10 ~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 87 (256)
T cd05039 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87 (256)
T ss_pred ceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence 457899999999999986 478899999975433 467899999999999999999999999988999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-ccc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-AQL 415 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 415 (565)
.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.++...... ...
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~ 160 (256)
T cd05039 88 VDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK 160 (256)
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccccCC
Confidence 999976442 2489999999999999999999998 99999999999999999999999999988764332 223
Q ss_pred ccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCC
Q 008431 416 HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSG 494 (565)
Q Consensus 416 ~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 494 (565)
.+..|+|||++....++.++|||||||++||+++ |+.||... ... .+........... . +
T Consensus 161 ~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~-~~~~~~~~~~~~~-----~-----~ 221 (256)
T cd05039 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLK-DVVPHVEKGYRME-----A-----P 221 (256)
T ss_pred CcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--------CHH-HHHHHHhcCCCCC-----C-----c
Confidence 3567999999988889999999999999999997 99998632 111 1111221111110 0 0
Q ss_pred HHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 495 EGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 495 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11224688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.29 Aligned_cols=243 Identities=21% Similarity=0.261 Sum_probs=191.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 347899999999999995 478999999997432 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 85 GGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999997543 389999999999999999999998 9999999999999999999999999998653211
Q ss_pred -----------------------------------------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcC
Q 008431 412 -----------------------------------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTG 450 (565)
Q Consensus 412 -----------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg 450 (565)
....||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 123588999999999888999999999999999999999
Q ss_pred CCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCC---HHHHHHH
Q 008431 451 KFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWD---LREAVEK 525 (565)
Q Consensus 451 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~evl~~ 525 (565)
+.||... ............. .....+.. . .....+.+++.+|+. +|.+|++ +.|+++.
T Consensus 236 ~~Pf~~~--------~~~~~~~~i~~~~--~~~~~~~~---~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSD--------NPQETYRKIINWK--ETLQFPDE---V---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCC--------CHHHHHHHHHcCC--CccCCCCC---C---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999632 1112222221110 01100100 0 112356677778886 9999998 9888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=320.77 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=197.6
Q ss_pred cceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
.+.||+|+||.||+|... ....+|+|.+.... ....+++.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 468999999999999853 22468888876432 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE
Q 008431 331 VPNGSLANLLHVRRAP-------------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL 391 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl 391 (565)
+++|+|.+++...... ....+++..++.++.|++.||.|||+. +|+||||||+|||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~nill 160 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAARNVLV 160 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----CeehhhhhhheEEE
Confidence 9999999998753211 112488999999999999999999998 99999999999999
Q ss_pred cCCCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCC
Q 008431 392 DNAYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGAN 464 (565)
Q Consensus 392 ~~~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~ 464 (565)
++++.+||+|||+++..... ....++..|+|||+..+..++.++|||||||++|||+| |+.||...
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------- 233 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI------- 233 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-------
Confidence 99999999999998764322 12234568999999888889999999999999999999 99998621
Q ss_pred cchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 465 ADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
..... .......... .. +......+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 234 -~~~~~-~~~~~~~~~~-----~~-----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 -APERL-FNLLKTGYRM-----ER-----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -CHHHH-HHHHhCCCCC-----CC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11121 1222221100 00 11122468889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.57 Aligned_cols=244 Identities=20% Similarity=0.375 Sum_probs=196.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..++||+|+||.||+|...++..||+|.+... ....++|.+|+.++++++||||+++++++ ..+..+++|||+++|+|
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L 87 (260)
T cd05067 10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSL 87 (260)
T ss_pred eeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCH
Confidence 45789999999999999888999999998743 33457899999999999999999999986 45678999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 88 VDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 999875432 2489999999999999999999988 99999999999999999999999999987654221
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||++....++.++|||||||++||+++ |+.||... ...+..... ...... ...
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~-~~~~~~-----~~~- 225 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM--------TNPEVIQNL-ERGYRM-----PRP- 225 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC--------ChHHHHHHH-HcCCCC-----CCC-
Confidence 2234567999999988889999999999999999999 99998621 111222111 111000 010
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
......+.+++.+|++.+|++|||++++.+.|+.
T Consensus 226 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 ----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112368889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=319.79 Aligned_cols=249 Identities=19% Similarity=0.300 Sum_probs=196.1
Q ss_pred ccceecccCceeEEEEEEeC------CCeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLT------GPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|.... +..||+|++..... ...+.|.+|+.+++.++||||+++++++...+..++++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence 34679999999999998532 46899999874332 224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcE
Q 008431 330 FVPNGSLANLLHVRRA-----------PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL 398 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~k 398 (565)
|+++++|.+++..... .....+++..+..++.|++.||+|+|+. +|+||||||+||++++++.+|
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCCCceE
Confidence 9999999999864321 0112488899999999999999999998 999999999999999999999
Q ss_pred EeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHH
Q 008431 399 LTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWV 471 (565)
Q Consensus 399 l~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 471 (565)
|+|||+++..... ....+++.|+|||++....++.++|||||||++|||+| |..||.. ....++.
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--------~~~~~~~ 236 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG--------YSNQDVI 236 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC--------CCHHHHH
Confidence 9999998765322 12234678999999888889999999999999999998 8888752 1122222
Q ss_pred HHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 472 NSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 472 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
....... ... . +......+.+++..||+.+|++||++.||++.|+.
T Consensus 237 ~~i~~~~-~~~-----~-----~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQ-VLP-----C-----PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCC-cCC-----C-----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2222211 100 0 11223457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.72 Aligned_cols=234 Identities=22% Similarity=0.261 Sum_probs=189.3
Q ss_pred ceecccCceeEEEEEE----eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 259 EVLGSGSFGSSYKAVL----LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
+.||+|+||.||+++. .+|..+|+|.+.... ......+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4799999999999974 367899999997532 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999986533 389999999999999999999998 9999999999999999999999999998765332
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....|++.|+|||++....++.++|||||||++|||+||+.||... ............. . .+
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--------~~~~~~~~i~~~~-~------~~ 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK--------DRKETMTMILKAK-L------GM 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC--------CHHHHHHHHHcCC-C------CC
Confidence 2345788999999998888999999999999999999999999621 1122222221111 0 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLRE 521 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e 521 (565)
. ......+.+++.+||+.||++|||+.+
T Consensus 218 p-----~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 P-----QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C-----CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 111235778888999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=312.05 Aligned_cols=241 Identities=20% Similarity=0.314 Sum_probs=202.4
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..++||+|+||.||||. ...|..+|||++... .+..++.+|+.+|++++.|++|+++|.|.....+|+|||||..|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 44689999999999998 568999999998753 457789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
+.+.++.++. .|.+..+..+++..++||+|||.. .-||||||..|||++-+|.+|++|||+|..+...
T Consensus 115 iSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 115 ISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred HHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999987665 499999999999999999999998 7899999999999999999999999999876543
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
.+..||+.|||||++..-.|++++||||+|++..||..|++||..+-+.... ++ +.---.|..
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FM--------IPT~PPPTF--- 249 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FM--------IPTKPPPTF--- 249 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------Ee--------ccCCCCCCC---
Confidence 5668999999999999999999999999999999999999999754332110 00 000001111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..++.-...+-+++..||-.+|++|-|+-++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 112334457889999999999999999887754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=320.29 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=187.4
Q ss_pred ccceecccCceeEEEEEE-e-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcC---CCCCccceEEEEEe-----cCce
Q 008431 257 SAEVLGSGSFGSSYKAVL-L-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSL---SHPNLLPLIAFYYR-----KEEK 324 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~~~ 324 (565)
..+.||+|+||+||+|.. . ++..||+|.++... ......+.+|+.+++.+ +||||++++++|.. ....
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 346899999999999985 3 46789999987432 22234567787777665 69999999999863 3468
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred EEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 99999996 699999875432 2489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh----h
Q 008431 405 VPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR----E 477 (565)
Q Consensus 405 a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 477 (565)
++..... ....+++.|+|||++....++.++|||||||++|||++|++||..... ......+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-----~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHHhCCCChh
Confidence 8765432 234578899999999888899999999999999999999999963211 111111111110 0
Q ss_pred cccCcc-c-cccccCC-CCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 EWTGEV-F-DKDMRGT-KSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ~~~~~~-~-d~~~~~~-~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+.... . ....... ... ......+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 010000 0 0000000 000 011235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.73 Aligned_cols=253 Identities=19% Similarity=0.321 Sum_probs=197.7
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 10 i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4578999999999999743 24579999876432 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRAP-----GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
|+++|+|.+++...... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+|++|||+
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcEEECcCCc
Confidence 99999999999754321 123467788899999999999999998 999999999999999999999999999
Q ss_pred ccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++..... ....++..|+|||++.+..++.++|||||||++|||++ |..||... ...+........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--------~~~~~~~~~~~~ 237 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--------SNEQVLKFVMDG 237 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcC
Confidence 8754322 11233567999999988889999999999999999999 78888621 122222222211
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
... .. +......+.+++.+|++.||++|||+.|+++.|++....
T Consensus 238 ~~~------~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 238 GYL------DQ-----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred CCC------CC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 110 00 011124788999999999999999999999999876433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.15 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=195.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe-cCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-KEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||++.. .|..+|+|.++.. ...+.|.+|+.++++++|+|++++++++.. .+..++||||+++|+
T Consensus 10 ~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 10 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred eeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 457899999999999976 4788999988643 335679999999999999999999998654 457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-ccc
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQ 414 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~ 414 (565)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++..... ...
T Consensus 87 L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 159 (256)
T cd05082 87 LVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159 (256)
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccCCCC
Confidence 9999976432 2488999999999999999999998 9999999999999999999999999998765432 223
Q ss_pred cccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 415 LHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 415 ~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..+..|+|||+.....++.++|||||||++|||++ |+.||.. ....+...... ...... .
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~~-~~~~~~-----~----- 220 (256)
T cd05082 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------IPLKDVVPRVE-KGYKMD-----A----- 220 (256)
T ss_pred ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHh-cCCCCC-----C-----
Confidence 34568999999988889999999999999999998 9999862 22222222221 111111 1
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011234678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.59 Aligned_cols=248 Identities=20% Similarity=0.276 Sum_probs=192.6
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCc--------------cCHHHHHHHHHHHhcCCCCCccceEEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN--------------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK 321 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 321 (565)
..+.||+|.||.|-+|+ ..+++.||||.+.+... ...+...+||.+|++++|||||+|+++..+.
T Consensus 101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence 34679999999999999 45789999999864211 1125789999999999999999999998764
Q ss_pred --CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEE
Q 008431 322 --EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL 399 (565)
Q Consensus 322 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl 399 (565)
+.+|||+|||..|.+... ....+.+++.+++++++++..||.|||.+ +||||||||+|+||++++++||
T Consensus 181 ~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred ccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCCCcEEe
Confidence 578999999999887532 12222389999999999999999999999 9999999999999999999999
Q ss_pred eccCCccccccc---------ccccccccccCCCccCCCC----CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcc
Q 008431 400 TDYALVPIVNKE---------HAQLHMVAYKSPEFNQTDG----VTRKTDVWSLGILILELLTGKFPANYLAQGKGANAD 466 (565)
Q Consensus 400 ~DfGla~~~~~~---------~~~~~t~~y~aPE~~~~~~----~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~ 466 (565)
+|||.+...... ....||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.. ..
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~--------~~ 323 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD--------DF 323 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc--------ch
Confidence 999998654211 2467999999999766532 35789999999999999999999962 11
Q ss_pred hHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 467 LATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
.......+ +...+.- +...+....+.++++++|+.||++|.+..+|.........
T Consensus 324 ~~~l~~KI---------vn~pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ELELFDKI---------VNDPLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHHH---------hcCcccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 22222222 2222211 1112345578889999999999999999999777655544
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.87 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=185.9
Q ss_pred eecccCceeEEEEEEeCC---CeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 260 VLGSGSFGSSYKAVLLTG---PAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.||+|+||+||+|...++ ..+|+|.+.... ......|.+|+..++.++||||+++++.+...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999985443 457777765332 2234578899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++...........++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432223357888899999999999999998 9999999999999999999999999998653221
Q ss_pred --ccccccccccCCCccC-------CCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 412 --HAQLHMVAYKSPEFNQ-------TDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~-------~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
....++..|+|||+.. ...++.++|||||||++|||++ |..||.... -........... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~-~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--------DEQVLKQVVREQ-DI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhhcc-Cc
Confidence 1223456799999753 3456889999999999999999 788886321 111111111111 11
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
...++.+.. .....+.+++..|+ .||++|||++||++.|.
T Consensus 229 ~~~~~~~~~-----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDL-----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccc-----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 122222211 11234556777888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.67 Aligned_cols=249 Identities=21% Similarity=0.354 Sum_probs=197.0
Q ss_pred ccceecccCceeEEEEEE-eCCC----eeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGP----AMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..++||+|+||+||+|.+ .++. .||+|.++... ....+++.+|+.+++.++||||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence 347899999999999984 4555 37899886432 3335678899999999999999999999875 457899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 90 ~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 90 MPYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999975432 389999999999999999999998 999999999999999999999999999987643
Q ss_pred ccc------ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 EHA------QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~~~------~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
... ..++..|+|||......++.++|||||||++|||+| |..||..... ..+..++ ......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~----~~~~~~-- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLL----EKGERL-- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH----HCCCcC--
Confidence 221 123567999999988889999999999999999998 9999863211 1122221 111000
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+ . +......+.+++.+||+.||++||++.|+++.|.++....
T Consensus 231 --~-~-----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 --P-Q-----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --C-C-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0 0 0112346788999999999999999999999999887665
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.74 Aligned_cols=238 Identities=26% Similarity=0.323 Sum_probs=188.0
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHH-HHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMT-RLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||+||+|+. .+|+.+|+|.+.... .....++..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999994 578999999987431 223345566655 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc---
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK--- 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~--- 410 (565)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99999886533 389999999999999999999998 999999999999999999999999999875321
Q ss_pred -cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 411 -EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 411 -~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.......... .+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~--------~~~~~~~~~~~~~~~---~~~~--- 217 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC--------RDVAEMYDNILHKPL---VLRP--- 217 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC--------CCHHHHHHHHHcCCc---cCCC---
Confidence 1234578999999999999999999999999999999999999962 122222222222110 0111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....+.+++.+|++.+|.+||++.+.++.
T Consensus 218 ------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 218 ------GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred ------CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 112356788889999999999988644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=322.88 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=198.7
Q ss_pred ccceecccCceeEEEEEEe-CCC--eeEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGP--AMVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|... ++. .+|+|.++.. .......+.+|+.++.++ +||||+++++++..++..|+||||+
T Consensus 11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred eeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence 3578999999999999954 454 4577776542 223346788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 332 PNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
++|+|.++++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCCcEEeC
Confidence 999999999764321 112488999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhh
Q 008431 401 DYALVPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 401 DfGla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
|||+++..... .....+..|+|||++....++.++|||||||++|||+| |..||... ...+..... .
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~~-~ 237 (303)
T cd05088 167 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELYEKL-P 237 (303)
T ss_pred ccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC--------ChHHHHHHH-h
Confidence 99998643211 11223567999999888889999999999999999998 99998621 111222111 1
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
..... .. +......+.+++.+|++.+|++||++.++++.|.++......
T Consensus 238 ~~~~~-----~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 238 QGYRL-----EK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred cCCcC-----CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 11000 00 011123678899999999999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.19 Aligned_cols=256 Identities=19% Similarity=0.316 Sum_probs=194.3
Q ss_pred ccceecccCceeEEEEEEeC---------------CCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLT---------------GPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 320 (565)
..+.||+|+||.||+|.... ...||+|.++.. .......|.+|++++++++||||+++++++..
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 88 (295)
T cd05097 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS 88 (295)
T ss_pred ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 44789999999999987532 224899988753 22334579999999999999999999999999
Q ss_pred cCceEEEEeccCCCCHHHHHhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC
Q 008431 321 KEEKLLVSDFVPNGSLANLLHVRRAP-------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN 393 (565)
Q Consensus 321 ~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~ 393 (565)
.+..++||||+++++|.+++...... ....++|..+..++.|++.||+|||+. +++||||||+||++++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nill~~ 164 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRNCLVGN 164 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhhEEEcC
Confidence 99999999999999999999653211 112378999999999999999999998 9999999999999999
Q ss_pred CCCcEEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc--CCCCccccccCCCCCc
Q 008431 394 AYEPLLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT--GKFPANYLAQGKGANA 465 (565)
Q Consensus 394 ~~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t--g~~p~~~~~~~~~~~~ 465 (565)
++.+||+|||++....... ...++..|+|||+.....++.++|||||||++|||++ |..||..... .
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-----~ 239 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-----E 239 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-----H
Confidence 9999999999987543221 1233568999999888889999999999999999998 6667753211 1
Q ss_pred chHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
.....+......... ..... . .......+.+++.+|++.||++||||.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~-~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGR-QIYLS-Q-----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhccc-cccCC-C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111100 00000 0 01122478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.85 Aligned_cols=252 Identities=20% Similarity=0.322 Sum_probs=199.9
Q ss_pred ccceecccCceeEEEEEEeC-----CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEe-cCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLT-----GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-KEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E 329 (565)
..++||+|+||.||+|.... +..|++|++.... ....+.+.+|+.++++++||||+++++++.. ....++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 45789999999999999765 6788999886432 3335678899999999999999999999876 467899999
Q ss_pred ccCCCCHHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 330 FVPNGSLANLLHVRRAP---GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 99999999999764321 113589999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 407 IVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 407 ~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
.+.... ...++..|+|||++....++.++|||||||++||+++ |+.||.... ..++.. ....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~-~~~~~~ 236 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--------PFEMAA-YLKDGY 236 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--------HHHHHH-HHHcCC
Confidence 653321 1234567999999988889999999999999999999 999986321 112211 111111
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
.. .. .......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 237 ~~-----~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 RL-----AQ-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC-----CC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 00 01112367889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.16 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=194.6
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 3478999999999999965 35678888876432 2334579999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC---CcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRAPG--QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY---EPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfGl 404 (565)
|+++|+|.+++...+... ...++|..+..++.||+.||+|||+. +++||||||+||+++.++ .+|++|||+
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceEeccCcc
Confidence 999999999997654211 12489999999999999999999998 899999999999998654 589999999
Q ss_pred cccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||... ............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~--------~~~~~~~~~~~~ 237 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR--------TNQEVMEFVTGG 237 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHcC
Confidence 87653221 1122457999999988889999999999999999997 99998631 111222111111
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
... .. +......+.+++.+|++.+|++|||+.||++.|+
T Consensus 238 ~~~------~~-----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRL------DP-----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcC------CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 100 00 1112246788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.43 Aligned_cols=248 Identities=19% Similarity=0.313 Sum_probs=197.1
Q ss_pred cceecccCceeEEEEEEe------CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.++||+|+||.||++... ++..+|+|.+........+.|.+|+++++.++||||+++++++...+..+++|||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 578999999999999742 35678999887665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEec
Q 008431 332 PNGSLANLLHVRRAP----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTD 401 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 401 (565)
++|+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCCCEEECC
Confidence 999999999764321 112489999999999999999999998 999999999999999999999999
Q ss_pred cCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHH
Q 008431 402 YALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSV 474 (565)
Q Consensus 402 fGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 474 (565)
||+++..... ....+++.|+|||+..+..++.++|||||||++|||++ |++||.... -...+...
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~ 237 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--------NTEAIECI 237 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC--------HHHHHHHH
Confidence 9998754322 12234578999999988889999999999999999998 999985321 11111111
Q ss_pred hhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 475 VREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 475 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
... ... .. +......+.+++.+||+.||++||++.||.+.|++
T Consensus 238 ~~~-~~~-----~~-----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 TQG-REL-----ER-----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HcC-ccC-----CC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111 000 00 01112367789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.40 Aligned_cols=249 Identities=20% Similarity=0.324 Sum_probs=197.3
Q ss_pred ccceecccCceeEEEEEEeC------CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLT------GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 45789999999999998542 3689999986432 2334578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRAPG-----QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
|+++|+|.+++....... ...++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEEECCccc
Confidence 999999999997543211 12478999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++..... ....++..|+|||......++.++|||||||++||++| |+.||... ...+...... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------~~~~~~~~~~-~ 236 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--------SNEEVLKFVI-D 236 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--------CHHHHHHHHh-c
Confidence 8754322 22345678999999888889999999999999999998 99998621 1122222111 1
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
..... . +......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 237 ~~~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GGHLD-----L-----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCC-----C-----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11100 1 01123478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.23 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=201.7
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||+|+||.||+|. ..++..+|||.+.... .....++.+|+.+++.++||||+++++++..++..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 4679999999999999 4588999999886432 22345789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||++......
T Consensus 87 ~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 87 GDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 9999998753221 23489999999999999999999998 9999999999999999999999999998765432
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....++..|+|||+.....++.++|||||||++|||++|..||.... .....+....... ..+...
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~------~~~~~~ 229 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQC------DYPPLP 229 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc------chHHHHhhhhhcC------CCCCCC
Confidence 23457788999999988889999999999999999999999986211 1112222211111 111111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
.......+.+++.+||+.||++||||.+|++.+.++.
T Consensus 230 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 ----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1123346888889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=316.69 Aligned_cols=246 Identities=19% Similarity=0.271 Sum_probs=194.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|+. .++..||+|++..........+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 13 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred hhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 457899999999999995 5788999999875544445678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 93 LQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 999987533 388999999999999999999998 9999999999999999999999999998765322
Q ss_pred ccccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 HAQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....++..|+|||.+. ...++.++|||||||++|||++|+.||........ ...+ . ......+..
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~~~~----~----~~~~~~~~~ 231 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFLM----S----KSNFQPPKL 231 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----heee----e----cCCCCCCCC
Confidence 2345778999999874 34578899999999999999999999853211100 0000 0 000111111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
... ......+.+++.+||+.+|++|||++++++.|
T Consensus 232 ~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDK---TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccc---cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110 11224678899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.44 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=196.8
Q ss_pred ccceecccCceeEEEEEEeC-----------------CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLT-----------------GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 318 (565)
..+.||+|+||.||+|.... +..||+|.+.... ....+++.+|++++++++||||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05051 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC 88 (296)
T ss_pred ccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 35789999999999998532 2457899887432 23456789999999999999999999999
Q ss_pred EecCceEEEEeccCCCCHHHHHhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc
Q 008431 319 YRKEEKLLVSDFVPNGSLANLLHVRRAP------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD 392 (565)
Q Consensus 319 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~ 392 (565)
..++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~Nili~ 164 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATRNCLVG 164 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchhceeec
Confidence 9999999999999999999999765421 112589999999999999999999998 999999999999999
Q ss_pred CCCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc--CCCCccccccCCCCC
Q 008431 393 NAYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT--GKFPANYLAQGKGAN 464 (565)
Q Consensus 393 ~~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t--g~~p~~~~~~~~~~~ 464 (565)
.++.++|+|||+++..... ....++..|+|||+.....++.++|||||||++|||++ |..||.... .
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-----~ 239 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-----D 239 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-----h
Confidence 9999999999998754322 12334678999999888889999999999999999998 677775211 1
Q ss_pred cchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 465 ADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
..+...+.............+ .+......+.+++.+|++.||++|||+.||++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111112111111111100000 011122478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.63 Aligned_cols=243 Identities=25% Similarity=0.365 Sum_probs=193.6
Q ss_pred ceecccCceeEEEEEEe-CC---CeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL-TG---PAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||.||+|... .+ ..+|+|.+..... ...+++.+|+++++++.|||||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999843 22 6899999875433 24567999999999999999999999875 4568999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 413 (565)
|+|.+++.... .+++..+..++.|++.||+|||.. +++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999997543 389999999999999999999998 899999999999999999999999999876543321
Q ss_pred -------ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 414 -------QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 414 -------~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
..++..|+|||......++.++|||||||++|||++ |+.||.... ..+..... .......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--------~~~~~~~~-~~~~~~~--- 218 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--------GAEVIAML-ESGERLP--- 218 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHH-HcCCcCC---
Confidence 112457999999988889999999999999999998 999986321 11222111 1111000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
.+......+.+++.+||..+|++|||+.++++.|+++.
T Consensus 219 -------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01112246789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.17 Aligned_cols=246 Identities=21% Similarity=0.421 Sum_probs=195.7
Q ss_pred ccceecccCceeEEEEEEe-CC---CeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TG---PAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|... ++ ..||+|.+... ......+|..|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 4578999999999999964 33 35999998643 2334568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 88 ~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 88 ENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred CCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999975432 389999999999999999999998 9999999999999999999999999998765332
Q ss_pred cc------cc---ccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 412 HA------QL---HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 412 ~~------~~---~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
.. .. .+..|+|||++....++.++|||||||++||+++ |..||.... ......++ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i----~~~~~- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAI----EQDYR- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHH----HcCCc-
Confidence 11 11 1347999999988899999999999999999887 999986321 11122222 11100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
. ..+.+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ------L---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00111224677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=332.30 Aligned_cols=243 Identities=18% Similarity=0.209 Sum_probs=192.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+++. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence 457899999999999995 468899999986421 2234457889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999998643 277888999999999999999998 9999999999999999999999999998765432
Q ss_pred ----ccccccccccCCCccCCC----CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 ----HAQLHMVAYKSPEFNQTD----GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~----~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
....||+.|+|||++... .++.++|||||||++|||++|+.||.. ............... ..
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~--~~ 266 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--------DSLVGTYSKIMDHKN--SL 266 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC--------CCHHHHHHHHHcCCC--cC
Confidence 234688999999987643 478999999999999999999999962 112222222222110 01
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAER--RWDLREAVEK 525 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 525 (565)
..+.. ......+.+++.+||+.+|++ |||+.|+++.
T Consensus 267 ~~~~~------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPDD------IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCc------CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00110 011246778888999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=326.73 Aligned_cols=234 Identities=20% Similarity=0.219 Sum_probs=186.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCC-CccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHP-NLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|... +++.||+|.+... .....+.+..|+.++..++|+ +|+++++++...+..|+||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence 3578999999999999954 6788999998743 223456788899999999765 5888999999899999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 84 NGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999987543 388999999999999999999998 999999999999999999999999999864321
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||... +............ ..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--------~~~~~~~~i~~~~-------~~ 219 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--------DEDELFQSIMEHN-------VS 219 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCC-------CC
Confidence 12345789999999999989999999999999999999999999621 1112222221111 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
+. ......+.+++.+||+.||++||+.
T Consensus 220 ~~-----~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YP-----KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC-----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 10 1112367788899999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=327.54 Aligned_cols=239 Identities=19% Similarity=0.234 Sum_probs=189.4
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||+||+|+. .+++.||+|.++... ....+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 467899999997532 22345688899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc---
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK--- 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~--- 410 (565)
|+|..++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99999886543 389999999999999999999998 999999999999999999999999999875321
Q ss_pred -cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 411 -EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 411 -~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......++......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~------~~p 223 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVILEKPI------RIP 223 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHHHhCCC------CCC
Confidence 123468899999999999999999999999999999999999996432211 11222333322222110 010
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
......+.+++.+||+.||++||++
T Consensus 224 -----~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 -----RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -----CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1112356788899999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=312.72 Aligned_cols=243 Identities=22% Similarity=0.305 Sum_probs=195.8
Q ss_pred ceecccCceeEEEEEEeC--C--CeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLLT--G--PAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||.||+|.+.+ + ..||+|.+..... ...++|.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 2589999876544 456689999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++..... ..++|..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999986542 2489999999999999999999998 9999999999999999999999999998766432
Q ss_pred -----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 -----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....++..|+|||++....++.++|||||||++|||+| |+.||... ...+...........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~----- 219 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--------SGSQILKKIDKEGER----- 219 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHhcCCc-----
Confidence 12345678999999988889999999999999999999 99998621 122222222211100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
.. .+......+.+++.+|++.+|++|||+.|+++.|.
T Consensus 220 --~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 --LE---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CC---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00 01112346888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.69 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=195.6
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|... +++.||+|+++... ......+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 3478999999999999954 78999999997432 2334578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 85 GGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997652 389999999999999999999998 99999999999999999999999999987654322
Q ss_pred ---------------------------------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcccccc
Q 008431 413 ---------------------------------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQ 459 (565)
Q Consensus 413 ---------------------------------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~ 459 (565)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-- 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-- 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC--
Confidence 345789999999999999999999999999999999999999631
Q ss_pred CCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCC-HHHHHHH
Q 008431 460 GKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWD-LREAVEK 525 (565)
Q Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~~ 525 (565)
........... +......+... .....+.+++.+|++ ||.+||+ +.|+++.
T Consensus 234 ------~~~~~~~~i~~--~~~~~~~p~~~------~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 ------TLQETYNKIIN--WKESLRFPPDP------PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------CHHHHHHHHhc--cCCcccCCCCC------CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111222111 00111111110 012367788889997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=311.42 Aligned_cols=253 Identities=20% Similarity=0.313 Sum_probs=203.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (267)
T cd08224 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCC
Confidence 3468999999999999965 88999999886322 2335679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++...... ...+++..+..++.+++.||.|||+. +|+||||||+||+++.++.++++|||++......
T Consensus 86 ~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 86 AGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99999998754322 23489999999999999999999998 9999999999999999999999999998765332
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....++..|+|||+..+..++.++|||||||++|||++|+.||... ............... . . ..
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~-~----~-~~ 228 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEKCD-Y----P-PL 228 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC------CccHHHHHhhhhcCC-C----C-CC
Confidence 2345678899999988888999999999999999999999998521 122222222111110 0 0 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
. .......+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 229 ~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 P----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 0122346788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=328.51 Aligned_cols=233 Identities=24% Similarity=0.310 Sum_probs=184.9
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHH-HHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMT-RLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||.||+|+. .++..||+|.+.... .....++.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 468899999987432 222344555654 67889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|..++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99998886533 378888999999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....+|+.|+|||++....++.++|||||||++|||++|+.||.. .+............ ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~-------~~~~ 216 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RDVSQMYDNILHKP-------LQLP 216 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC--------CCHHHHHHHHhcCC-------CCCC
Confidence 234578999999999888899999999999999999999999962 12222222222111 0010
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLR 520 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 520 (565)
......+.+++.+||+.||++||++.
T Consensus 217 -----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 -----GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11223678889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.16 Aligned_cols=241 Identities=20% Similarity=0.326 Sum_probs=195.8
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++......++||||+++|+|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 46799999999999984 57889999998765555567899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 9998642 278999999999999999999998 9999999999999999999999999998754332 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
...+++.|+|||++....++.++|||||||++|||++|+.||.... ...+........ . +.+.
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~--------~~~~~~~~~~~~-~-----~~~~--- 237 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNG-T-----PELQ--- 237 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--------HHHhHHHHhcCC-C-----CCCC---
Confidence 3357789999999888889999999999999999999999996321 111111111111 0 0010
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+......+.+++.+||+.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011222467889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.77 Aligned_cols=244 Identities=22% Similarity=0.369 Sum_probs=194.9
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|....+..+|+|.+... ....+.+.+|++++++++|||++++++++. .+..++||||+++|+|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L 87 (260)
T cd05069 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSL 87 (260)
T ss_pred eeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCH
Confidence 45689999999999999877778999987643 234567899999999999999999998874 5668999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... ..++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 88 LDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred HHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999975432 2488999999999999999999998 89999999999999999999999999987653321
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||+.....++.++|||||||++|||+| |+.||.... ....... ...... +..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~-~~~~~~-----~~~-- 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--------NREVLEQ-VERGYR-----MPC-- 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-HHcCCC-----CCC--
Confidence 2234567999999888889999999999999999999 999986321 1111111 111110 000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
+......+.+++.+||+.||++||++++|++.|++
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 ---PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11223468888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=319.56 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=198.0
Q ss_pred hhccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEE
Q 008431 255 RASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 326 (565)
+...+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 345689999999999999742 34579999887532 23346789999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 327 VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
||||+++|+|.++++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++
T Consensus 117 v~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999975432 2389999999999999999999998 89999999999999999999999999987
Q ss_pred cccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 407 IVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 407 ~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
...... ...++..|+|||++....++.++|||||||++|||+| |+.||.... ...-.......+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~--------~~~~~~~~~~~~~ 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP--------VDSKFYKLIKEGY 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC--------chHHHHHHHHcCC
Confidence 653321 1234567999999988889999999999999999998 999986321 1111111111111
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.. .. +......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 262 ~~-----~~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RM-----AQ-----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC-----CC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 00 011124688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=327.49 Aligned_cols=244 Identities=23% Similarity=0.247 Sum_probs=191.1
Q ss_pred ccceecccCceeEEEEEE----eCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL----LTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||+||+++. .++..||+|.+.... ....+.+.+|+.++..++ ||||+++++++...+..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 357899999999999985 367899999987421 223456888999999994 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 84 LDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999997543 388999999999999999999998 999999999999999999999999999876
Q ss_pred cccc-----ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 408 VNKE-----HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 408 ~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
.... ....||+.|+|||++.+. .++.++|||||||++|||+||+.||..... ......+.......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~~~~~~~~~--- 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE-----RNTQSEVSRRILKC--- 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC-----CCCHHHHHHHHhcC---
Confidence 4322 234578999999988765 478999999999999999999999963211 11111221111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEK 525 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 525 (565)
++.+.. .....+.+++.+||+.||++|| +++++++.
T Consensus 227 ---~~~~~~-----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 ---DPPFPS-----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCCC-----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111 1123567888899999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.31 Aligned_cols=245 Identities=22% Similarity=0.255 Sum_probs=193.7
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.++||+|+||+||++.. .+++.||+|++..... .....+.+|+.++++++||||+++++.+..++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 46899999999999995 4788999999874321 2234578899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 85 GDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999998865322 2489999999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....++..|+|||++....++.++|||||||++|||++|+.||..... ......+........ ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~------~~~-- 224 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-----KVKREEVERRVKEDQ------EEY-- 224 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-----hhHHHHHHHHhhhcc------ccc--
Confidence 234678899999999888899999999999999999999999963110 111111111111110 000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 525 (565)
+......+.+++.+|++.||++|| ++.++++.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 ---SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111223678899999999999999 77787543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=329.00 Aligned_cols=237 Identities=21% Similarity=0.255 Sum_probs=186.4
Q ss_pred ceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHH-HHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHM-TRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||+||+|+.. +++.||+|.+.... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999954 67789999987432 12223444454 456889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++.... .+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999997543 377888899999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.. ............... .+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~~---~~~~--- 217 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RNTAEMYDNILNKPL---QLKP--- 217 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC--------CCHHHHHHHHHhCCc---CCCC---
Confidence 234688999999999999999999999999999999999999962 122222222222110 0111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.....+.+++.+|++.||.+||++.+.+.
T Consensus 218 ------~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 ------NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ------CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11235778888999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=334.92 Aligned_cols=243 Identities=19% Similarity=0.226 Sum_probs=189.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||++.. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 347899999999999984 578999999986432 2234568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 85 GGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997543 388899999999999999999998 9999999999999999999999999998632110
Q ss_pred --------------------------------------------------ccccccccccCCCccCCCCCCcchhHHHHH
Q 008431 412 --------------------------------------------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLG 441 (565)
Q Consensus 412 --------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~G 441 (565)
....||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 013588999999999888999999999999
Q ss_pred HHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCC---CC
Q 008431 442 ILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR---WD 518 (565)
Q Consensus 442 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps 518 (565)
|++|||+||++||... ............ .....-+.. ......+.+++.+|+. +|.+| ||
T Consensus 236 vil~elltG~~Pf~~~--------~~~~~~~~i~~~--~~~~~~p~~------~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 236 AIMFECLIGWPPFCSE--------NSHETYRKIINW--RETLYFPDD------IHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhhcCCCCCCCC--------CHHHHHHHHHcc--CCccCCCCC------CCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999621 111111111111 111100110 0112356778888997 67765 59
Q ss_pred HHHHHHH
Q 008431 519 LREAVEK 525 (565)
Q Consensus 519 ~~evl~~ 525 (565)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=333.71 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=199.0
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
-+||+|.||+||.|+ ..+...+|||.+..........+.+||.+.++++|.|||+++|.|..++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999 4456789999998776666777899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-CCCCcEEeccCCccccc----ccc
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVN----KEH 412 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~----~~~ 412 (565)
++|+..-++ -.=.+...-.+.+||++||.|||+. .|||||||-.|||++ -.|.+||+|||.++.+. ...
T Consensus 661 sLLrskWGP--lKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 661 SLLRSKWGP--LKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred HHHHhccCC--CccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 999865442 1226788889999999999999998 899999999999996 57899999999987654 235
Q ss_pred cccccccccCCCccCCC--CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 AQLHMVAYKSPEFNQTD--GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
+..||..|||||++..+ .|+.++|||||||++.||.||++||-...... +.. ++-+. .+ +.|.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAM----FkVGm-yK-vHP~i-- 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAM----FKVGM-YK-VHPPI-- 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------Hhh----hhhcc-ee-cCCCC--
Confidence 67899999999998654 69999999999999999999999997432211 111 11110 00 11222
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+++...+...++++|+++||.+||++.++++.
T Consensus 801 ---Peelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 801 ---PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ---cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 34555678889999999999999999998753
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=331.39 Aligned_cols=191 Identities=25% Similarity=0.378 Sum_probs=167.4
Q ss_pred hccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CC-----CccceEEEEEecCceEEEE
Q 008431 256 ASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HP-----NLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~lv~ 328 (565)
...++||+|+||.|.+|. ..+++.||||.++.... -..+-..|+.+|..|+ |. |+|+++++|..+++.|||+
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf 267 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF 267 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence 356899999999999999 66899999999986532 2445677899999987 43 8999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC--CCCcEEeccCCcc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN--AYEPLLTDYALVP 406 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~ 406 (565)
|.+.. +|+++|+..+.. +++...++.++.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.+.
T Consensus 268 ELL~~-NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 268 ELLST-NLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred hhhhh-hHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 99964 999999987654 499999999999999999999988 9999999999999964 3479999999998
Q ss_pred ccccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 407 IVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 407 ~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
..... ...+.+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.
T Consensus 340 ~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 340 FESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 76554 35567889999999999999999999999999999999987775
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=315.45 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=193.4
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
...+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 34577999999999999954 57788888886554445667899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|..++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|++|||++......
T Consensus 88 ~l~~~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 88 AVDAVMLELER----PLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred cHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 99998865332 489999999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 -HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....++..|+|||++. ...++.++|||||||++|||++|++||.... ....+......... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~~~ 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPP-TLAQ 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhcCCC-CCCC
Confidence 2345788999999873 3457889999999999999999999986321 11111111111110 0100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+ ......+.+++.+||+.||++|||+.++++.
T Consensus 231 ~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 P--------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred c--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 1112367888899999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.10 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=197.0
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... ++..||+|.+.... .....+|.+|+.++++++||||+++++++...+..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 4568999999999999853 46789999987432 2334679999999999999999999999999899999999
Q ss_pred ccCCCCHHHHHhhcCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc
Q 008431 330 FVPNGSLANLLHVRRA-----------------PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD 392 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~ 392 (565)
|+++|+|.+++..... .....+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~nil~~ 164 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATRNCLVG 164 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHhheEec
Confidence 9999999999975421 1123478999999999999999999998 999999999999999
Q ss_pred CCCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCc
Q 008431 393 NAYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANA 465 (565)
Q Consensus 393 ~~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~ 465 (565)
+++.+||+|||++...... .....+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-------- 236 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-------- 236 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 9999999999998754322 12234567999999888899999999999999999998 88887521
Q ss_pred chHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
...++..... .+.... . +......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 237 ~~~~~~~~~~-~~~~~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEEVIYYVR-DGNVLS-----C-----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHHHHh-cCCCCC-----C-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1222222221 111100 0 01123468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.42 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=196.7
Q ss_pred hccceecccCceeEEEEEE-----eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEE
Q 008431 256 ASAEVLGSGSFGSSYKAVL-----LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLV 327 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 327 (565)
...+.||+|+||.||++.. .++..||+|.++... ....+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence 3457899999999999974 357889999987432 33346799999999999999999999998775 568999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++++|.+++..... .++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 87 MEFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEccCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999865432 389999999999999999999998 999999999999999999999999999876
Q ss_pred ccccc-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccC-------CCCCcchHHHHHH
Q 008431 408 VNKEH-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQG-------KGANADLATWVNS 473 (565)
Q Consensus 408 ~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~ 473 (565)
..... ...++..|+|||+..+..++.++|||||||++|||+|++.|....... .........++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 54321 223456799999988888999999999999999999988764321100 0000111111111
Q ss_pred HhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 474 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
....... .........+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 239 -~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -LEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111100 00112234788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=333.93 Aligned_cols=190 Identities=23% Similarity=0.307 Sum_probs=165.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||+||+|+. .+++.||+|++.... ......+.+|+.++++++|||||++++.+.+.+..|+||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 357899999999999994 578899999987532 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc--
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK-- 410 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~-- 410 (565)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 85 GGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999997543 388889999999999999999998 999999999999999999999999999743210
Q ss_pred -------------------------------------------------cccccccccccCCCccCCCCCCcchhHHHHH
Q 008431 411 -------------------------------------------------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLG 441 (565)
Q Consensus 411 -------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~G 441 (565)
.....||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0123578899999999988999999999999
Q ss_pred HHHHHHHcCCCCcc
Q 008431 442 ILILELLTGKFPAN 455 (565)
Q Consensus 442 vil~el~tg~~p~~ 455 (565)
|++|||++|++||.
T Consensus 236 vil~elltG~~Pf~ 249 (382)
T cd05625 236 VILYEMLVGQPPFL 249 (382)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=309.65 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=197.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|.. .++..|++|.+... .....+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 346899999999999995 47889999998642 334466799999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 84 GDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999986422 2488999999999999999999998 9999999999999999999999999998765433
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....+++.|+|||+.....++.++|||||||++|||+||+.||.... -.......... .. +.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~-----~~~~ 222 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRG-VF-----PPVS 222 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-CC-----CCCc
Confidence 22356788999999988889999999999999999999999986321 11111111111 11 0111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+|++.+|++||++.|+++.
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 -----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222468889999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=338.00 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=186.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEec--------CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--------EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lv 327 (565)
..++||+|+||.||+|.. .+++.||||++... .....+|+.+++.++|||||++++++... ...++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 457899999999999995 57889999988543 22345799999999999999999987542 136799
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCcc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVP 406 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~ 406 (565)
|||+++ +|.+++...... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 146 mE~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EecCCc-cHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 999985 787777543221 22489999999999999999999998 999999999999998654 79999999998
Q ss_pred ccccc---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc---
Q 008431 407 IVNKE---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW--- 479 (565)
Q Consensus 407 ~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 479 (565)
..... ....+|+.|+|||++.+ ..|+.++|||||||++|||+||++||...... ..+...+ .......
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~-~~~~~p~~~~ 294 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRII-QVLGTPTEDQ 294 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHH-HHhCCCCHHH
Confidence 65432 23467889999998765 46899999999999999999999999632110 0111111 1000000
Q ss_pred -------cCccccccccCC----CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhh
Q 008431 480 -------TGEVFDKDMRGT----KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELK 530 (565)
Q Consensus 480 -------~~~~~d~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~ 530 (565)
...+.-+..... ..+......+.+++.+||+.||.+|||+.|+++. +.++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000000000000 0001122468899999999999999999999854 44443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.97 Aligned_cols=234 Identities=20% Similarity=0.222 Sum_probs=186.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|... ++..||+|.+.... ....+.+..|..++..+ +|++|+++++++...+..|+||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 3468999999999999954 67899999987532 22234567788888777 5889999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 84 NGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999987543 388999999999999999999998 9999999999999999999999999998753221
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....||+.|+|||++....++.++|||||||++|||+||+.||... ............. . .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~--------~~~~~~~~i~~~~-~------~ 219 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHN-V------A 219 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-C------C
Confidence 2346789999999999999999999999999999999999999631 1122222222111 0 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
. +......+.+++.+|++.||++|++.
T Consensus 220 ~-----p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 Y-----PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred C-----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 01122367888999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=323.21 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=203.4
Q ss_pred chhHHHhhccceecccCceeEEEEEEeC--------CCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEE
Q 008431 249 ELNDLLRASAEVLGSGSFGSSYKAVLLT--------GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFY 318 (565)
Q Consensus 249 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 318 (565)
++....+...+.||+|+||.||+|.... ...||+|.++... ....+++.+|+++++++ +||||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3333444566899999999999997421 2368999876432 23356799999999999 799999999999
Q ss_pred EecCceEEEEeccCCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCC
Q 008431 319 YRKEEKLLVSDFVPNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSS 387 (565)
Q Consensus 319 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~ 387 (565)
...+..+++|||+++|+|.+++...... ....++|..++.++.|++.||+|||+. +|+||||||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~ 163 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAAR 163 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----Ceeccccccc
Confidence 9999999999999999999999764321 123488999999999999999999998 9999999999
Q ss_pred CEEEcCCCCcEEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccC
Q 008431 388 NVLLDNAYEPLLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQG 460 (565)
Q Consensus 388 NILl~~~~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~ 460 (565)
|||++.++.+||+|||+++...... ...++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~---- 239 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG---- 239 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC----
Confidence 9999999999999999987653321 1223467999999988899999999999999999998 8888862
Q ss_pred CCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 461 KGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 461 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
....++....... .... . +......+.+++.+|++.+|++|||+.|+++.|+++...
T Consensus 240 ----~~~~~~~~~~~~~-~~~~-----~-----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 240 ----IPVEELFKLLKEG-HRMD-----K-----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ----CCHHHHHHHHHcC-CCCC-----C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 2233333222211 1100 0 111224678899999999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.16 Aligned_cols=243 Identities=18% Similarity=0.217 Sum_probs=193.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||++.. .+++.||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 357899999999999994 478899999997532 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 85 GGDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999976532 389999999999999999999998 9999999999999999999999999999765432
Q ss_pred ----ccccccccccCCCccC------CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 412 ----HAQLHMVAYKSPEFNQ------TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~------~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
....+|+.|+|||++. ...++.++|||||||++|||++|+.||... ................
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--------~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG--------TSAKTYNNIMNFQRFL 228 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC--------CHHHHHHHHHcCCCcc
Confidence 2235789999999876 456789999999999999999999999621 1222222222111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. +. . ......+.+++..|++ +|++|||+.++++
T Consensus 229 ~~--~~---~---~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KF--PE---D---PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CC--CC---C---CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 00 0 1112357778889998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=310.95 Aligned_cols=248 Identities=20% Similarity=0.319 Sum_probs=186.9
Q ss_pred eecccCceeEEEEEEeCCC---eeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 260 VLGSGSFGSSYKAVLLTGP---AMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.||+|+||.||+|...++. .+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999855443 34566554332 2345689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK----- 410 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~----- 410 (565)
|.++++..... ...+++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999764322 22367778889999999999999998 899999999999999999999999999764221
Q ss_pred -cccccccccccCCCccCC-------CCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 411 -EHAQLHMVAYKSPEFNQT-------DGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 411 -~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
.....++..|+|||+... ..++.++|||||||++|||++ |..||... ............. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--------~~~~~~~~~~~~~-~~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--------SDREVLNHVIKDQ-QV 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHhhc-cc
Confidence 123456788999998643 245789999999999999997 56787521 1222233222222 22
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
...++.+.... ...+.+++..|+ .+|++|||++||++.|.
T Consensus 228 ~~~~~~~~~~~-----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELPY-----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCCC-----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33334332221 135666777899 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=300.25 Aligned_cols=243 Identities=23% Similarity=0.263 Sum_probs=197.0
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEee--ccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..++||+|.|+.||++. ..+|+.+|+|.+. .....+.+++.+|+.+.+.++|||||++.+.+.+....|+|+|+|.|
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 44689999999999998 5689999999875 33445678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCcccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIVNK 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~~ 410 (565)
|+|..-+-.+. .+++..+-..++||+.+|.|+|.+ +|||||+||+|+|+.+ .--+|++|||+|..+..
T Consensus 95 ~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 95 GELFEDIVARE-----FYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred hHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99987766542 378888999999999999999999 9999999999999953 34589999999988764
Q ss_pred c---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 E---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
. ....||++|||||++...+|+..+|||+.|||||-|+.|.+||.. .+.......+.... .++-.|.
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--------~~~~rlye~I~~g~--yd~~~~~ 235 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYEQIKAGA--YDYPSPE 235 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--------ccHHHHHHHHhccc--cCCCCcc
Confidence 3 345789999999999999999999999999999999999999973 12222222222221 1111112
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+. .......+++.+||..||++|.|+.|.++
T Consensus 236 w~------~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 236 WD------TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cC------cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 21 22236778888999999999999998865
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=309.79 Aligned_cols=243 Identities=23% Similarity=0.399 Sum_probs=196.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|...++..+|+|.+... .....+|.+|++++++++||||+++++++......++||||+++|+|
T Consensus 8 ~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd05112 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86 (256)
T ss_pred EEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence 34789999999999999877889999988643 33456799999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 87 SDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred HHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999975432 388999999999999999999998 89999999999999999999999999987543221
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||+..+..++.++|||||||++|||++ |+.||.. ........... .+. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--------~~~~~~~~~~~-~~~--~~~~~~~-- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN--------RSNSEVVETIN-AGF--RLYKPRL-- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc--------CCHHHHHHHHh-CCC--CCCCCCC--
Confidence 2233568999999988889999999999999999998 9999862 11222222211 110 1111111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
....+.+++.+||+.+|++|||+.||++.|.
T Consensus 226 ------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=310.47 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=198.5
Q ss_pred ceecccCceeEEEEEEeC----CCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLLT----GPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||.||+|.... +..+|+|.+...... ..+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999653 788999998754332 367899999999999999999999999998999999999999
Q ss_pred CCHHHHHhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 334 GSLANLLHVRRAP----GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 334 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999865211 013489999999999999999999998 99999999999999999999999999987765
Q ss_pred cc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 410 KE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 410 ~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
.. ....++..|+|||.+....++.++||||+||++|||++ |+.||... ...+....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~-~~~~- 226 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEYLRK-GYRL- 226 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHc-CCCC-
Confidence 42 23346778999999888889999999999999999999 69998732 11222222111 1100
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
.. +......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 227 ----~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ----PK-----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CC-----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 1112347889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=319.81 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=199.2
Q ss_pred hccceecccCceeEEEEEEe--------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceE
Q 008431 256 ASAEVLGSGSFGSSYKAVLL--------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKL 325 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 325 (565)
...+.||+|+||.||+|... ....+|+|.++... .....++.+|+.+++++ +||||+++++++...+..+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 35688999999999999742 24568899887432 23345788999999999 6999999999999888999
Q ss_pred EEEeccCCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC
Q 008431 326 LVSDFVPNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA 394 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~ 394 (565)
+||||+++|+|.+++...... ....++|..+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAARNVLVTED 170 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeeccccceeEEEcCC
Confidence 999999999999999764321 123489999999999999999999998 99999999999999999
Q ss_pred CCcEEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcch
Q 008431 395 YEPLLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADL 467 (565)
Q Consensus 395 ~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~ 467 (565)
+.+||+|||+++...... ...++..|+|||++....++.++|||||||++|||++ |..||... ..
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--------~~ 242 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--------PV 242 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC--------CH
Confidence 999999999997654321 1123457999999888889999999999999999999 88888521 11
Q ss_pred HHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..... ......... . +......+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 243 ~~~~~-~~~~~~~~~-----~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 EELFK-LLREGHRMD-----K-----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHH-HHHcCCCCC-----C-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 12221 111111100 0 111223677899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=312.00 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=196.0
Q ss_pred ccceecccCceeEEEEEEeCC----CeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLLTG----PAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|...+. ..||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 457899999999999985432 468889886543 3345679999999999999999999998865 5678999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 89 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 89 PLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999975432 389999999999999999999998 9999999999999999999999999998765433
Q ss_pred c-----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 H-----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ~-----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
. ...++..|+|||.+....++.++|||||||++||+++ |..||.... ..+...........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~~~~----- 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK--------NNDVIGRIENGERL----- 227 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcCCcC-----
Confidence 1 1223457999999888889999999999999999986 999986321 11111111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.. +......+.+++.+|+..+|++|||+.|+++.|++++..
T Consensus 228 -~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -PM-----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 011223678888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.05 Aligned_cols=255 Identities=21% Similarity=0.275 Sum_probs=196.3
Q ss_pred hccceecccCceeEEEEEE------eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEec-CceEE
Q 008431 256 ASAEVLGSGSFGSSYKAVL------LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRK-EEKLL 326 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~l 326 (565)
...+.||+|+||+||+|.. .+++.||||.++... ......+.+|+.++.++ +||||+++++++... ...++
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence 4567899999999999973 356789999997532 22345688999999999 689999999988654 46789
Q ss_pred EEeccCCCCHHHHHhhcCCC------------------------------------------------------------
Q 008431 327 VSDFVPNGSLANLLHVRRAP------------------------------------------------------------ 346 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~------------------------------------------------------------ 346 (565)
||||+++|+|.+++......
T Consensus 90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T cd05103 90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE 169 (343)
T ss_pred EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence 99999999999999753210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc------cccccc
Q 008431 347 --GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH------AQLHMV 418 (565)
Q Consensus 347 --~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~------~~~~t~ 418 (565)
....++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...++.
T Consensus 170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 170 DLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 012378889999999999999999998 99999999999999999999999999987643221 123456
Q ss_pred cccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHH
Q 008431 419 AYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGE 497 (565)
Q Consensus 419 ~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 497 (565)
.|+|||.+....++.++|||||||++|||++ |..||.... ...........+.... .+. ..
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~--~~~--------~~ 307 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--------IDEEFCRRLKEGTRMR--APD--------YT 307 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc--------ccHHHHHHHhccCCCC--CCC--------CC
Confidence 7999999888889999999999999999997 999986321 1111111121211100 000 11
Q ss_pred HHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 498 MLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 498 ~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
...+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 13678899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=308.51 Aligned_cols=242 Identities=23% Similarity=0.365 Sum_probs=195.3
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999767999999998754332 4567999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-----
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH----- 412 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~----- 412 (565)
+++..... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99975432 378999999999999999999998 89999999999999999999999999987654221
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+..|+|||++.+..++.++|||||||++|||+| |..||.... ...... ...... ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--------~~~~~~-~~~~~~--~~------- 214 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--------NQQTRE-RIESGY--RM------- 214 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--------HHHHHH-HHhcCC--CC-------
Confidence 1122456999999888889999999999999999999 888885321 111111 111110 00
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
..+......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 215 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 -PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 001122347888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=316.88 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=195.5
Q ss_pred ccceecccCceeEEEEEEe-----------------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-----------------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 318 (565)
..+.||+|+||.||++... +...+|+|.+.... .....+|.+|+.++++++||||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05095 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC 88 (296)
T ss_pred eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4578999999999998532 23468999887532 33356799999999999999999999999
Q ss_pred EecCceEEEEeccCCCCHHHHHhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc
Q 008431 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPG------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD 392 (565)
Q Consensus 319 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~ 392 (565)
...+..++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+. +++||||||+|||++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~Nili~ 164 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRNCLVG 164 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChheEEEc
Confidence 99999999999999999999997643221 12478889999999999999999998 999999999999999
Q ss_pred CCCCcEEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc--CCCCccccccCCCCC
Q 008431 393 NAYEPLLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT--GKFPANYLAQGKGAN 464 (565)
Q Consensus 393 ~~~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t--g~~p~~~~~~~~~~~ 464 (565)
.++.+||+|||+++...... ....+..|+|||+...+.++.++|||||||++|||+| |..||.....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~----- 239 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD----- 239 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-----
Confidence 99999999999987653221 1223567999998888889999999999999999998 7788753211
Q ss_pred cchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 465 ADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
................ ....+. +......+.+++.+||+.||++||||.||++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~-~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGEFFRDQGR-QVYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHHhhccc-cccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111111 011111 11122478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=333.49 Aligned_cols=243 Identities=20% Similarity=0.238 Sum_probs=188.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. .+++.||+|.+.... ......+.+|+.++++++||||+++++.+.+++..|+||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 357899999999999994 568899999986422 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc--
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK-- 410 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~-- 410 (565)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 85 GGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999997543 378889999999999999999998 999999999999999999999999999742210
Q ss_pred ---------------------------------------------cccccccccccCCCccCCCCCCcchhHHHHHHHHH
Q 008431 411 ---------------------------------------------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILIL 445 (565)
Q Consensus 411 ---------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~ 445 (565)
.....||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 01235889999999999999999999999999999
Q ss_pred HHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCC---CHHHH
Q 008431 446 ELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW---DLREA 522 (565)
Q Consensus 446 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---s~~ev 522 (565)
||++|+.||.... ........... ......+.. ......+.+++.+|+ .+|.+|+ |+.|+
T Consensus 236 ell~G~~Pf~~~~--------~~~~~~~i~~~--~~~~~~~~~------~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 236 EMLVGQPPFLADT--------PAETQLKVINW--ETTLHIPSQ------AKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ehhhCCCCCCCCC--------HHHHHHHHhcc--CccccCCCC------CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 9999999996321 11111111110 001101110 011124555666665 4999999 88998
Q ss_pred HHH
Q 008431 523 VEK 525 (565)
Q Consensus 523 l~~ 525 (565)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=309.04 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=198.5
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|...++..+|||.+... ....+++.+|+.++++++||||+++++++......++||||+++++|
T Consensus 10 i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 88 (261)
T cd05034 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL 88 (261)
T ss_pred eeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCH
Confidence 45789999999999999878888999998753 33467899999999999999999999999988899999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 89 ~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 89 LDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred HHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 999976432 2489999999999999999999998 89999999999999999999999999987654321
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+..|+|||.+.+..++.++|||||||++||++| |+.||... ............ .. ...
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--------~~~~~~~~~~~~-~~-----~~~-- 225 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--------TNREVLEQVERG-YR-----MPR-- 225 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcC-CC-----CCC--
Confidence 1223467999999988889999999999999999999 99998621 111111111111 00 000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
+......+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01112468889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=311.26 Aligned_cols=246 Identities=20% Similarity=0.370 Sum_probs=195.5
Q ss_pred ccceecccCceeEEEEEEe-C---CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-T---GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|... + +..+|+|.++... ....+.|.+|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 3578999999999999853 2 2368999886432 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+|++|||++......
T Consensus 88 ~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 88 ENGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999975432 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred cc-------ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 HA-------QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ~~-------~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
.. ..++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..+.... ..+...
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~--------~~~~~~~-~~~~~~--- 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS--------NQDVIKA-IEEGYR--- 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC--------HHHHHHH-HhCCCc---
Confidence 11 112457999999988889999999999999999887 999986321 1111111 111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.+. .......+.+++.+|++.+|++||||.++++.|+++
T Consensus 228 -~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -LPA------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CCC------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 011224678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=346.45 Aligned_cols=257 Identities=17% Similarity=0.226 Sum_probs=199.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||.||+|.. .+++.||+|+++... ....++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 347899999999999995 468999999987432 2234579999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 333 NGSLANLLHVRRAP------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 333 ~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999753211 112367788899999999999999998 99999999999999999999999999987
Q ss_pred ccccc----------------------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCC
Q 008431 407 IVNKE----------------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGAN 464 (565)
Q Consensus 407 ~~~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~ 464 (565)
..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~----- 236 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG----- 236 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch-----
Confidence 65210 113578999999999999999999999999999999999999963110
Q ss_pred cchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHhhccCC
Q 008431 465 ADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-DLREAVEKIMELKERDN 534 (565)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~~~~~ 534 (565)
..+ ... . ...++.-.. ........+.+++.+|++.||++|| +++++.+.|+.......
T Consensus 237 ~ki---~~~----~---~i~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 237 RKI---SYR----D---VILSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred hhh---hhh----h---hccChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 000 000 0 000000000 0011223577889999999999996 77888888888765543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=313.32 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=192.9
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.++||+|+||.||+|.. .++..||+|.+... ......++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 46899999999999984 57889999998643 22334678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--cc
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--HA 413 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--~~ 413 (565)
|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++...... ..
T Consensus 86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred hHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 97652 278889999999999999999998 9999999999999999999999999998765432 34
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||++....++.++|||||||++|||++|+.||......... .....+........ .+.+...
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~-- 223 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIVDED------PPVLPVG-- 223 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHhccC------CCCCCCC--
Confidence 46788999999998888999999999999999999999999643221111 11111111111110 1111111
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....+.+++.+|++.+|++||+++|+++.
T Consensus 224 --~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 --QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 112367889999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=322.00 Aligned_cols=254 Identities=20% Similarity=0.337 Sum_probs=200.6
Q ss_pred cccchhHHHhhccceecccCceeEEEEEEeCCCeeEEEEeec--cCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecC
Q 008431 246 EMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKE 322 (565)
Q Consensus 246 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 322 (565)
..+.+..-.+...+.||+||.+.||++...+...+|+|++.. .+.....-|.+|+..|.+|+ |.+||++++|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 345566666667789999999999999988888999998763 34455678999999999996 999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
.+|+||||=+ -||..+|+..... ...| .+..+..|++.++.++|++ +|||.||||.|.|+ -.|.+||+||
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLl-VkG~LKLIDF 503 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLL-VKGRLKLIDF 503 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEE-EeeeEEeeee
Confidence 9999999875 4999999876543 1335 7889999999999999999 99999999999999 4578999999
Q ss_pred CCccccccc------ccccccccccCCCccCCCC-----------CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCc
Q 008431 403 ALVPIVNKE------HAQLHMVAYKSPEFNQTDG-----------VTRKTDVWSLGILILELLTGKFPANYLAQGKGANA 465 (565)
Q Consensus 403 Gla~~~~~~------~~~~~t~~y~aPE~~~~~~-----------~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~ 465 (565)
|+|..+..+ .+++||+.||+||.+.... .+.++||||+|||||+|+.|++||...
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------- 575 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------- 575 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------
Confidence 999887665 3568999999999765432 568999999999999999999998621
Q ss_pred chHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.-.|.+ ...+.||.............++.++++.||++||++|||+.|+++.
T Consensus 576 -~n~~aK-------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 -INQIAK-------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHHHHH-------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112222 2223333221111111112248899999999999999999999764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.25 Aligned_cols=243 Identities=18% Similarity=0.232 Sum_probs=189.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..|+||||++
T Consensus 47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 4578999999999999954 67899999986421 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999643 278889999999999999999998 9999999999999999999999999999765432
Q ss_pred ----ccccccccccCCCccCCC----CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 ----HAQLHMVAYKSPEFNQTD----GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~----~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
....||+.|+|||++... .++.++||||+||++|||++|+.||.. .+................
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~~- 267 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA--------DSLVGTYSKIMDHKNSLN- 267 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCcccC-
Confidence 244689999999987653 378999999999999999999999962 122222222222111000
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAER--RWDLREAVEK 525 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 525 (565)
... .......+.+++.+|++.+|.+ |||+.|+++.
T Consensus 268 ----~p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ----FPE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----CCC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 0111235667777888755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=324.43 Aligned_cols=268 Identities=19% Similarity=0.323 Sum_probs=213.7
Q ss_pred ceeEecCCccccchhHHHhhccceecccCceeEEEEEEeC---C--CeeEEEEeec-cCccCHHHHHHHHHHHhcCCCCC
Q 008431 237 KLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLT---G--PAMVVKRFRQ-MSNVGKEDFHEHMTRLGSLSHPN 310 (565)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~n 310 (565)
...+.....+.+++..-.....+.||.|.||.||+|.+.+ | -.||||..+. ......+.|++|..+|+.++|||
T Consensus 373 dety~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHph 452 (974)
T KOG4257|consen 373 DETYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPH 452 (974)
T ss_pred cccccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcc
Confidence 3334444444555554444567899999999999999532 3 3689999886 44566788999999999999999
Q ss_pred ccceEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEE
Q 008431 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVL 390 (565)
Q Consensus 311 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NIL 390 (565)
||+++|.|.+ ...|+|||.++-|.|..||...+.. |+......++.||+.||+|||+. ++|||||..+|||
T Consensus 453 IikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~s----L~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiL 523 (974)
T KOG4257|consen 453 IIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDS----LPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNIL 523 (974)
T ss_pred hhheeeeeec-cceeEEEecccchhHHHHHHhcccc----chHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhhee
Confidence 9999999954 5789999999999999999876653 88888999999999999999999 9999999999999
Q ss_pred EcCCCCcEEeccCCcccccccccc---cc--cccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCC
Q 008431 391 LDNAYEPLLTDYALVPIVNKEHAQ---LH--MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGAN 464 (565)
Q Consensus 391 l~~~~~~kl~DfGla~~~~~~~~~---~~--t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~ 464 (565)
+.+..-+|++|||+++.+..+... .+ ...|||||.+.-++++.++|||-|||.+||+++ |..||......
T Consensus 524 VsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---- 599 (974)
T KOG4257|consen 524 VSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---- 599 (974)
T ss_pred ecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----
Confidence 999999999999999998765322 22 357999999999999999999999999999987 99999732211
Q ss_pred cchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 465 ADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
+... .++.+ ...+.++.+...+..++.+||+++|.+||+..|+...|.++...
T Consensus 600 -DVI~----~iEnG----------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 600 -DVIG----HIENG----------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred -ceEE----EecCC----------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 0000 00000 01122345566888999999999999999999999999988763
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=330.11 Aligned_cols=233 Identities=25% Similarity=0.294 Sum_probs=189.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
...+||+|+||+|+++.. .+++.+|||.+++.. ..+.+..+.|-+++... +||.++.++..|.+++++|+||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 468999999999999995 578899999998643 34456677788777766 5999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc--
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN-- 409 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~-- 409 (565)
.|||+..+.+.. .+++..+..++..|+.||+|||++ +||+||||.+|||||.+|.+||+|||+++..-
T Consensus 452 ~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 452 AGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred CCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999955444321 399999999999999999999999 99999999999999999999999999998643
Q ss_pred --ccccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 410 --KEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 410 --~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
...+.+||+.|||||++....|+..+|.|||||+||||+.|..||... +-.+....++.++ +
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--------dEee~FdsI~~d~----~---- 585 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--------DEEEVFDSIVNDE----V---- 585 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHhcCC----C----
Confidence 224668999999999999999999999999999999999999999721 1112222222221 1
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
.++.....+.+.++.+.+..+|++|--+
T Consensus 586 ----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1122333467788889999999999855
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.75 Aligned_cols=244 Identities=21% Similarity=0.268 Sum_probs=200.4
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.....||.|+||.||+|..+ ++-..|.|.+...+....++|+-||++|+.+.||+||+|++.|+..+.+++..|||.||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 34567899999999999954 55566788887777777889999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc----c
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN----K 410 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~----~ 410 (565)
-+..++-.... .|.+.++..++.|++.||.|||+. +|||||||..|||+.-+|.++++|||++.... .
T Consensus 115 AVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 115 AVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred hHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 99998877654 499999999999999999999999 99999999999999999999999999975443 2
Q ss_pred cccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 411 EHAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 411 ~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
..+.+||++|||||+.. ..+|+.++|||||||+|.||.-+.+|.... +....+..+.... .
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--------npMRVllKiaKSe------P 252 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSE------P 252 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--------chHHHHHHHhhcC------C
Confidence 35678999999999754 467999999999999999999999997532 2222222222222 2
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
|.+... ..-...+.++..+||..||..||++.++++
T Consensus 253 PTLlqP---S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 PTLLQP---SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcccCc---chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 222211 222346778888999999999999999864
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=310.67 Aligned_cols=244 Identities=18% Similarity=0.273 Sum_probs=192.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 346799999999999984 5688999999875544445678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 93 L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 93 LQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 999987543 388999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 HAQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... ..+....... ...+..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--------~~~~~~~~~~----~~~~~~ 231 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMTKSN----FQPPKL 231 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--------hhHHhhhccC----CCCCcc
Confidence 2346788999999864 456889999999999999999999998532110 0011111110 001111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.... .....+.+++.+|++.+|++|||++++++
T Consensus 232 ~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccC---CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1100 11135778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=308.52 Aligned_cols=242 Identities=21% Similarity=0.288 Sum_probs=193.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc-----cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN-----VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|++++++++||||+++++++...+..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 357899999999999984 5789999999864321 1235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 86 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 86 MPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999987543 388899999999999999999998 999999999999999999999999999875432
Q ss_pred c-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 E-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...-..........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~~--- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--------AMAAIFKIATQPTN--- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc--------hHHHHHHHhccCCC---
Confidence 2 12346678999999998889999999999999999999999986321 11111111111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+.+. ......+.+++.+||..+|++|||+.|+++.
T Consensus 226 --~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 --PQLP-----SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCC-----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111 1122367888899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=321.68 Aligned_cols=233 Identities=19% Similarity=0.224 Sum_probs=186.9
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
.+.||+|+||+||+|.. .+++.||+|++.... ....+.+..|..+++.+. |++|+++++++...+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 46899999999999995 478899999987432 233456788999988886 5678889999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999987543 389999999999999999999998 9999999999999999999999999998754221
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||... .............. ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--------~~~~~~~~i~~~~~-------~~ 220 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE--------DEDELFQSIMEHNV-------SY 220 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCC-------CC
Confidence 2345789999999998888999999999999999999999999631 11222222222110 00
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
+......+.+++.+|++.+|++|++.
T Consensus 221 -----p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 -----PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01112367788999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=317.28 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=195.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||++.. .++..+|+|.+.... .....++.+|++++++++||||++++++|..++..++||||+++|
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 346899999999999994 467888888876432 223456889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--c
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--H 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--~ 412 (565)
+|.+++.... .+++..+..++.|++.||.|||+.+ +++||||||+|||++.++.+||+|||++...... .
T Consensus 85 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 85 SLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 9999997543 3889999999999999999999742 7999999999999999999999999998765332 3
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC-----------
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG----------- 481 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 481 (565)
...++..|+|||+..+..++.++|||||||++|||++|+.||..... .....+...........
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-----hhHHHhhcCccccccccCCcccccCCCC
Confidence 34578899999998888899999999999999999999999853211 11111110000000000
Q ss_pred ---------cccccccc---CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 482 ---------EVFDKDMR---GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 482 ---------~~~d~~~~---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
+..+.... ...........+.+++.+||+.+|++|||+.||++..-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000000 00000012235889999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=313.42 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=193.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|+. .++..+|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+++++
T Consensus 16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 346799999999999995 4588999999876555556789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|..++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 96 l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 96 VDAIMLELDR----GLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 9988765432 389999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....++..|+|||++. ...++.++|||||||++|||++|+.||... ............. .+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~------~~ 233 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSE------PP 233 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc--------cHHHHHHHHhcCC------Cc
Confidence 2345678899999874 345788999999999999999999998621 1111111111111 01
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.... +......+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQ---PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1100 1112236788899999999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=308.64 Aligned_cols=243 Identities=19% Similarity=0.260 Sum_probs=196.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||++.. .++..+|+|.++.. .....+.+.+|+.+++.++||||+++++.+.+.+..++||||+++|
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 357899999999999995 47889999998642 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++++|||.++.....
T Consensus 84 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 84 DLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99999875432 2378899999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....++..|+|||+..+..++.++||||||+++|+|++|+.||.. .+......... .+.... +.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~--------~~~~~~~~~~~-~~~~~~-~~----- 221 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA--------NSWKNLILKVC-QGSYKP-LP----- 221 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC--------CCHHHHHHHHh-cCCCCC-CC-----
Confidence 234577889999999888899999999999999999999999862 11222222111 111110 00
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+||+.||++|||+.|++..
T Consensus 222 ----~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 ----SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112357788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=317.91 Aligned_cols=192 Identities=21% Similarity=0.338 Sum_probs=158.6
Q ss_pred cceecccCceeEEEEEEe---CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E~~~ 332 (565)
..+||+|+||+||+|+.. ++..+|+|.+... .....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999854 4678999998643 224567899999999999999999999865 346789999996
Q ss_pred CCCHHHHHhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE----cCCCCcEEeccCC
Q 008431 333 NGSLANLLHVRRAP----GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL----DNAYEPLLTDYAL 404 (565)
Q Consensus 333 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfGl 404 (565)
++|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5898887643211 112488999999999999999999998 99999999999999 4567899999999
Q ss_pred ccccccc-------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 008431 405 VPIVNKE-------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANY 456 (565)
Q Consensus 405 a~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~ 456 (565)
++..... ....+|+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9765432 23457889999998866 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=311.22 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=193.6
Q ss_pred eecccCceeEEEEEEeC-------CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 260 VLGSGSFGSSYKAVLLT-------GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998542 2578999876432 234567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-----CcEEeccCC
Q 008431 332 PNGSLANLLHVRRAP--GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-----EPLLTDYAL 404 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DfGl 404 (565)
++|+|.+++...... ....++|..++.++.|++.||+|||+. +++|+||||+||+++.+. .+|++|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999754321 123488999999999999999999988 899999999999999877 899999999
Q ss_pred ccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++..... .....+..|+|||++....++.++|||||||++|||+| |+.||.... ..+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--------~~~~~~~~-~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--------NQEVLQHV-TA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--------HHHHHHHH-hc
Confidence 8754322 12234578999999988899999999999999999998 999986211 11111111 11
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
... . ..+......+.+++.+||+.+|++||++.+|++.|++
T Consensus 229 ~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGR-------L---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCc-------c---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 100 0 0011223467889999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.29 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=195.8
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+..++.++||||+++++++...+..++|+||+++|+|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 46799999999999984 57899999999765555567889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9988642 389999999999999999999998 9999999999999999999999999998765432 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
...++..|+|||.+.+..++.++|||||||++|||++|+.||... +............ ... +..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~--------~~~~~~~~~~~~~-~~~-----~~~-- 237 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--------NPLRALYLIATNG-TPE-----LQN-- 237 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcC-Ccc-----cCC--
Confidence 235678899999998888999999999999999999999998631 1111111111110 000 000
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+......+.+++.+||..||++|||+.++++.
T Consensus 238 -~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 -PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11122357788899999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=331.59 Aligned_cols=185 Identities=22% Similarity=0.233 Sum_probs=161.2
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
...+.||+|+||.||+|... +++.||||... ...+.+|++++++++|||||++++++...+..++||||+. |
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 34578999999999999954 57889999642 2346789999999999999999999999999999999995 7
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 245 ~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 245 DLYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 99998865432 499999999999999999999998 9999999999999999999999999998765332
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
....||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 12358999999999999999999999999999999999887653
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=319.94 Aligned_cols=192 Identities=24% Similarity=0.330 Sum_probs=161.5
Q ss_pred cceeccc--CceeEEEEE-EeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 258 AEVLGSG--SFGSSYKAV-LLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G--~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
.++||+| +|++||++. ..+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3579999 788999998 4678999999987432 2223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc--
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK-- 410 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~-- 410 (565)
+|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+.......
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999975432 1389999999999999999999998 999999999999999999999999986433211
Q ss_pred ---------cccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 008431 411 ---------EHAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANY 456 (565)
Q Consensus 411 ---------~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~ 456 (565)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 112245677999998865 4689999999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.86 Aligned_cols=254 Identities=16% Similarity=0.234 Sum_probs=190.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 3478999999999999954 67889999987432 23345688999999999999999999999999999999999975
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 89 DLKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 88888865432 378899999999999999999998 9999999999999999999999999998754322
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc----c------
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE----W------ 479 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~------ 479 (565)
....++..|+|||++.+ ..++.++|||||||++|||+||++||..... .+....+....... +
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV-----EDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHhhhcch
Confidence 23456789999998754 5689999999999999999999999963211 01111111111000 0
Q ss_pred --cCccccccccCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 --TGEVFDKDMRGTK---SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 --~~~~~d~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....-.+...... ........+.+++.+|++.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000000 00011235678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=315.68 Aligned_cols=241 Identities=21% Similarity=0.328 Sum_probs=195.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 347899999999999994 5799999999976555556778999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 103 L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 103 LTDVVTET------CMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred HHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 99998642 378899999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....+++.|+|||...+..++.++|||||||++|++++|+.||....... ........+ .+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--------~~~~~~~~~------~~~~--- 235 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG------TPEL--- 235 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--------heeeeccCC------CCCC---
Confidence 23356788999999988889999999999999999999999996321100 000000000 0000
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+......+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011112235678889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.81 Aligned_cols=241 Identities=21% Similarity=0.329 Sum_probs=189.0
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEec------CceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRK------EEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~~~~lv~E 329 (565)
.+.||+|+||.||+|.. .+++.||+|.+... .....++.+|+.++.++ +||||+++++++... ...|+|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 46799999999999985 46788999988643 34456789999999998 699999999998753 35799999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++..... ..++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 90 ~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 90 FCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999976432 2489999999999999999999998 89999999999999999999999999987653
Q ss_pred cc----ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 410 KE----HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 410 ~~----~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
.. ....++..|+|||++. ...++.++|||||||++|||++|+.||..... ..... .. ....
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~-~~-~~~~- 232 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF-LI-PRNP- 232 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHH-HH-hcCC-
Confidence 22 2345788999999875 34688899999999999999999999863211 11111 00 0100
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+.... ......+.+++.+||..+|.+|||+.|+++
T Consensus 233 ----~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 ----APRLKS----KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----CCCCCC----CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111111 112236788899999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.22 Aligned_cols=190 Identities=23% Similarity=0.324 Sum_probs=167.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||++.. .+++.||+|.++... ......+.+|+.++..++||||+++++.+.+.+..|+||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 347899999999999995 478899999997422 2334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 85 GGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999997543 388999999999999999999998 9999999999999999999999999998644211
Q ss_pred --------------------------------------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 008431 412 --------------------------------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453 (565)
Q Consensus 412 --------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p 453 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 123588999999999999999999999999999999999999
Q ss_pred cc
Q 008431 454 AN 455 (565)
Q Consensus 454 ~~ 455 (565)
|.
T Consensus 236 f~ 237 (360)
T cd05627 236 FC 237 (360)
T ss_pred CC
Confidence 96
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.49 Aligned_cols=248 Identities=22% Similarity=0.375 Sum_probs=197.4
Q ss_pred ccceecccCceeEEEEEEe-CCC----eeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGP----AMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|... +|. .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++||||
T Consensus 11 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEec
Confidence 4578999999999999854 343 588888765432 334678999999999999999999999987 788999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 90 MPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred CCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999976433 389999999999999999999997 999999999999999999999999999976643
Q ss_pred ccc------ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 EHA------QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~~~------~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
... ..++..|+|||......++.++|||||||++||++| |+.||... ...++..... .... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~-~~~~--~ 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--------PAVEIPDLLE-KGER--L 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--------CHHHHHHHHh-CCCC--C
Confidence 321 112457999999888889999999999999999999 99998631 1222222111 1100 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.. +......+.+++.+||..+|++|||+.++++.|.++...
T Consensus 231 ~~--------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 PQ--------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CC--------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00 011223678889999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.06 Aligned_cols=244 Identities=22% Similarity=0.380 Sum_probs=195.4
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||++....+..+|+|.+... ....+.|.+|++++++++|+||+++++++.. ...+++|||+++|+|
T Consensus 10 ~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 87 (260)
T cd05073 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL 87 (260)
T ss_pred EEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcH
Confidence 45789999999999999777888999988643 2335679999999999999999999999877 778999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 88 LDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred HHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 999975432 2488999999999999999999998 89999999999999999999999999987553221
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||++....++.++|||||||++||++| |+.||... +..+... ......... .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--------~~~~~~~-~~~~~~~~~-----~-- 224 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------SNPEVIR-ALERGYRMP-----R-- 224 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC--------CHHHHHH-HHhCCCCCC-----C--
Confidence 1233467999999988889999999999999999999 99998621 1111111 111111100 0
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
.......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122468888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.85 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=192.9
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCc------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|...++..+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 3568999999999999988899999999864321 1234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 84 VPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999997543 378999999999999999999998 899999999999999999999999999865421
Q ss_pred ----------cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 411 ----------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 411 ----------~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~-~~~~~~~-- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-------RLAAM-FYIGAHR-- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-------hHHHH-HHhhhcc--
Confidence 112346788999999988889999999999999999999999996321 01111 0000000
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. ..+.+.. .....+.+++.+||+.+|++|||+.|+++
T Consensus 225 -~-~~~~~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -G-LMPRLPD-----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -C-CCCCCCC-----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0111111 12236788889999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=313.08 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=198.2
Q ss_pred cceecccCceeEEEEEEe-----CCCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E 329 (565)
.+.||+|+||.||+|.+. ++..+|||.+...... ..+.|.+|+++++.++||||+++++++.. ....++|||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 478999999999999853 3678999998754332 45689999999999999999999999877 557899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++....
T Consensus 89 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 89 YLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred cCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999976443 389999999999999999999998 99999999999999999999999999987765
Q ss_pred ccc-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCC------CcchHHHHHHHhh
Q 008431 410 KEH-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA------NADLATWVNSVVR 476 (565)
Q Consensus 410 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~ 476 (565)
... ...++..|+|||+.....++.++|||||||++|||+||+.|+......... .......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 221 122345699999988888999999999999999999999997532111000 0000111111111
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
.... . ..+......+.+++.+||+.+|++||||.||+++|+++.
T Consensus 241 ~~~~-------~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 241 EGER-------L---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cCCc-------C---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1100 0 001122246889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.01 Aligned_cols=254 Identities=15% Similarity=0.256 Sum_probs=190.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecC-----ceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-----EKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~ 328 (565)
..+.||+|+||.||++.. .+++.||+|++... .....+++.+|+.+++.++||||+++++++...+ ..|+||
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 357899999999999995 57899999998642 1223457889999999999999999999998766 789999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+. ++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9996 58888875432 389999999999999999999998 9999999999999999999999999998765
Q ss_pred ccc-----ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc----
Q 008431 409 NKE-----HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE---- 478 (565)
Q Consensus 409 ~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 478 (565)
... ....++..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.......
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-----IQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHcCCCCHHH
Confidence 432 123567889999987764 579999999999999999999999963211 00111111000000
Q ss_pred -----------ccCccc-cccccCC-CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 479 -----------WTGEVF-DKDMRGT-KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 479 -----------~~~~~~-d~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...... .+..... .........+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0000000 0001113467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=318.73 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=200.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCcc---CHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNV---GKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|.||.||+|+.+ +|+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.++++|.+.+..++|||++
T Consensus 39 l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~ 118 (382)
T KOG0032|consen 39 LGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELC 118 (382)
T ss_pred ehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEec
Confidence 3478999999999999954 5999999999764433 3468999999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC----CCcEEeccCCccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA----YEPLLTDYALVPI 407 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~----~~~kl~DfGla~~ 407 (565)
.||.|.+.+... .+++..+..+++|++.++.|||+. +|+||||||+|+|+... +.+|++|||++..
T Consensus 119 ~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 119 EGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred CCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999865 289999999999999999999998 99999999999999643 4799999999988
Q ss_pred cccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
.... ...+||+.|+|||++....|+..+||||.||++|.|++|.+||..... ... ........+ .+-
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-------~~~-~~~i~~~~~--~f~ 258 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE-------FEI-FLAILRGDF--DFT 258 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh-------hHH-HHHHHcCCC--CCC
Confidence 7653 456899999999999999999999999999999999999999973221 111 112222211 111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
++.+ ......+.+++..|+..||.+|+|+.++++.
T Consensus 259 ~~~w------~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 259 SEPW------DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCc------cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 2223467788889999999999999999983
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.17 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=190.4
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
..||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++|+||+++++++...+..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 5799999999999994 467789999987655555678999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCccccccc----c
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~----~ 412 (565)
+++...... ...++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++...... .
T Consensus 94 ~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 94 ALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred HHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence 999754321 0127888899999999999999998 9999999999999976 679999999998755322 2
Q ss_pred cccccccccCCCccCCC--CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 AQLHMVAYKSPEFNQTD--GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||++... .++.++|||||||++|||++|+.||...... ....+...... ..+.+.
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-------~~~~~~- 234 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMFK-------IHPEIP- 234 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhhc-------cCCCCC-
Confidence 23467899999987654 3789999999999999999999998632110 01111100000 011111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.+|++|||+.|++.
T Consensus 235 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 112246778899999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.31 Aligned_cols=244 Identities=22% Similarity=0.309 Sum_probs=194.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||++.. .++..+|+|.+........+.|.+|++++++++||||+++++++..+...++||||+++|+
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 346799999999999995 4688999999876555556789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 89 L~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 89 LDSIMLELER----GLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred HHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999876432 389999999999999999999998 9999999999999999999999999997654322
Q ss_pred ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....++..|+|||++. ...++.++|||||||++|||++|+.||... +....+........ +
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~~------~ 226 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL--------NPMRVLLKILKSEP------P 226 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC--------CHHHHHHHHhcCCC------C
Confidence 2335788999999864 345778999999999999999999998632 11122211111110 1
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+.. +......+.+++.+||+.+|++||++.++++.
T Consensus 227 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLDQ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcCC---cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1100 11112367788889999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=312.71 Aligned_cols=244 Identities=22% Similarity=0.259 Sum_probs=192.8
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.++||+|+||+||++.. .+++.||+|.+..... .....+.+|+.++++++|+||+++++.+.+.+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 36799999999999994 5788999999864322 1234578899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 85 GDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999865432 2489999999999999999999998 9999999999999999999999999998765332
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....++..|+|||++....++.++|||||||++|||++|+.||...... ....-........ .....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~~~~~~~~~~~~~------~~~~~- 225 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEV------QEEYS- 225 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-----chHHHHHhhhhhh------hhhcC-
Confidence 2346788999999998888999999999999999999999999632110 0001111111110 00010
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 524 (565)
......+.+++.+||+.||++||| +.|+++
T Consensus 226 ----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 ----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111235778889999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=310.66 Aligned_cols=244 Identities=23% Similarity=0.243 Sum_probs=191.4
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||+|+||+||+|.. .+++.+|+|.+..... .....+.+|++++++++|+||+++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 36799999999999995 5788999999864321 2234578899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 85 GDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 999998865432 2499999999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+........ .. ..
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~-----~~~~~~~~~~~~~~~--~~----~~- 225 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-----KVKREEVDRRVLETE--EV----YS- 225 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhhhccc--cc----cC-
Confidence 234678899999999888899999999999999999999999963110 000111111111110 00 10
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 524 (565)
......+.+++.+|++.||++||| +.|++.
T Consensus 226 ----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 ----AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111235778889999999999999 555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.86 Aligned_cols=187 Identities=20% Similarity=0.347 Sum_probs=160.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv 327 (565)
..+.||+|+||.||++.. .+|..||+|++... .......+.+|+.+++.++||||+++++++...+ ..|+|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 357899999999999985 56889999998642 2233567889999999999999999999986543 46999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++ +|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 999975 67666642 278889999999999999999998 999999999999999999999999999876
Q ss_pred cccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 5332 23467889999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.96 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=200.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||++.. .++..||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCC
Confidence 347899999999999995 468889999876432 334567999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--c
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--H 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--~ 412 (565)
+|.+++...+ .+++..+..++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++...... .
T Consensus 89 ~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 89 SLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred CHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 9999987533 3899999999999999999999742 7999999999999999999999999998654322 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCC---CCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKG---ANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||++.+..++.++|||||||++||++||+.||........ ....+..++....... .+.+.
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 234 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRLP 234 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCCC
Confidence 34678899999998888899999999999999999999999974322111 0111222222222111 01110
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
. ......+.+++.+|++.||++|||+.||++...-+.
T Consensus 235 ~----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 235 S----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred c----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0 112346888999999999999999999998754443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=319.30 Aligned_cols=246 Identities=20% Similarity=0.202 Sum_probs=187.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+++. .+++.||+|.+... .....+.+.+|+.++..++||||+++++++.+.+..|+||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 357899999999999995 46889999998742 22334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
+|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 g~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 85 GGDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999975332 388999999999999999999998 99999999999999999999999999986553321
Q ss_pred -----cccccccccCCCccCC-----CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 413 -----AQLHMVAYKSPEFNQT-----DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 413 -----~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
...||+.|+|||++.. ..++.++|||||||++|||++|+.||.. ....+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~--------~~~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHKEHFQ 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC--------CCHHHHHHHHHcCCCccc
Confidence 2358899999998763 4578899999999999999999999962 222233222222111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhcc--ccCcCCCCCHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCC--EWNAERRWDLREAVEK 525 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl--~~~P~~RPs~~evl~~ 525 (565)
+.+... .....+.+++.+|+ ..++..||++.++++.
T Consensus 229 -~~~~~~------~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -FPPDVT------DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCCccC------CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111110 01124455555655 4444558899998776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=312.64 Aligned_cols=249 Identities=22% Similarity=0.399 Sum_probs=194.2
Q ss_pred ccceecccCceeEEEEEE-eCCC----eeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGP----AMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||.||+|.. .++. .+|+|.+..... ....++.+|+.++++++||||++++++|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 446899999999999985 3454 468887764322 2234788999999999999999999998654 56799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 90 MPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred cCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999875432 388999999999999999999998 999999999999999999999999999976543
Q ss_pred cc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 EH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
.. ...++..|+|||++.+..++.++|||||||++|||++ |+.||.... . ............
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--------~-~~~~~~~~~~~~--- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--------T-REIPDLLEKGER--- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--------H-HHHHHHHHCCCC---
Confidence 21 1234568999999988889999999999999999998 899986211 1 111111211110
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
. +. .......+.+++.+||..+|++||++.|+++.|.++....
T Consensus 230 ~-~~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 L-PQ------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C-CC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 00 0112246788999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=306.84 Aligned_cols=241 Identities=22% Similarity=0.332 Sum_probs=194.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|... ++..+|+|.+..... .+++.+|++++++++||||+++++++......|+++||+++++
T Consensus 7 ~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 3467999999999999965 478999999875422 6789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 85 L~~~l~~~~~----~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 85 VSDIMKITNK----TLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred HHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999975432 489999999999999999999998 8999999999999999999999999998765433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....++..|+|||++.+..++.++|||||||++|||++|+.||...... .-.... .. ...+.+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~~~-~~-----~~~~~~~-- 220 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIFMI-PN-----KPPPTLS-- 220 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhhhh-cc-----CCCCCCC--
Confidence 2234678899999998888999999999999999999999998632111 000000 00 0000110
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+......+.+++.+|++.||++|||+.||++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11112246788999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.32 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=193.4
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|+.++++++||||+++++++.. +..++||||+++|+|
T Consensus 10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 85 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCCH
Confidence 457899999999999975 7788999998643 235679999999999999999999999865 457999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-cccc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQL 415 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~ 415 (565)
.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... ....
T Consensus 86 ~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (254)
T cd05083 86 VNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158 (254)
T ss_pred HHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCC
Confidence 999975432 2488999999999999999999998 9999999999999999999999999998764332 2223
Q ss_pred ccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCC
Q 008431 416 HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSG 494 (565)
Q Consensus 416 ~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 494 (565)
.+..|+|||++....++.++|||||||++|||++ |+.||... ....+.. ........ ++ .
T Consensus 159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~~~~-~~~~~~~~---~~-------~ 219 (254)
T cd05083 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM--------SLKEVKE-CVEKGYRM---EP-------P 219 (254)
T ss_pred CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC--------CHHHHHH-HHhCCCCC---CC-------C
Confidence 3567999999988889999999999999999998 99998621 1222221 11111110 00 0
Q ss_pred HHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 495 EGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 495 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
......+.+++.+||+.+|++||+++++++.|++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.28 Aligned_cols=244 Identities=19% Similarity=0.241 Sum_probs=189.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.+.+..|+||||++
T Consensus 47 i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (371)
T cd05622 47 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 126 (371)
T ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 4578999999999999954 67899999986421 2234557899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999998643 278888999999999999999998 9999999999999999999999999998765432
Q ss_pred ----ccccccccccCCCccCCC----CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 ----HAQLHMVAYKSPEFNQTD----GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~----~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
....||+.|+|||++... .++.++|||||||++|||++|+.||.. .+.................
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~~~ 268 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--------DSLVGTYSKIMNHKNSLTF 268 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCcccC
Confidence 244689999999987653 378999999999999999999999962 1222222222221111010
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHHH
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAER--RWDLREAVEKI 526 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~L 526 (565)
+ . .......+.+++.+|+..+|.+ ||++.|+++..
T Consensus 269 --~---~---~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 --P---D---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --C---C---cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 0 0112235677888999844433 77999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=303.86 Aligned_cols=243 Identities=22% Similarity=0.306 Sum_probs=198.0
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||.++ ..++..+++|++... ......++.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 34789999999999998 457889999998643 234456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
|+|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 84 GTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 999999976432 2489999999999999999999998 89999999999999999999999999987654332
Q ss_pred ---cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 ---AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ---~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...+++.|+|||+..+..++.++|||||||++|||++|+.||.. ....+.+......... ..
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~--------~~~~~~~~~~~~~~~~-~~------ 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA--------TNPLNLVVKIVQGNYT-PV------ 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHcCCCC-CC------
Confidence 34578899999998888889999999999999999999999862 1222233222221110 00
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+.+++.+||+.+|++|||+.|+++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01122467788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.89 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=186.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcC---CCCCccceEEEEEec-----CceE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSL---SHPNLLPLIAFYYRK-----EEKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~~~~ 325 (565)
..+.||+|+||+||+|.. .+++.||+|.++... ......+.+|+.+++.+ +||||+++++++... ...+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 346899999999999995 478899999987432 22234566777776655 799999999988642 3579
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+||||++ ++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 9999997 589998875432 2489999999999999999999998 9999999999999999999999999998
Q ss_pred cccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh----hhc
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV----REE 478 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~ 478 (565)
+..... ....++..|+|||++.+..++.++|||||||++|||++|++||...... ..+.... ... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~-~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIF-DLIGLPPEDD 230 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHH-HHhCCCChhh
Confidence 766433 2345688999999998888999999999999999999999998521110 0011111 110 000
Q ss_pred ccCc------cccccccCC--CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 479 WTGE------VFDKDMRGT--KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 479 ~~~~------~~d~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+... .+.+..... .........+.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1000 000000000 000112245788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.24 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=191.7
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCcc---------CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEE
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNV---------GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 327 (565)
...||+|+||.||+|.. .++..+|+|.+...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 46899999999999985 46789999988643221 124688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 85 LEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999997543 388899999999999999999998 999999999999999999999999999876
Q ss_pred cccc----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 408 VNKE----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 408 ~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
.... ....++..|+|||++....++.++|||||||++|||++|+.||..... ..-+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQAIFKIGE- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHHHHHHhc-
Confidence 6421 122467789999999888899999999999999999999999973211 111111100
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...+.+. ......+.+++.+||+.||++||++.||++
T Consensus 227 -----~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -----NASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----cCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111 112246778888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.30 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=193.5
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 36799999999999985 467889999886432 3334678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--- 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 412 (565)
|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.+|++|||++.......
T Consensus 89 L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 89 ALDLLKPG------PLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99988532 388999999999999999999998 99999999999999999999999999987654322
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
...++..|+|||++.+..++.++|||||||++|||+||+.|+..... ..+.. ..... ..+.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~-~~~~~-----~~~~~~-- 222 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--------MRVLF-LIPKN-----SPPTLE-- 222 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch--------hhHHh-hhhcC-----CCCCCC--
Confidence 23467889999999888899999999999999999999999863211 01111 11111 011111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+|++.+|++||||.||++.
T Consensus 223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ---GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223467889999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=302.10 Aligned_cols=244 Identities=22% Similarity=0.330 Sum_probs=196.1
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.++++++||||+++++++...+..+++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 46899999999999995 46788999998765445567899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...... .
T Consensus 88 ~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 88 QDIYQVTRG----PLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred HHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999876422 388999999999999999999998 9999999999999999999999999998765432 2
Q ss_pred cccccccccCCCccCCC---CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 AQLHMVAYKSPEFNQTD---GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~---~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||..... .++.++|||||||++|||+||+.||..... ..-........ ...+.+.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~~~~~----~~~~~~~ 227 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLISKSN----FPPPKLK 227 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcc----CCCcccc
Confidence 34567789999998776 789999999999999999999999863211 11111111110 0001110
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
........+.+++.+|+..+|.+|||+.+|+.
T Consensus 228 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 ---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11223346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.20 Aligned_cols=236 Identities=20% Similarity=0.207 Sum_probs=182.8
Q ss_pred ecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcC---CCCCccceEEEEEecCceEEEEeccCC
Q 008431 261 LGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSL---SHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 261 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
||+|+||+||+|+. .+++.||+|.+..... .....+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999995 4689999999864221 2223455677777665 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99999987543 388999999999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....||..|+|||++.+. .++.++|||||||++|||+||+.||.. ....+......... . .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~-~------~~ 216 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA--------EDTQQMYRNIAFGK-V------RF 216 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC--------CCHHHHHHHHHcCC-C------CC
Confidence 234688999999987654 489999999999999999999999862 12222222221111 0 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCC----HHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWD----LREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs----~~evl~ 524 (565)
... .....+.+++.+||+.||++||+ +.|+++
T Consensus 217 ~~~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKN----VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCc----cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000 11235678888999999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.73 Aligned_cols=253 Identities=17% Similarity=0.197 Sum_probs=189.0
Q ss_pred hccceecccCceeEEEEEEe---CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 256 ASAEVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
...+.||+|+||.||+|... .+..||+|.+... ..+.+|++++++++|||||++++++......++||||+.
T Consensus 95 ~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 95 NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred EEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 34578999999999999743 4567889887532 245689999999999999999999999999999999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 -~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 170 -CDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred -CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 68999884322 489999999999999999999998 9999999999999999999999999998765432
Q ss_pred -----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc---cC--
Q 008431 412 -----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW---TG-- 481 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 481 (565)
....||+.|+|||++....++.++|||||||++|||++|+.||....... ....+...+ ..+.... ..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~-~~~~~~~~~~~~~~ 317 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSII-RCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHH-HHhccCccccCCcc
Confidence 13458899999999999999999999999999999999999986322110 000011111 0000000 00
Q ss_pred --c------cccccccCCCCC------HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 482 --E------VFDKDMRGTKSG------EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 482 --~------~~d~~~~~~~~~------~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. .+....+..... ......+.+++.+||..||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000000000 0112356778899999999999999999876
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.51 Aligned_cols=240 Identities=19% Similarity=0.278 Sum_probs=194.1
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
..||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4699999999999985 478899999987554555677899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----cc
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----HA 413 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~~ 413 (565)
+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 107 ~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 107 DIVSQT------RLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred HHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 987542 388999999999999999999998 9999999999999999999999999998654322 23
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||++.+..++.++|||||||++|||++|+.||... .....+... ..... +.....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~--------~~~~~~~~~-~~~~~-----~~~~~~-- 240 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD--------SPVQAMKRL-RDSPP-----PKLKNA-- 240 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHH-hccCC-----CCcccc--
Confidence 45788999999998888999999999999999999999998621 111111111 11100 000000
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+|++.+|++||++.|+++.
T Consensus 241 -~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 -HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112357788889999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.98 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=192.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|.. .++..+|+|.+... .......|..|+.++++++|||||+++++|... ...||||||+
T Consensus 17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 357899999999999995 45678889888642 233356789999999999999999999998654 4689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCC---CCCCccCCCCCCCEEEcC---------------
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP---GVTLPHGHLKSSNVLLDN--------------- 393 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~---~~~ivHrDlkp~NILl~~--------------- 393 (565)
++|+|.++|...... ...+++..++.|+.||+.||+|||+... ..+||||||||+|||++.
T Consensus 97 ~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 999999999753221 1248999999999999999999998521 125999999999999964
Q ss_pred --CCCcEEeccCCccccccc---ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcc
Q 008431 394 --AYEPLLTDYALVPIVNKE---HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANAD 466 (565)
Q Consensus 394 --~~~~kl~DfGla~~~~~~---~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~ 466 (565)
...+||+|||+++..... ....+|+.|+|||++.. ..++.++||||||||||||+||+.||... ..
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~-------~~ 248 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA-------NN 248 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC-------Cc
Confidence 334899999999765432 23468999999998754 45899999999999999999999999621 12
Q ss_pred hHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH--HHHHh
Q 008431 467 LATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE--KIMEL 529 (565)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i 529 (565)
...++... ... +.+... .....+.+++..||+.+|.+|||+.|++. .+..+
T Consensus 249 ~~qli~~l-k~~-------p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 249 FSQLISEL-KRG-------PDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHH-hcC-------CCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 22222221 111 111101 11236788999999999999999999984 44444
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.94 Aligned_cols=185 Identities=21% Similarity=0.254 Sum_probs=159.0
Q ss_pred hhccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 255 RASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+...+.||+|+||.||+|... ++..||+|.... .....|+.++++++||||+++++++...+..++||||+.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 345678999999999999964 567888887432 234569999999999999999999999999999999995
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++..... .++|..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 141 SDLYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred CcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 689998875433 489999999999999999999998 9999999999999999999999999998754322
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCc
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPA 454 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~ 454 (565)
....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2346789999999999999999999999999999999865554
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.87 Aligned_cols=187 Identities=18% Similarity=0.311 Sum_probs=160.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv 327 (565)
..+.||+|+||.||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.... ..|+|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 347899999999999984 468899999987432 233467889999999999999999999886432 46999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 999975 67776642 278899999999999999999998 999999999999999999999999999976
Q ss_pred cccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.... ....+|..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 5433 23467899999999988899999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=310.62 Aligned_cols=254 Identities=16% Similarity=0.226 Sum_probs=190.8
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||++ +
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 3468999999999999854 67899999987432 3334568899999999999999999999999999999999997 5
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 89 ~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 89 DLKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 99998875432 388999999999999999999998 9999999999999999999999999998754322
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc---ccCcccc-
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE---WTGEVFD- 485 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d- 485 (565)
....++..|+|||++.+ ..++.++|||||||++|||+||++||..... ......+....... ....+.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhhhcc
Confidence 23356788999998755 4578899999999999999999999963211 01111111111000 0000000
Q ss_pred --------ccccCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 486 --------KDMRGTK---SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 486 --------~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+...... ........+.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00011235778999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=307.50 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=189.5
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||.||+|.. .++..||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 46899999999999995 478899999986432 2234678899999999999999999999999999999999997 6
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 84 DLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 89988865432 13489999999999999999999998 9999999999999999999999999998754322
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-------cc---
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-------EW--- 479 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~--- 479 (565)
....+++.|+|||++.+ ..++.++|||||||++|||+||++||..... .......... .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE--------IDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHHhCCCChhhhhcc
Confidence 22345788999997754 4578999999999999999999999863111 0111000000 00
Q ss_pred ---------cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 ---------TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 ---------~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
............ ......++.+++.+||+.||++|||+.||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSA--VKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHh--cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 0011235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.02 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=187.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv 327 (565)
..+.||+|+||+||+|.. .++..||||++.... ....+.+.+|+.++++++||||+++++++... ...|++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 347899999999999984 578899999986432 22345678999999999999999999987543 346899
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+|++ +++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 99 TNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred eecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCcccee
Confidence 9998 78999887532 389999999999999999999998 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc--ccCcc
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE--WTGEV 483 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 483 (565)
.... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+.+....... ...+.
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND--------YIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred cCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHHhCCCCHHH
Confidence 6443 34567899999998766 568999999999999999999999986311 111111111000 00000
Q ss_pred -----------ccccccCCCCC------HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 484 -----------FDKDMRGTKSG------EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 484 -----------~d~~~~~~~~~------~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
....+...... ......+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0011246789999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.94 Aligned_cols=187 Identities=17% Similarity=0.320 Sum_probs=161.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv 327 (565)
..+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++... ...|+|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence 357899999999999994 46889999998643 223346788999999999999999999987543 347999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++ +|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 999975 77777642 278899999999999999999998 999999999999999999999999999976
Q ss_pred cccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.... ....+|..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 5443 23467899999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=302.14 Aligned_cols=243 Identities=21% Similarity=0.277 Sum_probs=194.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec-CceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-EEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~E~~~ 332 (565)
..+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|++++++++|||++++++.+... ...++||||++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence 457899999999999995 467889999986432 23456788999999999999999999987644 45789999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+++|.+++..... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 84 GGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred CCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999976432 2489999999999999999999998 9999999999999999999999999998765322
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....+++.|+|||+..+..++.++|||||||+++||++|+.||.. .+...+....... ... .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~--------~~~~~~~~~~~~~-~~~-----~~ 222 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA--------KDMNSLVYRIIEG-KLP-----PM 222 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhc-CCC-----CC
Confidence 233567889999999888899999999999999999999999862 2222332222211 110 11
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+......+.+++.+|++.+|++|||+.|+++.
T Consensus 223 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 -----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11222468889999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.42 Aligned_cols=192 Identities=21% Similarity=0.344 Sum_probs=157.9
Q ss_pred cceecccCceeEEEEEEe---CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E~~~ 332 (565)
..+||+|+||+||+|+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 45689999886432 23468899999999999999999999864 456799999987
Q ss_pred CCCHHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE----cCCCCcEEeccCC
Q 008431 333 NGSLANLLHVRRA----PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL----DNAYEPLLTDYAL 404 (565)
Q Consensus 333 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfGl 404 (565)
++|.+++..... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 488888753321 1122488999999999999999999998 99999999999999 5667899999999
Q ss_pred ccccccc-------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 008431 405 VPIVNKE-------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANY 456 (565)
Q Consensus 405 a~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~ 456 (565)
++..... ....+|+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9765432 22356889999998766 4589999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=305.71 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=191.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc---c-------CHHHHHHHHHHHhcCCCCCccceEEEEEecCceE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---V-------GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 325 (565)
..+.||+|+||.||+|.. .++..+|+|.++.... . ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 457899999999999984 4788999998853111 1 1246788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|++|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred EEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999997642 388999999999999999999998 8999999999999999999999999998
Q ss_pred cccccc------ccccccccccCCCccCCCC--CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 406 PIVNKE------HAQLHMVAYKSPEFNQTDG--VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 406 ~~~~~~------~~~~~t~~y~aPE~~~~~~--~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
+..... ....++..|+|||+..... ++.++|||||||++||+++|+.||.... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~ 227 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--------AIAAMFKLGNK 227 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--------hHHHHHHhhcc
Confidence 764322 1234678899999876654 8899999999999999999999986211 11111111111
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ....+++... ......+.+++.+||+.+|++|||+.||++.
T Consensus 228 ~-~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 R-SAPPIPPDVS-----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-cCCcCCcccc-----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 1111111110 1123478888999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.06 Aligned_cols=189 Identities=22% Similarity=0.272 Sum_probs=155.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCC------CCccceEEEEEec-CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH------PNLLPLIAFYYRK-EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~~~-~~~~lv~ 328 (565)
..++||+|+||+||+|.. .+++.||||+++... ....++..|++++++++| ++++++++++... ...|+||
T Consensus 133 i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~ 211 (467)
T PTZ00284 133 ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM 211 (467)
T ss_pred EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence 457899999999999995 467889999986432 223455667777776654 4588899988764 4688999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-------------
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY------------- 395 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~------------- 395 (565)
|++ +++|.+++.... .+++..+..|+.||+.||+|||+++ +||||||||+|||++.++
T Consensus 212 ~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 212 PKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred ecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCC
Confidence 988 678999887543 3899999999999999999999732 899999999999998765
Q ss_pred ---CcEEeccCCccccccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 396 ---EPLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 396 ---~~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.+||+|||.+...... ....+|+.|+|||++.+..|+.++|||||||++|||+||+.||.
T Consensus 283 ~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred CCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999987654322 34578999999999999999999999999999999999999996
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.55 Aligned_cols=240 Identities=20% Similarity=0.290 Sum_probs=193.2
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
..||+|+||.||++.. .++..||||++........+.+.+|+..++.++||||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5699999999999985 468899999987544445667899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----cc
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----HA 413 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~~ 413 (565)
+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 108 ~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 108 DIVTHT------RMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 988532 388999999999999999999998 9999999999999999999999999998654322 23
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||+.....++.++|||||||++|||++|+.||.... ....+.. .... +.+......
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~-~~~~-----~~~~~~~~~- 242 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--------PLQAMRR-IRDN-----LPPRVKDSH- 242 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHhc-----CCCcccccc-
Confidence 457789999999888889999999999999999999999986211 1111111 1111 111111111
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....+.+++.+|+..||++|||+.|+++.
T Consensus 243 --~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 --KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112356778889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=304.51 Aligned_cols=240 Identities=22% Similarity=0.306 Sum_probs=194.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 346799999999999995 468899999886432 233567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 88 ~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 88 SALDLLRAG------PFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 999998642 378889999999999999999998 9999999999999999999999999998665432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....++..|+|||++.+..++.++|||||||++|||+||+.||..... ...... ..... .+.
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~~-~~~~~-----~~~--- 220 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--------MRVLFL-IPKNN-----PPT--- 220 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--------HhHhhh-hhcCC-----CCC---
Confidence 223467789999999888899999999999999999999999863211 111110 00100 011
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
........+.+++.+||+.+|++||++.|+++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 --LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112344578899999999999999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=304.69 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=194.7
Q ss_pred cceecccCceeEEEEEEe------CCCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
.+.||+|+||.||+|+.. +...+++|.+...... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 467999999999999954 2457888887654332 356799999999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 331 VPNGSLANLLHVRRAPG----QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+++|+|.+++....... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||+++
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999997654211 12489999999999999999999998 89999999999999999999999999986
Q ss_pred ccccc-----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 407 IVNKE-----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 407 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
..... ....++..|+|||.+....++.++|||||||++|||++ |..||.... ....+... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--------~~~~~~~~-~~~~~ 236 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------DEEVLNRL-QAGKL 236 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------hHHHHHHH-HcCCc
Confidence 54221 22345677999999888888999999999999999999 888885321 11112111 11111
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
.... .......+.+++.+||+.+|++|||+.|+++.|.
T Consensus 237 ~~~~---------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELPV---------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 0112236888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=309.14 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=193.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|.. .+++.||+|++..... ....++.+|+.+++.++||||++++++|.+.+..++||||++
T Consensus 19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 346899999999999995 4788999999864322 223568899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
|++.+++..... .+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++.......
T Consensus 99 -g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 99 -GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred -CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 578777754332 389999999999999999999998 99999999999999999999999999998776655
Q ss_pred cccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 AQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||++. ...++.++|||||||++|||+||+.||... ............. . +.+.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~--------~~~~~~~~~~~~~-~-----~~~~ 235 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQND-S-----PTLS 235 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc--------cHHHHHHHHhcCC-C-----CCCC
Confidence 667788999999864 456889999999999999999999998621 1111111111110 0 1110
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
.......+.+++.+||+.+|++||++.+|+...
T Consensus 236 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 236 ----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 112234688899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=305.09 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=194.8
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||.|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++.+....++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 46799999999999995 468899999987432 3334678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||+++.....
T Consensus 86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 86 CLDLLKPG------KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99998753 389999999999999999999998 8999999999999999999999999998776433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....++..|+|||+..+..++.++|||||||++|||+||+.||.... ....... ...... +.+...
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--------~~~~~~~-~~~~~~-----~~~~~~ 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--------PMRVLFL-IPKNNP-----PSLEGN 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--------hHHHHHH-hhhcCC-----CCCccc
Confidence 23456788999999988889999999999999999999999986321 1111111 111111 111111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....+.+++.+||..+|++|||++++++.
T Consensus 222 ----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 ----KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 022367788899999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=320.60 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=202.7
Q ss_pred ccceecccCceeEEEEEEe--CC--CeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL--TG--PAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..++||+|.||+|++|.|. .| ..||||.++..... ...+|++|+.+|-+|+|||+|+|||...+ ....+|||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3478999999999999965 33 36899999865443 67899999999999999999999999887 7788999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
+.|+|.+.|+.... ..|.-...-.++.|||.||.||..+ ++|||||..+|+|+.....+||+|||+.+.+...
T Consensus 193 plGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred ccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999987222 2477788889999999999999998 9999999999999999999999999999887654
Q ss_pred cccc-------ccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 HAQL-------HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ~~~~-------~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
.... -...|.|||.+....++.++|||+|||++|||+| |+.||... .-.+.++ .
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--------~g~qIL~----------~ 327 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--------RGIQILK----------N 327 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--------CHHHHHH----------h
Confidence 3322 1357999999999999999999999999999999 88898621 1122221 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+|.. .....+..+.+++.++++.||..+|++|||...+.+.+-......
T Consensus 328 iD~~-erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp 376 (1039)
T KOG0199|consen 328 IDAG-ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP 376 (1039)
T ss_pred cccc-ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence 2211 112234566778999999999999999999999986665555443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.93 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=197.2
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhc--CCCCCccceEEEEEecC----ceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGS--LSHPNLLPLIAFYYRKE----EKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~E~~ 331 (565)
.++||+|+||.||||.+ +++.||||++.. ..+..|..|-++.+. ++|+||++++++-.... +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 46799999999999998 459999999964 346678877777654 68999999999876555 789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCC-----CCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP-----GVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+.|+|.+||..+ .++|....+|+.-+++||+|||+..+ .++|+|||||++|||+..|+++.|+|||+|.
T Consensus 291 ~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 291 PKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred cCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999864 39999999999999999999998643 3579999999999999999999999999998
Q ss_pred ccccc------ccccccccccCCCccCCCC-CC-----cchhHHHHHHHHHHHHcCCCCcc--------cccc-CCCCCc
Q 008431 407 IVNKE------HAQLHMVAYKSPEFNQTDG-VT-----RKTDVWSLGILILELLTGKFPAN--------YLAQ-GKGANA 465 (565)
Q Consensus 407 ~~~~~------~~~~~t~~y~aPE~~~~~~-~~-----~~~DvwS~Gvil~el~tg~~p~~--------~~~~-~~~~~~ 465 (565)
.+... ...+||.+|||||++.+.. +. .+.||||+|.|||||+++-.-++ .... .-+...
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 76543 3468999999999987642 11 36899999999999998643331 0000 001111
Q ss_pred chHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
. .+-++..+-....+..+...+. ....+..+.+.+..||+.||+.|-|+.-|-+++.++....
T Consensus 445 t-~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 T-LEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred C-HHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1 2222222222111111111111 1234567888999999999999999999999999987654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=301.77 Aligned_cols=243 Identities=20% Similarity=0.302 Sum_probs=197.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||++.. .+++.||+|.+... .....+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 357899999999999994 57889999998642 233456799999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 84 ~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 84 GDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999875432 2378999999999999999999998 99999999999999999999999999987654321
Q ss_pred ---cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 ---AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ---~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||+..+..++.++|||||||+++||+||+.||.. ......+........ . ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~--------~~~~~~~~~~~~~~~-~-----~~- 221 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--------GNMKNLVLKIIRGSY-P-----PV- 221 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC--------CCHHHHHHHHhcCCC-C-----CC-
Confidence 23467889999999888899999999999999999999999862 222233322222211 0 00
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+......+.+++.+||+.+|++||+|.||++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11223468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=304.16 Aligned_cols=249 Identities=20% Similarity=0.324 Sum_probs=193.1
Q ss_pred cceecccCceeEEEEEEe----CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceE
Q 008431 258 AEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKL 325 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~ 325 (565)
.++||+|+||.||+|.+. ++..||+|.+.... ....+++.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 467999999999999853 46789999986432 233567899999999999999999999886542 247
Q ss_pred EEEeccCCCCHHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 326 LVSDFVPNGSLANLLHVRRAP-GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
+++||+++|+|.+++...... ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECcccc
Confidence 899999999999887643221 122478999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++...... ...++..|++||.+....++.++|||||||++|||++ |++||.... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~ 231 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--------NSEIYNYLIKG 231 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--------HHHHHHHHHcC
Confidence 87653221 2233467999999888889999999999999999999 889886211 11111111111
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
... . ........+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 232 ~~~--------~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL--------K---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC--------C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 0 0012234788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=303.70 Aligned_cols=248 Identities=20% Similarity=0.305 Sum_probs=193.8
Q ss_pred cceecccCceeEEEEEEeC--CCeeEEEEeeccC----------ccCHHHHHHHHHHHhc-CCCCCccceEEEEEecCce
Q 008431 258 AEVLGSGSFGSSYKAVLLT--GPAMVVKRFRQMS----------NVGKEDFHEHMTRLGS-LSHPNLLPLIAFYYRKEEK 324 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~ 324 (565)
.+.||+|+||.||+|.... +..+|+|.+.... .....++.+|+.++.+ ++||||+++++++...+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999999654 6789999875321 1123457788888865 7999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.. +++||||||+||+++.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999988643221 124889999999999999999999631 799999999999999999999999999
Q ss_pred ccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 405 VPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 405 a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
+...... ....++..|+|||+..+..++.++|||||||++|||++|+.||.. .............. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~--------~~~~~~~~~~~~~~-~- 230 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS--------TNMLSLATKIVEAV-Y- 230 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc--------cCHHHHHHHHhhcc-C-
Confidence 8765433 234567889999999888899999999999999999999999862 12222222221111 1
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
.+... ......+.+++.+||+.||++||++.||..++.
T Consensus 231 ---~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 ---EPLPE-----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---CcCCc-----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01000 011236788888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.48 Aligned_cols=246 Identities=17% Similarity=0.183 Sum_probs=188.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||+||+++.. +++.+|+|.+.+.. ......+.+|+.++..++|+||+++++++.+.+..|+||||++
T Consensus 5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence 3478999999999999954 57789999986421 2233458889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 85 GGDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred CCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999976432 389999999999999999999998 9999999999999999999999999998654322
Q ss_pred ----ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 412 ----HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.. .+..+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~--------~~~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHKERFQ 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC--------CCHHHHHHHHhCCCcccc
Confidence 1246889999999875 34688999999999999999999999962 223333333322211000
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhcccc--CcCCCCCHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEW--NAERRWDLREAVEK 525 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~--~P~~RPs~~evl~~ 525 (565)
+.... ......+.+++.+|+.. ++..||++.|+++.
T Consensus 229 -~p~~~------~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -FPAQV------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CCCcc------ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111 11123456666676654 44447899998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.38 Aligned_cols=242 Identities=21% Similarity=0.344 Sum_probs=194.6
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEee--c--cCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc--eEEEEec
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFR--Q--MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE--KLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~E~ 330 (565)
..+||+|+|-+||||.. .+|..||--.++ . ......++|..|+.+|+.|+|||||+++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 46799999999999994 467788754433 2 223445789999999999999999999999987655 7799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVN 409 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~ 409 (565)
|..|+|+.|++..+. .+......+++||++||.|||++.| +|||||||.+||+|+. .|.+||+|+|||+...
T Consensus 125 ~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~P--PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQDP--PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCCC--CccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999998765 7788999999999999999999855 7999999999999975 5899999999999887
Q ss_pred ccc--cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 410 KEH--AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 410 ~~~--~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
... ..+|||.|||||++. ..|+..+||||||+.++||+|+..||... .+.++..++....-.+ ..
T Consensus 198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-------~n~AQIYKKV~SGiKP-----~s 264 (632)
T KOG0584|consen 198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-------TNPAQIYKKVTSGIKP-----AA 264 (632)
T ss_pred ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-------CCHHHHHHHHHcCCCH-----HH
Confidence 653 458999999999887 77999999999999999999999999743 3334433333322111 11
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+.... -..+.+++.+|+.. .++|||+.|+++.
T Consensus 265 l~kV~-----dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 LSKVK-----DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhccC-----CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11111 12577888899999 9999999998653
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.80 Aligned_cols=246 Identities=27% Similarity=0.394 Sum_probs=193.2
Q ss_pred ccceecccCceeEEEEEEeC-CCeeEEEEeeccCccCH--HHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLT-GPAMVVKRFRQMSNVGK--EDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||++.... ++.+|+|.+........ ....+|+..+++++||||+++++++.+....++||||+++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 34789999999999999654 55899999986543222 2345699999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc----c
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV----N 409 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~----~ 409 (565)
++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+... .
T Consensus 83 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 83 GSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccc-----cccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc
Confidence 99999998333 389999999999999999999998 9999999999999999999999999998642 1
Q ss_pred ccccccccccccCCCccC-CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 410 KEHAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 410 ~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
......++..|+|||+.. ...++.++||||+|+++|+|++|+.||.... ..+............ . ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~----~-~~~~ 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRP----L-PSSS 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTH----H-HHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhccccc----c-cccc
Confidence 223456788999999988 7889999999999999999999999987320 001111111111110 0 0000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. .......+.+++.+||+.||++|||+.++++
T Consensus 224 ~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011257889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.42 Aligned_cols=246 Identities=20% Similarity=0.201 Sum_probs=189.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+++.. +++.||+|.+.... ......+.+|+.++..++|+||+++++++.+.+..|+||||++
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 3578999999999999954 67889999986421 2234458889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
+|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 85 GGDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999976432 388999999999999999999998 99999999999999999999999999987654321
Q ss_pred -----cccccccccCCCccCC-----CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 413 -----AQLHMVAYKSPEFNQT-----DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 413 -----~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+................
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~--------~~~~~~~~~i~~~~~~~~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHEERFQ 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC--------CCHHHHHHHHHcCCCccc
Confidence 2458899999998765 4678999999999999999999999962 122222222222110000
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAER--RWDLREAVEK 525 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 525 (565)
+.+.+ ......+.+++.+|+..++++ |++++++++.
T Consensus 229 -~p~~~------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 -FPSHI------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -CCCcc------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111 111235667777888765544 4688888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=308.52 Aligned_cols=245 Identities=18% Similarity=0.220 Sum_probs=193.5
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 47899999999999995 467899999987542 22345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 86 GDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999997543 388999999999999999999998 9999999999999999999999999998642100
Q ss_pred -----------------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHH
Q 008431 412 -----------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSV 474 (565)
Q Consensus 412 -----------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 474 (565)
....++..|+|||++....++.++|||||||++|||++|+.||.. ....++....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~--------~~~~~~~~~~ 228 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG--------DTPEELFGQV 228 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHH
Confidence 112456789999998888899999999999999999999999862 1222223222
Q ss_pred hhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 475 VREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 475 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
.... ...+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 229 ~~~~----~~~~~~~~-----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDD----IEWPEGDE-----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhcc----cCCCCccc-----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 2211 11111100 122357889999999999999997666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=307.41 Aligned_cols=240 Identities=19% Similarity=0.289 Sum_probs=202.4
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|.|.+|-+|+ .-+|..||||++.+. +......+.+|++.|+-++|||||+||++......+|||+|.-++
T Consensus 22 LekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~ 101 (864)
T KOG4717|consen 22 LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDG 101 (864)
T ss_pred hhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCC
Confidence 34679999999999998 569999999999753 344456899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE-cCCCCcEEeccCCccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL-DNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl-~~~~~~kl~DfGla~~~~~~- 411 (565)
|+|++|+-.+.. ++.+..+.+++.||..|+.|+|+. .+|||||||+||.+ ..-|-+|+.|||++..+.+.
T Consensus 102 GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 102 GDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred chHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999987654 499999999999999999999998 89999999999976 56788999999998766554
Q ss_pred --ccccccccccCCCccCCCCCC-cchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVT-RKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+.+|+..|-|||++.+..|+ +++||||+|||||-|+.|++||....+.+ ....++|-..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------------TLTmImDCKY 236 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------------TLTMIMDCKY 236 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------------hhhhhhcccc
Confidence 467899999999999999886 68999999999999999999997432211 1222333222
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. .+.....++.+++..||..||.+|.|.+||+.
T Consensus 237 t---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 T---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c---CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1 23455668889999999999999999999875
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.78 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=191.5
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
...||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 467999999999999965 68899999986432 223456889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
.|..++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 86 VLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred HHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 8888765322 389999999999999999999998 99999999999999999999999999987664432
Q ss_pred --cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh------------
Q 008431 413 --AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE------------ 477 (565)
Q Consensus 413 --~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 477 (565)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChHHhhhcccc
Confidence 3346788999998765 5678999999999999999999999963211 0000011110000
Q ss_pred cccCccccccccCCCCC----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSG----EGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+......+........ ......+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000110000000 011246788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=302.43 Aligned_cols=240 Identities=21% Similarity=0.306 Sum_probs=186.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc-----cCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN-----VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 328 (565)
..+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+.++++++||||+++++++... ...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 357899999999999985 5688999998863211 2234688999999999999999999988753 5678999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++++|.+++.... .+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 86 EYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999997543 388999999999999999999988 8999999999999999999999999998754
Q ss_pred ccc-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 409 NKE-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 409 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||... .....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~--------~~~~~~~~~~~~~--- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY--------EAMAAIFKIATQP--- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc--------chHHHHHHHhcCC---
Confidence 321 1234678899999998888999999999999999999999998632 1111111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+.+. ......+.+++ +||..+|++||||+||++
T Consensus 226 --~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --TNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111111 11112344444 788899999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.04 Aligned_cols=240 Identities=20% Similarity=0.285 Sum_probs=195.0
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+.||+|++|.||++.. .++..+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 36899999999999995 57889999998754444556789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++...... .
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 104 TDIVTHT------RMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9998752 388999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
...++..|+|||...+..++.++|||||||++|||++|+.||.. ............. .. +.+...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~--------~~~~~~~~~~~~~-~~-----~~~~~~- 238 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN--------EPPLQAMKRIRDN-LP-----PKLKNL- 238 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC--------CCHHHHHHHHHhc-CC-----CCCccc-
Confidence 34578899999998888899999999999999999999999862 1122222222111 11 111110
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.+|++|||+.|+++
T Consensus 239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 112236888999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.05 Aligned_cols=240 Identities=25% Similarity=0.354 Sum_probs=192.9
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccC-----ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-----NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 468999999999999965 78999999986432 123457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 85 PGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999997543 388999999999999999999998 9999999999999999999999999998765332
Q ss_pred ---ccccccccccCCCccCCCC-CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDG-VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....++..|+|||.+.... ++.++|+|||||++|||++|+.||.... ............... .
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~-----~ 222 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELP-----P 222 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCC-----C
Confidence 2345678899999887666 8999999999999999999999986321 111111111101010 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+ +......+.+++.+||+.+|++|||+.|++.
T Consensus 223 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 I-----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred c-----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 0112246778889999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=305.38 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=188.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEe-----cCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYR-----KEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~~~~~lv~E 329 (565)
..+.||+|+||.||++.. .+++.+|+|.+... .....++.+|+.+++++ +||||+++++++.. .+..++|||
T Consensus 22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 346899999999999985 46788999987643 22346788999999999 69999999998853 346899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 101 LCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred ecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 99999999988643221 22488999999999999999999998 99999999999999999999999999987654
Q ss_pred cc----ccccccccccCCCccCC-----CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 410 KE----HAQLHMVAYKSPEFNQT-----DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 410 ~~----~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
.. ....++..|+|||++.. ..++.++|||||||++|||++|+.||..... ..... ... ....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-------~~~~~-~~~-~~~~ 246 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------MRALF-KIP-RNPP 246 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-------hHHHh-hcc-ccCC
Confidence 32 23457889999998743 4578999999999999999999999863211 11110 000 0000
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
....++ ......+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 247 PTLHQP--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CcccCC--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 011111 1112368889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.49 Aligned_cols=243 Identities=20% Similarity=0.317 Sum_probs=195.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||++.. .++..+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 357899999999999984 57889999998643 233456799999999999999999999999989999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-CCcEEeccCCccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-YEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~- 411 (565)
++|.+++..... ..+++..+..++.+++.||.|||+. +++||||||+||+++.+ +.+|++|||++......
T Consensus 84 ~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 84 GTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999976432 2489999999999999999999998 99999999999999854 46899999998765433
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....++..|+|||......++.++|||||||++|+|++|+.||.. .+....+....... .... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~-----~ 222 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA--------ANLPALVLKIMSGT-FAPI-----S 222 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc--------CchHHHHHHHHhcC-CCCC-----C
Confidence 234567889999999888899999999999999999999999862 12222222222111 1111 0
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+||+.+|++|||+.|+++.
T Consensus 223 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 -----DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122367889999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.43 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=197.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+++. .++..+|+|++..... .....+.+|++++++++|||++++++++.+.+..++||||++
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 346899999999999995 4688999999864322 223578899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
|+|.+++..... .++|..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.......
T Consensus 109 -g~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 109 -GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred -CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 588887764432 389999999999999999999998 99999999999999999999999999988766656
Q ss_pred cccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 AQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||++. ...++.++|||||||++|||++|+.||... .............. +..
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~~------~~~- 244 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNES------PTL- 244 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhccC------CCC-
Confidence 667888999999863 456889999999999999999999998521 11111111111110 000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
........+.+++.+|++.+|.+||++.|+++.+-......
T Consensus 245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 01122245788899999999999999999998766554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.72 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=195.4
Q ss_pred cceecccCceeEEEEEEeC-----CCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLLT-----GPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.+.||.|+||.||+++... +..||+|.+...... ..+.+.+|+..++.++|+||+++++++.+.+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4689999999999999643 378999998754332 4668999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++++|.+++...... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||+++.....
T Consensus 84 ~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 84 EGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred CCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999754321 289999999999999999999998 9999999999999999999999999998765433
Q ss_pred c-----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 H-----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ~-----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
. ...++..|+|||......++.++||||+||+++||++ |++||.. .............. ...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~~~~~-~~~--- 224 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG--------MSNEEVLEYLKKGY-RLP--- 224 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHhcCC-CCC---
Confidence 1 1225678999999888889999999999999999998 8888762 12222222221111 100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
. .......+.+++.+|+..+|++|||+.|+++.|
T Consensus 225 --~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --K-----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --C-----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 011234688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.62 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=193.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||++... ++..||+|.++.. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 3468999999999999964 7899999988643 2233467899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--c
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--H 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--~ 412 (565)
+|..++..... ...+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++...... .
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 85 SLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred CHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 99999875321 124899999999999999999999632 7999999999999999999999999998765332 2
Q ss_pred cccccccccCCCccCCC------CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 413 AQLHMVAYKSPEFNQTD------GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~------~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
...++..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.... .... +
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~-~~~~-----~ 228 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIV-DGDP-----P 228 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHh-hcCC-----C
Confidence 34567889999987543 358899999999999999999999963110 11111111111 1100 1
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+ +......+.+++.+|++.+|++||++.+++..
T Consensus 229 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 TL-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CC-----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11 11233467889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.95 Aligned_cols=244 Identities=22% Similarity=0.290 Sum_probs=194.2
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~~ 332 (565)
.+.||.|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++... ...+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 46799999999999984 57789999988643 233356788999999999999999999988643 45799999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY-----KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH-----~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+++|.+++...... ...+++..++.++.|++.||.||| +. +++||||||+||+++.++.+|++|||++..
T Consensus 85 ~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 85 GGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred CCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999764321 234899999999999999999999 55 899999999999999999999999999887
Q ss_pred ccccc----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 408 VNKEH----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 408 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
..... ...++..|+|||++....++.++||||||+++|+|++|+.||... +...+... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~-~~~~~~--- 227 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR--------NQLQLASK-IKEGKF--- 227 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc--------CHHHHHHH-HhcCCC---
Confidence 65432 345788999999998888999999999999999999999998631 11122211 111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+.+. ......+.+++.+|++.+|++|||+.||++.
T Consensus 228 --~~~~-----~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 --RRIP-----YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCCc-----cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 1223478889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.36 Aligned_cols=254 Identities=20% Similarity=0.225 Sum_probs=191.1
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCcc-----CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNV-----GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.+.||+|+||.||+|.. .+++.||+|+++..... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 46799999999999995 46899999999754322 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
+|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 899999997543 1489999999999999999999998 9999999999999999999999999998765432
Q ss_pred ----ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh----cc---
Q 008431 412 ----HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE----EW--- 479 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~--- 479 (565)
....++..|+|||.+.+ ..++.++|||||||++|||++|.+||..... ............. .+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-----IDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-----HHHHHHHHHHcCCCchhhhhhc
Confidence 22345678999998754 4678999999999999999999887752111 0000001000000 00
Q ss_pred --cCccccccccCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 --TGEVFDKDMRGTK----SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 --~~~~~d~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
............. ........+.+++.+||++||++|||+.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 001223568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=299.53 Aligned_cols=240 Identities=20% Similarity=0.261 Sum_probs=187.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--c---cCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--N---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 328 (565)
..+.||+|+||.||+|.. .++..||+|.+.... . ...+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 357899999999999995 568999999886321 1 1235688899999999999999999988764 4578999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 86 EHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 9999999999987543 278888999999999999999998 8999999999999999999999999998754
Q ss_pred cc-------cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 409 NK-------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 409 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
.. .....++..|+|||++.+..++.++|||||||++|||++|+.||.... .. .-........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~-~~~~~~~~~~--- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AM-AAIFKIATQP--- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hH-HHHHHHhcCC---
Confidence 32 122357788999999888889999999999999999999999986211 11 1111111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+.. +......+.+++.+|+. +|++||+++|+++
T Consensus 226 --~~~~~-----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVL-----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCCC-----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01111 12223456777788885 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=306.45 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=194.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||++.. .++..||+|.+........+.+.+|+.++++++||||+++++++...+..|+|+||+++|+
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 346899999999999984 4788999999875444556789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 103 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 99998642 378999999999999999999998 9999999999999999999999999987654332
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....+++.|+|||+.....++.++|||||||++||+++|+.||...... ..+........ +..
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--------~~~~~~~~~~~------~~~--- 235 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGT------PEL--- 235 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------hheeehhcCCC------CCC---
Confidence 2235678899999988888999999999999999999999999632111 00000000000 000
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.........+.+++.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223467789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.30 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=194.6
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~~~ 333 (565)
.+.||.|++|.||++.. .+++.+|+|.+..... ....++.+|++++++++||||++++++|... +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 46899999999999996 4678899998874322 3356799999999999999999999998654 368999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 86 ~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 86 GSLDSIYKKVKKR-GGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 9999987643321 23488899999999999999999998 9999999999999999999999999998654332
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....++..|+|||.+.+..++.++|||||||++|||++|+.||....... ....+......... .... ......
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~-~~~~-~~~~~~- 234 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMP-NPEL-KDEPGN- 234 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHHHhcCC-chhh-ccCCCC-
Confidence 23346778999999988899999999999999999999999987432110 11112211111100 0000 000000
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+.+++.+||+.+|++|||+.|+++.
T Consensus 235 --~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 235 --GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred --CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 01123467899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=300.54 Aligned_cols=240 Identities=23% Similarity=0.330 Sum_probs=193.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred hheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 346799999999999985 478899999876432 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||++......
T Consensus 88 ~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 88 SALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 999998632 388999999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....++..|+|||+..+..++.++|||||||++|||++|..||.... ...+... ...... +.+.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~-----~~~~- 222 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFL-IPKNNP-----PTLE- 222 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHH-HhcCCC-----CCCC-
Confidence 22356788999999888888999999999999999999999986311 1111111 111100 1111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+|++.+|++||++.++++.
T Consensus 223 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 ----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122467788999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=302.87 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=189.3
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEec-----CceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRK-----EEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-----~~~~lv~E~ 330 (565)
.+.||+|+||.||++.. .+++.+|+|.+... ....+.+.+|+.+++++ +|||++++++++... +..++||||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 46899999999999995 57889999988643 22346788899999998 799999999998754 357999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.++++..... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 106 ~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 106 CNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred CCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 9999999998753221 12489999999999999999999998 999999999999999999999999999876542
Q ss_pred c----ccccccccccCCCccCCC-----CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 411 E----HAQLHMVAYKSPEFNQTD-----GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 411 ~----~~~~~t~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
. ....++..|+|||++... .++.++|||||||++|||++|+.||..... ..-+.... .....
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--------~~~~~~~~-~~~~~ 251 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--------VKTLFKIP-RNPPP 251 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--------HHHHHHHh-cCCCC
Confidence 2 234567889999987543 368999999999999999999999863211 11111111 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+.+ .......+.+++.+|++.+|++||++.|+++.
T Consensus 252 ~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 TLLH--------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCc--------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 11223468889999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.03 Aligned_cols=251 Identities=21% Similarity=0.243 Sum_probs=189.0
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||.||+|.. .+|..+|+|.++... ......+.+|++++++++||||+++++++.+.+..++|+||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 46799999999999995 478899999986432 2223567889999999999999999999999999999999997 5
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 84 DLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 88888765332 389999999999999999999998 9999999999999999999999999998765332
Q ss_pred -ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-------c--c
Q 008431 412 -HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-------W--T 480 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~--~ 480 (565)
....++..|+|||++.+. .++.++|||||||++|||+||..|+.... +............ + .
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC-------CHHHHHHHHHHHhCCCChHHhHHh
Confidence 223567889999987664 47899999999999999999998864211 1111111111000 0 0
Q ss_pred Ccccc----ccccCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 GEVFD----KDMRGTK----SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 ~~~~d----~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....+ +...... ........+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 0000000 00112346778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=298.84 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=195.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||.|+||+||+|.. .++..+|+|++.... ......+.+|+..++.++|+||+++++.+...+..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 356899999999999994 467889999886432 234567999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999976432 12489999999999999999999998 99999999999999999999999999986654322
Q ss_pred ------cccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 413 ------AQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 413 ------~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
...++..|+|||++... .++.++|||||||++|||++|+.||..... ........... .
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~------~ 224 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--------MKVLMLTLQND------P 224 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--------hhhHHHHhcCC------C
Confidence 22467889999987766 789999999999999999999999863211 11111111111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+.+............+.+++.+|++.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111000122346788999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=306.82 Aligned_cols=251 Identities=19% Similarity=0.249 Sum_probs=187.3
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..|+||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 46899999999999984 578899999986433 2233467899999999999999999999999999999999996 68
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 89 LAQYMIQHPG----GLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 8777654322 378888999999999999999998 9999999999999999999999999998754322
Q ss_pred ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh--------------
Q 008431 412 HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR-------------- 476 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------- 476 (565)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||..... ..+.+.....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD-------VFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh-------HHHHHHHHHHHcCCCChhhhhhhh
Confidence 22346788999998765 3578899999999999999999999963221 1111111000
Q ss_pred --hcccCccccc----cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 477 --EEWTGEVFDK----DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 477 --~~~~~~~~d~----~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.......... .+............+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 00000000011246778889999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.28 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=209.7
Q ss_pred hHHHhhccceecccCceeEEEEEE-eCC----CeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCce
Q 008431 251 NDLLRASAEVLGSGSFGSSYKAVL-LTG----PAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEK 324 (565)
Q Consensus 251 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 324 (565)
+|......++||+|+||+||||.+ +.| .+||+|++.... .....++++|+-+|.+++|||+++++|+|.... .
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 344444568999999999999984 344 378999887543 344678999999999999999999999997766 8
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
.||++||+.|+|.++++..+.. +.....+.+..|||+||.|||.+ +++||||..+|||+..-..+||.|||+
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~----igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgl 844 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDN----IGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGL 844 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhcc----ccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecch
Confidence 8999999999999999987653 88889999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccc------cccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKEHAQLH------MVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~~~~~~------t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++.+..+..... .+.|||-|.+....|+.++|||||||++||++| |..|++.. ..+.+...++.
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi---------~~~eI~dlle~ 915 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI---------PAEEIPDLLEK 915 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC---------CHHHhhHHHhc
Confidence 998876543322 357999999999999999999999999999999 99998732 22334444444
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+.. ...++.+..++..++.+||..|++.||+++++...+.++....
T Consensus 916 geR----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 916 GER----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccc----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 311 1223445567888899999999999999999999988876543
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=305.63 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=190.8
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 3478999999999999965 688999998764322 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
++|..+..... .++|..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 85 ~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 85 TVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99988765322 389999999999999999999998 89999999999999999999999999987653321
Q ss_pred ---cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHH--hh----------
Q 008431 413 ---AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSV--VR---------- 476 (565)
Q Consensus 413 ---~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~---------- 476 (565)
...++..|+|||+..+ ..++.++|||||||++|||++|++||.... ....+.... ..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS-------DIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc-------hHHHHHHHHHHhCCCchhhHHHh
Confidence 2346788999998765 457889999999999999999999985211 111111000 00
Q ss_pred -hc-ccCccccccccCCCC----CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 477 -EE-WTGEVFDKDMRGTKS----GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 477 -~~-~~~~~~d~~~~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. .......+....... .......+.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 000000111000000 0112346888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=299.42 Aligned_cols=243 Identities=23% Similarity=0.384 Sum_probs=192.7
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCc------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSN------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
.+.||+|+||.||++. ..++..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 4689999999999998 46789999999864321 1245789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVN 409 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~ 409 (565)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||.+....
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999997543 388999999999999999999998 999999999999998775 59999999987654
Q ss_pred cc--------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 410 KE--------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 410 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
.. ....++..|+|||++....++.++||||+||++|||++|+.||..... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~--- 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASAT--- 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhccC---
Confidence 32 123467889999998888899999999999999999999999862211 11111111111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+.. +......+.+++.+|++.+|++|||+.|+++
T Consensus 228 --~~~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 --TAPSI-----PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCC-----chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111 1223356888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.40 Aligned_cols=252 Identities=19% Similarity=0.296 Sum_probs=189.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 3468999999999999954 68899999987432 22234678899999999999999999999999999999999984
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 88 DLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99998875432 488999999999999999999998 9999999999999999999999999998654321
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh---hc----cc--
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR---EE----WT-- 480 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~----~~-- 480 (565)
....++..|+|||+..+ ..++.++|||||||++|||++|+.||..... ..+.+..... .. +.
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD-------VEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc-------HHHHHHHHHHhcCCCChhhhhhh
Confidence 12345778999998765 4588999999999999999999999863210 1111111100 00 00
Q ss_pred ------Cc----cc-cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 ------GE----VF-DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 ------~~----~~-d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. .. ...+............+.+++.+|++++|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00 0000000000011246778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.13 Aligned_cols=243 Identities=21% Similarity=0.278 Sum_probs=195.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|.. .+|..+|+|.+... .....+.+.+|+++++.++|+||+++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 346899999999999995 46888999998643 223456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCcccccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNKEH 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 412 (565)
++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+|++|||.+.......
T Consensus 84 ~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 84 GDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999975432 2479999999999999999999998 899999999999998875 46999999987654332
Q ss_pred ----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 413 ----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 413 ----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
...+++.|+|||+.....++.++|||||||++|||++|+.||.. ....+++....... . .+..
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~-~----~~~~ 223 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG--------NNLHQLVLKICQGY-F----APIS 223 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHhccc-C----CCCC
Confidence 23467889999998888899999999999999999999999862 22333333322211 1 1100
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 224 ------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 ------PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112368888999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=301.30 Aligned_cols=255 Identities=18% Similarity=0.251 Sum_probs=193.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|.. .+|..||+|++.... ....+.+.+|+.++++++||||+++++++......++||||+ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence 346899999999999995 478999999987543 333567999999999999999999999999999999999999 9
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.......
T Consensus 83 ~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 83 SDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999999875442 489999999999999999999998 99999999999999999999999999987654332
Q ss_pred ----cccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc----c----
Q 008431 413 ----AQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE----W---- 479 (565)
Q Consensus 413 ----~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~---- 479 (565)
...++..|+|||++.+. .++.++||||+||++|||+||++||..... .....++....... +
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-----IEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-----HHHHHHHHHHcCCCChHHHhhcc
Confidence 34567889999987654 468999999999999999999888752111 11111111111000 0
Q ss_pred ----cCccccccccCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 ----TGEVFDKDMRGTK---SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 ----~~~~~d~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...+..+...... ........+.+++.+|++.+|++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 001123578899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.63 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=192.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence 3468999999999999954 6889999988643 233456799999999999999999999999999999999999998
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
+.+..+..... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 85 ~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 85 TLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 77766654322 388999999999999999999998 99999999999999999999999999987654432
Q ss_pred ----cccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh---c-ccCcc
Q 008431 413 ----AQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE---E-WTGEV 483 (565)
Q Consensus 413 ----~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~ 483 (565)
...++..|+|||++... .++.++|||||||++|||++|++||..... .+........... . .....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhhcc
Confidence 23457789999998877 889999999999999999999999863211 0000000000000 0 00000
Q ss_pred ccccccC-------------CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 484 FDKDMRG-------------TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 484 ~d~~~~~-------------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.++...+ ...+......+.+++.+||..+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 0001112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=295.52 Aligned_cols=243 Identities=26% Similarity=0.339 Sum_probs=193.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCcc--CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNV--GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|.. .++..||+|.++..... ..+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 346899999999999985 47889999998754332 456799999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 84 GTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999997532 378899999999999999999998 99999999999999999999999999987654321
Q ss_pred -------cccccccccCCCccCCCC---CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 413 -------AQLHMVAYKSPEFNQTDG---VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 413 -------~~~~t~~y~aPE~~~~~~---~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
...++..|+|||++.... ++.++|||||||++||+++|+.||.... .......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-------~~~~~~~~~~-~~---- 222 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------NEFQIMFHVG-AG---- 222 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-------chHHHHHHHh-cC----
Confidence 234567899999987766 8899999999999999999999996321 0111111111 00
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+.+... ......+.+++.+||+.+|++|||+.|++.
T Consensus 223 -~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111111 111235678889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.37 Aligned_cols=241 Identities=21% Similarity=0.318 Sum_probs=187.9
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEe------cCceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYR------KEEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~~~~~lv~E 329 (565)
.+.||+|+||.||+|.. .+++.+|+|.+... .....++..|+.+++++ +||||+++++++.. .+..|++||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 46899999999999995 56788999987543 23346788999999998 69999999999863 356799999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 100 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 100 FCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred eCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 9999999999976442 2378888999999999999999998 99999999999999999999999999987543
Q ss_pred cc----ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 410 KE----HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 410 ~~----~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
.. ....++..|+|||.+. ...++.++|||||||++|||++|+.||....+.. . .... ...
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-------~-~~~~-~~~-- 241 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-------A-LFLI-PRN-- 241 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-------h-hhhH-hhC--
Confidence 21 2345788999999865 3467889999999999999999999986322110 0 0000 000
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+.+.. ......+.+++.+||+.||.+|||+.|+++
T Consensus 242 ---~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 ---PPPKLKS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---CCCCCcc----cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0111110 112246888999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=299.90 Aligned_cols=240 Identities=19% Similarity=0.225 Sum_probs=183.3
Q ss_pred eecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHH---hcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 260 VLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRL---GSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
+||+|+||.||++.. .+++.+|+|.+..... .....+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 4688999998864321 1122344554433 34579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||++......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999987543 389999999999999999999998 8999999999999999999999999998654322
Q ss_pred -ccccccccccCCCccC-CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 -HAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....++..|+|||... +..++.++|||||||++|||++|+.||...... . ...+...... ....+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~-~~~~~~~~~~------~~~~~~ 219 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----D-KHEIDRMTLT------VNVELP 219 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----C-HHHHHHHhhc------CCcCCc
Confidence 2346789999999876 456899999999999999999999999632211 1 1111111100 011111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 525 (565)
......+.+++.+|+..||++|| |++|+++.
T Consensus 220 -----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 -----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11224677888999999999999 58887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=317.38 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=199.3
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 328 (565)
..+.||+|+||.||+|+ ..+|+.||||.++.. .....+...+|+++|++++|||||++++.-.+. ....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 45689999999999999 679999999999853 355678899999999999999999999886543 3568999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC--CC--CcEEeccCC
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN--AY--EPLLTDYAL 404 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~--~~--~~kl~DfGl 404 (565)
|||.+|||+..|.... ...+|++...+.++.+++.||.|||++ +|+||||||.||++-. ++ .-||+|||.
T Consensus 97 EyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999997533 345799999999999999999999988 9999999999999842 23 369999999
Q ss_pred ccccccc---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc-
Q 008431 405 VPIVNKE---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW- 479 (565)
Q Consensus 405 a~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 479 (565)
|+.+... .+..||..|.+||++.. ..|+..+|.|||||++||++||..||......+ .....+........
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk----~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK----NNKEIMWHIITKKPS 246 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc----ccchhhhhhhccCCC
Confidence 9988766 35679999999999884 889999999999999999999999997433221 11111222111110
Q ss_pred -cCccccccccC-------CCC----CHHHHHHHHHHHhhccccCcCCCC--CHHHHHHHHHHhhcc
Q 008431 480 -TGEVFDKDMRG-------TKS----GEGEMLKLLKIGMCCCEWNAERRW--DLREAVEKIMELKER 532 (565)
Q Consensus 480 -~~~~~d~~~~~-------~~~----~~~~~~~~~~l~~~Cl~~~P~~RP--s~~evl~~L~~i~~~ 532 (565)
..-..++...+ .+. .......+-......+.++|.+|. ...+....+..|...
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11111111110 001 122233444555567778999999 767777776666554
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=300.17 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=187.6
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHH-HhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTR-LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||.||++.. .+|+.||+|+++... .....++..|+.. ++..+||||+++++++..++..|+||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 46799999999999995 478999999987532 2233456667665 666789999999999999999999999996 6
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++....... ..+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 85 SLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred cHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 8988887543222 35899999999999999999999853 7999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCC----CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 HAQLHMVAYKSPEFNQT----DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~----~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+......... .+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~------~~~ 227 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK-------TPFQQLKQVVEEP------SPQ 227 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc-------cCHHHHHHHHhcC------CCC
Confidence 22356788999998754 457899999999999999999999986211 1111111111110 111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+... .....+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 11236788999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=304.83 Aligned_cols=242 Identities=23% Similarity=0.280 Sum_probs=191.6
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+++++.++||||+++++.+...+..|+||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 468999999999999954 589999999875322 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 86 GELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999875332 2489999999999999999999998 99999999999999999999999999976542210
Q ss_pred --------------------------------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccC
Q 008431 413 --------------------------------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQG 460 (565)
Q Consensus 413 --------------------------------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~ 460 (565)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-- 236 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN-- 236 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc--
Confidence 1246778999999988889999999999999999999999986221
Q ss_pred CCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCC----HHHHHH
Q 008431 461 KGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWD----LREAVE 524 (565)
Q Consensus 461 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs----~~evl~ 524 (565)
............. .... .......+.+++.+||+.||++||| +.|+++
T Consensus 237 ------~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 ------RDETFSNILKKEV-------TFPG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ------hHHHHHHHhcCCc-------cCCC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111111111110 0000 0112347888999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=301.28 Aligned_cols=239 Identities=19% Similarity=0.274 Sum_probs=192.5
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
.+||+|+||.||++.. .++..||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 578999999986544445667999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----cc
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----HA 413 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~~ 413 (565)
+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...... ..
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 987532 378999999999999999999998 9999999999999999999999999987654322 23
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||+.....++.++|||||||++|||++|+.||... .....+.. ..... .+.+...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--------~~~~~~~~-~~~~~-----~~~~~~~-- 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKM-IRDNL-----PPKLKNL-- 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHH-HHhhC-----CcccCCc--
Confidence 45678899999988888899999999999999999999998621 11111111 11111 1111110
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.+|.+||++.|+++
T Consensus 240 -~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 -HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 111235677888999999999999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.59 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=197.4
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||+|+||.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++++...+..++++||+++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 467999999999999965 68899999987543 3345678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-hCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--c
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK-EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--H 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--~ 412 (565)
|.+++..... .+++..+..++.|++.||+|||+ . +++||||||+||+++.++.+||+|||.+...... .
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 86 LDKILKEVQG----RIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred HHHHHHHccC----CCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999976532 48899999999999999999999 6 8999999999999999999999999998665332 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
...++..|+|||+..+..++.++|||||||++|+|++|+.||...... .....+.+........ +.+..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~------~~~~~-- 226 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPP------PRLPS-- 226 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCCC------CCCCh--
Confidence 255678899999998889999999999999999999999998632211 1122223322222110 11100
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+||..+|++|||+.|++..
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 --GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0123467889999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=298.53 Aligned_cols=242 Identities=23% Similarity=0.330 Sum_probs=195.8
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|++.++.++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 367999999999999965 688999999875433 467789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...... .
T Consensus 103 ~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 103 TDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 99998754 1489999999999999999999998 9999999999999999999999999987654432 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
...++..|+|||++.+..++.++|||||||++|||++|+.||... ............. .....
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~~~~~-------- 237 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE--------PPLRALFLITTKG-IPPLK-------- 237 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcC-CCCCc--------
Confidence 334678899999988888999999999999999999999998621 1111111111111 10100
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
........+.+++.+|++.+|.+|||+.++++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011122467888999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=295.84 Aligned_cols=242 Identities=20% Similarity=0.239 Sum_probs=187.6
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHH-HhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTR-LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||.||+|.. .+++.||+|.++.... .....+..|..+ ....+|||++++++++..++..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 5688999999864321 112234455444 4456899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 413 (565)
|+|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++.......
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceecccccc
Confidence 99999997543 388999999999999999999998 999999999999999999999999999876655555
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||...+..++.++||||||+++|||+||..||... ............. .. ..+...
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~~--~~~~~~---- 217 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE--------TPDAVFDNILSRR-IN--WPEEVK---- 217 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhcc-cC--CCCccc----
Confidence 56788999999988888999999999999999999999998621 1122222211111 00 000010
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+||+.+|++|||+.++.+.
T Consensus 218 -~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 218 -EFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred -ccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 1122468889999999999999987655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=299.23 Aligned_cols=240 Identities=21% Similarity=0.336 Sum_probs=191.9
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCC---CCCccceEEEEEecCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLS---HPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
.+.||+|+||.||+|.. .++..+|+|.+... .....+++.+|+.++++++ |||++++++++......++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 46799999999999995 57899999998643 2334567889999999987 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+++|.+++... .+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++++|||++......
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999998642 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred ---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....++..|+|||++.. ..++.++|||||||++|||++|+.||.... ...+... .. ....+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~--------~~~~~~~-~~-----~~~~~~ 221 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--------AFRAMML-IP-----KSKPPR 221 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC--------hhhhhhc-cc-----cCCCCC
Confidence 23357788999998765 456899999999999999999999986321 1111110 00 011111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+... .....+.+++.+|++.||++||++.|+++.
T Consensus 222 ~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDN----GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 2111 123467888999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=300.60 Aligned_cols=238 Identities=22% Similarity=0.243 Sum_probs=191.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 347899999999999995 468899999986432 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||+++.....
T Consensus 85 ~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 85 GGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 999999997643 388999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....+++.|+|||.+....++.++||||||+++|||++|+.||.... ......... .+. ..+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~------~~~~~- 219 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKIL-EGK------VRFPS- 219 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHh-cCC------ccCCc-
Confidence 23457889999999888888999999999999999999999986211 111111111 110 01111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAV 523 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl 523 (565)
.....+.+++.+||+.||++|| +++|++
T Consensus 220 ----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 220 ----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1123677888999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=300.75 Aligned_cols=250 Identities=18% Similarity=0.207 Sum_probs=189.3
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~~ 332 (565)
.+.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.++++++||||+++++++... +..|+||||++
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 468999999999999964 688999999874322 2234678899999999999999999999877 78999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 90 -~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 90 -HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred -cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 599998875432 489999999999999999999998 9999999999999999999999999998765433
Q ss_pred ---ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh----------
Q 008431 412 ---HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE---------- 477 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 477 (565)
....++..|+|||.+.+. .++.++|||||||++|||++|++||.... ...........
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~--------~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS--------EIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCchHHHH
Confidence 233467889999987654 46899999999999999999999986321 11111111000
Q ss_pred ----------cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 ----------EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ----------~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..........+............+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000000000002346778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=300.00 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=188.5
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||.||+|+. .++..||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 46799999999999985 478899999886432 2233578999999999999999999999999999999999996 6
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 84 DLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred CHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 89998875432 2489999999999999999999998 8999999999999999999999999998765332
Q ss_pred -ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-----------
Q 008431 412 -HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE----------- 478 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 478 (565)
....++..|+|||++.+. .++.++|||||||++|||+||+.||..... ...+.+.....-...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 223457789999977654 468899999999999999999999863111 001111110000000
Q ss_pred ----ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 479 ----WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 479 ----~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
............. .......+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 0011235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=294.32 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=198.5
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||+|++|.||+|... +++.||+|++..... .....+.+|+..+++++||||+++++++...+..++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 478999999999999965 589999999875433 345789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-hCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK-EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
|.+++.... .+++..+..++.|++.||+|||+ . +++||||+|+||+++.++.++|+|||++.......
T Consensus 86 L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 86 LADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999997542 38999999999999999999999 7 99999999999999999999999999987664332
Q ss_pred --cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 --AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 --~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...++..|+|||......++.++||||||+++|||+||+.||..... ....+......... .+....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~------~~~~~~ 225 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGP------PPSLPA 225 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCC------CCCCCc
Confidence 33567889999999888899999999999999999999999864321 01122222221111 011111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. .....+.+++.+|+..+|++|||+.|+++.
T Consensus 226 ~----~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 E----EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred c----cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 023478889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=298.37 Aligned_cols=245 Identities=26% Similarity=0.361 Sum_probs=190.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecC------ceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKE------EKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------~~~lv~ 328 (565)
..+.||+|+||.||+|... +++.+++|.+.... ...+.+.+|+.+++++ +||||+++++++.... ..++||
T Consensus 10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 88 (275)
T cd06608 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM 88 (275)
T ss_pred heeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence 3478999999999999964 67889999886543 3456799999999999 6999999999997654 489999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++...
T Consensus 89 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 89 ELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 999999999998754311 12489999999999999999999998 9999999999999999999999999998654
Q ss_pred ccc----ccccccccccCCCccCC-----CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 409 NKE----HAQLHMVAYKSPEFNQT-----DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 409 ~~~----~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
... ....++..|+|||++.. ..++.++|||||||++|||++|+.||..... .......... .
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~ 234 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--------MRALFKIPRN-P 234 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--------HHHHHHhhcc-C
Confidence 322 23457788999998643 3467899999999999999999999862111 1111111111 0
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+.+. ........+.+++.+||..||++|||+.|+++
T Consensus 235 -----~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 -----PPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----CCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 11122346788999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=303.41 Aligned_cols=254 Identities=21% Similarity=0.241 Sum_probs=185.6
Q ss_pred eecccCceeEEEEEEeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 260 VLGSGSFGSSYKAVLLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
.+|.|+++.||++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344445555555544 7999999998743 3344568999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc------
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE------ 411 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~------ 411 (565)
+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+......
T Consensus 88 ~~l~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 88 DLLKTHFPE---GLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999864322 388999999999999999999998 9999999999999999999999999987644221
Q ss_pred -----ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh----c--
Q 008431 412 -----HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE----E-- 478 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~-- 478 (565)
....++..|+|||++.. ..++.++|||||||++|||++|+.||...... ....+........ .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCch
Confidence 12235678999998765 35889999999999999999999999732110 0000100000000 0
Q ss_pred -----ccCc----cccccccC---CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 479 -----WTGE----VFDKDMRG---TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 479 -----~~~~----~~d~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.... ..++.... ..........+.+++.+||++||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000000 00111223467889999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.24 Aligned_cols=242 Identities=26% Similarity=0.361 Sum_probs=197.6
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+.||+|++|.||++... ++..+++|++..........+.+|++.+++++|||++++++++...+..++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 468999999999999965 6889999999765444567899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---cc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---HA 413 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---~~ 413 (565)
.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+...... ..
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 99987643 2489999999999999999999997 9999999999999999999999999998776543 34
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||+.....++.++||||||+++|+|++|+.||... +.......... .......+
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~-~~~~~~~~-------- 219 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL--------PPMKALFKIAT-NGPPGLRN-------- 219 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------chHHHHHHHHh-cCCCCcCc--------
Confidence 45678899999988888999999999999999999999998632 11111111111 11111100
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.......+.+++.+|++.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0001246888999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.62 Aligned_cols=242 Identities=23% Similarity=0.318 Sum_probs=192.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. .++..||+|++..... .....+.+|+++++.++|||++++++++.+.+..|+||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 346799999999999995 4688999999864322 223568899999999999999999999999999999999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
|++.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 105 -~~l~~~l~~~~~----~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~ 175 (313)
T cd06633 105 -GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN 175 (313)
T ss_pred -CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC
Confidence 588888765432 389999999999999999999998 99999999999999999999999999987655555
Q ss_pred cccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 AQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||++. ...++.++|||||||++|||++|..||... .....+........ +...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~~------~~~~ 241 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNDS------PTLQ 241 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhcCC------CCCC
Confidence 567788999999874 456889999999999999999999998632 11222222211111 1110
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ......+.+++.+||+.+|.+||++.+++..
T Consensus 242 ~----~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 S----NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred c----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111357788889999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=304.16 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=190.5
Q ss_pred eeccc--CceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 260 VLGSG--SFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 260 ~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.||+| +||+||+++. .+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|...+..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999995 588999999986432 223467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+......
T Consensus 85 ~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 85 SANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999876532 2488999999999999999999998 9999999999999999999999999854322111
Q ss_pred --------ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHH--------
Q 008431 412 --------HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNS-------- 473 (565)
Q Consensus 412 --------~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 473 (565)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCCCCCCccc
Confidence 01123456999998866 34789999999999999999999999632110 000000000
Q ss_pred --------Hh----------------hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HH
Q 008431 474 --------VV----------------REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IM 527 (565)
Q Consensus 474 --------~~----------------~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~ 527 (565)
.. .......+.+..+.. .........+.+++.+||+.||++|||+.|+++. +.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 00 000000011111111 1112345678999999999999999999999753 44
Q ss_pred Hhhc
Q 008431 528 ELKE 531 (565)
Q Consensus 528 ~i~~ 531 (565)
.++.
T Consensus 313 ~~~~ 316 (328)
T cd08226 313 QVKE 316 (328)
T ss_pred HHHH
Confidence 4443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=294.79 Aligned_cols=234 Identities=24% Similarity=0.268 Sum_probs=183.3
Q ss_pred ecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhc-CCCCCccceEEEEEecCceEEEEeccCCCCHHH
Q 008431 261 LGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGS-LSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLAN 338 (565)
Q Consensus 261 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 338 (565)
||+|+||.||++.. .++..+|+|.+........ |+..... .+||||+++++.+...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 69999999999994 5778899998864322111 2222221 269999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCccccccccccccc
Q 008431 339 LLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNKEHAQLHM 417 (565)
Q Consensus 339 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~t 417 (565)
++.... .++|..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++.........++
T Consensus 99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 169 (267)
T PHA03390 99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT 169 (267)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCC
Confidence 997643 389999999999999999999998 899999999999999988 9999999998877665566788
Q ss_pred ccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHH
Q 008431 418 VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGE 497 (565)
Q Consensus 418 ~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 497 (565)
..|+|||++....++.++|||||||++|||++|+.||..... .......+.... .. .. +. ....
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~-~~----~~--~~------~~~~ 233 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQ-QK----KL--PF------IKNV 233 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhh-cc----cC--Cc------cccc
Confidence 999999999888899999999999999999999999973211 111222232221 10 00 00 0112
Q ss_pred HHHHHHHHhhccccCcCCCCC-HHHHHH
Q 008431 498 MLKLLKIGMCCCEWNAERRWD-LREAVE 524 (565)
Q Consensus 498 ~~~~~~l~~~Cl~~~P~~RPs-~~evl~ 524 (565)
...+.+++.+||+.+|.+||+ ++|+++
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 236788888999999999995 688764
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.46 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=194.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|+. .++..+|+|.+... ......++.+|+++++.++|+|++++++++...+..++||||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 346799999999999995 46788999998642 12233568899999999999999999999999999999999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
|++.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 -~~l~~~~~~~~~----~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 99 -GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred -CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 688887764332 388999999999999999999998 89999999999999999999999999988766655
Q ss_pred cccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 AQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||++. ...++.++|||||||++|||++|+.||... .-........... . +...
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~-~-----~~~~ 235 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNE-S-----PALQ 235 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc--------cHHHHHHHHhhcC-C-----CCcC
Confidence 667788999999864 356788999999999999999999998521 1111111111111 0 1110
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
.......+.+++.+||+.+|++||++.++++.-....
T Consensus 236 ----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0122246788899999999999999999987654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=299.90 Aligned_cols=248 Identities=15% Similarity=0.204 Sum_probs=176.1
Q ss_pred ccceecccCceeEEEEEEeCC----CeeEEEEeeccCccC-H----------HHHHHHHHHHhcCCCCCccceEEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTG----PAMVVKRFRQMSNVG-K----------EDFHEHMTRLGSLSHPNLLPLIAFYYRK 321 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~niv~l~~~~~~~ 321 (565)
..++||+|+||+||+|...++ ..+|+|......... . .....+...+..+.|+||+++++++...
T Consensus 16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 457899999999999996543 455555432211111 0 1122344556678999999999977654
Q ss_pred C----ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCc
Q 008431 322 E----EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEP 397 (565)
Q Consensus 322 ~----~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~ 397 (565)
. ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 96 ~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 96 RCRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cCCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCcE
Confidence 3 34788888753 6777665432 257888899999999999999998 99999999999999999999
Q ss_pred EEeccCCccccccc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcc
Q 008431 398 LLTDYALVPIVNKE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANAD 466 (565)
Q Consensus 398 kl~DfGla~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~ 466 (565)
||+|||+++..... ....||+.|+|||+..+..++.++|||||||++|||++|+.||...... ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~----~~ 241 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN----GN 241 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc----hH
Confidence 99999998765311 1235889999999999999999999999999999999999999743211 11
Q ss_pred hHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 467 LATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
........ ....+..+.+.. ......+.+++..|++.+|++||++.++.+.+
T Consensus 242 ~~~~~~~~----~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCD----FIKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHH----HHHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111100 001111111100 11124677888899999999999999998876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.89 Aligned_cols=260 Identities=20% Similarity=0.318 Sum_probs=203.7
Q ss_pred chhHHHhhccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEE
Q 008431 249 ELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 249 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 326 (565)
.++|+..-+.+.||+|+|+.|--++ ..+|..+|||.+.+.....+.+..+|++++.+++ |+||++|++||.++..+||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 3567777788999999999999998 7899999999998887777889999999999985 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC---cEEeccC
Q 008431 327 VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE---PLLTDYA 403 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfG 403 (565)
|||-|.||.|..++++++. +++.++.+++++|+.||.|||.+ +|.||||||+|||-.+... +|||||.
T Consensus 154 VfEKm~GGplLshI~~~~~-----F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRKH-----FNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEecccCchHHHHHHHhhh-----ccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999988764 89999999999999999999999 9999999999999965443 7999998
Q ss_pred Cccccccc-----------ccccccccccCCCcc-----CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCC--Cc
Q 008431 404 LVPIVNKE-----------HAQLHMVAYKSPEFN-----QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA--NA 465 (565)
Q Consensus 404 la~~~~~~-----------~~~~~t~~y~aPE~~-----~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~--~~ 465 (565)
+..-.... .+.+|+..|||||+. ....|+.++|.||+|||||-|++|.+||......... ..
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 86432111 234566789999964 2346899999999999999999999999754432111 11
Q ss_pred chHHHHHHH----hhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 466 DLATWVNSV----VREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 466 ~~~~~~~~~----~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.. ++++ ..+.-|..+ ........+++...+..||.+|-++.++++
T Consensus 305 e~Cr~CQ~~LFesIQEG-kYeFPdkdW------ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEG-KYEFPDKDW------AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhcc-CCcCChhhh------HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 122222222 2222 122222222 122345667777888899999999999887
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=293.47 Aligned_cols=233 Identities=22% Similarity=0.243 Sum_probs=188.7
Q ss_pred ecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 261 LGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 261 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
||.|+||.||+|+.. ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999954 58899999987432 23346799999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---cc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---HA 413 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---~~ 413 (565)
.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 99997543 288999999999999999999998 9999999999999999999999999998776543 23
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||++....++.++|+|||||++|||++|+.||..... +.............. .. .
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~-----~~-----~ 215 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGK-----LE-----F 215 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCC-----CC-----C
Confidence 4567889999998888899999999999999999999999863211 122222222211100 00 0
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCC
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWD 518 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs 518 (565)
+......+.+++.+||+.+|++||+
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcC
Confidence 1111347888999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.56 Aligned_cols=255 Identities=17% Similarity=0.161 Sum_probs=189.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCc-----eEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEE-----KLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~-----~~lv 327 (565)
..+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.++ ||||+++++++...+. .|+|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 346899999999999995 478899999876432 223457889999999995 6999999999987665 7999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCcc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVP 406 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~ 406 (565)
|||+++ +|.+++..........+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 999985 899988754432223589999999999999999999998 9999999999999998 8999999999987
Q ss_pred ccccc----ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-cc
Q 008431 407 IVNKE----HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-WT 480 (565)
Q Consensus 407 ~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 480 (565)
..... ....+++.|+|||++.+ ..++.++|||||||++|||++|..||.... ............ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~ 231 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS--------ELQQLLHIFKLLGTP 231 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHHHhCCC
Confidence 54322 22345778999997754 457899999999999999999999986311 111111111100 00
Q ss_pred Ccccc------------ccccCC---CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 GEVFD------------KDMRGT---KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 ~~~~d------------~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..... +..... .........+.+++.+||+.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 000000 000112346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.70 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=190.2
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||.|++|.||+|.. .+|..||+|++.... ....+.+.+|++++++++|||++++++++.+.+..+++|||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 46899999999999985 478999999987432 2234578899999999999999999999999999999999995 6
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||+++.....
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 83 DLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred CHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 99999875442 2489999999999999999999998 8999999999999999999999999998765322
Q ss_pred -ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh---cc-------
Q 008431 412 -HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE---EW------- 479 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~------- 479 (565)
....++..|+|||++.+. .++.++|||||||++|||++|++||...... ..+...+...... .+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhhhhhch
Confidence 223457889999987654 5789999999999999999999998632110 0011111100000 00
Q ss_pred -----cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 -----TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 -----~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+..... .......+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKV--VPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhh--cCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000 0111246788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.86 Aligned_cols=252 Identities=19% Similarity=0.223 Sum_probs=187.9
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCC-CCCccceEEEEEec--CceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRK--EEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~E~~~ 332 (565)
.+.||+|+||.||+|.. .++..||+|+++... ........+|+..+.++. ||||+++++++.+. +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 46799999999999994 578899999987532 222334567899999885 99999999999887 88999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
|+|.+++..... .++|..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 84 -~~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 84 -MNLYELIKGRKR----PLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred -ccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 588888865432 489999999999999999999998 9999999999999999 99999999998765432
Q ss_pred --ccccccccccCCCccC-CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh-----------h
Q 008431 412 --HAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR-----------E 477 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~ 477 (565)
....++..|+|||++. ...++.++|||||||++|||++|++||..... .....+...... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcCCCCHHHHHhhcc
Confidence 2234678899999754 45578999999999999999999999963211 111112111110 0
Q ss_pred cccCccccccccCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 EWTGEVFDKDMRGTK---SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
........+...... ........+.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000 00122457889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=299.24 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=188.8
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||.||++.. .++..+|+|++.... ......+.+|+.++.++. ||||+++++++..++..+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 36799999999999994 468999999987432 234557889999999996 99999999999998999999999864
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
++.++...........+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 6655432211111124899999999999999999999742 7999999999999999999999999998754332
Q ss_pred ccccccccccCCCccCCC---CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 HAQLHMVAYKSPEFNQTD---GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~---~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....++..|+|||++... .++.++|||||||++|||++|+.||.... .....+....... .+.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~------~~~~ 231 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD------PPIL 231 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC------CCcC
Confidence 234577889999988765 68999999999999999999999986311 1111111111110 1111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.... .......+.+++.+|++.+|++|||+.||++.
T Consensus 232 ~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 11233468899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=293.90 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=198.2
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhc--CCCCCccceEEEEEecC----ceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGS--LSHPNLLPLIAFYYRKE----EKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~E~~ 331 (565)
.+.||+|.||.||+|.+ .|+.||||.+.. .+.+.+.+|.++.+. |+|+||..+++.-..+. ++|||++|-
T Consensus 216 ~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 47899999999999998 688999999963 445678899988876 69999999998765432 589999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC----CCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF----PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+.|||+|||... .++-...++++.-+|.||++||... ..+.|.|||||+.|||+..++..-|+|+|+|-.
T Consensus 292 e~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 292 EHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999752 3889999999999999999999753 123799999999999999999999999999855
Q ss_pred cccc--------ccccccccccCCCccCCCC----C--CcchhHHHHHHHHHHHHcC----------CCCccccccCCCC
Q 008431 408 VNKE--------HAQLHMVAYKSPEFNQTDG----V--TRKTDVWSLGILILELLTG----------KFPANYLAQGKGA 463 (565)
Q Consensus 408 ~~~~--------~~~~~t~~y~aPE~~~~~~----~--~~~~DvwS~Gvil~el~tg----------~~p~~~~~~~~~~ 463 (565)
.... ...+||.+|||||++.... + -..+||||||.|+||++-. ++||....+....
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 4332 4568999999999875431 2 2469999999999999852 4666654433221
Q ss_pred CcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 464 NADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
..+ ++..+- .+-+.|.+.......+.+..+.+++..||..+|..|-|+--+-+.|.++..
T Consensus 446 ---~ee-MrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 446 ---FEE-MRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ---HHH-Hhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 111 111110 111223333333456788999999999999999999999999999988864
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.68 Aligned_cols=194 Identities=21% Similarity=0.350 Sum_probs=163.3
Q ss_pred cceecccCceeEEEEEEe---CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 329 (565)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 467999999999999954 47899999997632 33346788999999999999999999999987 78999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC----CCCcEEeccCCc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN----AYEPLLTDYALV 405 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~----~~~~kl~DfGla 405 (565)
|+++ +|.+++..........+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9975 777777644332223588999999999999999999998 8999999999999999 999999999998
Q ss_pred cccccc-------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 008431 406 PIVNKE-------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANY 456 (565)
Q Consensus 406 ~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~ 456 (565)
+..... ....++..|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 765332 12345788999997765 4588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=294.29 Aligned_cols=241 Identities=20% Similarity=0.252 Sum_probs=194.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|+||+.
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 3478999999999999964 68999999987532 2345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+++|.+++.... .+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 84 GGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999997542 388999999999999999999998 8999999999999999999999999998765433
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....++..|+|||+.....++.++|||||||++|+|++|+.||..... ....++....... .....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~--~~~~~---- 222 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR------TIRDQIRAKQETA--DVLYP---- 222 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc------cHHHHHHHHhccc--cccCc----
Confidence 334567889999998888899999999999999999999999873221 1122222221110 00111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCH--HHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDL--REAV 523 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~--~evl 523 (565)
......+.+++.+||+.||.+||++ +|++
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 -----ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122478889999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=294.95 Aligned_cols=240 Identities=21% Similarity=0.274 Sum_probs=191.5
Q ss_pred ecccCceeEEEEEEe-CCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 261 LGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 261 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
||+|+||.||++... +|+.+|+|.+..... ...+.+.+|++++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 589999999865332 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99997643 389999999999999999999998 9999999999999999999999999998654322
Q ss_pred -------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 412 -------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 412 -------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
....++..|+|||......++.++|||||||++||+++|+.||... ............. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~---- 218 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE--------TPEEIFQNILNGK-I---- 218 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhcCC-c----
Confidence 1234567899999988888899999999999999999999998621 1222222221110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
. .... ......+.+++.+|++.+|++|||+.+|.+.|+
T Consensus 219 ~--~~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 E--WPED---VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C--CCcc---ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 0000 001346788999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=294.33 Aligned_cols=241 Identities=19% Similarity=0.227 Sum_probs=187.9
Q ss_pred ecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 261 LGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 261 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
||+|+||+||+|.. .+|+.+|+|.+.... ......+.+|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 478899999986432 22344578899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---cc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---HA 413 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---~~ 413 (565)
.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 999976542 2489999999999999999999998 9999999999999999999999999998765422 22
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..++..|+|||+..+..++.++|||||||++|||++|+.||...... .. ...+....... ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~~------~~~~----- 217 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VE-KEELKRRTLEM------AVEY----- 217 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----cc-HHHHHhccccc------cccC-----
Confidence 34567899999988888999999999999999999999998632110 00 11111100000 0001
Q ss_pred CHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
+......+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 011123677888999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=281.99 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=193.2
Q ss_pred cchhHHHhhccceecccCceeEEEEE-EeCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCce
Q 008431 248 FELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEK 324 (565)
Q Consensus 248 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 324 (565)
-+.+|+. ....||.|+.|+|++++ ..+|..+|||.+++.. ....++++..+.++.+.+ .|.||+.+|||..+...
T Consensus 89 ~dindl~--~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLE--NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhh--hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 3445543 23569999999999999 4578999999998643 344566777777776654 89999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
++.||.|.. -+..+++.... ++++..+-++...+.+||.||-+++ +|+|||+||+|||+|+.|++|+||||+
T Consensus 167 ~IcMelMs~-C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKeKH---~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHHhc---ceeecccCccceEEccCCCEEeecccc
Confidence 999999953 56666655443 3888888899999999999998763 899999999999999999999999999
Q ss_pred ccccccc---ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 405 VPIVNKE---HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 405 a~~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
+..+... ....|.+.|||||.+.. ..|+.++|||||||+++||.||+.||.... .+. +.+...+.++
T Consensus 239 sGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~------tdF-e~ltkvln~e 311 (391)
T KOG0983|consen 239 SGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK------TDF-EVLTKVLNEE 311 (391)
T ss_pred cceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC------ccH-HHHHHHHhcC
Confidence 9877554 34567789999998754 468999999999999999999999997321 111 1222222221
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.|.+++.. .....+.+++..||..|+.+||...++++.
T Consensus 312 ------PP~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 ------PPLLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------CCCCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 12332211 133478889999999999999998877653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=283.75 Aligned_cols=267 Identities=19% Similarity=0.262 Sum_probs=196.2
Q ss_pred hccceecccCceeEEEEEEeC-----CCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEe-cCceEEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLLT-----GPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-KEEKLLV 327 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv 327 (565)
.....||+|.||.||+|...+ ...+|+|+++.... .-.....+|+.+++.++|||||.+..++.. +...+++
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 356789999999999997332 33799999985432 223567899999999999999999999877 6788999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC----CCcEEeccC
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA----YEPLLTDYA 403 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~----~~~kl~DfG 403 (565)
+||.+. ||..+++-++......++......|+-||+.|+.|||++ -|+||||||+|||+..+ |.+||+|||
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999986 999999877665556789999999999999999999999 79999999999999877 999999999
Q ss_pred Cccccccc-------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCC-CcchHHHHHHH
Q 008431 404 LVPIVNKE-------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA-NADLATWVNSV 474 (565)
Q Consensus 404 la~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~ 474 (565)
+++..... ...+.|..|+|||.+.+ ..||.+.||||.|||+.||+|-++-|......... ...-.+-+.++
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99887543 23356889999997766 56899999999999999999998887532221111 01111222222
Q ss_pred hhh-cccCccccccccCCCCC-------------HH-----------HHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 475 VRE-EWTGEVFDKDMRGTKSG-------------EG-----------EMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 475 ~~~-~~~~~~~d~~~~~~~~~-------------~~-----------~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
+.- +...+-..|.+...+.- .. .....+++..++|..||.+|.|++++++..-
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 210 11111111111111000 00 0012677888999999999999999877643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=284.66 Aligned_cols=246 Identities=19% Similarity=0.235 Sum_probs=198.2
Q ss_pred hccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEe----cCceEEEEe
Q 008431 256 ASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYR----KEEKLLVSD 329 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~lv~E 329 (565)
.+.++||-|-.|.|..+. ..+++.+|+|.+... ...++|+++.-.. .|||||.++++|.. ...+.+|||
T Consensus 65 is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 65 ISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred ehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 345899999999999998 568999999998643 3457888876655 59999999998854 345789999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc---CCCCcEEeccCCcc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD---NAYEPLLTDYALVP 406 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~ 406 (565)
.|+||.|+..+..++.. .+++.++-.|++||+.|++|||+. +|.||||||+|+|.. .+...|++|||+|+
T Consensus 140 ~meGGeLfsriq~~g~~---afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQ---AFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred cccchHHHHHHHHcccc---cchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEeccccccc
Confidence 99999999999876543 599999999999999999999998 999999999999995 45679999999998
Q ss_pred ccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 407 IVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 407 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
..... .+.+.|+.|.|||++...+|+..+|+||+||++|-|+.|.+||... .+..+..-+++.++.+. .++
T Consensus 213 ~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~-----hg~aispgMk~rI~~gq-y~F 286 (400)
T KOG0604|consen 213 ETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN-----HGLAISPGMKRRIRTGQ-YEF 286 (400)
T ss_pred ccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc-----CCccCChhHHhHhhccC-ccC
Confidence 86633 3567789999999999999999999999999999999999999732 12334444555554442 122
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
-++++ ....+...+++...|..+|.+|.|+.|++..
T Consensus 287 P~pEW------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 PEPEW------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CChhH------hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22222 3344567788999999999999999999764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.92 Aligned_cols=252 Identities=21% Similarity=0.239 Sum_probs=188.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|.. .+|..||+|+++.... .....+.+|+.++++++|+||+++++++... +..++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 346899999999999995 4689999999874322 2233567899999999999999999998765 4689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
. ++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 91 ~-~~l~~~l~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 91 E-QDLASLLDNMPT----PFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred C-CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 7 489888875432 489999999999999999999998 9999999999999999999999999998765432
Q ss_pred ----ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-ccCcccc
Q 008431 412 ----HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-WTGEVFD 485 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d 485 (565)
....++..|+|||.+.+ ..++.++||||+||++|||++|++||.... ....+....... .......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--------~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--------EIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhcCCCChhhc
Confidence 12234678999998765 557899999999999999999999986211 111111111100 0000000
Q ss_pred c-----------cccCCC--C----CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 486 K-----------DMRGTK--S----GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 486 ~-----------~~~~~~--~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+ .+.... . .......+.+++.+|+++||++|||+.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000 0 00123467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.02 Aligned_cols=239 Identities=28% Similarity=0.407 Sum_probs=191.7
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+||.|.||.||-|. ..+|...|+|-++-. .......+.+|+.++..++|||+|+++|+-.+++..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4689999999999999 778999999988633 2344467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+.+...+. .++.....+..|++.|++|||++ +||||||||+||+|+.+|.+|..|||.|..+...
T Consensus 1320 sLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred cHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 99999975432 67777788899999999999999 9999999999999999999999999999776543
Q ss_pred -----ccccccccccCCCccCCC---CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHH-hhhcccCc
Q 008431 412 -----HAQLHMVAYKSPEFNQTD---GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSV-VREEWTGE 482 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~~---~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 482 (565)
....||+.|||||++.+. +...+.||||+|||++||+||+.||..... .|.... +..+.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~~gh--- 1458 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVAAGH--- 1458 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHhccC---
Confidence 235789999999988653 456789999999999999999999974321 222111 11111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.|.+ ++.....-.+++.+||+.||+.|+++.|+++
T Consensus 1459 --~Pq~-----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 --KPQI-----PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred --CCCC-----chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1111 1223345567778999999999999886543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.11 Aligned_cols=257 Identities=16% Similarity=0.251 Sum_probs=189.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv 327 (565)
..+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++||||+++++++... ...|+|
T Consensus 20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence 347899999999999994 57899999998642 223345688899999999999999999988643 346999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 100 MELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred EeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 99996 588888753 278889999999999999999998 999999999999999999999999999976
Q ss_pred cccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCC-------CCcchHHHHHH----
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKG-------ANADLATWVNS---- 473 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~---- 473 (565)
.... ....++..|+|||++.+..++.++|||||||++|+|++|+.||........ .......+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 5433 233567889999999888999999999999999999999999863210000 00000000000
Q ss_pred ---Hhhhcc------cCccccccccCCCC---CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 474 ---VVREEW------TGEVFDKDMRGTKS---GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 474 ---~~~~~~------~~~~~d~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...... ..+.....+..... .......+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00000000000000 11234467899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=292.36 Aligned_cols=239 Identities=19% Similarity=0.221 Sum_probs=183.8
Q ss_pred eecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHH---HHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 260 VLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHM---TRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
+||+|+||.||+|.. .+++.||+|.+..... .....+..|. ..++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 5688999999864321 1122244443 34555689999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999999886432 389999999999999999999998 8999999999999999999999999998754322
Q ss_pred -ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 -HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....++..|+|||++..+ .++.++||||+||++|||++|+.||...... .. ......... .++.+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~-~~~~~~~~~------~~~~~~ 219 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DK-HEIDRMTLT------MAVELP 219 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----ch-HHHHHHhhc------cCCCCC
Confidence 244678899999988644 6899999999999999999999999732111 11 111111100 011111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
. .....+.+++.+|+..+|++|| ++.|+++
T Consensus 220 ~-----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 D-----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C-----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 1124688888999999999999 9999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=287.28 Aligned_cols=240 Identities=20% Similarity=0.241 Sum_probs=192.1
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCcc---CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNV---GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||.|.-|+||+++.. ++..+|+|++.+.... ...+...|-++|+.++||.++.|++.|..++..|+|||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 468999999999999965 5689999999764332 234566788999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc----
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN---- 409 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~---- 409 (565)
|+|..+.+.+.. ..+++..+..++.+|+-||+|||-. |||.|||||+||||.++|++.|+||-++....
T Consensus 162 GdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 162 GDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred ccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999876554 3599999999999999999999998 99999999999999999999999998753210
Q ss_pred ------------------------------c-c-------------------------ccccccccccCCCccCCCCCCc
Q 008431 410 ------------------------------K-E-------------------------HAQLHMVAYKSPEFNQTDGVTR 433 (565)
Q Consensus 410 ------------------------------~-~-------------------------~~~~~t~~y~aPE~~~~~~~~~ 433 (565)
. . .+.+||-.|.|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0114567799999999999999
Q ss_pred chhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCc
Q 008431 434 KTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNA 513 (565)
Q Consensus 434 ~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P 513 (565)
++|.|+|||++|||+.|+.||..... ...+ ..++-..+.-... ......+.+||.+.|..||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~----~~Tl-------------~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNN----KETL-------------RNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCc----hhhH-------------HHHhcCCCcCCCC-CcchhHHHHHHHHHhccCh
Confidence 99999999999999999999973211 1111 1222222211111 2344578899999999999
Q ss_pred CCCCC----HHHH
Q 008431 514 ERRWD----LREA 522 (565)
Q Consensus 514 ~~RPs----~~ev 522 (565)
.+|-- +.||
T Consensus 377 ~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 377 SKRLGSKRGAAEI 389 (459)
T ss_pred hhhhccccchHHh
Confidence 99997 7776
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=286.96 Aligned_cols=240 Identities=23% Similarity=0.396 Sum_probs=194.8
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|++|.||++... ++..|++|.+..... ...+.+.+|++++++++|||++++++++...+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 3478999999999999854 678999999975433 3456799999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 84 GSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999987542 389999999999999999999998 99999999999999999999999999987665432
Q ss_pred ---cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 ---AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ---~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...++..|+|||......++.++||||+|+++|||++|+.||.... ....... ..... . +.+.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~~-~~~~~-~-----~~~~ 220 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALFR-IVQDD-H-----PPLP 220 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHH-HhccC-C-----CCCC
Confidence 2356788999999888778999999999999999999999986211 1111111 11110 0 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||..+|++|||+.|++.
T Consensus 221 -----~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 -----EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111246778889999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.43 Aligned_cols=245 Identities=23% Similarity=0.348 Sum_probs=187.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|... ++..||||.++... .....++.+|+..+.+.. ||||+++++++.+....|+||||+.
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS- 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-
Confidence 4578999999999999975 48899999987532 223456777887777765 9999999999999999999999985
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
+++.+++..... .+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++......
T Consensus 98 ~~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 98 TCLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred cCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 578777755332 4899999999999999999999732 7999999999999999999999999998765432
Q ss_pred -ccccccccccCCCccCCCC----CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 -HAQLHMVAYKSPEFNQTDG----VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~----~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....++..|+|||++.... ++.++|||||||++|||++|+.||.... ...+......... . +
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~-~-----~ 237 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-------TEFEVLTKILQEE-P-----P 237 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch-------hHHHHHHHHhcCC-C-----C
Confidence 2234567899999886553 7899999999999999999999986311 1111122222111 0 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+. ........+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 010 001123468889999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.78 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=190.7
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~~ 332 (565)
.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+.++++++|||++++++++... +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 467999999999999955 58899999998542 33346788999999999999999999999887 78999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
+ +|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 4 8998886542 2489999999999999999999998 89999999999999999999999999987654432
Q ss_pred -----cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc---ccCcc
Q 008431 413 -----AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE---WTGEV 483 (565)
Q Consensus 413 -----~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 483 (565)
...++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... ......+....... .....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-----LEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchhhcccc
Confidence 2345678999997654 4578999999999999999999999863211 01111111111000 00000
Q ss_pred c----cccccCCC---------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 484 F----DKDMRGTK---------SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 484 ~----d~~~~~~~---------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. ........ ....+...+.+++.+|++.+|++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000000 00001457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=289.11 Aligned_cols=244 Identities=21% Similarity=0.270 Sum_probs=196.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||++.. .++..+|+|++... ......++.+|++++++++||||+++++++......++||||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 346899999999999984 47889999998743 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++|.+++...... ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+|++|||+++.....
T Consensus 84 ~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 158 (256)
T cd08530 84 GDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158 (256)
T ss_pred CCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc
Confidence 9999998764321 23489999999999999999999998 9999999999999999999999999998766443
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....++..|+|||...+..++.++|+||||+++|||++|+.||... +....... ....... .+
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--------~~~~~~~~-~~~~~~~-----~~--- 221 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR--------SMQDLRYK-VQRGKYP-----PI--- 221 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHH-HhcCCCC-----CC---
Confidence 2345678899999998888999999999999999999999998631 11111111 1111110 01
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+......+.+++.+|++.+|++|||+.|+++
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 --PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1123346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.91 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=185.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC--------ceE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE--------EKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~ 325 (565)
..+.||+|+||.||+|.. .++..||||++.... ......+.+|++++++++||||+++++++...+ ..+
T Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence 346899999999999995 478899999986432 222345678999999999999999999987654 349
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+||||+. ++|.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 96 lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 96 LVFEFCE-HDLAGLLSNKNV----KFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEcCCC-cCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 9999996 588888865432 389999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc--------cccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 406 PIVNKEH--------AQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 406 ~~~~~~~--------~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
....... ...++..|+|||++.+. .++.++|||||||++|||+||++||..... ......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~~~~~ 241 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLISQLCG 241 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhC
Confidence 7653221 22456789999987654 478899999999999999999999863211 011111111110
Q ss_pred h---cccC-----ccccc-cccCCC--------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 477 E---EWTG-----EVFDK-DMRGTK--------SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 477 ~---~~~~-----~~~d~-~~~~~~--------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. .... ...+. ...... ........+.+++.+||..||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 0000 00000 000000 00001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=319.82 Aligned_cols=193 Identities=21% Similarity=0.298 Sum_probs=153.0
Q ss_pred hccceecccCceeEEEEEEeC--CCeeEEEEe--------------e---ccCccCHHHHHHHHHHHhcCCCCCccceEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLLT--GPAMVVKRF--------------R---QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 316 (565)
...+.||+|+||+||+|.... +...++|.+ . .........+.+|+.+|++++|||||++++
T Consensus 151 ~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 230 (501)
T PHA03210 151 RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEE 230 (501)
T ss_pred EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeE
Confidence 345789999999999987432 222222211 0 011122346889999999999999999999
Q ss_pred EEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC
Q 008431 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE 396 (565)
Q Consensus 317 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~ 396 (565)
++...+..|+|+|++. ++|.+++...............+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 231 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 231 ILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred EEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCC
Confidence 9999999999999995 5888877643321112234556778999999999999998 9999999999999999999
Q ss_pred cEEeccCCccccccc-----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 008431 397 PLLTDYALVPIVNKE-----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453 (565)
Q Consensus 397 ~kl~DfGla~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p 453 (565)
+||+|||+++..... ....||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999766432 134689999999999999999999999999999999998754
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.90 Aligned_cols=253 Identities=19% Similarity=0.288 Sum_probs=187.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC-----ceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-----EKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~E 329 (565)
..+.||+|+||.||+|.. .+|..||+|++.... ......+.+|+.++++++||||+++++++.... ..++|+|
T Consensus 9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 357899999999999984 578999999986422 233467889999999999999999999876543 4799999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 89 LME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred hcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 997 4888887542 389999999999999999999998 99999999999999999999999999987653
Q ss_pred ccc-------cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc-
Q 008431 410 KEH-------AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT- 480 (565)
Q Consensus 410 ~~~-------~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 480 (565)
... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCCHH
Confidence 321 2356788999997654 5689999999999999999999999852110 0111111111110000
Q ss_pred --Ccccccc-------ccCCCC-C-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 --GEVFDKD-------MRGTKS-G-----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 --~~~~d~~-------~~~~~~-~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..+.+.. ...... . ......+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000000 0 0113468899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.00 Aligned_cols=252 Identities=19% Similarity=0.231 Sum_probs=188.0
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccC--------------HHHHHHHHHHHhcCCCCCccceEEEEEecC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVG--------------KEDFHEHMTRLGSLSHPNLLPLIAFYYRKE 322 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 322 (565)
.+.||+|+||+||+|.. .+++.||+|+++...... ...+.+|++++++++||||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 46799999999999995 478999999986432211 125789999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
..++||||++ |+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEECCc
Confidence 9999999997 69999986432 388999999999999999999998 9999999999999999999999999
Q ss_pred CCccccccc------------------ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCC
Q 008431 403 ALVPIVNKE------------------HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGA 463 (565)
Q Consensus 403 Gla~~~~~~------------------~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~ 463 (565)
|+++..... ....++..|+|||++.+. .++.++|||||||++|||+||++||.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~---- 239 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE---- 239 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 998765410 122346789999987654 478999999999999999999999863211
Q ss_pred CcchHHHHHHHhhhc----ccCcccccc----ccCCCC-----CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 464 NADLATWVNSVVREE----WTGEVFDKD----MRGTKS-----GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 464 ~~~~~~~~~~~~~~~----~~~~~~d~~----~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+....... +......+. ...... .......+.+++.+||+.+|++|||++|++.
T Consensus 240 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 -IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111111110 000000000 000000 0111346788999999999999999999985
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=290.66 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=189.5
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcC---CCCCccceEEEEEecCc-----eEE
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSL---SHPNLLPLIAFYYRKEE-----KLL 326 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----~~l 326 (565)
.+.||+|+||.||+|+.. ++..+|+|+++.... .....+.+|+.+++++ +||||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 468999999999999965 589999999874322 2234567788776655 69999999999988776 899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 327 VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+|||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999997 489998875432 2489999999999999999999998 89999999999999999999999999987
Q ss_pred cccccc---cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-----
Q 008431 407 IVNKEH---AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE----- 478 (565)
Q Consensus 407 ~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 478 (565)
...... ...++..|+|||++.+..++.++|||||||++|||++|++||.... ..+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--------EADQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--------hHHHHHHHHHHcCCCCh
Confidence 654332 2346778999999988889999999999999999999999986321 122222222110
Q ss_pred --ccCc------cccccccCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 479 --WTGE------VFDKDMRGTK--SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 479 --~~~~------~~d~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+... .+........ ........+.+++.+||+.||++||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 0000000000 00122356778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=286.28 Aligned_cols=244 Identities=20% Similarity=0.297 Sum_probs=198.0
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||++... ++..+|+|++..... .....+.+|+++++.++|||++++.+.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 3468999999999999954 688999999875322 4566789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++|.+++...... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 84 GDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999865321 13599999999999999999999998 9999999999999999999999999998765433
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....+++.|+|||......++.++||||+|+++++|++|+.||... ...+......... . +.+.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~-----~~~~ 224 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE--------NLLELALKILKGQ-Y-----PPIP 224 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC--------cHHHHHHHHhcCC-C-----CCCC
Confidence 2345678899999988888999999999999999999999998621 2222222222111 1 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||..+|++|||+.|+++
T Consensus 225 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 -----SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 112236788899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=285.24 Aligned_cols=241 Identities=25% Similarity=0.344 Sum_probs=196.1
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~~ 332 (565)
.+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|+..+++++||||+++++.+... +..++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 468999999999999965 788999999875432 3466899999999999999999999999888 88999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
+++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999997644 389999999999999999999998 99999999999999999999999999987654432
Q ss_pred ------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 413 ------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 413 ------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
...++..|+|||......++.++||||||+++|+|++|+.||.... .....+......... +
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-----~ 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEP-----P 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCC-----c
Confidence 3456788999999988889999999999999999999999986321 111111111110000 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+ +......+.+++.+|++.+|++||++.|+++
T Consensus 224 ~~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EI-----PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CC-----CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11 1112347888899999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=292.70 Aligned_cols=252 Identities=18% Similarity=0.258 Sum_probs=191.0
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||+|++|.||+|+.. +|..||||+++... ....+.+.+|+.++++++||||+++++++...+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 468999999999999964 68899999987543 23356788999999999999999999999999999999999985 8
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||++......
T Consensus 84 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 84 LKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred HHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9988875432 22489999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh---c----c----
Q 008431 412 HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE---E----W---- 479 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~----~---- 479 (565)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+........ . +
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--------EDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCChhhHHHHh
Confidence 23446788999998755 4578999999999999999999999863211 1111111100 0 0
Q ss_pred cCccccccccCCCC------CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 TGEVFDKDMRGTKS------GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 ~~~~~d~~~~~~~~------~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....+......... .......+.+++.+|++.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000 0111245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=304.90 Aligned_cols=240 Identities=18% Similarity=0.293 Sum_probs=196.8
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
....||+|.|++|.+|+ ..++..||||.+.+.. ......+.+|+++|..++|||||+++.+......+|+||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 45789999999999999 5589999999987532 23345689999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|.+++++..... .....+..++.|+.+|++|+|++ .|||||||++||||+.++++||+|||++..+...
T Consensus 140 ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 140 GELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred chhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeeccccc
Confidence 999999987764 55588899999999999999999 8999999999999999999999999999887644
Q ss_pred -ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 -HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
.+.+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||+.. .+...-. .++-..++
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~--------~lk~Lr~---------rvl~gk~r 273 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ--------NLKELRP---------RVLRGKYR 273 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc--------ccccccc---------hheeeeec
Confidence 46789999999999988877 58999999999999999999999831 1111101 11111111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
-.. -...++-+++++.+-.+|.+|++++++.+.
T Consensus 274 Ip~---~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 IPF---YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccc---eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111 111246677778999999999999999764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.00 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=206.5
Q ss_pred ccchhHHHhhccceecccCceeEEEEEEe----C----CCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEE
Q 008431 247 MFELNDLLRASAEVLGSGSFGSSYKAVLL----T----GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIA 316 (565)
Q Consensus 247 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~ 316 (565)
.+++..-.....+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ +|||||.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34444333345569999999999999843 1 3479999998532 34567899999999998 5999999999
Q ss_pred EEEecCceEEEEeccCCCCHHHHHhhcC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCC
Q 008431 317 FYYRKEEKLLVSDFVPNGSLANLLHVRR---------APGQP--GLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLK 385 (565)
Q Consensus 317 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlk 385 (565)
+|..++..++|+||+..|+|.++|+..+ ..... .+.....+.++.|||.|++||++. ++|||||.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLA 445 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLA 445 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----Cccchhhh
Confidence 9999999999999999999999999877 11111 288899999999999999999998 89999999
Q ss_pred CCCEEEcCCCCcEEeccCCccccccccc-----cc--ccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCcccc
Q 008431 386 SSNVLLDNAYEPLLTDYALVPIVNKEHA-----QL--HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYL 457 (565)
Q Consensus 386 p~NILl~~~~~~kl~DfGla~~~~~~~~-----~~--~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~ 457 (565)
.+|||+..+..+||+|||+++....... .. -...|||||.+....|+.|+|||||||+|||++| |..||...
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999986443211 11 2346999999999999999999999999999999 88998631
Q ss_pred ccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 458 AQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
. ...+. ...++++.. ...+..+..++.++++.||+.+|++||+..|+++.+....
T Consensus 526 ~-------~~~~l-~~~l~~G~r----------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 526 P-------PTEEL-LEFLKEGNR----------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred C-------cHHHH-HHHHhcCCC----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1 01122 223333321 1122334557889999999999999999999999999853
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=293.62 Aligned_cols=251 Identities=18% Similarity=0.217 Sum_probs=186.5
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 468999999999999954 788999999864322 234578899999999999999999999999999999999996 5
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~-- 411 (565)
+|.+++..... ..+++..+..++.||+.||+|||+. +++||||||+||+++. ++.+||+|||++......
T Consensus 86 ~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 86 DLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 88888754332 2367888889999999999999998 9999999999999985 567899999998754322
Q ss_pred --ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh--cccCccc--
Q 008431 412 --HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE--EWTGEVF-- 484 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-- 484 (565)
....+++.|+|||++.+ ..++.++|||||||++|||+||++||..... ... ....... .......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-------~~~-~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-------IDE-LFKIFRILGTPNEETWPG 230 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHH-HHHHHHHhCCCChhhccc
Confidence 23356788999998765 4578999999999999999999999863211 111 1111100 0000000
Q ss_pred ----------cccccCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 485 ----------DKDMRGTK---SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 485 ----------d~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
-+...... ........+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 00111235788999999999999999999986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=292.12 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=192.0
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|++|.||+|.. .++..+++|++..... .....+.+|++++++++||||+++++++...+..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 36799999999999995 4788999999875322 2356788999999999999999999999999999999999975
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
+|.+++..... .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||.+.......
T Consensus 83 ~l~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 83 DLYKLIKDRQR----GLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CHHHHHHhhcc----cCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 89888876432 489999999999999999999998 99999999999999999999999999987654432
Q ss_pred --cccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc---ccCcccc-
Q 008431 413 --AQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE---WTGEVFD- 485 (565)
Q Consensus 413 --~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d- 485 (565)
...++..|+|||.+.+. .++.++|||||||++|+|+||+.||..... .+....+....... ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-----IDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCchHhcccchhh
Confidence 23467789999987766 789999999999999999999999862110 00000010000000 0000000
Q ss_pred --------ccccCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 486 --------KDMRGTK---SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 486 --------~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+...... ........+.+++.+||+.||.+||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 01123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=291.40 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=188.4
Q ss_pred cceecccCceeEEEEEE----eCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEE
Q 008431 258 AEVLGSGSFGSSYKAVL----LTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 328 (565)
.+.||+|+||.||++.. .+|..||+|.++... ....+++.+|+.+++++ +|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46899999999999985 378899999987422 22346788999999999 5999999999999888999999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 85 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 85 DYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999997543 388899999999999999999998 9999999999999999999999999998765
Q ss_pred ccc-----ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 409 NKE-----HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 409 ~~~-----~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
... ....++..|+|||+... ..++.++|||||||++|||++|+.||..... ......+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~--- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE--- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccC---
Confidence 432 12346788999998765 3467899999999999999999999863111 111222222221111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
+.. +......+.+++.+|++.||++|| ++.+++.
T Consensus 229 ----~~~-----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----PPY-----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCC-----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001 111223677888999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.29 Aligned_cols=254 Identities=22% Similarity=0.253 Sum_probs=187.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC----------c
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE----------E 323 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----------~ 323 (565)
..+.||+|+||.||+|... ++..||+|.++... ......+.+|++++++++||||+++++++.+.. .
T Consensus 11 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence 4578999999999999964 68899999987432 223456788999999999999999999987654 7
Q ss_pred eEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccC
Q 008431 324 KLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA 403 (565)
Q Consensus 324 ~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 403 (565)
.++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEeCccc
Confidence 8999999986 7777776432 2489999999999999999999998 99999999999999999999999999
Q ss_pred Ccccccccc-----cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 404 LVPIVNKEH-----AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 404 la~~~~~~~-----~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++....... ...++..|+|||++.. ..++.++|||||||++|||++|++||..... ......+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~~~~~~~ 236 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELISRLCGS 236 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCC
Confidence 987654322 1234678999997754 4578999999999999999999999863111 1111111111111
Q ss_pred ccc---Cccc--------ccccc--CC--CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 EWT---GEVF--------DKDMR--GT--KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ~~~---~~~~--------d~~~~--~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
... ..+. ++.-. .. .........+.+++.+||+.||++|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0000 00000 00 000011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.99 Aligned_cols=254 Identities=17% Similarity=0.254 Sum_probs=188.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEe----cCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR----KEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~E 329 (565)
..+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++++++||||+++++++.. ....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 346899999999999994 578999999987432 2345678889999999999999999998763 346799999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+. |+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 89 ~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 89 LME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred hhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 995 68999886432 389999999999999999999998 99999999999999999999999999987653
Q ss_pred cc--------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh---
Q 008431 410 KE--------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE--- 477 (565)
Q Consensus 410 ~~--------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 477 (565)
.. ....++..|+|||++.. ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY-----VHQLKLILSVLGSPSE 233 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh-----HHHHHHHHHHhCCChh
Confidence 22 12356788999998655 4688999999999999999999999963211 0001111110000
Q ss_pred --------cccCccccccccCCCCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 478 --------EWTGEVFDKDMRGTKSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 478 --------~~~~~~~d~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+..-...... ......+.+++.+||+.+|++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000000000 1123568899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.04 Aligned_cols=240 Identities=20% Similarity=0.277 Sum_probs=187.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc-----CccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM-----SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 328 (565)
..+.||+|+||.||+|.. .++..||+|.+... .......+.+|++++++++||||+++++++.+. ...++++
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 457899999999999994 56899999987532 112235788999999999999999999998764 3578999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++++|.+++.... .+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 86 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 86 EYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999987533 378899999999999999999998 9999999999999999999999999998754
Q ss_pred ccc-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 409 NKE-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 409 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...-+....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~- 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--------AMAAIFKIATQP-T- 226 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--------HHHHHHHHHcCC-C-
Confidence 321 12346788999999988889999999999999999999999986321 111111111111 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+.+ +......+.+++.+|+. +|..|||+.+++.
T Consensus 227 ---~~~~-----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ---KPML-----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCC-----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111 11223467888889999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=282.38 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=188.7
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeeccC-ccCHHHHHHHHHHHh-cCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS-NVGKEDFHEHMTRLG-SLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..||.|+||+|+|-. .+.|+..|||+++... ..+..+++.|.+... .-+.||||+++|.+..++..|+.||.|+- |
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 579999999999987 5689999999998543 355678888887654 45799999999999999999999999964 7
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---c
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---H 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---~ 412 (565)
|..+-+.--.-....+++...-.|......||.||-... .|||||+||+|||+|..|.+|+||||++..+..+ +
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 765443211111124888888889999999999998764 7999999999999999999999999998776544 3
Q ss_pred cccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 AQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...|...|||||.+.. ..|+.++||||+|++|||+.||+.|+.. ..++.+.+...+.... |.+..
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-------w~svfeql~~Vv~gdp------p~l~~ 292 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-------WDSVFEQLCQVVIGDP------PILLF 292 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-------HHHHHHHHHHHHcCCC------CeecC
Confidence 3457788999997754 3589999999999999999999999862 1222222222222221 11111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.....+....+..++..|+..|-+.||...++.+
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1111233457888999999999999999988754
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=297.84 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=187.0
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc--CccCHHHHHHHHHHHhcC-CCCCccceEEEEEec--CceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRK--EEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~~lv~E~ 330 (565)
..+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +||||++++++|... ...++||||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 3468999999999999954 6889999988542 223345678899999999 999999999998654 357999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
++ ++|.+++... .++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 91 ME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 97 5999988643 388999999999999999999998 999999999999999999999999999876533
Q ss_pred cc---------cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh-----
Q 008431 411 EH---------AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV----- 475 (565)
Q Consensus 411 ~~---------~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----- 475 (565)
.. ...++..|+|||++.. ..++.++|||||||++|||+||+.||..... ......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST-----LNQLEKIIEVIGPPSA 234 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCH
Confidence 21 2346788999997654 5678999999999999999999999853211 00000000000
Q ss_pred ------hhcccCcccc----ccccCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 476 ------REEWTGEVFD----KDMRGTK-SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 476 ------~~~~~~~~~d----~~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+++ ....... ........+.+++.+|++.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000111 0000000 000123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=291.49 Aligned_cols=248 Identities=21% Similarity=0.237 Sum_probs=192.9
Q ss_pred ccceecccCceeEEEEEE----eCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL----LTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||.||+++. .++..||||.++... ....+.+.+|++++.++ +||||+++++.+......++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 346899999999999984 356789999987422 22345688999999999 599999999999988999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++.++++|||+++.
T Consensus 84 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 84 LDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999987532 388999999999999999999998 999999999999999999999999999876
Q ss_pred ccccc-----cccccccccCCCccCCCC--CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 408 VNKEH-----AQLHMVAYKSPEFNQTDG--VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 408 ~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
..... ...++..|+|||...+.. .+.++||||||+++|||+||..||..... ...............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~-- 228 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE----QNSQSEISRRILKSK-- 228 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc----cchHHHHHHHHHccC--
Confidence 43321 234678899999876654 78899999999999999999999862110 011111111111110
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
+... ......+.+++.+||+.||++|||+.+|.+.|...
T Consensus 229 -----~~~~-----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 -----PPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----CCCC-----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111 11123577888999999999999999887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=297.27 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=197.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC-----ceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-----EKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~ 328 (565)
..+.||+|+||.||+|+.. ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..|+||
T Consensus 4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence 3468999999999999954 58899999987543 334567999999999999999999999998765 789999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 84 e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 84 ELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9998 58999886533 489999999999999999999998 9999999999999999999999999998765
Q ss_pred cccc-------cccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc--
Q 008431 409 NKEH-------AQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-- 478 (565)
Q Consensus 409 ~~~~-------~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 478 (565)
.... ...++..|+|||++.+. .++.++|||||||++|+|++|++||.... ..+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~ 225 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD--------YIDQLNLIVEVLGT 225 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC--------HHHHHHHHHHhcCC
Confidence 4332 23467789999998877 78999999999999999999999996321 111111111100
Q ss_pred -c-----------cCccccccccCCCC-----CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhhcc
Q 008431 479 -W-----------TGEVFDKDMRGTKS-----GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELKER 532 (565)
Q Consensus 479 -~-----------~~~~~d~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~ 532 (565)
. ....+......... .......+.+++.+||+++|++|||+.++++. ++.++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0 00000000000000 01123467889999999999999999999984 6666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=294.53 Aligned_cols=238 Identities=21% Similarity=0.240 Sum_probs=191.0
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
++||+|+||.||-++ ..+|+.+|.|++.+.. .....-.+.|-.+|.+++.+.||.+--.|.+.+.+++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 689999999999999 5689999999986421 222344678999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
||.-+|.+.+. +++++..++.++.+|+.||.+||.. +||.||+||+|||+|++|+++|+|.|+|..+...
T Consensus 271 DLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 271 DLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999887654 4699999999999999999999999 9999999999999999999999999999876544
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
...+||.+|||||++....|+...|.||+||++|||+.|+.||..-- . ..-.+.+.+..... + .
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---e--Kvk~eEvdrr~~~~-------~----~ 407 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---E--KVKREEVDRRTLED-------P----E 407 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---h--hhhHHHHHHHHhcc-------h----h
Confidence 34589999999999999999999999999999999999999996210 0 00001111111111 0 1
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
..++....+..++....|+.||++|--.
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1122333455666667899999999743
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=290.38 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=190.4
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc-cCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||+||+|+.. +++.||+|++..... .......+|+..+++++ ||||+++++++...+..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 467999999999999964 578899999865322 22334567999999999 999999999999999999999999 78
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++.....
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 83 NLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred CHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 99999876541 2489999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCccC-CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCC--------CcchHHHHHHHhhhcccCc
Q 008431 412 HAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA--------NADLATWVNSVVREEWTGE 482 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 482 (565)
....++..|+|||++. ...++.++||||||++++||++|++||......... ...-..|............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2345678899999764 456789999999999999999999998532110000 0000001111100000000
Q ss_pred cccccccCC--CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGT--KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+....... .........+.+++.+|++.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 000011356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=286.44 Aligned_cols=243 Identities=18% Similarity=0.241 Sum_probs=188.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-----ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-----NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||.||++... .+..+++|.++... .....++..|+.++++++||||+++++++.+.+..++||||
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEe
Confidence 3468999999999999854 34456666654321 22334577899999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++ +.+|++|||+++....
T Consensus 84 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 84 CEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred CCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999998753322 23489999999999999999999998 9999999999999975 5699999999876533
Q ss_pred c----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 411 E----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 411 ~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
. ....++..|+|||+.....++.++||||||+++|+|++|..||.. .............. .+
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~------~~ 223 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG--------QNFLSVVLRIVEGP------TP 223 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHHcCC------CC
Confidence 2 234567889999998888889999999999999999999999862 11222222221111 11
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. +......+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 SL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 1122347788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=300.39 Aligned_cols=258 Identities=17% Similarity=0.237 Sum_probs=191.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec-----CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-----EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~ 328 (565)
..+.||+|+||+||+|+. .++..||||++... .......+.+|+.+++.++||||+++++++... ...|+||
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 346899999999999994 57899999998642 223345678899999999999999999988654 2479999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 89 e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 89 ELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred eCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9996 68998886432 389999999999999999999998 9999999999999999999999999998765
Q ss_pred ccc----ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh------
Q 008431 409 NKE----HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE------ 477 (565)
Q Consensus 409 ~~~----~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 477 (565)
... ....++..|+|||.+.. ..++.++|||||||++|||++|++||..... .............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPSEEDL 233 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCChHHh
Confidence 433 23356788999997654 4688999999999999999999999863110 0000000000000
Q ss_pred -----cccC-------ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhhc
Q 008431 478 -----EWTG-------EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELKE 531 (565)
Q Consensus 478 -----~~~~-------~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~ 531 (565)
.... ...++..... .......+.+++.+||+.+|++|||+.|+++. +..+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARL--FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHH--cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000 0000000000 01223467899999999999999999999877 655543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=298.65 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=184.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEec--------------
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-------------- 321 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------------- 321 (565)
..+.||.|+||.||+|.. .++..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 347899999999999995 57889999998765555567789999999999999999999876543
Q ss_pred CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-CCCCcEEe
Q 008431 322 EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLT 400 (565)
Q Consensus 322 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~ 400 (565)
...++||||++ ++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+|++
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEEEC
Confidence 34789999997 5998887532 388999999999999999999998 999999999999997 45678999
Q ss_pred ccCCccccccc-------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHH
Q 008431 401 DYALVPIVNKE-------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVN 472 (565)
Q Consensus 401 DfGla~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 472 (565)
|||+++..... ....++..|+|||++.. ..++.++|||||||++|||++|+.||..... ..-..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--------~~~~~ 229 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE--------LEQMQ 229 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 99998765322 12346778999997543 5688999999999999999999999962211 11111
Q ss_pred HHhhhc--------------ccCccccccccCCCCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 473 SVVREE--------------WTGEVFDKDMRGTKSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 473 ~~~~~~--------------~~~~~~d~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...... ....... .......+ ......+.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRN-DGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhh-cccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 110000 0000000 00000000 011246778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.52 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=184.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecC--------ceE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE--------EKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~ 325 (565)
..+.||+|+||.||+|.. .+++.+|+|++..... .....+.+|+++++.++||||+++++++.... ..+
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 346899999999999995 4688999999864322 22346788999999999999999999876543 369
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+||||+.+ +|...+..... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 92 lv~~~~~~-~l~~~~~~~~~----~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 92 MVTPYMDH-DLSGLLENPSV----KLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred EEEecCCc-CHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 99999975 78777764322 489999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc---------------cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHH
Q 008431 406 PIVNKEH---------------AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLAT 469 (565)
Q Consensus 406 ~~~~~~~---------------~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~ 469 (565)
+...... ...++..|+|||++.+ ..++.++|||||||++|||++|++||...... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~~~~ 237 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----DQLH 237 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence 7543221 1234677999997654 45889999999999999999999998632110 0000
Q ss_pred HHHHHhhh----cc-----cCc----cccccccCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 470 WVNSVVRE----EW-----TGE----VFDKDMRGTK--SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 470 ~~~~~~~~----~~-----~~~----~~d~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+...... .+ ... .......... ........+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 00 000 0000000000 00011246789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=293.23 Aligned_cols=257 Identities=20% Similarity=0.294 Sum_probs=188.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEe-cCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-KEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++.++|.. ....++|+||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 357899999999999984 47899999988642 22335678899999999999999999999876 55789999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 93 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 93 GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 56999888632 378888899999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCC-------CcchHHHHHHHhhhcccCcc
Q 008431 412 HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA-------NADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 483 (565)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||......... .....++........ ..+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 241 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN-TLRF 241 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh-hHHH
Confidence 23456788999998755 56899999999999999999999998632110000 000011111110000 0000
Q ss_pred ccccccCCCCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 484 FDKDMRGTKSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 484 ~d~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+.........+ ......+.+++.+|++.+|++|||+.|++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0112478889999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.26 Aligned_cols=256 Identities=19% Similarity=0.274 Sum_probs=189.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv 327 (565)
..+.||+|+||.||+|.. .+|..||+|++... .......+.+|+.++++++||||+++++++.... ..++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 347899999999999995 57899999998642 1223456889999999999999999999987543 45899
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+||+.. +|.++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 999964 7777652 1388999999999999999999998 899999999999999999999999999876
Q ss_pred cccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh--------
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-------- 477 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 477 (565)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...-+......
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhcCCCCHHH
Confidence 5433 23456788999998765 468899999999999999999999996311 11111111100
Q ss_pred ------cccCcccc--ccccCCCC---CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhhcc
Q 008431 478 ------EWTGEVFD--KDMRGTKS---GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELKER 532 (565)
Q Consensus 478 ------~~~~~~~d--~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~ 532 (565)
........ +....... .......+.+++.+||+.||++|||+.|++.. ++.++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000000 00000000 00112357789999999999999999999854 7776554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=287.10 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=192.0
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++||||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 357999999999999954 58999999987542 3335678899999999999999999999999999999999998 5
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++......
T Consensus 83 ~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 83 DLKKYLDKRPG----PLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 99999976432 389999999999999999999998 99999999999999999999999999987654332
Q ss_pred --cccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc----c--cCcc
Q 008431 413 --AQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE----W--TGEV 483 (565)
Q Consensus 413 --~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~ 483 (565)
....+..|+|||++... .++.++|||||||++||+++|++||..... ......+....... + ....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-----IDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHHHhCCCcHHHHHhhccc
Confidence 23346779999987666 789999999999999999999999863110 00111111111000 0 0000
Q ss_pred --ccccccC---CCC---CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 484 --FDKDMRG---TKS---GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 484 --~d~~~~~---~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+..... ... .......+.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000 0011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.81 Aligned_cols=188 Identities=23% Similarity=0.324 Sum_probs=164.0
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
++||+|.||+||||+ +.+++.||+|.++-. +..-....++||.+++.++|.|||++++....+...-+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 689999999999999 678899999999743 333456789999999999999999999999999999999999964 8
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.++.....+ .++......++.|+++||.|+|++ ++.|||+||.|.||+.+|+.|++|||+++...-.
T Consensus 87 lkkyfdslng----~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 87 LKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 9888876544 388999999999999999999999 8999999999999999999999999999876533
Q ss_pred ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHc-CCCCcc
Q 008431 412 HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLT-GKFPAN 455 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~t-g~~p~~ 455 (565)
+..+.|..|++|.++.+. -|++..|+||-|||+.|+.. |++.|.
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 455678999999987664 58999999999999999987 665564
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.28 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=186.5
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEEE
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLVS 328 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 328 (565)
.+.||+|+||.||+|. ..++..||||++.... ....+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 4689999999999998 4578999999985421 223456889999999999999999999987543 358999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++...
T Consensus 100 e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 100 PFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 999 77999888532 389999999999999999999998 9999999999999999999999999998765
Q ss_pred ccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCC-------CCcchHHHHHHHhhhcc
Q 008431 409 NKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKG-------ANADLATWVNSVVREEW 479 (565)
Q Consensus 409 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 479 (565)
... ....++..|+|||++.. ..++.++|||||||++|++++|+.||........ .......+........
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 247 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED- 247 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh-
Confidence 443 23456788999998765 4588999999999999999999999863110000 0000000110000000
Q ss_pred cCcccc--ccccCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 TGEVFD--KDMRGTK---SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 ~~~~~d--~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...... +...... ........+.+++.+|++.||++|||+.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000000 00112235789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=280.80 Aligned_cols=232 Identities=23% Similarity=0.269 Sum_probs=188.8
Q ss_pred ecccCceeEEEEEEe-CCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 261 LGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 261 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
||+|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 588999999875322 2345789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----c
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----H 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----~ 412 (565)
.+++.... .+++..+..++.|++.||.|+|+. +++|+||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 99997543 389999999999999999999997 9999999999999999999999999998765432 2
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
...++..|+|||...+...+.++|+||||+++||+++|+.||... +............ ..+.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~~~-------~~~~--- 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE--------DRKEIYEKILKDP-------LRFP--- 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHhcCC-------CCCC---
Confidence 345678899999988888899999999999999999999998621 1122222222110 0010
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLRE 521 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e 521 (565)
......+.+++.+||..||++|||+.+
T Consensus 214 --~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 --EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111246788899999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=317.03 Aligned_cols=240 Identities=21% Similarity=0.312 Sum_probs=179.5
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEe----------------
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR---------------- 320 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------------- 320 (565)
++||+||||.|||++ .-||+.||||++.-. +......+.+|+.++++|+|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 689999999999999 559999999999743 33445678899999999999999998731100
Q ss_pred --------------------------------------------------------------------------------
Q 008431 321 -------------------------------------------------------------------------------- 320 (565)
Q Consensus 321 -------------------------------------------------------------------------------- 320 (565)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------c--------CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC
Q 008431 321 ---------------K--------EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377 (565)
Q Consensus 321 ---------------~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~ 377 (565)
+ ..+||-||||+.-.++++++..... -.-...++++++|+.||+|+|+.
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYIH~~---- 716 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYIHDQ---- 716 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHHHhC----
Confidence 0 1247899999998888888754421 13567789999999999999999
Q ss_pred CCccCCCCCCCEEEcCCCCcEEeccCCccccc----------------------ccccccccccccCCCccCCC---CCC
Q 008431 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN----------------------KEHAQLHMVAYKSPEFNQTD---GVT 432 (565)
Q Consensus 378 ~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~----------------------~~~~~~~t~~y~aPE~~~~~---~~~ 432 (565)
+||||||||.||++|++..+||+|||+|+... ..++.+||.-|+|||++.+. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999997621 01234688899999987664 499
Q ss_pred cchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccC
Q 008431 433 RKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWN 512 (565)
Q Consensus 433 ~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~ 512 (565)
.|+|+||+|||++||+. ||.. ...-+..+ ..++.+....- +.+ .......-.+++.++++.|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~T-------sMERa~iL-~~LR~g~iP~~--~~f-----~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGT-------SMERASIL-TNLRKGSIPEP--ADF-----FDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCc-------hHHHHHHH-HhcccCCCCCC--ccc-----ccccchHHHHHHHHHhcCC
Confidence 99999999999999987 4541 11111111 11222211111 111 2234446678888999999
Q ss_pred cCCCCCHHHHHH
Q 008431 513 AERRWDLREAVE 524 (565)
Q Consensus 513 P~~RPs~~evl~ 524 (565)
|++|||+.|+++
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999865
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=293.27 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=185.8
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEEE
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLVS 328 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 328 (565)
.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 46799999999999984 578899999986422 22345788999999999999999999988643 3467888
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
+++ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 887 78999887532 389999999999999999999998 9999999999999999999999999998765
Q ss_pred ccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-c-----c
Q 008431 409 NKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-W-----T 480 (565)
Q Consensus 409 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~ 480 (565)
... ....++..|+|||...+ ..++.++|||||||++|||++|+.||.... ............ . .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCCCCHHHH
Confidence 433 23456788999998755 568899999999999999999999985211 111111110000 0 0
Q ss_pred Ccccc----------ccccCCCC---CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 GEVFD----------KDMRGTKS---GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 ~~~~d----------~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..+.+ +....... .......+.+++.+|++.||++|||+.|++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 00000000 00112357889999999999999999998765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=290.66 Aligned_cols=252 Identities=19% Similarity=0.238 Sum_probs=184.3
Q ss_pred ccceecccCceeEEEEEEe-C--CCeeEEEEeeccC--ccCHHHHHHHHHHHhcC-CCCCccceEEEEEec----CceEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-T--GPAMVVKRFRQMS--NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRK----EEKLL 326 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~~~l 326 (565)
..+.||+|+||.||++... + +..||+|++.... ....+.+.+|+.+++++ +||||+++++++... ...++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence 3468999999999999954 4 7789999986422 22345788999999999 599999999976432 35788
Q ss_pred EEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 327 VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
++||+. ++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 84 YEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 999986 69999886432 389999999999999999999998 99999999999999999999999999987
Q ss_pred ccccc--------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHH--------
Q 008431 407 IVNKE--------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLAT-------- 469 (565)
Q Consensus 407 ~~~~~--------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~-------- 469 (565)
..... ....++..|+|||+..+ ..++.++|||||||++|||++|++||..... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~ 228 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQVLGT 228 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHHHhCC
Confidence 54321 12357888999997655 5689999999999999999999999863110 00111
Q ss_pred ----HHHHHhhhc---c---cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 470 ----WVNSVVREE---W---TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 470 ----~~~~~~~~~---~---~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+........ . ....-...+... .......+.+++.+|++.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESI--FPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhh--CCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0 000000000000 00112468889999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=287.03 Aligned_cols=239 Identities=21% Similarity=0.294 Sum_probs=191.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++ ||||+++++++...+..++||||+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 346799999999999995 478999999886421 223457889999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||++......
T Consensus 85 ~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 85 PNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999997643 399999999999999999999998 9999999999999999999999999998754332
Q ss_pred c------------------------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcch
Q 008431 412 H------------------------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADL 467 (565)
Q Consensus 412 ~------------------------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~ 467 (565)
. ...++..|+|||......++.++|||||||+++|+++|+.||.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~ 227 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--------E 227 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--------H
Confidence 1 1235678999999888889999999999999999999999987321 1
Q ss_pred HHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCH----HHHHH
Q 008431 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL----REAVE 524 (565)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~----~evl~ 524 (565)
...........+ .+ +......+.+++.+||+.+|++|||+ +|+++
T Consensus 228 ~~~~~~~~~~~~---~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTFQKILKLEY---SF---------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHHhcCC---CC---------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111111100 00 01112467889999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=315.43 Aligned_cols=140 Identities=24% Similarity=0.314 Sum_probs=125.1
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||+|+||+||+|... +++.||+|+++.... .....+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999965 788999999875322 2235788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
|+|.+++.... .+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999997543 388899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=279.30 Aligned_cols=220 Identities=19% Similarity=0.207 Sum_probs=175.2
Q ss_pred cCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHHHHHhh
Q 008431 264 GSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHV 342 (565)
Q Consensus 264 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 342 (565)
|.||.||+++. .+++.+|+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999994 578899999986532 234455556666799999999999999999999999999999999875
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-cccccccccc
Q 008431 343 RRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQLHMVAYK 421 (565)
Q Consensus 343 ~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~t~~y~ 421 (565)
.. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+...... ....++..|+
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC 149 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcccc
Confidence 43 389999999999999999999998 9999999999999999999999999987655432 2334466799
Q ss_pred CCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHH
Q 008431 422 SPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKL 501 (565)
Q Consensus 422 aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 501 (565)
|||+.....++.++||||+||++|||++|+.|+........ . .....+. ......+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~-----~~~~~~~-----~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------T-----HTTLNIP-----EWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------c-----ccccCCc-----ccCCHHH
Confidence 99998888899999999999999999999988752110000 0 0000010 1112367
Q ss_pred HHHHhhccccCcCCCCCHHH
Q 008431 502 LKIGMCCCEWNAERRWDLRE 521 (565)
Q Consensus 502 ~~l~~~Cl~~~P~~RPs~~e 521 (565)
.+++.+|++.||++|||+.+
T Consensus 206 ~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHccCCHHHhcCCCc
Confidence 78899999999999999744
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=292.63 Aligned_cols=249 Identities=19% Similarity=0.274 Sum_probs=187.4
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc------eEEEE
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE------KLLVS 328 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lv~ 328 (565)
...||+|+||.||+|+.. ++..||+|++... .....+.+.+|+.++++++||||+++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 468999999999999964 6789999988642 12234567889999999999999999998876554 89999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 100 e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 100 HLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 999 57999988642 389999999999999999999998 9999999999999999999999999998765
Q ss_pred ccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-c------
Q 008431 409 NKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-W------ 479 (565)
Q Consensus 409 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~------ 479 (565)
... ....++..|+|||.... ..++.++|||||||++|||+||+.||.... ....+....... .
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD--------HIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHhcCCCCHHHH
Confidence 433 33456788999998654 467899999999999999999999986211 111111111000 0
Q ss_pred -------cCcccccc-ccCCCC----CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 -------TGEVFDKD-MRGTKS----GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 -------~~~~~d~~-~~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
....+... ...... .......+.+++.+||+.+|++|||+.||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 000000 00113478899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=288.96 Aligned_cols=241 Identities=22% Similarity=0.374 Sum_probs=194.2
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
.++||+|.||+||-|+ .++|+.||||.+.+. .......+++|+.+|+.++||.||.+.-.|...+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5899999999999999 678999999999753 344456799999999999999999999999999999999999964
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC---CCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA---YEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGla~~~~~~ 411 (565)
|..+.+-.... ..|++.....++.||+.||.|||.+ +|+|+||||+|||+.+. -.+||||||+|++..+.
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 66555543322 2489989999999999999999998 99999999999999643 46899999999998765
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+.+||+.|+|||++....|...-|+||.|||+|--++|..||+.. .++.+-++... -++.+..
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-------EdIndQIQNAa------FMyPp~P 787 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-------EDINDQIQNAA------FMYPPNP 787 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-------cchhHHhhccc------cccCCCc
Confidence 4668999999999999999999999999999999999999999842 23333222111 1111111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+.....++++...|+..-.+|.|.+..+.
T Consensus 788 -----W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 -----WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -----hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1222346778888889999999999887643
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=271.30 Aligned_cols=198 Identities=22% Similarity=0.294 Sum_probs=172.9
Q ss_pred ccchhHHHhhccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCH---HHHHHHHHHHhcCCCCCccceEEEEEecC
Q 008431 247 MFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGK---EDFHEHMTRLGSLSHPNLLPLIAFYYRKE 322 (565)
Q Consensus 247 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 322 (565)
..+.+++. ..++||+|.||.|.+++ ..+++.+|+|.+++.--..+ ..-+.|-++|+..+||.+..+.-.|...+
T Consensus 164 kvTm~dFd--fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 164 KVTMEDFD--FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred eeccchhh--HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34555543 34789999999999999 66899999999986433223 34567889999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
.+|+||||..||.|+-+|...+ .+++...+.+...|..||.|||++ +||.||||.+|.|+|.+|++||+||
T Consensus 242 rlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeec
Confidence 9999999999999998887544 489999999999999999999998 9999999999999999999999999
Q ss_pred CCccccc----ccccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 403 ALVPIVN----KEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 403 Gla~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
|+++.-- ..++.+||+.|+|||++....|+..+|.|.+||++|||+.|+.||.
T Consensus 313 GLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 313 GLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred ccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 9987532 2256789999999999999999999999999999999999999997
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=249.30 Aligned_cols=203 Identities=22% Similarity=0.356 Sum_probs=167.2
Q ss_pred cchhHHHhhccceecccCceeEEEEE-EeCCCeeEEEEeec-cCccCHHHHHHHHHHHhc-CCCCCccceEEEEEecCce
Q 008431 248 FELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ-MSNVGKEDFHEHMTRLGS-LSHPNLLPLIAFYYRKEEK 324 (565)
Q Consensus 248 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~ 324 (565)
|++.+........||+|+||.|-+-+ ..+|...|+|.++. ...+..++.++|+.+..+ ...|.+|.++|...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 55554444456789999999998887 45899999999974 334556678888887554 5799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
++.||.|+. ||..+-++--..+ ..+++...-+|+..|..||.|||++. .+||||+||+|||++.+|++|+||||+
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEccccc
Confidence 999999975 8877665432222 24889999999999999999999985 799999999999999999999999999
Q ss_pred cccccccc---cccccccccCCCccCC----CCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 405 VPIVNKEH---AQLHMVAYKSPEFNQT----DGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 405 a~~~~~~~---~~~~t~~y~aPE~~~~----~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
+..+..+- -..|...|||||.+.. ..|+-|+||||+|+++.||.+++.||+
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 98876552 2456778999997643 379999999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=264.90 Aligned_cols=235 Identities=25% Similarity=0.313 Sum_probs=190.5
Q ss_pred CceeEEEEEEe-CCCeeEEEEeeccCccC-HHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHHHHHhh
Q 008431 265 SFGSSYKAVLL-TGPAMVVKRFRQMSNVG-KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHV 342 (565)
Q Consensus 265 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 342 (565)
+||.||+|... ++..+|+|.+....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999997654444 67899999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---cccccccc
Q 008431 343 RRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---HAQLHMVA 419 (565)
Q Consensus 343 ~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---~~~~~t~~ 419 (565)
... +++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+...... ....++..
T Consensus 81 ~~~-----~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 81 RGR-----LSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred ccC-----CCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 432 88999999999999999999998 9999999999999999999999999998776543 34556788
Q ss_pred ccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHH
Q 008431 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEML 499 (565)
Q Consensus 420 y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 499 (565)
|++||......++.++||||||++++|+++|..||... .......... ....... .. .......
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-------~~~~~~~~~~-~~~~~~~----~~----~~~~~~~ 215 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-------DQLLELFKKI-GKPKPPF----PP----PEWKISP 215 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHH-hccCCCC----cc----ccccCCH
Confidence 99999988888999999999999999999999998621 1111222111 1110000 00 0000224
Q ss_pred HHHHHHhhccccCcCCCCCHHHHHH
Q 008431 500 KLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 500 ~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 7888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.70 Aligned_cols=245 Identities=20% Similarity=0.281 Sum_probs=185.4
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeecc---CccC----HHHHHHHHHHHhcCCCCCccceEEEEE-ecCceEEEEe
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVG----KEDFHEHMTRLGSLSHPNLLPLIAFYY-RKEEKLLVSD 329 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~E 329 (565)
.+||+|||+.||||.. ...+.||||.-... .... .+...+|.++.+.|.||-||+++++|. +.+.+|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 5799999999999994 45667777764311 1111 234678999999999999999999996 5678899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc---CCCCcEEeccCCcc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD---NAYEPLLTDYALVP 406 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~ 406 (565)
||+|.+|.-||+..+. +++..+..|+.||+.||.||....+ +|||-||||.|||+- ..|.+||.|||+++
T Consensus 549 YceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikp--PIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKP--PIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCC--CeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999987664 8999999999999999999988754 799999999999994 46789999999999
Q ss_pred cccccc-----------cccccccccCCCccCC----CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHH
Q 008431 407 IVNKEH-----------AQLHMVAYKSPEFNQT----DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWV 471 (565)
Q Consensus 407 ~~~~~~-----------~~~~t~~y~aPE~~~~----~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 471 (565)
+++.+. ...||.+|++||.+.- .+++.|+||||.|||+|..+.|+.||..... -
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-----------Q 690 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-----------Q 690 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-----------H
Confidence 987542 2357899999997543 3578999999999999999999999963111 1
Q ss_pred HHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 472 NSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 472 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..++.+..+-....-..... +....+..+++.+||++.-++|....++..
T Consensus 691 QdILqeNTIlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 QDILQENTILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHHhhhchhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 12222222211111111111 112235677888999999999998877654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=290.89 Aligned_cols=243 Identities=22% Similarity=0.320 Sum_probs=196.5
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEe-----cCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYR-----KEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~~~~~lv~E 329 (565)
..++||+|.+|.||+++ .++++.+|||..... ....+++..|.++++.. .|||++.++|+|.. ++++|||||
T Consensus 23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 34789999999999999 678888888887654 34466788888988887 59999999999864 468999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
||.+||..+++++... ..+.|..+..|++.++.|+.+||.. .++|||||-.|||++.++.+|++|||++..++
T Consensus 102 fC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred ccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 9999999999987662 3599999999999999999999998 89999999999999999999999999987765
Q ss_pred cc----ccccccccccCCCccCCC-----CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 410 KE----HAQLHMVAYKSPEFNQTD-----GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 410 ~~----~~~~~t~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
.. .+.+||+.|||||++... .|+..+|+||+|++..||.-|.+|+.++-+ ...+-. +
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------mraLF~------I 240 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------MRALFL------I 240 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------hhhhcc------C
Confidence 43 466899999999987654 477899999999999999999999763221 111111 1
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..--.|.+.. +..-.+++.+++..||..|-++||++.+.++
T Consensus 241 pRNPPPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 PRNPPPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111222221 2344568899999999999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.23 Aligned_cols=233 Identities=20% Similarity=0.233 Sum_probs=183.9
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
...+|.|+|+.|-++. ..+++..+||.+.+.. .+-.+|+.++... +||||+++.+.+.+..+.|+|||++.+|-
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 3459999999999998 5678899999987542 2233466555444 79999999999999999999999999998
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE-cCCCCcEEeccCCcccccccc-c
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL-DNAYEPLLTDYALVPIVNKEH-A 413 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl-~~~~~~kl~DfGla~~~~~~~-~ 413 (565)
+.+.+...+. +. ..+..|+.+|+.|+.|||.+ +||||||||+|||+ ++.++++|+|||.++...... +
T Consensus 403 ll~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~t 472 (612)
T KOG0603|consen 403 LLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDT 472 (612)
T ss_pred HHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCchhhcc
Confidence 8887765432 22 67778999999999999998 99999999999999 589999999999998876652 3
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
.+-|..|.|||+.....|++++|+||||++||||++|+.||..-.. + . .+...+..+..
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~------~-~-ei~~~i~~~~~------------- 531 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA------G-I-EIHTRIQMPKF------------- 531 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc------h-H-HHHHhhcCCcc-------------
Confidence 4567889999999999999999999999999999999999973211 1 1 11111111111
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.........+|+..||+.||.+||+|.++...
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 12223367788889999999999999998653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=267.66 Aligned_cols=251 Identities=21% Similarity=0.288 Sum_probs=198.7
Q ss_pred cceecccCceeEEEEEEeC------CCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEec-CceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAVLLT------GPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-EEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~E 329 (565)
..++-+|.||.||+|.+++ .+.|-+|.++.. ++.....++.|...+..+.|||+.++.+.+... +..+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 4568899999999997653 345677777643 334456789999999999999999999998754 56789999
Q ss_pred ccCCCCHHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 330 FVPNGSLANLLHVRRAP---GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
++.-|+|..+|..-+.. ....++-.+...++.|++.|++|||.+ +|||.||..+|++||+...+|++|=.+++
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----CcccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999844321 223467778889999999999999999 99999999999999999999999999998
Q ss_pred ccccccc------ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 407 IVNKEHA------QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 407 ~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
-+-+... ......||+||.+....|+.++|||||||+||||+| |+.|+.++.+ . .+...+.++.
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--------f-Em~~ylkdGy 515 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------F-EMEHYLKDGY 515 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------H-HHHHHHhccc
Confidence 7654322 123468999999999999999999999999999998 9999874332 1 2333344432
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
. ...+-++..++..++..||+..|++||+.++++..|.+...
T Consensus 516 R----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 516 R----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred e----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 1 11122444578889999999999999999999999988754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.87 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=188.0
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeec--cCccCHHHHHHHHHHHhcCCCCCccceEEEEEec--------CceEEE
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--------EEKLLV 327 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lv 327 (565)
.+||+|.||.||+|+ ..+|+.||+|++-- ....-.....+|+.+|..++|+|++.+++.|... ..+|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 579999999999999 45678889887642 2233345678999999999999999999988542 347999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|++|+. +|.-+|.+... .++...+.+++.++..||.|+|.. .|+|||+||+|+||+.++.+||+|||+++.
T Consensus 103 f~~ceh-DLaGlLsn~~v----r~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKV----RFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred HHHhhh-hHHHHhcCccc----cccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 999986 99999876543 388999999999999999999998 899999999999999999999999999976
Q ss_pred ccccc--------cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh---
Q 008431 408 VNKEH--------AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV--- 475 (565)
Q Consensus 408 ~~~~~--------~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 475 (565)
..... ..+.|..|++||.+.+ ..|+++.|||..|||+.||.||.+-+..-.. ......+....
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-----qqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-----QQQLHLISQLCGSI 248 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-----HHHHHHHHHHhccC
Confidence 54321 2234889999997655 5799999999999999999999988752111 11111221111
Q ss_pred -hhcccC-------ccc-cccccCCCC--CHHHHH------HHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 476 -REEWTG-------EVF-DKDMRGTKS--GEGEML------KLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 476 -~~~~~~-------~~~-d~~~~~~~~--~~~~~~------~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
.+-|.. +.+ -+.+..... .++.++ ..++++...+..||.+|+++++++..---
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 111110 000 000100000 011111 56778889999999999999999766443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.48 Aligned_cols=190 Identities=24% Similarity=0.283 Sum_probs=169.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||.|..+++ .+++.||+|++.+. ......-|..|-.+|...+.+-||.++-.|.++.++|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 457899999999999995 57889999999763 23444568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
||||-.++.... .+++..+..++..|.-||.-+|+. |+|||||||+|||||..|++|++|||.+-.+..+
T Consensus 159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 999999998655 389999999999999999999998 9999999999999999999999999988666543
Q ss_pred ----ccccccccccCCCccC----C-CCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 412 ----HAQLHMVAYKSPEFNQ----T-DGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~----~-~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
...+|||-|.+||++. + +.|++.+|.||+||++|||+.|..||.
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 3568999999999764 2 578999999999999999999999996
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=269.72 Aligned_cols=232 Identities=19% Similarity=0.232 Sum_probs=183.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
...+||+|+||.|.+|..+ +.+.+|||.+++.- ..+.+--+.|-++|+-- +-|.+++++.+|..-+.+|+||||+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence 3478999999999999854 56789999987532 12222234555666554 4678999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
.||+|--++++.+. +.+..+..++.+||.||-|||++ +||.||||..|||+|.+|++||+|||+++..--
T Consensus 433 nGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 433 NGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred cCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999988876654 78889999999999999999999 999999999999999999999999999875422
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
..+.+||+.|+|||++...+|+..+|.|||||+||||+.|++||+. .+-.+..+.+....
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--------eDE~elF~aI~ehn--------- 566 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--------EDEDELFQAIMEHN--------- 566 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHHcc---------
Confidence 2456899999999999999999999999999999999999999973 22233333333322
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCC
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRW 517 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 517 (565)
..++.....+.+++...-+...|.+|-
T Consensus 567 ---vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ---VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112233334566677777888888884
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=270.80 Aligned_cols=253 Identities=19% Similarity=0.284 Sum_probs=192.3
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCC--C----CccceEEEEEecCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH--P----NLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~~~~~~~~~~~lv~E~ 330 (565)
...+|+|.||.|-.+. ..++..||+|.++... .-.+..+-|+++++++.+ | -+|.+.+||.-.++.|+|+|.
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfel 172 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFEL 172 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEec
Confidence 3579999999999999 4567899999987642 335667789999999943 2 278888999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-----------------
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN----------------- 393 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~----------------- 393 (565)
+ |-|+++++....- ..++...+..++.|++++++|||+. +++|-||||+|||+.+
T Consensus 173 l-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 173 L-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred c-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEeccCCccceec
Confidence 9 4599999976443 3588999999999999999999998 9999999999999832
Q ss_pred ---CCCcEEeccCCcccccccc-cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHH
Q 008431 394 ---AYEPLLTDYALVPIVNKEH-AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLAT 469 (565)
Q Consensus 394 ---~~~~kl~DfGla~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~ 469 (565)
+..+||+|||-|+...... ..+.|..|+|||++.+-+++.++||||+||||+|+.||...|..-. ....+ .
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe----n~EHL-a 319 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE----NLEHL-A 319 (415)
T ss_pred cCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC----cHHHH-H
Confidence 3458999999998876654 4467899999999999999999999999999999999999885211 00111 1
Q ss_pred HHHHHhh-----------------hc---ccC--------cccccccc---CCCCCHHHHHHHHHHHhhccccCcCCCCC
Q 008431 470 WVNSVVR-----------------EE---WTG--------EVFDKDMR---GTKSGEGEMLKLLKIGMCCCEWNAERRWD 518 (565)
Q Consensus 470 ~~~~~~~-----------------~~---~~~--------~~~d~~~~---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs 518 (565)
.+...+. .+ |.. .+.++... -......+...+.+|+.++|..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 2222111 00 000 00000000 01112456678999999999999999999
Q ss_pred HHHHHH
Q 008431 519 LREAVE 524 (565)
Q Consensus 519 ~~evl~ 524 (565)
+.|++.
T Consensus 400 l~EAL~ 405 (415)
T KOG0671|consen 400 LREALS 405 (415)
T ss_pred HHHHhc
Confidence 999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=282.94 Aligned_cols=253 Identities=16% Similarity=0.221 Sum_probs=172.6
Q ss_pred ccceecccCceeEEEEEE-----------------eCCCeeEEEEeeccCccCHHH--------------HHHHHHHHhc
Q 008431 257 SAEVLGSGSFGSSYKAVL-----------------LTGPAMVVKRFRQMSNVGKED--------------FHEHMTRLGS 305 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~l~~ 305 (565)
..++||+|+||+||+|.. ..++.||||++........++ +..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 457899999999999963 235679999986543322333 3446777777
Q ss_pred CCCCCc-----cceEEEEEe--------cCceEEEEeccCCCCHHHHHhhcCCC-------------------CCCCCCH
Q 008431 306 LSHPNL-----LPLIAFYYR--------KEEKLLVSDFVPNGSLANLLHVRRAP-------------------GQPGLDW 353 (565)
Q Consensus 306 l~H~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~~l~~ 353 (565)
++|.++ ++++++|.. .+..+|||||+++|+|.++++..... ....++|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 776654 677888753 35689999999999999999753211 0123578
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-----cccccccccCCCccCC
Q 008431 354 PIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-----AQLHMVAYKSPEFNQT 428 (565)
Q Consensus 354 ~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-----~~~~t~~y~aPE~~~~ 428 (565)
..+..++.|++.||.|+|+. +|+||||||+|||++.++.+||+|||+++...... ...+++.|+|||.+..
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 88999999999999999998 89999999999999999999999999986543221 1234688999997653
Q ss_pred CC--------------------C--CcchhHHHHHHHHHHHHcCCC-CccccccCCCC----CcchHHHHHHHhhhcccC
Q 008431 429 DG--------------------V--TRKTDVWSLGILILELLTGKF-PANYLAQGKGA----NADLATWVNSVVREEWTG 481 (565)
Q Consensus 429 ~~--------------------~--~~~~DvwS~Gvil~el~tg~~-p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 481 (565)
.. | ..+.||||+||++|||++|.. |+......... ..++..|.. ...
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~---- 458 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKG---- 458 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcc----
Confidence 22 1 235799999999999999985 66421110000 011111110 000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCc---CCCCCHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNA---ERRWDLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P---~~RPs~~evl~ 524 (565)
..++-.. .........+++.+++..+| .+|+|++|+++
T Consensus 459 ~~~~~~~-----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFSL-----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCccc-----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0001000 01112356777778888765 78999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=292.23 Aligned_cols=255 Identities=18% Similarity=0.215 Sum_probs=162.2
Q ss_pred ccceecccCceeEEEEEEe-C----CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEE------EEecCceE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-T----GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF------YYRKEEKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~~~~~~~ 325 (565)
..+.||+|+||.||+|++. + +..||+|++..... .+.+..| .+....+.+++.+... +......+
T Consensus 136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 4578999999999999964 4 68999998764221 2222222 1222223333332222 23456789
Q ss_pred EEEeccCCCCHHHHHhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEE
Q 008431 326 LVSDFVPNGSLANLLHVRRAPG---------------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVL 390 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NIL 390 (565)
+||||+++++|.+++....... .....+..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDLKP~NIL 287 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDVKPQNII 287 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcCCHHHEE
Confidence 9999999999999987542110 00112334567999999999999998 9999999999999
Q ss_pred EcC-CCCcEEeccCCccccccc-----ccccccccccCCCccCCC----------------------CCCcchhHHHHHH
Q 008431 391 LDN-AYEPLLTDYALVPIVNKE-----HAQLHMVAYKSPEFNQTD----------------------GVTRKTDVWSLGI 442 (565)
Q Consensus 391 l~~-~~~~kl~DfGla~~~~~~-----~~~~~t~~y~aPE~~~~~----------------------~~~~~~DvwS~Gv 442 (565)
++. ++.+||+|||+++..... ....+++.|+|||.+... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 985 579999999999765322 334678899999954321 2445679999999
Q ss_pred HHHHHHcCCCCcccccc-----CCCCCcchHHHHHHHhhhcccCccccccccC-CCCCHHHHHHHHHHHhhccccCcCCC
Q 008431 443 LILELLTGKFPANYLAQ-----GKGANADLATWVNSVVREEWTGEVFDKDMRG-TKSGEGEMLKLLKIGMCCCEWNAERR 516 (565)
Q Consensus 443 il~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~R 516 (565)
++|||+++..|++.... ......+...|....... ..+.+.. ............+++.+||+.||++|
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999998777542100 000001122221111000 0000000 00000011234578899999999999
Q ss_pred CCHHHHHHH
Q 008431 517 WDLREAVEK 525 (565)
Q Consensus 517 Ps~~evl~~ 525 (565)
||+.|+++.
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=277.78 Aligned_cols=233 Identities=20% Similarity=0.239 Sum_probs=190.3
Q ss_pred ceecccCceeEEEEEEeCCC-eeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAVLLTGP-AMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..||-|+||.|-+....... .+|+|.+++. +....+....|-++|..++.|.||+++..|.+....|+.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 46999999999998854433 4888887642 3445677889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
.|...|+.++. ++...+..++..+.+|++|||++ +||.|||||+|+++|.+|-+||.|||+|+.+....
T Consensus 506 ElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 506 ELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 99999987654 88889999999999999999999 99999999999999999999999999999886553
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
+.+||+.|.|||++.....+..+|.||+|+++|||+||++||....+. .-...++..- .. .
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--------ktYn~ILkGi--d~--------i 638 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--------KTYNLILKGI--DK--------I 638 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--------HHHHHHHhhh--hh--------h
Confidence 568999999999999999999999999999999999999999843221 1111111111 00 1
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCC
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWD 518 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs 518 (565)
..+....+...+++++.+..+|.+|--
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 111222335677888888999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=272.06 Aligned_cols=193 Identities=21% Similarity=0.317 Sum_probs=166.9
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCccC---HHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVG---KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||-|+||.|.++. .++...+|.|.+++.+... ......|-.+|.....+-||+|+-.|.+++.+|+||||++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 3569999999999998 5677789999998654322 34577899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc-----
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV----- 408 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~----- 408 (565)
||+-.+|-..+. |.+..++.++.++..|+++.|.. |+|||||||+|||||.+|++||.||||+.-.
T Consensus 714 GDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 714 GDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 999999976553 88999999999999999999998 9999999999999999999999999997421
Q ss_pred ----ccc-------------------------------------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHH
Q 008431 409 ----NKE-------------------------------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILEL 447 (565)
Q Consensus 409 ----~~~-------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el 447 (565)
... +..+||..|+|||++....|+..+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 100 011478899999999999999999999999999999
Q ss_pred HcCCCCcccccc
Q 008431 448 LTGKFPANYLAQ 459 (565)
Q Consensus 448 ~tg~~p~~~~~~ 459 (565)
+.|++||-...+
T Consensus 865 ~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 865 LVGQPPFLADTP 876 (1034)
T ss_pred hhCCCCccCCCC
Confidence 999999975443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=281.00 Aligned_cols=239 Identities=18% Similarity=0.230 Sum_probs=180.9
Q ss_pred ccceecccCce-eEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFG-SSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+++|.|+.| .||+|.. .|+.||||++-.. ...-..+||..|+.- +|||||++++.-.++...||..|.|. .
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 45679999988 6799987 6889999998532 233456899999987 59999999999889999999999996 5
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-----CCCcEEeccCCccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-----AYEPLLTDYALVPIVN 409 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DfGla~~~~ 409 (565)
+|.+++..... ......-...+.+..|+++||++||+. +||||||||.||||+. ..+++|+|||+++.+.
T Consensus 588 sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 588 SLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999987411 111111134577889999999999997 9999999999999975 2578999999999876
Q ss_pred ccc-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcC-CCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 410 KEH-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTG-KFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 410 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
... ...||-+|+|||++....-+.++||+|+||++|..+|| ..||...-.. - ..++....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---------~-~NIl~~~~-- 730 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---------Q-ANILTGNY-- 730 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---------h-hhhhcCcc--
Confidence 542 34678999999999888888899999999999999996 9999632110 0 00111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+.......++ ...+++.+++.++|..||++.+|+.
T Consensus 731 -----~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 -----TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00001111122 6788999999999999999999963
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=253.62 Aligned_cols=254 Identities=17% Similarity=0.306 Sum_probs=187.3
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec-----CceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-----EEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~E 329 (565)
.+-||-|+||+||... -++|+.||.|++... .-...+.+.+|+.+|..++|.|+...++..... .+.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 3679999999999998 458999999998642 233457899999999999999999998877543 35789999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
.|.. +|.+++-... .++...+.-++.||++||.|||+. +|.||||||.|.|++++...||||||+++..+
T Consensus 138 LmQS-DLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHh-hhhheeccCC-----CCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccc
Confidence 9964 8888875432 378888888999999999999999 99999999999999999999999999999876
Q ss_pred cccc-----ccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHH------------
Q 008431 410 KEHA-----QLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWV------------ 471 (565)
Q Consensus 410 ~~~~-----~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~------------ 471 (565)
.+.. .+.|.+|+|||++.+ ..|+.+.||||.|||+.||+-.+.-|.-..+ ..-.+.+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-----iqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-----IEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-----HHHHHHHHHHhCCCcHHHH
Confidence 5432 245778999998766 5699999999999999999998887752211 1111111
Q ss_pred HHHhhhcccCcccc-----cccc---CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 472 NSVVREEWTGEVFD-----KDMR---GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 472 ~~~~~~~~~~~~~d-----~~~~---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
+...+.. ...++. |... ....+...-...+.+.+..+..||+.|.+..+.+..+.
T Consensus 283 r~ACEGA-k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 283 KYACEGA-KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhhh-HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111111 011111 1111 11111122234566777889999999999998876644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=268.92 Aligned_cols=275 Identities=19% Similarity=0.289 Sum_probs=213.0
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.+|.|.||.|||++ ..+++..|+|.++-.......-..+|+-+++.++|||||.++|.+..++..++.||||.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 45789999999999999 56789999999986655566677889999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc----cc
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN----KE 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~----~~ 411 (565)
|++.-+.-. .+++.++..+++...+||.|||+. +-+|||||-.|||+++.+.+|++|||.+..++ ..
T Consensus 99 lQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 99 LQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred ccceeeecc-----cchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 999876433 488999999999999999999998 88899999999999999999999999986554 34
Q ss_pred ccccccccccCCCcc---CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 HAQLHMVAYKSPEFN---QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~---~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+..||++|||||+. ..+.|..++|||+.|++..|+---++|.... ...-...+.. ....-.|.+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl----------hpmr~l~LmT--kS~~qpp~l 237 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL----------HPMRALFLMT--KSGFQPPTL 237 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc----------chHHHHHHhh--ccCCCCCcc
Confidence 677899999999964 4567999999999999999998888885421 1111111111 011112222
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHH---------------HHHHHHhhccCCCCCCcCccccccccccccc
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREA---------------VEKIMELKERDNDNEDYSSYASEDYVYSSRA 553 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev---------------l~~L~~i~~~~~~~~~~~~~~~~~~~~~~~~ 553 (565)
.... .-...+-++++.|+-.+|++|||+... +++|+++........+..++..|++...-.+
T Consensus 238 kDk~---kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 238 KDKT---KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred cCCc---cchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 2211 122357788889999999999998765 4566666665544555566666777665554
Q ss_pred CC
Q 008431 554 MT 555 (565)
Q Consensus 554 ~~ 555 (565)
+.
T Consensus 315 i~ 316 (829)
T KOG0576|consen 315 IC 316 (829)
T ss_pred hh
Confidence 44
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=235.09 Aligned_cols=206 Identities=28% Similarity=0.442 Sum_probs=180.0
Q ss_pred ecccCceeEEEEEEeC-CCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHHH
Q 008431 261 LGSGSFGSSYKAVLLT-GPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLAN 338 (565)
Q Consensus 261 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 338 (565)
||+|++|.||++.... +..+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999654 889999998754322 34679999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCccccccc----cc
Q 008431 339 LLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVNKE----HA 413 (565)
Q Consensus 339 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~----~~ 413 (565)
++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. +..++++|||.+...... ..
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 997643 1388999999999999999999998 9999999999999999 899999999998765443 23
Q ss_pred ccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 414 QLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
..+...|++||..... .++.+.|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4466789999988776 788999999999999998
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257788889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=242.26 Aligned_cols=240 Identities=18% Similarity=0.232 Sum_probs=185.7
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
...+||+|+|+.|..++ .++.+.+|+|++++.- ..+.+=...|-.+..+. +||.+|.+..+|..+..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 45789999999999999 5577889999987521 11222233455555444 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
+||+|--+++..+. ++++.+..+...|+.||.|||++ +||.||||..|+|+|..+++|+.|+|+++..-.
T Consensus 334 ~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 334 NGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred cCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999877765543 99999999999999999999999 999999999999999999999999999876432
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.++.+||+.|.|||++.+..|+..+|.|++||+++||+.|+.||+-.... ....+..+++-..+.+..
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-n~d~ntedylfqvilekq-------- 475 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-NPDMNTEDYLFQVILEKQ-------- 475 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-CcccchhHHHHHHHhhhc--------
Confidence 24568999999999999999999999999999999999999999854322 222344444444333321
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCC
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRW 517 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 517 (565)
++.. .....+...+.+.-|..||.+|-
T Consensus 476 irip---rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRIP---RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccc---ceeehhhHHHHHHhhcCCcHHhc
Confidence 1111 11112444566677888999885
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=248.98 Aligned_cols=128 Identities=23% Similarity=0.308 Sum_probs=107.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-----CC---CccceEEEEEec----Cc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-----HP---NLLPLIAFYYRK----EE 323 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~---niv~l~~~~~~~----~~ 323 (565)
..++||.|.|++||+|.. .+.+.||+|+.+.. ..-.+..+.||.+|++++ |+ .||+|++.|... .+
T Consensus 82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred EEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 457999999999999994 46678999988754 334567789999999884 33 699999999753 47
Q ss_pred eEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc
Q 008431 324 KLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD 392 (565)
Q Consensus 324 ~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~ 392 (565)
.|+|+|++ |-+|..+|...... +++...+.+|++||+.||.|||.+| +|||-||||+|||+.
T Consensus 161 VCMVfEvL-GdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLLC 222 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeeee
Confidence 89999999 66999999865543 4899999999999999999999997 899999999999973
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=242.89 Aligned_cols=247 Identities=17% Similarity=0.282 Sum_probs=186.5
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeec--cCccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEEEe
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLVSD 329 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv~E 329 (565)
..+|.|.- .|..+. .-.++.||+|++.. ......++..+|..++..+.|+||++++.+|.-. .+.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45677776 555554 34688999999853 2234456778899999999999999999999753 35799999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
||. ++|.+.+.. .++-.+...|..|++.|++|||+. +|+||||||+||++..++.+||.|||+|+...
T Consensus 102 ~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 102 LMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred hhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhhcccC
Confidence 996 599988873 277788999999999999999999 99999999999999999999999999997655
Q ss_pred cc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc----
Q 008431 410 KE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE---- 482 (565)
Q Consensus 410 ~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 482 (565)
.. +..+.|..|.|||++.+..|.+.+||||.||++.||++|+.-|.. ...+.+|.+..-.-+....
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-------~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-------KDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-------chHHHHHHHHHHHhcCCCHHHHH
Confidence 43 345678899999999998899999999999999999999988762 2345555543322111110
Q ss_pred -----------------------cc-cccccC-CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 483 -----------------------VF-DKDMRG-TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 483 -----------------------~~-d~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+ |..... ...+.-....+.+++.++|-.||++|.+++++++.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 000000 01111223456778889999999999999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=227.32 Aligned_cols=250 Identities=18% Similarity=0.251 Sum_probs=187.0
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecC--ceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKE--EKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lv~E~~~ 332 (565)
..+++|+|.|+.||.|. ..+.+.++||.++. ..++.+.+|+.+|+.++ ||||+++++...+.. ...||+||+.
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~ 118 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN 118 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence 34789999999999999 56778899999874 34677899999999998 999999999987754 4679999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~ 411 (565)
+.+...+.. .|+...+..++.++++||.|+|+. ||+|||+||.|++||. ..+.+++|+|+|.+..+.
T Consensus 119 n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 119 NTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred cccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 988776643 377788999999999999999999 9999999999999985 456999999999887655
Q ss_pred c---cccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc-------c
Q 008431 412 H---AQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW-------T 480 (565)
Q Consensus 412 ~---~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 480 (565)
. -.+.+..|..||.+.. ..|+..-|+|||||++.+|+..+.||....+.. ..++..++ .+.... .
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~---DQLVkIak-VLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVKIAK-VLGTDELYAYLNKY 262 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH---HHHHHHHH-HhChHHHHHHHHHH
Confidence 3 2345678999997654 568889999999999999999999987432211 11222111 110000 0
Q ss_pred CccccccccC---------------CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 GEVFDKDMRG---------------TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 ~~~~d~~~~~---------------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.-.+||...+ .....-...+.++++.+.|..|-.+|||++|++..
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0012332211 00000012467788889999999999999998653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=232.56 Aligned_cols=190 Identities=27% Similarity=0.429 Sum_probs=167.6
Q ss_pred cceecccCceeEEEEEEeC-CCeeEEEEeeccCcc-CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVLLT-GPAMVVKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||+|++|.||++.... +..+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999999654 889999999765443 56789999999999999999999999998899999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... .+++.....++.+++.++.|||.. +++|+|++|+||+++.++.++|+|||.+......
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999976432 178899999999999999999998 9999999999999999999999999998776543
Q ss_pred -ccccccccccCCCcc-CCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 412 -HAQLHMVAYKSPEFN-QTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~-~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
....++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 334566789999988 66778889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=252.19 Aligned_cols=190 Identities=22% Similarity=0.347 Sum_probs=162.5
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--------ccCHHHHHHHHHHHhcCC---CCCccceEEEEEecCce
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--------NVGKEDFHEHMTRLGSLS---HPNLLPLIAFYYRKEEK 324 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~ 324 (565)
+.+.+|+|+||.|+.|.++ +...|+||.+.+.. ....-..-.||++|..++ |+||++++++|.+++.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 4578999999999999965 45678888875421 111123456999999998 99999999999999999
Q ss_pred EEEEecc-CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccC
Q 008431 325 LLVSDFV-PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA 403 (565)
Q Consensus 325 ~lv~E~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 403 (565)
||+||-- ++-+|++++..+. .+++..+..|++||+.|+++||+. +|||||||-+|+.+|.+|-+|++|||
T Consensus 645 yl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred EEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeecc
Confidence 9999975 4569999997544 399999999999999999999999 99999999999999999999999999
Q ss_pred Cccccccc--ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCcc
Q 008431 404 LVPIVNKE--HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 404 la~~~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
-+...... ....||..|.|||++.+.+| +..-|||++||+||.++....||.
T Consensus 716 saa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98766544 45689999999999999887 567899999999999999999975
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=275.96 Aligned_cols=191 Identities=14% Similarity=0.112 Sum_probs=140.0
Q ss_pred cCCC-CCccceEEEE-------EecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC
Q 008431 305 SLSH-PNLLPLIAFY-------YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376 (565)
Q Consensus 305 ~l~H-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~ 376 (565)
.++| +||++++++| ...+.+++++||+ +++|.++|.... ..+++..++.++.||++||.|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 4456 5888888887 2334577888988 569999997432 2489999999999999999999998
Q ss_pred CCCccCCCCCCCEEEc-------------------CCCCcEEeccCCccccccc--------------------cccccc
Q 008431 377 VTLPHGHLKSSNVLLD-------------------NAYEPLLTDYALVPIVNKE--------------------HAQLHM 417 (565)
Q Consensus 377 ~~ivHrDlkp~NILl~-------------------~~~~~kl~DfGla~~~~~~--------------------~~~~~t 417 (565)
+|+||||||+|||++ .++.+|++|||+++..... ....+|
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999994 3556778888887642110 012467
Q ss_pred ccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHH
Q 008431 418 VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGE 497 (565)
Q Consensus 418 ~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 497 (565)
+.|||||++.+..|+.++|||||||+||||++|.+|+... ...+.... . ...++.. ...
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----------~~~~~~~~-~----~~~~~~~------~~~ 237 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----------SRTMSSLR-H----RVLPPQI------LLN 237 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----------HHHHHHHH-H----hhcChhh------hhc
Confidence 8899999999999999999999999999999999886421 01111111 0 0111111 011
Q ss_pred HHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 498 MLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 498 ~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....+++.+||+.+|.+||||.||++.
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 2345677889999999999999999763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=245.11 Aligned_cols=190 Identities=22% Similarity=0.253 Sum_probs=161.2
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC------CCCccceEEEEEecCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS------HPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
....|+|-|++|.+|. ...|..||||.++.. ....+.=++|+++|++|+ --|+++|+-.|...+++|||+|-
T Consensus 437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~ 515 (752)
T KOG0670|consen 437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEP 515 (752)
T ss_pred EeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehh
Confidence 4567999999999999 446789999999864 233445578999999995 23799999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-CCcEEeccCCccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-YEPLLTDYALVPIVN 409 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~ 409 (565)
+. -+|.++|+..+.. .+|....+..++.|+.-||..|-.. +|+|.||||.|||+++. ..+||||||-|....
T Consensus 516 Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 516 LS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred hh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCcceeeeccCccccccc
Confidence 85 5999999987653 3588888999999999999999876 99999999999999865 568999999987765
Q ss_pred ccc--cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 410 KEH--AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 410 ~~~--~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
... .+..+..|.|||++.+-.|+...|+||.||+||||.||+.-|.
T Consensus 589 eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 589 ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 442 2344567999999999999999999999999999999998886
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=221.15 Aligned_cols=244 Identities=22% Similarity=0.314 Sum_probs=175.2
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEE-EEecCceEEEEeccC
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAF-YYRKEEKLLVSDFVP 332 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~~~~~~lv~E~~~ 332 (565)
...+.+|+|.||.+.++.++ +...+|+|.+..- .....+|.+|..-=-.|. |.||+.-++. |...+..++++||++
T Consensus 27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 35678999999999999965 5667888887643 455788999987655554 8899987765 566778889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc--CCCCcEEeccCCcccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD--NAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfGla~~~~~ 410 (565)
.|||..-+.. .++.+.....++.|+++|+.|+|++ ++||||||.+||||- +..++|+||||+.+..+.
T Consensus 106 ~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 106 RGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999987643 2488888999999999999999999 999999999999993 445899999999865443
Q ss_pred c-ccccccccccCCCccCCC-----CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 411 E-HAQLHMVAYKSPEFNQTD-----GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 411 ~-~~~~~t~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
. ...-.+..|.|||..... ...+.+|||.|||+++.++||++||.-.... ......|.+..-+..
T Consensus 176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w~~rk~------ 246 (378)
T KOG1345|consen 176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQWLKRKN------ 246 (378)
T ss_pred eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHHhcccC------
Confidence 2 122235678999964332 3467899999999999999999999722111 123344443222221
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHH
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREA 522 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev 522 (565)
+.+.... .....+++++-.+-+.++|++|--+.++
T Consensus 247 -~~~P~~F--~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 247 -PALPKKF--NPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred -ccCchhh--cccCHHHHHHHHHhcCCcccccchhHHH
Confidence 1111100 0112356667778899999999444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=214.57 Aligned_cols=169 Identities=22% Similarity=0.187 Sum_probs=128.0
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 413 (565)
|+|.++++.++. .++|..+..++.|++.||+|||+. + ||+|||++.++.+|+ ||+++..... .
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~-~ 63 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPE-Q 63 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeeccc-c
Confidence 789999976433 399999999999999999999987 4 999999999999999 9998776543 3
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
..+|+.|||||++.+..++.++|||||||++|||+||+.||.... ................ ++.. ...
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~-------~~~~~~~~~~~~~~~~---~~~~--~~~ 131 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER-------ELSAILEILLNGMPAD---DPRD--RSN 131 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc-------hhcHHHHHHHHHhccC---Cccc--ccc
Confidence 367899999999999999999999999999999999999986321 1112222221111000 0000 001
Q ss_pred CHHHH--HHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 494 GEGEM--LKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 494 ~~~~~--~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
..... ..+.+++.+||+.+|++|||+.|+++.+..+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11111 258899999999999999999999999887754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=231.65 Aligned_cols=255 Identities=21% Similarity=0.308 Sum_probs=187.0
Q ss_pred ccceecccCceeEEEEEEe----CCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..++||+|.|++||++.+. ..+.||+|.+...+ .......|+++|..+. +.||+++.+++..++...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 3578999999999999843 46789999987532 3456899999999985 899999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVN- 409 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~- 409 (565)
+.-+..++... ++...+..+++.+..||+++|+. |||||||||+|+|.+. .++-.|.|||+|...+
T Consensus 118 ~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 118 EHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999888863 77889999999999999999999 9999999999999974 4667899999986210
Q ss_pred ----------------c-c------------------------------ccccccccccCCCccC-CCCCCcchhHHHHH
Q 008431 410 ----------------K-E------------------------------HAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLG 441 (565)
Q Consensus 410 ----------------~-~------------------------------~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~G 441 (565)
. . ....||++|.|||++. ...-++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 0 0114789999999764 45568999999999
Q ss_pred HHHHHHHcCCCCccccccCCCCCcchHHHHH-HHhh-----hcc--cC---------------cccc-ccccCC------
Q 008431 442 ILILELLTGKFPANYLAQGKGANADLATWVN-SVVR-----EEW--TG---------------EVFD-KDMRGT------ 491 (565)
Q Consensus 442 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~-----~~~--~~---------------~~~d-~~~~~~------ 491 (565)
||++-+++++.||.......+....++.... ..++ .+. .. +-++ +.+...
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999998644333222222221110 0000 011 00 0000 011110
Q ss_pred --CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 492 --KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 492 --~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...+.....++++..+|++.||.+|.|++|.++.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011112367889999999999999999998653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-25 Score=203.79 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=186.6
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEee--ccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+|.+...|..|+|++. |..+++|.+. ..+....++|..|.-.|+-+.||||+.++|.|.......++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 46788889999999984 5556667664 34445567899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccccccc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH 416 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 416 (565)
+..|+....- ..+-.++.+++.++|+|++|||+.-+ -|.--.|.+..+++|++.+++|+ .+-+++.-+......
T Consensus 275 ynvlhe~t~v---vvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltaris-mad~kfsfqe~gr~y 348 (448)
T KOG0195|consen 275 YNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVGRAY 348 (448)
T ss_pred HHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhhee-cccceeeeecccccc
Confidence 9999865432 36677899999999999999998743 34455789999999999999874 222232223344556
Q ss_pred cccccCCCccCCCCCC---cchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 417 MVAYKSPEFNQTDGVT---RKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 417 t~~y~aPE~~~~~~~~---~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
.+.||+||.+...+-+ ..+|+|||.|++|||.|...||....+.+.. ++ ...++ ...-+.|.
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mk-ialeg-lrv~ippg------ 413 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MK-IALEG-LRVHIPPG------ 413 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hh-hhhcc-ccccCCCC------
Confidence 7899999988766543 4799999999999999999999865543221 11 11111 11112222
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
....+.+++.-|...||.+||..+.|+-.|+++.
T Consensus 414 ---is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 414 ---ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2235777888899999999999999999888764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=214.41 Aligned_cols=163 Identities=15% Similarity=0.214 Sum_probs=123.6
Q ss_pred ccceecccCceeEEEEEEe--CCCeeEEEEeecc-----CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL--TGPAMVVKRFRQM-----SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|... ++..+|||++... .....+.|.+|+++|++++|+|+++.+.. .+..|+|||
T Consensus 22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE 98 (365)
T PRK09188 22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRG 98 (365)
T ss_pred EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEE
Confidence 3578999999999999854 5777899987532 11224568999999999999999963322 256899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCC-CCCCEEEcCCCCcEEeccCCcccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHL-KSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDl-kp~NILl~~~~~~kl~DfGla~~~ 408 (565)
|+++++|... . . .. ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+|||+++..
T Consensus 99 ~~~G~~L~~~-~---~-----~~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 99 WTEGVPLHLA-R---P-----HG---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred ccCCCCHHHh-C---c-----cc---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 9999999632 1 1 11 145788999999999998 9999999 999999999999999999999865
Q ss_pred cccc------------cccccccccCCCccCCCC------CCcchhHH
Q 008431 409 NKEH------------AQLHMVAYKSPEFNQTDG------VTRKTDVW 438 (565)
Q Consensus 409 ~~~~------------~~~~t~~y~aPE~~~~~~------~~~~~Dvw 438 (565)
.... ...+++.|+|||++.... .+..+|-|
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 4321 224567799999875542 23346666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-22 Score=199.13 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=190.6
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCcc---CHHHHHHHHHHHhcCCCC-CccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV---GKEDFHEHMTRLGSLSHP-NLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||.|+||.||++... ..+++|.+...... ....|.+|+..++.+.|+ +|+++.+++......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 467999999999999976 78899998754332 367899999999999988 799999999777778999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNKE- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~- 411 (565)
+++.+++...... ..+.......++.|++.++.|+|.. +++|||+||+||+++... .++++|||.++.....
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999777654321 2388889999999999999999998 899999999999999988 7999999998754322
Q ss_pred ---------ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 412 ---------HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 412 ---------~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
....++..|+|||.... ..++...|+||+|++++++++|..||...... ..............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~ 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcC
Confidence 34567899999998877 57889999999999999999999996522110 01111111111111
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. ........... ......+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 10 00000000000 1223467788889999999999999887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-23 Score=222.31 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=180.4
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeecc--CccCH----HHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM--SNVGK----EDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
...++|.|++|.|+... .......+.|..+.. ..... ..+..|+.+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45789999999888777 334454555554311 11111 125567777888999999888877777666666699
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
||++ ||..++.... .+....+..++.|+..|++|+|+. +|.|||+|++|+++..++.+||+|||.+....
T Consensus 402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 9999987542 277788999999999999999999 99999999999999999999999999986543
Q ss_pred cc--------ccccccccccCCCccCCCCCCc-chhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 410 KE--------HAQLHMVAYKSPEFNQTDGVTR-KTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 410 ~~--------~~~~~t~~y~aPE~~~~~~~~~-~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
.. ....|+-.|+|||++....|.+ ..||||.||++..|++|+.||.......... .......+
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~- 543 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQ- 543 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccc-
Confidence 21 2346778899999999999986 5899999999999999999997433221110 00000000
Q ss_pred CccccccccCCCC-CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhhc
Q 008431 481 GEVFDKDMRGTKS-GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELKE 531 (565)
Q Consensus 481 ~~~~d~~~~~~~~-~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~ 531 (565)
..+.. +... ..........++.++|++||.+|.||++|++. ++++..
T Consensus 544 ~~~~~----~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 544 RNIFE----GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ccccc----ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 00000 0000 01122345667889999999999999999763 444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=205.97 Aligned_cols=214 Identities=26% Similarity=0.385 Sum_probs=163.5
Q ss_pred HhcCCCCCccceEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCC-cc
Q 008431 303 LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTL-PH 381 (565)
Q Consensus 303 l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~i-vH 381 (565)
|+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+..... .++|.....++++|+.||+|+|+. +| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~----~~d~~F~~s~~rdi~~Gl~ylh~s----~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI----KLDYFFILSFIRDISKGLAYLHNS----PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc----CccHHHHHHHHHHHHHHHHHHhcC----cceee
Confidence 4678999999999999999999999999999999999987433 499999999999999999999986 34 89
Q ss_pred CCCCCCCEEEcCCCCcEEeccCCcccccc------cccccccccccCCCccCCCC-------CCcchhHHHHHHHHHHHH
Q 008431 382 GHLKSSNVLLDNAYEPLLTDYALVPIVNK------EHAQLHMVAYKSPEFNQTDG-------VTRKTDVWSLGILILELL 448 (565)
Q Consensus 382 rDlkp~NILl~~~~~~kl~DfGla~~~~~------~~~~~~t~~y~aPE~~~~~~-------~~~~~DvwS~Gvil~el~ 448 (565)
+.++++|+++|..+.+|++|||+...... ........-|.|||.+.... .+.++||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999999999876632 11122235699999876531 467899999999999999
Q ss_pred cCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 449 TGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 449 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
+.+.||+........ ..++..++. .....+-|.+.... +....+..++..||..+|++||++++|-..+..
T Consensus 153 ~r~~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred hccCccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 999999853322211 122222222 11222223332111 222368889999999999999999999988887
Q ss_pred hhccC
Q 008431 529 LKERD 533 (565)
Q Consensus 529 i~~~~ 533 (565)
+....
T Consensus 224 ~~~~~ 228 (484)
T KOG1023|consen 224 INKGG 228 (484)
T ss_pred hcccc
Confidence 76543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-21 Score=193.42 Aligned_cols=254 Identities=17% Similarity=0.173 Sum_probs=185.2
Q ss_pred ccceecccCceeEEEEEEeCC--CeeEEEEeeccCccCHHHHHHHHHHHhcCCC----CCccceEEEE-EecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLTG--PAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH----PNLLPLIAFY-YRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~lv~E 329 (565)
..+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......|+||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 457899999999999996554 4677777654333322367888888888873 5888888888 46778899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-----CCcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-----YEPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DfGl 404 (565)
.+ |.+|.++..... ...++..+.+.|+.|++.+|.++|+. +++||||||+|+++... ..+.+.|||+
T Consensus 102 l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred cc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 88 679999876544 23599999999999999999999998 99999999999999754 4689999999
Q ss_pred cc--ccc-cc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHH
Q 008431 405 VP--IVN-KE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATW 470 (565)
Q Consensus 405 a~--~~~-~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~ 470 (565)
++ ... .. ....||..|.++....+...+.+.|+||++-++.|+..|..||....... ...-
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~-----~~~~ 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD-----LKSK 248 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc-----hHHH
Confidence 98 321 10 12348999999999999999999999999999999999999996332110 1111
Q ss_pred HHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 471 VNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 471 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+....... .... . ....+. .+.++...+-..+..++|....+...|+......
T Consensus 249 ~~~~~~~~----~~~~-~--~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 FEKDPRKL----LTDR-F--GDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHhhhh----cccc-c--cCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111 1110 0 111123 3444444555579999999999999988876553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=184.42 Aligned_cols=139 Identities=17% Similarity=0.157 Sum_probs=107.1
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCcc--C-------HHHH-----------------HHHHHHHhcCCCCCcc
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV--G-------KEDF-----------------HEHMTRLGSLSHPNLL 312 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~niv 312 (565)
..||+|+||.||+|...+|+.||||+++..... . ...| .+|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999879999999999753211 1 1122 3499999999888764
Q ss_pred ceEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhhCCCCCCccCCCCCCCEEE
Q 008431 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLL 391 (565)
Q Consensus 313 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yl-H~~~~~~~ivHrDlkp~NILl 391 (565)
....+. ....++||||++++++........ .+++.....++.|++.+|.|+ |+. +|+||||||+|||+
T Consensus 83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLY 151 (190)
T ss_pred CCcEEE--ecCCEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEE
Confidence 433322 223489999999887765432221 388899999999999999999 566 89999999999999
Q ss_pred cCCCCcEEeccCCccccc
Q 008431 392 DNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 392 ~~~~~~kl~DfGla~~~~ 409 (565)
+ ++.++++|||++....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=183.10 Aligned_cols=165 Identities=10% Similarity=0.123 Sum_probs=127.5
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHH---------HHHHHHHHHhcCCCCCccceEEEEEec------
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKE---------DFHEHMTRLGSLSHPNLLPLIAFYYRK------ 321 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~H~niv~l~~~~~~~------ 321 (565)
..+++|.|+||.||.... ++..+|+|.++........ .+.+|+..+.++.||+|.....++...
T Consensus 35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence 468899999999999655 6778999999754322222 268999999999999999999886643
Q ss_pred --CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEE
Q 008431 322 --EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL 399 (565)
Q Consensus 322 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl 399 (565)
...++||||++|.+|.++.. ++. ....+++.+|..+|+. +++|||+||+||+++.++ +++
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCCC-EEE
Confidence 35789999999999988732 322 3456999999999998 999999999999999888 999
Q ss_pred eccCCcccccccccccccccccCCCccCCCCCCcchhHHHHHHHHHHHH
Q 008431 400 TDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELL 448 (565)
Q Consensus 400 ~DfGla~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~ 448 (565)
+|||..+......+.. .+.....|..++|+||||+++.-+.
T Consensus 176 iDfg~~~~~~e~~a~d--------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKD--------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHH--------HHHHHhHhcccccccceeEeehHHH
Confidence 9999876543221110 1334445677999999999887543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=176.83 Aligned_cols=138 Identities=17% Similarity=0.230 Sum_probs=109.5
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCcc---------------------C-----HHHHHHHHHHHhcCCCCCcc
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV---------------------G-----KEDFHEHMTRLGSLSHPNLL 312 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~niv 312 (565)
..||+|+||.||+|...+|+.||||.++..... . ...+.+|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999778999999998753211 0 11235789999999999875
Q ss_pred ceEEEEEecCceEEEEeccCCCCHHHH-HhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-hCCCCCCccCCCCCCCEE
Q 008431 313 PLIAFYYRKEEKLLVSDFVPNGSLANL-LHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK-EFPGVTLPHGHLKSSNVL 390 (565)
Q Consensus 313 ~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~-~~~~~~ivHrDlkp~NIL 390 (565)
....+... ..++||||++++++... +.. . .++......++.|++.++.|+|+ . +|+||||||+|||
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~-----~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIl 150 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD-V-----PLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNIL 150 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh-c-----cCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEE
Confidence 54444332 35899999998855433 322 1 36778899999999999999999 7 9999999999999
Q ss_pred EcCCCCcEEeccCCccccc
Q 008431 391 LDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 391 l~~~~~~kl~DfGla~~~~ 409 (565)
++ ++.++|+|||++....
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 98 7899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-21 Score=208.61 Aligned_cols=239 Identities=22% Similarity=0.259 Sum_probs=173.1
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC-ccCHHHHHHHHHH--HhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS-NVGKEDFHEHMTR--LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||++.|=+|.+|+.+.|. |+||++.+.. ....+.|.++++- ..-++|||.+++.-+.......|||=+|..+
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 3467999999999999988887 8899986533 4555666655443 4456899999987776667778999999965
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc--ccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV--NKE 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~--~~~ 411 (565)
+|+|.+.-+. -+...+...|+.|++.||.-+|.. +|+|+|||.+|||+..-.-+.|+||.--+.. ..+
T Consensus 106 -nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 106 -NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred -hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9999887543 377778889999999999999998 9999999999999999888999999765432 111
Q ss_pred c-cc--------cccccccCCCccCCC----------C-CCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHH
Q 008431 412 H-AQ--------LHMVAYKSPEFNQTD----------G-VTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATW 470 (565)
Q Consensus 412 ~-~~--------~~t~~y~aPE~~~~~----------~-~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 470 (565)
. +. ..-..|.|||.+... . .+++.||||.||++.||++ |++||.. .+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----------SQL 244 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----------SQL 244 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----------HHH
Confidence 1 11 112479999965331 1 5788999999999999988 7888863 222
Q ss_pred HHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 471 VNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 471 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..-.-......+.+-+.+ +. ..+..++..|++.||++|-++++.++.
T Consensus 245 ~aYr~~~~~~~e~~Le~I---ed-----~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEKI---ED-----VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhHhccCccCHHHHHHhC---cC-----ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111000000001111111 10 146678889999999999999999887
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=168.18 Aligned_cols=177 Identities=15% Similarity=0.121 Sum_probs=132.5
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCccC----HHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVG----KEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
...|++|+||+||.+.. .+..++.+.+.....-. ...|.+|+++|+++. |+++++++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46899999999997765 67777777776433211 125789999999995 5789999886 45799999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCC-CCCCEEEcCCCCcEEeccCCccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHL-KSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDl-kp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
|.+|.+.+.. ....++.|++.+|.++|+. +|+|||| ||+|||++.++.++|+|||++......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9998754311 1135778999999999999 9999999 799999999999999999999754432
Q ss_pred cc-----------------ccccccccCCCccCC-CCCC-cchhHHHHHHHHHHHHcCCCCcc
Q 008431 412 HA-----------------QLHMVAYKSPEFNQT-DGVT-RKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 412 ~~-----------------~~~t~~y~aPE~~~~-~~~~-~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.. ...++.|++|+-..- ...+ ...+.++-|+-+|.++|+..|.-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 21 012455666663211 1233 45677799999999999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-20 Score=172.04 Aligned_cols=134 Identities=16% Similarity=0.233 Sum_probs=105.5
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-----CCCCccceEEEEEecC---ceE-EEE
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-----SHPNLLPLIAFYYRKE---EKL-LVS 328 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~~-lv~ 328 (565)
.+.||+|+||.||. ++.....+||++........+.+.+|+..++.+ .||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 47899999999996 333344478888754444567899999999999 5799999999998864 333 789
Q ss_pred ec--cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhhCCCCCCccCCCCCCCEEEcC----CCCcEEec
Q 008431 329 DF--VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL-AYLYKEFPGVTLPHGHLKSSNVLLDN----AYEPLLTD 401 (565)
Q Consensus 329 E~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~ylH~~~~~~~ivHrDlkp~NILl~~----~~~~kl~D 401 (565)
|| +++|+|.+++.... +++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 85 e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 66899999996421 5554 35678888888 999998 9999999999999973 34799999
Q ss_pred cCCc
Q 008431 402 YALV 405 (565)
Q Consensus 402 fGla 405 (565)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-21 Score=199.41 Aligned_cols=185 Identities=26% Similarity=0.316 Sum_probs=159.2
Q ss_pred eecccCceeEEEEE----EeCCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccC
Q 008431 260 VLGSGSFGSSYKAV----LLTGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
++|+|+||.|+.+. .+.|..+|.|.+++... ..+.....|..++..++ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999775 34577888888765322 22225667888888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
+|+|...+.... .+.+.....+...++-|++++|+. +|+|||+|++||+++.+|++|+.|||+++..-...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999998886544 367777778888999999999998 99999999999999999999999999999877666
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
..+||..|||||++. .....+|.||||++++||+||-.||.
T Consensus 152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 669999999999987 56789999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=162.96 Aligned_cols=190 Identities=18% Similarity=0.250 Sum_probs=153.8
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCC-CCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH-PNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||.|+||.+|.|. ..+|..||||.-... ....++..|..+.+.++| ..|..+..|..++..-.+|||.+ |.
T Consensus 19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GP 95 (341)
T KOG1163|consen 19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GP 95 (341)
T ss_pred EEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Cc
Confidence 34789999999999999 678999999985432 233467788888888875 45666667777888889999998 67
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~~~ 411 (565)
+|.+++.--.. .++..+.+-++-|+..-++|+|.+ ++|||||||+|.|..- ...+.++|||+|+.....
T Consensus 96 sLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 96 SLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99998875443 388999999999999999999999 8999999999999853 345789999999875432
Q ss_pred -----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcccc
Q 008431 412 -----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYL 457 (565)
Q Consensus 412 -----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~ 457 (565)
....||..|.+--...+..-+.+-|+=|+|-+|..+--|..||...
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 2346788888876655556678899999999999999999999754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-18 Score=165.91 Aligned_cols=254 Identities=15% Similarity=0.172 Sum_probs=183.2
Q ss_pred hccceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCC
Q 008431 256 ASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
...++||+|+||+.+.|+ +-+++.||||.=...+ ...++..|.+..+.|. .+.|...+-|-...-+-.||+|.+ |
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 356899999999999999 7789999999755432 2446677877777765 578888777766777788999998 6
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-----CCCcEEeccCCcccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-----AYEPLLTDYALVPIV 408 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DfGla~~~ 408 (565)
-||.++..-... .|+.++..-||+|+..-++|+|++ .+|.|||||+|.||.. ...+.++|||+|+.+
T Consensus 108 PSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 108 PSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred cCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 799888865443 399999999999999999999999 8999999999999964 345789999999876
Q ss_pred ccc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 409 NKE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 409 ~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
... .+..||..||+-..-.+..-+.+-|.=|+|-+++..+-|..||...-.. ...+....+-..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-----tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-----TNKEKYEKIGET 254 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-----chHHHHHHhccc
Confidence 433 3446899999998888888899999999999999999999999743211 111111111000
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.....+ . .+. ...+++....+..+.+. +=++-|.-+-+...+..+.+.
T Consensus 255 Kr~T~i-~-~Lc--~g~P~efa~Yl~yvR~L---~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 255 KRSTPI-E-VLC--EGFPEEFATYLRYVRRL---DFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cccCCH-H-HHH--hcCHHHHHHHHHHHHhc---CcccCCCHHHHHHHHHHHHHh
Confidence 000000 0 010 11244555556655544 667888877666666655443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.3e-19 Score=172.05 Aligned_cols=229 Identities=24% Similarity=0.355 Sum_probs=145.4
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCC-----------CCccceEE------
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSH-----------PNLLPLIA------ 316 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-----------~niv~l~~------ 316 (565)
.+.||.|+++.||.+... +++.+|+|.+.... ....+++.+|.-....+.+ .-++++--
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 468999999999999964 68999999986322 2234677777766555433 11222111
Q ss_pred --EEEecC--------ceEEEEeccCCCCHHHHHhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCC
Q 008431 317 --FYYRKE--------EKLLVSDFVPNGSLANLLHV---RRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGH 383 (565)
Q Consensus 317 --~~~~~~--------~~~lv~E~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrD 383 (565)
++.... ..+++|+-+. +||.+++.. .... ...+....++.+..|+.+-+++||+. +++|+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlVHgd 170 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSY----GLVHGD 170 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHT----TEEEST
T ss_pred CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhc----ceEecc
Confidence 111111 2367888774 689888653 2111 11244456677889999999999999 999999
Q ss_pred CCCCCEEEcCCCCcEEeccCCccccccccc-ccccccccCCCccCC--------CCCCcchhHHHHHHHHHHHHcCCCCc
Q 008431 384 LKSSNVLLDNAYEPLLTDYALVPIVNKEHA-QLHMVAYKSPEFNQT--------DGVTRKTDVWSLGILILELLTGKFPA 454 (565)
Q Consensus 384 lkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~t~~y~aPE~~~~--------~~~~~~~DvwS~Gvil~el~tg~~p~ 454 (565)
|||+|++++.+|.++|+||+.....+.... ...+..|.+||.... -.++.+.|.|++|+++|.|.+|+.||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 999999999999999999987655544332 344577999996533 24788999999999999999999999
Q ss_pred cccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCC
Q 008431 455 NYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR 516 (565)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R 516 (565)
......... .| ...... +....+.+++...|+++|.+|
T Consensus 251 ~~~~~~~~~-----~~----------------~f~~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 251 GLSSPEADP-----EW----------------DFSRCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCCGGGSTS-----GG----------------GGTTSS------HHHHHHHHHHT-SSGGGS
T ss_pred CCCCccccc-----cc----------------cchhcC---CcCHHHHHHHHHHccCCcccC
Confidence 854332211 00 111111 334467788889999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.2e-18 Score=161.73 Aligned_cols=134 Identities=16% Similarity=0.262 Sum_probs=113.6
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCcc--------CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV--------GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
+.||+|++|.||+|.. +|..+++|+....... ....+.+|+.++..+.|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 7778999986532211 124578899999999999998888888788889999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
++|++|.+++... .+ .+..++.+++.+|.++|+. +++|||++|+|||++ ++.++++|||+++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998632 22 7888999999999999998 999999999999999 78899999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-18 Score=164.67 Aligned_cols=139 Identities=19% Similarity=0.225 Sum_probs=106.7
Q ss_pred ccceecccCceeEEEEE--EeCCCeeEEEEeeccCcc------------------------CHHHHHHHHHHHhcCCCCC
Q 008431 257 SAEVLGSGSFGSSYKAV--LLTGPAMVVKRFRQMSNV------------------------GKEDFHEHMTRLGSLSHPN 310 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~n 310 (565)
..+.||+|+||.||+|. ..+|+.||+|.++..... ....+.+|+..+.++.+..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 45789999999999998 568999999998743210 0123568999999997633
Q ss_pred --ccceEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC-CccCCCCCC
Q 008431 311 --LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT-LPHGHLKSS 387 (565)
Q Consensus 311 --iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~-ivHrDlkp~ 387 (565)
+.+.+++ ...++||||+++++|........ .+.......++.|++.++.|||+. + |+||||||+
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dikp~ 178 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKE----GELVHGDLSEY 178 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCChh
Confidence 3333332 24589999999988876542211 255556788999999999999998 8 999999999
Q ss_pred CEEEcCCCCcEEeccCCccccc
Q 008431 388 NVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 388 NILl~~~~~~kl~DfGla~~~~ 409 (565)
||+++ +++++++|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999986543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.8e-18 Score=158.98 Aligned_cols=130 Identities=16% Similarity=0.264 Sum_probs=107.6
Q ss_pred eecccCceeEEEEEEeCCCeeEEEEeeccCcc--------CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 260 VLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV--------GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.||+|+||.||+|.+ ++..+++|........ ..+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 6788999986532211 1256778999999999988766666666777889999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+|++|.+++.... . .++.+++.+|.++|+. +++|||++|+||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875311 0 7899999999999998 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=180.02 Aligned_cols=133 Identities=20% Similarity=0.260 Sum_probs=109.0
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEe-eccCc-------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRF-RQMSN-------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||+||+|.+.... +++|+. ..... ...+++.+|+++++.++|++++....++...+..++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3578999999999999875443 444433 22111 12356889999999999999998888888878889999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998874 3467899999999999998 99999999999999 6789999999998653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.7e-18 Score=163.68 Aligned_cols=192 Identities=18% Similarity=0.202 Sum_probs=133.1
Q ss_pred CCCCccceEEEEEec---------------------------CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHH
Q 008431 307 SHPNLLPLIAFYYRK---------------------------EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKI 359 (565)
Q Consensus 307 ~H~niv~l~~~~~~~---------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 359 (565)
+|||||++.++|.+. ...|+||.-.+. +|++++..+. .+...+.-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 699999999887642 135899988764 9999998654 445566778
Q ss_pred HHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE--cCCC--CcEEeccCCccccccc----------ccccccccccCCCc
Q 008431 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL--DNAY--EPLLTDYALVPIVNKE----------HAQLHMVAYKSPEF 425 (565)
Q Consensus 360 ~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl--~~~~--~~kl~DfGla~~~~~~----------~~~~~t~~y~aPE~ 425 (565)
+.|+++|+.|||++ +|.|||+|++|||+ |+|. ...|+|||++-..+.. -..-|.-.-||||+
T Consensus 347 laQlLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 89999999999999 99999999999998 4444 3568999986432221 11223456899998
Q ss_pred cCCCC------CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHH
Q 008431 426 NQTDG------VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEML 499 (565)
Q Consensus 426 ~~~~~------~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 499 (565)
..... --.|+|.|+.|.+.||+++...||... + +..+..- .+++.. -|.+. +....
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r--G---em~L~~r---~Yqe~q-----LPalp-----~~vpp 484 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR--G---EMLLDTR---TYQESQ-----LPALP-----SRVPP 484 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCccccc--c---hheechh---hhhhhh-----CCCCc-----ccCCh
Confidence 65432 135899999999999999999999731 1 1111110 011111 12221 22234
Q ss_pred HHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 500 KLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 500 ~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
.+.+++...|+.||++||+..-....|+
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 6778888999999999998775554443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=155.26 Aligned_cols=136 Identities=15% Similarity=0.234 Sum_probs=106.6
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccCc----------------------cCHHHHHHHHHHHhcCCCCC--c
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN----------------------VGKEDFHEHMTRLGSLSHPN--L 311 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~n--i 311 (565)
...+.||+|+||.||++...+|+.||||.++.... .....+..|+..+.++.|++ +
T Consensus 18 ~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 18 SLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred hcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 34578999999999999988899999998763210 01123677888999998874 4
Q ss_pred cceEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE
Q 008431 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL 391 (565)
Q Consensus 312 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl 391 (565)
.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +|+||||||+||++
T Consensus 98 ~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nill 158 (198)
T cd05144 98 PKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNILV 158 (198)
T ss_pred Cceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEEE
Confidence 44443 3456899999999998765320 23457889999999999998 99999999999999
Q ss_pred cCCCCcEEeccCCcccccc
Q 008431 392 DNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 392 ~~~~~~kl~DfGla~~~~~ 410 (565)
++++.++|+|||.+.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.3e-17 Score=179.81 Aligned_cols=187 Identities=20% Similarity=0.280 Sum_probs=146.1
Q ss_pred HhhccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC---CCCccceEEEEEecCceEEEEec
Q 008431 254 LRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS---HPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 254 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
.+.....||+|+||+||+|...+|+.||+|.=+... .=+|.-=.+++.+|+ -+-|..+...+.-.+..+||+||
T Consensus 699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred eEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 334567899999999999998789999999865321 112222233444444 23455555555567788999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-------CCCCcEEeccC
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-------NAYEPLLTDYA 403 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-------~~~~~kl~DfG 403 (565)
.+-|+|.+++... ..++|.....++.|++.-+..||.. +|||+||||+|.||. +...++|+|||
T Consensus 776 ~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 776 SPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred cccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999833 3489999999999999999999998 999999999999993 34568999999
Q ss_pred Cccccc---cc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCC
Q 008431 404 LVPIVN---KE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKF 452 (565)
Q Consensus 404 la~~~~---~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~ 452 (565)
.+--+. .. ....+|-.+-.+|+..++.++..+|-|.++-+++-|+-|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 873321 22 23456778899999999999999999999999999999984
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=169.19 Aligned_cols=118 Identities=26% Similarity=0.434 Sum_probs=103.5
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
..|+.|++|...+|.+||..++.. ...+|...+.++.|++.|+.| + +.+|||+||.||....+..+||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhh
Confidence 578999999999999999755432 247888999999999999999 4 7899999999999999999999999
Q ss_pred CCccccccc----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc
Q 008431 403 ALVPIVNKE----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT 449 (565)
Q Consensus 403 Gla~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t 449 (565)
|+....... ....||..||+||.+.+..|+.|+||||+|++|+|+++
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 997554322 24568899999999999999999999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-16 Score=139.74 Aligned_cols=135 Identities=18% Similarity=0.131 Sum_probs=111.8
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCC--CCccceEEEEEecCceEEEEeccCCCCH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH--PNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++.++++++...+..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 579999999999999744 7889998764322 5678999999999987 4889998888777889999999998766
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
..+ +......++.+++.+++++|... ..+++|+|+||+||+++..+.+++.|||.++...
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 533 44567788999999999999752 1269999999999999998999999999986543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-16 Score=172.61 Aligned_cols=198 Identities=19% Similarity=0.240 Sum_probs=134.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
+.+.|-.|+||.||..+++ +.+.+|+ ++.+... +.+- ++.....|.+| ||
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhh-cccccch-----hhhc--cccccCCccee---------------------ch
Confidence 5678999999999999854 4567787 4432211 1111 22222333333 55
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK----- 410 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~----- 410 (565)
-...++..+. ++- +++.+++|+|+. +|+|||+||+|.+|..-|++|+.|||+++..-.
T Consensus 138 c~tllk~~g~-----lPv--------dmvla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 138 CATLLKNIGP-----LPV--------DMVLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred hhhhcccCCC-----Ccc--------hhhHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 5565554322 222 237899999998 999999999999999999999999999764211
Q ss_pred --------------cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 411 --------------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 411 --------------~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
++..+||+.|+|||++....|+..+|.|++|+|+||.+-|..||.... ..+.+...+.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt--------peelfg~vis 272 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFGQVIS 272 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC--------HHHHHhhhhh
Confidence 123378999999999999999999999999999999999999997321 1222222222
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCC
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW 517 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 517 (565)
+. +..++- .+....++.+++.+.|+.+|..|-
T Consensus 273 d~----i~wpE~-----dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DD----IEWPEE-----DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hh----cccccc-----CcCCCHHHHHHHHHHHHhChHhhc
Confidence 21 101100 112223566777788999999996
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.6e-15 Score=145.23 Aligned_cols=137 Identities=18% Similarity=0.218 Sum_probs=106.9
Q ss_pred hccceec-ccCceeEEEEEEeCCCeeEEEEeeccC-------------ccCHHHHHHHHHHHhcCCCCCc--cceEEEEE
Q 008431 256 ASAEVLG-SGSFGSSYKAVLLTGPAMVVKRFRQMS-------------NVGKEDFHEHMTRLGSLSHPNL--LPLIAFYY 319 (565)
Q Consensus 256 ~~~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~ 319 (565)
.....|| .||.|+||+.... +..+++|.+.... ......+.+|++++.+++|++| ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3457898 8999999999874 7788998875311 1223568889999999998885 67777654
Q ss_pred ecCc----eEEEEeccCC-CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC
Q 008431 320 RKEE----KLLVSDFVPN-GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA 394 (565)
Q Consensus 320 ~~~~----~~lv~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~ 394 (565)
.+.. .++||||+++ .+|.+++... .++.. .+.+++.+|.+||+. +|+||||||+|||++.+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDA----GVYHADLNAHNILLDPD 178 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCC
Confidence 4322 2599999997 6999988542 14433 367899999999998 99999999999999988
Q ss_pred CCcEEeccCCccc
Q 008431 395 YEPLLTDYALVPI 407 (565)
Q Consensus 395 ~~~kl~DfGla~~ 407 (565)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 8999999998765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=142.16 Aligned_cols=135 Identities=20% Similarity=0.296 Sum_probs=96.0
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCcc--CHHHH----------------------HHHHHHHhcCCCCC--cc
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV--GKEDF----------------------HEHMTRLGSLSHPN--LL 312 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--iv 312 (565)
+.||+|+||+||+|...+++.||||.++..... ....+ ..|...+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 579999999999999878999999988643211 11111 24555555554432 33
Q ss_pred ceEEEEEecCceEEEEeccCCCCHHH-HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-hCCCCCCccCCCCCCCEE
Q 008431 313 PLIAFYYRKEEKLLVSDFVPNGSLAN-LLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK-EFPGVTLPHGHLKSSNVL 390 (565)
Q Consensus 313 ~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~-~~~~~~ivHrDlkp~NIL 390 (565)
+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. . +|+||||||+||+
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nil 147 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNIL 147 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEE
Confidence 33332 34689999999854321 111110 11 4677899999999999998 6 8999999999999
Q ss_pred EcCCCCcEEeccCCccccc
Q 008431 391 LDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 391 l~~~~~~kl~DfGla~~~~ 409 (565)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-15 Score=166.72 Aligned_cols=114 Identities=37% Similarity=0.630 Sum_probs=101.8
Q ss_pred ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEc
Q 008431 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDL 116 (565)
Q Consensus 39 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l 116 (565)
.++.|+|++|.|+|.+|.. +..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|.. .+++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~-i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHH-HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 3788999999999999986 899999999999999999999999999999999999999999999984 7899999999
Q ss_pred ccCCCccCCCccccCC----CCCcccCCCCCCCCCC-ccccc
Q 008431 117 SYNQLVGRIPDTLSNF----DATSFQGNKGLCGKPL-EACKS 153 (565)
Q Consensus 117 s~N~l~g~~p~~~~~~----~~~~~~~n~~~cg~p~-~~c~~ 153 (565)
++|+|+|.+|..+... ....+.+|+.+|+.|. ..|..
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~ 539 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP 539 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcc
Confidence 9999999999887543 3456889999999764 57753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-16 Score=172.90 Aligned_cols=242 Identities=21% Similarity=0.279 Sum_probs=176.2
Q ss_pred ceecccCceeEEEEEEe--CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL--TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++++||.++
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 45899999999888753 33455666554322 223344555777777777 99999999999999999999999999
Q ss_pred CCHHHHHh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCcccccc
Q 008431 334 GSLANLLH-VRRAPGQPGLDWPIRLKIIKGVAKGLAYLY-KEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNK 410 (565)
Q Consensus 334 gsL~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH-~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~ 410 (565)
|++.+.+. ... ...+....-.+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|.....
T Consensus 106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccccccccCCc----cCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 99998873 221 13556677889999999999999 66 899999999999999999 999999999976654
Q ss_pred -c------ccccc-cccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 411 -E------HAQLH-MVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 411 -~------~~~~~-t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
. ....| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|...... ..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~---~~ 251 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGR---FT 251 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccc---cc
Confidence 2 23467 8999999988774 44678999999999999999999987433221 111222211100 00
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAV 523 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 523 (565)
.. ....-.....++..+++..+|+.|.+.+++-
T Consensus 252 ~~---------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 QL---------PWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cC---------ccccCChhhhhcccccccCCchhcccccccc
Confidence 00 0011122456677788889999999988863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.8e-14 Score=165.49 Aligned_cols=125 Identities=37% Similarity=0.567 Sum_probs=74.4
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcccc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLA 84 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 84 (565)
|.+|.+.+..+++|++|+|++|++++.+|.....+|++|+|++|.++|.+|.. |+++++|+.|+|++|.+.+.+|..|+
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~~~ 185 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPND-IGSFSSLKVLDLGGNVLVGKIPNSLT 185 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChH-HhcCCCCCEEECccCcccccCChhhh
Confidence 45555444455555555555555555555333334566666666666555544 66666666777766666666666666
Q ss_pred CCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCcccc
Q 008431 85 GLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLS 130 (565)
Q Consensus 85 ~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~ 130 (565)
++++|++|+|++|++++.+|.. .+.+|+.|+|++|++++.+|..++
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 233 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHh
Confidence 6666666666666666666542 455566666666666655555443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.4e-14 Score=146.35 Aligned_cols=141 Identities=18% Similarity=0.285 Sum_probs=100.0
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccC--------------------------H--------------HHHHH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVG--------------------------K--------------EDFHE 298 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~--------------~~~~~ 298 (565)
+.||.|++|.||+|++.+|+.||||+.+...... . -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986421000 0 02445
Q ss_pred HHHHHhcC----CCCCccceEEEEEe-cCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 008431 299 HMTRLGSL----SHPNLLPLIAFYYR-KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK-GLAYLYK 372 (565)
Q Consensus 299 E~~~l~~l----~H~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gL~ylH~ 372 (565)
|...+.++ +|.+-|.+-..+.+ ....+|||||++|++|.++...... .. .+..++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence 55555554 23333444333332 3457999999999999887753221 12 23456666665 4677888
Q ss_pred hCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 373 ~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
. +++|+|+||.||+++.+++++++|||++..+..
T Consensus 276 ~----g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D----GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C----CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 999999999999999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=8e-13 Score=126.56 Aligned_cols=200 Identities=19% Similarity=0.254 Sum_probs=136.9
Q ss_pred HHHHhcCCCCCccceEEEEEecC-----ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC
Q 008431 300 MTRLGSLSHPNLLPLIAFYYRKE-----EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374 (565)
Q Consensus 300 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~ 374 (565)
..-+-++.|.|||+++.|+.+.. ...++.|||..|++.++|+..+... ..+....-.+++.||..||.|||+.-
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34556677999999999987543 4689999999999999998765432 23666777889999999999999874
Q ss_pred CCCCCccCCCCCCCEEEcCCCCcEEeccCCccc------c--cccccccccccccCCCccCCCCCCcchhHHHHHHHHHH
Q 008431 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI------V--NKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILE 446 (565)
Q Consensus 375 ~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~------~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~e 446 (565)
| .|+|+++..+-|.+..++-+|+.----... . .......+.++|.|||+-.....+.++|||+||...+|
T Consensus 197 P--piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 P--PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred C--ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 4 699999999999999888888642111000 0 00112245688999998877778889999999999999
Q ss_pred HHcCCCC-ccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 447 LLTGKFP-ANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 447 l~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
|..+..- -+... ....+ ...... +.+...+ .-...+.+|++..|..||+|.+.+..
T Consensus 275 mailEiq~tnseS------~~~~e--------e~ia~~----i~~len~-----lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 275 MAILEIQSTNSES------KVEVE--------ENIANV----IIGLENG-----LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHheeccCCCcc------eeehh--------hhhhhh----eeeccCc-----cccCcCcccccCCCCCCcchhhhhcC
Confidence 9887643 11100 00000 000000 0000000 12235668999999999999987543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.7e-14 Score=144.60 Aligned_cols=139 Identities=25% Similarity=0.292 Sum_probs=96.5
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccc--cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGK--LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|....+..+.+.+|+.|+.|+||+|.|+..-+..+. .+|+.|+||+|+|+ .++++.|..|++|++|+|++|+++...
T Consensus 279 N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~ 357 (873)
T KOG4194|consen 279 NRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLA 357 (873)
T ss_pred chhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHH
Confidence 444555566677777777777777777765553322 26888888888888 788877888888888888888887766
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC-----CCCCCCEEEcccCCCccCCCccccCCCC---CcccCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF-----PLAHLTLLDLSYNQLVGRIPDTLSNFDA---TSFQGNK 141 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~ 141 (565)
...|..+++|+.|||++|.|++.+.+. .+++|+.|+|.+|+|....-.+|..++. +.+.+|+
T Consensus 358 e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 358 EGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNA 427 (873)
T ss_pred hhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCc
Confidence 777888888888888888888777652 5677777777777776444345544433 3445553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=135.83 Aligned_cols=251 Identities=17% Similarity=0.168 Sum_probs=174.9
Q ss_pred hhHHHhhccceecc--cCceeEEEEEE---eCCCeeEEEEee--ccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEec
Q 008431 250 LNDLLRASAEVLGS--GSFGSSYKAVL---LTGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRK 321 (565)
Q Consensus 250 ~~~~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 321 (565)
..+........+|. |.+|.||.+.. .++..+|+|+-+ .........=.+|+....+++ |+|.|+.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 33333445677899 99999999985 467888998843 222233333456666666664 99999988888899
Q ss_pred CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhhCCCCCCccCCCCCCCEEEcCC-CC
Q 008431 322 EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK----GLAYLYKEFPGVTLPHGHLKSSNVLLDNA-YE 396 (565)
Q Consensus 322 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~ylH~~~~~~~ivHrDlkp~NILl~~~-~~ 396 (565)
+..++-+|++. .+|.++.+.... .++....+.+..+..+ ||.++|.. +++|-|+||.||.+..+ ..
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheecccccce
Confidence 99999999995 688888775433 2556667777777777 99999998 89999999999999988 88
Q ss_pred cEEeccCCcccccccc---------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcch
Q 008431 397 PLLTDYALVPIVNKEH---------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADL 467 (565)
Q Consensus 397 ~kl~DfGla~~~~~~~---------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~ 467 (565)
.++.|||+...+.... ...+...|++||...+ -++...|+||+|.+..|..++..+... +..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~--------g~~ 332 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV--------GKN 332 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC--------CCC
Confidence 9999999976654332 1145567999997654 478899999999999999998877541 111
Q ss_pred HHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
..|.. .+.. .+-+.-+.+. ..++...+..+++.+|-.|++.+++ ..+.-|+
T Consensus 333 ~~W~~--~r~~---~ip~e~~~~~------s~~l~~~~~~~~d~~~~~~~~~q~~-~~l~~i~ 383 (524)
T KOG0601|consen 333 SSWSQ--LRQG---YIPLEFCEGG------SSSLRSVTSQMLDEDPRLRLTAQIL-TALNVIH 383 (524)
T ss_pred CCccc--cccc---cCchhhhcCc------chhhhhHHHHhcCcchhhhhHHHHH-hcccccc
Confidence 22221 0000 0111111111 1233447778999999999997765 3444343
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.6e-12 Score=115.10 Aligned_cols=131 Identities=18% Similarity=0.186 Sum_probs=95.8
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccc-eEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLP-LIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
+.++.|.++.||++... +..+++|....... ....+.+|+..++.+.+.++++ ++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 46889999999999864 77899998754321 2335678999999887666554 4433 334568999999998775
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCC-CCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP-GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~-~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+. . . ....++.+++++|+.||.... +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~----~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE----D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 42 0 1 112456789999999998721 22469999999999998 66899999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.6e-12 Score=138.63 Aligned_cols=109 Identities=34% Similarity=0.564 Sum_probs=95.5
Q ss_pred CCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEec
Q 008431 17 GLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNL 94 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 94 (565)
.++.|+|++|.|+|.+| .+..+ +|+.|+|++|+|+|.+|+. ++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~-~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChH-HhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 37899999999999998 45444 7999999999999999976 899999999999999999999999999999999999
Q ss_pred cCCcCCCCCCCC---CCCCCCEEEcccCCCccCCC
Q 008431 95 EGNSFQGKIPDF---PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 95 ~~N~l~g~~p~~---~~~~L~~l~ls~N~l~g~~p 126 (565)
++|+|+|.+|.. ...++..+++++|...+..|
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999974 23467789999997644333
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.8e-12 Score=134.00 Aligned_cols=141 Identities=18% Similarity=0.218 Sum_probs=90.5
Q ss_pred ceecccCceeEEEEEEeC-CCeeEEEEeeccCcc--------------------------C--------HH------HHH
Q 008431 259 EVLGSGSFGSSYKAVLLT-GPAMVVKRFRQMSNV--------------------------G--------KE------DFH 297 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~~------~~~ 297 (565)
+.||+|++|.||+|++.+ |+.||||+.+..-.. . .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999876 999999998742100 0 01 234
Q ss_pred HHHHHHhcCC----CCCccceEEEEEe-cCceEEEEeccCCCCHHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHH
Q 008431 298 EHMTRLGSLS----HPNLLPLIAFYYR-KEEKLLVSDFVPNGSLANLLHVRRAP-GQPGLDWPIRLKIIKGVAKGLAYLY 371 (565)
Q Consensus 298 ~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~ylH 371 (565)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.++-.-.... ....+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4444444442 4444554444443 45678999999999998753211110 00012222222223333 3
Q ss_pred hhCCCCCCccCCCCCCCEEEcCCC----CcEEeccCCcccccc
Q 008431 372 KEFPGVTLPHGHLKSSNVLLDNAY----EPLLTDYALVPIVNK 410 (565)
Q Consensus 372 ~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfGla~~~~~ 410 (565)
.. +++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 278 ~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 899999999999999888 999999999876654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.4e-13 Score=116.88 Aligned_cols=119 Identities=22% Similarity=0.429 Sum_probs=95.6
Q ss_pred cCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCC
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 90 (565)
+.++++++.|.||+|+++..+|.+..+ +|+.|++++|+++ ++|.. ++.|++|+.|+++-|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~-issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTS-ISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChh-hhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 456778888999999999888877655 7999999999998 89987 788999999999999998 7899999999999
Q ss_pred EEeccCCcCCC-CCCC--CCCCCCCEEEcccCCCccCCCccccCCCC
Q 008431 91 QLNLEGNSFQG-KIPD--FPLAHLTLLDLSYNQLVGRIPDTLSNFDA 134 (565)
Q Consensus 91 ~L~l~~N~l~g-~~p~--~~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 134 (565)
.|||++|+++. .+|. +.+..|+.|+|+.|.+. .+|..++++..
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~ 151 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTN 151 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcc
Confidence 99999999874 3454 24667777888888876 45555554443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.4e-13 Score=116.86 Aligned_cols=138 Identities=25% Similarity=0.445 Sum_probs=109.7
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCc-ccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS-GQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~-g~~ 79 (565)
|.+..+|| .+..|.+|+.|+|++|++...+++++.+ +|+.|+++-|++. .+|.+ |+.++.|+.|||++|++. ..+
T Consensus 43 NKl~~vpp-nia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprg-fgs~p~levldltynnl~e~~l 119 (264)
T KOG0617|consen 43 NKLTVVPP-NIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRG-FGSFPALEVLDLTYNNLNENSL 119 (264)
T ss_pred CceeecCC-cHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccc-cCCCchhhhhhccccccccccC
Confidence 45667887 5899999999999999999888777655 7999999999998 88887 999999999999999987 357
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCccccCCCC---CcccCCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLSNFDA---TSFQGNKGL 143 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~~ 143 (565)
|+.|..++.|.-|+|++|.|.-.+|+. .+++|+.|.+..|.|- .+|..++.+.. ...+||...
T Consensus 120 pgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 120 PGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred CcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 888888888888888888888666664 6778888888888775 56666554433 345666533
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.7e-12 Score=125.70 Aligned_cols=61 Identities=28% Similarity=0.437 Sum_probs=43.3
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-c-cccc-cceeecccccccccCCcchhcCCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-V-GKLT-LRALYLSLNKFTGEIPSDAFAGMD 63 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~-~~~~-L~~L~Ls~N~l~g~ip~~~~~~l~ 63 (565)
|.+..||+++|+.+++|+.||||+|+|+..-|. + +..+ ++.+++++|+|+ .||.++|.+|.
T Consensus 77 N~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~ 140 (498)
T KOG4237|consen 77 NQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLS 140 (498)
T ss_pred CCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHH
Confidence 778999999999999999999999999976662 2 3323 333445556666 55555544433
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.6e-13 Score=135.20 Aligned_cols=128 Identities=30% Similarity=0.432 Sum_probs=103.3
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeeccccccc-------------------------ccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFT-------------------------GEIP 55 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~-------------------------g~ip 55 (565)
|.+.+||...|-+|+.|-.||||+|+|...+|.+..+ .|+.|.||+|-|. ..||
T Consensus 136 N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 136 NNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred CccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCC
Confidence 6678999888899999999999999999888876554 6888888888543 1366
Q ss_pred cchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCccccCC
Q 008431 56 SDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLSNF 132 (565)
Q Consensus 56 ~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~ 132 (565)
+. +.+|.+|..+|||.|.|. ..|+.+-++.+|..|+||+|+++..--.. .+.+|+.|+||.|+|+ .+|+++..+
T Consensus 216 ts-ld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 216 TS-LDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred Cc-hhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 55 678899999999999998 79999999999999999999998533222 4678999999999998 567765443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-10 Score=121.00 Aligned_cols=164 Identities=23% Similarity=0.289 Sum_probs=124.8
Q ss_pred EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCH
Q 008431 274 LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDW 353 (565)
Q Consensus 274 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~ 353 (565)
..++.+|.|...+.......+...+-++.|+.++||||++++..+...+..|||+|-+. -|..+++.. ..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HH
Confidence 45778888888776544334456777889999999999999999999999999999985 577777653 33
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccccc----ccccccccCCCccCCC
Q 008431 354 PIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA----QLHMVAYKSPEFNQTD 429 (565)
Q Consensus 354 ~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~----~~~t~~y~aPE~~~~~ 429 (565)
......+.||+.||.|||+.| +++|++|.-..|.++..|.-||.+|-++........ ...-..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 455567899999999999775 799999999999999999999999987644322211 1111235666644322
Q ss_pred CCCcchhHHHHHHHHHHHHcCCC
Q 008431 430 GVTRKTDVWSLGILILELLTGKF 452 (565)
Q Consensus 430 ~~~~~~DvwS~Gvil~el~tg~~ 452 (565)
. ...|.|-|||+++|++.|..
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c--cchhhhhHHHHHHHHhCccc
Confidence 2 34699999999999999943
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.1e-12 Score=128.21 Aligned_cols=127 Identities=27% Similarity=0.320 Sum_probs=88.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccC--CCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGP--MPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+.+||...|.+|+.|+.|+|..|+|.-. ...-+..+|+.|.|..|.++ .+.+++|-+|.++++|+|+.|+++..-
T Consensus 207 NrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn 285 (873)
T KOG4194|consen 207 NRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVN 285 (873)
T ss_pred CcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhh
Confidence 455666666666666666666666666421 11123335666777777776 677777888888888888888888777
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
.+++.+|++|+.|+||+|.+..+-++. ..++|++|+||+|+|+...+..|
T Consensus 286 ~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf 337 (873)
T KOG4194|consen 286 EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSF 337 (873)
T ss_pred cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHH
Confidence 777888888888888888888766653 56788888888888886666554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.3e-11 Score=125.18 Aligned_cols=240 Identities=17% Similarity=0.108 Sum_probs=167.5
Q ss_pred cceecccCceeEEEEEE--eCCCeeEEEEeeccCccCHHH--HHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVL--LTGPAMVVKRFRQMSNVGKED--FHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
...||.|.|+.|++... .++..+++|.+.+.......+ -..|+.+...+ .|.++++.+..+......|+--|||+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 35799999999999873 467889999886543322222 24556555555 48889998888888888889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-CCcEEeccCCccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-YEPLLTDYALVPIVNKE 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~ 411 (565)
++++...+.-. ..++...++++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||++..+.-.
T Consensus 350 ~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 350 GGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred CcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhcccccccccccee
Confidence 99887665321 1377788899999999999999988 89999999999999876 88899999998643322
Q ss_pred c-ccccccccc--CCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 H-AQLHMVAYK--SPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ~-~~~~t~~y~--aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
. ...++-+++ +|+......+..+.|++|||..+.|.++|..--.. ..+|. .+....+
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----------~~~~~----------~i~~~~~ 480 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----------GVQSL----------TIRSGDT 480 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCcc----------cccce----------eeecccc
Confidence 2 122233344 55556666778899999999999999998754211 11111 0000001
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
... ......+..++......++..||.+.+........
T Consensus 481 p~~---~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 PNL---PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cCC---CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 000 11114566677788889999999988876555443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.5e-10 Score=104.84 Aligned_cols=136 Identities=15% Similarity=0.114 Sum_probs=95.6
Q ss_pred ceecccCceeEEEEEEeC-------CCeeEEEEeeccCc----------------------cCHHHHH----HHHHHHhc
Q 008431 259 EVLGSGSFGSSYKAVLLT-------GPAMVVKRFRQMSN----------------------VGKEDFH----EHMTRLGS 305 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~~ 305 (565)
..||.|.=+.||.|...+ +..+|||..+.... .....+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47899998652110 0011233 78888888
Q ss_pred CCC--CCccceEEEEEecCceEEEEeccCCCCHHH-HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhhCCCCCCcc
Q 008431 306 LSH--PNLLPLIAFYYRKEEKLLVSDFVPNGSLAN-LLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPGVTLPH 381 (565)
Q Consensus 306 l~H--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yl-H~~~~~~~ivH 381 (565)
+.. -++.+.+++ ...+|||||+.++.+.. .++.. .++......+..+++.+|.++ |.. +|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~----glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKEC----NLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhC----Ceec
Confidence 853 345555543 56789999997654422 22211 144456677889999999999 666 8999
Q ss_pred CCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 382 GHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 382 rDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
+||++.|||++ ++.+.++|||.+-...
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4679999999875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-10 Score=109.00 Aligned_cols=143 Identities=20% Similarity=0.195 Sum_probs=108.2
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCC--CccceEEEEEec---CceEEEEeccC
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHP--NLLPLIAFYYRK---EEKLLVSDFVP 332 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~E~~~ 332 (565)
+.|+.|.++.||++...+|..+++|....... .....+.+|+++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999976678899998764322 2355789999999999764 456677776543 25689999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF-------------------------------------- 374 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~-------------------------------------- 374 (565)
|.++.+.+.. ..++......++.+++++|.+||+.-
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765421 12667777888888888888888521
Q ss_pred --------------CCCCCccCCCCCCCEEEcC--CCCcEEeccCCccc
Q 008431 375 --------------PGVTLPHGHLKSSNVLLDN--AYEPLLTDYALVPI 407 (565)
Q Consensus 375 --------------~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~ 407 (565)
.+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1235789999999999998 56688999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.8e-12 Score=124.86 Aligned_cols=131 Identities=31% Similarity=0.526 Sum_probs=96.3
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKS 82 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~ 82 (565)
...+|++.+. ++.|+.||..+|-+...+|.++.+ +|..|||..|+|. .+|+ |.++..|.+|+++.|++. .+|..
T Consensus 172 l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lPe--f~gcs~L~Elh~g~N~i~-~lpae 246 (565)
T KOG0472|consen 172 LKALPENHIA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLPE--FPGCSLLKELHVGENQIE-MLPAE 246 (565)
T ss_pred hhhCCHHHHH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCCC--CCccHHHHHHHhcccHHH-hhHHH
Confidence 3445554443 666777777777776666666655 5778888888887 7783 888888888888888887 67777
Q ss_pred cc-CCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCC--CCcccCCC
Q 008431 83 LA-GLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFD--ATSFQGNK 141 (565)
Q Consensus 83 ~~-~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~--~~~~~~n~ 141 (565)
.. .+.+|..|||.+|+++ ..|+. -+.+|+.||+|+|.+++ +|..++++. ...+.|||
T Consensus 247 ~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 247 HLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNLHLKFLALEGNP 308 (565)
T ss_pred Hhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccceeeehhhcCCc
Confidence 65 7889999999999998 56653 57889999999999984 666777663 33456665
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-11 Score=127.05 Aligned_cols=133 Identities=26% Similarity=0.379 Sum_probs=98.4
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
..||+ .+..|..|+.||||+|+|...+..+... ++-.|+||+|+|. +||...|.+|+.|-.||||+|+|. .+|..+
T Consensus 93 sGiP~-diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~ 169 (1255)
T KOG0444|consen 93 SGIPT-DIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQI 169 (1255)
T ss_pred CCCCc-hhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHH
Confidence 45776 4668999999999999998766555443 5778999999998 899888999999999999999998 678888
Q ss_pred cCCCCCCEEeccCCcCCC----CCCC---------------------C--CCCCCCEEEcccCCCccCCCccccCCC---
Q 008431 84 AGLQKLLQLNLEGNSFQG----KIPD---------------------F--PLAHLTLLDLSYNQLVGRIPDTLSNFD--- 133 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g----~~p~---------------------~--~~~~L~~l~ls~N~l~g~~p~~~~~~~--- 133 (565)
..|..|++|.|++|.|.- .+|. . .+.+|..+|||.|+|. .+|.++.++.
T Consensus 170 RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~Lr 248 (1255)
T KOG0444|consen 170 RRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLR 248 (1255)
T ss_pred HHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhh
Confidence 888889999999987642 1221 1 2457778888888886 5666654332
Q ss_pred CCcccCCC
Q 008431 134 ATSFQGNK 141 (565)
Q Consensus 134 ~~~~~~n~ 141 (565)
.+.+.+|.
T Consensus 249 rLNLS~N~ 256 (1255)
T KOG0444|consen 249 RLNLSGNK 256 (1255)
T ss_pred eeccCcCc
Confidence 33445553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.4e-11 Score=131.39 Aligned_cols=235 Identities=20% Similarity=0.195 Sum_probs=154.9
Q ss_pred eecccCceeEEEEE-EeCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 260 VLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
-+-+|+++.++.+. ...|...++|...... ....+....+-.++-..+||-++...--+......+||++|..+|+
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 56778888888776 3344444444433211 1122233333333333455666665555556778899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc------
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN------ 409 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~------ 409 (565)
|...|+.... .+..-.......+.++++|||.. .+.|||++|.|+|+..++..+++|||+.....
T Consensus 891 ~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 891 LPSKLHNSGC-----LSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred chhhhhcCCC-----cccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999986542 44444555667788999999987 68999999999999999999999998432110
Q ss_pred ------------------------c-----cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccC
Q 008431 410 ------------------------K-----EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQG 460 (565)
Q Consensus 410 ------------------------~-----~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~ 460 (565)
. .....+|+.|.+||...+......+|.|++|++++|.++|.+||+...+.
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 01224678899999999999999999999999999999999999743221
Q ss_pred CCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 008431 461 KGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLR 520 (565)
Q Consensus 461 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 520 (565)
. .+ ..+....+.....+........+++..-+..+|.+|-.|.
T Consensus 1042 ~--------~f---------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 Q--------IF---------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h--------hh---------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1 11 1111111111111122223455566667777888887665
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-10 Score=86.81 Aligned_cols=60 Identities=35% Similarity=0.594 Sum_probs=55.3
Q ss_pred ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcC
Q 008431 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99 (565)
Q Consensus 39 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 99 (565)
+|+.|+|++|+|+ .||+++|.++++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5889999999999 89999999999999999999999988888999999999999999975
|
... |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.4e-09 Score=94.97 Aligned_cols=130 Identities=20% Similarity=0.294 Sum_probs=95.9
Q ss_pred eecccCceeEEEEEEeCCCeeEEEEeeccCc--------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 260 VLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN--------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.+++|+=+.+|.+.+. |..+++|.-..... ...++-.+|+.++.+++--.|..-.=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999763 33455554322211 11245678899988876444433333556778889999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++.++. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998998888643 245777788888899998 999999999999997654 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.6e-09 Score=93.09 Aligned_cols=141 Identities=13% Similarity=0.228 Sum_probs=103.1
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccC--------ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--------NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
.++-+|+-+.|+++.+ .|+...||.-.... ...+.+..+|++.+.+++--.|.--.=++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5788999999999987 67777777643211 12345678899999988654444333456677778899999
Q ss_pred cCC-CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC---CcEEeccCCcc
Q 008431 331 VPN-GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY---EPLLTDYALVP 406 (565)
Q Consensus 331 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfGla~ 406 (565)
+++ -++.+++...-.. .........+++.|-+.+.-||.. +|||+||..+||++..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence 976 4788888765432 122233367889999999999998 999999999999996554 35799999975
Q ss_pred c
Q 008431 407 I 407 (565)
Q Consensus 407 ~ 407 (565)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.3e-10 Score=102.18 Aligned_cols=106 Identities=27% Similarity=0.367 Sum_probs=37.1
Q ss_pred cCCCCCCcEEEcccCcCccCCCccc--ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc-cCCCC
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVG--KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL-AGLQK 88 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~--~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~ 88 (565)
+.+...++.|+|++|.|+. +..++ ..+|+.|+||+|.|+ .|+. +..+++|++|+|++|+|+. ++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-ccchhhhhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 4566678999999999985 33444 236899999999998 6763 7889999999999999984 54444 46899
Q ss_pred CCEEeccCCcCCCCCCC---CCCCCCCEEEcccCCCc
Q 008431 89 LLQLNLEGNSFQGKIPD---FPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 89 L~~L~l~~N~l~g~~p~---~~~~~L~~l~ls~N~l~ 122 (565)
|+.|+|++|++...-.- ..+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 99999999999753211 25788999999988875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-10 Score=114.73 Aligned_cols=118 Identities=23% Similarity=0.311 Sum_probs=105.2
Q ss_pred CCcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 1 ~n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
.|+.++||+ .++.|.+|..|+|.+|.|... |+++.+ .|..|+++.|+|. .+|.+...++++|..|||..|++. ..
T Consensus 192 ~N~L~tlP~-~lg~l~~L~~LyL~~Nki~~l-Pef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 192 SNLLETLPP-ELGGLESLELLYLRRNKIRFL-PEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hhhhhcCCh-hhcchhhhHHHHhhhcccccC-CCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 378899997 699999999999999999965 466555 6999999999999 999998889999999999999998 89
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~ 122 (565)
|+.+--+.+|.+||+|+|.+++..+...--.|+.|-+-+|.|.
T Consensus 268 Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred chHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence 9999999999999999999998877753238899999999885
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1e-08 Score=104.67 Aligned_cols=169 Identities=19% Similarity=0.282 Sum_probs=127.9
Q ss_pred ceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe----cCceEEEEeccCC-CCHHHH
Q 008431 266 FGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR----KEEKLLVSDFVPN-GSLANL 339 (565)
Q Consensus 266 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~E~~~~-gsL~~~ 339 (565)
-.+.||+. ..+|..|+.|++.............-++.++++.|+|+|++.++|.. +..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 34789998 66899999999953322222233455788999999999999998863 3468999999885 578776
Q ss_pred HhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 340 LHVRRAP----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 340 l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
--..... .....++...+.++.|+..||.++|+. |..-+-|-|.+||++.+.+++|+..|+...+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5433221 123477889999999999999999998 88889999999999999999999999877665
Q ss_pred ccccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCC
Q 008431 410 KEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGK 451 (565)
Q Consensus 410 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~ 451 (565)
.+.. |-+.. -.+-|.=.||.+++-|.||.
T Consensus 445 ~d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 445 EDPT----------EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCCC----------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 4431 11111 13568888999999999984
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.1e-11 Score=120.86 Aligned_cols=145 Identities=23% Similarity=0.369 Sum_probs=121.2
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
|-+..||. .+.+|..|+.|||+.|+++-.++.+..+.|+.|.+++|+++ .+|++ ++.+..|..||.+.|.+. .+|.
T Consensus 108 n~~r~ip~-~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~sNNkl~-~lp~~-ig~~~tl~~ld~s~nei~-slps 183 (722)
T KOG0532|consen 108 NCIRTIPE-AICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVSNNKLT-SLPEE-IGLLPTLAHLDVSKNEIQ-SLPS 183 (722)
T ss_pred ccceecch-hhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEecCccc-cCCcc-cccchhHHHhhhhhhhhh-hchH
Confidence 45567875 78999999999999999998777888888999999999999 89988 778999999999999998 7999
Q ss_pred cccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccccCCCCC---cccCCCCCCCCCCcccc
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFDAT---SFQGNKGLCGKPLEACK 152 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~---~~~~n~~~cg~p~~~c~ 152 (565)
.++++.+|..|++..|++...++....-.|..||+|.|+++ .+|-.|.++..+ .+.+|| +..+|..-|.
T Consensus 184 ql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP-LqSPPAqIC~ 255 (722)
T KOG0532|consen 184 QLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP-LQSPPAQICE 255 (722)
T ss_pred HhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCC-CCCChHHHHh
Confidence 99999999999999999996666554557889999999998 788887766544 455554 5666666664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.9e-08 Score=95.64 Aligned_cols=141 Identities=16% Similarity=0.105 Sum_probs=98.1
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCc-----------cCHHHHHHHHHHHhcCCCCC--ccceEEEEEe-----
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN-----------VGKEDFHEHMTRLGSLSHPN--LLPLIAFYYR----- 320 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~----- 320 (565)
+.+-......|++..+ .|+.+.||....... .....+.+|...+.++...+ ..+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444434445666654 677899997643210 11124778988887774333 3445555543
Q ss_pred cCceEEEEeccCCC-CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC------
Q 008431 321 KEEKLLVSDFVPNG-SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN------ 393 (565)
Q Consensus 321 ~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~------ 393 (565)
....+||+|++++- +|.+++..... ...+...+..++.+++..+.-||.. +|+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCCC
Confidence 23478999999876 89999853221 1245567788999999999999999 9999999999999975
Q ss_pred -CCCcEEeccCCccc
Q 008431 394 -AYEPLLTDYALVPI 407 (565)
Q Consensus 394 -~~~~kl~DfGla~~ 407 (565)
+..+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46789999998753
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.7e-09 Score=115.84 Aligned_cols=99 Identities=22% Similarity=0.376 Sum_probs=54.3
Q ss_pred CCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEecc
Q 008431 16 PGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLE 95 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 95 (565)
+.|+.|+|++|+|+..++.+. .+|+.|+|++|+|+ .||.. +. .+|+.|+|++|++. .+|..+. .+|+.|+|+
T Consensus 199 ~~L~~L~Ls~N~LtsLP~~l~-~nL~~L~Ls~N~Lt-sLP~~-l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 199 EQITTLILDNNELKSLPENLQ-GNIKTLYANSNQLT-SIPAT-LP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred cCCcEEEecCCCCCcCChhhc-cCCCEEECCCCccc-cCChh-hh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 356667777776664332222 35666666666666 56643 22 34666666666665 4555443 356666666
Q ss_pred CCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 96 GNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 96 ~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
+|+|+. +|.....+|+.|++++|+|++
T Consensus 271 ~N~L~~-LP~~l~~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 271 HNKISC-LPENLPEELRYLSVYDNSIRT 297 (754)
T ss_pred CCccCc-cccccCCCCcEEECCCCcccc
Confidence 666653 343323456666666666553
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.2e-10 Score=123.35 Aligned_cols=103 Identities=28% Similarity=0.529 Sum_probs=49.3
Q ss_pred CCcEEEcccCcCcc-CCCcc-cccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEec
Q 008431 17 GLRSLSFINNSFDG-PMPSV-GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNL 94 (565)
Q Consensus 17 ~L~~L~l~~N~l~~-~~p~~-~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 94 (565)
.|+.|+|.+|.|+. .+|-+ +...|+.|+|++|+|. ++|+..+.++..|++|+||+|+|+ .+|....++..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 34444555555542 22222 2223555555555554 455555555555555555555554 34455555555555555
Q ss_pred cCCcCCCCCCCC-CCCCCCEEEcccCCCc
Q 008431 95 EGNSFQGKIPDF-PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 95 ~~N~l~g~~p~~-~~~~L~~l~ls~N~l~ 122 (565)
.+|++.. .|.. .++.|+.+|+|.|+|+
T Consensus 438 hsN~l~~-fPe~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 438 HSNQLLS-FPELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred cCCceee-chhhhhcCcceEEecccchhh
Confidence 5555542 2222 4445555555555554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.5e-08 Score=92.14 Aligned_cols=125 Identities=18% Similarity=0.264 Sum_probs=81.4
Q ss_pred eEEEEEEeCCCeeEEEEeeccCc-------------c-------------CHHHHHHHHHHHhcCCCC--CccceEEEEE
Q 008431 268 SSYKAVLLTGPAMVVKRFRQMSN-------------V-------------GKEDFHEHMTRLGSLSHP--NLLPLIAFYY 319 (565)
Q Consensus 268 ~Vy~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 319 (565)
.||.|...+|..+|+|..+.... . ......+|.+.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988999999998642100 0 012356799999999765 45555543
Q ss_pred ecCceEEEEeccC--CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhhCCCCCCccCCCCCCCEEEcCCCC
Q 008431 320 RKEEKLLVSDFVP--NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLDNAYE 396 (565)
Q Consensus 320 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yl-H~~~~~~~ivHrDlkp~NILl~~~~~ 396 (565)
...+|||||++ |..+..+.... ++......++.++...+..+ |.. +|+|+||.+.|||++++ .
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-C
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-e
Confidence 24579999998 65555443321 11334566777888877765 555 99999999999999887 9
Q ss_pred cEEeccCCcccc
Q 008431 397 PLLTDYALVPIV 408 (565)
Q Consensus 397 ~kl~DfGla~~~ 408 (565)
+.++|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.8e-09 Score=95.39 Aligned_cols=109 Identities=28% Similarity=0.362 Sum_probs=51.1
Q ss_pred cccccChhhcC-CCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC-
Q 008431 3 LMGMIDVDTLS-RLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI- 79 (565)
Q Consensus 3 ~~g~i~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~- 79 (565)
.+..|. .++ .+++|+.|+|++|.|+.. +.+.. ..|+.|+|++|+|+ .+++.....+++|++|+|++|+|...-
T Consensus 30 ~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~ 105 (175)
T PF14580_consen 30 QISTIE--NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNE 105 (175)
T ss_dssp --------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCC
T ss_pred cccccc--chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHH
Confidence 344553 355 578999999999999964 34433 47999999999999 787653456899999999999997422
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC------CCCCCCEEEc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF------PLAHLTLLDL 116 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~------~~~~L~~l~l 116 (565)
=..+..+++|+.|+|.+|.++.. +.. .+++|+.||-
T Consensus 106 l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 106 LEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp CGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred hHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 13567899999999999999854 442 5788999873
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.8e-09 Score=115.79 Aligned_cols=109 Identities=22% Similarity=0.341 Sum_probs=58.2
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
|.+..||.. + .++|+.|+|++|+|+..+..+. .+|+.|+|++|+|+ .+|.. +. ++|+.|+|++|+|+. +|.
T Consensus 251 N~L~~LP~~-l--~s~L~~L~Ls~N~L~~LP~~l~-~sL~~L~Ls~N~Lt-~LP~~-lp--~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 251 NRITELPER-L--PSALQSLDLFHNKISCLPENLP-EELRYLSVYDNSIR-TLPAH-LP--SGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred CccCcCChh-H--hCCCCEEECcCCccCccccccC-CCCcEEECCCCccc-cCccc-ch--hhHHHHHhcCCcccc-CCc
Confidence 334466643 2 2468888888888875322332 36778888888777 56654 21 345555555555553 343
Q ss_pred cccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCc
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~ 122 (565)
.+. ++|+.|++++|.|++ +|....++|+.|++++|+|+
T Consensus 322 ~l~--~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 322 TLP--PGLKTLEAGENALTS-LPASLPPELQVLDVSKNQIT 359 (754)
T ss_pred ccc--ccceeccccCCcccc-CChhhcCcccEEECCCCCCC
Confidence 322 345555555555543 23222244555555555544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.9e-08 Score=111.33 Aligned_cols=70 Identities=23% Similarity=0.347 Sum_probs=32.5
Q ss_pred CccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccccCCCCCcccCC
Q 008431 64 QLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGN 140 (565)
Q Consensus 64 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 140 (565)
+|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|....++..+.+.+|
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~-LP~l-~~~L~~LdLs~N~Lt~-LP~l~s~L~~LdLS~N 412 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTS-LPAL-PSGLKELIVSGNRLTS-LPVLPSELKELMVSGN 412 (788)
T ss_pred ccceEecCCCccCC-CCCCC---cccceehhhcccccc-Cccc-ccccceEEecCCcccC-CCCcccCCCEEEccCC
Confidence 45666666666653 44322 234444455554443 3322 2345555555555553 3333333444444444
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2e-09 Score=116.12 Aligned_cols=106 Identities=31% Similarity=0.442 Sum_probs=90.6
Q ss_pred hcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQK 88 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 88 (565)
.|-+..+|+.|+|++|+|...+. .+..+ .|+.|+||+|+|+ .||. ...++..|++|...+|++. ..| .+..++.
T Consensus 378 ~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~-tva~~~~L~tL~ahsN~l~-~fP-e~~~l~q 453 (1081)
T KOG0618|consen 378 VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPD-TVANLGRLHTLRAHSNQLL-SFP-ELAQLPQ 453 (1081)
T ss_pred hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhH-HHHhhhhhHHHhhcCCcee-ech-hhhhcCc
Confidence 47788999999999999986444 23334 6999999999999 9995 4889999999999999998 788 8999999
Q ss_pred CCEEeccCCcCCCC-CCCC-CCCCCCEEEcccCC
Q 008431 89 LLQLNLEGNSFQGK-IPDF-PLAHLTLLDLSYNQ 120 (565)
Q Consensus 89 L~~L~l~~N~l~g~-~p~~-~~~~L~~l~ls~N~ 120 (565)
|+.+|||.|+|+-. +|.. +.++|++|||++|.
T Consensus 454 L~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 454 LKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred ceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 99999999999853 4443 55899999999997
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.2e-08 Score=100.48 Aligned_cols=97 Identities=30% Similarity=0.445 Sum_probs=85.7
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCC-cc-cccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SV-GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~-~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
.+.-|...|..|++|+.|+|++|+|++.-+ .+ +...++.|+|..|+|. .+...+|.++..|++|+|.+|+|+-.-|.
T Consensus 262 d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~ 340 (498)
T KOG4237|consen 262 DSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPG 340 (498)
T ss_pred CCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecc
Confidence 345677889999999999999999998766 23 4447999999999998 88889999999999999999999999999
Q ss_pred cccCCCCCCEEeccCCcCCC
Q 008431 82 SLAGLQKLLQLNLEGNSFQG 101 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g 101 (565)
+|..+.+|.+|+|-.|.|..
T Consensus 341 aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 341 AFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred cccccceeeeeehccCcccC
Confidence 99999999999999998863
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-08 Score=76.28 Aligned_cols=59 Identities=34% Similarity=0.502 Sum_probs=53.8
Q ss_pred CCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCC
Q 008431 63 DQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQL 121 (565)
Q Consensus 63 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l 121 (565)
++|++|+|++|+|+...+..|.++++|++|+|++|+++...|.. .+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57999999999999877789999999999999999999877764 789999999999986
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.7e-08 Score=108.98 Aligned_cols=45 Identities=24% Similarity=0.416 Sum_probs=23.2
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCC
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIP 55 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip 55 (565)
.+||+ .+. ++|+.|+|++|+|+. +|.. ..+|++|+|++|+|+ .||
T Consensus 214 tsLP~-~l~--~~L~~L~L~~N~Lt~-LP~l-p~~Lk~LdLs~N~Lt-sLP 258 (788)
T PRK15387 214 TTLPD-CLP--AHITTLVIPDNNLTS-LPAL-PPELRTLEVSGNQLT-SLP 258 (788)
T ss_pred CcCCc-chh--cCCCEEEccCCcCCC-CCCC-CCCCcEEEecCCccC-ccc
Confidence 35654 232 256666666666664 2221 134666666666665 455
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.9e-07 Score=91.02 Aligned_cols=262 Identities=16% Similarity=0.178 Sum_probs=150.7
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEE----E--ecCc-eEEEEe
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFY----Y--RKEE-KLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~----~--~~~~-~~lv~E 329 (565)
..-||+|+-+.+|---- -...+.|+...-......+ -+..|... .||-+-.=+.+= + ++.. .-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 45699999999995431 1123455554322222221 12223332 455332211110 0 1122 456777
Q ss_pred ccCCC-CHHHHHhh-cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 330 FVPNG-SLANLLHV-RRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 330 ~~~~g-sL~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
.+++. -+..++.- .+....+...|...+++++.+|.+.+-||.. |.+-+|+.++|+|+.++..+.+.|-.--.+
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEcccceee
Confidence 76653 22333221 1233445689999999999999999999998 777899999999999999999887432222
Q ss_pred cccc---ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcC-CCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTG-KFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
.... ...+|...|.+||.-. +-.-+...|-|.+||++++++.| +.||..+............-+.. +
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~----g 242 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH----G 242 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc----c
Confidence 2222 2345677899999643 33456789999999999999886 99998765543332222211111 0
Q ss_pred ccCcccc--ccccCCC--CC-HHHHHHHHHHHhhccccC--cCCCCCHHHHHHHHHHhhcc
Q 008431 479 WTGEVFD--KDMRGTK--SG-EGEMLKLLKIGMCCCEWN--AERRWDLREAVEKIMELKER 532 (565)
Q Consensus 479 ~~~~~~d--~~~~~~~--~~-~~~~~~~~~l~~~Cl~~~--P~~RPs~~evl~~L~~i~~~ 532 (565)
....--| +.++..+ .+ .--...+..+-.+|+... |.-|||++--+..|.++...
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0000000 0010000 01 111224445555777643 56899999988888777653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.6e-07 Score=84.72 Aligned_cols=106 Identities=23% Similarity=0.330 Sum_probs=82.6
Q ss_pred HHHHHHHHHHHhcCCCC--CccceEEEEEecC----ceEEEEeccCCC-CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHH
Q 008431 293 KEDFHEHMTRLGSLSHP--NLLPLIAFYYRKE----EKLLVSDFVPNG-SLANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365 (565)
Q Consensus 293 ~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 365 (565)
.....+|...+..+... .+.+.+++..... ..++|+|++++. +|.+++..... .+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 44677888877776533 3456666665532 358999999874 89999875332 445677889999999
Q ss_pred HHHHHHhhCCCCCCccCCCCCCCEEEcCCC---CcEEeccCCccc
Q 008431 366 GLAYLYKEFPGVTLPHGHLKSSNVLLDNAY---EPLLTDYALVPI 407 (565)
Q Consensus 366 gL~ylH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfGla~~ 407 (565)
.++-||.. +|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 130 ~i~~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 999999999999998876 789999997665
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.54 E-value=9.3e-09 Score=97.74 Aligned_cols=106 Identities=26% Similarity=0.226 Sum_probs=82.0
Q ss_pred CCCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 13 SRLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 13 ~~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
-.+..|+.||||+|.|+..-.+.-. ..++.|++|+|.|. .+.. +..+++|+.||||+|.++ .+-++-..|.++++
T Consensus 281 dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred chHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eehh--hhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 3466788999999998853333322 36899999999998 6654 778899999999999998 56666677889999
Q ss_pred EeccCCcCCCCCCCCCCCCCCEEEcccCCCc
Q 008431 92 LNLEGNSFQGKIPDFPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 92 L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~ 122 (565)
|.|++|.+...-.-..+-+|..||+++|++.
T Consensus 357 L~La~N~iE~LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 357 LKLAQNKIETLSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred eehhhhhHhhhhhhHhhhhheeccccccchh
Confidence 9999998863222225678999999999986
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4e-07 Score=86.67 Aligned_cols=136 Identities=20% Similarity=0.271 Sum_probs=94.2
Q ss_pred HHHhhccceecccCceeEEEEEEeCCCeeEEEEeeccC----------------------ccCHHHHHHHHHHHhcCCCC
Q 008431 252 DLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS----------------------NVGKEDFHEHMTRLGSLSHP 309 (565)
Q Consensus 252 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~ 309 (565)
+...+..+.||-|.=+.||.|..+.|..+|||.=+... ........+|.+.|++|.-.
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 34455678999999999999999999999999532100 01123456889999988644
Q ss_pred --CccceEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCC
Q 008431 310 --NLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSS 387 (565)
Q Consensus 310 --niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~ 387 (565)
.+.+-+++ +...+||||++|-.|...- ++-...-.++..|..-+.-+-.. ||||+|+.+=
T Consensus 170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSef 231 (304)
T COG0478 170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEF 231 (304)
T ss_pred CCCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchh
Confidence 45555443 4568999999986665431 11222333444444444444445 8999999999
Q ss_pred CEEEcCCCCcEEeccCCc
Q 008431 388 NVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 388 NILl~~~~~~kl~DfGla 405 (565)
||+++++|.+.++||--+
T Consensus 232 NIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 232 NILVTEDGDIVVIDWPQA 249 (304)
T ss_pred eEEEecCCCEEEEeCccc
Confidence 999999999999999543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.4e-07 Score=96.35 Aligned_cols=149 Identities=16% Similarity=0.290 Sum_probs=95.8
Q ss_pred hHHHhhcc-ceecccCceeEEEEEEeCCCeeEEEEeeccCcc--------------------------CH----H-----
Q 008431 251 NDLLRASA-EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV--------------------------GK----E----- 294 (565)
Q Consensus 251 ~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~----~----- 294 (565)
++....+. +-|+.++-|.||+|++.+|+.||||+.+..-.. .. +
T Consensus 122 ee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~ 201 (517)
T COG0661 122 EELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR 201 (517)
T ss_pred HHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH
Confidence 33333333 678999999999999999999999987532110 00 0
Q ss_pred -----HHHHHHHHHhcCC----CCCccceEEEEEe-cCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 008431 295 -----DFHEHMTRLGSLS----HPNLLPLIAFYYR-KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVA 364 (565)
Q Consensus 295 -----~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 364 (565)
++.+|...+.+++ +..=+++-..|++ .....|+|||++|-.+.+....... +++... ++..++
T Consensus 202 l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~k~---ia~~~~ 274 (517)
T COG0661 202 LREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDRKE---LAELLV 274 (517)
T ss_pred HHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCHHH---HHHHHH
Confidence 1344555554442 2223444444543 4677899999999888887433222 244332 333333
Q ss_pred HHH-HHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 365 KGL-AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 365 ~gL-~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
++. ..+-.. +++|.|..|.||+++.++++-+.|||+.....+
T Consensus 275 ~~f~~q~~~d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 275 RAFLRQLLRD----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHhc----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 221 222223 899999999999999999999999999876654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.50 E-value=5e-07 Score=106.89 Aligned_cols=124 Identities=22% Similarity=0.214 Sum_probs=67.5
Q ss_pred CCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEe
Q 008431 15 LPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93 (565)
Q Consensus 15 l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 93 (565)
+.+|+.|+|++|++......... .+|+.|+|++|+..+.+|. +..+++|+.|+|++|..-..+|..++++++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 44555666666555533222222 2466666665543335553 55566666666666554456666666666666666
Q ss_pred ccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCccccCCCCCcccCC
Q 008431 94 LEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGN 140 (565)
Q Consensus 94 l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 140 (565)
|++|..-+.+|.. .+++|+.|+|++|...+.+|....++....+.+|
T Consensus 688 L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n 735 (1153)
T PLN03210 688 MSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDET 735 (1153)
T ss_pred CCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCC
Confidence 6665433344432 4566666666666554455544444444444444
|
syringae 6; Provisional |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.9e-06 Score=78.14 Aligned_cols=138 Identities=15% Similarity=0.154 Sum_probs=100.4
Q ss_pred ecccCceeEEEEEEeCCCeeEEEEeecc---C---ccCHHHHHHHHHHHhcCCCCC--ccceEEEEE-ec----CceEEE
Q 008431 261 LGSGSFGSSYKAVLLTGPAMVVKRFRQM---S---NVGKEDFHEHMTRLGSLSHPN--LLPLIAFYY-RK----EEKLLV 327 (565)
Q Consensus 261 lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~-~~----~~~~lv 327 (565)
-|+||-+.|++-.+ .|..+-+|+-... + +.....|.+|+..+.++..-+ +.+.. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 37788889998765 4446888876421 1 335678999999998885332 34444 332 21 135899
Q ss_pred EeccCC-CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC--cEEeccCC
Q 008431 328 SDFVPN-GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PLLTDYAL 404 (565)
Q Consensus 328 ~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfGl 404 (565)
+|-+++ -+|.+++..... ...+...+..++.+++..++-||+. ++.|+|+.+.||+++.++. ++++||--
T Consensus 104 Te~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 997764 489988865322 1256677889999999999999999 9999999999999986666 89999976
Q ss_pred ccc
Q 008431 405 VPI 407 (565)
Q Consensus 405 a~~ 407 (565)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.1e-07 Score=100.58 Aligned_cols=143 Identities=20% Similarity=0.220 Sum_probs=94.0
Q ss_pred HHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccccc-------------cccccccCCCccC
Q 008431 361 KGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQ-------------LHMVAYKSPEFNQ 427 (565)
Q Consensus 361 ~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-------------~~t~~y~aPE~~~ 427 (565)
.+++.|+.|+|... ++||++|.|++|.++..+..|++.|+.+-........ .-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sA---k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA---KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCc---ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 45569999999863 7999999999999999999999999986443321100 1124699999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHh
Q 008431 428 TDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGM 506 (565)
Q Consensus 428 ~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~ 506 (565)
....+.++|+||+||++|-+.. |+.-+.. . ......-..... .+..... .+.+...++.+-+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a----~---~~~~~~~~~~~~-------~~~~~~~--~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA----N---GGLLSYSFSRNL-------LNAGAFG--YSNNLPSELRESLK 246 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhc----c---CCcchhhhhhcc-------ccccccc--ccccCcHHHHHHHH
Confidence 8888999999999999999984 4443321 0 011111110000 0111111 11122335566666
Q ss_pred hccccCcCCCCCHHHH
Q 008431 507 CCCEWNAERRWDLREA 522 (565)
Q Consensus 507 ~Cl~~~P~~RPs~~ev 522 (565)
+.+..++.-||++.++
T Consensus 247 k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLL 262 (700)
T ss_pred HHhcCCcccCcchhhh
Confidence 7889999999987776
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.4e-06 Score=90.40 Aligned_cols=142 Identities=16% Similarity=0.207 Sum_probs=90.7
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccC-------------------------------H------HHHHHHHH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVG-------------------------------K------EDFHEHMT 301 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~------~~~~~E~~ 301 (565)
+.||.-+.|.||+|++++|+.||||+-+..-... . -+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999865321110 0 02445554
Q ss_pred HHhc----CCCCC---ccceEEEEEe-cCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhh
Q 008431 302 RLGS----LSHPN---LLPLIAFYYR-KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373 (565)
Q Consensus 302 ~l~~----l~H~n---iv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~ 373 (565)
-..+ ++|-+ =|.+-.++++ .....|+||||+|.-+.+.-.-.+. +++...+..-+.+...-+-+ ..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~~l~~~~~~qIf--~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR----GISPHDILNKLVEAYLEQIF--KT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc----CCCHHHHHHHHHHHHHHHHH--hc
Confidence 4333 23444 1223334433 3468999999999877665433222 25555444333333222222 22
Q ss_pred CCCCCCccCCCCCCCEEEc----CCCCcEEeccCCcccccc
Q 008431 374 FPGVTLPHGHLKSSNVLLD----NAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 374 ~~~~~ivHrDlkp~NILl~----~~~~~kl~DfGla~~~~~ 410 (565)
|++|+|=.|.||++. .++.+.+-|||+......
T Consensus 321 ----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 899999999999998 367899999999876544
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.7e-06 Score=100.71 Aligned_cols=119 Identities=22% Similarity=0.353 Sum_probs=57.2
Q ss_pred cChhhcCCCCCCcEEEcccCcCc------cCCC-cccc--cccceeecccccccccCCcchhcCCCCccEEEccCCcCcc
Q 008431 7 IDVDTLSRLPGLRSLSFINNSFD------GPMP-SVGK--LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSG 77 (565)
Q Consensus 7 i~~~~~~~l~~L~~L~l~~N~l~------~~~p-~~~~--~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g 77 (565)
++.++|.+|++|+.|.+.++.+. ..+| .+.. ..|+.|.+.+|.+. .+|.. | .+.+|+.|+|++|++.
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~-f-~~~~L~~L~L~~s~l~- 624 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSN-F-RPENLVKLQMQGSKLE- 624 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCc-C-CccCCcEEECcCcccc-
Confidence 44556667777777766555321 2222 1111 13555555555554 45543 3 2345555555555554
Q ss_pred cCCccccCCCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCccc
Q 008431 78 QIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 78 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
.+|..+..+++|+.|+|++|...+.+|.. .+++|+.|+|++|.....+|..+
T Consensus 625 ~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si 677 (1153)
T PLN03210 625 KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSI 677 (1153)
T ss_pred ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhh
Confidence 34444455555555555554433344432 34455555555544434444443
|
syringae 6; Provisional |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.6e-06 Score=77.82 Aligned_cols=143 Identities=13% Similarity=0.103 Sum_probs=84.8
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCC--ccceEEEEEecCceEEEEeccCCCC-
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN--LLPLIAFYYRKEEKLLVSDFVPNGS- 335 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~E~~~~gs- 335 (565)
..||+|..+.||+. .+..+++|..... .......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 3556778877542 23456788999998886433 3566777766777789999999863
Q ss_pred HHHHHh--------------h----cCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhhCCCCCCccCCCC
Q 008431 336 LANLLH--------------V----RRAPGQPGLDWPIRL-KIIK----------GVAK-GLAYLYKEFPGVTLPHGHLK 385 (565)
Q Consensus 336 L~~~l~--------------~----~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~ylH~~~~~~~ivHrDlk 385 (565)
+...+. . -.............. .+.. .+.. ...+|...-....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 000000011111100 0100 1111 12233222112356899999
Q ss_pred CCCEEEcCCCCcEEeccCCccc
Q 008431 386 SSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 386 p~NILl~~~~~~kl~DfGla~~ 407 (565)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999987643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.6e-07 Score=96.82 Aligned_cols=117 Identities=30% Similarity=0.476 Sum_probs=97.4
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
|.+..+|. .+..|+ |+.|-+++|+++..++.++.. +|..||.|.|++. .+|+. ++++.+|+.|++..|++. .+|
T Consensus 131 NqlS~lp~-~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsq-l~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 131 NQLSHLPD-GLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQ-LGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred chhhcCCh-hhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHH-hhhHHHHHHHHHhhhhhh-hCC
Confidence 44556775 566775 999999999999877777644 7999999999998 89987 899999999999999998 688
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~ 124 (565)
..+..| .|..||+|.|+++.++-.+ .+..|++|.|.+|.|..+
T Consensus 206 ~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 206 EELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred HHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCCC
Confidence 888855 5899999999999544344 789999999999999843
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-07 Score=99.42 Aligned_cols=178 Identities=17% Similarity=0.140 Sum_probs=129.8
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCC-ccceEEEEEecCceEEEEeccCCC-CH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN-LLPLIAFYYRKEEKLLVSDFVPNG-SL 336 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~E~~~~g-sL 336 (565)
.-.++|+++.+||.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++|+.+| +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 346899999999987433333334444321 44566889999999999 777777777778889999999887 22
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---cc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---HA 413 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---~~ 413 (565)
..... .....+.......+.+.-.++++|+|+. .-+||| ||+..+ ...|..||+....+... ..
T Consensus 323 ~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 323 ALEMT----VSEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred cccCC----hhhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCccccccc
Confidence 11110 0111244445556677778999999986 347998 887755 67899999998766544 45
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCc
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPA 454 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~ 454 (565)
..+++.|+|||+.....+..+.|+|+.|+--.++.-|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 56789999999999999999999999998877888787764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.1e-07 Score=88.69 Aligned_cols=119 Identities=27% Similarity=0.282 Sum_probs=88.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
|.+..|+. +..-+|.++.|++|+|.|...-.-....+|+.||||+|.++ .+. +.-..+.++++|.|+.|.|.. + .
T Consensus 294 N~I~~iDE-SvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~-Gwh~KLGNIKtL~La~N~iE~-L-S 368 (490)
T KOG1259|consen 294 NLITQIDE-SVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECV-GWHLKLGNIKTLKLAQNKIET-L-S 368 (490)
T ss_pred cchhhhhh-hhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhh-hhHhhhcCEeeeehhhhhHhh-h-h
Confidence 56667764 67778999999999999984322112347999999999998 444 234568899999999999862 2 3
Q ss_pred cccCCCCCCEEeccCCcCCCCCCC---CCCCCCCEEEcccCCCccCC
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPD---FPLAHLTLLDLSYNQLVGRI 125 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~---~~~~~L~~l~ls~N~l~g~~ 125 (565)
.++.|-+|..||+++|++...-.- -.++-|+.|.|-+|.|.+.+
T Consensus 369 GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 369 GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 467788999999999999742211 14667899999999998643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.3e-08 Score=104.18 Aligned_cols=127 Identities=32% Similarity=0.369 Sum_probs=90.5
Q ss_pred CCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc-cccCCCCCCEE
Q 008431 15 LPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK-SLAGLQKLLQL 92 (565)
Q Consensus 15 l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L 92 (565)
+..|...+.+.|.|...=.++... .|+.||||+|+|+ .+. .+..|+.|++|||++|+|+ .+|. ...++. |..|
T Consensus 163 Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L 237 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFT-KVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLL 237 (1096)
T ss_pred hhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-hhH--HHHhcccccccccccchhc-cccccchhhhh-heee
Confidence 446777888888887432233333 5889999999998 443 5888999999999999998 4554 233444 9999
Q ss_pred eccCCcCCCCCCCCCCCCCCEEEcccCCCccCC---Cc-cccCCCCCcccCCCCCCCC
Q 008431 93 NLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRI---PD-TLSNFDATSFQGNKGLCGK 146 (565)
Q Consensus 93 ~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~---p~-~~~~~~~~~~~~n~~~cg~ 146 (565)
+|+||.++....-..+.+|+.||+|+|-|++-- |- .+..+..+.+.|||..|.+
T Consensus 238 ~lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 238 NLRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred eecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999999986544447889999999999887532 11 1233445567899877753
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.2e-07 Score=80.34 Aligned_cols=81 Identities=26% Similarity=0.338 Sum_probs=37.0
Q ss_pred CCcEEEcccCcCccCCCccccc--ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEec
Q 008431 17 GLRSLSFINNSFDGPMPSVGKL--TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNL 94 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p~~~~~--~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 94 (565)
.|+..+|++|.|...++.+... .++.|+|++|.|+ .+|.+ +..|+.|+.|+++.|.|. ..|..+..|.+|..|+.
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE-~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEE-LAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHH-HhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 3444445555544433322111 3444555555554 44544 444555555555555544 34444444444455555
Q ss_pred cCCcCC
Q 008431 95 EGNSFQ 100 (565)
Q Consensus 95 ~~N~l~ 100 (565)
.+|.+.
T Consensus 131 ~~na~~ 136 (177)
T KOG4579|consen 131 PENARA 136 (177)
T ss_pred CCCccc
Confidence 444443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.8e-07 Score=91.18 Aligned_cols=110 Identities=23% Similarity=0.230 Sum_probs=53.7
Q ss_pred cCCCCCCcEEEcccCcCccCCC-------ccc-ccccceeecccccccccCCcchhcCCCC---ccEEEccCCcCcc---
Q 008431 12 LSRLPGLRSLSFINNSFDGPMP-------SVG-KLTLRALYLSLNKFTGEIPSDAFAGMDQ---LKKVHLARNHFSG--- 77 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p-------~~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~---L~~L~l~~N~l~g--- 77 (565)
+...++|+.|+++.|.+.+... .+. ..+|+.|+|++|.+.+..+. .|..+.+ |+.|++++|++++
T Consensus 47 l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~ 125 (319)
T cd00116 47 LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGL 125 (319)
T ss_pred HhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHH
Confidence 4445556666666665542111 011 11466666666666533222 2333333 6666666666552
Q ss_pred -cCCccccCC-CCCCEEeccCCcCCCCCCC------CCCCCCCEEEcccCCCc
Q 008431 78 -QIPKSLAGL-QKLLQLNLEGNSFQGKIPD------FPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 78 -~~p~~~~~l-~~L~~L~l~~N~l~g~~p~------~~~~~L~~l~ls~N~l~ 122 (565)
.+...+..+ ++|+.|+|++|.+++.... ..+.+|+.|++++|.++
T Consensus 126 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 126 RLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIG 178 (319)
T ss_pred HHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCc
Confidence 222334444 5666666666666532211 02345666666666665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.16 E-value=4e-07 Score=92.33 Aligned_cols=114 Identities=25% Similarity=0.338 Sum_probs=84.1
Q ss_pred hhcCCCCCCcEEEcccCcCccCCC-cccc----cccceeecccccccc----cCCcchhcCC-CCccEEEccCCcCccc-
Q 008431 10 DTLSRLPGLRSLSFINNSFDGPMP-SVGK----LTLRALYLSLNKFTG----EIPSDAFAGM-DQLKKVHLARNHFSGQ- 78 (565)
Q Consensus 10 ~~~~~l~~L~~L~l~~N~l~~~~p-~~~~----~~L~~L~Ls~N~l~g----~ip~~~~~~l-~~L~~L~l~~N~l~g~- 78 (565)
..+..+++|+.|+|++|.+.+..+ .+.. ..|+.|++++|++++ .+. ..+..+ ++|+.|+|++|.+++.
T Consensus 75 ~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~-~~l~~~~~~L~~L~L~~n~l~~~~ 153 (319)
T cd00116 75 QGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA-KGLKDLPPALEKLVLGRNRLEGAS 153 (319)
T ss_pred HHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH-HHHHhCCCCceEEEcCCCcCCchH
Confidence 356778999999999999986444 2221 239999999999873 122 225566 8999999999999843
Q ss_pred ---CCccccCCCCCCEEeccCCcCCCCC----CC--CCCCCCCEEEcccCCCccC
Q 008431 79 ---IPKSLAGLQKLLQLNLEGNSFQGKI----PD--FPLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 79 ---~p~~~~~l~~L~~L~l~~N~l~g~~----p~--~~~~~L~~l~ls~N~l~g~ 124 (565)
++..+..+++|+.|+|++|.+++.. +. ...++|+.|++++|.+++.
T Consensus 154 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 154 CEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 3445677789999999999998521 11 1346899999999998743
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.3e-06 Score=89.68 Aligned_cols=78 Identities=24% Similarity=0.452 Sum_probs=38.3
Q ss_pred CCcEEEcccCcCccCCCccc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEecc
Q 008431 17 GLRSLSFINNSFDGPMPSVG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLE 95 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p~~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 95 (565)
+|+.|++++|++......+. ...|+.|++++|+++ .+|.. .+.++.|+.|++++|+++ .+|.....+..|++|.++
T Consensus 141 nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~-~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKL-LSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchhhhhhhhhccccccccccCCchhh-hhhhh-hhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 55555666665554321222 224555555555555 45543 224455555555555555 344443344445555555
Q ss_pred CC
Q 008431 96 GN 97 (565)
Q Consensus 96 ~N 97 (565)
+|
T Consensus 218 ~N 219 (394)
T COG4886 218 NN 219 (394)
T ss_pred CC
Confidence 55
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=8.2e-08 Score=101.29 Aligned_cols=108 Identities=28% Similarity=0.365 Sum_probs=84.9
Q ss_pred hcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 90 (565)
++.-++.|+.|+|++|+|+..-.-.....|+.|||++|.|. .+|.-.-.++. |+.|.|.+|.++. +- .+.+|.+|.
T Consensus 182 SLqll~ale~LnLshNk~~~v~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~t-L~-gie~LksL~ 257 (1096)
T KOG1859|consen 182 SLQLLPALESLNLSHNKFTKVDNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTT-LR-GIENLKSLY 257 (1096)
T ss_pred HHHHHHHhhhhccchhhhhhhHHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHh-hh-hHHhhhhhh
Confidence 56678899999999999986432123347999999999999 88853334554 9999999999983 32 378899999
Q ss_pred EEeccCCcCCCCC---CCCCCCCCCEEEcccCCCc
Q 008431 91 QLNLEGNSFQGKI---PDFPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 91 ~L~l~~N~l~g~~---p~~~~~~L~~l~ls~N~l~ 122 (565)
-|||++|-|.+.- |-+.+..|..|+|.+|.|.
T Consensus 258 ~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 258 GLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9999999988643 3346788999999999885
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.7e-05 Score=73.62 Aligned_cols=104 Identities=18% Similarity=0.120 Sum_probs=80.1
Q ss_pred HHHHHHHhcCCC-CCccceEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCC
Q 008431 297 HEHMTRLGSLSH-PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375 (565)
Q Consensus 297 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~ 375 (565)
..|.-+++.+.+ +++.+++|+| ..++|.||...+++...-.... .-..-+|..|.+||.++++.+.++++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~--~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLS--QFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccc--cccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357788888876 5999999999 4478999998776542100000 00126899999999999999999998655
Q ss_pred CCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 376 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+ .+.-.|++++|+-+++++++|+.|..-+-.
T Consensus 81 ~-~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 G-FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred C-cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 4 377799999999999999999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.96 E-value=9e-05 Score=69.42 Aligned_cols=114 Identities=12% Similarity=0.191 Sum_probs=72.3
Q ss_pred CCCeeEEEEeeccCccCHHH---------HHHHHHHHhcCCC---CCccceEEEEEe-----cCceEEEEeccCCCCHHH
Q 008431 276 TGPAMVVKRFRQMSNVGKED---------FHEHMTRLGSLSH---PNLLPLIAFYYR-----KEEKLLVSDFVPNGSLAN 338 (565)
Q Consensus 276 ~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H---~niv~l~~~~~~-----~~~~~lv~E~~~~gsL~~ 338 (565)
+|..+++|..+.......+. ..+++..+.+++. -..+.++-+... ....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 67788888876543222221 2234443444432 223333333222 234568999999988766
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 339 LLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 339 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+.. ++. .++..+.+++.-+|.. |+.|+|..|.|++++++ .+++.||+..+.
T Consensus 133 ~~~---------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 133 IED---------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred chh---------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECC-cEEEEECccccc
Confidence 532 322 2445677889999998 99999999999999865 499999987543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.3e-06 Score=56.59 Aligned_cols=35 Identities=31% Similarity=0.569 Sum_probs=15.5
Q ss_pred cceeecccccccccCCcchhcCCCCccEEEccCCcCc
Q 008431 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS 76 (565)
Q Consensus 40 L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~ 76 (565)
|++|+|++|+|+ .||+. +.+|++|+.|+|++|+|+
T Consensus 3 L~~L~l~~N~i~-~l~~~-l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 3 LEELDLSNNQIT-DLPPE-LSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp -SEEEETSSS-S-SHGGH-GTTCTTSSEEEETSSCCS
T ss_pred ceEEEccCCCCc-ccCch-HhCCCCCCEEEecCCCCC
Confidence 444444444444 44432 444444444444444444
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.95 E-value=6e-06 Score=86.56 Aligned_cols=136 Identities=26% Similarity=0.345 Sum_probs=99.4
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCcc-cccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
-+..+| ..++.+++|+.|++++|+++...+.. ....|+.|++++|+++ .||.. ...+..|++|.+++|++. .++.
T Consensus 151 ~i~~l~-~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~-~~~~~~L~~l~~~~N~~~-~~~~ 226 (394)
T COG4886 151 KIESLP-SPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPE-IELLSALEELDLSNNSII-ELLS 226 (394)
T ss_pred chhhhh-hhhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCccc-cCchh-hhhhhhhhhhhhcCCcce-ecch
Confidence 344554 35789999999999999999776655 4557999999999999 89975 345566999999999654 5777
Q ss_pred cccCCCCCCEEeccCCcCCCCCC-CCCCCCCCEEEcccCCCccCCC-ccccCCCCCcccCCCC
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIP-DFPLAHLTLLDLSYNQLVGRIP-DTLSNFDATSFQGNKG 142 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p-~~~~~~L~~l~ls~N~l~g~~p-~~~~~~~~~~~~~n~~ 142 (565)
.+.++.++..|.+++|++...+- -..+++++.|++++|+++-..+ ..+.++....+.+|..
T Consensus 227 ~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~ 289 (394)
T COG4886 227 SLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSL 289 (394)
T ss_pred hhhhcccccccccCCceeeeccchhccccccceeccccccccccccccccCccCEEeccCccc
Confidence 88889999999999998875321 1256779999999998874333 1123344445555543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=8e-05 Score=72.46 Aligned_cols=141 Identities=17% Similarity=0.159 Sum_probs=81.7
Q ss_pred ecccCc-eeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCCCCHHH
Q 008431 261 LGSGSF-GSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNGSLAN 338 (565)
Q Consensus 261 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 338 (565)
|-.|.+ ..||+.... +..+.+|...... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 334444 688998754 4677777765432 345678888887774 3335566777666667899999999887764
Q ss_pred HH-------------------hhcCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHhhC---
Q 008431 339 LL-------------------HVRRAPGQPGLDW--PIRLKIIK--------------------GVAKGLAYLYKEF--- 374 (565)
Q Consensus 339 ~l-------------------~~~~~~~~~~l~~--~~~~~i~~--------------------~ia~gL~ylH~~~--- 374 (565)
.. +...... ..+.. ........ .+...+..|-...
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVAD-CPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCccc-CCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 32 1110000 01110 00010000 0111122221111
Q ss_pred CCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 375 ~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
.+..++|+|+.|.|||++.+....|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12358999999999999987778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.1e-05 Score=72.36 Aligned_cols=144 Identities=18% Similarity=0.182 Sum_probs=83.8
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCC--ccceEEEEEec---CceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN--LLPLIAFYYRK---EEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~---~~~~lv~E~~~~ 333 (565)
+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.+.... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999866 58899987543 34567788888888775333 45666654332 346899999999
Q ss_pred CCHHH----------------HHh---hcCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 008431 334 GSLAN----------------LLH---VRRAPGQPGLDWPIR---------LKI------------IKGVAK-GLAYLYK 372 (565)
Q Consensus 334 gsL~~----------------~l~---~~~~~~~~~l~~~~~---------~~i------------~~~ia~-gL~ylH~ 372 (565)
..+.. .+. ..... ...+.+... ... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPP-FSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTT-CCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhccccccc-ccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 88877 111 11111 111111110 000 112222 3444443
Q ss_pred hC---CCCCCccCCCCCCCEEEc-CCCCcEEeccCCcc
Q 008431 373 EF---PGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVP 406 (565)
Q Consensus 373 ~~---~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~ 406 (565)
.. .+..++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 233689999999999999 55666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.2e-05 Score=55.22 Aligned_cols=38 Identities=29% Similarity=0.552 Sum_probs=31.3
Q ss_pred CCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCC
Q 008431 63 DQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQG 101 (565)
Q Consensus 63 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 101 (565)
++|++|+|++|+|+ .+|..+++|++|+.|++++|+++.
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 47899999999998 577779999999999999999884
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 565 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-31 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 91/304 (29%), Positives = 152/304 (50%), Gaps = 22/304 (7%)
Query: 227 FVNSQNDEISKLHFVNNDREMFELNDLLRA-----SAEVLGSGSFGSSYKAVLLTGPAMV 281
F + +E ++H R F L +L A + +LG G FG YK L G +
Sbjct: 1 FFDVPAEEDPEVHLGQLKR--FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVA 58
Query: 282 VKRFRQMSNVGKE-DFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLL 340
VKR ++ G E F + + H NLL L F E+LLV ++ NGS+A+ L
Sbjct: 59 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118
Query: 341 HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF-PGVTLPHGHLKSSNVLLDNAYEPLL 399
R QP LDWP R +I G A+GLAYL+ P + H +K++N+LLD +E ++
Sbjct: 119 R-ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII--HRDVKAANILLDEEFEAVV 175
Query: 400 TDYALVPIVNKEHAQLHM---VA----YKSPEFNQTDGVTRKTDVWSLGILILELLTGKF 452
D+ L ++ ++ H+ V + +PE+ T + KTDV+ G+++LEL+TG+
Sbjct: 176 GDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 453 PANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWN 512
+ + L WV +++E+ + D D++G E E+ +L+++ + C + +
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSS 292
Query: 513 AERR 516
R
Sbjct: 293 PMER 296
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 87/329 (26%), Positives = 143/329 (43%), Gaps = 33/329 (10%)
Query: 215 MGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRA-----SAEVLGSGSFGSS 269
MG +++ NS ND +S + V + L DL A ++G G FG
Sbjct: 1 MGSKYSKAT-----NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKV 55
Query: 270 YKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329
YK VL G + +KR S+ G E+F + L HP+L+ LI F + E +L+
Sbjct: 56 YKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115
Query: 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNV 389
++ NG+L L+ P + W RL+I G A+GL YL+ + H +KS N+
Sbjct: 116 YMENGNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINI 170
Query: 390 LLDNAYEPLLTDYAL---VPIVNKEHAQLHMVA----YKSPEFNQTDGVTRKTDVWSLGI 442
LLD + P +TD+ + +++ H +V Y PE+ +T K+DV+S G+
Sbjct: 171 LLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 443 LILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLL 502
++ E+L + + N LA W ++ D ++ E + K
Sbjct: 230 VLFEVLCARSAIVQSLPREMVN--LAEWAVESHNNGQLEQIVDPNLADKIRPE-SLRKFG 286
Query: 503 KIGMCCCEWNAERR-------WDLREAVE 524
+ C ++E R W L A+
Sbjct: 287 DTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-42
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 29/278 (10%)
Query: 252 DLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV----GKEDFHEHMTRLGSLS 307
+ +G G FG YK + + VK+ M ++ K+ F + + +
Sbjct: 30 RPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 308 HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL 367
H NL+ L+ F ++ LV ++PNGSL + L G P L W +R KI +G A G+
Sbjct: 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGI 146
Query: 368 AYLYKEFPGVTLPHGH--LKSSNVLLDNAYEPLLTDYAL---VPIVNKEHAQLHMV---A 419
+L++ H H +KS+N+LLD A+ ++D+ L + +V A
Sbjct: 147 NFLHEN------HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479
Y +PE +T K+D++S G+++LE++TG + L + EE
Sbjct: 201 YMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE----HREPQLLLDIKEEIEDEEK 255
Query: 480 T-GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR 516
T + DK M + + + + C +R
Sbjct: 256 TIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKR 291
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 32/171 (18%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMP-SVGKLT--LRALYLSLNKFTGEIPSDAFAGMDQLKK 67
++S LP L ++F N G +P S G + ++ +S N+ TG+IP FA ++ L
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT-FANLN-LAF 201
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIP 126
V L+RN G + +++L NS + +L LDL N++ G +P
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261
Query: 127 DTL--------------------------SNFDATSFQGNKGLCGKPLEAC 151
L FD +++ NK LCG PL AC
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 10 DTLSRLPGLRSLSFIN-NSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
+L+ LP L L N+ GP+P ++ KLT L LY++ +G IP + + L
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLV 128
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHL-TLLDLSYNQLVG 123
+ + N SG +P S++ L L+ + +GN G IPD + L T + +S N+L G
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 124 RIPDTLSNFD 133
+IP T +N +
Sbjct: 189 KIPPTFANLN 198
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 31/118 (26%), Positives = 54/118 (45%), Gaps = 6/118 (5%)
Query: 20 SLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIP-SDAFAGMDQLKKVHLA-RNHF 75
+ N ++ G + + + + L LS P + A + L +++ N+
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 76 SGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN 131
G IP ++A L +L L + + G IPDF + L LD SYN L G +P ++S+
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 67/301 (22%), Positives = 111/301 (36%), Gaps = 34/301 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF- 317
EV G FG +KA L + VK F + + L + H N+L I
Sbjct: 30 EVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAE 87
Query: 318 ---YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ L++ F GSL++ L + W I + +A+GLAYL+++
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLKANV------VSWNELCHIAETMARGLAYLHEDI 141
Query: 375 PGVTLP------HGHLKSSNVLLDNAYEPLLTDY--ALVPIVNKEHAQLHMVA----YKS 422
PG+ H +KS NVLL N + D+ AL K H Y +
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 423 PE-----FNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477
PE N + D++++G+++ EL + A+ + + + E
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL-E 260
Query: 478 EWTGEVFDKDMR----GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533
+ V K R M L + C + +AE R E+I +++
Sbjct: 261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320
Query: 534 N 534
N
Sbjct: 321 N 321
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-32
Identities = 44/170 (25%), Positives = 61/170 (35%), Gaps = 31/170 (18%)
Query: 20 SLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSG 77
+ F G + +L+ ++ + G F + + ++ N SG
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT-FDNNGSMMFLDMSYNMLSG 646
Query: 78 QIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN---- 131
IPK + + L LNL N G IPD L L +LDLS N+L GRIP +S
Sbjct: 647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706
Query: 132 ----------------------FDATSFQGNKGLCGKPLEACKSSISKKT 159
F F N GLCG PL C S +
Sbjct: 707 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-29
Identities = 37/133 (27%), Positives = 57/133 (42%), Gaps = 6/133 (4%)
Query: 2 NLMGMI--DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDA 58
++ G L+ L+ N G + V + L L +S N F+ IP
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIPF-- 218
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSY 118
L+ + ++ N SG ++++ +L LN+ N F G IP PL L L L+
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAE 278
Query: 119 NQLVGRIPDTLSN 131
N+ G IPD LS
Sbjct: 279 NKFTGEIPDFLSG 291
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 47/134 (35%), Positives = 68/134 (50%), Gaps = 6/134 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFA 60
L G +S L+ L+ +N F GP+P L L+ L L+ NKFTGEIP
Sbjct: 234 KLSGDFS-RAISTCTELKLLNISSNQFVGPIPP-LPLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD---FPLAHLTLLDLS 117
D L + L+ NHF G +P L L L N+F G++P + L +LDLS
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 118 YNQLVGRIPDTLSN 131
+N+ G +P++L+N
Sbjct: 352 FNEFSGELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 50/137 (36%), Positives = 63/137 (45%), Gaps = 7/137 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAF 59
G I L L N F G +P G + L +L LS N F+GE+P D
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ-LNLEGNSFQGKIPD----FPLAHLTLL 114
M LK + L+ N FSG++P+SL L L L+L N+F G I P L L
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399
Query: 115 DLSYNQLVGRIPDTLSN 131
L N G+IP TLSN
Sbjct: 400 YLQNNGFTGKIPPTLSN 416
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 47/135 (34%), Positives = 64/135 (47%), Gaps = 6/135 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAF 59
G I TLS L SL N G +P S+G L+ LR L L LN GEIP +
Sbjct: 405 GFTGKIP-PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE-L 462
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLS 117
+ L+ + L N +G+IP L+ L ++L N G+IP + L +L +L LS
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 118 YNQLVGRIPDTLSNF 132
N G IP L +
Sbjct: 523 NNSFSGNIPAELGDC 537
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-26
Identities = 47/136 (34%), Positives = 67/136 (49%), Gaps = 7/136 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLT---LRALYLSLNKFTGEIPSD 57
G + + L +L +N+F GP+ ++ + L+ LYL N FTG+IP
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLD 115
+ +L +HL+ N+ SG IP SL L KL L L N +G+IP + L L
Sbjct: 414 -LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 116 LSYNQLVGRIPDTLSN 131
L +N L G IP LSN
Sbjct: 473 LDFNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-26
Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 9/138 (6%)
Query: 2 NLMGMI-DVDTLSRLPGLRSLSFINNSFDG--PMPSVGKLT-LRALYLSLNKFTGEIPSD 57
+L G + + +L GL+ L+ +N+ D + KL L L LS N +G
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 58 --AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP-LAHLTLL 114
G +LK + ++ N SG + ++ L L++ N+F IP + L L
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHL 228
Query: 115 DLSYNQLVGRIPDTLSNF 132
D+S N+L G +S
Sbjct: 229 DISGNKLSGDFSRAISTC 246
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 44/133 (33%), Positives = 61/133 (45%), Gaps = 8/133 (6%)
Query: 13 SRLPGLRSLSFINNSFDGPMPS--VGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVH 69
L L+ LS N F G +P G L L LS N F G +P F L+ +
Sbjct: 266 LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF-FGSCSLLESLA 324
Query: 70 LARNHFSGQIPK-SLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLDLSYNQLVGRI 125
L+ N+FSG++P +L ++ L L+L N F G++P+ A L LDLS N G I
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384
Query: 126 PDTLSNFDATSFQ 138
L + Q
Sbjct: 385 LPNLCQNPKNTLQ 397
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 31/122 (25%), Positives = 46/122 (37%), Gaps = 7/122 (5%)
Query: 12 LSRLPGLRSLSFINNSFDGPMP---SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L SL NS GP+ S+G + L+ L +S N ++ L+
Sbjct: 96 FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155
Query: 68 VHLARNHFSGQIPKSLA---GLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGR 124
+ L+ N SG G +L L + GN G + +L LD+S N
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTG 215
Query: 125 IP 126
IP
Sbjct: 216 IP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 31/131 (23%), Positives = 49/131 (37%), Gaps = 10/131 (7%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDA-FAGMDQLKK 67
+L L GL SL N+ +G + L +L LS N +G + + LK
Sbjct: 71 SSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF 130
Query: 68 VHLARNHFSGQIPKS-LAGLQKLLQLNLEGNSFQGKIPDFP-----LAHLTLLDLSYNQL 121
++++ N S L L L+L NS G L L +S N++
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 122 VGRIPDTLSNF 132
G + +S
Sbjct: 191 SGDVD--VSRC 199
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-19
Identities = 34/149 (22%), Positives = 51/149 (34%), Gaps = 27/149 (18%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKK 67
LS L +S NN G +P +G+L L L LS N F+G IP++ L
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE-LGDCRSLIW 542
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNL----------------------EGNSFQGKIPD 105
+ L N F+G IP ++ + N FQG +
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602
Query: 106 --FPLAHLTLLDLSYNQLVGRIPDTLSNF 132
L+ +++ G T N
Sbjct: 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNN 631
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 9e-14
Identities = 20/97 (20%), Positives = 35/97 (36%), Gaps = 8/97 (8%)
Query: 34 SVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93
V + L LN + S + + L+ + L+ +H +G + L L+
Sbjct: 51 KVTSIDLS--SKPLNVGFSAVSS-SLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 94 LEGNSFQGKIPDFP----LAHLTLLDLSYNQLVGRIP 126
L NS G + + L L++S N L
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 20/59 (33%), Positives = 24/59 (40%), Gaps = 1/59 (1%)
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP-LAHLTLLDLSYNQLVGRIPDTLS 130
N + SL L L L L + G + F A LT LDLS N L G + S
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTS 121
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 56/298 (18%), Positives = 96/298 (32%), Gaps = 59/298 (19%)
Query: 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
EVLG G FG + K TG MV+K + + F + + + L HPN+L I
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
Y+ + +++++ G+L ++ + W R+ K +A G+AYL
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYL------- 124
Query: 378 TLPHGH------LKSSNVLLD------------------NAYEPLLTDYALVPIVNKEHA 413
H L S N L+ +P P K +
Sbjct: 125 ---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNS 473
+ + +PE K DV+S GI++ E++
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----------LPRTM 230
Query: 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR---WDLREAVEKIME 528
G + I + CC+ + E+R L +E +
Sbjct: 231 DF-----GLNVRGFLDRYCP-PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
EV+G G+FG KA + +K+ S ++ F + +L ++HPN++ L
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
LV ++ GSL N+LH P + ++G+AYL+ P
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQP-KA 125
Query: 379 LPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHM------VAYKSPEFNQTDGV 431
L H LK N+LL L + D+ + HM A+ +PE +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNY 180
Query: 432 TRKTDVWSLGILILELLTGKFP 453
+ K DV+S GI++ E++T + P
Sbjct: 181 SEKCDVFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
L G +K G +VVK + S DF+E RL SHPN+LP++
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 317 FYYRKEEKLL--VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
++ ++P GSL N+LH +D +K +A+G+A+L+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEF---NQTDGV 431
P + P L S +V++D ++ + + +++ A+ +PE D
Sbjct: 132 PLI--PRHALNSRSVMIDEDMTARISMADVK-FSFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 432 TRKTDVWSLGILILELLTGKFP 453
R D+WS +L+ EL+T + P
Sbjct: 189 RRSADMWSFAVLLWELVTREVP 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 75/330 (22%), Positives = 132/330 (40%), Gaps = 51/330 (15%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHE--HMTRLGSLSHPNLLPLIA 316
E++G G +G+ YK L + VK F + +++F ++ R+ + H N+ I
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 317 FYYR-----KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
R + E LLV ++ PNGSL L + DW ++ V +GLAYL+
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLH 128
Query: 372 KEFPGVTLP-----HGHLKSSNVLLDNAYEPLLTDYAL---------VPIVNKEHAQLHM 417
E P H L S NVL+ N +++D+ L V +++A +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 418 V---AYKSPE-------FNQTDGVTRKTDVWSLGILILELL---TGKFPANYLAQGKGAN 464
V Y +PE + ++ D+++LG++ E+ T FP + + + A
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 465 ADLATWVNSVVREEWTGEVFDKDMR-----GTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519
+ E+ V + R K + L + C + +AE R
Sbjct: 249 QTEVGNHPTF--EDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306
Query: 520 REAVEKIMELKERDNDNEDYSSYASEDYVY 549
+ A E++ EL N+ S A + +
Sbjct: 307 QXAEERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR----QMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
E++G G FG Y+A + G + VK R + + E+ + L HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
++ LV +F G L +L +R + I + +A+G+ YL+ E
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDEA 125
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI----VNKEHAQLHM------VAYKSPE 424
+ H LKSSN+L+ E ++ I + +E + A+ +PE
Sbjct: 126 IVPII-HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE 184
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ ++ +DVWS G+L+ ELLTG+ P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 47/215 (21%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFRQMSNVGK-------EDFHEHMTRLGSLSHPN 310
+ +G G FG +K L+ ++V +K + G+ ++F + + +L+HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
++ L +V +FVP G L + L + P + W ++L+++ +A G+ Y+
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGIEYM 138
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPL-----LTDYALVPIVNKEHAQLHM-----VAY 420
+ P + H L+S N+ L + E + D+ L ++ +
Sbjct: 139 QNQNPPIV--HRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQW 192
Query: 421 KSPE--FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE + + T K D +S +++ +LTG+ P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGK--EDFHEHMTRLGSLSHPNLLPLIA 316
E +G+GSFG+ ++A G + VK + + +F + + L HPN++ +
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+ +V++++ GSL LLH A Q LD RL + VAKG+ YL+ P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVT 432
+ H +LKS N+L+D Y + D+ L + A + +PE + +
Sbjct: 160 IV--HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 433 RKTDVWSLGILILELLTGKFP 453
K+DV+S G+++ EL T + P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 62/303 (20%), Positives = 109/303 (35%), Gaps = 38/303 (12%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHE-HMTRLGSLSHPNLLPLIAF 317
E +G G FG ++ G + VK F + F E + + L H N+L IA
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 318 YYRKEEK----LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+ LVSD+ +GSL + L+ + + +K+ A GLA+L+ E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 374 FPGVTLP----HGHLKSSNVLLDNAYEPLLTDY--ALVPIVNKEHAQLHM------VAYK 421
G H LKS N+L+ + D A+ + + Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 422 SPE-----FNQTDG-VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV 475
+PE N ++ D++++G++ E+ + DL SV
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV- 277
Query: 476 REEWTGEVFDKDMR----GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531
EE V ++ +R + + KI C N R + + +L +
Sbjct: 278 -EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
Query: 532 RDN 534
++
Sbjct: 337 QEG 339
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 59/306 (19%), Positives = 101/306 (33%), Gaps = 44/306 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHE-HMTRLGSLSHPNLLPLIA- 316
+ +G G +G + G + VK F F E + + + H N+L IA
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAA 99
Query: 317 ---FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+ L++D+ NGSL + L LD LK+ GL +L+ E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 374 FPGVTLP----HGHLKSSNVLLDNAYEPLLTDY--ALVPIVNKEHAQLHMVA------YK 421
H LKS N+L+ + D A+ I + + Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 422 SPE------FNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV 475
PE D++S G+++ E+ + + + DL S
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY- 272
Query: 476 REEWTGEVFDKDMR-------GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528
E+ V K +R + +M KL+ C N R + + +
Sbjct: 273 -EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLAK 328
Query: 529 LKERDN 534
+ E +
Sbjct: 329 MSESQD 334
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 30/135 (22%), Positives = 47/135 (34%), Gaps = 4/135 (2%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
NL M + L L L + + L+ L L ++ N F D F
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLS 117
+ L + L++ P + L L LN+ N+F L L +LD S
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526
Query: 118 YNQLVGRIPDTLSNF 132
N ++ L +F
Sbjct: 527 LNHIMTSKKQELQHF 541
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 30/127 (23%), Positives = 42/127 (33%), Gaps = 4/127 (3%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
+ L+ L N + L L L + F + L +
Sbjct: 367 QSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 69 HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKI-PDFP--LAHLTLLDLSYNQLVGRI 125
++ H GL L L + GNSFQ PD L +LT LDLS QL
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 126 PDTLSNF 132
P ++
Sbjct: 487 PTAFNSL 493
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 30/136 (22%), Positives = 53/136 (38%), Gaps = 6/136 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
N + + + P L+ L L+ L L L+ N + AF
Sbjct: 38 NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAF 96
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQG-KIPDF--PLAHLTLLDL 116
+G+ L+K+ + + + L+ L +LN+ N Q K+P++ L +L LDL
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 117 SYNQLVGRIPDTLSNF 132
S N++ L
Sbjct: 157 SSNKIQSIYCTDLRVL 172
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-19
Identities = 26/132 (19%), Positives = 45/132 (34%), Gaps = 7/132 (5%)
Query: 7 IDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQ 64
+ + S L L+ L + + +G L L+ L ++ N + F+ +
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKL----LQLNLEGNSFQGKIPD-FPLAHLTLLDLSYN 119
L+ + L+ N L L ++ L L+L N P F L L L N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 120 QLVGRIPDTLSN 131
+ T
Sbjct: 211 FDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 28/140 (20%), Positives = 47/140 (33%), Gaps = 10/140 (7%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ I+ L L +L N + + L+ L+ L
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN-FPI 120
Query: 60 AGMDQLKKVHLARNHF-SGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTL--- 113
+ LK++++A N S ++P+ + L L L+L N Q L + L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 114 -LDLSYNQLVGRIPDTLSNF 132
LDLS N + P
Sbjct: 181 SLDLSLNPMNFIQPGAFKEI 200
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 25/143 (17%), Positives = 43/143 (30%), Gaps = 8/143 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
+ D + L L L + P+ L+ L+ L +S N F +
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT-FPY 514
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ-LNLEGNSFQGKIP--DFP--LAHLTLL 114
++ L+ + + NH + L L LNL N F F + L
Sbjct: 515 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQL 574
Query: 115 DLSYNQLVGRIPDTLSNFDATSF 137
+ ++ P S
Sbjct: 575 LVEVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 29/121 (23%), Positives = 45/121 (37%), Gaps = 7/121 (5%)
Query: 9 VDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
V S G + L +N F P++ +L+ L + NK + L+ +
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQ-FPTLKLKSLKRLTFTSNKGGNAFS---EVDLPSLEFL 352
Query: 69 HLARNH--FSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRI 125
L+RN F G +S G L L+L N +F L L LD ++ L
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 126 P 126
Sbjct: 413 E 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 20/101 (19%), Positives = 31/101 (30%), Gaps = 6/101 (5%)
Query: 33 PSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQL 92
P V + F +IP + K + L+ N S +L L
Sbjct: 2 PCVEVVPNITYQCMELNFY-KIPDNLPFS---TKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 93 NLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN 131
+L Q L+HL+ L L+ N + S
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 27/185 (14%), Positives = 42/185 (22%), Gaps = 38/185 (20%)
Query: 7 IDVDTLSRLPGLR----SLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAG 61
I L L + SL N + P K + L L L N + + G
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 62 MDQLKKVHLARNHFSG---------------------------------QIPKSLAGLQK 88
+ L+ L F I L
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 89 LLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGLCGKPL 148
+ +L + + L+L + L + +F NKG
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343
Query: 149 EACKS 153
S
Sbjct: 344 VDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 25/137 (18%), Positives = 43/137 (31%), Gaps = 13/137 (9%)
Query: 2 NLMGMIDVDTLSRLPGLR----SLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPS 56
+ D L L L L++++ D + LT + + L
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD- 299
Query: 57 DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDL 116
F+ + + L F L L++L + +G + + L L LDL
Sbjct: 300 --FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA---FSEVDLPSLEFLDL 354
Query: 117 SYNQL--VGRIPDTLSN 131
S N L G +
Sbjct: 355 SRNGLSFKGCCSQSDFG 371
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 46/206 (22%), Positives = 85/206 (41%), Gaps = 22/206 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
+ +GSGSFG+ YK A VK + + F + L H N+L +
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVA--VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
Y + +V+ + SL + LH + + I + A+G+ YL
Sbjct: 88 -YSTAPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYL--HAKS 140
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPE---FNQ 427
+ H LKS+N+ L + D+ L ++ + + +PE
Sbjct: 141 II--HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP 453
++ + ++DV++ GI++ EL+TG+ P
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 60/301 (19%), Positives = 104/301 (34%), Gaps = 44/301 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHE-HMTRLGSLSHPNLLPLIAF 317
E +G G +G ++ G + VK F K F E + L H N+L IA
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIAS 70
Query: 318 YYRKEEK----LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L++ + GSL + L + LD L+I+ +A GLA+L+ E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSIASGLAHLHIE 124
Query: 374 FPGVTLPHG--H--LKSSNVLLDNAYEPLLTDYAL--------VPIVNKEHAQLHMVAYK 421
G H LKS N+L+ + + D L + + ++ Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 422 SPE------FNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV 475
+PE ++ D+W+ G+++ E+ + K D+ S
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF- 243
Query: 476 REEWTGEVFDKDMR-------GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528
E+ V R + + KL+K C N R + + +
Sbjct: 244 -EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPSARLTALRIKKTLTK 299
Query: 529 L 529
+
Sbjct: 300 I 300
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 22/207 (10%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
VLG G++G Y L + +K + + + HE + L H N I
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN----IVQ 83
Query: 318 YY---RKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
Y + + + + VP GSL+ LL + P + I K + +GL YL+
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL-KDNEQTIG-FYTKQILEGLKYLHDN 141
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHMVA----YKSPE--FN 426
+ H +K NVL++ L ++D+ + + Y +PE
Sbjct: 142 --QIV--HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
G + D+WSLG I+E+ TGK P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 38/221 (17%), Positives = 80/221 (36%), Gaps = 43/221 (19%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
E++G G FG Y A ++ + + + F + H N++ +
Sbjct: 39 ELIGKGRFGQVYHGRWHGEVA--IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+++ +L +++ + LD +I + + KG+ YL
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIV----LDVNKTRQIAQEIVKGMGYL------ 146
Query: 377 VTLPHGH------LKSSNVLLDNAYEPLLTDYAL---VPIVNKEHAQLHM------VAYK 421
H LKS NV DN + ++TD+ L ++ + + + +
Sbjct: 147 ----HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 422 SPE---------FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE ++ +DV++LG + EL ++P
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 42/207 (20%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+G GSF + YK + T + R+++ ++ F E L L HPN++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 316 AFY---YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ + ++ + LV++ + +G+L L + + + + + KGL +L+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKV--MKIKVLRSWCRQILKGLQFLH 146
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNKEHAQLHMVAYKSPEF----N 426
P + H LK N+ + + D L + A+ ++ +PEF
Sbjct: 147 TRTPPII--HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVI--GTPEFMAPEM 201
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
+ DV++ G+ +LE+ T ++P
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 31/212 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKR---FRQMSNVGKEDFHEHMTRLGSLSHPNLLPL 314
+ +G G F Y+A LL G + +K+ F M + D + + L L+HPN+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV--- 94
Query: 315 IAFY--YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
I +Y + ++ +L +V + G L+ ++ + + + K + L ++
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCSALEHM- 152
Query: 372 KEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YK 421
H +K +NV + L D L + + H + Y
Sbjct: 153 ---------HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 422 SPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
SPE +G K+D+WSLG L+ E+ + P
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 27/207 (13%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+G GSFG ++ TG VK+ R +E + LS P ++PL
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE-----LVACAGLSSPRIVPLYGA 118
Query: 318 YYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
R+ + + + + GSL L+ L L + +GL YL+
Sbjct: 119 V-REGPWVNIFMELLEGGSLGQLIKQMGC-----LPEDRALYYLGQALEGLEYLHTR--R 170
Query: 377 VTLPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHMVAYKS---------PEFN 426
+ HG +K+ NVLL + L D+ + + ++ PE
Sbjct: 171 IL--HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
K D+WS ++L +L G P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 31/137 (22%), Positives = 51/137 (37%), Gaps = 7/137 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
N + ++ + +LP L+ L+ +N T L L+L N I ++ F
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPF 117
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD----FPLAHLTLLD 115
L + L+ N S + L+ L +L L N Q + F + L L+
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 116 LSYNQLVGRIPDTLSNF 132
LS NQ+ P
Sbjct: 178 LSSNQIKEFSPGCFHAI 194
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 32/142 (22%), Positives = 52/142 (36%), Gaps = 5/142 (3%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDA 58
N + + +R L SL N+ P + KL L+ L L N+ + +
Sbjct: 34 HNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKT 92
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDL 116
FA L ++HL N + L+ L+L N L +L L L
Sbjct: 93 FAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL 152
Query: 117 SYNQLVGRIPDTLSNFDATSFQ 138
S N++ + L F +S +
Sbjct: 153 SNNKIQALKSEELDIFANSSLK 174
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-19
Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 6/125 (4%)
Query: 14 RLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLA 71
L L+ N L L L L LN+ E+ + G++ + +++L+
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 72 RNHFSGQIPKSLAGLQKLLQLNLEGNSFQG--KIPDF--PLAHLTLLDLSYNQLVGRIPD 127
N + S A + L +L L + + P PL +LT+LDLS N + D
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 128 TLSNF 132
L
Sbjct: 499 MLEGL 503
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 29/146 (19%), Positives = 49/146 (33%), Gaps = 10/146 (6%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
N + I + + L +L +N + + +L L+ L LS NK + S+
Sbjct: 107 NSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEEL 165
Query: 60 A--GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD-----FPLAHLT 112
LKK+ L+ N P + +L L L + + +
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 113 LLDLSYNQLVGRIPDTLSNFDATSFQ 138
L LS +QL T T+
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLT 251
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 5/121 (4%)
Query: 15 LPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLAR 72
+ L+ +N P + + + L +L + N + + + + LK ++L
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQH 82
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQLVGRIPDTLS 130
N S K+ A L +L+L NS Q + +L LDLS+N L T
Sbjct: 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 131 N 131
Sbjct: 143 Q 143
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-18
Identities = 35/149 (23%), Positives = 54/149 (36%), Gaps = 8/149 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP--SVGKLT-LRALYLSLNKFTGEIPSDA 58
N + I+ D S L L L N + L + +YLS NK+ + ++
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ-LTRNS 449
Query: 59 FAGMDQLKKVHLARNHFSG--QIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLL 114
FA + L+++ L R P L+ L L+L N+ D L L +L
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509
Query: 115 DLSYNQLVGRIPDTLSNFDATSFQGNKGL 143
DL +N L +G L
Sbjct: 510 DLQHNNLARLWKHANPGGPIYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 25/143 (17%), Positives = 48/143 (33%), Gaps = 13/143 (9%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTG-EIPSDA 58
+ + L + + N + + + L+ L L +
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN--------SFQGKIPDF--PL 108
F + L + L+ N+ + L GL+KL L+L+ N + G F L
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535
Query: 109 AHLTLLDLSYNQLVGRIPDTLSN 131
+HL +L+L N + +
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKD 558
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 31/134 (23%), Positives = 50/134 (37%), Gaps = 16/134 (11%)
Query: 14 RLPGLRSLSFINNSFDGPMPSV----GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVH 69
+R+LS N+ + L L LS N + +D+FA + QL+
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFF 278
Query: 70 LARNHFSGQIPKSLAGLQKLLQLNLEGNSFQG--------KIPDFPLAH---LTLLDLSY 118
L N+ SL GL + LNL+ + + KI DF L L++
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 119 NQLVGRIPDTLSNF 132
N + G + +
Sbjct: 339 NDIPGIKSNMFTGL 352
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 26/147 (17%), Positives = 50/147 (34%), Gaps = 16/147 (10%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTG------- 52
N + ++ D+ + LP L N+ L +R L L +
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317
Query: 53 -EIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIP------D 105
+I +F + L+ +++ N G GL L L+L + +
Sbjct: 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377
Query: 106 FPLAHLTLLDLSYNQLVGRIPDTLSNF 132
+ L +L+L+ N++ D S
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWL 404
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 34/144 (23%), Positives = 55/144 (38%), Gaps = 15/144 (10%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSF---------DGPMPSVGKLT-LRALYLSLNKFT 51
N + I+ D L L L L +N+ GP+ + L+ L L L N F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 52 GEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF---PL 108
IP + F + +LK + L N+ + L LNL+ N
Sbjct: 550 E-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608
Query: 109 AHLTLLDLSYNQLVGRIPDTLSNF 132
+LT LD+ +N ++++ F
Sbjct: 609 RNLTELDMRFNPFDC-TCESIAWF 631
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 18/94 (19%), Positives = 30/94 (31%), Gaps = 3/94 (3%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
N I V+ L L+ + N+ + SV L++L L N T
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFG 605
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93
L ++ + N F S+A +
Sbjct: 606 PAFRNLTELDMRFNPFDCTCE-SIAWFVNWINET 638
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 33/226 (14%), Positives = 77/226 (34%), Gaps = 47/226 (20%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKR--FRQMSNVGKEDFHEHMTRLGSLS-HPNLLPL 314
E +GSG FGS +K V L G +KR +V +++ + L H + +
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH---V 73
Query: 315 IAFY--YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ ++ + +++ + + +++ GSLA+ + ++ V +GL Y+
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGLRYI- 131
Query: 372 KEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA------ 419
H +K SN+ + P + + +
Sbjct: 132 ---------HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 420 -------------YKSPE-FNQTDGVTRKTDVWSLGILILELLTGK 451
+ + E + K D+++L + ++ +
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 26/135 (19%), Positives = 43/135 (31%), Gaps = 4/135 (2%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
L + + L L L + + LT L L ++ N F S+ F
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLS 117
A L + L++ L +L LN+ N+ L L+ LD S
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 118 YNQLVGRIPDTLSNF 132
+N++
Sbjct: 530 FNRIETSKGILQHFP 544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 29/137 (21%), Positives = 44/137 (32%), Gaps = 6/137 (4%)
Query: 2 NLMGMIDVDTLSRL--PGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDA 58
N + + S L LR L N + L L+ L + A
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLD 115
F +++L + ++ + GL L L + GNSF+ +LT LD
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479
Query: 116 LSYNQLVGRIPDTLSNF 132
LS QL
Sbjct: 480 LSKCQLEQISWGVFDTL 496
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 27/137 (19%), Positives = 49/137 (35%), Gaps = 6/137 (4%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDA 58
N + ++ + S L+ L + L L L L+ N +
Sbjct: 41 FNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGS 99
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQG-KIPDF--PLAHLTLLD 115
F+G+ L+ + + + L L +LN+ N K+P + L +L +D
Sbjct: 100 FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVD 159
Query: 116 LSYNQLVGRIPDTLSNF 132
LSYN + + L
Sbjct: 160 LSYNYIQTITVNDLQFL 176
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 23/125 (18%), Positives = 40/125 (32%), Gaps = 6/125 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV--GKLT-LRALYLSLNKFTGEIPSDA 58
+ L L +L NSF S T L L LS + +I
Sbjct: 434 TNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE-QISWGV 492
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDL 116
F + +L+ ++++ N+ L L L+ N + L +L
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552
Query: 117 SYNQL 121
+ N +
Sbjct: 553 TNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 27/133 (20%), Positives = 44/133 (33%), Gaps = 9/133 (6%)
Query: 7 IDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQ 64
+ S L L +L + +G+L L+ L ++ N F+ +
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKL----LQLNLEGNSFQGKIPDFPLAHLTL--LDLSY 118
L V L+ N+ L L++ L L++ N I D + L L L
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRG 213
Query: 119 NQLVGRIPDTLSN 131
N I T
Sbjct: 214 NFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 27/124 (21%), Positives = 42/124 (33%), Gaps = 9/124 (7%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMPSV----GKLTLRALYLSLNKFTGEIPSDAFAGMDQLK 66
LP L L N+ G +LR L LS N I S F G+++L+
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI--IMSANFMGLEELQ 402
Query: 67 KVHLARNHFSGQIPKS-LAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVG 123
+ + S L+KLL L++ + + L L L ++ N
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 124 RIPD 127
Sbjct: 463 NTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 30/141 (21%), Positives = 46/141 (32%), Gaps = 12/141 (8%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
+ I+ L L +L N P LT L L K + S
Sbjct: 66 CEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA-SLESFPI 124
Query: 60 AGMDQLKKVHLARNHFSG-QIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTL----- 113
+ LKK+++A N ++P + L L+ ++L N Q I L L
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVN 183
Query: 114 --LDLSYNQLVGRIPDTLSNF 132
LD+S N +
Sbjct: 184 LSLDMSLNPIDFIQDQAFQGI 204
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 19/103 (18%), Positives = 35/103 (33%), Gaps = 6/103 (5%)
Query: 31 PMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90
P + + K + ++P D + K + L+ N S + +L
Sbjct: 4 LNPCIEVVPNITYQCMDQKLS-KVPDDIPSS---TKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 91 QLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN 131
L+L + L HL+ L L+ N + P + S
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 24/140 (17%), Positives = 44/140 (31%), Gaps = 10/140 (7%)
Query: 1 MNLMGMIDVDTLSRLPGLR----SLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPS 56
+ + + + L + L++ N+ D + + A+ L+ +
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLED 302
Query: 57 DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDL 116
+ + + + R Q P L L L L N L L+ LDL
Sbjct: 303 VPK--HFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDL 357
Query: 117 SYNQLVGRIPDTLSNFDATS 136
S N L + S+ S
Sbjct: 358 SRNALSFSGCCSYSDLGTNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 20/141 (14%), Positives = 34/141 (24%), Gaps = 11/141 (7%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRAL---YLSLNKFTGE---- 53
+N + I + L L+ N + L L L L +F E
Sbjct: 190 LNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 54 -IPSDAFAGMDQLKKVHL--ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAH 110
G+ + + L + ++L G S +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK 308
Query: 111 LTLLDLSYNQLVGRIPDTLSN 131
L + QL L
Sbjct: 309 WQSLSIIRCQLKQFPTLDLPF 329
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 28/135 (20%), Positives = 58/135 (42%), Gaps = 12/135 (8%)
Query: 12 LSRLPGLRSLSFINNSF-DGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
++ + N+ P+ S+ K+ L L N+ G++P+ F +L +
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA--FGSEIKLASL 358
Query: 69 HLARNHFSGQIPKSLAG-LQKLLQLNLEGNSFQGKIPDFP----LAHLTLLDLSYNQLVG 123
+LA N + IP + G +++ L+ N + IP+ ++ ++ +D SYN++
Sbjct: 359 NLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS 416
Query: 124 RIPDTLSNFDATSFQ 138
D T F+
Sbjct: 417 VDGKNFDPLDPTPFK 431
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 26/134 (19%), Positives = 53/134 (39%), Gaps = 14/134 (10%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
+L ++ L L + N +G +P+ G L +L L+ N+ T IP++ +Q++ +
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENL 382
Query: 69 HLARNHFSGQIPKSLA--GLQKLLQLNLEGNSFQGKIPD---------FPLAHLTLLDLS 117
A N IP + + ++ N F +++ ++LS
Sbjct: 383 SFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 118 YNQLVGRIPDTLSN 131
NQ+ + S
Sbjct: 442 NNQISKFPKELFST 455
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 27/139 (19%), Positives = 49/139 (35%), Gaps = 21/139 (15%)
Query: 12 LSRLPGLRSL--------SFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGM 62
+ + ++ S +FD P+ K + ++ LS N+ + P + F+
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFSTG 456
Query: 63 DQLKKVHLARNHFSG-------QIPKSLAGLQKLLQLNLEGNSFQGKIPDFP---LAHLT 112
L ++L N + ++ L ++L N DF L +L
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLV 516
Query: 113 LLDLSYNQLVGRIPDTLSN 131
+DLSYN P N
Sbjct: 517 GIDLSYNSFSK-FPTQPLN 534
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 20/131 (15%), Positives = 41/131 (31%), Gaps = 10/131 (7%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPS--VGKLT-LRALYLSLNKFTGEIPSDAF-----AG 61
+ L S+ N L L + LS N F+ P+ G
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
Query: 62 MDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
+ N + P+ + L QL + N + + + ++++LD+ N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDIKDNPN 599
Query: 122 VGRIPDTLSNF 132
+ + +
Sbjct: 600 ISIDLSYVCPY 610
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 24/142 (16%), Positives = 48/142 (33%), Gaps = 17/142 (11%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGP---------MPSVGKLT-LRALYLSLNKF- 50
+ + L LP ++ ++ N + ++ +Y+ N
Sbjct: 260 PNLTKLP-TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 51 TGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP--L 108
T + + M +L + N G++P + KL LNL N +F
Sbjct: 319 TFPVETS-LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFT 376
Query: 109 AHLTLLDLSYNQLVGRIPDTLS 130
+ L ++N+L IP+
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFD 397
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 25/143 (17%), Positives = 49/143 (34%), Gaps = 21/143 (14%)
Query: 7 IDVDTLSRLPGLRSLSFINNSFDG--PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMD 63
I + + +LSF +N + ++ + A+ S N+ + F +D
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS-VDGKNFDPLD 426
Query: 64 -------QLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP--------- 107
+ ++L+ N S + + L +NL GN +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 108 LAHLTLLDLSYNQLVGRIPDTLS 130
LT +DL +N+L + D
Sbjct: 487 TYLLTSIDLRFNKLTK-LSDDFR 508
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 17/135 (12%), Positives = 41/135 (30%), Gaps = 9/135 (6%)
Query: 12 LSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
+ ++N+ +V +LT LR Y+ + F E +A + +
Sbjct: 179 SRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEA------WENENS 232
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQLVGRIPDT 128
L+ L + + K+P L + L++++ N+ +
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292
Query: 129 LSNFDATSFQGNKGL 143
+ +
Sbjct: 293 DDWQALADAPVGEKI 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 19/129 (14%), Positives = 40/129 (31%), Gaps = 13/129 (10%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYL------SLNKFTGEI 54
L + D + LP L + NSF + L+ + N+ E
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558
Query: 55 PSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLT 112
P + L ++ + N + + + + L+++ N P
Sbjct: 559 P-EGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAG 614
Query: 113 LLDLSYNQL 121
+ L Y++
Sbjct: 615 MYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 17/140 (12%), Positives = 32/140 (22%), Gaps = 11/140 (7%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPM-----PSVGKLT-LRALYLSLNKFTGEI 54
G + D + +L L L+ ++ + +
Sbjct: 91 FGASGRVP-DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149
Query: 55 PS-DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHL 111
D L K + + I KS K Q+ N+ + L L
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKL 208
Query: 112 TLLDLSYNQLVGRIPDTLSN 131
+ + V
Sbjct: 209 RQFYMGNSPFVAENICEAWE 228
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 18/130 (13%), Positives = 38/130 (29%), Gaps = 10/130 (7%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPS---DAFAGMDQL 65
+L+ + LS G +P ++G+LT L L L + +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 66 KKVHLARNHFSGQIPKSLAGLQ--KLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQL 121
++ R H+ L++ + + Q I T + N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 122 VGRIPDTLSN 131
+ +
Sbjct: 196 TF-VSKAVMR 204
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 13/127 (10%), Positives = 33/127 (25%), Gaps = 9/127 (7%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGK----LTLRALYLSLNKFTGEIPSDAFAGMDQL 65
+S + + L ++ + I + + +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL-KD 185
Query: 66 KKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRI 125
++ N+ + + K++ L KL Q + + F + + Y Q
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN---ICEAWENENSEYAQQYKTE 241
Query: 126 PDTLSNF 132
N
Sbjct: 242 DLKWDNL 248
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 13/99 (13%), Positives = 27/99 (27%), Gaps = 6/99 (6%)
Query: 64 QLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF------PLAHLTLLDLS 117
++ + L SG++P ++ L +L L L + + F
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 118 YNQLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSIS 156
D D + + ++ K S
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 6/65 (9%)
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQLVG----RIP 126
+ + Q SL ++ L+LEG G++PD L L +L L + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 127 DTLSN 131
+S
Sbjct: 127 KGISA 131
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 26/216 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+ LG G F L G +KR +E+ +HPN+L L+A+
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 318 YYRKEEK----LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
R+ L+ F G+L N + + G L L ++ G+ +GL ++ +
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIHAK 153
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA-------------Y 420
H LK +N+LL + +P+L D + Y
Sbjct: 154 ----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 421 KSPE---FNQTDGVTRKTDVWSLGILILELLTGKFP 453
++PE + +TDVWSLG ++ ++ G+ P
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 11/205 (5%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+G+GS+G K G +V K + M+ K+ + L L HPN++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 316 -AFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YK 372
R L +V ++ G LA+++ Q LD L+++ + L +
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRR 130
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQT 428
G T+ H LK +NV LD L D+ L I+N + + Y SPE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 429 DGVTRKTDVWSLGILILELLTGKFP 453
K+D+WSLG L+ EL P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-18
Identities = 28/130 (21%), Positives = 45/130 (34%), Gaps = 7/130 (5%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L L L+SL+ N + L L L+ + + F + LK
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP-----LAHLTLLDLSYNQLV 122
++L+ + + GL L LNL+GN F L L +L LS+ L
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 123 GRIPDTLSNF 132
++
Sbjct: 490 SIDQHAFTSL 499
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 27/137 (19%), Positives = 50/137 (36%), Gaps = 7/137 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS--VGKLT-LRALYLSLNKFTG-EIPSD 57
N + + S P L LS N+ + + + L LR L LS + + +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP---LAHLTLL 114
+ L+ ++L+ N ++ +L L+L + K P L L +L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 115 DLSYNQLVGRIPDTLSN 131
+LS++ L
Sbjct: 431 NLSHSLLDISSEQLFDG 447
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-17
Identities = 29/136 (21%), Positives = 42/136 (30%), Gaps = 5/136 (3%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDA 58
N++ I T SRL L L L L L+ N + A
Sbjct: 42 FNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETA 100
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDL 116
+G LK + + S L + L L L N FP L +LD
Sbjct: 101 LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDF 160
Query: 117 SYNQLVGRIPDTLSNF 132
N + + +S+
Sbjct: 161 QNNAIHYLSKEDMSSL 176
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 34/144 (23%), Positives = 48/144 (33%), Gaps = 6/144 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
N + + LS L+ L FI L +LYL N + I
Sbjct: 91 NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS-IKLPKG 149
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKL--LQLNLEGNSFQGKIPD-FPLAHLTLLDL 116
++LK + N + ++ LQ+ L LNL GN G P F A L+
Sbjct: 150 FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNF 209
Query: 117 SYNQLVGRIPDTLSNFDATSFQGN 140
Q + I L N S
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLG 233
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 22/136 (16%), Positives = 46/136 (33%), Gaps = 5/136 (3%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTG--EIPSD 57
L L L+ L+ ++ D + L L+ L L N F ++
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD-FPLAHLTLLDL 116
+ + +L+ + L+ S + L+ + ++L N + L+L
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNL 530
Query: 117 SYNQLVGRIPDTLSNF 132
+ N + +P L
Sbjct: 531 ASNHISIILPSLLPIL 546
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 24/129 (18%), Positives = 36/129 (27%), Gaps = 10/129 (7%)
Query: 12 LSRLPG-----LRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQ 64
L+ +PG L F N + +L L L L+ + I D F +
Sbjct: 24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHR 82
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLV 122
L + L N +L+G + L L L L L N +
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 123 GRIPDTLSN 131
Sbjct: 143 SIKLPKGFP 151
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 25/137 (18%), Positives = 44/137 (32%), Gaps = 8/137 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ I DT L +L N ++ L+ L+ + I
Sbjct: 67 CQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPL 125
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTL--LD 115
L+ ++L NH S +KL L+ + N+ + L T L+
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185
Query: 116 LSYNQLVGRIPDTLSNF 132
L+ N + G I +
Sbjct: 186 LNGNDIAG-IEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 27/161 (16%), Positives = 56/161 (34%), Gaps = 31/161 (19%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSF----DGPMPSVGKLTLRALYLSLNKFTGEIPS- 56
NL+ + S + L +F + + ++++ ++ L + F +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 57 ---------------------DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLE 95
G+ LKK+ L+ N F S + L L+++
Sbjct: 274 FHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333
Query: 96 GNSFQGKIPDF---PLAHLTLLDLSYNQL--VGRIPDTLSN 131
GN+ + ++ L +L LDLS++ + L N
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 25/140 (17%), Positives = 48/140 (34%), Gaps = 11/140 (7%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT----LRALYLSLNKFTGEIPS 56
N + I+ +SL+F + K + L +I
Sbjct: 188 GNDIAGIE-PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISP 245
Query: 57 DAFAGMD--QLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLT 112
F G+ ++ ++L +++F + L +L+L ++P L+ L
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK 304
Query: 113 LLDLSYNQLVGRIPDTLSNF 132
L LS N+ + SNF
Sbjct: 305 KLVLSANKFENLCQISASNF 324
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 24/145 (16%), Positives = 37/145 (25%), Gaps = 10/145 (6%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ ID L L SL +N +P L+ L N + +
Sbjct: 115 TGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDM 173
Query: 60 AGMDQLKKV--HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD----FPLAHLTL 113
+ + Q + +L N +G I LN G I + L L
Sbjct: 174 SSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 114 LDLSYNQLVGRIPDTLSNFDATSFQ 138
P S +
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVE 257
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 23/116 (19%), Positives = 40/116 (34%), Gaps = 6/116 (5%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKK 67
++L L L L L + + LS N+ T +A + + +
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIY- 527
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123
++LA NH S +P L L + +NL N + L + +L
Sbjct: 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF--LEWYKENMQKLED 581
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 43/208 (20%), Positives = 75/208 (36%), Gaps = 26/208 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+ +G GSFG + G V+K +MS+ +E+ + L ++ HPN++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
+ +V D+ G L + G L + L ++
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVL-FQEDQILDWFVQICLALKHV----- 141
Query: 376 GVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEF 425
H +KS N+ L L D+ + ++N Y SPE
Sbjct: 142 -----HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ K+D+W+LG ++ EL T K
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 31/218 (14%), Positives = 70/218 (32%), Gaps = 27/218 (12%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR---QMSNVGKEDFH---EHMTRLGSLSHPNLL 312
+LG G+F Y+A K+ +F+ + M RL +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
+ + + +LV + G+L N +++ + + + + + + + ++
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPL-----------LTD------YALVPIVNKEHAQL 415
+ HG +K N +L N + L D L P A+
Sbjct: 191 ----CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 416 HMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
++ E + D + + + +L G +
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 46/236 (19%), Positives = 86/236 (36%), Gaps = 54/236 (22%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
VLG G+FG KA L +K+ R + + L SL+H ++ A
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 318 Y------------YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVA 364
+ +K+ L + ++ NG+L +L+H Q W ++ + +
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFRQIL 126
Query: 365 KGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV 418
+ L+Y+ H LK N+ +D + + D+ L V++ L +
Sbjct: 127 EALSYI----------HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 419 A------------------YKSPE-FNQTDGVTRKTDVWSLGILILELLTGKFPAN 455
+ Y + E + T K D++SLGI+ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 46/256 (17%), Positives = 95/256 (37%), Gaps = 24/256 (9%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
LG+G+ G +K +G M K + R L + P +
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYI-- 93
Query: 314 LIAFY--YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
+ FY + + ++ + + + GSL +L + I K+ V KGL YL
Sbjct: 94 -VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYL 147
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM--VAYKSPEFNQT 428
++ + H +K SN+L+++ E L D+ + + A + +Y SPE Q
Sbjct: 148 REKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 204
Query: 429 DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488
+ ++D+WS+G+ ++E+ G++P + + +
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 489 RGTKSGEGEMLKLLKI 504
+ + ++
Sbjct: 265 NKFGMDSRPPMAIFEL 280
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 41/211 (19%), Positives = 64/211 (30%), Gaps = 29/211 (13%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSL-SHPNLLPL 314
LG GS+G +K G VKR + + + HP + L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ L ++ SL A L ++ LA+L
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGAS----LPEAQVWGYLRDTLLALAHL---- 173
Query: 375 PGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV---AYKSPEF 425
H +K +N+ L L D+ L+ + A Y +PE
Sbjct: 174 ------HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFPANY 456
Q DV+SLG+ ILE+ +
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNMELPHG 257
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 23/204 (11%)
Query: 260 VLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPL 314
LG G FG+ Y A + + +K + + + K + R L HPN+L L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLL-HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+++ L+ ++ P G++ L + + D I +A L+Y + +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSK 128
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----AYKSPEFNQTD 429
V H +K N+LL +A E + D+ V+ ++ + Y PE +
Sbjct: 129 --RVI--HRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 430 GVTRKTDVWSLGILILELLTGKFP 453
K D+WSLG+L E L GK P
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 59/234 (25%), Positives = 90/234 (38%), Gaps = 30/234 (12%)
Query: 237 KLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGK 293
KL F DL +G G++GS K V +G M VKR R + K
Sbjct: 8 KLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65
Query: 294 EDFHEHMTRLGSLSHPNLLPLIAFY--YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPG 350
+ + + S P + + FY +E + + + + S +
Sbjct: 66 QLLMDLDVVMRSSDCPYI---VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDV 121
Query: 351 LDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY----ALVP 406
+ I KI K L +L + + H +K SN+LLD + L D+ LV
Sbjct: 122 IPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 407 IVNKEHAQLHMV---AYKSPE----FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ A+ Y +PE G ++DVWSLGI + EL TG+FP
Sbjct: 179 SI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 43/222 (19%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN------- 310
E++GSG FG +KA + G V+KR E + L L H N
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR----VKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 311 --------LLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIK 361
K + L + +F G+L + RR G+ LD + L++ +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEK-LDKVLALELFE 129
Query: 362 GVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL 415
+ KG+ Y+ H LK SN+ L + + + D+ LV + + +
Sbjct: 130 QITKGVDYI----------HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 416 HMV---AYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPA 454
Y SPE + ++ D+++LG+++ ELL A
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 45/203 (22%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
LG G +G Y+ V V VK ++ + E+F + + + HPNL+ L+
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPG 376
R+ ++++F+ G+L + L R + + + L + ++ + YL K F
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 339
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN-----KEHAQLHMVAYKSPEFNQTDGV 431
+ H +L + N L+ + + D+ L ++ + + +PE +
Sbjct: 340 I---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 432 TRKTDVWSLGILILELLT-GKFP 453
+ K+DVW+ G+L+ E+ T G P
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSP 419
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 36/147 (24%), Positives = 56/147 (38%), Gaps = 19/147 (12%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN---SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDA 58
N + I + L L L N MP TL+ L + N+ T ++
Sbjct: 86 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPK----TLQELRVHENEIT-KVRKSV 140
Query: 59 FAGMDQLKKVHLARNHF-SGQIPK-SLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDL 116
F G++Q+ V L N S I + G++KL + + + IP LT L L
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHL 199
Query: 117 SYNQLVGRIPDTLSNFDATSFQGNKGL 143
N+ ++ DA S +G L
Sbjct: 200 DGNK--------ITKVDAASLKGLNNL 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 29/147 (19%), Positives = 54/147 (36%), Gaps = 19/147 (12%)
Query: 6 MIDVDTLSRLPGLRSLSFINN---SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGM 62
I+ + L + + + +P +L L+L NK T ++ + + G+
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNITTIPQGLPP----SLTELHLDGNKIT-KVDAASLKGL 215
Query: 63 DQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQ 120
+ L K+ L+ N S SLA L +L+L N K+P ++ ++ L N
Sbjct: 216 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 274
Query: 121 LVGRIPDTLSNFDATSFQGNKGLCGKP 147
+S + F K
Sbjct: 275 --------ISAIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 24/89 (26%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
L L NK T EI F + L + L N S P + A L KL +L L N
Sbjct: 53 DTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 99 FQGKIPDFPLAHLTLLDLSYNQLVGRIPD 127
+ ++P+ L L + N++ ++
Sbjct: 112 LK-ELPEKMPKTLQELRVHENEIT-KVRK 138
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 27/143 (18%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLT-LRALYLSLNKFT 51
N + I L L +L INN +F L L LYLS N+
Sbjct: 61 NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP-------LVKLERLYLSKNQLK 113
Query: 52 GEIPSDAFAGMDQLKKVHLARNHFSGQIPK-SLAGLQKLLQLNLEGNSFQ-GKIPD--F- 106
E+P L+++ + N + ++ K GL +++ + L N + I + F
Sbjct: 114 -ELPEKMPKT---LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 107 PLAHLTLLDLSYNQLVGRIPDTL 129
+ L+ + ++ + IP L
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGL 190
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 26/145 (17%), Positives = 47/145 (32%), Gaps = 30/145 (20%)
Query: 15 LPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLK 66
P L L N S G + + L L LS N + + + + A L+
Sbjct: 191 PPSLTELHLDGNKITKVDAASLKG-LNN-----LAKLGLSFNSIS-AVDNGSLANTPHLR 243
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGN--------SFQGKIPDFPLAHLTLLDLSY 118
++HL N ++P LA + + + L N F + A + + L
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302
Query: 119 NQLVGRIPDTLSNFDATSFQGNKGL 143
N + ++F+
Sbjct: 303 NPV------QYWEIQPSTFRCVYVR 321
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 13/73 (17%), Positives = 21/73 (28%), Gaps = 9/73 (12%)
Query: 10 DTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFT-GEIPSDAFA 60
L+ ++ + NN F P + K + + L N EI F
Sbjct: 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
Query: 61 GMDQLKKVHLARN 73
+ V L
Sbjct: 317 CVYVRAAVQLGNY 329
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 27/136 (19%), Positives = 50/136 (36%), Gaps = 18/136 (13%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTGE 53
N + ++ L L+SL +N +F G + S L L L T
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG-LNS-----LEQLTLEKCNLT-S 166
Query: 54 IPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHL 111
IP++A + + L + L + + S L +L L + + + +L
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226
Query: 112 TLLDLSYNQLVGRIPD 127
T L +++ L +P
Sbjct: 227 TSLSITHCNLT-AVPY 241
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 31/154 (20%), Positives = 49/154 (31%), Gaps = 27/154 (17%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTG 52
N + ++ D + P L L N +F+ + + LR L L N+
Sbjct: 41 KNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN-LFN-----LRTLGLRSNRLK- 93
Query: 53 EIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD---FPLA 109
IP F G+ L K+ ++ N + L L L + N I L
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152
Query: 110 HLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGL 143
L L L L++ + GL
Sbjct: 153 SLEQLTLEKCN--------LTSIPTEALSHLHGL 178
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 30/118 (25%), Positives = 46/118 (38%), Gaps = 7/118 (5%)
Query: 10 DTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L SLS + + P +V L LR L LS N + I + +L++
Sbjct: 218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQE 276
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--F-PLAHLTLLDLSYNQLV 122
+ L + P + GL L LN+ GN + + F + +L L L N L
Sbjct: 277 IQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 36/237 (15%), Positives = 71/237 (29%), Gaps = 46/237 (19%)
Query: 259 EVLGSGSFGSSYKA------------VLLTGP-------------AMVVKRFRQMSNVGK 293
VLG + +A V + ++ R + N +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 294 EDFHEH-MTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV----PNGSLANLLH--VRRAP 346
H + + P +I + + ++S F +L + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 347 GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406
L RL++ V + LA L+ G+ H +L+ +++LD LT + +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY--GLV--HTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 407 IVNKEHAQLHMVAYKSPEF----------NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ PE + +T D W+LG+ I + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 34/139 (24%), Positives = 54/139 (38%), Gaps = 21/139 (15%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTG 52
N + + + L L +N +F G + L L LS N
Sbjct: 41 GNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG-LAL-----LEQLDLSDNAQLR 94
Query: 53 EIPSDAFAGMDQLKKVHLARNHFSGQIPK-SLAGLQKLLQLNLEGNSFQGKIPD--F-PL 108
+ F G+ +L +HL R ++ GL L L L+ N+ Q +PD F L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 109 AHLTLLDLSYNQLVGRIPD 127
+LT L L N++ +P+
Sbjct: 153 GNLTHLFLHGNRIS-SVPE 170
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 7/126 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ + L L+ L +N+ P + L L L+L N+ + +P AF
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAF 173
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD---FPLAHLTLLDL 116
G+ L ++ L +N + P + L +L+ L L N+ +P PL L L L
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRL 232
Query: 117 SYNQLV 122
+ N V
Sbjct: 233 NDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 23/108 (21%), Positives = 38/108 (35%), Gaps = 12/108 (11%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
+ ++L N+ + +P+ +F L + L N + + GL L QL+L N+
Sbjct: 33 ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 99 FQGKIPD--F-PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGL 143
+ F L L L L L F+G L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCG--------LQELGPGLFRGLAAL 131
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 26/147 (17%), Positives = 48/147 (32%), Gaps = 19/147 (12%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-------PMPSVGKLTLRALYLSLNKFTGEI 54
L + ++ + + S+ F N M + + LS N+
Sbjct: 630 KLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-F 688
Query: 55 PSDAFAGMDQLKKVHLARNHFS-------GQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP 107
P++ FA + + L+ N + + L ++L N DF
Sbjct: 689 PTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR 748
Query: 108 ---LAHLTLLDLSYNQLVGRIPDTLSN 131
L +L+ +D+SYN P N
Sbjct: 749 ATTLPYLSNMDVSYNCF-SSFPTQPLN 774
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 8e-15
Identities = 29/144 (20%), Positives = 48/144 (33%), Gaps = 19/144 (13%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-----------LRALYLSLNK 49
M + D L LP L+SL+ N T ++ Y+ N
Sbjct: 501 CPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 50 FTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--- 106
S + M +L + N + + KL L L+ N + IP+
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-IPEDFCA 616
Query: 107 PLAHLTLLDLSYNQLVGRIPDTLS 130
+ L S+N+L IP+ +
Sbjct: 617 FTDQVEGLGFSHNKLKY-IPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 28/159 (17%), Positives = 53/159 (33%), Gaps = 32/159 (20%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPS---- 56
M I D+ L + + N ++ +LT L+ +Y + + FT + +
Sbjct: 412 PEMKPIKKDSRISLKDT-QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
Query: 57 --------------DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQG- 101
+++ + L V L Q+P L L +L LN+ N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 102 --------KIPD--FPLAHLTLLDLSYNQLVGRIPDTLS 130
++ D + + + YN L P + S
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASAS 568
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 23/121 (19%), Positives = 39/121 (32%), Gaps = 12/121 (9%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPS--VGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
L ++ N L L + +S N F+ P+ QLK
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPL-NSSQLK 779
Query: 67 KVHLAR------NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQ 120
+ N Q P + L+QL + N + K+ + L +LD++ N
Sbjct: 780 AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNP 838
Query: 121 L 121
Sbjct: 839 N 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 22/145 (15%), Positives = 43/145 (29%), Gaps = 12/145 (8%)
Query: 9 VDTLSRLPGLRSLSFINNSFDGPMPSVGKLT--LRALYLSLNKFTGEIPSDAFAG-MDQL 65
++ L L N + T + L S NK IP+ A + +
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646
Query: 66 KKVHLARNHFSGQIPKSLAGLQ-----KLLQLNLEGNSFQGKIPDFP--LAHLTLLDLSY 118
V + N + + + L N Q + + ++ + LS
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706
Query: 119 NQLVGRIPDTLSNFDATSFQGNKGL 143
N + IP+ +++ L
Sbjct: 707 NLM-TSIPENSLKPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 19/139 (13%), Positives = 44/139 (31%), Gaps = 16/139 (11%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSF-----DGPMPSVGKLTLRALYLSL--NKFTGEI 54
+ L L + ++ P+ +++L+ + N+ T I
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-I 440
Query: 55 PSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLT 112
A + +L+ ++ A + F+ N + L LT
Sbjct: 441 SK-AIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLT 494
Query: 113 LLDLSYNQLVGRIPDTLSN 131
++L + ++PD L +
Sbjct: 495 DVELYNCPNMTQLPDFLYD 513
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 22/161 (13%), Positives = 41/161 (25%), Gaps = 34/161 (21%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVG--KLTLRALYLSLNKFTGEIPSDA 58
G + D + +L L+ LSF +S G +LT ++
Sbjct: 333 FGAKGRVP-DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391
Query: 59 FAGMDQLKKVHLARNHFSG----------------------------QIPKSLAGLQKLL 90
+L L ++ + I K++ L KL
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQ 451
Query: 91 QLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN 131
+ + F + Y + + SN
Sbjct: 452 IIYFANSPFTYDN---IAVDWEDANSDYAKQYENEELSWSN 489
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 20/130 (15%), Positives = 38/130 (29%), Gaps = 10/130 (7%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
L + LS G +P ++G+LT L+ L + T
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRLFGDEELTPDMS 376
Query: 69 HLARNHFSGQIPK-SLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG---- 123
++ K L Q+L +L ++ P+ + + L Q+
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 124 --RIPDTLSN 131
I +
Sbjct: 437 ITFISKAIQR 446
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 11/56 (19%), Positives = 21/56 (37%), Gaps = 2/56 (3%)
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQLVGRIP 126
+ + Q L ++ L+L G +G++PD L L +L +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 9/107 (8%)
Query: 52 GEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHL 111
G+ P ++ + LA G++P ++ L +L L+ +S F L
Sbjct: 312 GDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL 371
Query: 112 TL---------LDLSYNQLVGRIPDTLSNFDATSFQGNKGLCGKPLE 149
T + + Y ++ L+ D N+ KP++
Sbjct: 372 TPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 46/221 (20%), Positives = 82/221 (37%), Gaps = 42/221 (19%)
Query: 259 EVLGSGSFGSSYKAVL-------LTGPAMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPN 310
E LG G+F +K V V +K + E F E + + LSH +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
L+ +E +LV +FV GSL L ++ + W +L++ K +A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 371 -YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV---------PIVNKEHAQLHMVAY 420
+ HG++ + N+LL + + + ++ K+
Sbjct: 130 EENTL--I---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-------L 177
Query: 421 K------SPE-FNQTDGVTRKTDVWSLGILILELLT-GKFP 453
+ PE + TD WS G + E+ + G P
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 35/232 (15%), Positives = 62/232 (26%), Gaps = 44/232 (18%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ---MSNVGKEDFHEHMTRLGSLSHPNLL-- 312
E L G + + +K F S E HE L +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 313 ------------------PLIAFYYRKEEKLLVSDFV-----PNGSLANLLHV--RRAPG 347
P A ++ V++++ + L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 348 QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407
+ + + + A L + G+ HGH N+ + +L D + +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK--GLV--HGHFTPDNLFIMPDGRLMLGDVSAL-- 241
Query: 408 VNKEHAQLHMVA----YKSPEF--NQTDGVTRKTDVWSLGILILELLTGKFP 453
K + + Y EF T T + W LG+ I + P
Sbjct: 242 -WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 26/226 (11%)
Query: 243 NDREMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFR-QMSNVGKEDFHEHM 300
+R+ +EL EV+GSG+ A + +KR + ++ + +
Sbjct: 12 INRDDYEL-------QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEI 64
Query: 301 TRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQP---GLDWPIRL 357
+ HPN++ + K+E LV + GS+ +++ A G+ LD
Sbjct: 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 358 KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM 417
I++ V +GL YL+K G H +K+ N+LL + D+ + +
Sbjct: 125 TILREVLEGLEYLHKN--GQI--HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 418 VAYKS---------PE-FNQTDGVTRKTDVWSLGILILELLTGKFP 453
K+ PE Q G K D+WS GI +EL TG P
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFH----EHMTRLGSLSHPNLLP 313
LG G++G K + +G M VKR R + V ++ + + ++ P
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVDCPFT-- 68
Query: 314 LIAFY--YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
+ FY +E + + + + + SL GQ + I KI + K L +L
Sbjct: 69 -VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVKALEHL 125
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV---AYKSPE--- 424
+ + + H +K SNVL++ + + D+ + + + A+ Y +PE
Sbjct: 126 HSKLSVI---HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 425 -FNQTDGVTRKTDVWSLGILILELLTGKFP 453
G + K+D+WSLGI ++EL +FP
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 42/214 (19%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM----SNVGKEDFHEHMTRLGSLSHPNLLP 313
E +G GSFG +K + T + +K + + ED + +T L P +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVLSQCDSPYV-- 82
Query: 314 LIAFY--YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
+Y Y K+ KL ++ +++ GS +LL LD I++ + KGL YL
Sbjct: 83 -TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYL 135
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK--------- 421
+ E H +K++NVLL E L D+ + QL K
Sbjct: 136 HSE--KKI--HRDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVGTPF 184
Query: 422 --SPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE + K D+WSLGI +EL G+ P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 30/137 (21%), Positives = 53/137 (38%), Gaps = 6/137 (4%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDA 58
N + + + P L+ L L+ L L L+ N + A
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGA 95
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ-GKIPDF--PLAHLTLLD 115
F+G+ L+K+ + + + L+ L +LN+ N Q K+P++ L +L LD
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155
Query: 116 LSYNQLVGRIPDTLSNF 132
LS N++ L
Sbjct: 156 LSSNKIQSIYCTDLRVL 172
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 27/123 (21%), Positives = 52/123 (42%), Gaps = 7/123 (5%)
Query: 14 RLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTG-EIPSDAFAGMDQLKKVHLAR 72
+L L+ L+F +N V +L L LS N + S + G LK + L+
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF----PLAHLTLLDLSYNQLVGRIPDT 128
N + + GL++L L+ + ++ + ++ +F L +L LD+S+
Sbjct: 383 NGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 129 LSN 131
+
Sbjct: 441 FNG 443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 27/125 (21%), Positives = 42/125 (33%), Gaps = 6/125 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
NL M + L L L + + L+ L L ++ N F D F
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLDL 116
+ L + L++ P + L L LN+ N + +PD L L + L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWL 525
Query: 117 SYNQL 121
N
Sbjct: 526 HTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 28/140 (20%), Positives = 49/140 (35%), Gaps = 10/140 (7%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ I+ L L +L N + + L+ L+ L + +
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPI 120
Query: 60 AGMDQLKKVHLARNHF-SGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTL--- 113
+ LK++++A N S ++P+ + L L L+L N Q L + L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 114 -LDLSYNQLVGRIPDTLSNF 132
LDLS N + P
Sbjct: 181 SLDLSLNPMNFIQPGAFKEI 200
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 26/136 (19%), Positives = 47/136 (34%), Gaps = 9/136 (6%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
N + + + S L L+ L + + +G L L+ L ++ N + F
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKL----LQLNLEGNSFQGKIPDFPLAHLTL-- 113
+ + L+ + L+ N L L ++ L L+L N I + L
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHK 204
Query: 114 LDLSYNQLVGRIPDTL 129
L L N + T
Sbjct: 205 LTLRNNFDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 27/116 (23%), Positives = 37/116 (31%), Gaps = 4/116 (3%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
+ L+ L N + L L L + F + L +
Sbjct: 367 QSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 69 HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLDLSYNQL 121
++ H GL L L + GNSFQ L +LT LDLS QL
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 24/126 (19%), Positives = 45/126 (35%), Gaps = 9/126 (7%)
Query: 8 DVDTLSRLPGLRSLSFINNSFD----GPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMD 63
+ + LP L L N G +L+ L LS N + S+ F G++
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN-FLGLE 396
Query: 64 QLKKVHLARNHFSGQIPKS-LAGLQKLLQLNLEGNSFQGKIPDFP--LAHLTLLDLSYNQ 120
QL+ + ++ S L+ L+ L++ + L+ L +L ++ N
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456
Query: 121 LVGRIP 126
Sbjct: 457 FQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 20/102 (19%), Positives = 34/102 (33%), Gaps = 4/102 (3%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV--GKLT-LRALYLSLNKFTGEIPSDA 58
+ + L L L NSF +L L L LS + ++ A
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 489
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
F + L+ +++A N L L ++ L N +
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 18/125 (14%), Positives = 34/125 (27%), Gaps = 13/125 (10%)
Query: 7 IDVDTLSRLPGLRSLSFINNSF----------DGPMPSVGKLTLRALYLSLNKFTGEIPS 56
+ + L GL + F + + LT+ L+ + +
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 57 DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDL 116
D F + + L ++ + L L F P L L L
Sbjct: 276 DLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCKFGQ-FPTLKLKSLKRLTF 332
Query: 117 SYNQL 121
+ N+
Sbjct: 333 TSNKG 337
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 22/102 (21%), Positives = 34/102 (33%), Gaps = 8/102 (7%)
Query: 33 PSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQL 92
P V + F +IP + K + L+ N S +L L
Sbjct: 2 PCVEVVPNITYQCMELNFY-KIPDNLPFS---TKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 93 NLEGNSFQGKIPD--F-PLAHLTLLDLSYNQLVGRIPDTLSN 131
+L Q I D + L+HL+ L L+ N + S
Sbjct: 58 DLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 28/147 (19%), Positives = 46/147 (31%), Gaps = 17/147 (11%)
Query: 2 NLMGMIDVDTLSRLPGLR----SLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPS 56
+ D L L L L++++ D + LT + + L +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD 299
Query: 57 DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDL 116
++ + + L F Q P L+ L +L N + L L LDL
Sbjct: 300 FSY--NFGWQHLELVNCKFG-QFPTL--KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDL 354
Query: 117 SYNQLVGRIPDTLSNFDATSFQGNKGL 143
S N L + + S G L
Sbjct: 355 SRNGL------SFKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 25/131 (19%), Positives = 38/131 (29%), Gaps = 16/131 (12%)
Query: 7 IDVDTLSRLPGLR----SLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAG 61
I L L + SL N + P K + L L L N + + G
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 62 MDQLKKVHLARNHFSGQ-----IPKS-LAGLQKLLQLNLEGNSFQGKIPDFP-----LAH 110
+ L+ L F + KS L GL L + D L +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 111 LTLLDLSYNQL 121
++ L +
Sbjct: 284 VSSFSLVSVTI 294
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 32/223 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIA 316
VL G F Y+A + +G +KR + + + LS HPN++ +
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 317 FYYRKEEK-------LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
+E+ L+ + G L L + G L LKI + + +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQTCRAVQH 151
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTD------YALVPIVNKEHAQLHMV----- 418
++++ P + H LK N+LL N L D + P + + +V
Sbjct: 152 MHRQKPPII--HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 419 -----AYKSPE---FNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y++PE + K D+W+LG ++ L + P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 25/213 (11%)
Query: 259 EVLGSG--SFGSSYKAV-LLTGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLP 313
V+G G + A TG + V+R SN + +HPN++P
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
A + E +V+ F+ GS +L+ G++ I++GV K L Y++
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTD----YALVPIVNKEHAQLHMVAYK-------S 422
G H +K+S++L+ + L+ +++ ++ Y S
Sbjct: 148 --GYV--HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 423 PE--FNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE G K+D++S+GI EL G P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 40/165 (24%), Positives = 60/165 (36%), Gaps = 42/165 (25%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTG 52
N + MI DT L L L N +F+G + S L L L N T
Sbjct: 84 ENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNG-LAS-----LNTLELFDNWLT- 136
Query: 53 EIPSDAFAGMDQLKKVHLARNH--------FSG-------------QI----PKSLAGLQ 87
IPS AF + +L+++ L N F+ ++ + GL
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196
Query: 88 KLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLSN 131
L LNL + + +P+ PL L L++S N P +
Sbjct: 197 NLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 35/126 (27%), Positives = 55/126 (43%), Gaps = 7/126 (5%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ + I L L+ L+ + MP++ L L L +S N F EI +F
Sbjct: 181 LKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFP-EIRPGSF 238
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--F-PLAHLTLLDL 116
G+ LKK+ + + S + GL L++LNL N+ +P F PL +L L L
Sbjct: 239 HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHL 297
Query: 117 SYNQLV 122
+N
Sbjct: 298 HHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 40/154 (25%), Positives = 60/154 (38%), Gaps = 30/154 (19%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLS-LNKFTG 52
N + +I L LR L NN +F+ +PS L L L L K
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR-VPS-----LMRLDLGELKKLE- 185
Query: 53 EIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD---FPLA 109
I AF G+ LK ++L + +P +L L L +L + GN F +I L+
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLS 242
Query: 110 HLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGL 143
L L + +Q +S + +F G L
Sbjct: 243 SLKKLWVMNSQ--------VSLIERNAFDGLASL 268
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 26/92 (28%), Positives = 33/92 (35%), Gaps = 6/92 (6%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
R L L N I +D F + L+ + L RN + GL L L L N
Sbjct: 76 NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 99 FQGKIPD---FPLAHLTLLDLSYNQLVGRIPD 127
IP L+ L L L N + IP
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPS 164
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 38/238 (15%), Positives = 72/238 (30%), Gaps = 47/238 (19%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK------------------------RFRQMSNVGK 293
VLG + +A TG + V R + N +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 294 EDFHEH-MTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV----PNGSLANLLH--VRRAP 346
H + + P +I + + ++S F +L + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 347 GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406
L RL++ V + LA L+ G+ H +L+ +++LD LT + +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY--GLV--HTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 407 IVNKEHAQLHMVAYKSPEFNQTDG-----------VTRKTDVWSLGILILELLTGKFP 453
++ PE +T D W+LG++I + P
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 38/146 (26%), Positives = 58/146 (39%), Gaps = 7/146 (4%)
Query: 12 LSRLPGLRSLSFINNSFDGPMPSV---GKLTLRALYLSLNKFTG----EIPSDAFAGMDQ 64
L R+P L+ L N F +L L+L N E+ D F G+
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGR 124
L+ ++L N+ + P + L L L+L N + A+L +LD+S NQL+
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAP 541
Query: 125 IPDTLSNFDATSFQGNKGLCGKPLEA 150
PD + NK +C L
Sbjct: 542 NPDVFVSLSVLDITHNKFICECELST 567
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 30/144 (20%), Positives = 45/144 (31%), Gaps = 14/144 (9%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT----LRALYLSLNKFTGEIPSD 57
+ + + D L L L + G L L LS N+
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQ--KLLQLNLEGNSFQGKIPD--------FP 107
+F ++ LK + + N L LQ L +L NS ++ F
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
Query: 108 LAHLTLLDLSYNQLVGRIPDTLSN 131
L +LD+S N I SN
Sbjct: 203 NMVLEILDVSGNGWTVDITGNFSN 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 27/115 (23%), Positives = 38/115 (33%), Gaps = 6/115 (5%)
Query: 13 SRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
L L N S L L+ L L I +AF + L+ + L
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGK-IPDFPLAHLT---LLDLSYNQL 121
+ P + GL L +L L + D +L LDLS NQ+
Sbjct: 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 32/126 (25%), Positives = 52/126 (41%), Gaps = 7/126 (5%)
Query: 2 NLMGMIDVDTLSRLP--GLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSD 57
+ + D +T + L +R L + V L L+ L L+ NK +I +
Sbjct: 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADE 308
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLD 115
AF G+D L+ ++L+ N + GL K+ ++L+ N L L LD
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368
Query: 116 LSYNQL 121
L N L
Sbjct: 369 LRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 30/141 (21%), Positives = 54/141 (38%), Gaps = 14/141 (9%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ ++ L L+ L+ N + + L L+ L LS N E+ S F
Sbjct: 276 GFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNF 334
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
G+ ++ + L +NH + ++ L+KL L+L N+ I P + + LS N
Sbjct: 335 YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIP--SIPDIFLSGN 391
Query: 120 QLVGRIPDTLSNFDATSFQGN 140
+ L + N
Sbjct: 392 K--------LVTLPKINLTAN 404
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 33/167 (19%), Positives = 56/167 (33%), Gaps = 33/167 (19%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN--SFDGPMPSVGKLTL---------------RALY 44
N + +I T L L++L +N + +PS+ + L ++
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIH 407
Query: 45 LSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNSFQGKI 103
LS N+ + L+ + L +N FS + L QL L N Q
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 104 PDF-------PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGL 143
L+HL +L L++N L++ F L
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNY--------LNSLPPGVFSHLTAL 506
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 21/106 (19%), Positives = 39/106 (36%), Gaps = 16/106 (15%)
Query: 41 RALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
R + T ++P ++ +++ L+ N+ S L++L L L
Sbjct: 7 RIAFYRFCNLT-QVPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 101 GKIPD--F-PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGL 143
I F L +L +LDL ++ + +FQG L
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSK--------IYFLHPDAFQGLFHL 99
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 22/156 (14%), Positives = 51/156 (32%), Gaps = 25/156 (16%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSF----DGPMPSVGKLTLRALYLSLNKFTGEIPSD 57
+ + + +L L+S+ F +N + + + TL L+ N + D
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193
Query: 58 AFAGMD-----QLKKVHLARNHFSGQIPK------------SLAGLQKLLQLNLEGNSFQ 100
M+ L+ + ++ N ++ I SL ++ ++ +
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 101 GKIPDF--PLAHLTL--LDLSYNQLVGRIPDTLSNF 132
+ LA ++ LDLS+ +
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
LG G FG + + +K + + E F + + L H L+ L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPGV 377
+E +V++++ GSL + L + L P + + +A G+AY+ +
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-- 302
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---AQLHMVAYK--SPEFNQTDGVT 432
H L+++N+L+ + D+ L ++ Q K +PE T
Sbjct: 303 ---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 433 RKTDVWSLGILILELLT-GKFP 453
K+DVWS GIL+ EL T G+ P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 58/291 (19%), Positives = 103/291 (35%), Gaps = 52/291 (17%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
E +G G+FG + L +V VK R+ + K F + L SHPN++ LI
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFP 375
+K+ +V + V G L L L+++ A G+ YL K
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKCC- 234
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----HAQLHMVAYK--SPEFNQTD 429
+ H L + N L+ ++D+ + L V K +PE
Sbjct: 235 -I---HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 430 GVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488
+ ++DVWS GIL+ E + G P Y N + +
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP--Y--PN---------LSNQ--------QTREFVE 329
Query: 489 RGTKSGEGEMLK-------LLKIGMCCCEWNAERRWDLREAVEKIMELKER 532
+G G + + ++ C + +R +++ +++R
Sbjct: 330 KG-----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 50/208 (24%), Positives = 78/208 (37%), Gaps = 30/208 (14%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLI 315
LG GSF Y+A + TG + +K + + K + + L HP++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDK-KAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
++ LV + NG + L R P + + G+ YL
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP----FSENEARHFMHQIITGMLYL----- 128
Query: 376 GVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----AYKSPEF 425
H H L SN+LL + D+ L + H + + + Y SPE
Sbjct: 129 -----HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
++DVWSLG + LL G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 17/202 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
LG G FG + + +K + + E F + + L H L+ L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPGV 377
+E +V++++ GSL + L + L P + + +A G+AY+ + V
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMNY--V 385
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---AQLHMVAYK--SPEFNQTDGVT 432
H L+++N+L+ + D+ L ++ Q K +PE T
Sbjct: 386 ---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 433 RKTDVWSLGILILELLT-GKFP 453
K+DVWS GIL+ EL T G+ P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP 464
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 25/115 (21%), Positives = 41/115 (35%), Gaps = 5/115 (4%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ L+ L L L N +V LT L+ L + N+ + + QL
Sbjct: 235 DLSPLANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD---ISVLNNLSQLN 290
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
+ L N + + + GL L L L N P L+ + D + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 31/126 (24%), Positives = 48/126 (38%), Gaps = 9/126 (7%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ L+ L L + N + V +T L +L + NK T A + QL
Sbjct: 191 DISPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITD---LSPLANLSQLT 246
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRI 125
+ + N S ++ L KL LN+ N I L+ L L L+ NQL
Sbjct: 247 WLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNED 303
Query: 126 PDTLSN 131
+ +
Sbjct: 304 MEVIGG 309
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 28/115 (24%), Positives = 47/115 (40%), Gaps = 7/115 (6%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ LS + GL L+ + + + LT L +L L+ N+ P A + L
Sbjct: 147 DLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSLNYNQIEDISP---LASLTSLH 202
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
N + P +A + +L L + N P L+ LT L++ NQ+
Sbjct: 203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 28/136 (20%), Positives = 49/136 (36%), Gaps = 7/136 (5%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ L L LR L ++ + + LT + +L L N ++ + M L
Sbjct: 102 DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDLS--PLSNMTGLN 158
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP 126
+ + + P +A L L L+L N + P L L NQ+ P
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP 216
Query: 127 -DTLSNFDATSFQGNK 141
++ ++ NK
Sbjct: 217 VANMTRLNSLKIGNNK 232
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 7e-12
Identities = 26/120 (21%), Positives = 42/120 (35%), Gaps = 6/120 (5%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ L+ L + SL+ N + + +T L L ++ +K P A + L
Sbjct: 124 DISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP---IANLTDLY 180
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP 126
+ L N P LA L L N P + L L + N++ P
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 28/125 (22%), Positives = 47/125 (37%), Gaps = 8/125 (6%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
DV T L + L + + LT L L L+ N+ T P + + +L
Sbjct: 36 DVVTQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITDISP---LSNLVKLT 91
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP 126
+++ N + +L L L +L L ++ P L + L+L N +
Sbjct: 92 NLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLS-DL 148
Query: 127 DTLSN 131
LSN
Sbjct: 149 SPLSN 153
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 38/215 (17%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHM---TRLGSLSHPNLLPL 314
LG G+FG YKA TG K + +E+ +++ L + HP ++ L
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAK---VIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ YY + ++ +F P G++ ++ L P + + + + L +L+ +
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSK- 136
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK-----------SP 423
+ H LK+ NVL+ + L D+ + A+ K +P
Sbjct: 137 -RII--HRDLKAGNVLMTLEGDIRLADFGVS-------AKNLKTLQKRDSFIGTPYWMAP 186
Query: 424 E-----FNQTDGVTRKTDVWSLGILILELLTGKFP 453
E + K D+WSLGI ++E+ + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 31/126 (24%), Positives = 54/126 (42%), Gaps = 7/126 (5%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ + I L LR L+ + +P++ L L L LS N + I +F
Sbjct: 170 LKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS-AIRPGSF 227
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--F-PLAHLTLLDL 116
G+ L+K+ + ++ + LQ L+++NL N+ +P F PL HL + L
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHL 286
Query: 117 SYNQLV 122
+N
Sbjct: 287 HHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 42/154 (27%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTGE 53
N + +I V++ L L L N +F+G + + L L L N+ T
Sbjct: 74 NQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNG-LAN-----LNTLELFDNRLT-T 126
Query: 54 IPSDAFAGMDQLKKVHLARNH--------FSG-------------QI----PKSLAGLQK 88
IP+ AF + +LK++ L N F+ ++ + GL
Sbjct: 127 IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN 186
Query: 89 LLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQL 121
L LNL + + +IP+ PL L LDLS N L
Sbjct: 187 LRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 26/92 (28%), Positives = 37/92 (40%), Gaps = 6/92 (6%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
R L L N+ I ++F + L+ + L+RNH + GL L L L N
Sbjct: 65 NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 99 FQGKIPD---FPLAHLTLLDLSYNQLVGRIPD 127
IP+ L+ L L L N + IP
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS 153
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 23/204 (11%)
Query: 260 VLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPL 314
LG G FG+ Y A M +K + S + KE + R L HPN+L +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFK-SQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLL-HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+++ ++ L+ +F P G L L R D ++ +A L Y ++
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQKHGR------FDEQRSATFMEELADALHYCHER 133
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----AYKSPEFNQTD 429
V H +K N+L+ E + D+ V+ + + Y PE +
Sbjct: 134 --KVI--HRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRTMCGTLDYLPPEMIEGK 187
Query: 430 GVTRKTDVWSLGILILELLTGKFP 453
K D+W G+L E L G P
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLL 312
+VLGSG+FG+ YK + + V +K R+ S ++ + + S+ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY- 371
L+ L++ +P G L + + + + L +AKG+ YL
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED 135
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK------SPE- 424
+ V H L + NVL+ +TD+ L ++ E + H K + E
Sbjct: 136 RRL--V---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 425 FNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
+ T ++DVWS G+ + EL+T G P
Sbjct: 191 IL--HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+ LG+G FG + A + VK + ++ E F + +L H L+ L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
KE ++++F+ GSL + L ++ P + +A+G+A++ +
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----N 304
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVN------KEHAQLHMVAYKSPEFNQTDGVT 432
H L+++N+L+ + + D+ L ++ +E A+ + + +PE T
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFT 363
Query: 433 RKTDVWSLGILILELLT-GKFP 453
K+DVWS GIL++E++T G+ P
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP 385
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 38/259 (14%), Positives = 85/259 (32%), Gaps = 51/259 (19%)
Query: 215 MGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVL 274
MG + D + + K+ F +VLG G+ G+ +
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFC---------------PKDVLGHGAEGTIVYRGM 45
Query: 275 LTGPAMVVKRFRQMSNVGKEDFHEHMTR-----LGSLSHPNLLPLIAFYYRKEEKLLVSD 329
+ VKR + R S HPN++ ++ + + +
Sbjct: 46 FDNRDVAVKRILP-------ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98
Query: 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNV 389
+L + ++ GL+ + +++ GLA+L+ + H LK N+
Sbjct: 99 LCA-ATLQEYV-EQKDFAHLGLE---PITLLQQTTSGLAHLHSL--NIV--HRDLKPHNI 149
Query: 390 LLDNAYE-----PLLTDYALVPIVNKEHAQLHMVA-------YKSPE---FNQTDGVTRK 434
L+ +++D+ L + + + +PE + + T
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 435 TDVWSLGILILELLTGKFP 453
D++S G + +++
Sbjct: 210 VDIFSAGCVFYYVISEGSH 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 49/229 (21%), Positives = 98/229 (42%), Gaps = 19/229 (8%)
Query: 230 SQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM 288
S + + KL + + + + E +G G+ G+ Y A+ + TG + +++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRF----EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 289 SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQ 348
KE + + +PN++ + Y +E +V +++ GSL +++
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---- 112
Query: 349 PGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408
+D + + + L +L+ V H +KS N+LL LTD+ +
Sbjct: 113 --MDEGQIAAVCRECLQALEFLHSN--QVI--HRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 409 NKEHAQLH-MVA---YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
E ++ MV + +PE K D+WSLGI+ +E++ G+ P
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 28/123 (22%), Positives = 45/123 (36%), Gaps = 4/123 (3%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
L P + +L NN+ S G+ + +YL+ NK T + +++ + L
Sbjct: 94 ELLVGPSIETLHAANNNISRVSCSRGQG-KKNIYLANNKIT-MLRDLDEGCRSRVQYLDL 151
Query: 71 ARNHFSG-QIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTL 129
N + A L LNL+ N A L LDLS N+L +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEF 210
Query: 130 SNF 132
+
Sbjct: 211 QSA 213
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 19/83 (22%), Positives = 32/83 (38%), Gaps = 3/83 (3%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
+ ++ + + + +K++ L+ N S LA KL LNL N
Sbjct: 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 100 QGKIPDF-PLAHLTLLDLSYNQL 121
D L+ L LDL+ N +
Sbjct: 71 YE-TLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 17/132 (12%), Positives = 35/132 (26%), Gaps = 11/132 (8%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ + ++ L N + T L L LS N E
Sbjct: 20 SSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL--DL 76
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
+ L+ + L N+ L + L+ N+ ++ + L+ N
Sbjct: 77 ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANN 130
Query: 120 QLVGRIPDTLSN 131
++
Sbjct: 131 KITMLRDLDEGC 142
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 28/142 (19%), Positives = 45/142 (31%), Gaps = 4/142 (2%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVH 69
+ + L L+ N V L+ L LS NK + F + +
Sbjct: 163 ELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMG-PEFQSAAGVTWIS 220
Query: 70 LARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ-GKIPDFPLAHLTLLDLSYNQLVGRIPDT 128
L N I K+L Q L +L GN F G + DF + + ++ +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 129 LSNFDATSFQGNKGLCGKPLEA 150
+ C + L A
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPA 301
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 2/68 (2%)
Query: 56 SDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTL 113
+ ++ K + + + + +L+L GN P L L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 114 LDLSYNQL 121
L+LS N L
Sbjct: 63 LNLSSNVL 70
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 15/119 (12%), Positives = 23/119 (19%), Gaps = 8/119 (6%)
Query: 10 DTLSRLPGLRSLSFINNSFD-GPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
L L N F G + R ++ ++
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLG 289
Query: 69 HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD------FPLAHLTLLDLSYNQL 121
H L L + S QG + A +D Q
Sbjct: 290 HYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 11/127 (8%), Positives = 27/127 (21%), Gaps = 8/127 (6%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG------PMPSVGKLTLRALYLSLNKFTGEIP 55
+ RL L+ S G + R + ++ +
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVI 352
Query: 56 SDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS-FQGKIPDFPLAHLTLL 114
+ + Q+ +L + + + + L LL
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL 412
Query: 115 DLSYNQL 121
+
Sbjct: 413 RAIVKRY 419
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 26/125 (20%), Positives = 45/125 (36%), Gaps = 7/125 (5%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
++ L+ L L +L N + + L L L L N + P + + +L+
Sbjct: 279 NISPLAGLTALTNLELNENQLEDI-SPISNLKNLTYLTLYFNNISDISP---VSSLTKLQ 334
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP 126
++ N S SLA L + L+ N P L +T L L+
Sbjct: 335 RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPV 392
Query: 127 DTLSN 131
+ +N
Sbjct: 393 NYKAN 397
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 31/116 (26%), Positives = 45/116 (38%), Gaps = 7/116 (6%)
Query: 7 IDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQL 65
D+ L+ L L L +N + KLT L +L + N+ + P + L
Sbjct: 168 TDLKPLANLTTLERLDISSNKVSDI-SVLAKLTNLESLIATNNQISDITP---LGILTNL 223
Query: 66 KKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
++ L N +LA L L L+L N P L LT L L NQ+
Sbjct: 224 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQI 277
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 44/136 (32%), Positives = 60/136 (44%), Gaps = 8/136 (5%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ L++L L SL NN + +G LT L L L+ N+ +I + A + L
Sbjct: 191 DISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQLK-DIGT--LASLTNLT 246
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP 126
+ LA N S P L+GL KL +L L N P L LT L+L+ NQL P
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 304
Query: 127 -DTLSNFDATSFQGNK 141
L N + N
Sbjct: 305 ISNLKNLTYLTLYFNN 320
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 7/115 (6%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D + + L + +L V L L + S N+ T P + +L
Sbjct: 38 DTVSQTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP---LKNLTKLV 93
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
+ + N + P LA L L L L N P L +L L+LS N +
Sbjct: 94 DILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTI 146
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 34/125 (27%), Positives = 49/125 (39%), Gaps = 10/125 (8%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ L L L + NN + LT L L L N+ T P + L
Sbjct: 82 DITPLKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITDIDP---LKNLTNLN 137
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP 126
++ L+ N S +L+GL L QL+ GN P L L LD+S N++
Sbjct: 138 RLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLANLTTLERLDISSNKV--SDI 192
Query: 127 DTLSN 131
L+
Sbjct: 193 SVLAK 197
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 7/115 (6%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
+D + L L ++F NN + + LT L + ++ N+ P A + L
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP---LANLTNLT 115
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
+ L N + P L L L +L L N+ L L L
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT 168
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 20/114 (17%), Positives = 37/114 (32%), Gaps = 5/114 (4%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
+ T + L + + + L I ++ L +
Sbjct: 16 QIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID--GVEYLNNLTQ 72
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
++ + N + P L L KL+ + + N P L +LT L L NQ+
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 124
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 16/87 (18%), Positives = 26/87 (29%), Gaps = 5/87 (5%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
L T + +DQ+ + R + L L Q+N N
Sbjct: 26 KMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQL 80
Query: 100 QGKIPDFPLAHLTLLDLSYNQLVGRIP 126
P L L + ++ NQ+ P
Sbjct: 81 TDITPLKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 22/118 (18%), Positives = 42/118 (35%), Gaps = 11/118 (9%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ +S L L+ L F NN S+ LT + L N+ + P A + ++
Sbjct: 323 DISPVSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTP---LANLTRIT 378
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAH---LTLLDLSYNQL 121
++ L ++ + N N I ++ T D+++N
Sbjct: 379 QLGLNDQAWTNAPVNYK---ANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP 433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
LG G +G Y+ V V VK ++ M E+F + + + HPNL+ L+
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
R+ ++++F+ G+L + L R + + + L + ++ + YL E
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL--EKK 130
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---YK--SPEFNQTDG 430
H L + N L+ + + D+ L ++ + H A K +PE +
Sbjct: 131 NFI--HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYN 187
Query: 431 V-TRKTDVWSLGILILELLT-GKFP 453
+ K+DVW+ G+L+ E+ T G P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 31/241 (12%)
Query: 229 NSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQ 287
+ + + + + R E+NDL +GSG+ G +K TG + VK+ R
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMR- 59
Query: 288 MSNVGKEDFH----EHMTRLGSLSHPNLLPLIAFY--YRKEEKL-LVSDFVPNGSLANLL 340
+ KE+ + L S P + + + + + + + + +
Sbjct: 60 -RSGNKEENKRILMDLDVVLKSHDCPYI---VQCFGTFITNTDVFIAMELMGTCAEKLKK 115
Query: 341 HVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400
++ + I K+ + K L YL ++ + H +K SN+LLD + L
Sbjct: 116 RMQG-----PIPERILGKMTVAIVKALYYLKEKHGVI---HRDVKPSNILLDERGQIKLC 167
Query: 401 DYALVPIVNKEHAQLHMV---AYKSPE-----FNQTDGVTRKTDVWSLGILILELLTGKF 452
D+ + + + A+ AY +PE + DVWSLGI ++EL TG+F
Sbjct: 168 DFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
Query: 453 P 453
P
Sbjct: 228 P 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 63/338 (18%), Positives = 117/338 (34%), Gaps = 42/338 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
++LG G+ + ++ TG +K F +S + D R L L+H N++
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD---VQMREFEVLKKLNHKNIVK 71
Query: 314 LIAFYYRKEEKL--LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
L A + L+ +F P GSL +L GL L +++ V G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY--GLPESEFLIVLRDVVGGMNHLR 129
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPL----LTDYALVPIVNKEHAQLHMV----AYKSP 423
+ G+ H ++K N++ + LTD+ + + Q + Y P
Sbjct: 130 EN--GIV--HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHP 184
Query: 424 E--------FNQTDGVTRKTDVWSLGILILELLTGKFP--------ANYLAQGKGANADL 467
+ + D+WS+G+ TG P N K
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLK-IGMCCCEWNAERRWDLREAVEKI 526
+ ++ V + E + DM + S + LL + E + E+ W + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 527 MELKERDNDNEDYSSYASEDYVYSSRAMTDEDFSFSVA 564
++ R + + +Y T F V
Sbjct: 305 SDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVY 342
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLL 312
+VLGSG+FG+ YK + + V +K R+ S ++ + + S+ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY- 371
L+ L++ +P G L + + + + L +AKG+ YL
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED 135
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK------SPEF 425
+ V H L + NVL+ +TD+ L ++ E + H K + E
Sbjct: 136 RRL--V---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 426 NQTDGVTRKTDVWSLGILILELLT-GKFP 453
T ++DVWS G+ + EL+T G P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 43/230 (18%), Positives = 83/230 (36%), Gaps = 54/230 (23%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
+ LG G FG ++A + +KR R + +E + L L HP + +
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI---VR 67
Query: 317 FYYRKEEKLLVSDFVP---------------NGSLANLLHVRRAPGQPGLDWPIRLKIIK 361
++ EK P +L + ++ R + + + L I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER--ERSVCLHIFL 125
Query: 362 GVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL 415
+A+ + +L H LK SN+ + D+ LV ++++ +
Sbjct: 126 QIAEAVEFL----------HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 416 HMVA----------------YKSPEFNQTDGVTRKTDVWSLGILILELLT 449
++ Y SPE + + K D++SLG+++ ELL
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 29/147 (19%), Positives = 48/147 (32%), Gaps = 20/147 (13%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN---SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDA 58
N + I S L L+ L N +PS +L L + N+ ++P
Sbjct: 88 NKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPS----SLVELRIHDNRIR-KVPKGV 142
Query: 59 FAGMDQLKKVHLARNHFSGQI--PKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDL 116
F+G+ + + + N P + GL KL L + IP L L L
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLPETLNELHL 200
Query: 117 SYNQLVGRIPDTLSNFDATSFQGNKGL 143
+N+ + + L
Sbjct: 201 DHNK--------IQAIELEDLLRYSKL 219
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
L L N + E+ D F G+ L + L N S K+ + L+KL +L + N
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 99 FQGKIPDFPLAHLTLLDLSYNQLVGRIPD 127
+IP + L L + N++ ++P
Sbjct: 114 LV-EIPPNLPSSLVELRIHDNRIR-KVPK 140
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 26/155 (16%), Positives = 45/155 (29%), Gaps = 27/155 (17%)
Query: 2 NLMGMIDVDTLSRLPGLR----SLSFI-NNSFDGPMPSVGKLTLRALYLSLNKFTGEIPS 56
+ I D L L + I L L L N+ I +
Sbjct: 182 AKLTGIPKDLPETLNELHLDHNKIQAIELEDLLR-YSK-----LYRLGLGHNQIR-MIEN 234
Query: 57 DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN--------SFQGKIPDFPL 108
+ + + L+++HL N S ++P L L+ L + L N F
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKR 293
Query: 109 AHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGL 143
A+ + L N + +F+
Sbjct: 294 AYYNGISLFNNPV------PYWEVQPATFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 33/142 (23%), Positives = 55/142 (38%), Gaps = 26/142 (18%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLT-LRALYLSLNKFT 51
N + + D L L +L +NN +F L L+ LY+S N
Sbjct: 63 NNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSP-------LRKLQKLYISKNHLV 115
Query: 52 GEIPSDAFAGMDQLKKVHLARNHFSGQIPK-SLAGLQKLLQLNLEGNSFQ-GKIPDFPLA 109
EIP + + L ++ + N ++PK +GL+ + + + GN +
Sbjct: 116 -EIPPNLPSS---LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 110 HLTL--LDLSYNQLVGRIPDTL 129
L L L +S +L IP L
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDL 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 10/73 (13%), Positives = 17/73 (23%), Gaps = 9/73 (12%)
Query: 10 DTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFT-GEIPSDAFA 60
L L L+ + N F V + + L N E+ F
Sbjct: 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
Query: 61 GMDQLKKVHLARN 73
+ +
Sbjct: 318 CVTDRLAIQFGNY 330
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 3/83 (3%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
+ ++ + + + +K++ L+ N S LA KL LNL N
Sbjct: 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 100 QGKIPDF-PLAHLTLLDLSYNQL 121
+ D L+ L LDL+ N +
Sbjct: 71 Y-ETLDLESLSTLRTLDLNNNYV 92
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 17/133 (12%), Positives = 35/133 (26%), Gaps = 11/133 (8%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ + ++ L N + T L L LS N E
Sbjct: 20 SSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD--L 76
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
+ L+ + L N+ L + L+ N+ ++ + L+ N
Sbjct: 77 ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANN 130
Query: 120 QLVGRIPDTLSNF 132
++
Sbjct: 131 KITMLRDLDEGCR 143
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 20/119 (16%), Positives = 43/119 (36%), Gaps = 8/119 (6%)
Query: 15 LPGLRSLSFINNSFDGPMPSVGKLT--LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLAR 72
+ ++S + S+ + ++ L LS N + +I + A +L+ ++L+
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSS 67
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN 131
N + L L L L+L N Q ++ + L + N +
Sbjct: 68 NVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELL--VGPSIETLHAANNNISRVSCSRGQG 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 22/126 (17%), Positives = 42/126 (33%), Gaps = 13/126 (10%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
+ L L LR+L NN + + L+ + N + + G K
Sbjct: 72 ETLDLESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNIS-RVSCSRGQG---KK 123
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQG-KIPDFP--LAHLTLLDLSYNQLVG 123
++LA N + ++ L+L+ N + L L+L YN +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 124 RIPDTL 129
+ +
Sbjct: 183 DVKGQV 188
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 25/113 (22%), Positives = 40/113 (35%), Gaps = 4/113 (3%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVH 69
+ + L L+ N V L+ L LS NK + F + +
Sbjct: 163 ELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMG-PEFQSAAGVTWIS 220
Query: 70 LARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ-GKIPDFPLAHLTLLDLSYNQL 121
L N I K+L Q L +L GN F G + DF + + ++ +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 2/68 (2%)
Query: 56 SDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTL 113
+ ++ K + + + + +L+L GN P L L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 114 LDLSYNQL 121
L+LS N L
Sbjct: 63 LNLSSNVL 70
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 32/224 (14%)
Query: 248 FELN-DLLRASAEVLGSGSFGSSYKAVLLTGPAMV---VKRFRQ--MSNVGKEDFHEHMT 301
L+ LL + LGSG+FG+ K + VK + K++
Sbjct: 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 70
Query: 302 RLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIK 361
+ L +P ++ +I E +LV + G L L R + ++++
Sbjct: 71 VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVH 124
Query: 362 GVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM--- 417
V+ G+ YL F V H L + NVLL + ++D+ L + +
Sbjct: 125 QVSMGMKYLEESNF--V---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 418 ----VAYKSPE---FNQTDGVTRKTDVWSLGILILELLT-GKFP 453
V + +PE + + + K+DVWS G+L+ E + G+ P
Sbjct: 180 GKWPVKWYAPECINYYK---FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 7e-13
Identities = 53/288 (18%), Positives = 99/288 (34%), Gaps = 38/288 (13%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
E LG+G FG + + TG + +K+ RQ + E + L+HPN++
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWCLEIQIMKKLNHPNVVS 76
Query: 314 LIAFY------YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL 367
+ LL ++ G L L+ GL ++ ++ L
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC--GLKEGPIRTLLSDISSAL 134
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL---LTDYALVPIVNKEHAQLHMV---AYK 421
YL++ + H LK N++L + L + D +++ V Y
Sbjct: 135 RYLHEN--RII--HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 422 SPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQ--------GKGANADLATWVNS 473
+PE + T D WS G L E +TG P Q + +N + + +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLRE 521
+++ + + L+ M W+ +R +
Sbjct: 251 TGAVKFSSVLPTPNHL--SGILAGKLERWLQCM--LMWHQRQRGTDPQ 294
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 231 QNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS 289
++ ++++L F ++ ++F +G GSFG+ Y A + + +K+
Sbjct: 39 KDPDVAELFFKDDPEKLFSD-------LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG 91
Query: 290 NVGKEDFHEHM---TRLGSLSHPNLLPLIAFY--YRKEEKL-LVSDFVPNGSLANLLHVR 343
E + + + L L HPN I + Y +E LV ++ GS ++LL V
Sbjct: 92 KQSNEKWQDIIKEVRFLQKLRHPNT---IQYRGCYLREHTAWLVMEYCL-GSASDLLEVH 147
Query: 344 RAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA 403
+ P L + G +GLAYL+ + H +K+ N+LL L D+
Sbjct: 148 KKP----LQEVEIAAVTHGALQGLAYLHSH--NMI--HRDVKAGNILLSEPGLVKLGDFG 199
Query: 404 LVPIVNKEHAQLHMVA---YKSPE---FNQTDGVTRKTDVWSLGILILELLTGKFP 453
I+ ++ V + +PE K DVWSLGI +EL K P
Sbjct: 200 SASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 9e-13
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+ +GSG FG + V +K R+ + + +EDF E + LSHP L+ L
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPG 376
+ LV++F+ +G L++ L +R L + V +G+AYL
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---AQLHMVAYK--SPE-FNQTDG 430
+ H L + N L+ ++D+ + V + + K SPE F+
Sbjct: 126 I---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS--FS 180
Query: 431 V-TRKTDVWSLGILILELLT-GKFP 453
+ K+DVWS G+L+ E+ + GK P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 37/216 (17%), Positives = 79/216 (36%), Gaps = 32/216 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKR--FRQMSNVGKEDFHEHMTRLGSLSHPNL--LPL 314
+ +GSG ++ + +K + N + + + L L + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ + +V + N L + L +++ +D R K + + + +++
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQH- 146
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPE---- 424
G+ H LK +N L+ + L D+ + + + + V Y PE
Sbjct: 147 -GIV--HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 425 -------FNQTDGVTRKTDVWSLGILILELLTGKFP 453
++ K+DVWSLG ++ + GK P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 25/207 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGP--AM-VVKRFRQMSNVGKEDFHEHMTR----LGSLSHPN 310
LG G F ++ T A +V + S + K E M+ SL+H +
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPK----SLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
++ F+ + +V + SL L R+A L P ++ + G YL
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA-----LTEPEARYYLRQIVLGCQYL 157
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----AYKSPEFN 426
++ V H LK N+ L+ E + D+ L V + + ++ Y +PE
Sbjct: 158 HRN--RVI--HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 213
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
G + + DVWS+G ++ LL GK P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGK-EDFHEHMTRLGSLSHPNLLPLIA 316
E LG GS+GS YKA+ TG + +K Q+ ++ + ++ + P+++
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIK---QVPVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
Y++ + +V ++ GS+++++ +R L I++ KGL YL+
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHFM--R 145
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK-----------SPEF 425
H +K+ N+LL+ L D+ + QL K +PE
Sbjct: 146 KI--HRDIKAGNILLNTEGHAKLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
Q G D+WSLGI +E+ GK P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 25/207 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGP--AM-VVKRFRQMSNVGKEDFHEHMTR----LGSLSHPN 310
LG G F ++ T A +V + S + K E M+ SL+H +
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPK----SLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
++ F+ + +V + SL L R+A L P ++ + G YL
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA-----LTEPEARYYLRQIVLGCQYL 131
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----AYKSPEFN 426
++ V H LK N+ L+ E + D+ L V + + ++ Y +PE
Sbjct: 132 HRN--RVI--HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
G + + DVWS+G ++ LL GK P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 29/207 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+G GS G A +G + VK +E + + H N++ +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
Y EE ++ +F+ G+L +++ R L+ + + V + LAYL+ + GV
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR------LNEEQIATVCEAVLQALAYLHAQ--GV 162
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK-----------SPEFN 426
H +KS ++LL L+D+ AQ+ K +PE
Sbjct: 163 I--HRDIKSDSILLTLDGRVKLSDFGFC-------AQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
+ D+WSLGI+++E++ G+ P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 28/125 (22%), Positives = 39/125 (31%), Gaps = 16/125 (12%)
Query: 7 IDVDTLSRLPGLRSLSFINN-------SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAF 59
+ L+ L N +F G + L L + F
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-LEQ-----LEHLDFQHSNLKQMSEFSVF 122
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD---FPLAHLTLLDL 116
+ L + ++ H GL L L + GNSFQ L +LT LDL
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 117 SYNQL 121
S QL
Sbjct: 183 SQCQL 187
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 24/126 (19%), Positives = 44/126 (34%), Gaps = 7/126 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV--GKLT-LRALYLSLNKFTGEIPSDA 58
+ + L L L NSF +L L L LS + ++ A
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN---SFQGKIPDFPLAHLTLLD 115
F + L+ ++++ N+F L L L+ N + + + + L L+
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 254
Query: 116 LSYNQL 121
L+ N
Sbjct: 255 LTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 24/136 (17%), Positives = 48/136 (35%), Gaps = 11/136 (8%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT----LRALYLSLNKFTGEIPSD 57
N + + +L L LS +N L+ L LS N + S
Sbjct: 38 NKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS- 95
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNSFQGKIPDF---PLAHLTL 113
F G++QL+ + ++ S+ L+ L+ L++ + + L+ L +
Sbjct: 96 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV 154
Query: 114 LDLSYNQLVGRIPDTL 129
L ++ N +
Sbjct: 155 LKMAGNSFQENFLPDI 170
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 5/92 (5%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ--IPKSLAGLQKLLQLNLEG 96
+ L L NK +P F + QL K+ L+ N S + +S G L L+L
Sbjct: 29 SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 97 NSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPD 127
N +F L L LD ++ L ++ +
Sbjct: 88 NGVITMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 47/229 (20%), Positives = 82/229 (35%), Gaps = 53/229 (23%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVG-KEDFHEHMTRLGSLSHPNL 311
LG G+FG Y+ + P V VK ++ + + DF + +H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR--LKIIKGVAKGLAY 369
+ I + + ++ + + G L + L R + L + + +A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 370 L-YKEFPGVTLPHGHLKSSNVLLDNAYEPLL--------------TDY------ALVPIV 408
L F + H + + N LL + Y A++P+
Sbjct: 197 LEENHF--I---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV- 250
Query: 409 NKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
K PE +G+ T KTD WS G+L+ E+ + G P
Sbjct: 251 ------------KWMPPE-AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 37/216 (17%), Positives = 79/216 (36%), Gaps = 32/216 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKR--FRQMSNVGKEDFHEHMTRLGSLSHPNL--LPL 314
+ +GSG ++ + +K + N + + + L L + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ + +V + N L + L +++ +D R K + + + +++
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQH- 127
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPE---- 424
G+ H LK +N L+ + L D+ + + + + V Y PE
Sbjct: 128 -GIV--HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 425 -------FNQTDGVTRKTDVWSLGILILELLTGKFP 453
++ K+DVWSLG ++ + GK P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 23/223 (10%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMV---VKRFRQ-MSNVGKEDFHEH 299
D+++F D L + LG G+FGS + V + +K +Q E+
Sbjct: 327 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 386
Query: 300 MTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKI 359
+ L +P ++ LI + E +LV + G L L +R + ++
Sbjct: 387 AQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAEL 441
Query: 360 IKGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM- 417
+ V+ G+ YL K F V H +L + NVLL N + ++D+ L + + +
Sbjct: 442 LHQVSMGMKYLEEKNF--V---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496
Query: 418 ------VAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
+ + +PE + ++DVWS G+ + E L+ G+ P
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
E LG+G FG + + VK +Q ++ + F + L H L+ L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+E ++++++ NGSL + L + P L L + +A+G+A++ E
Sbjct: 77 VTQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYI 131
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVN------KEHAQLHMVAYKSPE-FNQTDGV 431
H L+++N+L+ + + D+ L ++ +E A+ + + +PE N G
Sbjct: 132 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAIN--YGT 186
Query: 432 -TRKTDVWSLGILILELLT-GKFP 453
T K+DVWS GIL+ E++T G+ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 28/138 (20%), Positives = 46/138 (33%), Gaps = 7/138 (5%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDA 58
N + I L L+ L ++ + L L L LS N + + S
Sbjct: 35 FNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW 93
Query: 59 FAGMDQLKKVHLARNHFSG-QIPKSLAGLQKLLQLNLEGNSFQGKIP--DF-PLAHLTLL 114
F + LK ++L N + + L L L + +I DF L L L
Sbjct: 94 FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153
Query: 115 DLSYNQLVGRIPDTLSNF 132
++ L +L +
Sbjct: 154 EIKALSLRNYQSQSLKSI 171
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 24/126 (19%), Positives = 47/126 (37%), Gaps = 7/126 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFD--GPMPSVGKLT-LRALYLSLNKFTGEIPSDA 58
N + + L L+ L+ + N + G LT L+ L + + EI
Sbjct: 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLD 115
FAG+ L ++ + +SL ++ + L L + + + L+ + L+
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLE 202
Query: 116 LSYNQL 121
L L
Sbjct: 203 LRDTNL 208
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 25/127 (19%), Positives = 44/127 (34%), Gaps = 7/127 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEI--PSD 57
+ S L ++ ++ N+ P L L L LS N E S
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 58 AFAGMDQLKKVHLARNHFS--GQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP-LAHLTLL 114
L+ + L++NH + + L L+ L L++ N+F + L
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFL 415
Query: 115 DLSYNQL 121
+LS +
Sbjct: 416 NLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 23/126 (18%), Positives = 45/126 (35%), Gaps = 9/126 (7%)
Query: 14 RLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARN 73
L GL + + + V +T+R L++ S ++ ++++K++ + +
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENS 320
Query: 74 HFSGQIPKS-LAGLQKLLQLNLEGNSFQGKIPDFP-----LAHLTLLDLSYNQLVGRIPD 127
+P S L+ L L+L N + L L LS N L +
Sbjct: 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQK 378
Query: 128 TLSNFD 133
T
Sbjct: 379 TGEILL 384
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 27/119 (22%), Positives = 42/119 (35%), Gaps = 8/119 (6%)
Query: 15 LPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLAR 72
++SL N + L+ L L ++ I DAF + L+ + L+
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSD 83
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP----LAHLTLLDLSYNQLVGRIPD 127
NH S L L LNL GN +Q + L +L L + + I
Sbjct: 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 26/135 (19%), Positives = 43/135 (31%), Gaps = 17/135 (12%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
+ L L L SL N+F S +R L LS + + L+ +
Sbjct: 381 EILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP---QTLEVL 436
Query: 69 HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDT 128
++ N+ L LQ+L + N + L ++ +S NQ
Sbjct: 437 DVSNNNLD-SFSLFLPRLQEL---YISRNKLKTLPDASLFPVLLVMKISRNQ-------- 484
Query: 129 LSNFDATSFQGNKGL 143
L + F L
Sbjct: 485 LKSVPDGIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 16/151 (10%), Positives = 34/151 (22%), Gaps = 17/151 (11%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
I + L L L S + + L L L++ +
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFA 192
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD-------------F 106
+ ++ + L + + L + + + D
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR-GSVLTDESFNELLKLLRYIL 251
Query: 107 PLAHLTLLDLSYNQLVGRIPDTLSNFDATSF 137
L+ + D + N L P
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 18/158 (11%), Positives = 40/158 (25%), Gaps = 18/158 (11%)
Query: 2 NLMGMIDVDTLSRLPGLRSL--SFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDA 58
+ L L++L + + LT L L + S +
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQS 167
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQG-------------KIPD 105
+ + + L + + + L + L L + +
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227
Query: 106 FPLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGL 143
L D S+N+L+ ++ + F
Sbjct: 228 LAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLN 264
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 11/89 (12%)
Query: 15 LPGLRSLSFINN---SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLA 71
L L NN SF +P L+ LY+S NK +P + L + ++
Sbjct: 430 PQTLEVLDVSNNNLDSFSLFLPR-----LQELYISRNKLK-TLPDASL--FPVLLVMKIS 481
Query: 72 RNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
RN L L ++ L N +
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 27/139 (19%), Positives = 43/139 (30%), Gaps = 22/139 (15%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
N + + +P L L N P L L +S N I D F
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 161
Query: 60 AGMDQLKKVHLARNHFSGQIP-----------------KSLAGLQKLLQLNLEGNSFQGK 102
L+ + L+ N + + +LA + +L+ NS
Sbjct: 162 QATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-V 219
Query: 103 IPDFPLAHLTLLDLSYNQL 121
+ LT+L L +N L
Sbjct: 220 VRGPVNVELTILKLQHNNL 238
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 28/126 (22%), Positives = 49/126 (38%), Gaps = 8/126 (6%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
TL+ + L +NS + + + L L L N T + L +V L
Sbjct: 200 TLAIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLT-DTA--WLLNYPGLVEVDL 255
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDT 128
+ N + +Q+L +L + N + + P+ L +LDLS+N L+ +
Sbjct: 256 SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 313
Query: 129 LSNFDA 134
FD
Sbjct: 314 QPQFDR 319
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 32/156 (20%), Positives = 51/156 (32%), Gaps = 12/156 (7%)
Query: 7 IDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQ 64
D L PGL + N + K+ L LY+S N+ + +
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNL-YGQPIPT 296
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG- 123
LK + L+ NH + ++ +L L L+ NS + L L LS+N
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 354
Query: 124 RIPDTLSNFDATSFQGNKGLCGKPLE-----ACKSS 154
+ N + C + CK S
Sbjct: 355 SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 16/127 (12%), Positives = 38/127 (29%), Gaps = 13/127 (10%)
Query: 20 SLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79
+ + + + + ++P+ Q++ ++L
Sbjct: 27 HIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLDLSYNQLVGRIPDTLSNFDATS 136
+ A + +L + N+ + +P + LT+L L N LS+
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND--------LSSLPRGI 136
Query: 137 FQGNKGL 143
F L
Sbjct: 137 FHNTPKL 143
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLL 312
+VLGSG FG+ +K V + + +K S + +HM +GSL H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-Y 371
L+ LV+ ++P GSL + + R L + L +AKG+ YL
Sbjct: 79 RLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEE 133
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK------SPEF 425
V H +L + NVLL + + + D+ + ++ + QL K + E
Sbjct: 134 HGM--V---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 426 NQTDGVTRKTDVWSLGILILELLT-GKFP 453
T ++DVWS G+ + EL+T G P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 18/116 (15%), Positives = 43/116 (37%), Gaps = 4/116 (3%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ + ++ L+ N + L+ L L + T + + +G+ L
Sbjct: 58 DLTGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPN-LSGLTSLT 115
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQL 121
+ ++ + I + L K+ ++L N I L L L++ ++ +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 22/120 (18%), Positives = 44/120 (36%), Gaps = 12/120 (10%)
Query: 8 DVDTLSRLPGLRSLSFINNSF-DGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQL 65
+ + +S L L L + +P++ LT L L +S + I + + ++
Sbjct: 80 NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT-KINTLPKV 138
Query: 66 KKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP----LAHLTLLDLSYNQL 121
+ L+ N I L L +L LN++ + + D+ L L +
Sbjct: 139 NSIDLSYNGAITDI-MPLKTLPELKSLNIQFD----GVHDYRGIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 21/124 (16%), Positives = 50/124 (40%), Gaps = 8/124 (6%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVH 69
T +++ L ++ N + + + ++ L ++ T + +G+ L+++
Sbjct: 39 TEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATN---YNPISGLSNLERLR 94
Query: 70 LARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPD 127
+ + +L+GL L L++ ++ I L + +DLSYN + I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153
Query: 128 TLSN 131
L
Sbjct: 154 PLKT 157
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 17/98 (17%), Positives = 35/98 (35%), Gaps = 6/98 (6%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSF-DGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ + LS L L L +++ D + + L + ++ LS N +I
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI--MPL 155
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN 97
+ +LK +++ + + KL QL
Sbjct: 156 KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 53/232 (22%), Positives = 84/232 (36%), Gaps = 59/232 (25%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV----VK--RFRQMSNVGKEDFHEHMTRLGSLSHPNLL 312
++LG G FGS + L VK + S E+F + SHPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 313 PLIAFYYRKE-----EKLLVSDFVPNGSLANLLHVRRAPGQPG-LDWPIRLKIIKGVAKG 366
L+ + +++ F+ G L L R P + LK + +A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 367 LAYL-YKEFPGVTLPHGHLKSSNVLLD--------------NAYEPLLTDY------ALV 405
+ YL + F + H L + N +L Y DY A +
Sbjct: 160 MEYLSNRNF--L---HRDLAARNCMLRDDMTVCVADFGLSKKIYS---GDYYRQGRIAKM 211
Query: 406 PIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
P+ K + E + D V T K+DVW+ G+ + E+ T G P
Sbjct: 212 PV-------------KWIAIE-SLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 48/229 (20%), Positives = 82/229 (35%), Gaps = 53/229 (23%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVG-KEDFHEHMTRLGSLSHPNL 311
LG G+FG Y+ + P V VK ++ + + DF + +H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG--LDWPIRLKIIKGVAKGLAY 369
+ I + + ++ + + G L + L R L L + + +A G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 370 L-YKEFPGVTLPHGHLKSSNVLLDNAYEPLL--------------TDY------ALVPIV 408
L F + H + + N LL + Y A++P+
Sbjct: 156 LEENHF--I---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV- 209
Query: 409 NKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
K PE +G+ T KTD WS G+L+ E+ + G P
Sbjct: 210 ------------KWMPPE-AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 28/148 (18%), Positives = 50/148 (33%), Gaps = 7/148 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFD--GPMPSVGKLT-LRALYLSLNKFTGEIPSDA 58
N + + L L L+ + N + G LT L+ L + +I
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLD 115
FAG+ L+++ + + PKSL +Q + L L + + + + L+
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 116 LSYNQLVGRIPDTLSNFDATSFQGNKGL 143
L L LS + S
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTF 256
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 17/127 (13%), Positives = 35/127 (27%), Gaps = 12/127 (9%)
Query: 6 MIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAFAGMD 63
I + L L L + P + + L L + + +
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTS 222
Query: 64 QLKKVHLARNHFSG----QIPK----SLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLL 114
++ + L ++ SL + + S + ++ L L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLEL 282
Query: 115 DLSYNQL 121
+ S NQL
Sbjct: 283 EFSRNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 25/113 (22%), Positives = 42/113 (37%), Gaps = 12/113 (10%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
+++L LS N+ T I + L+ + L N + S + L L L+L N
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 99 FQGKIPD--F-PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGLCGKPL 148
+ F PL+ LT L+L N + + + F L +
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYK-------TLGETSLFSHLTKLQILRV 156
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNS 98
L+AL L+ N I D+F+ + L+ + L+ N+ S + S L L LNL GN
Sbjct: 78 LQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNP 135
Query: 99 FQGKIPDF----PLAHLTLLDLSYNQLVGRIPD 127
++ + + L L +L + +I
Sbjct: 136 YK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 14/70 (20%), Positives = 31/70 (44%), Gaps = 2/70 (2%)
Query: 7 IDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQL 65
+ ++L + R++ + S M + +++ L L S N+ +P F + L
Sbjct: 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSL 303
Query: 66 KKVHLARNHF 75
+K+ L N +
Sbjct: 304 QKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 14/110 (12%), Positives = 33/110 (30%), Gaps = 14/110 (12%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS----------VGKLTLRALYLSLNKFT 51
++ + + L + D S + K T R + ++
Sbjct: 208 KQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
Query: 52 GEIPSDAFAGMDQLKKVHLARNHFSGQIPKS-LAGLQKLLQLNLEGNSFQ 100
++ + L ++ +RN +P L L ++ L N +
Sbjct: 268 -QVM-KLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 47/222 (21%)
Query: 259 EVLGSGSFGSSYKAVLLTGP----AMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLP 313
LG G+FGS A+V VK+ + + DF + L +L ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 314 LIAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL- 370
Y + LV +++P+G L + L R LD L + KG+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG 144
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYE------------PLLTDYALVPIVNKEHAQLHMV 418
+ V H L + N+L+++ PL DY +V +E Q +
Sbjct: 145 SRRC--V---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV----REPGQSP-I 194
Query: 419 AYKSPE------FNQTDGVTRKTDVWSLGILILELLT-GKFP 453
+ +PE F +R++DVWS G+++ EL T
Sbjct: 195 FWYAPESLSDNIF------SRQSDVWSFGVVLYELFTYCDKS 230
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
+ LGSG FG + VK ++ MS +++F + + LSHP L+
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFP 375
++ +V++++ NG L N L GL+ L++ V +G+A+L +F
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQF- 125
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---YK--SPE-FNQTD 429
+ H L + N L+D ++D+ + V + + K +PE F+
Sbjct: 126 -I---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH--Y 179
Query: 430 GV-TRKTDVWSLGILILELLT-GKFP 453
+ K+DVW+ GIL+ E+ + GK P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 49/216 (22%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+ +G G FG G + VK + + + F + + L H NL+ L+
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 319 YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPG 376
++ L +V++++ GSL + L R+ G+ L LK V + + YL F
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 138
Query: 377 VTLPHGHLKSSNVLLD--------------NAYEPLLTDYALVPIVNKEHAQLHMVAYK- 421
V H L + NVL+ A D +P+ K
Sbjct: 139 V---HRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPV-------------KW 180
Query: 422 -SPE-FNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
+PE + + K+DVWS GIL+ E+ + G+ P
Sbjct: 181 TAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 48/233 (20%), Positives = 86/233 (36%), Gaps = 60/233 (25%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV----VKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLL 312
+LG G FGS +A L VK + +++ E+F + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 313 PLIAF------YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG-LDWPIRLKIIKGVAK 365
L+ R +++ F+ +G L L R P L ++ + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 366 GLAYL-YKEFPGVTLPHGHLKSSNVLLDNA--------------YEPLLTDY------AL 404
G+ YL + F + H L + N +L Y DY +
Sbjct: 149 GMEYLSSRNF--I---HRDLAARNCMLAEDMTVCVADFGLSRKIYS---GDYYRQGCASK 200
Query: 405 VPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
+P+ K + E + D + T +DVW+ G+ + E++T G+ P
Sbjct: 201 LPV-------------KWLALE-SLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 57/296 (19%), Positives = 103/296 (34%), Gaps = 42/296 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
++LG G+ + ++ TG +K F +S + D R L L+H N++
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD---VQMREFEVLKKLNHKNIVK 71
Query: 314 LIAFYYRKEEKL--LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
L A + L+ +F P GSL +L GL L +++ V G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY--GLPESEFLIVLRDVVGGMNHLR 129
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPL----LTDYALVPIVNKEHAQLH----------- 416
+ G+ H ++K N++ + LTD+ + + Q
Sbjct: 130 EN--GIV--HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHP 184
Query: 417 -MVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP--------ANYLAQGKGANADL 467
M + D+WS+G+ TG P N K
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCC-EWNAERRWDLREA 522
+ ++ V + E + DM + S + LL + E + E+ W +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+ +G G FG G + VK + + + F + + L H NL+ L+
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 319 YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
++ L +V++++ GSL + L R+ G+ L LK V + + YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---- 308
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK--SPEFNQTDGVTRKT 435
H L + NVL+ ++D+ L + + K +PE + + K+
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-GKLPVKWTAPEALREKKFSTKS 367
Query: 436 DVWSLGILILELLT-GKFP 453
DVWS GIL+ E+ + G+ P
Sbjct: 368 DVWSFGILLWEIYSFGRVP 386
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 47/220 (21%), Positives = 88/220 (40%), Gaps = 53/220 (24%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+ LG+G FG G V +K ++ S + +++F E + +LSH L+ L
Sbjct: 30 KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPG 376
++ ++++++ NG L N L R L++ K V + + YL K+F
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 377 VTLPHGHLKSSNVLL------------------DNAYEPLLTDYALVPIVNKEHAQLHMV 418
+ H L + N L+ D+ Y + + P+
Sbjct: 142 L---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPV----------- 185
Query: 419 AYK--SPE-FNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
+ PE + K+D+W+ G+L+ E+ + GK P
Sbjct: 186 --RWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 259 EVLGSGSFGSSYKAVLLT---GPAMV-VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLP 313
+++GSG G L V +K + + + DF + +G HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YK 372
L R ++V++++ NGSL L R GQ + +++GV G+ YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQ--FTIMQLVGMLRGVGAGMRYLSDL 170
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKS---------- 422
+ V H L + NVL+D+ ++D+ L ++ + AY +
Sbjct: 171 GY--V---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDD----PDAAYTTTGGKIPIRWT 221
Query: 423 -PE------FNQTDGVTRKTDVWSLGILILELLT-GKFP 453
PE F + +DVWS G+++ E+L G+ P
Sbjct: 222 APEAIAFRTF------SSASDVWSFGVVMWEVLAYGERP 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-----VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLL 312
+V+G+G FG YK +L T +K + + + DF +G SH N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-Y 371
L + + +++++++ NG+L L R G+ + +++G+A G+ YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL--REKDGE--FSVLQLVGMLRGIAAGMKYLAN 165
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKS--------- 422
+ V H L + N+L+++ ++D+ L ++ + Y +
Sbjct: 166 MNY--V---HRDLAARNILVNSNLVCKVSDFGLSRVLEDD----PEATYTTSGGKIPIRW 216
Query: 423 --PE-FNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
PE + T +DVWS GI++ E++T G+ P
Sbjct: 217 TAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 29/124 (23%), Positives = 44/124 (35%), Gaps = 8/124 (6%)
Query: 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-----LRALYLSLNKFTGEIPSDAF 59
G+I + P L+ L+ N + P L L+ L LS N + +
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
QL ++L+ Q+PK L KL L+L N L + L L N
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGN 306
Query: 120 QLVG 123
+
Sbjct: 307 PFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 28/118 (23%), Positives = 37/118 (31%), Gaps = 11/118 (9%)
Query: 15 LPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIP---SDAFAGMDQLKKVH 69
PGL+ LS V L L LS N GE + L+ +
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 70 LARNHF---SGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAH---LTLLDLSYNQL 121
L SG A +L L+L NS + L L+LS+ L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 25/131 (19%), Positives = 37/131 (28%), Gaps = 16/131 (12%)
Query: 14 RLPGLRSLSFINNS------FDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
P L L+ N S + + K L+ L ++ + L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALST 177
Query: 68 VHLARNHFSGQI-------PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSY 118
+ L+ N G+ P LQ L N + G L LDLS+
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237
Query: 119 NQLVGRIPDTL 129
N L
Sbjct: 238 NSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 27/142 (19%), Positives = 46/142 (32%), Gaps = 18/142 (12%)
Query: 15 LPGLRSLSFINNSFDGPMP-SVGKLTLRAL-YLSLNKFTGEIPSDAFAGMDQ-----LKK 67
+ GL+ L+ N G P + + T L L+L + A + Q LK
Sbjct: 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIP------DFPLAHLTLLDLSYNQL 121
+ +A+ H + + L L+L N G+ L +L L +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 122 VGRIPDTLSNFDATSFQGNKGL 143
+T S + L
Sbjct: 214 -----ETPSGVCSALAAARVQL 230
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 20/128 (15%), Positives = 40/128 (31%), Gaps = 10/128 (7%)
Query: 15 LPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMD--QLKKVHLAR 72
L L + L+L+ L + + I A + L+++ L
Sbjct: 45 LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104
Query: 73 NHFSGQIPKSLAGLQ--KLLQLNLEGNSFQG------KIPDFPLAHLTLLDLSYNQLVGR 124
+G P L L LNL S+ ++ + L +L ++ +
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 125 IPDTLSNF 132
+ + F
Sbjct: 165 SCEQVRVF 172
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 30/124 (24%), Positives = 48/124 (38%), Gaps = 10/124 (8%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIP-SDAFAGMDQLKKVH 69
+L RL +R+ + G + +G L+ L L + TG P A L ++
Sbjct: 69 SLKRL-TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127
Query: 70 LARNHFSGQIPKSLAGLQKLLQLNLEGNSFQG-KIPDFP------LAHLTLLDLSYNQLV 122
L ++ LA LQ+ L+ L+ S +F L+ LDLS N +
Sbjct: 128 LRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186
Query: 123 GRIP 126
G
Sbjct: 187 GERG 190
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 58/225 (25%), Positives = 84/225 (37%), Gaps = 53/225 (23%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV----VKRFRQMSNVG-KEDFHEHMTRLGSLSHPNLLP 313
EV+G G FG Y LL VK +++++G F + SHPN+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 314 LIAFYYRKEEKLL-VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-Y 371
L+ R E L V ++ +G L N + + VAKG+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 372 KEFPGVTLPHGHLKSSNVLLD-------------------NAYEPLLTDYALVPIVNKEH 412
K+F V H L + N +LD Y A +P+
Sbjct: 147 KKF--V---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----- 196
Query: 413 AQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
K + E + T K+DVWS G+L+ EL+T G P
Sbjct: 197 --------KWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 68/363 (18%), Positives = 123/363 (33%), Gaps = 45/363 (12%)
Query: 116 LSYNQLVGRIPDTLSNFDA-----TSFQGNKGLCGKPLEACKSSISKKTILIICTVAGAT 170
+SY G P L++F+ S +K K + K + + + + +
Sbjct: 250 ISYLTDKGANPTHLADFNQVQTIQYSNSEDK--DRKGMLQLKIAGAPEPLTVTAPSLTIA 307
Query: 171 LALAAIVAFSCTRGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNS 230
+A ++ C N + S I + E N G S +
Sbjct: 308 ENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDY 367
Query: 231 Q--NDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLLT---GPAMV-VKR 284
DE + + + +G G FG ++ + ++ V +K
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPAMAVAIKT 425
Query: 285 FRQ-MSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVR 343
+ S+ +E F + + HP+++ LI + ++ + G L + L VR
Sbjct: 426 CKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVR 484
Query: 344 RAPGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402
+ LD + ++ LAYL K F V H + + NVL+ + L D+
Sbjct: 485 K----FSLDLASLILYAYQLSTALAYLESKRF--V---HRDIAARNVLVSSNDCVKLGDF 535
Query: 403 ALVPIVNKEHAQLHMVAYKS-----------PEFNQTDGVTRKTDVWSLGILILELLT-G 450
L + YK+ PE T +DVW G+ + E+L G
Sbjct: 536 GLSRYMEDS------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 451 KFP 453
P
Sbjct: 590 VKP 592
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 50/220 (22%), Positives = 80/220 (36%), Gaps = 44/220 (20%)
Query: 259 EVLGSGSFGSSYKAVLLT--GPAMVV-----KRFRQMSNVGKEDFHEHMTRLGSLSHPNL 311
E LG GSFG + G + V K +DF + + SL H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 312 LPLIA------FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365
+ L +V++ P GSL + L + + VA+
Sbjct: 84 IRLYGVVLTPPMK-------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAE 132
Query: 366 GLAYL-YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----HAQLHM--- 417
G+ YL K F + H L + N+LL + D+ L+ + + Q H
Sbjct: 133 GMGYLESKRF--I---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 418 VAYKSPE---FNQTDGVTRKTDVWSLGILILELLT-GKFP 453
A+ +PE + +D W G+ + E+ T G+ P
Sbjct: 188 FAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 27/139 (19%), Positives = 43/139 (30%), Gaps = 22/139 (15%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
N + + +P L L N P L L +S N I D F
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167
Query: 60 AGMDQLKKVHLARNHFSGQIP-----------------KSLAGLQKLLQLNLEGNSFQGK 102
L+ + L+ N + + +LA + +L+ NS
Sbjct: 168 QATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-V 225
Query: 103 IPDFPLAHLTLLDLSYNQL 121
+ LT+L L +N L
Sbjct: 226 VRGPVNVELTILKLQHNNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 16/127 (12%), Positives = 38/127 (29%), Gaps = 13/127 (10%)
Query: 20 SLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79
+ + + + + ++P+ Q++ ++L
Sbjct: 33 HIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLDLSYNQLVGRIPDTLSNFDATS 136
+ A + +L + N+ + +P + LT+L L N LS+
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND--------LSSLPRGI 142
Query: 137 FQGNKGL 143
F L
Sbjct: 143 FHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 27/117 (23%), Positives = 43/117 (36%), Gaps = 6/117 (5%)
Query: 7 IDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQ 64
D L PGL + N + K+ L LY+S N+ + +
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNL-YGQPIPT 302
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
LK + L+ NH + ++ +L L L+ NS + L L LS+N
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 28/126 (22%), Positives = 49/126 (38%), Gaps = 8/126 (6%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
TL+ + L +NS + + + L L L N T + L +V L
Sbjct: 206 TLAIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLT-DTA--WLLNYPGLVEVDL 261
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDT 128
+ N + +Q+L +L + N + + P+ L +LDLS+N L+ +
Sbjct: 262 SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 319
Query: 129 LSNFDA 134
FD
Sbjct: 320 QPQFDR 325
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 49/222 (22%)
Query: 259 EVLGSGSFGSSYKAVLLT---GPAMV-VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLP 313
+V+G+G FG L V +K + + + DF + +G HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YK 372
L + + ++V++++ NGSL + L R+ Q + +++G+A G+ YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQ--FTVIQLVGMLRGIASGMKYLSDM 166
Query: 373 EFPGVTLPHGHLKSSNVLL------------------DNAYEPLLTDYALVPIVNKEHAQ 414
+ V H L + N+L+ D+ T +PI
Sbjct: 167 GY--V---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI------- 214
Query: 415 LHMVAYK--SPEFNQTDGVTRKTDVWSLGILILELLT-GKFP 453
+ SPE T +DVWS GI++ E+++ G+ P
Sbjct: 215 ------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 46/217 (21%)
Query: 259 EVLGSGSFGSSYKAVLLTGP----AMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLP 313
+ LG G+FGS +V VK+ + + DF + L SL H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 314 LIAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL- 370
Y + L+ +++P GSL + L + +D L+ + KG+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG 162
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKS-------- 422
K + + H L + N+L++N + D+ L ++ ++ YK
Sbjct: 163 TKRY--I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKE-----YYKVKEPGESPI 212
Query: 423 ----PE------FNQTDGVTRKTDVWSLGILILELLT 449
PE F + +DVWS G+++ EL T
Sbjct: 213 FWYAPESLTESKF------SVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 46/217 (21%)
Query: 259 EVLGSGSFGSSYKAVLLTGP----AMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLP 313
+ LG G+FGS +V VK+ + + DF + L SL H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 314 LIAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL- 370
Y + L+ +++P GSL + L + +D L+ + KG+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG 131
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKS-------- 422
K + + H L + N+L++N + D+ L ++ ++ +K
Sbjct: 132 TKRY--I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKE-----FFKVKEPGESPI 181
Query: 423 ----PE------FNQTDGVTRKTDVWSLGILILELLT 449
PE F + +DVWS G+++ EL T
Sbjct: 182 FWYAPESLTESKF------SVASDVWSFGVVLYELFT 212
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 37/216 (17%), Positives = 78/216 (36%), Gaps = 32/216 (14%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKR--FRQMSNVGKEDFHEHMTRLGSLSHPNL--LPL 314
+ +GSG ++ + +K + N + + + L L + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ + +V + N L + L ++ +D R K + + + +++
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH- 174
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPE---- 424
G+ H LK +N L+ + L D+ + + + + V Y PE
Sbjct: 175 -GIV--HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 425 -------FNQTDGVTRKTDVWSLGILILELLTGKFP 453
++ K+DVWSLG ++ + GK P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 27/98 (27%), Positives = 41/98 (41%), Gaps = 5/98 (5%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
L +L LS N I S+AF + L+ + L+ NH + LQ L L L N
Sbjct: 66 LHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124
Query: 100 QGKIPD--FP-LAHLTLLDLSYNQLVGRIPDTLSNFDA 134
+ F +A L L LS NQ+ + + + +
Sbjct: 125 V-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNK 161
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 36/144 (25%), Positives = 51/144 (35%), Gaps = 24/144 (16%)
Query: 11 TLSRLPGLRSLSFINN--------SFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAG 61
T +RL L SL +N +F + LR L LS N + F+
Sbjct: 59 TPTRLTNLHSLLLSHNHLNFISSEAFVP-------VPNLRYLDLSSNHLH-TLDEFLFSD 110
Query: 62 MDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD------FPLAHLTLLD 115
+ L+ + L NH + + +L +L L N + P L L LLD
Sbjct: 111 LQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169
Query: 116 LSYNQLVGRIPDTLSNFDATSFQG 139
LS N+L L A G
Sbjct: 170 LSSNKLKKLPLTDLQKLPAWVKNG 193
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 19/96 (19%), Positives = 31/96 (32%), Gaps = 13/96 (13%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK-SLAGLQKLLQLNLEGN 97
L LS N + + L + L+ NH + I + + L L+L N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 98 SFQGKIPDFP------LAHLTLLDLSYNQLVGRIPD 127
+ L L +L L N +V +
Sbjct: 99 ----HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDR 129
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 34/128 (26%), Positives = 50/128 (39%), Gaps = 23/128 (17%)
Query: 7 IDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLT-LRALYLSLNKFTGEIPSD 57
I + +P LR L +N F L L L L N + +
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSD-------LQALEVLLLYNNHIV-VVDRN 130
Query: 58 AFAGMDQLKKVHLARNHFSGQIP----KSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTL 113
AF M QL+K++L++N S + P K L KL+ L+L N + K+P L L
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPA 188
Query: 114 LDLSYNQL 121
+ L
Sbjct: 189 WVKNGLYL 196
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 49/225 (21%), Positives = 81/225 (36%), Gaps = 53/225 (23%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV----VKRFRQMSNVG-KEDFHEHMTRLGSLSHPNLLP 313
V+G G FG Y + +K +++ + E F + L+HPN+L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 314 LIAFYYRKEE-KLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-Y 371
LI E ++ ++ +G L + + + VA+G+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAE 142
Query: 372 KEFPGVTLPHGHLKSSNVLL-------------------DNAYEPLLTDYALVPIVNKEH 412
++F V H L + N +L Y +A +P+
Sbjct: 143 QKF--V---HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV----- 192
Query: 413 AQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
K + E + T K+DVWS G+L+ ELLT G P
Sbjct: 193 --------KWTALE-SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 36/230 (15%)
Query: 243 NDREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMV---VKRFRQ-MSNVGKEDFHE 298
+ + + ++LL A E LG G+FGS + V + +K +Q E+
Sbjct: 1 DKKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 59
Query: 299 HMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
+ L +P ++ LI + E +LV + G L L + + +
Sbjct: 60 EAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFL--VGKREE--IPVSNVAE 114
Query: 359 IIKGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM 417
++ V+ G+ YL K F V H L + NVLL N + ++D+ L + + +
Sbjct: 115 LLHQVSMGMKYLEEKNF--V---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169
Query: 418 -------VAYKSPE------FNQTDGVTRKTDVWSLGILILELLT-GKFP 453
+ + +PE F + ++DVWS G+ + E L+ G+ P
Sbjct: 170 RSAGKWPLKWYAPECINFRKF------SSRSDVWSYGVTMWEALSYGQKP 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 65/290 (22%), Positives = 107/290 (36%), Gaps = 46/290 (15%)
Query: 187 SKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDRE 246
I + + + +L K + D +N + + + +
Sbjct: 30 GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89
Query: 247 MFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMV----VKRFRQMSNVG-KEDFHEHMT 301
+ N EV+G G FG Y LL VK +++++G F
Sbjct: 90 IVHFN-------EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 302 RLGSLSHPNLLPLIAFYYRKEEKLL-VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKII 360
+ SHPN+L L+ R E L V ++ +G L N + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFG 198
Query: 361 KGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLDNA--------------YEPLLTDYALV 405
VAKG+ +L K+F V H L + N +LD Y+ ++
Sbjct: 199 LQVAKGMKFLASKKF--V---HRDLAARNCMLDEKFTVKVADFGLARDMYD---KEF--D 248
Query: 406 PIVNKEHAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
+ NK A+L V + + E + T K+DVWS G+L+ EL+T G P
Sbjct: 249 SVHNKTGAKLP-VKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 29/179 (16%), Positives = 49/179 (27%), Gaps = 28/179 (15%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN---------SFDGPMPSVGKLT-LRALYLSLNKFT 51
+ I S LP + + + SF L+ + + + +
Sbjct: 41 THLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYN-------LSKVTHIEIRNTRNL 93
Query: 52 GEIPSDAFAGMDQLKKVHLARNHFSGQIP--KSLAGLQKLLQLNLEGNSFQGKIPDFPLA 109
I DA + LK + + P + L + N + IP
Sbjct: 94 TYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
Query: 110 HLT----LLDLSYNQLVGRIPD---TLSNFDATSFQGNKGLCGKPLEACKSSISKKTIL 161
L L L N + + DA NK L +A S ++L
Sbjct: 153 GLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 30/123 (24%), Positives = 47/123 (38%), Gaps = 9/123 (7%)
Query: 7 IDVDTLSRLPGLRSLSFINN---SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGM- 62
ID D L LP L+ L N F L ++ N + IP +AF G+
Sbjct: 96 IDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155
Query: 63 DQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FP--LAHLTLLDLSY 118
++ + L N F+ + KL + L N + I F + +LLD+S
Sbjct: 156 NETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQ 214
Query: 119 NQL 121
+
Sbjct: 215 TSV 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 38/215 (17%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV----VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLP 313
+G G FG ++ + ++ +K + S+ +E F + + HP+++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YK 372
LI + ++ + G L + L VR+ LD + ++ LAYL K
Sbjct: 81 LIGV-ITENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK 135
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKS---------- 422
F V H + + NVL+ + L D+ L + YK+
Sbjct: 136 RF--V---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWM 184
Query: 423 -PE-FNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
PE N T +DVW G+ + E+L G P
Sbjct: 185 APESIN--FRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 55/227 (24%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVG--KEDFHEHMTRLGSLS-HPNLLPL 314
E++G+G++G YK + TG +K M G +E+ + + L S H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 315 IAFYYRK-----EEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK------IIKG 362
+ +K +++L LV +F GS+ +L+ + LK I +
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---------TLKEEWIAYICRE 137
Query: 363 VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK- 421
+ +GL++L++ V H +K NVLL E L D+ + AQL +
Sbjct: 138 ILRGLSHLHQH--KVI--HRDIKGQNVLLTENAEVKLVDFGVS-------AQLDRTVGRR 186
Query: 422 ----------SPE-----FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE N K+D+WSLGI +E+ G P
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 51/236 (21%), Positives = 82/236 (34%), Gaps = 63/236 (26%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLL 312
LG G+FG + A +V VK ++ S ++DF L L H +++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR----------LKIIKG 362
L+V +++ +G L L + L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 363 VAKGLAYL-YKEFPGVTLPHGHLKSSNVLLD--------------NAYEPLLTDY----- 402
VA G+ YL F V H L + N L+ + Y TDY
Sbjct: 167 VAAGMVYLAGLHF--V---HRDLATRNCLVGQGLVVKIGDFGMSRDIYS---TDYYRVGG 218
Query: 403 -ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
++PI + PE + T ++DVWS G+++ E+ T GK P
Sbjct: 219 RTMLPI-------------RWMPPE-SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 49/215 (22%), Positives = 80/215 (37%), Gaps = 38/215 (17%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV----VKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLLP 313
+LG G FG Y+ V VK ++ + KE F + +L HP+++
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL-YK 372
LI +E ++ + P G L + L R + + + K +AYL
Sbjct: 78 LIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKV--LTLVLYSLQICKAMAYLESI 132
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKS---------- 422
V H + N+L+ + L D+ L + E YK+
Sbjct: 133 NC--V---HRDIAVRNILVASPECVKLGDFGLSRYIEDED------YYKASVTRLPIKWM 181
Query: 423 -PE-FNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
PE N T +DVW + + E+L+ GK P
Sbjct: 182 SPESIN--FRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+ G G+FG+ TG ++ +K+ Q + M L L HPN++ L ++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSY 87
Query: 318 YYRKEEK-------LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
+Y E+ +V ++VP+ +L I++ + + + + L
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIGCL 145
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHMVA---YKSPE-- 424
+ V H +K NVL++ A L L D+ ++ + + Y++PE
Sbjct: 146 HLPSVNVC--HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELI 203
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGK--FP 453
F T D+WS+G + E++ G+ F
Sbjct: 204 FGNQH-YTTAVDIWSVGCIFAEMMLGEPIFR 233
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 29/125 (23%), Positives = 53/125 (42%), Gaps = 4/125 (3%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSF-DGPMPSVGKLT-LRALYLSLNKFTG-EIPSD 57
++ M+ + S++ L F NN D + G LT L L L +N+ ++
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDL 116
M L+++ +++N S K + + LL LN+ N I + +LDL
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDL 428
Query: 117 SYNQL 121
N++
Sbjct: 429 HSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 20/83 (24%), Positives = 34/83 (40%), Gaps = 2/83 (2%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
L +S N + E+ + + +L+ + ++ N Q+L L+L N
Sbjct: 22 KTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 99 FQGKIPDFPLAHLTLLDLSYNQL 121
KI P +L LDLS+N
Sbjct: 81 LV-KISCHPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 23/126 (18%), Positives = 45/126 (35%), Gaps = 9/126 (7%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
+ S + +++ + M K++ L S N T + + + +L+ +
Sbjct: 297 EIFSNMN-IKNFTVSGTRM-VHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETL 353
Query: 69 HLARNHFS--GQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP---LAHLTLLDLSYNQLVG 123
L N +I + ++ L QL++ NS L L++S N L
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413
Query: 124 RIPDTL 129
I L
Sbjct: 414 TIFRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 27/132 (20%), Positives = 51/132 (38%), Gaps = 10/132 (7%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVG---KLT-LRALYLSLNKFTGEIPSD 57
NL+ + L L +L N ++ L+ L +S N + +
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLD 115
+ L ++++ N + I + L ++ L+L N + IP L L L+
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450
Query: 116 LSYNQLVGRIPD 127
++ NQL +PD
Sbjct: 451 VASNQL-KSVPD 461
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 25/141 (17%), Positives = 42/141 (29%), Gaps = 3/141 (2%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFA 60
N + +D+ L L +N + L+ L LS N F F
Sbjct: 55 NRIQYLDISVFKFNQELEYLDLSHNKLVK-ISC-HPTVNLKHLDLSFNAFDALPICKEFG 112
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQ 120
M QLK + L+ H +A L L + G ++ K L L
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172
Query: 121 LVGRIPDTLSNFDATSFQGNK 141
+ + + + +
Sbjct: 173 PTNKEFHFILDVSVKTVANLE 193
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 19/100 (19%), Positives = 37/100 (37%), Gaps = 4/100 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAG 61
++ S L SL+ +N + ++ L L NK IP
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVV-K 442
Query: 62 MDQLKKVHLARNHFSGQIPK-SLAGLQKLLQLNLEGNSFQ 100
++ L+++++A N +P L L ++ L N +
Sbjct: 443 LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 54/265 (20%), Positives = 100/265 (37%), Gaps = 69/265 (26%)
Query: 226 YFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLL-----TGPAM 280
YF + + RE ++ LG GSFG Y+ V
Sbjct: 8 YFSAADVYVPDEWEV---AREKITMS-------RELGQGSFGMVYEGVAKGVVKDEPETR 57
Query: 281 V-VKRFRQMSNVG-KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLAN 338
V +K + +++ + +F + + + +++ L+ + + L++ + + G L +
Sbjct: 58 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 339 LLHVRR-----APGQPGLDWPIRLKIIKGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLD 392
L R P +++ +A G+AYL +F V H L + N ++
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF--V---HRDLAARNCMVA 172
Query: 393 --------------NAYEPLLTDY------ALVPIVNKEHAQLHMVAYK--SPEFNQTDG 430
+ YE TDY L+P+ + SPE + DG
Sbjct: 173 EDFTVKIGDFGMTRDIYE---TDYYRKGGKGLLPV-------------RWMSPE-SLKDG 215
Query: 431 V-TRKTDVWSLGILILELLT-GKFP 453
V T +DVWS G+++ E+ T + P
Sbjct: 216 VFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 51/237 (21%), Positives = 86/237 (36%), Gaps = 64/237 (27%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVGKEDFHEHMTRLGSLSHPNLL 312
LG G+FG + A +V VK + + ++DF L +L H +++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR-----------LKIIK 361
+ ++V +++ +G L L +D R L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 362 GVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLD--------------NAYEPLLTDY---- 402
+A G+ YL + F V H L + N L+ + Y TDY
Sbjct: 141 QIASGMVYLASQHF--V---HRDLATRNCLVGANLLVKIGDFGMSRDVYS---TDYYRVG 192
Query: 403 --ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
++PI + PE + T ++DVWS G+++ E+ T GK P
Sbjct: 193 GHTMLPI-------------RWMPPE-SIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 47/212 (22%), Positives = 79/212 (37%), Gaps = 35/212 (16%)
Query: 259 EVLGSGSFGSSYKAVLLT----GPAMV-VKRFRQMSNV-GKEDFHEHMTRLGSLSHPNLL 312
LG G FG V VK + S D + + L +L H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 313 PLIAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
L+ +F+P+GSL L + ++ +LK + KG+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142
Query: 371 -YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKS------- 422
+++ V H L + NVL+++ ++ + D+ L + + Y
Sbjct: 143 GSRQY--V---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-----YYTVKDDRDSP 192
Query: 423 -----PEFNQTDGVTRKTDVWSLGILILELLT 449
PE +DVWS G+ + ELLT
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 36/131 (27%), Positives = 56/131 (42%), Gaps = 11/131 (8%)
Query: 13 SRLPGLRSLSFINNSFDGPMPSVG-KLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
LP L +L +N +P +G L L L +S N+ T +P A G+ +L++++L
Sbjct: 74 GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--F-PLAHLTLLDLSYNQLVGRIPD 127
N P L KL +L+L N+ ++P L +L L L N L IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 128 TLSNFDATSFQ 138
F +
Sbjct: 190 GF--FGSHLLP 198
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 23/83 (27%), Positives = 31/83 (37%), Gaps = 6/83 (7%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
+ T +P D L HL+ N +L +L QLNL+
Sbjct: 12 HLEVNCDKRNLT-ALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 100 QGKIPDF-PLAHLTLLDLSYNQL 121
K+ L L LDLS+NQL
Sbjct: 68 T-KLQVDGTLPVLGTLDLSHNQL 89
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 25/96 (26%), Positives = 36/96 (37%), Gaps = 4/96 (4%)
Query: 7 IDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAFAGMDQ 64
+ + L L L+ L N P + L L L+ N T E+P+ G++
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLEN 173
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
L + L N IPK G L L GN +
Sbjct: 174 LDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 37/213 (17%), Positives = 71/213 (33%), Gaps = 41/213 (19%)
Query: 259 EVLGSGSFGSSYKAV--LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNL- 311
+ G G Y A+ + G +V+K + + G + L + HP++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKG---LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 312 ----------LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIK 361
Y +V ++V SL + L + +
Sbjct: 143 QIFNFVEHTDRHGDPVGY------IVMEYVGGQSLKRSKGQK-------LPVAEAIAYLL 189
Query: 362 GVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYK 421
+ L+YL+ G+ + LK N++L + L D V +N ++
Sbjct: 190 EILPALSYLHSI--GLV--YNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQ 244
Query: 422 SPEFNQ-TDGVTRKTDVWSLGILILELLTGKFP 453
+PE G T TD++++G + L
Sbjct: 245 APE--IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 31/151 (20%), Positives = 50/151 (33%), Gaps = 8/151 (5%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTG-EIPSDA 58
+I +T L L L N F + L L L L+ G + +
Sbjct: 65 TPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNSFQ----GKIPDFPLAHLTL 113
F + L+ + L N+ P S +++ L+L N + + +F H TL
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL 184
Query: 114 LDLSYNQLVGRIPDTLSNFDATSFQGNKGLC 144
L LS L L + N +
Sbjct: 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 22/87 (25%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKS-LAGLQKLLQLNLEGNS 98
L+ L + I ++ F G+ L + L N F Q+ GL L L L +
Sbjct: 56 LQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCN 114
Query: 99 FQG-KIPDF---PLAHLTLLDLSYNQL 121
G + PL L +L L N +
Sbjct: 115 LDGAVLSGNFFKPLTSLEMLVLRDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
L L L+ N+ +I +AF G+ L K++L++N + L KL L+L N
Sbjct: 300 DLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358
Query: 99 FQGKIPD--F-PLAHLTLLDLSYNQLVGRIPD 127
+ + D F L +L L L NQL +PD
Sbjct: 359 IRA-LGDQSFLGLPNLKELALDTNQLK-SVPD 388
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 29/146 (19%), Positives = 44/146 (30%), Gaps = 16/146 (10%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVG---KLT-LRALYLSLNKFTGEIPSD 57
N ++ + L L L+ + DG + S LT L L L N P+
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQK--LLQLNLEGNSFQ----GKIPDFP---- 107
F M + + L N + L Q L L + Q +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 108 --LAHLTLLDLSYNQLVGRIPDTLSN 131
+T LDLS N + +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFD 234
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 23/103 (22%), Positives = 34/103 (33%), Gaps = 17/103 (16%)
Query: 7 IDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLT-LRALYLSLNKFTGEIPSD 57
ID + L L L+ N F+ L L L LS N +
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN-------LDKLEVLDLSYNHIR-ALGDQ 365
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
+F G+ LK++ L N L L ++ L N +
Sbjct: 366 SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 31/133 (23%), Positives = 49/133 (36%), Gaps = 21/133 (15%)
Query: 14 RLPGLRSLSFINNSFDGPMPSV-----GKLTLRALYLSLNKFTG---------EIPSDAF 59
+ + +L N F M +++L LS + G + + F
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 60 AGMD--QLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--F-PLAHLTLL 114
G++ +K L+++ + + L QL L N KI D F L HL L
Sbjct: 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 115 DLSYNQLVGRIPD 127
+LS N L G I
Sbjct: 329 NLSQNFL-GSIDS 340
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 35/286 (12%)
Query: 183 RGNNSKTSEPIIVNETQETKALKKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKLHFVN 242
+ + + P+++ + + + SS+ + V
Sbjct: 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 243 NDREMFELN-DLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHM 300
+ + D+ E LG+G+FG ++ TG K KE + +
Sbjct: 150 IKHDHVLDHYDIH----EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 205
Query: 301 TRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL-------ANLLHVRRAPGQPGLDW 353
+ L HP L+ L + E +++ +F+ G L N + A
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA-------- 257
Query: 354 PIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL--TDYALVPIVNKE 411
++ ++ V KGL ++++ H LK N++ L D+ L +
Sbjct: 258 ---VEYMRQVCKGLCHMHEN--NYV--HLDLKPENIMFTTKRSNELKLIDFGLTAHL-DP 309
Query: 412 HAQLHMVA----YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ + + +PE + V TD+WS+G+L LL+G P
Sbjct: 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 36/229 (15%), Positives = 68/229 (29%), Gaps = 50/229 (21%)
Query: 260 VLGSGSFGSSY---------------KAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTR-- 302
L G F K++L ++S K +
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY---DDFKNEL 94
Query: 303 --LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVR---RAPGQPGLDWPIRL 357
+ + + L +E ++ +++ N S+ + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 358 KIIKGVAKGLAYLYKEFPGVTLPHGH-------LKSSNVLLDNAYEPLLTDYALVPIVNK 410
IIK V +Y+ H +K SN+L+D L+D+
Sbjct: 155 CIIKSVLNSFSYI----------HNEKNICHRDVKPSNILMDKNGRVKLSDFGES--EYM 202
Query: 411 EHAQLHMV----AYKSPEF--NQTDGVTRKTDVWSLGILILELLTGKFP 453
++ + PEF N++ K D+WSLGI + + P
Sbjct: 203 VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 25/125 (20%), Positives = 45/125 (36%), Gaps = 5/125 (4%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
L L+SL S+ L L++L + + + + A + +L+++
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALG-PAIHHLPKLEEL 234
Query: 69 HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126
L P G L +L L+ S +P L L LDL + R+P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 127 DTLSN 131
++
Sbjct: 295 SLIAQ 299
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 26/131 (19%), Positives = 53/131 (40%), Gaps = 16/131 (12%)
Query: 13 SRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLA 71
+ PG +L + +L+ L+ + + E+P D L+ + LA
Sbjct: 78 ATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELP-DTMQQFAGLETLTLA 135
Query: 72 RNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD-----------FPLAHLTLLDLSYNQ 120
RN +P S+A L +L +L++ ++P+ L +L L L +
Sbjct: 136 RNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
Query: 121 LVGRIPDTLSN 131
+ +P +++N
Sbjct: 195 IR-SLPASIAN 204
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 25/128 (19%), Positives = 45/128 (35%), Gaps = 4/128 (3%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKV 68
+++ L L+SL N+ P++ L L L L P F G LK++
Sbjct: 200 ASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPI-FGGRAPLKRL 258
Query: 69 HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP--LAHLTLLDLSYNQLVGRIP 126
L +P + L +L +L+L G ++P L ++ + +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
Query: 127 DTLSNFDA 134
A
Sbjct: 319 HRPVARPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 19/105 (18%), Positives = 37/105 (35%), Gaps = 6/105 (5%)
Query: 38 LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN 97
AL L + P D + L+ + + ++P ++ L L L N
Sbjct: 81 PGRVALELRSVPLP-QFP-DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARN 137
Query: 98 SFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGN 140
+ +P L L L + + +P+ L++ DA+
Sbjct: 138 PLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 46/209 (22%), Positives = 78/209 (37%), Gaps = 28/209 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV-VKRFR-QMSNVGKEDFHEHMTR----LGSLSHPNLL 312
++G G G Y+A +V +K +S+ F M R G L P++
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS--DPVFRTRMQREARTAGRLQEPHV- 96
Query: 313 PLIAFYYRKEEK---LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
+ + E + + LA +L R+ P L P + I++ + L
Sbjct: 97 --VPIHDFGEIDGQLYVDMRLINGVDLAAMLR-RQGP----LAPPRAVAIVRQIGSALDA 149
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA-QLHMV----AYKSPE 424
+ G T H +K N+L+ L D+ + E QL Y +PE
Sbjct: 150 AHAA--GAT--HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP 453
T + D+++L ++ E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 38/230 (16%), Positives = 80/230 (34%), Gaps = 47/230 (20%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTR-----LGSLSHPNLLP 313
++LG GS G+ G + VKR DF + S HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIR 73
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR--LKIIKGVAKGLAYLY 371
+ + N +L +L+ + + + +++ +A G+A+L+
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEP-------------LLTDYALVPIVNKEHAQLHMV 418
+ H LK N+L+ + L++D+ L ++ +
Sbjct: 133 SL--KII--HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 419 A--------YKSPE-------FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+++PE +TR D++S+G + +L+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 25/200 (12%), Positives = 62/200 (31%), Gaps = 40/200 (20%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
G ++A+ + + V +D + L + P +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDP-QGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
++ + + L+V++++ GSL + +P ++ ++ +A ++
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-------AIRAMQSLAAAADAAHRA 148
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTR 433
GV S V + + +L A +P
Sbjct: 149 --GV--ALSIDHPSRVRVSIDGDVVLAYPATMP-----------------------DANP 181
Query: 434 KTDVWSLGILILELLTGKFP 453
+ D+ +G + LL ++P
Sbjct: 182 QDDIRGIGASLYALLVNRWP 201
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 31/172 (18%), Positives = 66/172 (38%), Gaps = 44/172 (25%)
Query: 305 SLSHPNL----------LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWP 354
+L+HP + P Y +V ++V +L +++H +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPY------IVMEYVDGVTLRDIVHTEGP-----MTPK 116
Query: 355 IRLKIIKGVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIV 408
+++I + L + H + +K +N+++ + D+ + +
Sbjct: 117 RAIEVIADACQALNF----------SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166
Query: 409 NKEHAQLHM-------VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ Y SPE + D V ++DV+SLG ++ E+LTG+ P
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+V+G+GSFG Y+A L +G + +K+ Q + E + L H N++ L F
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQI-MRKLDHCNIVRLRYF 115
Query: 318 YYRKEEKL------LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+Y EK LV D+VP ++ + Q ++L + + + LAY+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 172
Query: 372 KEFPGVTLPHGH------LKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHMVA---YK 421
H +K N+LLD L L D+ + + + + Y+
Sbjct: 173 ---------HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 422 SPE--FNQTDGVTRKTDVWSLGILILELLTGK--FP 453
+PE F TD T DVWS G ++ ELL G+ FP
Sbjct: 224 APELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFP 258
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 22/125 (17%), Positives = 42/125 (33%), Gaps = 12/125 (9%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
+ L L+ + NNS L + N+ E+P + L
Sbjct: 145 KLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE--FIAAGNNQLE-ELPE--LQNLPFLTA 199
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP-LAHLTLLDLSYNQLVGRIP 126
++ N ++P L+ + N + ++P+ L LT + N L +P
Sbjct: 200 IYADNNSLK-KLPDLPLSLESI---VAGNNILE-ELPELQNLPFLTTIYADNNLLK-TLP 253
Query: 127 DTLSN 131
D +
Sbjct: 254 DLPPS 258
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 22/123 (17%), Positives = 43/123 (34%), Gaps = 15/123 (12%)
Query: 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVH 69
+ L L + + P L L +S N+ ++P LK +
Sbjct: 108 ELPQSLKSLLVDNNNLKALSDLPPL-----LEYLGVSNNQLE-KLPE--LQNSSFLKIID 159
Query: 70 LARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP-LAHLTLLDLSYNQLVGRIPDT 128
+ N ++P L+ + N + ++P+ L LT + N L ++PD
Sbjct: 160 VDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPDL 213
Query: 129 LSN 131
+
Sbjct: 214 PLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 26/125 (20%), Positives = 45/125 (36%), Gaps = 16/125 (12%)
Query: 12 LSRLPG----LRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
L +LP L ++ NN + P + L L A+Y N ++P L+
Sbjct: 165 LKKLPDLPPSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLK-KLPD----LPLSLE 218
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP 126
+ N L L L + + N + +PD L L++ N L +P
Sbjct: 219 SIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDL-PPSLEALNVRDNYLT-DLP 273
Query: 127 DTLSN 131
+ +
Sbjct: 274 ELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 19/137 (13%), Positives = 43/137 (31%), Gaps = 25/137 (18%)
Query: 12 LSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLA 71
R + + + L L+ + +P L+ + +
Sbjct: 46 WERNAPPGNGEQREMAV-SRLRDCLDRQAHELELNNLGLS-SLPEL----PPHLESLVAS 99
Query: 72 RNHFSGQIPKSLAGLQKLLQLNLEGNSFQG----------------KIPDFP-LAHLTLL 114
N + ++P+ L+ LL N + K+P+ + L ++
Sbjct: 100 CNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKII 158
Query: 115 DLSYNQLVGRIPDTLSN 131
D+ N L ++PD +
Sbjct: 159 DVDNNSLK-KLPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 13/108 (12%)
Query: 15 LPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARN 73
P L SL NS L L +L + P L+ + ++ N
Sbjct: 90 PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPPL--------LEYLGVSNN 141
Query: 74 HFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
++P L L ++++ NS + K+PD L + NQL
Sbjct: 142 QLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDL-PPSLEFIAAGNNQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 22/130 (16%), Positives = 44/130 (33%), Gaps = 20/130 (15%)
Query: 15 LPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPS------------DAFAG 61
P L +L+ +N LT L + + P+
Sbjct: 256 PPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDL 315
Query: 62 MDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
L++++++ N ++P L++L N ++P+ +L L + YN L
Sbjct: 316 PPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL-PQNLKQLHVEYNPL 369
Query: 122 VGRIPDTLSN 131
PD +
Sbjct: 370 R-EFPDIPES 378
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 25/119 (21%), Positives = 41/119 (34%), Gaps = 15/119 (12%)
Query: 13 SRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLAR 72
P L L+ NN +L L S N E+P LK++H+
Sbjct: 314 DLPPSLEELNVSNNKLIELPALPPRLE--RLIASFNHLA-EVPE----LPQNLKQLHVEY 366
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN 131
N + P ++ L + ++P+ P +L L + N L PD +
Sbjct: 367 NPLR-EFPDIPESVEDLRMNSH-----LAEVPELP-QNLKQLHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 13/101 (12%), Positives = 32/101 (31%), Gaps = 12/101 (11%)
Query: 31 PMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90
+V L+ + T E+P +A + + + A + + P +++
Sbjct: 4 NPRNVSNTFLQEPLRHSSNLT-EMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 91 QLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN 131
+ D L+L+ L +P+ +
Sbjct: 62 VSR---------LRDCLDRQAHELELNNLGLS-SLPELPPH 92
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 31/209 (14%)
Query: 259 EVLGSGSFGSSYKAVLL----TGPAMV-VKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLL 312
LG G FG MV VK + + + + + + L +L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 313 PLIAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
LV ++VP GSL + L + L + + +G+AYL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYL 150
Query: 371 -YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN--------KEHAQLHMVAYK 421
+ + + H L + NVLLDN + D+ L V +E V +
Sbjct: 151 HAQHY--I---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-VFWY 204
Query: 422 SPEFNQTDGV-TRKTDVWSLGILILELLT 449
+PE + +DVWS G+ + ELLT
Sbjct: 205 APE-CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 27/134 (20%), Positives = 44/134 (32%), Gaps = 21/134 (15%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTGE 53
N + + + S L L+ L + TL+ L ++ N
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL------KTLKELNVAHNLIQSF 139
Query: 54 IPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKL----LQLNLEGNSFQGKIPD--FP 107
+ F+ + L+ + L+ N L L ++ L L+L N I F
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 108 LAHLTLLDLSYNQL 121
L L L NQL
Sbjct: 199 EIRLKELALDTNQL 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 21/93 (22%), Positives = 32/93 (34%), Gaps = 8/93 (8%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGN 97
+ + L LS N + S +F +L+ + L+R I L L L L GN
Sbjct: 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 98 ---SFQGKIPDFPLAHLTLLDLSYNQLVGRIPD 127
S L+ L L L + +
Sbjct: 87 PIQSLALGAFS-GLSSLQKLVAVETNLA-SLEN 117
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 23/99 (23%), Positives = 34/99 (34%), Gaps = 12/99 (12%)
Query: 10 DTLSRLPGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAG 61
+ S L L L +N + + L L L LSLN I AF
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRV-LHQMPLLNLS-LDLSLNPMN-FIQPGAFKE 199
Query: 62 MDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
+ +LK++ L N L L ++ L N +
Sbjct: 200 I-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 54/246 (21%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVG-KEDFH---EHMTRLGSLSH 308
+ LG+G+FG +A V VK + +++ +E + ++ LG+ H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--H 86
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG------ 362
N++ L+ L+++++ G L N L +R P ++ +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 363 -------VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL 415
VAKG+A+L H L + N+LL + + D+ L + +
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCI--HRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199
Query: 416 HMVAYK------------SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFPANYLAQGK 461
Y +PE + + V T ++DVWS GI + EL + G P Y G
Sbjct: 200 ---NYVVKGNARLPVKWMAPE-SIFNCVYTFESDVWSYGIFLWELFSLGSSP--Y--PGM 251
Query: 462 GANADL 467
++
Sbjct: 252 PVDSKF 257
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 31/163 (19%), Positives = 65/163 (39%), Gaps = 32/163 (19%)
Query: 305 SLSHPNLLPLIAFY-YRKEEKL--LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIK 361
LSH N+ ++ +E+ LV +++ +L+ + L +
Sbjct: 67 QLSHQNI---VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINFTN 118
Query: 362 GVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEH--- 412
+ G+ + H +K N+L+D+ + D+ + +++
Sbjct: 119 QILDGIKH----------AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168
Query: 413 --AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
L V Y SPE + + TD++S+GI++ E+L G+ P
Sbjct: 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 59/224 (26%)
Query: 260 VLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPN 310
+LG GSF + V+L T +K + ++ KE+ ++TR + L HP
Sbjct: 37 ILGEGSFST----VVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 311 LLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK---- 365
+ L F ++ +EKL + NG L L ++R+ + +
Sbjct: 92 FVKLY-FTFQDDEKLYFGLSYAKNGEL--LKYIRKIG-----------SFDETCTRFYTA 137
Query: 366 ----GLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL 415
L YL HG LK N+LL+ +TD+ +++ E Q
Sbjct: 138 EIVSALEYL----------HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 416 HM------VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y SPE + +D+W+LG +I +L+ G P
Sbjct: 188 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 15/102 (14%)
Query: 25 NNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83
+ +F LT LR LYL+ NK +P+ F + L+ + + N +P +
Sbjct: 54 SKAFHR-------LTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGV 104
Query: 84 -AGLQKLLQLNLEGNSFQGKIPD--FP-LAHLTLLDLSYNQL 121
L L +L L+ N + +P F L LT L L YN+L
Sbjct: 105 FDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 36/133 (27%), Positives = 50/133 (37%), Gaps = 23/133 (17%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNS--------FDGPMPSVGKLT-LRALYLSLNKFTG 52
N + + RL LR L +N F L L L+++ NK
Sbjct: 47 NKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKE-------LKNLETLWVTDNKLQ- 98
Query: 53 EIPSDAFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNSFQGKIPD--F-PL 108
+P F + L ++ L RN +P + L KL L+L N Q +P F L
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 109 AHLTLLDLSYNQL 121
L L L NQL
Sbjct: 157 TSLKELRLYNNQL 169
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 31/127 (24%), Positives = 47/127 (37%), Gaps = 21/127 (16%)
Query: 7 IDVDTLSRLPGLRSLSFINNS--------FDGPMPSVGKLTLRALYLSLNKFTGEIPSDA 58
+ L L +L +N FD + L L L N+ +P
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLV------NLAELRLDRNQLK-SLPPRV 128
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNSFQGKIPD--F-PLAHLTLL 114
F + +L + L N +PK + L L +L L N + ++P+ F L L L
Sbjct: 129 FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTL 186
Query: 115 DLSYNQL 121
L NQL
Sbjct: 187 KLDNNQL 193
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 23/126 (18%)
Query: 7 IDVDTLSRLPGLRSLSFINNS--------FDGPMPSVGKLT-LRALYLSLNKFTGEIPSD 57
+ + +L L L N FD LT L L L N+ +P
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFD-------SLTKLTYLSLGYNELQ-SLPKG 151
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNSFQGKIPDF---PLAHLTL 113
F + LK++ L N ++P+ L +L L L+ N + ++P+ L L +
Sbjct: 152 VFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKM 209
Query: 114 LDLSYN 119
L L N
Sbjct: 210 LQLQEN 215
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 4/84 (4%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGN 97
+AL LS N + E+ + + +L+ + L+ N + + Q L L++ N
Sbjct: 53 RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110
Query: 98 SFQGKIPDFPLAHLTLLDLSYNQL 121
Q I P+A L LDLS+N
Sbjct: 111 RLQ-NISCCPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 22/113 (19%), Positives = 42/113 (37%), Gaps = 7/113 (6%)
Query: 24 INNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS--GQIP 80
I+++ M + L + N FT + + + +L+ + L RN ++
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLKNFFKVA 396
Query: 81 KSLAGLQKLLQLNLEGNSFQGKIPDFP---LAHLTLLDLSYNQLVGRIPDTLS 130
+ L L++ NS D + +L+LS N L G + L
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 30/132 (22%), Positives = 48/132 (36%), Gaps = 10/132 (7%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT----LRALYLSLNKFTGEIPSD 57
N+ S L L++L N L L +SLN
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLD 115
A + + ++L+ N +G + + L K+ L+L N IP L L L+
Sbjct: 423 TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479
Query: 116 LSYNQLVGRIPD 127
++ NQL +PD
Sbjct: 480 VASNQLK-SVPD 490
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 24/123 (19%), Positives = 43/123 (34%), Gaps = 5/123 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFA 60
N + +D L L +N + + LR L LS N F F
Sbjct: 86 NRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISC-CPMASLRHLDLSFNDFDVLPVCKEFG 143
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQ-KLLQLNLEGNSFQGKIPD-FPLAHLTLLDLSY 118
+ +L + L+ F +A L + L+L +G + + + T+L L +
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
Query: 119 NQL 121
+
Sbjct: 204 HPN 206
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 49/238 (20%), Positives = 83/238 (34%), Gaps = 65/238 (27%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVG-KEDFHEHMTRLGSLSHPNL 311
E LG FG YK L V +K + + +E+F L HPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR-----------LKII 360
+ L+ + + ++ + +G L L +R G R + ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 361 KGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLD--------------NAYEPLLTDY--- 402
+A G+ YL V H L + NVL+ Y DY
Sbjct: 135 AQIAAGMEYLSSHHV--V---HKDLATRNVLVYDKLNVKISDLGLFREVYA---ADYYKL 186
Query: 403 ---ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
+L+PI + +PE G + +D+WS G+++ E+ + G P
Sbjct: 187 LGNSLLPI-------------RWMAPE-AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 45/208 (21%), Positives = 84/208 (40%), Gaps = 28/208 (13%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E LGSG+FG ++ V TG V K + K ++ + L HP L+ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 318 YYRKEEKLLVSDFVPNGSL-------ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
+ K E +L+ +F+ G L + + ++ +GL ++
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV-----------INYMRQACEGLKHM 165
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLL--TDYALVPIVNKEHAQLHMVA---YKSPEF 425
++ + H +K N++ + + D+ L +N + A + +PE
Sbjct: 166 HEH--SIV--HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ V TD+W++G+L LL+G P
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 39/214 (18%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+ LGSG++G +T +K R +S E + L L HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------IIKGVAKG 366
F+ K LV + G L D I IIK V G
Sbjct: 103 DFFEDKRNYYLVMECYKGGEL--------------FDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMV---AY 420
+ YL+K + H LK N+LL++ + + + D+ L + + + Y
Sbjct: 149 VTYLHKH--NIV--HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYY 204
Query: 421 KSPE-FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE + K DVWS+G+++ LL G P
Sbjct: 205 IAPEVLRK--KYDEKCDVWSIGVILFILLAGYPP 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 58/232 (25%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMV---VKRFRQMSNVG-KEDFHEHMTRLGSL-SHPNLLP 313
+V+G G+FG KA + + +KR ++ ++ DF + L L HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR-----------LKIIKG 362
L+ + L ++ P+G+L + L R L
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 363 VAKGLAYLY-KEFPGVTLPHGHLKSSNVLL----------------DNAYEPLLTDYALV 405
VA+G+ YL K+F + H L + N+L+ Y +
Sbjct: 151 VARGMDYLSQKQF--I---HRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRL 203
Query: 406 PIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFP 453
P+ + + E + V T +DVWS G+L+ E+++ G P
Sbjct: 204 PV-------------RWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 57/243 (23%), Positives = 96/243 (39%), Gaps = 52/243 (21%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVG-KEDFH---EHMTRLGSLSH 308
+ LG+G+FG +A V VK + ++ KE + M+ LG H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ--H 109
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR---------LKI 359
N++ L+ L+++++ G L N L + + + I L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 360 IKGVAKGLAYLY-KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV 418
VA+G+A+L K + H + + NVLL N + + D+ L + +
Sbjct: 170 SSQVAQGMAFLASKNC--I---HRDVAARNVLLTNGHVAKIGDFGLARDIMNDS------ 218
Query: 419 AYK------------SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFPANYLAQGKGAN 464
Y +PE + D V T ++DVWS GIL+ E+ + G P Y G N
Sbjct: 219 NYIVKGNARLPVKWMAPE-SIFDCVYTVQSDVWSYGILLWEIFSLGLNP--Y--PGILVN 273
Query: 465 ADL 467
+
Sbjct: 274 SKF 276
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 33/113 (29%), Positives = 49/113 (43%), Gaps = 16/113 (14%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98
T+ + L N IP AF+ +L+++ L+ N S P + GL+ L L L GN
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN- 90
Query: 99 FQGKIPDFP------LAHLTLLDLSYNQLVGRIP----DTLSNFDATSFQGNK 141
KI + P L L LL L+ N++ + L N + S NK
Sbjct: 91 ---KITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 7/86 (8%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL-AGLQKLLQLNLEGNS 98
LR + LS N+ + E+ DAF G+ L + L N + ++PKSL GL L L L N
Sbjct: 58 LRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK 115
Query: 99 FQGKIPDF---PLAHLTLLDLSYNQL 121
+ L +L LL L N+L
Sbjct: 116 IN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 23/102 (22%), Positives = 36/102 (35%), Gaps = 17/102 (16%)
Query: 7 IDVDTLSRLPGLRSLSFINNS--------FDGPMPSVGKLT-LRALYLSLNKFTGEIPSD 57
+ D L L SL N F+ L L+ L L+ NK + D
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKITELPKSLFE-------GLFSLQLLLLNANKIN-CLRVD 122
Query: 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
AF + L + L N + + L+ + ++L N F
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 53/223 (23%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPL 314
+V+G+GSFG ++A L+ + +K+ Q R + + HPN++ L
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVDL 97
Query: 315 IAFYY-----RKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG----VA 364
AF+Y + E L LV ++VP ++ Q + + +IK +
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQ-----TMPMLLIKLYMYQLL 151
Query: 365 KGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHM 417
+ LAY+ H +K N+LLD L L D+ I+ +
Sbjct: 152 RSLAYI----------HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 418 VA---YKSPE--FNQTDGVTRKTDVWSLGILILELLTGK--FP 453
+ Y++PE F T+ T D+WS G ++ EL+ G+ FP
Sbjct: 202 ICSRYYRAPELIFGATN-YTTNIDIWSTGCVMAELMQGQPLFP 243
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 50/246 (20%), Positives = 84/246 (34%), Gaps = 73/246 (29%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQM-SNVGKEDFHEHMTRLGSLSHPNL 311
+G G+FG ++A MV VK ++ S + DF + +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR--------------- 356
+ L+ + L+ +++ G L L L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 357 ----LKIIKGVAKGLAYL-YKEFPGVTLPHGHLKSSNVLLD--------------NAYEP 397
L I + VA G+AYL ++F V H L + N L+ N Y
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF--V---HRDLATRNCLVGENMVVKIADFGLSRNIYS- 226
Query: 398 LLTDY------ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELL 448
DY +PI + PE + T ++DVW+ G+++ E+
Sbjct: 227 --ADYYKADGNDAIPI-------------RWMPPE-SIFYNRYTTESDVWAYGVVLWEIF 270
Query: 449 T-GKFP 453
+ G P
Sbjct: 271 SYGLQP 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 70/360 (19%), Positives = 115/360 (31%), Gaps = 114/360 (31%)
Query: 259 EVLGSGSFGSSYKAVLL-------TGPAMV-VKRFRQMSNVG-KEDF---HEHMTRLGSL 306
+ LG G+FG A + V VK + + D E M +G
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK- 133
Query: 307 SHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR---------- 356
H N++ L+ + ++ ++ G+L L RR PG P
Sbjct: 134 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 357 -LKIIKGVAKGLAYLY-KEFPGVTLPHGHLKSSNVLLD--------------NAYEPLLT 400
+ VA+G+ YL K+ + H L + NVL+ + +
Sbjct: 193 LVSCAYQVARGMEYLASKKC--I---HRDLAARNVLVTEDNVMKIADFGLARDIHH---I 244
Query: 401 DY------ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-G 450
DY +P+ K +PE D + T ++DVWS G+L+ E+ T G
Sbjct: 245 DYYKKTTNGRLPV-------------KWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLG 290
Query: 451 KFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLK-------LLK 503
P Y G E+F G M K L
Sbjct: 291 GSP--Y--PGVPVE-----------------ELFKLLKEG-----HRMDKPSNCTNELYM 324
Query: 504 IGMCCC-EWNAERR---WDLREAVEKIMELKERDNDNEDYSSYASEDYVYSSRAMTDEDF 559
+ M C +R L E +++I+ N++ Y + T+ +
Sbjct: 325 M-MRDCWHAVPSQRPTFKQLVEDLDRIVA----LTSNQEMGYYHHHHHHDYDIPTTENLY 379
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 23/124 (18%), Positives = 43/124 (34%), Gaps = 19/124 (15%)
Query: 16 PGLRSLSFINN--------SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L F+ +F G L + +S N I +D F+ + +L +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSG-FGD-----LEKIEISQNDVLEVIEADVFSNLPKLHE 83
Query: 68 VHLAR-NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLDLSYNQLVG 123
+ + + N+ P++ L L L + + +PD LLD+ N +
Sbjct: 84 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIH 142
Query: 124 RIPD 127
I
Sbjct: 143 TIER 146
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 27/132 (20%), Positives = 48/132 (36%), Gaps = 19/132 (14%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINN--SFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAF 59
N + I+ + LP L+ L N + + L L + N I ++F
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 60 AGM-DQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN---------SFQGKIPDFPLA 109
G+ + + L +N +I S +L +LNL N F G +
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG------AS 202
Query: 110 HLTLLDLSYNQL 121
+LD+S ++
Sbjct: 203 GPVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 26/116 (22%), Positives = 38/116 (32%), Gaps = 6/116 (5%)
Query: 7 IDVDTLSRLPG-LRSLSFINNSFDGPMPSV-GKLTLRALYLSLNKFTGEIPSDAFAGMDQ 64
I+ ++ L L N S L L LS N E+P+D F G
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG 203
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYN 119
+ ++R L L+KL + K+P L L L+Y
Sbjct: 204 PVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYP 256
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 52/266 (19%), Positives = 88/266 (33%), Gaps = 65/266 (24%)
Query: 230 SQNDEISKLHFVNNDREMFELNDLLRASA--------------EVLGSGSFGSSYKAV-L 274
+ N EI+ + ++F DL + LGSG+ G A
Sbjct: 101 NNNSEIA---LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER 157
Query: 275 LTGPAMVVKRFRQMSNVGKEDFHEHMTR--------LGSLSHPNLLPLIAFYYRKEEKL- 325
T + ++ + L L+HP ++ + F+ E
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYY 215
Query: 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------IIKGVAKGLAYLYKEFPG 376
+V + + G L D + K + + YL++ G
Sbjct: 216 IVLELMEGGEL--------------FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN--G 259
Query: 377 VTLPHGHLKSSNVLLDNAYEPL---LTDYALVPIVNKEHAQLHMV---AYKSPE---FNQ 427
+ H LK NVLL + E +TD+ I+ + + Y +PE
Sbjct: 260 II--HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 317
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP 453
T G R D WSLG+++ L+G P
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 31/191 (16%), Positives = 65/191 (34%), Gaps = 34/191 (17%)
Query: 287 QMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAP 346
S + + R+ S N + + K + +L + ++ R +
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 347 GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLT 400
+ + L I +A+ + +L H LK SN+ +
Sbjct: 159 EDR--EHGVCLHIFIQIAEAVEFL----------HSKGLMHRDLKPSNIFFTMDDVVKVG 206
Query: 401 DYALVPIVNKEHAQLHMVA----------------YKSPEFNQTDGVTRKTDVWSLGILI 444
D+ LV ++++ + ++ Y SPE + + K D++SLG+++
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266
Query: 445 LELLTGKFPAN 455
ELL
Sbjct: 267 FELLYSFSTQM 277
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 52/243 (21%), Positives = 85/243 (34%), Gaps = 72/243 (29%)
Query: 259 EVLGSGSFGSSYKAVLL-------TGPAMV-VKRFRQMSNVG-KEDF---HEHMTRLGSL 306
+ LG G+FG A + V VK + + D E M +G
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 99
Query: 307 SHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR---------- 356
H N++ L+ + ++ ++ G+L L RR PG R
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 357 -LKIIKGVAKGLAYLY-KEFPGVTLPHGHLKSSNVLLD--------------NAYEPLLT 400
+ +A+G+ YL ++ + H L + NVL+ +
Sbjct: 159 LVSCTYQLARGMEYLASQKC--I---HRDLAARNVLVTENNVMKIADFGLARDINN---I 210
Query: 401 DY------ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-G 450
DY +P+ K +PE D V T ++DVWS G+L+ E+ T G
Sbjct: 211 DYYKKTTNGRLPV-------------KWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 451 KFP 453
P
Sbjct: 257 GSP 259
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 58/216 (26%), Positives = 84/216 (38%), Gaps = 42/216 (19%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
VLG GSFG +TG VK + K D E + R L L HPN++
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-KESLLREVQLLKQLDHPNIMK 90
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------IIKGVA 364
L F+ K LV + G L D I K II+ V
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGEL--------------FDEIISRKRFSEVDAARIIRQVL 136
Query: 365 KGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMV--- 418
G+ Y++K + H LK N+LL++ + + + D+ L +
Sbjct: 137 SGITYMHKN--KIV--HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 192
Query: 419 AYKSPE-FNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE + T K DVWS G+++ LL+G P
Sbjct: 193 YYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPP 226
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 52/243 (21%), Positives = 84/243 (34%), Gaps = 72/243 (29%)
Query: 259 EVLGSGSFGSSYKAVLL-------TGPAMV-VKRFRQMSNVG-KEDFH---EHMTRLGSL 306
+ LG G FG A + V VK + + D E M +G
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 145
Query: 307 SHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR---------- 356
H N++ L+ + ++ ++ G+L L RR PG R
Sbjct: 146 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 357 -LKIIKGVAKGLAYLY-KEFPGVTLPHGHLKSSNVLLD--------------NAYEPLLT 400
+ +A+G+ YL ++ + H L + NVL+ +
Sbjct: 205 LVSCTYQLARGMEYLASQKC--I---HRDLAARNVLVTENNVMKIADFGLARDINN---I 256
Query: 401 DY------ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-G 450
DY +P+ K +PE D V T ++DVWS G+L+ E+ T G
Sbjct: 257 DYYKKTTNGRLPV-------------KWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLG 302
Query: 451 KFP 453
P
Sbjct: 303 GSP 305
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 22/109 (20%), Positives = 43/109 (39%), Gaps = 15/109 (13%)
Query: 43 LYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGK 102
L L+ N+FT + F + QL+K++ + N + + G + ++ L N +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN----R 92
Query: 103 IPDFP------LAHLTLLDLSYNQLVGRIP----DTLSNFDATSFQGNK 141
+ + L L L L N++ + LS+ S N+
Sbjct: 93 LENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 10/99 (10%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
LR + S NK T +I AF G + ++ L N K GL+ L L L N
Sbjct: 59 LRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI 117
Query: 100 QGKIPD--F-PLAHLTLLDLSYNQLVGRIP----DTLSN 131
+ + F L+ + LL L NQ+ + DTL +
Sbjct: 118 T-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 23/104 (22%), Positives = 39/104 (37%), Gaps = 19/104 (18%)
Query: 7 IDVDTLSRLPGLRSLSFINNS--------FDGPMPSVGKLT-LRALYLSLNKFTGEIPSD 57
I+ G+ + +N F G L L+ L L N+ T + +D
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLENVQHKMFKG-------LESLKTLMLRSNRIT-CVGND 123
Query: 58 AFAGMDQLKKVHLARNHFSGQIPK-SLAGLQKLLQLNLEGNSFQ 100
+F G+ ++ + L N + + + L L LNL N F
Sbjct: 124 SFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 51/246 (20%), Positives = 85/246 (34%), Gaps = 73/246 (29%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVG-KEDFHEHMTRLGSLSHPNL 311
+ LG G FG KA G V VK ++ ++ D L ++HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG--------- 362
+ L + LL+ ++ GSL L R G L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 363 ----------VAKGLAYLY-KEFPGVTLPHGHLKSSNVLLD--------------NAYEP 397
+++G+ YL + V H L + N+L+ + YE
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKL--V---HRDLAARNILVAEGRKMKISDFGLSRDVYE- 202
Query: 398 LLTDY------ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELL 448
D +P+ K + E + D + T ++DVWS G+L+ E++
Sbjct: 203 --EDSYVKRSQGRIPV-------------KWMAIE-SLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 449 T-GKFP 453
T G P
Sbjct: 247 TLGGNP 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 51/256 (19%), Positives = 91/256 (35%), Gaps = 75/256 (29%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVG-KEDFH---EHMTRLGSLSH 308
+ LG G+FG +A V VK ++ + + + +G H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG--HH 90
Query: 309 PNLLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIR----------- 356
N++ L+ + L ++ +F G+L+ L +R P P
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 357 LKIIKGVAKGLAYLY-KEFPGVTLPHGHLKSSNVLLD--------------NAYEPLLTD 401
+ VAKG+ +L ++ + H L + N+LL + Y+
Sbjct: 151 ICYSFQVAKGMEFLASRKC--I---HRDLAARNILLSEKNVVKICDFGLARDIYK---DP 202
Query: 402 Y------ALVPIVNKEHAQLHMVAYK--SPEFNQTDGV-TRKTDVWSLGILILELLT-GK 451
A +P+ K +PE D V T ++DVWS G+L+ E+ + G
Sbjct: 203 DYVRKGDARLPL-------------KWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 452 FPANYLAQGKGANADL 467
P Y G + +
Sbjct: 249 SP--Y--PGVKIDEEF 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 28/115 (24%), Positives = 49/115 (42%), Gaps = 7/115 (6%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D T + L G+ +LS + V L L L L N+ T ++ + ++
Sbjct: 33 DTVTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQIT-DLA--PLKNLTKIT 88
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
++ L+ N ++AGLQ + L+L P L++L +L L NQ+
Sbjct: 89 ELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI 141
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 7/115 (6%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
DV L+ L L+ L N + + LT L+ L + + + ++ A + +L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQVS-DL--TPLANLSKLT 176
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
+ N S I LA L L++++L+ N P ++L ++ L+ +
Sbjct: 177 TLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 9/126 (7%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
++ L+ L L+ LS N + + L+ L L NK + +I A + L
Sbjct: 143 NISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKIS-DIS--PLASLPNLI 198
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRI- 125
+VHL N S P LA L + L + P F +L + ++ I
Sbjct: 199 EVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIA 255
Query: 126 PDTLSN 131
P T+S+
Sbjct: 256 PATISD 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 60/251 (23%), Positives = 97/251 (38%), Gaps = 59/251 (23%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMV-VKRFRQMSNVG-KEDFH---EHMTRLGSLSH 308
+VLGSG+FG A V VK ++ ++ +E + MT+LGS H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--H 108
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG------ 362
N++ L+ L+ ++ G L N L +R K ++
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 363 ------------VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410
VAKG+ +L EF H L + NVL+ + + D+ L +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL--EFKSCV--HRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 411 EHAQLHMVAYK------------SPEFNQTDGV-TRKTDVWSLGILILELLT-GKFPANY 456
+ Y +PE + +G+ T K+DVWS GIL+ E+ + G P Y
Sbjct: 225 DS------NYVVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNP--Y 275
Query: 457 LAQGKGANADL 467
G +A+
Sbjct: 276 --PGIPVDANF 284
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 18/85 (21%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
L LY+ + + G+ +L+ + + ++ P + +L +LNL N+
Sbjct: 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92
Query: 100 QGKIPDFPLAHLTL--LDLSYNQLV 122
+ + + L+L L LS N L
Sbjct: 93 E-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 24/100 (24%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFA 60
+ +++ L L LR+L+ + + + DAF
Sbjct: 41 QQHLQHLELRDLRGLGELRNLTIVKSGLR-----------------------FVAPDAFH 77
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
+L +++L+ N K++ GL L +L L GN
Sbjct: 78 FTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 3e-08
Identities = 87/555 (15%), Positives = 146/555 (26%), Gaps = 158/555 (28%)
Query: 105 DFPLAHLTLLDLSYNQLVGR-IPDTLSNFDATSFQGNKGLCGKPLEACKSSISK---KTI 160
DF Y ++ + NFD C + KS +SK I
Sbjct: 8 DFETGEH---QYQYKDILSVFEDAFVDNFD----------CKDVQDMPKSILSKEEIDHI 54
Query: 161 LIICTVAGATLALAAIVAFSCTRGNNSKT----------------SEPIIVNETQETKAL 204
++ TL L F + PI + Q +
Sbjct: 55 IMSKDAVSGTLRL-----FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109
Query: 205 KKYGANNYHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELNDLLRASAEVL-GS 263
+ Y D N+ Q Y V+ KL R+ L +L A ++ G
Sbjct: 110 RMY--IEQRDRLYNDNQVFAKYNVSRL-QPYLKL------RQA--LLELRPAKNVLIDGV 158
Query: 264 GSFGSSYKAVLLTGPAMVVKRFRQMS---------NVGK----EDFHEHMTRLGSLSHPN 310
G K + V ++ N+ E E + +L PN
Sbjct: 159 LGSG---KTWVA---LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN 212
Query: 311 LLPLI----AFYYRKEE------KLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKII 360
R +LL S N L LL+V+ A + + KI+
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN-CLLVLLNVQNAKAWNAFN--LSCKIL 269
Query: 361 -----KGVAKGL-AYLYKEFPGVTLPHG--HLKSSNVL---LDNAYEPLLTDYALVPIVN 409
K V L A + ++L LD + L P
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL-------PREV 322
Query: 410 KEHAQLH--MVAYKSPEFNQTDGVTRKTDVWSLGILI---LELLTGKFPANYLAQGKGAN 464
++A + T + + L +I L +L PA Y +
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE---PAEY----RKMF 375
Query: 465 ADLA-----TWVNSVVREE-WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW- 517
L+ + +++ W + M ++ L + E
Sbjct: 376 DRLSVFPPSAHIPTILLSLIWFDVIKSDVM--------VVVNKLHKYSLVEKQPKESTIS 427
Query: 518 ------DLREAVEKIMEL---------KERDNDNEDYSSYASEDYVYS-------SRAMT 555
+L+ +E L + D++D + Y YS +
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
Query: 556 DE---------DFSF 561
+ DF F
Sbjct: 488 ERMTLFRMVFLDFRF 502
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 75/463 (16%), Positives = 131/463 (28%), Gaps = 146/463 (31%)
Query: 15 LPGLRSLSFINNSFDGPMPSVGK--LTLRAL--YLSLNKFTGEI----------PSDAFA 60
L LR + DG + GK + L Y K +I P
Sbjct: 144 LLELRPAKNV--LIDG-VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 61 GMD----QLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDL 116
+ Q+ +R+ S I + +Q L+ L K + L LL++
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL-------KSKPYENCLLVLLNV 253
Query: 117 SYNQLVGRIPDTLSNFDATSFQGNKGLCGKPLEACKSSISKKTILIICTVAGATLALAAI 176
+ F+ CK IL+ T L+A
Sbjct: 254 QN-------AKAWNAFN---LS------------CK-------ILLTTRFKQVTDFLSAA 284
Query: 177 VAFSCTRGNNSKTSEPIIVNETQETKAL-KKYGANNYHDMGQNEIQSSD----CYFVNSQ 231
+ ++S T P E K+L KY D+ E+ +++ S
Sbjct: 285 TTTHISLDHHSMTLTP------DEVKSLLLKYLDCRPQDL-PREVLTTNPRRLSIIAESI 337
Query: 232 NDEISKLHF---VNNDREMFELNDLLRASAEVLGSGSFGSSYKA-------------VLL 275
D ++ VN D+ L ++ +S VL + + +L
Sbjct: 338 RDGLATWDNWKHVNCDK----LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS 393
Query: 276 --------TGPAMVVKRFRQMSNVGKE-------------DFHEHMTRLGSLSHPNLLPL 314
+ +VV + + S V K+ + + +L H +++
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVD- 451
Query: 315 IAFYYRKEEKLLVSDFVPNGS-----------LANLLHVRRAPGQPG----LDWPIRLKI 359
+Y + D +P L N+ H R + + KI
Sbjct: 452 ---HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF-LEQKI 507
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTD 401
A+ G L N L Y+P + D
Sbjct: 508 RH---DSTAW---NASGSIL--------NTLQQLKFYKPYICD 536
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 34/211 (16%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E+LG G FG +K TG + K + KE+ ++ + L H NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK----------IIKGVAKGL 367
+ K + +LV ++V G L D I +K + +G+
Sbjct: 155 FESKNDIVLVMEYVDGGEL--------------FDRIIDESYNLTELDTILFMKQICEGI 200
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL--TDYALVPIVNKEHAQLHMVA---YKS 422
++++ + H LK N+L N + D+ L + +
Sbjct: 201 RHMHQM--YIL--HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLA 256
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE D V+ TD+WS+G++ LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 20/119 (16%), Positives = 44/119 (36%), Gaps = 13/119 (10%)
Query: 13 SRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLAR 72
+ L + ++ + L ++ N +P L+ +
Sbjct: 56 CLINQFSELQLNRLNLSSLPDNLPPQ-ITVLEITQNALI-SLPEL----PASLEYLDACD 109
Query: 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN 131
N S +P+ A L+ L +++ N +P+ P A L ++ NQL +P+ ++
Sbjct: 110 NRLS-TLPELPASLKHL---DVDNNQLT-MLPELP-ALLEYINADNNQLT-MLPELPTS 161
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 22/127 (17%), Positives = 51/127 (40%), Gaps = 10/127 (7%)
Query: 6 MIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQ 64
M+ ++ L + I+ ++ + K + N+ + ++Q
Sbjct: 4 MLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE---CLINQ 60
Query: 65 LKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGR 124
++ L R + S +P +L ++ L + N+ +P+ P A L LD N+L
Sbjct: 61 FSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELP-ASLEYLDACDNRLS-T 114
Query: 125 IPDTLSN 131
+P+ ++
Sbjct: 115 LPELPAS 121
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 25/130 (19%), Positives = 42/130 (32%), Gaps = 19/130 (14%)
Query: 12 LSRLP----GLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L+ LP L ++ NN L L + N+ T +P + L+
Sbjct: 132 LTMLPELPALLEYINADNNQLTMLPELPTSL--EVLSVRNNQLT-FLPE----LPESLEA 184
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQ----LNLEGNSFQGKIPD--FPLAHLTLLDLSYNQL 121
+ ++ N +P + N IP+ L + L N L
Sbjct: 185 LDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
Query: 122 VGRIPDTLSN 131
RI ++LS
Sbjct: 243 SSRIRESLSQ 252
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 14/118 (11%)
Query: 12 LSRLP----GLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L+ LP L LS NN L AL +S N +P+ ++
Sbjct: 152 LTMLPELPTSLEVLSVRNNQLTFLPELPESL--EALDVSTNLLE-SLPAV-PVRNHHSEE 207
Query: 68 V----HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
N + IP+++ L + LE N L+ T +
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPR 263
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 52/214 (24%), Positives = 78/214 (36%), Gaps = 39/214 (18%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+LG GSFG K +T VK N + L L HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------IIKGVAKG 366
+V + G L D I+ K IIK V G
Sbjct: 88 EILEDSSSFYIVGELYTGGEL--------------FDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMV---AY 420
+ Y++K + H LK N+LL++ + + + D+ L + + Y
Sbjct: 134 ITYMHKH--NIV--HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 421 KSPE-FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE T K DVWS G+++ LL+G P
Sbjct: 190 IAPEVLRGT--YDEKCDVWSAGVILYILLSGTPP 221
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 20/118 (16%), Positives = 40/118 (33%), Gaps = 13/118 (11%)
Query: 14 RLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARN 73
G L+ + + + L + N T +P+ +L+ + ++ N
Sbjct: 38 LNNGNAVLNVGESGLTTLPDCLPA-HITTLVIPDNNLT-SLPA----LPPELRTLEVSGN 91
Query: 74 HFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN 131
+ +P GL +L + +P P + L L + NQL +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTH----LPALP-SGLCKLWIFGNQL-TSLPVLPPG 142
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 30/121 (24%), Positives = 45/121 (37%), Gaps = 15/121 (12%)
Query: 12 LSRLP-GLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
L LP GL L N L L +S N+ +P A +L K+
Sbjct: 116 LPALPSGLCKLWIFGNQLTSLPVLPPGLQ--ELSVSDNQLA-SLP----ALPSELCKLWA 168
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLS 130
N + +P +GLQ+L ++ N +P P + L L N+L +P S
Sbjct: 169 YNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLP-SELYKLWAYNNRLT-SLPALPS 221
Query: 131 N 131
Sbjct: 222 G 222
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 27/114 (23%), Positives = 43/114 (37%), Gaps = 13/114 (11%)
Query: 12 LSRLP----GLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L+ LP GL+ L N +L L +S N+ T +P L
Sbjct: 213 LTSLPALPSGLKELIVSGNRLTSLPVLPSELK--ELMVSGNRLT-SLP----MLPSGLLS 265
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
+ + RN + ++P+SL L +NLEGN + L +T +
Sbjct: 266 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 28/137 (20%), Positives = 39/137 (28%), Gaps = 30/137 (21%)
Query: 13 SRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLA 71
+ P LR+L N L L L L K+ +
Sbjct: 78 ALPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSG--------LCKLWIF 129
Query: 72 RNHFSGQIPKSLAGLQKL----------------LQ-LNLEGNSFQGKIPDFPLAHLTLL 114
N + +P GLQ+L L L N +P + L L
Sbjct: 130 GNQLT-SLPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLT-SLPML-PSGLQEL 186
Query: 115 DLSYNQLVGRIPDTLSN 131
+S NQL +P S
Sbjct: 187 SVSDNQLA-SLPTLPSE 202
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 50/244 (20%), Positives = 84/244 (34%), Gaps = 49/244 (20%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK-----RFRQMSNVGKEDFHEHMTRLGSLSHPNLL 312
+G GS+G A+ T +K + RQ++ E + + L HPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSL---------------ANLLHVRRAPGQPGLDWPIRL 357
L Y ++ LV + G L A + + P +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 358 KIIKGVAKGLAYLYKE----------FPGVTLPHGH------LKSSNVLL--DNAYEPLL 399
I G + L ++ +E F + H +K N L + ++E L
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 400 TDYAL----VPIVNKEHAQLHMVA----YKSPE--FNQTDGVTRKTDVWSLGILILELLT 449
D+ L + N E+ + A + +PE + K D WS G+L+ LL
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 450 GKFP 453
G P
Sbjct: 272 GAVP 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 35/215 (16%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTR----LGSLSHPNL 311
E LGSG F K TG K + RQ + E + R L + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSL------ANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365
+ L Y + + +L+ + V G L L A IK +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----------TSFIKQILD 126
Query: 366 GLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL----LTDYALVPIVNKEHAQLHMVA-- 419
G+ YL+ + + H LK N++L + P+ L D+ L + ++
Sbjct: 127 GVNYLHTK--KIA--HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 420 -YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ +PE + + + D+WS+G++ LL+G P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 37/216 (17%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTR----LGSLSHPNL 311
E LGSG F K TG K + RQ + E + R L + HPN+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSL------ANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365
+ L Y + + +L+ + V G L L A IK +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----------TSFIKQILD 126
Query: 366 GLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL----LTDYALVPIVNKEHAQLHMVA-- 419
G+ YL+ + + H LK N++L + P+ L D+ L + ++ + +
Sbjct: 127 GVNYLHTK--KIA--HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGT 181
Query: 420 --YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ +PE + + + D+WS+G++ LL+G P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 47/232 (20%), Positives = 83/232 (35%), Gaps = 58/232 (25%)
Query: 261 LGSGSFGSSYKAV---LLTGPAMVVKRFRQ----MSNVGKEDFHEHMTRLGSLSHPNLLP 313
+G G++G YKA +K+ MS E L L HPN++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-----EIAL-LRELKHPNVIS 82
Query: 314 LI-AFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVA----KGL 367
L F + K+ L+ D+ + L +++ RA + ++K + G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 368 AYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPL----LTDYAL-----VPIVNKEH 412
YL H + LK +N+L+ + D P+
Sbjct: 142 HYL----------HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 413 AQLHMVA--YKSPEF-----NQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
+V Y++PE + T + D+W++G + ELLT + F
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSEPIFHCR 239
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 53/226 (23%), Positives = 82/226 (36%), Gaps = 52/226 (23%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK---------RFRQMSNVGKEDFHEHMTR----LG 304
LGSG++G +K N E FHE + L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 305 SLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK------ 358
SL HPN++ L + K+ LV++F G L + I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--------------FEQIINRHKFDECD 147
Query: 359 ---IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEH 412
I+K + G+ YL+K + H +K N+LL+N + + D+ L +
Sbjct: 148 AANIMKQILSGICYLHKH--NIV--HRDIKPENILLENKNSLLNIKIVDFGL-SSFFSKD 202
Query: 413 AQLHMVA----YKSPE-FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+L Y +PE + K DVWS G+++ LL G P
Sbjct: 203 YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 68/253 (26%), Positives = 100/253 (39%), Gaps = 55/253 (21%)
Query: 228 VNSQNDEISKLHFVNNDREMFELND--LLRASAEVLGSGSFGSSYKAVLLTGP------A 279
+ EI+ H V E + + LL+ VLG GSFG + ++G A
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQFELLK----VLGQGSFGKVFLVKKISGSDARQLYA 56
Query: 280 MVVKRFRQMSNVGKEDFHEHMTR--LGSLSHPNLLPLI-AFYYRKEEKL-LVSDFVPNGS 335
M K ++ + ++ M R L ++HP ++ L AF + E KL L+ DF+ G
Sbjct: 57 M--KVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF--QTEGKLYLILDFLRGGD 112
Query: 336 LANLLHVRRAPGQPGLDWPIRLKI-IKGVAKGLAYLYKEFPGVTLPHGH------LKSSN 388
L L + +K + +A L +L H LK N
Sbjct: 113 LFTRLSKEVMFTEE------DVKFYLAELALALDHL----------HSLGIIYRDLKPEN 156
Query: 389 VLLDNAYEPLLTDYALVPIVNKEHAQLHMVA--------YKSPEFNQTDGVTRKTDVWSL 440
+LLD LTD+ L KE A Y +PE G T+ D WS
Sbjct: 157 ILLDEEGHIKLTDFGLS----KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 212
Query: 441 GILILELLTGKFP 453
G+L+ E+LTG P
Sbjct: 213 GVLMFEMLTGTLP 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 29/111 (26%), Positives = 48/111 (43%), Gaps = 10/111 (9%)
Query: 12 LSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
LS+ L L+ +N V LT L L NK T ++ + L ++
Sbjct: 81 LSQNTNLTYLACDSNKL--TNLDVTPLTKLTYLNCDTNKLT-KLD---VSQNPLLTYLNC 134
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
ARN + +I ++ +L +L+ N K+ P LT LD S+N++
Sbjct: 135 ARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 26/111 (23%), Positives = 41/111 (36%), Gaps = 8/111 (7%)
Query: 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
+S L L N + + L L S NK T E+ + L +++
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD---VSQNKLLNRLNC 198
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
N+ + ++ L +L L+ N +I PL LT D S N L
Sbjct: 199 DTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVTPLTQLTYFDCSVNPL 245
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 21/134 (15%), Positives = 38/134 (28%), Gaps = 11/134 (8%)
Query: 12 LSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70
L+ L V T L L T E+ + +L ++L
Sbjct: 271 LTHNTQLIYFQAEGCRKI-KELDVTHNTQLYLLDCQAAGIT-ELD---LSQNPKLVYLYL 325
Query: 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP-LAHLTLLDLSYNQLVGRIPDTL 129
+ ++ ++ KL L+ Q + L + Q + +TL
Sbjct: 326 NNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPKETL 381
Query: 130 SNFDATSFQGNKGL 143
+N T L
Sbjct: 382 TNNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 16/114 (14%)
Query: 12 LSRLPGLRSLSFINN---SFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKK 67
L++ L L +N D V LT L S+N T E+ + +L
Sbjct: 208 LNQNIQLTFLDCSSNKLTEID-----VTPLTQLTYFDCSVNPLT-ELDVSTLS---KLTT 258
Query: 68 VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
+H + +I L +L+ EG ++ L LLD +
Sbjct: 259 LHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 43/236 (18%), Positives = 81/236 (34%), Gaps = 46/236 (19%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+ LG+GSFG + + +G +K+ Q + E + L H N++ L+ +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYKNRELDI-MKVLDHVNIIKLVDY 68
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL-----------------KII 360
+Y ++ P+ K++
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 361 KGVAKGL---------AYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPL-LTDYAL 404
K + Y+Y+ F V H +K N+L+++ L L D+
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188
Query: 405 VPIVNKEHAQLHMVA---YKSPE--FNQTDGVTRKTDVWSLGILILELLTGK--FP 453
+ + + Y++PE T+ T D+WS+G + EL+ GK F
Sbjct: 189 AKKLIPSEPSVAYICSRFYRAPELMLGATE-YTPSIDLWSIGCVFGELILGKPLFS 243
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 42/208 (20%), Positives = 80/208 (38%), Gaps = 18/208 (8%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK-----RFRQMSNVGKEDFHEHMTRLGSLSHPNLL 312
EV+G G F + + TG VK +F + ED + L HP+++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L+ Y +V +F+ L + V+RA + ++ + + L Y +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEI-VKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMVA----YKSPEF 425
+ H +K VLL + P+ L + + + + + +PE
Sbjct: 149 N--NII--HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFP 453
+ + + DVW G+++ LL+G P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 53/218 (24%), Positives = 79/218 (36%), Gaps = 47/218 (21%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+LG GSFG K +T VK N + L L HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------IIKGVAKG 366
+V + G L D I+ K IIK V G
Sbjct: 88 EILEDSSSFYIVGELYTGGEL--------------FDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMV---AY 420
+ Y++K + H LK N+LL++ + + + D+ L + + Y
Sbjct: 134 ITYMHKH--NIV--HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 421 KSPEFNQTDGVTRKT-----DVWSLGILILELLTGKFP 453
+PE V R T DVWS G+++ LL+G P
Sbjct: 190 IAPE------VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 39/130 (30%), Positives = 58/130 (44%), Gaps = 15/130 (11%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ +L L L+SLS +N + + L L +LYL NK T +I + + +L
Sbjct: 101 DLSSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKIT-DI--TVLSRLTKLD 156
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP----LAHLTLLDLSYNQLV 122
+ L N S I LAGL KL L L N I D L +L +L+L + +
Sbjct: 157 TLSLEDNQIS-DIV-PLAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECL 210
Query: 123 GRIPDTLSNF 132
+ + SN
Sbjct: 211 NKPINHQSNL 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 32/119 (26%), Positives = 45/119 (37%), Gaps = 15/119 (12%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
V + LP + L N + + L L L+L NK ++ + + +LK
Sbjct: 57 SVQGIQYLPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDENKIK-DL--SSLKDLKKLK 112
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP----LAHLTLLDLSYNQL 121
+ L N S I L L +L L L N KI D L L L L NQ+
Sbjct: 113 SLSLEHNGIS-DIN-GLVHLPQLESLYLGNN----KITDITVLSRLTKLDTLSLEDNQI 165
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 13/82 (15%), Positives = 28/82 (34%), Gaps = 5/82 (6%)
Query: 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSF 99
L T + ++ + ++ + + + + L + +L L GN
Sbjct: 23 TIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL 77
Query: 100 QGKIPDFPLAHLTLLDLSYNQL 121
P L +L L L N++
Sbjct: 78 TDIKPLTNLKNLGWLFLDENKI 99
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 26/117 (22%), Positives = 43/117 (36%), Gaps = 10/117 (8%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
D+ L L L LS N + + L L+L N+ + S + L+
Sbjct: 77 DLSPLKDLTKLEELSVNRNRLKN-LNGIPSACLSRLFLDNNELR-DTDS--LIHLKNLEI 132
Query: 68 VHLARNHFSGQIPK--SLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLV 122
+ + N ++ L L KL L+L GN L + +DL+ + V
Sbjct: 133 LSIRNN----KLKSIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 26/121 (21%), Positives = 60/121 (49%), Gaps = 20/121 (16%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ + L G+++ + N++ + + T L+ L+LS N+ + ++ + +L+
Sbjct: 33 DLVSQKELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHNQIS-DL--SPLKDLTKLE 88
Query: 67 KVHLARNHFSGQIPKSLAGLQ--KLLQLNLEGNSFQGKIPDFP----LAHLTLLDLSYNQ 120
++ + RN ++ K+L G+ L +L L+ N ++ D L +L +L + N+
Sbjct: 89 ELSVNRN----RL-KNLNGIPSACLSRLFLDNN----ELRDTDSLIHLKNLEILSIRNNK 139
Query: 121 L 121
L
Sbjct: 140 L 140
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 25/119 (21%), Positives = 45/119 (37%), Gaps = 16/119 (13%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
+ + L+ L +N + + LT L L ++ N+ + A L
Sbjct: 55 SLAGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLK-NLNGIPSA---CLS 109
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP----LAHLTLLDLSYNQL 121
++ L N SL L+ L L++ N K+ L+ L +LDL N++
Sbjct: 110 RLFLDNNELRD--TDSLIHLKNLEILSIRNN----KLKSIVMLGFLSKLEVLDLHGNEI 162
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 39/129 (30%), Positives = 58/129 (44%), Gaps = 15/129 (11%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
D+ +L L L+SLS +N + + L L +LYL NK T +I + + +L
Sbjct: 104 DLSSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKIT-DI--TVLSRLTKLD 159
Query: 67 KVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP----LAHLTLLDLSYNQLV 122
+ L N S I LAGL KL L L N I D L +L +L+L + +
Sbjct: 160 TLSLEDNQIS-DIV-PLAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECL 213
Query: 123 GRIPDTLSN 131
+ + SN
Sbjct: 214 NKPINHQSN 222
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 21/82 (25%), Positives = 28/82 (34%), Gaps = 5/82 (6%)
Query: 43 LYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGK 102
L L + F G+ +L ++L N L +L L L N
Sbjct: 40 LDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 103 IPD--F-PLAHLTLLDLSYNQL 121
+P F L L L L NQL
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 31/119 (26%), Positives = 45/119 (37%), Gaps = 18/119 (15%)
Query: 19 RSLSFINNSFDGPMPSV--GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS 76
L + + G L L L N+ + + F + +L + LA N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN--- 93
Query: 77 GQIPKSL-----AGLQKLLQLNLEGNSFQGKIPD--F-PLAHLTLLDLSYNQLVGRIPD 127
Q+ SL L +L +L L GN + +P F L L L L+ NQL IP
Sbjct: 94 -QL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPA 148
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 41/142 (28%), Positives = 54/142 (38%), Gaps = 30/142 (21%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNS--------FDGPMPSVGKLTLRALYLSLNKFTGE 53
+ + T L L L+ N FD L L L+ N+
Sbjct: 45 TGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT------ELGTLGLANNQLA-S 97
Query: 54 IPSDAFAGMDQLKKVHLARNHFSGQIPKSLA-----GLQKLLQLNLEGNSFQGKIPD--F 106
+P F + QL K++L N Q+ KSL L KL +L L N Q IP F
Sbjct: 98 LPLGVFDHLTQLDKLYLGGN----QL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 107 -PLAHLTLLDLSYNQLVGRIPD 127
L +L L LS NQL +P
Sbjct: 152 DKLTNLQTLSLSTNQL-QSVPH 172
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 46/211 (21%), Positives = 81/211 (38%), Gaps = 37/211 (17%)
Query: 259 EVLGSGSFGSSYKAV-LLTGP--AMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
E LG G+F + V +L G A ++ +++S + L HPN++ L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL---------KIIKGVAKG 366
+ L+ D V G L + + I+ + +
Sbjct: 77 DSISEEGHHYLIFDLVTGGEL--------------FEDIVAREYYSEADASHCIQQILEA 122
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMVA---- 419
+ + ++ GV H +LK N+LL + + + L D+ L V E A
Sbjct: 123 VLHCHQM--GVV--HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTG 450
Y SPE + D + D+W+ G+++ LL G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 49/214 (22%), Positives = 81/214 (37%), Gaps = 38/214 (17%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
E LG G+F + V TG K +++S + L HPN++ L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL---------KIIKGVAKG 366
+ LV D V G L + + I+ + +
Sbjct: 72 DSIQEESFHYLVFDLVTGGEL--------------FEDIVAREFYSEADASHCIQQILES 117
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMVA---- 419
+AY + G+ H +LK N+LL + + + L D+ L V + H A
Sbjct: 118 IAYCHSN--GIV--HRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPG 172
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y SPE + D ++ D+W+ G+++ LL G P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 47/223 (21%), Positives = 77/223 (34%), Gaps = 48/223 (21%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR--------LGSLSHP 309
+ LGSG+ G A T + +K + L L+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 310 NLLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------I 359
++ + F+ E +V + + G L D + K
Sbjct: 76 CIIKIKNFF--DAEDYYIVLELMEGGEL--------------FDKVVGNKRLKEATCKLY 119
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL---LTDYALVPIVNKEHAQLH 416
+ + YL++ G+ H LK NVLL + E +TD+ I+ +
Sbjct: 120 FYQMLLAVQYLHEN--GII--HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 417 MV---AYKSPE---FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ Y +PE T G R D WSLG+++ L+G P
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 41/218 (18%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTR----LGSLSHPNL 311
E LGSG F K TG K + R++S+ + E + R L + HPN+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR---------LKIIKG 362
+ L + K + +L+ + V G L D+ + +K
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGEL--------------FDFLAEKESLTEDEATQFLKQ 116
Query: 363 VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL----LTDYALVPIVNKEHAQLHMV 418
+ G+ YL+ + + H LK N++L + P L D+ + + + ++
Sbjct: 117 ILDGVHYLHSK--RIA--HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 419 A---YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ +PE + + + D+WS+G++ LL+G P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 47/212 (22%), Positives = 75/212 (35%), Gaps = 37/212 (17%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
EVLGSG+F + LTG +K ++ + L + H N++ L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL---------KIIKGVAKGLA 368
Y LV V G L D + +I+ V +
Sbjct: 75 YESTTHYYLVMQLVSGGEL--------------FDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMVA----YK 421
YL++ G+ H LK N+L E + +TD+ L + + Y
Sbjct: 121 YLHEN--GIV--HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 422 SPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE ++ D WS+G++ LL G P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 40/221 (18%), Positives = 78/221 (35%), Gaps = 53/221 (23%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+VLG G G + TG +K +E +H + P+++ ++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV--DHHWQA--SGGPHIVCILDV 90
Query: 318 Y----YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL--------------KI 359
Y + K L++ + + G L R+ +I
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL--------------FS---RIQERGDQAFTEREAAEI 133
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLH 416
++ + + +L+ + H +K N+L + + L LTD+ + L
Sbjct: 134 MRDIGTAIQFLHSH--NIA--HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQ 187
Query: 417 MVA----YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE + + D+WSLG+++ LL G P
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 9/96 (9%)
Query: 43 LYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGK 102
L L+ N+ F + L K+ L RN +G P + G + +L L N + +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 103 IPD--F-PLAHLTLLDLSYNQLVGRIP----DTLSN 131
I + F L L L+L NQ+ + + L++
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNS 127
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 46/222 (20%), Positives = 85/222 (38%), Gaps = 47/222 (21%)
Query: 254 LRASAEVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTRLGSLSHPN 310
L + LG GSF K V + A VK R +N KE + HPN
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI--TALKLCE--GHPN 67
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL------------K 358
++ L ++ + LV + + G L + R+
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGEL--------------FE---RIKKKKHFSETEASY 110
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQL 415
I++ + +++++ GV H LK N+L + + + + D+ + ++ L
Sbjct: 111 IMRKLVSAVSHMHDV--GVV--HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 416 HMVA----YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE +G D+WSLG+++ +L+G+ P
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 53/264 (20%), Positives = 96/264 (36%), Gaps = 44/264 (16%)
Query: 211 NYHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELND--LLRASAEVLGSGSFGS 268
+ + + + + +N+ L+ +LG G+FG
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK----LLGKGTFGK 163
Query: 269 SYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLIAFYY 319
V+L TG +K ++ V K++ H L + HP L L + +
Sbjct: 164 ----VILVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTALK-YSF 217
Query: 320 RKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLAYLYKEFPGV 377
+ ++L V ++ G L L R + R + + L YL+ E V
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALDYLHSEKNVV 271
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA--------YKSPEFNQTD 429
+ LK N++LD +TD+ L KE + Y +PE + +
Sbjct: 272 ---YRDLKLENLMLDKDGHIKITDFGLC----KEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 430 GVTRKTDVWSLGILILELLTGKFP 453
R D W LG+++ E++ G+ P
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 39/213 (18%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G GS+ + + T VK + E+ E + R HPN++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI-EILLRY--GQHPNIITLKDV 84
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------IIKGVAKGLA 368
Y + +V++ + G L LD +R K ++ + K +
Sbjct: 85 YDDGKYVYVVTELMKGGEL--------------LDKILRQKFFSEREASAVLFTITKTVE 130
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYE---PL-LTDYALVPIVNKEHAQLHMVA----Y 420
YL+ + GV H LK SN+L + + + D+ + E+ L +
Sbjct: 131 YLHAQ--GVV--HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186
Query: 421 KSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE + G D+WSLG+L+ +LTG P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 44/212 (20%), Positives = 85/212 (40%), Gaps = 31/212 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTRLGSLSH-PNLLPL 314
+ LG G F + + TG K + R+ + + + L P ++ L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL------KIIKGVAKGLA 368
Y E +L+ ++ G + +L + + ++IK + +G+
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLC-LPELAE--------MVSENDVIRLIKQILEGVY 145
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMVA----YK 421
YL++ + H LK N+LL + Y + + D+ + + +L + Y
Sbjct: 146 YLHQN--NIV--HLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYL 200
Query: 422 SPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE D +T TD+W++GI+ LLT P
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 57/321 (17%), Positives = 107/321 (33%), Gaps = 71/321 (22%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEH---------------MTR 302
LG G F + + A ++ + +K R G + + E T+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 303 LGSLSHPNLLPLI-AFYYRKEEKL---LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
S+ ++L L+ F ++ + +V F G NLL + + G+ +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMV--FEVLGE--NLLALIKKYEHRGIPLIYVKQ 135
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV-------NKE 411
I K + GL Y+++ + H +K NVL++ P + + I E
Sbjct: 136 ISKQLLLGLDYMHRRCGII---HTDIKPENVLMEIVDSP--ENLIQIKIADLGNACWYDE 190
Query: 412 HAQLHMV--AYKSPEFNQTDGVTRKTDVWSLGILILELLTGK--FPANYLAQGKGANADL 467
H + Y+SPE D+WS LI EL+TG F + + +
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 468 ATWV-------NSVVRE-EWTGEVFDKDMR-------GTKSGEGEMLKLLKIGMC----- 507
A + + ++R ++T F+ E + + K
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 508 ------CCEWNAERRWDLREA 522
+ + +R D
Sbjct: 311 SDFLSPMLQLDPRKRADAGGL 331
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 35/215 (16%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK--RFRQMSNVGKEDFHEHMTR----LGSLSHPNL 311
E LGSG F K TG K + R+ + + E + R L + HPN+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSL------ANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365
+ L Y K + +L+ + V G L L A + +K +
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA-----------TEFLKQILN 125
Query: 366 GLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL----LTDYALVPIVNKEHAQLHMVA-- 419
G+ YL+ + H LK N++L + P + D+ L ++ + ++
Sbjct: 126 GVYYLHSL--QIA--HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 420 -YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ +PE + + + D+WS+G++ LL+G P
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 48/217 (22%), Positives = 80/217 (36%), Gaps = 45/217 (20%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
+ LG G+FG LTG + VK + + D + R L HP+++
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK----------IIKGV 363
L + +V ++V G L + + + R++ I+ V
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYI-CKHG----------RVEEMEARRLFQQILSAV 124
Query: 364 AKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----A 419
Y ++ V H LK NVLLD + D+ L +++ L
Sbjct: 125 D----YCHRH--MVV--HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPN 175
Query: 420 YKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFP 453
Y +PE G + D+WS G+++ LL G P
Sbjct: 176 YAAPEVISGRLYAG--PEVDIWSCGVILYALLCGTLP 210
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 34/93 (36%), Positives = 45/93 (48%), Gaps = 14/93 (15%)
Query: 37 KLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAG----LQKLLQ 91
+LT L L L+ N+ +P+ F + LK++ L N Q+ G L L
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN----QLQSLPDGVFDKLTNLTY 137
Query: 92 LNLEGNSFQGKIPD--F-PLAHLTLLDLSYNQL 121
LNL N Q +P F L +LT LDLSYNQL
Sbjct: 138 LNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 37/130 (28%), Positives = 50/130 (38%), Gaps = 30/130 (23%)
Query: 14 RLPGLRSLSFINNS--------FDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQL 65
L L L N FD L+ L L N+ +P F + L
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLT------NLKELVLVENQLQ-SLPDGVFDKLTNL 135
Query: 66 KKVHLARNHFSGQIPKSL-AG----LQKLLQLNLEGNSFQGKIPD--F-PLAHLTLLDLS 117
++LA N Q+ +SL G L L +L+L N Q +P+ F L L L L
Sbjct: 136 TYLNLAHN----QL-QSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLY 189
Query: 118 YNQLVGRIPD 127
NQL +PD
Sbjct: 190 QNQL-KSVPD 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 38/211 (18%), Positives = 77/211 (36%), Gaps = 35/211 (16%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E LG G FG ++ V + + K + + + ++ L H N+L L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR----------LKIIKGVAKGL 367
+ EE +++ +F+ + + + + V + L
Sbjct: 70 FESMEELVMIFEFISGLDI--------------FERINTSAFELNEREIVSYVHQVCEAL 115
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL--TDYALVPIVNKEHAQLHMVA---YKS 422
+L+ + H ++ N++ + ++ + + Y +
Sbjct: 116 QFLHSH--NIG--HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE +Q D V+ TD+WSLG L+ LL+G P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 47/224 (20%), Positives = 80/224 (35%), Gaps = 47/224 (20%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK-----RFRQMSNVGKEDFHEHMTR----LGSLS- 307
E+LG G + + T VK S ++ E + L +S
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 308 HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK--------- 358
HPN++ L Y LV D + G L D+
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGEL--------------FDYLTEKVTLSEKETRK 128
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV 418
I++ + + + L+K + H LK N+LLD+ LTD+ ++ +
Sbjct: 129 IMRALLEVICALHKL--NIV--HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 419 ---AYKSPE------FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+Y +PE + G ++ D+WS G+++ LL G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 57/239 (23%), Positives = 88/239 (36%), Gaps = 46/239 (19%)
Query: 237 KLHFVNNDREMFELND--LLRASAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMS 289
L + +R+ N R VLG G FG V TG K+ +
Sbjct: 170 FLQWKWLERQPVTKNTFRQYR----VLGKGGFGE----VCACQVRATGKMYACKKLEK-- 219
Query: 290 NVGKEDFHEHMTR-----LGSLSHPNLLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVR 343
K+ E M L ++ ++ L A+ Y ++ L LV + G L H+
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL--KFHIY 276
Query: 344 RAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEP 397
GQ G + + GL L H LK N+LLD+
Sbjct: 277 HM-GQAGFPEARAVFYAAEICCGLEDL----------HRERIVYRDLKPENILLDDHGHI 325
Query: 398 LLTDYAL---VPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
++D L VP ++ V Y +PE + + T D W+LG L+ E++ G+ P
Sbjct: 326 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF-RQMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
LGSG+FG + +G V+K + S V E + L SL HPN++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL------KIIKGVAKGLAYL 370
+ +V + G L + +A G+ L +++K + LAY
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGK-------ALSEGYVAELMKQMMNALAYF 140
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMV---AYKSPE 424
+ + V H LK N+L + P+ + D+ L + + + Y +PE
Sbjct: 141 HSQ--HVV--HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 425 -FNQTDGVTRKTDVWSLGILILELLTGKFP 453
F + VT K D+WS G+++ LLTG P
Sbjct: 197 VFKR--DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 19/82 (23%), Positives = 33/82 (40%), Gaps = 6/82 (7%)
Query: 41 RALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
R L+L+ T + + + + L+ N +P +LA L+ L L N+ +
Sbjct: 444 RVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
Query: 101 GKIPDFP-LAHLTLLDLSYNQL 121
+ L L L L N+L
Sbjct: 500 -NVDGVANLPRLQELLLCNNRL 520
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 1e-05
Identities = 23/116 (19%), Positives = 43/116 (37%), Gaps = 12/116 (10%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLK 66
+ L +L + L +N P++ L L L S N + A + +L+
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQ 511
Query: 67 KVHLARNHFSG-QIPKSLAGLQKLLQLNLEGNSFQGKIPDFP------LAHLTLLD 115
++ L N + L +L+ LNL+GNS + L ++ +
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 24/130 (18%), Positives = 46/130 (35%), Gaps = 17/130 (13%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAF 59
+ + + +R L + + + +L + L LS N+ +P A
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPP-AL 482
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP-------LAHLT 112
A + L+ + + N + +A L +L +L L N ++ L
Sbjct: 483 AALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN----RLQQSAAIQPLVSCPRLV 536
Query: 113 LLDLSYNQLV 122
LL+L N L
Sbjct: 537 LLNLQGNSLC 546
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 55/274 (20%), Positives = 96/274 (35%), Gaps = 66/274 (24%)
Query: 209 ANNYHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELND--LLRASAEVLGSGSF 266
N +E +S + ++ D + K + + +L+ ++ LG+GSF
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKK--WETPSQNTAQLDQFDRIK----TLGTGSF 54
Query: 267 GSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLIAF 317
G V+L +G +K + V K EH L +++ P L+ L F
Sbjct: 55 GR----VMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-F 108
Query: 318 YYRKEEKL-LVSDFVPNGSLANLL-HVRRAPGQPGLDWPIRLKIIKG-VAKGLAYLYKEF 374
++ L +V ++V G + + L + R + + YL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIVLTFEYL---- 157
Query: 375 PGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNK---------EHAQLHMVA 419
H LK N+L+D +TD+ V E
Sbjct: 158 ------HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-------- 203
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE + G + D W+LG+LI E+ G P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 39/214 (18%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
E LG G+F + V TG K +++S + L HPN++ L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------IIKGVAKG 366
+ LV D V G L + + + I+ + +
Sbjct: 95 DSIQEESFHYLVFDLVTGGEL--------------FEDIVAREFYSEADASHCIQQILES 140
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMVA---- 419
+AY + G+ H +LK N+LL + + + L D+ L VN H A
Sbjct: 141 IAYCHSN--GIV--HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPG 195
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y SPE + D ++ D+W+ G+++ LL G +P
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG-YP 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 9e-06
Identities = 49/221 (22%), Positives = 84/221 (38%), Gaps = 47/221 (21%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMT--R----LGSLSHPNL 311
+G GS+G +K TG + +K+F + ++D R L L HPNL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLE----SEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ L+ + RK LV ++ + +LH + + ++ I + + +
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVK-SITWQTLQAVNFC- 118
Query: 372 KEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL-HMVA---YK 421
H H +K N+L+ L D+ ++ VA Y+
Sbjct: 119 ---------HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 422 SPE--FNQTD---GVTRKTDVWSLGILILELLTGK--FPAN 455
SPE T V DVW++G + ELL+G +P
Sbjct: 170 SPELLVGDTQYGPPV----DVWAIGCVFAELLSGVPLWPGK 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 43/245 (17%), Positives = 74/245 (30%), Gaps = 55/245 (22%)
Query: 237 KLHFVNNDREMFELND--LLRASAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMS 289
L + + + + R VLG G FG V TG K+ +
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFR----VLGRGGFGE----VFACQMKATGKLYACKKLNK-- 220
Query: 290 NVGKEDFHEHMTR-----LGSLSHPNLLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVR 343
K+ L + ++ L A+ + + L LV + G + H+
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDI--RYHIY 277
Query: 344 RAPGQPGLDWPIRLKI-IKGVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYE 396
R + GL +L H LK NVLLD+
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHL----------HQRNIIYRDLKPENVLLDDDGN 327
Query: 397 PLLTDYALVPIVNKEHAQLHMVA--------YKSPEFNQTDGVTRKTDVWSLGILILELL 448
++D L E + +PE + D ++LG+ + E++
Sbjct: 328 VRISDLGLA----VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 449 TGKFP 453
+ P
Sbjct: 384 AARGP 388
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 39/215 (18%), Positives = 76/215 (35%), Gaps = 33/215 (15%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF--RQMSNVGKEDFHEH-------MTRL-GSLS 307
+LG G FG+ + L + +K ++ + ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 308 HPNLLPLIAFYYRKEEKLLVSDF-VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKG 366
HP ++ L+ ++ +E +LV + +P L + + + L V
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-----LGEGPSRCFFGQVVAA 151
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHMV----AYK 421
+ + + GV H +K N+L+D L D+ +++ E Y
Sbjct: 152 IQHCHSR--GVV--HRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDGTRVYS 205
Query: 422 SPEFNQT---DGVTRKTDVWSLGILILELLTGKFP 453
PE+ VWSLGIL+ +++ G P
Sbjct: 206 PPEWISRHQYHA--LPATVWSLGILLYDMVCGDIP 238
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 34/97 (35%), Positives = 44/97 (45%), Gaps = 16/97 (16%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL-AG----LQKLLQLN 93
+ L L NK +P F + QL K+ L++N QI +SL G L KL L
Sbjct: 29 SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQN----QI-QSLPDGVFDKLTKLTILY 82
Query: 94 LEGNSFQGKIPD--F-PLAHLTLLDLSYNQLVGRIPD 127
L N Q +P+ F L L L L NQL +PD
Sbjct: 83 LHENKLQ-SLPNGVFDKLTQLKELALDTNQL-KSVPD 117
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 61/245 (24%), Positives = 88/245 (35%), Gaps = 63/245 (25%)
Query: 241 VNNDREMFELND--LLRASAEVLGSGSFGSSYKAVLL--------TGPAMVVKRFRQMSN 290
VN E LLR VLG G +G K V TG +K ++
Sbjct: 7 VNRGPEKIRPECFELLR----VLGKGGYG---K-VFQVRKVTGANTGKIFAMKVLKKAMI 58
Query: 291 VGKEDFHEHMTR-----LGSLSHPNLLPLI-AFYYRKEEKL-LVSDFVPNGSLANLLHVR 343
V H T+ L + HP ++ LI AF + KL L+ +++ G L L
Sbjct: 59 VRNAKDTAH-TKAERNILEEVKHPFIVDLIYAF--QTGGKLYLILEYLSGGELFMQLERE 115
Query: 344 RAPGQPGLDWPIRLKI-IKGVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYE 396
+ + ++ L +L H LK N++L++
Sbjct: 116 GIFMED------TACFYLAEISMALGHL----------HQKGIIYRDLKPENIMLNHQGH 159
Query: 397 PLLTDYALVPIVNKEHAQLHMVA--------YKSPEFNQTDGVTRKTDVWSLGILILELL 448
LTD+ L KE V Y +PE G R D WSLG L+ ++L
Sbjct: 160 VKLTDFGLC----KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 449 TGKFP 453
TG P
Sbjct: 216 TGAPP 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 38/212 (17%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
LG G+ Y+ T +K ++ V K+ + L LSHPN++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL---------KIIKGVAKGLA 368
+ E LV + V G L D + +K + + +A
Sbjct: 117 FETPTEISLVLELVTGGEL--------------FDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMVA----YK 421
YL++ G+ H LK N+L PL + D+ L IV + + V Y
Sbjct: 163 YLHEN--GIV--HRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTVCGTPGYC 217
Query: 422 SPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+PE + + D+WS+GI+ LL G P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 28/113 (24%), Positives = 48/113 (42%), Gaps = 17/113 (15%)
Query: 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAG----LQKLLQLNL 94
+ LYL N+ T ++ F + LK+++L N Q+ G L +L L+L
Sbjct: 41 NAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSN----QLGALPVGVFDSLTQLTVLDL 95
Query: 95 EGNSFQGKIPD--F-PLAHLTLLDLSYNQLVGRIP---DTLSNFDATSFQGNK 141
N +P F L HL L + N+L +P + L++ + N+
Sbjct: 96 GTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQ 146
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 34/118 (28%), Positives = 47/118 (39%), Gaps = 17/118 (14%)
Query: 19 RSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS 76
+ L +N P V L L+ LYL N+ +P F + QL + L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN--- 98
Query: 77 GQIPKSL-AG----LQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQLVGRIPD 127
Q+ L + L L +L + N ++P L HLT L L NQL IP
Sbjct: 99 -QL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPH 152
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 21/85 (24%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---YKSPEFNQTDGVTRKTDV 437
H LK SN+++ + + D+ L V Y++PE G D+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 438 WSLGILILELLTGK--FP-ANYLAQ 459
WS+G ++ E++ G FP +++ Q
Sbjct: 210 WSVGCIMGEMIKGGVLFPGTDHIDQ 234
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 50/217 (23%), Positives = 80/217 (36%), Gaps = 45/217 (20%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
+ LG G+FG LTG + VK + + D + R L HP+++
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK----------IIKGV 363
L + +V ++V G L + + + RL I+ GV
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYI-CKNG----------RLDEKESRRLFQQILSGV 129
Query: 364 AKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----A 419
Y ++ V H LK NVLLD + D+ L +++ L
Sbjct: 130 D----YCHRH--MVV--HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPN 180
Query: 420 YKSPEF---NQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE G + D+WS G+++ LL G P
Sbjct: 181 YAAPEVISGRLYAG--PEVDIWSSGVILYALLCGTLP 215
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 17/95 (17%)
Query: 54 IPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAH 110
IP D +++L N F+ +PK L+ + L ++L N + + +
Sbjct: 29 IPRDV-------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 111 LTLLDLSYNQLVGRIP----DTLSNFDATSFQGNK 141
L L LSYN+L IP D L + S GN
Sbjct: 80 LLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGND 113
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 26/88 (29%), Positives = 38/88 (43%), Gaps = 7/88 (7%)
Query: 43 LYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGK 102
LYL N+FT + L + L+ N S +S + + +LL L L N +
Sbjct: 36 LYLDGNQFTLV--PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 103 IPD--F-PLAHLTLLDLSYNQLVGRIPD 127
IP F L L LL L N + +P+
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDI-SVVPE 119
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 49/216 (22%), Positives = 73/216 (33%), Gaps = 45/216 (20%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+G GS+G AV T K+ + + F + + + SL HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------IIKGVAKGLA 368
+ + LV + G L + + + I+K V +A
Sbjct: 75 FEDNTDIYLVMELCTGGEL--------------FERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMV---AYKS 422
Y +K V H LK N L PL L D+ L V Y S
Sbjct: 121 YCHKL--NVA--HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 423 PEFNQTDGVTRKT-----DVWSLGILILELLTGKFP 453
P+ V D WS G+++ LL G P
Sbjct: 177 PQ------VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 47/221 (21%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMT--R----LGSLSHPNL 311
++G GS+G K TG + +K+F + +D R L L H NL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE----SDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ L+ +K+ LV +FV + +L GLD+ + K + + G+ +
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPN-GLDYQVVQKYLFQIINGIGFC- 140
Query: 372 KEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL-HMVA---YK 421
H H +K N+L+ + L D+ + VA Y+
Sbjct: 141 ---------HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 422 SPE--FNQTD---GVTRKTDVWSLGILILELLTGK--FPAN 455
+PE V DVW++G L+ E+ G+ FP +
Sbjct: 192 APELLVGDVKYGKAV----DVWAIGCLVTEMFMGEPLFPGD 228
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 44/212 (20%), Positives = 84/212 (39%), Gaps = 29/212 (13%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVK---RFRQMSNVGKED-FHEHMTR----LGSLSHP 309
LGSG+FG + AV +VVK + + + + ED +T L + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 310 NLLPLIAFYYRKEEKLLVSDF-VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLA 368
N++ ++ + + LV + L + R P LD P+ I + + +
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRH----PRLDEPLASYIFRQLVSAVG 144
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----AYKSPE 424
YL + + H +K N+++ + L D+ + + + Y +PE
Sbjct: 145 YLRLK--DII--HRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFCGTIEYCAPE 199
Query: 425 F---NQTDGVTRKTDVWSLGILILELLTGKFP 453
N G + ++WSLG+ + L+ + P
Sbjct: 200 VLMGNPYRG--PELEMWSLGVTLYTLVFEENP 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 57/269 (21%), Positives = 92/269 (34%), Gaps = 57/269 (21%)
Query: 212 YHDMGQNEIQSSDCYFVNSQNDEISKLHFVNNDREMFELND--LLRASAEVLGSGSFGSS 269
+ +I + ISK N +R+ +L D L VLG GSFG
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFD-NNGNRDRMKLTDFNFLM----VLGKGSFG-- 355
Query: 270 YKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLIAFYYR 320
K V+L T VK ++ + +D M P L L ++
Sbjct: 356 -K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQ 412
Query: 321 KEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLAYLYKEFPGVT 378
++L V ++V G L + +P +A GL +L
Sbjct: 413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFL-------- 458
Query: 379 LPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA--------YKSPE 424
LK NV+LD+ + D+ + KE+ + Y +PE
Sbjct: 459 --QSKGIIYRDLKLDNVMLDSEGHIKIADFGMC----KENIWDGVTTKTFCGTPDYIAPE 512
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ D W+ G+L+ E+L G+ P
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 59/261 (22%), Positives = 96/261 (36%), Gaps = 84/261 (32%)
Query: 228 VNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLL-----TGP--AM 280
V +N++++ HF ++LR +G GSFG V + T AM
Sbjct: 5 VFDENEDVNFDHF-----------EILR----AIGKGSFGK----VCIVQKNDTKKMYAM 45
Query: 281 ------VVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLI-AFYYRKEEKL-LVSDFVP 332
++ NV KE + + L HP L+ L +F + EE + +V D +
Sbjct: 46 KYMNKQKCVERNEVRNVFKE---LQI--MQGLEHPFLVNLWYSF--QDEEDMFMVVDLLL 98
Query: 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK--------GLAYLYKEFPGVTLPHGH- 383
G L H+++ + + K L YL
Sbjct: 99 GGDL--RYHLQQ-----------NVHFKEETVKLFICELVMALDYL----------QNQR 135
Query: 384 -----LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM---VAYKSPE---FNQTDGVT 432
+K N+LLD +TD+ + ++ +E M Y +PE + G +
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYS 195
Query: 433 RKTDVWSLGILILELLTGKFP 453
D WSLG+ ELL G+ P
Sbjct: 196 FAVDWWSLGVTAYELLRGRRP 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 42/222 (18%), Positives = 79/222 (35%), Gaps = 47/222 (21%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
++LG GS+G + + T VK ++ + ++ + L L H N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 314 LIAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK----------IIK 361
L+ Y +E++ +V ++ G L V R +I
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------RFPVCQAHGYFCQLID 120
Query: 362 GVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL--VPIVNKEHAQLHMV- 418
G+ YL+ + G+ H +K N+LL ++ +
Sbjct: 121 GLE----YLHSQ--GIV--HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 419 ---AYKSPEFNQT----DGVTRKTDVWSLGILILELLTGKFP 453
A++ PE G K D+WS G+ + + TG +P
Sbjct: 173 GSPAFQPPEIANGLDTFSG--FKVDIWSAGVTLYNITTGLYP 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 52/261 (19%), Positives = 96/261 (36%), Gaps = 52/261 (19%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFH---EHMTRLGSLSHPNLLPL 314
+VLG G+ + L+T VK + + E + + H N+L L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ--GHRNVLEL 76
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRR------APGQPGLDWPIRLKIIKGVAKGLA 368
I F+ ++ LV + + GS+ + +H RR A +++ VA L
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-----------VVVQDVASALD 125
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLHMVA------ 419
+L+ G+ H LK N+L ++ + P+ + D+ L + +
Sbjct: 126 FLHN--KGIA--HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 420 -----YKSPE-----FNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLAT 469
Y +PE + ++ D+WSLG+++ LL+G +P G
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG-YPPFV-----GRCGSDCG 235
Query: 470 WVNSVVREEWTGEVFDKDMRG 490
W +F+ G
Sbjct: 236 WDRGEACPACQNMLFESIQEG 256
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 47/213 (22%), Positives = 86/213 (40%), Gaps = 31/213 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRF--RQMSNVGKEDFHEHMTR----LGSLSH--P 309
+LGSG FGS Y + + + +K ++S+ G+ + L +S
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 310 NLLPLIAFYYRKEEKLLVSDFV-PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLA 368
++ L+ ++ R + +L+ + P L + + R A L + V + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAVR 163
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVNKEHAQLHMV----AYKSP 423
+ + GV H +K N+L+D N E L D+ ++ Y P
Sbjct: 164 HCHNC--GVL--HRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPP 217
Query: 424 EFNQT---DGVTRKTDVWSLGILILELLTGKFP 453
E+ + G R VWSLGIL+ +++ G P
Sbjct: 218 EWIRYHRYHG--RSAAVWSLGILLYDMVCGDIP 248
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 1e-04
Identities = 19/129 (14%), Positives = 41/129 (31%), Gaps = 21/129 (16%)
Query: 14 RLPGLRSLSFINNSF-DGPMPSVGKLTLRAL-----YLSLNKFTGEIPSDAFAG------ 61
P L+SL I+ D + + L L Y+ + + + + F
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250
Query: 62 MDQLKKVHLARNHFSGQIPKSLAG---LQKLLQLNLEGNSFQGKIPDF------PLAHLT 112
LK + + + + L +L +++ + + HL
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 113 LLDLSYNQL 121
+++ YN L
Sbjct: 311 FINMKYNYL 319
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 43/265 (16%), Positives = 74/265 (27%), Gaps = 81/265 (30%)
Query: 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL------ 391
+LL GL P KII+ V +GL YL+ + + H +K N+LL
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK---CRIIHTDIKPENILLSVNEQY 186
Query: 392 -------------------------------------------DNAYEPLLTDYALVPIV 408
+ + D V
Sbjct: 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV 246
Query: 409 NKEHAQLHM-VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP-ANYLAQGKGANAD 466
+K + Y+S E G D+WS + EL TG + + + + D
Sbjct: 247 HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306
Query: 467 -LATWV--------NSVVREEWTGEVFDKD------------------MRGTKSGEGEML 499
+A + +V +++ E F K + + + E
Sbjct: 307 HIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAA 366
Query: 500 KLLKIGMCCCEWNAERRWDLREAVE 524
+ E E+R E +
Sbjct: 367 GFTDFLLPMLELIPEKRATAAECLR 391
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 37/119 (31%), Positives = 50/119 (42%), Gaps = 18/119 (15%)
Query: 19 RSLSFINNSFDGPMPSV--GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS 76
L NS V +L LYL NK +P+ F + L ++L+ N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN--- 86
Query: 77 GQIPKSL-AG----LQKLLQLNLEGNSFQGKIPD--F-PLAHLTLLDLSYNQLVGRIPD 127
Q+ +SL G L +L +L L N Q +PD F L L L L NQL +PD
Sbjct: 87 -QL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPD 141
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 26/97 (26%), Positives = 39/97 (40%), Gaps = 13/97 (13%)
Query: 32 MPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAG----LQ 87
+P+ L L N +P+ F + L +++L N ++ G L
Sbjct: 22 VPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGN----KLQSLPNGVFNKLT 76
Query: 88 KLLQLNLEGNSFQGKIPD--F-PLAHLTLLDLSYNQL 121
L LNL N Q +P+ F L L L L+ NQL
Sbjct: 77 SLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL 112
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 58/251 (23%), Positives = 93/251 (37%), Gaps = 56/251 (22%)
Query: 230 SQNDEISKLHFVNNDREMFELND--LLRASAEVLGSGSFGSSYKAVLL-----TGPAMVV 282
+ E L D LLR V+G GS+ K VLL T +
Sbjct: 31 EEEKEAMNTRESGKASSSLGLQDFDLLR----VIGRGSYA---K-VLLVRLKKTDRIYAM 82
Query: 283 KRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLIAFYYRKEEKL-LVSDFVPNGSLA 337
+ ++ ED T + +HP L+ L ++ E +L V ++V G L
Sbjct: 83 RVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL- 140
Query: 338 NLLHVRRAPGQPGLDWPIRLKIIKG-VAKGLAYLYKEFPGVTLPHGH------LKSSNVL 390
+ H++R + + + ++ L YL H LK NVL
Sbjct: 141 -MFHMQRQ-RKLPEE---HARFYSAEISLALNYL----------HERGIIYRDLKLDNVL 185
Query: 391 LDNAYEPLLTDYALVPIVNKEHAQLHMVA--------YKSPEFNQTDGVTRKTDVWSLGI 442
LD+ LTDY + KE + Y +PE + + D W+LG+
Sbjct: 186 LDSEGHIKLTDYGMC----KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 443 LILELLTGKFP 453
L+ E++ G+ P
Sbjct: 242 LMFEMMAGRSP 252
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 54/260 (20%), Positives = 97/260 (37%), Gaps = 70/260 (26%)
Query: 227 FVNSQNDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLL-----TGPAMV 281
F++ D I+K+ + E +E+ ++ V+G G+FG V L T
Sbjct: 50 FLSRYKDTINKIRDLRMKAEDYEV---VK----VIGRGAFGE----VQLVRHKSTRKVYA 98
Query: 282 VKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLIAFYYRKEEKL-LVSDFVPNGSL 336
+K + + + D + + P ++ L + ++ + L +V +++P G L
Sbjct: 99 MKLLSKFEMIKRSDS-AFFWEERDIMAFANSPWVVQL-FYAFQDDRYLYMVMEYMPGGDL 156
Query: 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAK--------GLAYLYKEFPGVTLPHGH----- 383
NL+ P + A+ L + H
Sbjct: 157 VNLMSNYDVPEK--------------WARFYTAEVVLALDAI----------HSMGFIHR 192
Query: 384 -LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA-----YKSPEFNQTDGV----TR 433
+K N+LLD + L D+ +NKE A Y SPE ++ G R
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252
Query: 434 KTDVWSLGILILELLTGKFP 453
+ D WS+G+ + E+L G P
Sbjct: 253 ECDWWSVGVFLYEMLVGDTP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 44/221 (19%), Positives = 78/221 (35%), Gaps = 53/221 (23%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+VLG G G + T +K + +E E R P+++ ++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE--VELHWRA--SQCPHIVRIVDV 123
Query: 318 Y---YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL--------------KI 359
Y Y + L +V + + G L R+ +I
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL--------------FS---RIQDRGDQAFTEREASEI 166
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLH 416
+K + + + YL+ + H +K N+L + L LTD+ H L
Sbjct: 167 MKSIGEAIQYLHSI--NIA--HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 221
Query: 417 MVA----YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE + + D+WSLG+++ LL G +P
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-YP 261
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 52/231 (22%), Positives = 88/231 (38%), Gaps = 55/231 (23%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
+G G+FG +KA TG + +K+ M N KE F R L L H N++
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL-MEN-EKEGFPITALREIKILQLLKHENVVN 80
Query: 314 LI-------AFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365
LI + Y R + + LV DF + LA LL ++++ +
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK----FTLSEIKRVMQMLLN 135
Query: 366 GLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYAL-----VPIVNKEHAQ 414
GL Y+ H + +K++NVL+ L D+ L + ++ +
Sbjct: 136 GLYYI----------HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 415 LHMVA---YKSPEF-----NQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
+ V Y+ PE + + D+W G ++ E+ T N
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRSPIMQGN 232
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 39/225 (17%), Positives = 78/225 (34%), Gaps = 49/225 (21%)
Query: 252 DLLRASAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHM------ 300
+ R ++G G FG V TG +K + + +
Sbjct: 192 SVHR----IIGRGGFGE----VYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIM 242
Query: 301 -TRLGSLSHPNLLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
+ + + P ++ + ++ + +KL + D + G L H+ + ++
Sbjct: 243 LSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFS----EADMR 295
Query: 359 I-IKGVAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKE 411
+ GL ++ H LK +N+LLD ++D L +K+
Sbjct: 296 FYAAEIILGLEHM----------HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345
Query: 412 HAQLHM--VAYKSPE-FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ Y +PE + D +SLG ++ +LL G P
Sbjct: 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPL 314
E +G G++G YKA G + +KR R + E R L L HPN++ L
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR-LDA-EDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 315 IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
I + + LV +F+ L +L + Q I+ + + +G+A+
Sbjct: 85 IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQ---IK-IYLYQLLRGVAHC---- 135
Query: 375 PGVTLPHGH------LKSSNVLLDNAYEPLLTDYAL-----VPIVNKEHAQLHMVA---Y 420
H H LK N+L+++ L D+ L +P+ + H V Y
Sbjct: 136 ------HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV----RSYTHEVVTLWY 185
Query: 421 KSPEF-----NQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
++P+ + V D+WS+G + E++TGK FP
Sbjct: 186 RAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGKPLFPGV 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 44/224 (19%), Positives = 82/224 (36%), Gaps = 48/224 (21%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR--------LGSLS-H 308
+V+G G + V TG VK + + E + L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK---------I 359
P+++ LI Y LV D + G L D+ I
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGEL--------------FDYLTEKVALSEKETRSI 205
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA 419
++ + + +++L+ + H LK N+LLD+ + L+D+ + +L +
Sbjct: 206 MRSLLEAVSFLHAN--NIV--HRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELC 260
Query: 420 ----YKSPE------FNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE G ++ D+W+ G+++ LL G P
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 54/227 (23%)
Query: 252 DLLRASAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR---- 302
DLLR V+G GS+ K VLL T +K ++ ED T
Sbjct: 12 DLLR----VIGRGSYA---K-VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 303 LGSLSHPNLLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIK 361
+ +HP L+ L ++ E +L V ++V G L + H++R + + +
Sbjct: 64 EQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQ-RKLPEE---HARFYS 116
Query: 362 G-VAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHAQ 414
++ L YL H LK NVLLD+ LTDY + KE +
Sbjct: 117 AEISLALNYL----------HERGIIYRDLKLDNVLLDSEGHIKLTDYGMC----KEGLR 162
Query: 415 LHMVA--------YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE + + D W+LG+L+ E++ G+ P
Sbjct: 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 49/228 (21%), Positives = 76/228 (33%), Gaps = 56/228 (24%)
Query: 252 DLLRASAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR---- 302
L + +LG GSFG K V L T +K ++ + +D M
Sbjct: 20 ILHK----MLGKGSFG---K-VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 303 LGSLSHPNLLPLI-AFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKII 360
+ HP L + F + +E L V +++ G L + R
Sbjct: 72 SLAWEHPFLTHMFCTF--QTKENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFY 123
Query: 361 KG-VAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413
+ GL +L H LK N+LLD + D+ + KE+
Sbjct: 124 AAEIILGLQFL----------HSKGIVYRDLKLDNILLDKDGHIKIADFGMC----KENM 169
Query: 414 QLHMVA--------YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE D WS G+L+ E+L G+ P
Sbjct: 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 40/217 (18%), Positives = 72/217 (33%), Gaps = 65/217 (29%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+VLG G G + T +K + +E E R P+++ ++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV--ELHWRA--SQCPHIVRIVDV 79
Query: 318 Y----YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL--------------KI 359
Y ++ L+V + + G L R+ +I
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL--------------FS---RIQDRGDQAFTEREASEI 122
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PL-LTDYALVPIVNKEHAQLH 416
+K + + + YL+ + H +K N+L + L LTD+ E
Sbjct: 123 MKSIGEAIQYLHSI--NIA--HRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK---- 174
Query: 417 MVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y + D+WSLG+++ LL G P
Sbjct: 175 ---Y-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 381 HGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---YKSPEFNQTDGVTRKTDV 437
H LK SN+++ + + D+ L V Y++PE G D+
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 438 WSLGILILELLTGK--FPA-NYLAQ 459
WS+G ++ E++ K FP +Y+ Q
Sbjct: 247 WSVGCIMGEMVRHKILFPGRDYIDQ 271
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 57/228 (25%)
Query: 252 DLLRASAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR---- 302
D L+ +LG G+FG K V+L TG +K R+ + K++ H
Sbjct: 8 DYLK----LLGKGTFG---K-VILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRV 58
Query: 303 LGSLSHPNLLPLI-AFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKII 360
L + HP L L AF + ++L V ++ G L H+ R + R +
Sbjct: 59 LQNTRHPFLTALKYAF--QTHDRLCFVMEYANGGEL--FFHLSRE-RVFTEE---RARFY 110
Query: 361 KG-VAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413
+ L YL H +K N++LD +TD+ L KE
Sbjct: 111 GAEIVSALEYL----------HSRDVVYRDIKLENLMLDKDGHIKITDFGLC----KEGI 156
Query: 414 QLHMVA--------YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y +PE + + R D W LG+++ E++ G+ P
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 49/229 (21%), Positives = 94/229 (41%), Gaps = 59/229 (25%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKED------FHEHMTRLGSLSHPNL 311
E LG+G++ + YK + TG + +K + + E+ E ++ + L H N+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIRE-ISLMKELKHENI 65
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVA----KGL 367
+ L + + + LV +F+ N L + R P + L ++K +GL
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPR---GLELNLVKYFQWQLLQGL 121
Query: 368 AYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYAL-----VPIVNKEHAQLH 416
A+ H + LK N+L++ + L D+ L +P+ +
Sbjct: 122 AFC----------HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV----NTFSS 167
Query: 417 MVA---YKSPEF-----NQTDGVTRKTDVWSLGILILELLTGK--FPAN 455
V Y++P+ + + D+WS G ++ E++TGK FP
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGKPLFPGT 212
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 53/235 (22%), Positives = 84/235 (35%), Gaps = 74/235 (31%)
Query: 252 DLLRASAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHM----TR 302
+LR LG+GSFG V L G +K ++ V + EH
Sbjct: 9 QILR----TLGTGSFGR----VHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLM 59
Query: 303 LGSLSHPNLLPLIAFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIK 361
L ++HP ++ + ++ +++ ++ D++ G L +R++ +
Sbjct: 60 LSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRKSQ-----------RFPN 105
Query: 362 GVAK--------GLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPI 407
VAK L YL H LK N+LLD +TD+
Sbjct: 106 PVAKFYAAEVCLALEYL----------HSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 155
Query: 408 VNK---------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
V + Y +PE T + D WS GILI E+L G P
Sbjct: 156 VPDVTYTLCGTPD--------YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 48/217 (22%), Positives = 82/217 (37%), Gaps = 48/217 (22%)
Query: 261 LGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLPLI 315
LG G++G AV +T A+ VK + D E++ + L+H N++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK----------IIKGVAK 365
+ L ++ G L + + I + ++ GV
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPD----------IGMPEPDAQRFFHQLMAGVV- 119
Query: 366 GLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL--VPIVNKEHAQLHMV----A 419
YL+ G+T H +K N+LLD ++D+ L V N L+ +
Sbjct: 120 ---YLHGI--GIT--HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 420 YKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFP 453
Y +PE + DVWS GI++ +L G+ P
Sbjct: 173 YVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELP 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 56/228 (24%)
Query: 252 DLLRASAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMSNVGKEDFHEHMTR---- 302
+ +R VLG GSFG K V+L TG VK ++ + +D MT
Sbjct: 26 EFIR----VLGKGSFG---K-VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRIL 77
Query: 303 LGSLSHPNLLPLI-AFYYRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKII 360
+ +HP L L F + ++L V +FV G L + H++++ + R +
Sbjct: 78 SLARNHPFLTQLFCCF--QTPDRLFFVMEFVNGGDL--MFHIQKS-RRFDEA---RARFY 129
Query: 361 KG-VAKGLAYLYKEFPGVTLPHGH------LKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413
+ L +L H LK NVLLD+ L D+ + KE
Sbjct: 130 AAEIISALMFL----------HDKGIIYRDLKLDNVLLDHEGHCKLADFGMC----KEGI 175
Query: 414 QLHMVA--------YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ Y +PE Q D W++G+L+ E+L G P
Sbjct: 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 565 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.73 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.72 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.69 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.69 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.67 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.66 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.66 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.65 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.65 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.65 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.65 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.63 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.63 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.62 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.61 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.6 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.6 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.6 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.59 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.58 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.57 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.56 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.55 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.55 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.55 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.54 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.54 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.53 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.52 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.52 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.5 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.5 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.5 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.49 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.49 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.49 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.48 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.48 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.47 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.47 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.47 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.47 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.47 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.47 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.46 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.46 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.46 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.45 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.45 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.45 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.45 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.45 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.44 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.44 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.44 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.44 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.44 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.43 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.43 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.43 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.43 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.42 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.42 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.41 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.41 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.41 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.41 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.4 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.4 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.39 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.39 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.38 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.37 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.37 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.37 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.36 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.36 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.36 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.35 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.35 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.35 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.34 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.34 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.33 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.33 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.32 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.32 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.28 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.27 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.27 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.23 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.22 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.2 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.1 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.97 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.96 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.93 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.9 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.89 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.67 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.44 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.38 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.1 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.09 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.03 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.74 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.49 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.45 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.41 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.39 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.34 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.22 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.93 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.9 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.71 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.38 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.31 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.28 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.19 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.03 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.69 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.07 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 92.74 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.21 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.45 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.11 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=450.90 Aligned_cols=253 Identities=20% Similarity=0.333 Sum_probs=207.2
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..||||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 4578999999999999864 4678999999876566677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 331 VPNGSLANLLHVRR--------APGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 331 ~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
|++|+|.++|+..+ ......++|..++.++.|||.||+|||++ +||||||||+|||+++++.+||+||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcEEECCc
Confidence 99999999998643 11223599999999999999999999998 9999999999999999999999999
Q ss_pred CCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHh
Q 008431 403 ALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVV 475 (565)
Q Consensus 403 Gla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 475 (565)
|+|+..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||... ...+.+....
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--------~~~~~~~~i~ 244 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--------SNNEVIECIT 244 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHHHHH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHH
Confidence 999865432 12357899999999999999999999999999999999 99999732 2222222222
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.+.... . +......+.+++.+||+.||++||||+||++.|+++...
T Consensus 245 -~~~~~~-----~-----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 -QGRVLQ-----R-----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -HTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCCCCC-----C-----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 221110 0 112234688899999999999999999999999998654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=454.14 Aligned_cols=254 Identities=19% Similarity=0.314 Sum_probs=205.0
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..++||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..||||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578999999999999864 4778999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 331 VPNGSLANLLHVRRAP----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
|++|+|.++++..... ....++|..++.|+.|||.||+|||+. +||||||||+|||+++++.+||+
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEEC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCCcEEEc
Confidence 9999999999865421 123599999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHH
Q 008431 401 DYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNS 473 (565)
Q Consensus 401 DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 473 (565)
|||+++..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||... ...+.+..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--------~~~~~~~~ 272 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--------SNTEAIDC 272 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--------CHHHHHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--------CHHHHHHH
Confidence 99999865432 23468899999999999999999999999999999999 89999632 22222222
Q ss_pred HhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 474 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.. .+... .. +......+.+++.+||+.||++||||.||+++|+.+.+..
T Consensus 273 i~-~g~~~-----~~-----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 273 IT-QGREL-----ER-----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HH-HTCCC-----CC-----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HH-cCCCC-----CC-----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 22 22110 11 1122346788999999999999999999999999997653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=448.65 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=204.5
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|.+. +++.||||+++.. .....++|.+|+.+|++++|||||+++|+|.+.+..+||||
T Consensus 30 ~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 30 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEE
Confidence 3478999999999999863 5678999999753 33446789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcE
Q 008431 330 FVPNGSLANLLHVRRAPG-----------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL 398 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~k 398 (565)
||++|||.++|....... ...++|..++.|+.|||.||+|||+. +||||||||+|||+++++.+|
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECCCCCEE
Confidence 999999999997643211 13599999999999999999999998 999999999999999999999
Q ss_pred EeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHH
Q 008431 399 LTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWV 471 (565)
Q Consensus 399 l~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 471 (565)
|+|||+++..... ....||+.|||||++.+..|+.++|||||||+||||+| |+.||... ...+.+
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--------~~~~~~ 257 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQDVV 257 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--------CHHHHH
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------CHHHHH
Confidence 9999999876432 23467899999999999999999999999999999999 89999632 222222
Q ss_pred HHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 472 NSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 472 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.. +..+.... .+......+.+++.+||+.||++||||.||++.|+.+
T Consensus 258 ~~-i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EM-IRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH-HHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH-HHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22 22221110 1122334688899999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=444.94 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=199.7
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|++. ..||||+++... ....++|.+|+.+|++++|||||+++|+|. ++..|||||||++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 4578999999999999854 369999987432 334568999999999999999999999875 46789999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.++|+.... .++|..++.|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 117 sL~~~l~~~~~----~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 117 SLYKHLHVQET----KFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp BHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CHHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999976543 499999999999999999999998 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 ---HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....||+.|||||++.+ ..|+.++|||||||+||||+||+.||... .....+...+..+. ..
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~--------~~~~~~~~~~~~~~----~~ 256 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI--------NNRDQIIFMVGRGY----AS 256 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC--------CCHHHHHHHHHTTC----CC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC--------ChHHHHHHHHhcCC----CC
Confidence 23478999999998753 46999999999999999999999999631 12222222222221 12
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
|.+... +......+.+++.+||+.||++||||.||++.|+.++..
T Consensus 257 p~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 257 PDLSKL--YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCSTTS--CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCcccc--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 222111 112334688899999999999999999999999988643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=437.94 Aligned_cols=264 Identities=20% Similarity=0.236 Sum_probs=200.6
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecC----ceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE----EKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|+|.+++ ..|||||||+
T Consensus 7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 357899999999999987 689999999864321 1222345666678899999999999998764 4799999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC----CCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF----PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
+|+|.++++.. .++|..+.+++.|+|.||+|||+++ +.++||||||||+|||++.++++||+|||+|+..
T Consensus 85 ~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 85 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999753 3899999999999999999999762 2347999999999999999999999999999876
Q ss_pred cccc--------cccccccccCCCccCCC------CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCC------cchH
Q 008431 409 NKEH--------AQLHMVAYKSPEFNQTD------GVTRKTDVWSLGILILELLTGKFPANYLAQGKGAN------ADLA 468 (565)
Q Consensus 409 ~~~~--------~~~~t~~y~aPE~~~~~------~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~------~~~~ 468 (565)
.... ...||+.|||||++.+. .|+.++|||||||++|||+||++||.......... ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 4321 23689999999988654 36789999999999999999998875322111000 0011
Q ss_pred HHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 469 TWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+...... +.++|.+.......+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 239 ~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 122222211 222333332222345667889999999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=438.02 Aligned_cols=241 Identities=18% Similarity=0.259 Sum_probs=202.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|||||||++|+
T Consensus 78 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 157 (346)
T 4fih_A 78 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157 (346)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred EeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 346899999999999996 4799999999986555667789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 158 L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 158 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 99999753 389999999999999999999999 9999999999999999999999999999876433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
.+.+||+.|||||++.+..|+.++|||||||++|||++|++||.. .+..+.+.... .... +.+.
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--------~~~~~~~~~i~-~~~~-----~~~~-- 291 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--------EPPLKAMKMIR-DNLP-----PRLK-- 291 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHH-HSSC-----CCCS--
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHH-cCCC-----CCCC--
Confidence 356799999999999999999999999999999999999999962 12222222222 1111 1111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
........+.+++.+||+.||++|||+.|+++
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112246788899999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=426.56 Aligned_cols=242 Identities=20% Similarity=0.353 Sum_probs=193.7
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEe----cCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR----KEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~E~ 330 (565)
.++||+|+||+||+|.. .++..||+|++... .....+.|.+|+++|++++|||||+++++|.+ ++..||||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 35799999999999995 46889999999743 23345679999999999999999999999875 3457999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVN 409 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~ 409 (565)
|++|+|.+++.... .+++..+..++.||+.||+|||++.+ +||||||||+|||++. ++.+||+|||+|+...
T Consensus 111 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~--~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTP--PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSS--CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCC--CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999998654 39999999999999999999999821 3999999999999984 7899999999998654
Q ss_pred cc--ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 410 KE--HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 410 ~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.. .+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||... ......... +..+.....++
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~-------~~~~~~~~~-i~~~~~~~~~~-- 252 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRR-VTSGVKPASFD-- 252 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHH-HTTTCCCGGGG--
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CcHHHHHHH-HHcCCCCCCCC--
Confidence 43 34579999999998865 6999999999999999999999999621 122222222 22211111111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 253 --~~-----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 --KV-----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cc-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1135778899999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=437.82 Aligned_cols=243 Identities=20% Similarity=0.296 Sum_probs=198.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|+. .+|+.||||++... .....+.|.+|+++|++++|||||++++++.+++..|||||||++
T Consensus 28 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~g 107 (350)
T 4b9d_A 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107 (350)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 457899999999999995 57999999999753 233456899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++...+. ..+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 108 g~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 108 GDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999976543 2478999999999999999999998 9999999999999999999999999999887543
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...+||+.|||||++.+..|+.++|||||||++|||+||++||.. .+..+.+......... .+.
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i~~~~~~------~~~ 246 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA--------GSMKNLVLKIISGSFP------PVS 246 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTCCC------CCC
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHcCCCC------CCC
Confidence 244699999999999999999999999999999999999999962 2334444444333211 111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+||+.||++|||+.|+++.
T Consensus 247 -----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 247 -----LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112367888999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=433.64 Aligned_cols=245 Identities=20% Similarity=0.207 Sum_probs=199.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..++||+|+||+||+|+. .+|+.||||+++.... +.+|+.+|++++|||||++++++.+++..|||||||+||+
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 346899999999999995 4789999999975322 2479999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCccccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~--- 411 (565)
|.++++..+ .+++..+..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.....
T Consensus 137 L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 137 LGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999998654 399999999999999999999998 999999999999999887 6999999999876432
Q ss_pred ------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 ------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
...+||+.|||||++.+..|+.++|||||||++|||+||++||..... ..+.. ..........
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~---~i~~~~~~~~--- 276 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-----GPLCL---KIASEPPPIR--- 276 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-----SCCHH---HHHHSCCGGG---
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHH---HHHcCCCCch---
Confidence 123689999999999999999999999999999999999999973221 11221 1111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.+. ......+.+++.+||+.||++|||+.|+++.|......
T Consensus 277 -~~~-----~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 -EIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -GSC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -hcC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 111 11223677889999999999999999999988877554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=439.14 Aligned_cols=241 Identities=18% Similarity=0.257 Sum_probs=202.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|||||||++|+
T Consensus 155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 457899999999999995 4799999999986656667789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++... .+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.....
T Consensus 235 L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 235 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred HHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 99999753 389999999999999999999999 9999999999999999999999999999876433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
.+.+||+.|||||++.+..|+.++|||||||++|||++|++||.. ....+.+...... . .+.+...
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--------~~~~~~~~~i~~~-~-----~~~~~~~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--------EPPLKAMKMIRDN-L-----PPRLKNL 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHS-C-----CCCCSCT
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHcC-C-----CCCCccc
Confidence 355799999999999999999999999999999999999999962 2222222222211 1 1111111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.||++|||+.|+++
T Consensus 371 ---~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 ---HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111236778899999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=435.67 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=206.1
Q ss_pred hccceecccCceeEEEEEEeC------CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCC-CCccceEEEEEec-CceEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLLT------GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSH-PNLLPLIAFYYRK-EEKLL 326 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~-~~~~l 326 (565)
...+.||+|+||+||+|.+.. ++.||||++.... ....++|.+|+++|++++| ||||+++|+|.+. +..|+
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 356889999999999998643 2479999997543 2345679999999999975 8999999999765 56899
Q ss_pred EEeccCCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC
Q 008431 327 VSDFVPNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY 395 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~ 395 (565)
|||||++|+|.++|+..... ....++|..++.++.|||+||+|||++ +||||||||+|||+++++
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGG
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCccCccceeeCCCC
Confidence 99999999999999864321 123489999999999999999999998 999999999999999999
Q ss_pred CcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchH
Q 008431 396 EPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLA 468 (565)
Q Consensus 396 ~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~ 468 (565)
.+||+|||+|+..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||... ...
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~--------~~~ 294 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--------KID 294 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--------CCS
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC--------CHH
Confidence 9999999999876433 23457899999999999999999999999999999998 99999632 222
Q ss_pred HHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 469 TWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..+...+..+.... . +......+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 295 ~~~~~~i~~g~~~~-----~-----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 295 EEFCRRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCC-----C-----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 33333333332111 1 1112246788899999999999999999999999987543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=424.38 Aligned_cols=240 Identities=20% Similarity=0.283 Sum_probs=201.9
Q ss_pred hccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 256 ASAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
...++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 35 ~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~ 114 (311)
T 4aw0_A 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 114 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 3568999999999999995 57899999999742 2344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 115 ~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 115 KNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp TTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999998654 399999999999999999999999 9999999999999999999999999999876432
Q ss_pred ------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 ------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
.+.+||+.|||||++.+..|+.++||||+||++|||+||++||.. .+.............
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--------~~~~~~~~~i~~~~~------ 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--------GNEGLIFAKIIKLEY------ 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCC------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCC------
Confidence 345799999999999999999999999999999999999999962 223333333333221
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+.. .....+.+++.+||+.||++|||++|++.
T Consensus 252 -~~p~-----~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 -DFPE-----KFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -CCCT-----TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -CCCc-----ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1111 11235778999999999999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=412.47 Aligned_cols=238 Identities=18% Similarity=0.289 Sum_probs=187.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 457899999999999994 579999999997432 233567999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 96 GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 689999997654 399999999999999999999998 9999999999999999999999999999876543
Q ss_pred --ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.+..||+.|||||++.+..| +.++||||+||++|||+||+.||.. .+............. .+
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~--------~~~~~~~~~i~~~~~-------~~ 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD--------ESIPVLFKNISNGVY-------TL 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCC-------CC
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHcCCC-------CC
Confidence 34679999999999988876 5799999999999999999999962 223333333322211 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. .....+.+++.+||+.||++|||++|+++
T Consensus 232 p~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PK-----FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC-----CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 11236778899999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=417.92 Aligned_cols=235 Identities=22% Similarity=0.252 Sum_probs=188.8
Q ss_pred hccceecccCceeEEEEEEe----CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 256 ASAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
...+.||+|+||+||+|+.. +++.||||+++... ......+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 106 (304)
T 3ubd_A 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106 (304)
T ss_dssp EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence 35678999999999999853 46789999997432 2334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
||+||+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 107 y~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 107 FLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp CCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999998654 399999999999999999999998 99999999999999999999999999998653
Q ss_pred cc----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 410 KE----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 410 ~~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
.. .+.+||+.|||||++.+..|+.++||||+||++|||+||++||.. .+..+.+........
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i~~~~~------ 243 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG--------KDRKETMTMILKAKL------ 243 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCC------
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC--------cCHHHHHHHHHcCCC------
Confidence 22 345799999999999999999999999999999999999999962 223333333332211
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
... ......+.+++.+||+.||++|||+
T Consensus 244 -~~p-----~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -GMP-----QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCC-----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCC-----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 010 1112367888999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=405.65 Aligned_cols=241 Identities=20% Similarity=0.277 Sum_probs=184.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------------
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------------ 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------------ 322 (565)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+.+
T Consensus 9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence 457899999999999995 478999999997533 334567999999999999999999999997654
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
..|+|||||++|+|.+++...... ...++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEccC
Confidence 368999999999999999865431 2356778899999999999999998 9999999999999999999999999
Q ss_pred CCccccccc----------------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcc
Q 008431 403 ALVPIVNKE----------------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANAD 466 (565)
Q Consensus 403 Gla~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~ 466 (565)
|+|+..... .+.+||+.|||||++.+..|+.++|||||||++|||++ ||... ..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~~ 232 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------ME 232 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------HH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------cH
Confidence 999876432 12368999999999999999999999999999999997 76421 11
Q ss_pred hHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 467 LATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....+... ..... .+. .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~-~~~~~----p~~------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDV-RNLKF----PPL------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-HTTCC----CHH------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH-hcCCC----CCC------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 11100 000 0122235677999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=401.71 Aligned_cols=251 Identities=17% Similarity=0.247 Sum_probs=192.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv 327 (565)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++... +..|||
T Consensus 58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv 137 (398)
T 4b99_A 58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137 (398)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence 457899999999999995 579999999997432 23346789999999999999999999998643 568999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
||||+ |+|.+++...+ .+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 138 mE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 138 LDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99996 78999997543 499999999999999999999998 999999999999999999999999999986
Q ss_pred cccc--------ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 408 VNKE--------HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 408 ~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
.... .+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.. .+....+.......
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g--------~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG--------KNYVHQLQLIMMVL 279 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC--------SSHHHHHHHHHHHH
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC--------CCHHHHHHHHHHhc
Confidence 5321 345799999999987765 569999999999999999999999962 11222222221110
Q ss_pred c-cC-cccc-----------ccccC-CCCCH-----HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 479 W-TG-EVFD-----------KDMRG-TKSGE-----GEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 479 ~-~~-~~~d-----------~~~~~-~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. .. .... ..+.. ...+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00 0000 00000 00000 112367889999999999999999998763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=391.29 Aligned_cols=185 Identities=18% Similarity=0.333 Sum_probs=162.6
Q ss_pred ccceecccCceeEEEEEEe----CCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|+.. +++.||+|++... ....++.+|+++|+.+ +|||||++++++.+.+..|+|||||
T Consensus 25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 4578999999999999854 4678999998653 3356788999999998 6999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-CCcEEeccCCcccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-YEPLLTDYALVPIVNK 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~~ 410 (565)
++|+|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 103 ~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 103 EHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999984 289999999999999999999998 99999999999999877 7999999999975432
Q ss_pred c--------------------------------ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 411 E--------------------------------HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 411 ~--------------------------------~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
. ...+||+.|||||++.+. .|+.++||||+||++|||+||+.||.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 1 123689999999988765 58999999999999999999999995
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=411.26 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=202.9
Q ss_pred hccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
...+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+.+..|+|||||++|
T Consensus 160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 3467899999999999995 579999999998655556678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC--CCcEEeccCCccccccc-
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA--YEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~--~~~kl~DfGla~~~~~~- 411 (565)
+|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 240 ~L~~~i~~~~~----~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 240 ELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp BHHHHHTCTTS----CEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999965432 399999999999999999999999 99999999999999854 89999999999887544
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...+||+.|||||++.+..|+.++||||+||++|||++|++||.. .+..+.+......... ..++...
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~--------~~~~~~~~~i~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG--------ENDDETLRNVKSCDWN--MDDSAFS 381 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHTTCCC--CCSGGGT
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHhCCCC--CCccccc
Confidence 345789999999999999999999999999999999999999962 2222333333222111 1111111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. ....+.+++.+||+.||++|||+.|+++
T Consensus 382 ~------~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 G------ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp T------SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1235778899999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=377.57 Aligned_cols=269 Identities=26% Similarity=0.429 Sum_probs=226.5
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|...++..||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 35689999999999999888999999998766555677899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
.+++...... ...++|..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 123 ~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 123 KRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp GGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred HHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9998654322 23499999999999999999999998 9999999999999999999999999998764321
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .......|.............+++.+..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVDPNLAD 275 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhccccccHHHhcChhhcc
Confidence 2335789999999988888999999999999999999999999743322 2345566666555555555666665543
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.. .......+.+++.+||+.||++|||+.||++.|+.+....
T Consensus 276 ~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 276 KI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CS-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cc-CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 32 4667788999999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=405.39 Aligned_cols=242 Identities=19% Similarity=0.207 Sum_probs=193.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHH---HHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFH---EHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..++||+|+||+||+|+. .+|+.||||++.+.. ......+. .++.+++.++|||||+++++|.+.+.+|+|||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 458999999999999995 478999999997421 12222333 34677788899999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
||+||+|.++|.... .+++..+..++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+...
T Consensus 273 y~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp CCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999998654 399999999999999999999998 99999999999999999999999999998765
Q ss_pred cc--ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 410 KE--HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 410 ~~--~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
.. .+.+||+.|||||++.. ..|+.++||||+||++|||++|++||..... .+............ .
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-----~~~~~i~~~i~~~~-------~ 411 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMA-------V 411 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-----CCHHHHHHHHHHCC-------C
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhhcCCC-------C
Confidence 43 45689999999999864 5799999999999999999999999963221 11222222221111 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 524 (565)
.+ +......+.+++.+||+.||++|++ ++||.+
T Consensus 412 ~~-----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 EL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC-----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC-----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01 1111236788899999999999998 678754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=378.88 Aligned_cols=270 Identities=30% Similarity=0.534 Sum_probs=226.6
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|...+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 34 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 113 (326)
T 3uim_A 34 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113 (326)
T ss_dssp STTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCB
T ss_pred cceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCC
Confidence 357899999999999998889999999987532 2233479999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++...... ...++|..+..++.|++.||+|||+.+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (326)
T 3uim_A 114 VASCLRERPES-QPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191 (326)
T ss_dssp HHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHHHSSSS-CEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCE
T ss_pred HHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCchhhEEECCCCCEEeccCccccccCcccccc
Confidence 99999865432 33599999999999999999999997433 7999999999999999999999999999765432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...............|+.............+..+..
T Consensus 192 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 3uim_A 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 271 (326)
T ss_dssp ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT
T ss_pred cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc
Confidence 2334889999999988888999999999999999999999999754444444556777777766666666666666544
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
. ........+.+++.+||+.||++|||+.||++.|+..
T Consensus 272 ~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 272 N-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp S-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred c-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 3 3467788999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.12 Aligned_cols=251 Identities=22% Similarity=0.400 Sum_probs=207.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|... ++..||+|++........+.|.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 4578999999999999964 688999999876656667789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--- 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 412 (565)
|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 94 LRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp HHHHHHHCCT----TSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999986433 399999999999999999999998 99999999999999999999999999997654321
Q ss_pred ---------------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCC-CcchHHHHHHHhh
Q 008431 413 ---------------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA-NADLATWVNSVVR 476 (565)
Q Consensus 413 ---------------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~ 476 (565)
...||+.|+|||++.+..++.++|||||||++|||++|..|+......... .........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~---- 241 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD---- 241 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----
Confidence 345889999999999999999999999999999999999998643222111 111111111
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
. .... .....+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 242 ~---------~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 242 R---------YCPP-----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp H---------TCCT-----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred c---------cCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 0000 11125788999999999999999999999999997653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=363.04 Aligned_cols=241 Identities=21% Similarity=0.320 Sum_probs=200.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 457899999999999994 6789999999986656667889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 99999753 289999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.. ................ ...
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~~~~~~~~-~~~------- 237 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN--------ENPLRALYLIATNGTP-ELQ------- 237 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHHCSC-CCS-------
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC-CCC-------
Confidence 334689999999999999999999999999999999999999962 1222222222222111 110
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 238 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01122246788999999999999999999975
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=355.48 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=206.1
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|...++..||+|++... ....+++.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (269)
T 4hcu_A 14 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 92 (269)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence 45789999999999999888889999999754 33467899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 93 SDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp HHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred HHHHHhcCc----ccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999976443 389999999999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+++.|+|||++....++.++|||||||++|||++ |+.||.. .............. ....+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~--------~~~~~~~~~~~~~~---~~~~~---- 229 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDISTGF---RLYKP---- 229 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTTC---CCCCC----
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC--------CCHHHHHHHHhcCc---cCCCC----
Confidence 23345678999999988889999999999999999999 9999862 12222222222111 00011
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
......+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 230 ----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 ----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11123678889999999999999999999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=370.32 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=202.1
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc----eEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE----KLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~lv~E~~~ 332 (565)
..++||+|+||+||+|+. .++.||||++... ......+.+|+.++++++|||||++++++..... .++||||++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~ 105 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105 (322)
T ss_dssp EEEEEECSTTCEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred hhheecccCceEEEEEEE-CCCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence 457899999999999986 4789999998653 2334456779999999999999999999987553 699999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC------CCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF------PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~------~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+|+|.+++... .++|..+..++.|++.||+|||+.+ +..+|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 106 KGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999999753 2899999999999999999999751 12279999999999999999999999999997
Q ss_pred ccccc------ccccccccccCCCccCCC-----CCCcchhHHHHHHHHHHHHcCCCCccccccCCCC--------Ccch
Q 008431 407 IVNKE------HAQLHMVAYKSPEFNQTD-----GVTRKTDVWSLGILILELLTGKFPANYLAQGKGA--------NADL 467 (565)
Q Consensus 407 ~~~~~------~~~~~t~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~--------~~~~ 467 (565)
..... ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||......... ....
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 65432 234689999999988763 4567899999999999999999999743221110 0011
Q ss_pred HHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+....... ...+.+............+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 260 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 260 EDMQEVVVHK-----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhcc-----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111 11111111111234556799999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=364.29 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=197.7
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
...+.||+|+||+||+|+. ++..||||.+.... ....++|.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 3467899999999999986 68899999987543 23345799999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--CccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT--LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~--ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
|+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 119 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 119 GSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999975331 11388999999999999999999998 7 999999999999999999999999999765433
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....||+.|+|||++.+..++.++|||||||++|||+||+.||... ................ .
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~--------~~~~~~~~~~~~~~~~-----~ 259 (309)
T 3p86_A 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--------NPAQVVAAVGFKCKRL-----E 259 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHHSCCCC-----C
T ss_pred ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcCCCC-----C
Confidence 3456889999999999999999999999999999999999999632 2222222211111100 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
+ +......+.+++.+||+.||++|||+.|+++.|+.+.....+
T Consensus 260 ~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 260 I-----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 1 111223678899999999999999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=364.61 Aligned_cols=240 Identities=19% Similarity=0.301 Sum_probs=199.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..|+||||+++
T Consensus 19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 357899999999999996 68999999999753 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 99 GEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999997654 389999999999999999999998 9999999999999999999999999999765433
Q ss_pred -ccccccccccCCCccCCCCCC-cchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVT-RKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..++ .++|||||||++|||++|+.||.. .+.............. +
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~~~-------~- 233 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--------QNLKELRERVLRGKYR-------I- 233 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCC-------C-
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC-------C-
Confidence 345789999999998887765 799999999999999999999962 2333333333222110 0
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 234 ----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 ----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01112367788899999999999999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=371.86 Aligned_cols=254 Identities=20% Similarity=0.310 Sum_probs=204.6
Q ss_pred ccceecccCceeEEEEEEe--------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL--------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 326 (565)
..+.||+|+||.||+|... ++..||||+++... ....+.+.+|+.+++++ +|||||+++++|.+.+..|+
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 4678999999999999853 34469999997542 23356799999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC
Q 008431 327 VSDFVPNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY 395 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~ 395 (565)
||||+++|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhEEECCCC
Confidence 99999999999999875421 123489999999999999999999998 999999999999999999
Q ss_pred CcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchH
Q 008431 396 EPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLA 468 (565)
Q Consensus 396 ~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~ 468 (565)
.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ...
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~--------~~~ 312 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--------PVE 312 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CGG
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC--------CHH
Confidence 9999999999865432 22345678999999988999999999999999999999 99998632 111
Q ss_pred HHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 469 TWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..... +...... .. +......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 313 ~~~~~-~~~~~~~-----~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 313 ELFKL-LKEGHRM-----DK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GHHHH-HHTTCCC-----CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHH-HhcCCCC-----CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 12211 1111110 01 1122246888999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.53 Aligned_cols=242 Identities=19% Similarity=0.269 Sum_probs=201.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 3468999999999999975 799999999986666667889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 129 LTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp HHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence 99998642 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .............. . +.+..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~--------~~~~~~~~~~~~~~-~-----~~~~~- 263 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS--------DSPVQAMKRLRDSP-P-----PKLKN- 263 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSS-C-----CCCTT-
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhcCC-C-----CCcCc-
Confidence 345689999999999999999999999999999999999999962 12222222222111 1 11100
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 264 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 264 --SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122367788899999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=364.99 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=202.1
Q ss_pred ccceecccCceeEEEEEEe----CCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|... .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 4688999999999999964 3345999999753 3334567999999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 133 ENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp TTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999975432 399999999999999999999998 9999999999999999999999999999876433
Q ss_pred c-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 H-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
. ...+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ...............
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--------~~~~~~~~~~~~~~~--- 273 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--------TNRDVISSVEEGYRL--- 273 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHHHHHHHTTCCC---
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHHcCCCC---
Confidence 1 2234668999999988889999999999999999999 99998621 122222222111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
. .+......+.+++.+||+.||++|||+.||++.|+.+....
T Consensus 274 ---~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 274 ---P-----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---C-----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 0 01122246888999999999999999999999999997654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=374.76 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=203.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|... ++..||||.++... ....++|.+|+++|++++|||||++++++...+..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 4678999999999999975 78899999987532 223457899999999999999999999999989999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 198 ~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 198 DFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp BHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999986543 389999999999999999999998 9999999999999999999999999998764332
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....+++.|+|||.+....++.++|||||||++|||+| |+.||... .. ..+...+..+... .
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~--------~~-~~~~~~~~~~~~~-----~ 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--------SN-QQTREFVEKGGRL-----P 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--------CH-HHHHHHHHTTCCC-----C
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CH-HHHHHHHHcCCCC-----C
Confidence 11234678999999888889999999999999999999 99998632 11 1122222221110 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
. +......+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 336 ~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 C-----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0 111223678899999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=352.87 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=204.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|...++..||+|++... ....+++.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (268)
T 3sxs_A 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90 (268)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcH
Confidence 45789999999999999888889999999754 33467899999999999999999999999998999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 91 LNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp HHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred HHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999986543 389999999999999999999998 99999999999999999999999999987654332
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||... ............. ....+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~---~~~~~---- 227 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY--------TNSEVVLKVSQGH---RLYRP---- 227 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHHHHHTTC---CCCCC----
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc--------ChHHHHHHHHcCC---CCCCC----
Confidence 2345677999999988889999999999999999999 99998621 1222222221111 01111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
......+.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus 228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 111236788999999999999999999999999997654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=358.20 Aligned_cols=251 Identities=21% Similarity=0.340 Sum_probs=194.9
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhc--CCCCCccceEEEEEec----CceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGS--LSHPNLLPLIAFYYRK----EEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~lv~E~ 330 (565)
..+.||+|+||+||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... ...++||||
T Consensus 12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~ 87 (301)
T 3q4u_A 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87 (301)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred EEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence 457899999999999987 7899999998642 34566677777666 8999999999997653 357999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY--------KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH--------~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
+++|+|.++++.. .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 88 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 88 HEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp CTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEECCC
T ss_pred ccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999532 3899999999999999999999 66 8999999999999999999999999
Q ss_pred CCcccccccc--------cccccccccCCCccCCC------CCCcchhHHHHHHHHHHHHcC----------CCCccccc
Q 008431 403 ALVPIVNKEH--------AQLHMVAYKSPEFNQTD------GVTRKTDVWSLGILILELLTG----------KFPANYLA 458 (565)
Q Consensus 403 Gla~~~~~~~--------~~~~t~~y~aPE~~~~~------~~~~~~DvwS~Gvil~el~tg----------~~p~~~~~ 458 (565)
|+++...... ...||+.|+|||++.+. .++.++|||||||++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654322 23689999999988776 455799999999999999999 77875332
Q ss_pred cCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 459 QGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 459 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
... ... ..+......... .+.+............+.+++.+||+.||++|||+.||++.|+++
T Consensus 238 ~~~---~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PND---PSF-EDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSS---CCH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---cch-hhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 211 111 122222111111 111111111234567899999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=370.59 Aligned_cols=249 Identities=21% Similarity=0.372 Sum_probs=194.0
Q ss_pred ccceecccCceeEEEEEEe----CCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|+.. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 4678999999999999864 5778999999753 2334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~~~sL~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 129 ENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp TTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999976432 489999999999999999999998 9999999999999999999999999999876433
Q ss_pred c-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 H-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
. ...+++.|+|||++....++.++|||||||++|||++ |+.||... ......... .....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--------~~~~~~~~i-~~~~~--- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--------SNQDVIKAV-DEGYR--- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--------CHHHHHHHH-HTTEE---
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHH-HcCCC---
Confidence 1 1223567999999988899999999999999999998 99998621 122222211 11110
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.+ .+......+.+++.+||+.||++|||+.||++.|+++...
T Consensus 269 -~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 -LP------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -CC------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CC------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 00 0112234688899999999999999999999999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=357.90 Aligned_cols=259 Identities=20% Similarity=0.338 Sum_probs=201.4
Q ss_pred ccceecccCceeEEEEEE-----eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-----LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 329 (565)
..+.||+|+||+||+|++ .+++.||||++........+.|.+|+.++++++||||+++++++... ...++|||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 457899999999999984 36789999999865555567899999999999999999999998654 56899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp CCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred eCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999986543 389999999999999999999998 99999999999999999999999999998764
Q ss_pred cc-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccC-------CCCCcchHHHHHHHh
Q 008431 410 KE-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQG-------KGANADLATWVNSVV 475 (565)
Q Consensus 410 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~ 475 (565)
.. ....++..|+|||.+.+..++.++|||||||++|||+||..|+...... ..........+....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 33 1234567799999998889999999999999999999999997532110 000000011111111
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..... ...+......+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 246 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 246 KNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hccCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11100 0011122346888999999999999999999999999997653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.71 Aligned_cols=248 Identities=20% Similarity=0.353 Sum_probs=202.4
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|...++..||+|++... ....+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106 (283)
T ss_dssp EEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBH
T ss_pred hHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcH
Confidence 45789999999999999888889999999754 33457899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 107 ~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 107 LNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp HHHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred HHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 999976433 399999999999999999999998 9999999999999999999999999999765432
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ............. ....+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~--------~~~~~~~~~~~~~---~~~~~---- 243 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSETAEHIAQGL---RLYRP---- 243 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHHHHHTTC---CCCCC----
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--------ChhHHHHHHhccc---CCCCC----
Confidence 23345678999999988889999999999999999999 99998631 1222222221111 00000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
......+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 244 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11123678899999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=351.66 Aligned_cols=259 Identities=19% Similarity=0.307 Sum_probs=205.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|.. .++..||+|.+..... ...+.|.+|+.++++++||||+++++++.+.+..|+||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 357899999999999995 4688999999864322 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 95 GPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp SCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999998654 389999999999999999999998 9999999999999999999999999999876433
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||.. ................ .. ...
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~-~~-~~~ 235 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG--------ETAVSIAIKHIQDSVP-NV-TTD 235 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS--------SCHHHHHHHHHSSCCC-CH-HHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHhhccCC-Cc-chh
Confidence 234579999999999999999999999999999999999999962 1222222222222111 00 011
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHhhccCCCCCCc
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRW-DLREAVEKIMELKERDNDNEDY 539 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~~~~~~~~~~ 539 (565)
... .....+.+++.+||+.||++|| +++++.+.|+++........+.
T Consensus 236 ~~~-----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~ 283 (294)
T 4eqm_A 236 VRK-----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDV 283 (294)
T ss_dssp SCT-----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCC
T ss_pred ccc-----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcch
Confidence 111 1123678899999999999999 9999999999987665444443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=376.69 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=205.0
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
...+.||+|+||+||+|...++..||||+++.. ....++|.+|+.+|++++|||||++++++. .+..++||||+++|+
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 356789999999999999988889999999754 345788999999999999999999999985 667899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.++++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 269 LLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp HHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred HHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 9999975432 1388999999999999999999998 9999999999999999999999999999876432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....+++.|+|||++....++.++|||||||++|||+| |+.||... ...+..... ..+...
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i-~~~~~~-------- 404 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------SNPEVIRAL-ERGYRM-------- 404 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHHH-HHTCCC--------
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHH-HcCCCC--------
Confidence 22345678999999988889999999999999999999 99999631 222222222 121110
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..+......+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 001122346888999999999999999999999999986543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=357.79 Aligned_cols=240 Identities=20% Similarity=0.234 Sum_probs=199.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+.. +|+.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 4578999999999999964 6899999999753 23446678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc--
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK-- 410 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~-- 410 (565)
+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999997654 389999999999999999999998 999999999999999999999999999976432
Q ss_pred --cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 411 --EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 411 --~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+............. .+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~~-------~~ 224 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHERLFELILMEEI-------RF 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCC-------CC
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCC-------CC
Confidence 2345789999999999999999999999999999999999999962 222222222222210 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 525 (565)
. ......+.+++.+||+.||++|| ++.|+++.
T Consensus 225 p-----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 P-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C-----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 11123678888999999999999 89999764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=365.36 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=206.3
Q ss_pred hccceecccCceeEEEEEEe--------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceE
Q 008431 256 ASAEVLGSGSFGSSYKAVLL--------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKL 325 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 325 (565)
...+.||+|+||+||+|... .+..||||+++... ....+++.+|+++++++ +|||||++++++...+..+
T Consensus 72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 151 (382)
T 3tt0_A 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 151 (382)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceE
Confidence 45688999999999999853 22469999987542 33346799999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC
Q 008431 326 LVSDFVPNGSLANLLHVRRAPG-----------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA 394 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~ 394 (565)
+||||+++|+|.+++......+ ...+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTT
T ss_pred EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcceEEEcCC
Confidence 9999999999999998754211 23499999999999999999999998 99999999999999999
Q ss_pred CCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcch
Q 008431 395 YEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADL 467 (565)
Q Consensus 395 ~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~ 467 (565)
+.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.. ...
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~--------~~~ 299 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPV 299 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------CCH
Confidence 99999999999865432 23346788999999989999999999999999999999 9999862 222
Q ss_pred HHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
....... ....... . +......+.+++.+||+.||++|||+.||++.|+++....
T Consensus 300 ~~~~~~~-~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 300 EELFKLL-KEGHRMD-----K-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHH-HTTCCCC-----C-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHH-HcCCCCC-----C-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2222222 2211110 0 0112236888999999999999999999999999997654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=350.67 Aligned_cols=259 Identities=26% Similarity=0.460 Sum_probs=208.6
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
+.||+|+||+||+|.. ++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 37 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 115 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115 (307)
T ss_dssp CEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCC
Confidence 6899999999999986 68899999987432 223567999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... ...++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 116 SLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp BHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred cHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999975432 23499999999999999999999998 9999999999999999999999999998765432
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-ccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-WTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~ 487 (565)
....+|+.|+|||.+.+ .++.++|||||||++|||++|+.||...... ..+..+........ .....+++.
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----QLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----SBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----HHHHHHHHHhhhhhhhhhhhcccc
Confidence 23467899999998765 5899999999999999999999999743221 22233332222211 112233333
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
+.. ........+.+++.+||+.||++|||+.||++.|+++..
T Consensus 265 ~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 265 MND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred ccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 322 235667789999999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=373.10 Aligned_cols=248 Identities=22% Similarity=0.373 Sum_probs=202.5
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecC-ceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-EKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|.. .+..||||.++... ..+.|.+|+.+|++++|||||++++++...+ ..++||||+++|+
T Consensus 197 ~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 457899999999999987 47799999997543 4678999999999999999999999988765 7899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-ccc
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQ 414 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~ 414 (565)
|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 274 L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 346 (450)
T 1k9a_A 274 LVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346 (450)
T ss_dssp HHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence 9999986543 2378999999999999999999998 9999999999999999999999999999765432 233
Q ss_pred cccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 415 LHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 415 ~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
.+++.|+|||++....++.++|||||||++|||+| |+.||..... ..+... +..+... ..
T Consensus 347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~----i~~~~~~-----~~----- 407 (450)
T 1k9a_A 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPR----VEKGYKM-----DA----- 407 (450)
T ss_dssp CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHHH----HHTTCCC-----CC-----
T ss_pred CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH----HHcCCCC-----CC-----
Confidence 56788999999999999999999999999999999 9999973211 112211 1111110 00
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 1122346788999999999999999999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=365.84 Aligned_cols=253 Identities=20% Similarity=0.300 Sum_probs=203.0
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|.+. ++..||||+++.. ......++.+|+.++++++|||||++++++......++|||
T Consensus 75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 4578999999999999843 4568999998643 23345579999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC---CcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRAP--GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY---EPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfGl 404 (565)
|+++|+|.+++...+.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 99999999999875432 123489999999999999999999998 999999999999999544 599999999
Q ss_pred cccccc------cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNK------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++.... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.. .............
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~--------~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS--------KSNQEVLEFVTSG 302 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHHHHHHHHHTT
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHHcC
Confidence 875422 223456889999999988899999999999999999998 9999862 1222222222221
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
... + . +......+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 303 ~~~----~--~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRM----D--P-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCC----C--C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC----C--C-----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 110 0 0 111223678899999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=350.82 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=200.9
Q ss_pred ccceecccCceeEEEEEEe-CC-------CeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TG-------PAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||+||+|... ++ ..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence 4578999999999999954 34 469999997665666788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC--------cEEe
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--------PLLT 400 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~--------~kl~ 400 (565)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+
T Consensus 92 e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp ECCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred ECCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999986543 389999999999999999999998 9999999999999998887 9999
Q ss_pred ccCCcccccccccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCC-CccccccCCCCCcchHHHHHHHhhhc
Q 008431 401 DYALVPIVNKEHAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKF-PANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 401 DfGla~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
|||++..........+|+.|+|||++.+ ..++.++|||||||++|||++|.. |+.. ........ .....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~--------~~~~~~~~-~~~~~ 234 (289)
T 4fvq_A 164 DPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA--------LDSQRKLQ-FYEDR 234 (289)
T ss_dssp CCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT--------SCHHHHHH-HHHTT
T ss_pred cCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc--------cchHHHHH-Hhhcc
Confidence 9999987766666678899999998877 678999999999999999999654 4431 11111111 11110
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
....+.. ...+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 235 ---~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 235 ---HQLPAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp ---CCCCCCS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ---CCCCCCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0001111 125778889999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=344.93 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=205.7
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (267)
T 3t9t_A 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL 90 (267)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred eeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence 457899999999999998888899999997543 3457899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 91 SDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp HHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred HHHHhhCcc----cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999986543 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....++..|+|||++....++.++|||||||++|||++ |+.||.. ............. .. ...+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~~~i~~~-~~--~~~~---- 227 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDISTG-FR--LYKP---- 227 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTT-CC--CCCC----
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC--------CCHHHHHHHHhcC-Cc--CCCC----
Confidence 23345678999999888889999999999999999999 8999862 1222222222211 10 0000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
......+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 ----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11123678899999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=359.13 Aligned_cols=243 Identities=21% Similarity=0.328 Sum_probs=198.5
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|... +|..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence 4578999999999999964 689999999975332 135789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC----CcEEeccCCc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY----EPLLTDYALV 405 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfGla 405 (565)
|+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 96 ~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp CCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999996533 399999999999999999999998 999999999999998777 7999999999
Q ss_pred cccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
+..... ....||+.|+|||++.+..++.++|||||||++|||++|++||.. ...............
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~--------~~~~~~~~~i~~~~~--- 235 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANITAVSY--- 235 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHTTCC---
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhcCC---
Confidence 876543 345689999999999988999999999999999999999999962 122222222222111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+++.... .....+.+++.+||..||++|||+.|+++
T Consensus 236 ~~~~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 DFDEEFFS-----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchhcc-----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111101 11235788999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=358.64 Aligned_cols=248 Identities=22% Similarity=0.381 Sum_probs=194.6
Q ss_pred ccceecccCceeEEEEEEe-CCCe----eEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPA----MVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|+.. +++. ||+|.++.. .....++|.+|+.++++++||||++++++|... ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEEC
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 4578999999999999953 4544 577777532 234567899999999999999999999999865 47899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 98 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CTTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred cCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999987543 399999999999999999999998 999999999999999999999999999976543
Q ss_pred cc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 EH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
.. ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+.. .+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~----~~~~~~~~-- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISS----ILEKGERL-- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHH----HHHTTCCC--
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHH----HHHcCCCC--
Confidence 32 2345778999999989999999999999999999999 9999963211 11111 11111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 00112234688899999999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=355.23 Aligned_cols=244 Identities=19% Similarity=0.282 Sum_probs=199.0
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|... ++..+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus 9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred eeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence 4578999999999999964 6788999988643 3345678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC--CCCcEEeccCCccccccc--
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN--AYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~-- 411 (565)
|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 88 L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 88 IFERINTSAF----ELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999975432 489999999999999999999998 9999999999999987 789999999999876443
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||.. ......+......... .++....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~---~~~~~~~ 228 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--------ETNQQIIENIMNAEYT---FDEEAFK 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCC---CCHHHHT
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC--------CCHHHHHHHHHcCCCC---CChhhhc
Confidence 234678999999999888899999999999999999999999962 2222333333222111 0100000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 229 -----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 229 -----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112367889999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=359.27 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=203.9
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... ++..||||.++... ....+.|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 4578999999999999974 34789999997542 2335679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEE
Q 008431 330 FVPNGSLANLLHVRRAP-------------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVL 390 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NIL 390 (565)
|+++|+|.+++...... ....+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl 206 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCL 206 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEE
Confidence 99999999999864321 013599999999999999999999998 9999999999999
Q ss_pred EcCCCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCC
Q 008431 391 LDNAYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGA 463 (565)
Q Consensus 391 l~~~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~ 463 (565)
++.++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~------- 279 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG------- 279 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-------
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC-------
Confidence 999999999999998765322 23456788999999888889999999999999999999 9999862
Q ss_pred CcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 464 NADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.......... ..+.... . +......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 280 -~~~~~~~~~~-~~~~~~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 280 -MAHEEVIYYV-RDGNILA-----C-----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -SCHHHHHHHH-HTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -CChHHHHHHH-hCCCcCC-----C-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1222222222 2211110 0 0112236888999999999999999999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=352.94 Aligned_cols=243 Identities=21% Similarity=0.326 Sum_probs=197.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... +|..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 4678999999999999964 689999999875322 235789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC----CcEEeccCCc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY----EPLLTDYALV 405 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfGla 405 (565)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 95 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 95 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp CCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999997533 389999999999999999999998 999999999999998887 7999999999
Q ss_pred cccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
+..... ....+|+.|+|||++....++.++|||||||++|||++|+.||.. ............... .
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~~~~~~~--~ 235 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANVSAVNY--E 235 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHTCC--C
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC--------CCHHHHHHHHHhcCC--C
Confidence 876432 345689999999999988999999999999999999999999962 112222222211110 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..++... .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 FEDEYFS------NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCHHHHT------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCccccc------cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 11235778899999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=360.00 Aligned_cols=259 Identities=17% Similarity=0.173 Sum_probs=201.1
Q ss_pred ccceecccCceeEEEEEEeC------CCeeEEEEeeccCcc-----------CHHHHHHHHHHHhcCCCCCccceEEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLT------GPAMVVKRFRQMSNV-----------GKEDFHEHMTRLGSLSHPNLLPLIAFYY 319 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~~~ 319 (565)
..+.||+|+||+||+|.+.. ++.||||.+...... ....+.+|+..++.++||||+++++++.
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 45789999999999998754 478999998754211 1123455667788889999999999997
Q ss_pred ec----CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc--C
Q 008431 320 RK----EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD--N 393 (565)
Q Consensus 320 ~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~--~ 393 (565)
.. ...++||||+ +|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++ .
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEANAK----RFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEESSC
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEecCC
Confidence 75 4589999999 9999999986432 499999999999999999999998 999999999999999 8
Q ss_pred CCCcEEeccCCccccccc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCC
Q 008431 394 AYEPLLTDYALVPIVNKE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKG 462 (565)
Q Consensus 394 ~~~~kl~DfGla~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~ 462 (565)
++.+||+|||+++..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~--- 266 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK--- 266 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT---
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence 899999999999765432 123489999999999999999999999999999999999999974211
Q ss_pred CCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 463 ANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
......+....... ....++++.+..... ...+.+++..||+.||++|||+.++++.|+++....
T Consensus 267 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 267 -DPKYVRDSKIRYRE-NIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp -CHHHHHHHHHHHHH-CHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -CHHHHHHHHHHhhh-hHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11122222222222 223344444322222 236788888999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=377.66 Aligned_cols=249 Identities=20% Similarity=0.391 Sum_probs=204.6
Q ss_pred hccceecccCceeEEEEEEeC-CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLLT-GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
...+.||+|+||.||+|.+.. +..||||.++.. ....++|.+|+.+|++++|||||+++++|...+..++||||+++|
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 456889999999999999764 789999999754 335678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 302 ~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 302 NLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp BHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred CHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 99999986432 2489999999999999999999998 99999999999999999999999999998764321
Q ss_pred ---cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 413 ---AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 413 ---~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
...+++.|+|||++....++.++|||||||++|||+| |+.||.... ..+.. ..+......
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--------~~~~~-~~~~~~~~~------- 438 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVY-ELLEKDYRM------- 438 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--------GGGHH-HHHHTTCCC-------
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHcCCCC-------
Confidence 2234678999999988889999999999999999999 999986321 11111 111111100
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
..+......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 439 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0011222467889999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=371.69 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=201.0
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
...+.||+|+||+||+|.+..+..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||+++|+
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 3567899999999999998887889999997543 346789999999999999999999999865 77899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 265 L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 265 LLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp HHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 9999975322 1389999999999999999999998 9999999999999999999999999999876432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....++..|+|||++....++.++|||||||++|||+| |+.||... ...+..... ..+...
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i-~~~~~~-------- 400 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQV-ERGYRM-------- 400 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHH-HTTCCC--------
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHH-HcCCCC--------
Confidence 12345678999999888899999999999999999999 99998621 122222222 221110
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCC
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDN 534 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 534 (565)
..+......+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 401 --~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 401 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 0011223467889999999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=361.92 Aligned_cols=243 Identities=22% Similarity=0.310 Sum_probs=195.7
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+.||+|+||.||+|.. .+|..||+|+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999995 46899999999865555667899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE--cCCCCcEEeccCCccccccc---
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL--DNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl--~~~~~~kl~DfGla~~~~~~--- 411 (565)
.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 174 ~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 174 FDRIIDESY----NLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp HHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 999875432 389999999999999999999998 99999999999999 66788999999999876543
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|+|||++....++.++|||||||++|||++|+.||.. ......+.......+. ..++...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~--------~~~~~~~~~i~~~~~~--~~~~~~~-- 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG--------DNDAETLNNILACRWD--LEDEEFQ-- 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCC--SCSGGGT--
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhccCC--CChhhhc--
Confidence 234689999999999888999999999999999999999999962 2222333333332211 1111111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.....+.+++.+||+.||++|||+.|+++
T Consensus 314 ----~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 ----DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11236788999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=349.59 Aligned_cols=265 Identities=20% Similarity=0.305 Sum_probs=208.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC--ceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE--EKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~E~~~ 332 (565)
..++||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCC
Confidence 3578999999999999965 58999999997533 344677899999999999999999999998765 6799999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE----cCCCCcEEeccCCcccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL----DNAYEPLLTDYALVPIV 408 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfGla~~~ 408 (565)
+|+|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 93 ~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 93 CGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp TCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999865432 2389999999999999999999998 99999999999999 88888999999999876
Q ss_pred ccc---ccccccccccCCCccC--------CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 409 NKE---HAQLHMVAYKSPEFNQ--------TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 409 ~~~---~~~~~t~~y~aPE~~~--------~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
... ....+|+.|+|||++. ...++.++|||||||++|||+||+.||..... .......+......
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG----PRRNKEVMYKIITG 242 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC----GGGCHHHHHHHHHH
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----cchhHHHHHHHhcC
Confidence 543 2446889999999865 56789999999999999999999999974221 12223333333322
Q ss_pred ccc---Ccc---------ccccccC-CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 478 EWT---GEV---------FDKDMRG-TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 478 ~~~---~~~---------~d~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
... ..+ ..+.+.. ..........+.+++.+||+.||++|||++|+++...+..-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 110 000 0011111 11234566678899999999999999999999999887643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=362.29 Aligned_cols=243 Identities=19% Similarity=0.256 Sum_probs=192.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..++||+|+||+||+|+.. +++.||+|+++... ....+.+.+|..++.++ +|||||++++++.+.+..|+||||+
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 4578999999999999965 57889999997532 22335688899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 136 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999998654 399999999999999999999998 999999999999999999999999999976322
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||................+......... .
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~ 280 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R 280 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------C
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------C
Confidence 2345789999999999999999999999999999999999999963221111111122222222222111 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
+ +......+.+++.+||+.||++||++
T Consensus 281 ~-----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 I-----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp C-----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred C-----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 11122367888999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=364.74 Aligned_cols=255 Identities=20% Similarity=0.268 Sum_probs=202.3
Q ss_pred hccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCc-eEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEE-KLL 326 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~-~~l 326 (565)
...+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|+++++++ +|||||++++++.+.+. .++
T Consensus 25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i 104 (359)
T 3vhe_A 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 104 (359)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence 35678999999999999843 34689999997532 23346799999999999 79999999999987654 899
Q ss_pred EEeccCCCCHHHHHhhcCCCC-----------------------------------------------------------
Q 008431 327 VSDFVPNGSLANLLHVRRAPG----------------------------------------------------------- 347 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~~----------------------------------------------------------- 347 (565)
||||+++|+|.+++.......
T Consensus 105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3vhe_A 105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184 (359)
T ss_dssp EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence 999999999999998654210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc------cccccccc
Q 008431 348 --QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE------HAQLHMVA 419 (565)
Q Consensus 348 --~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~------~~~~~t~~ 419 (565)
...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....+|+.
T Consensus 185 ~~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 185 LYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp TTTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred hhccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 11288999999999999999999998 9999999999999999999999999999765332 23456788
Q ss_pred ccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHH
Q 008431 420 YKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEM 498 (565)
Q Consensus 420 y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 498 (565)
|+|||++.+..++.++|||||||++|||+| |+.||... .....+........... . +....
T Consensus 261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~~~~~~~~~~-----~-----~~~~~ 322 (359)
T 3vhe_A 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--------KIDEEFCRRLKEGTRMR-----A-----PDYTT 322 (359)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--------CCSHHHHHHHHHTCCCC-----C-----CTTCC
T ss_pred eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc--------chhHHHHHHHHcCCCCC-----C-----CCCCC
Confidence 999999988899999999999999999999 99999631 11122222222221111 0 01112
Q ss_pred HHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 499 LKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 499 ~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 3678889999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=347.96 Aligned_cols=249 Identities=20% Similarity=0.350 Sum_probs=191.2
Q ss_pred hccceecccCceeEEEEEEeC----CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 256 ASAEVLGSGSFGSSYKAVLLT----GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
...+.||+|+||+||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++ ..+..++||||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 96 (281)
T 1mp8_A 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMEL 96 (281)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEec
Confidence 356789999999999998643 3468999886532 33456799999999999999999999997 45678999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 97 CTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp CTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred CCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999986542 389999999999999999999998 999999999999999999999999999977643
Q ss_pred cc-----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 411 EH-----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 411 ~~-----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
.. ...+++.|+|||++....++.++|||||||++|||++ |+.||..... ... ........ ..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~---~~~i~~~~-~~--- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDV---IGRIENGE-RL--- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGH---HHHHHTTC-CC---
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHH---HHHHHcCC-CC---
Confidence 32 2345678999999888889999999999999999997 9999863211 111 11111111 00
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.. +......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 237 --~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 --PM-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01 111224678899999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.59 Aligned_cols=245 Identities=21% Similarity=0.259 Sum_probs=198.4
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|||||++++++.+.+..|+||||++
T Consensus 32 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 111 (362)
T 2bdw_A 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111 (362)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 35678999999999999964 68899999997532 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC---CCcEEeccCCccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA---YEPLLTDYALVPIVN 409 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGla~~~~ 409 (565)
+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 112 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 112 GGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp SCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999997543 389999999999999999999998 99999999999999865 459999999998765
Q ss_pred cc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 410 KE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 410 ~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
.. ....||+.|+|||++.+..++.++|||||||++|||++|++||.. .+............. ....+
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~--------~~~~~~~~~i~~~~~--~~~~~ 252 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYAQIKAGAY--DYPSP 252 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCC--CCCTT
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCCC--CCCcc
Confidence 43 235789999999999998999999999999999999999999962 122222222222111 00011
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. ......+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 EW------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GG------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 1112467889999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=355.16 Aligned_cols=239 Identities=18% Similarity=0.242 Sum_probs=195.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 357899999999999995 57899999998742 1233457899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 92 GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 789999987654 389999999999999999999999 9999999999999999999999999999876543
Q ss_pred --ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ....+.....
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------------~~~~i~~~~~ 225 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------------LFKKVNSCVY 225 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------CBCCCCSSCC
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------------HHHHHHcCCC
Confidence 34578999999999988776 789999999999999999999997321100 0001100000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. .+......+.+++.+||+.||++|||+.|+++.
T Consensus 226 ~---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 V---MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp C---CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C---CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 011122467889999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.91 Aligned_cols=244 Identities=20% Similarity=0.228 Sum_probs=197.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|.. .+|+.+|+|++.... ....+.+.+|+.+++.++|||||++++++.+.+..|+||||+++
T Consensus 15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 457899999999999985 478899999987533 23345789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc---CCCCcEEeccCCcccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD---NAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~~~~~ 410 (565)
|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 95 g~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 95 GELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999998654 389999999999999999999998 999999999999998 467899999999977654
Q ss_pred c----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 411 E----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 411 ~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
. ....||+.|+|||++.+..|+.++||||+||++|||++|++||.. .+............. ....+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~--~~~~~ 235 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD--------EDQHRLYQQIKAGAY--DFPSP 235 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTCC--CCCTT
T ss_pred CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHHhCCC--CCCcc
Confidence 3 234789999999999998999999999999999999999999962 122222222222211 11111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
... .....+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~------~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 EWD------TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccc------cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111 112367888999999999999999999873
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=360.36 Aligned_cols=239 Identities=22% Similarity=0.228 Sum_probs=194.8
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..+++.+ +||||+++++++.+.+..|+||||+
T Consensus 27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 106 (353)
T 3txo_A 27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCC
Confidence 4578999999999999964 6899999999753 233456788999999988 6999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 107 NGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999998654 389999999999999999999998 9999999999999999999999999999764322
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....||+.|+|||++.+..|+.++|||||||++|||++|+.||.. .+.............. .|
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~~~----~p- 244 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA--------ENEDDLFEAILNDEVV----YP- 244 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCC----CC-
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCC----CC-
Confidence 345689999999999888899999999999999999999999962 2223333333222110 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCH------HHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL------REAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~------~evl~ 524 (565)
......+.+++.+||+.||++||++ .|+++
T Consensus 245 -------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 -------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1112367788899999999999998 67654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=344.21 Aligned_cols=244 Identities=24% Similarity=0.374 Sum_probs=188.2
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|.. .+..||||.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence 357899999999999996 58899999986432 2234679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC---CccCCCCCCCEEEcC--------CCCcEEec
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT---LPHGHLKSSNVLLDN--------AYEPLLTD 401 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~---ivHrDlkp~NILl~~--------~~~~kl~D 401 (565)
+|+|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||++. ++.+||+|
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 90 GGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp TEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred CCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999998532 389999999999999999999998 6 899999999999986 77899999
Q ss_pred cCCccccccc--ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 402 YALVPIVNKE--HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 402 fGla~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
||+++..... ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||... ..............
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~~ 231 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--------DGLAVAYGVAMNKL 231 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHTSCC
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHhhhcCCC
Confidence 9999765433 3456889999999998888999999999999999999999999631 11111111111111
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
. ... +......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 ~-----~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 A-----LPI-----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C-----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C-----CCC-----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 011 111224688899999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=344.01 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=200.3
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. ++..||||.+.... ....+.|.+|+.++++++||||+++++++.+. +..++||||++
T Consensus 14 ~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence 457899999999999997 48899999987532 33356799999999999999999999999876 67899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--CccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT--LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~--ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+|+|.+++..... ..+++..+..++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 93 YGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp TCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred CCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 9999999986432 2489999999999999999999997 6 9999999999999999999999998875432
Q ss_pred cccccccccccCCCccCCCCCCc---chhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 EHAQLHMVAYKSPEFNQTDGVTR---KTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ~~~~~~t~~y~aPE~~~~~~~~~---~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.....+|+.|+|||++.+..++. ++|||||||++|||+||+.||.. ................ +.
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~--------~~~~~~~~~~~~~~~~-----~~ 231 (271)
T 3kmu_A 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD--------LSNMEIGMKVALEGLR-----PT 231 (271)
T ss_dssp CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT--------SCHHHHHHHHHHSCCC-----CC
T ss_pred ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc--------cChHHHHHHHHhcCCC-----CC
Confidence 23457789999999887665544 89999999999999999999962 1222222222222211 11
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
+. ......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 232 ~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 IP-----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11 1122367888999999999999999999999999865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=345.20 Aligned_cols=247 Identities=22% Similarity=0.393 Sum_probs=195.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccC-------HHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVG-------KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||+||+|.. .+++.||+|++....... .+.+.+|+.++++++||||+++++++.+. .++||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~lv~ 100 (287)
T 4f0f_A 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVM 100 (287)
T ss_dssp EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--TEEEE
T ss_pred ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--CeEEE
Confidence 457899999999999996 478899999986432211 16789999999999999999999998544 47999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--CccCCCCCCCEEEcCCCC-----cEEec
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT--LPHGHLKSSNVLLDNAYE-----PLLTD 401 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~--ivHrDlkp~NILl~~~~~-----~kl~D 401 (565)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++. +||+|
T Consensus 101 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ECCTTCBHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EecCCCCHHHHHhcccC----CccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 99999999999875443 499999999999999999999998 7 999999999999988776 99999
Q ss_pred cCCccccccc-ccccccccccCCCcc--CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 402 YALVPIVNKE-HAQLHMVAYKSPEFN--QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 402 fGla~~~~~~-~~~~~t~~y~aPE~~--~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
||+++..... ....+|+.|+|||++ ....++.++|||||||++|||++|+.||.... ..-..+........
T Consensus 173 fg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 173 FGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS------YGKIKFINMIREEG 246 (287)
T ss_dssp CTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC------CCHHHHHHHHHHSC
T ss_pred CCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc------ccHHHHHHHHhccC
Confidence 9999765443 345688999999988 44567899999999999999999999996321 11122222222221
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.. +.+. ......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 247 ~~-----~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LR-----PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CC-----CCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CC-----CCCC-----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 1111 11224688899999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.02 Aligned_cols=247 Identities=17% Similarity=0.263 Sum_probs=197.7
Q ss_pred hccceecccCceeEEEEEE-eCCCeeEEEEeecc-----CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 256 ASAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM-----SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
...+.||+|+||+||+|.. .+++.||||.+... .....+.+.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus 27 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 106 (351)
T 3c0i_A 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106 (351)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4568899999999999995 47899999998632 12246789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC---cEEeccCCcc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE---PLLTDYALVP 406 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfGla~ 406 (565)
|+++|+|.+++...... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 107 ~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 107 FMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp CCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred CCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999888654321 12489999999999999999999998 9999999999999986654 9999999997
Q ss_pred ccccc----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 407 IVNKE----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 407 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||... -.............
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~i~~~~~~-- 250 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---------KERLFEGIIKGKYK-- 250 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---------HHHHHHHHHHTCCC--
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---------HHHHHHHHHcCCCC--
Confidence 76543 2346899999999999989999999999999999999999999621 11122222211110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 251 -~~~~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -MNPRQWS-----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCHHHHT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCccccc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0110000 11236788999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=352.84 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=203.6
Q ss_pred hccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 328 (565)
...+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence 35678999999999999852 34789999987532 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCE
Q 008431 329 DFVPNGSLANLLHVRRAP-------------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNV 389 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NI 389 (565)
||+++|+|.+++...... ....+++..+..++.|++.||.|||+. +|+||||||+||
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dikp~NI 181 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVHRDLAARNI 181 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGE
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCcccccchheE
Confidence 999999999999865431 112388999999999999999999998 999999999999
Q ss_pred EEcCCCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCC
Q 008431 390 LLDNAYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKG 462 (565)
Q Consensus 390 Ll~~~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~ 462 (565)
+++.++.+||+|||+++..... ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 258 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--- 258 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999999765432 22345678999999888889999999999999999999 9999863211
Q ss_pred CCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 463 ANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+.. ........ .. +......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 259 --~~~~~----~~~~~~~~-----~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 --ERLFN----LLKTGHRM-----ER-----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp --GGHHH----HHHTTCCC-----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHHH----HhhcCCcC-----CC-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 11111 11111110 00 111224688899999999999999999999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.22 Aligned_cols=239 Identities=20% Similarity=0.267 Sum_probs=199.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+.. +|+.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 4578999999999999964 7899999999753 12345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 90 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 999999998643 389999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+............. ...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~~-------~~p-- 223 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD--------SNTMKTYEKILNAEL-------RFP-- 223 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHCCC-------CCC--
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCC-------CCC--
Confidence 355789999999999999999999999999999999999999962 222233333322210 010
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
......+.+++.+||+.||++|| +++|+++
T Consensus 224 ---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 ---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11123677888899999999999 8888874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=353.16 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=192.5
Q ss_pred hccceecccCceeEEEEEEeC-CC---eeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCce-----
Q 008431 256 ASAEVLGSGSFGSSYKAVLLT-GP---AMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEK----- 324 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----- 324 (565)
...+.||+|+||+||+|.... +. .||||.++.. .....+.+.+|++++++++||||+++++++...+..
T Consensus 26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 346789999999999998543 32 7999998753 234457899999999999999999999999876654
Q ss_pred -EEEEeccCCCCHHHHHhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 325 -LLVSDFVPNGSLANLLHVRRAPG-QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 325 -~lv~E~~~~gsL~~~l~~~~~~~-~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcCCCCEEEeec
Confidence 99999999999999997544221 22489999999999999999999998 9999999999999999999999999
Q ss_pred CCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHh
Q 008431 403 ALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVV 475 (565)
Q Consensus 403 Gla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 475 (565)
|+++..... ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... .........
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~ 253 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE--------NAEIYNYLI 253 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------GGGHHHHHH
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC--------hHHHHHHHh
Confidence 999765432 12345678999999988899999999999999999999 999986321 111222221
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..... ..+......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 254 ~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 254 GGNRL-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TTCCC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCCCC-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11100 001112246888999999999999999999999999997764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.11 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=195.2
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|+..+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||++ |
T Consensus 25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 103 (311)
T 3niz_A 25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-K 103 (311)
T ss_dssp EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-E
T ss_pred hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-C
Confidence 347899999999999998889999999987432 2234678999999999999999999999999999999999998 5
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 104 DLKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 88888875443 489999999999999999999998 9999999999999999999999999999765432
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc-----
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF----- 484 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 484 (565)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.............
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-----DDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST-----TTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHHCCCChHHhhhhhcc
Confidence 33467899999998765 5689999999999999999999999973221 12222222222111100000
Q ss_pred ----cccccCC-CCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 485 ----DKDMRGT-KSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 485 ----d~~~~~~-~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+...... ... ......+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 000 011246788999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.24 Aligned_cols=244 Identities=23% Similarity=0.296 Sum_probs=199.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|.. .+++.||||++..... ...+++.+|+.++++++|||||++++++...+..++||||+.
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 457899999999999995 5788999999975322 223578999999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 138 -g~l~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 208 (348)
T 1u5q_A 138 -GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 208 (348)
T ss_dssp -EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred -CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC
Confidence 689888865443 389999999999999999999998 99999999999999999999999999998877777
Q ss_pred cccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 413 AQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
...+|+.|+|||++. ...++.++|||||||++|||+||+.||.. ......+........ +...
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~--------~~~~~~~~~~~~~~~------~~~~ 274 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQNES------PALQ 274 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSCC------CCCC
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHHhcCC------CCCC
Confidence 778999999999873 56789999999999999999999999862 122222322222211 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
.. .....+.+++.+||+.||++|||+.|+++..-
T Consensus 275 ~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 275 SG----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CC----CCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11 11235778889999999999999999986533
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.16 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=199.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|... +++.||+|.+..........+.+|+.+++.++|||||++++++.+.+..++||||+++|+
T Consensus 55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 4578999999999999964 688999999876544456689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC--CCCcEEeccCCccccccc--
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN--AYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~-- 411 (565)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 135 L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 135 LFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp HHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999865432 489999999999999999999998 9999999999999974 577999999999876543
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ......+.......+. .++...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~--------~~~~~~~~~i~~~~~~---~~~~~~- 274 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--------EDDLETLQNVKRCDWE---FDEDAF- 274 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHCCCC---CCSSTT-
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC---CCcccc-
Confidence 234689999999999999999999999999999999999999962 1222222222222111 111110
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+||+.||++|||+.|+++.
T Consensus 275 ----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 ----SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1112367889999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.87 Aligned_cols=241 Identities=19% Similarity=0.268 Sum_probs=192.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc-----------
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE----------- 323 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----------- 323 (565)
..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.++++++|||||+++++|.+.+.
T Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 4578999999999999975 78999999997433 3345789999999999999999999999866432
Q ss_pred ----------------------------------------------eEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHH
Q 008431 324 ----------------------------------------------KLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRL 357 (565)
Q Consensus 324 ----------------------------------------------~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~ 357 (565)
.++||||+++|+|.+++...... ...++..++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--EDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cchhhHHHH
Confidence 79999999999999999865432 236777899
Q ss_pred HHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----------------cccccccccc
Q 008431 358 KIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----------------HAQLHMVAYK 421 (565)
Q Consensus 358 ~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----------------~~~~~t~~y~ 421 (565)
.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....+|+.|+
T Consensus 168 ~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999999998 9999999999999999999999999999776433 2235889999
Q ss_pred CCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHH
Q 008431 422 SPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKL 501 (565)
Q Consensus 422 aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 501 (565)
|||++.+..++.++|||||||++|||++|..|+... ...... ......... .......+
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~-~~~~~~~~~----------~~~~~~~~ 302 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITD-VRNLKFPLL----------FTQKYPQE 302 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHH-HHTTCCCHH----------HHHHCHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHH-hhccCCCcc----------cccCChhH
Confidence 999999989999999999999999999998875411 111111 111100000 11223466
Q ss_pred HHHHhhccccCcCCCCCHHHHHH
Q 008431 502 LKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 502 ~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+++.+||+.||++|||+.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 88999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=347.09 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=196.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|.. .++.||+|++... ...+.|.+|+.++++++||||+++++++. +..++||||+++|+|
T Consensus 12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L 86 (307)
T 2eva_A 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBH
T ss_pred eeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCH
Confidence 457899999999999987 5788999998642 34578999999999999999999999875 558999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC-cEEeccCCccccccc-ccc
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE-PLLTDYALVPIVNKE-HAQ 414 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~-~kl~DfGla~~~~~~-~~~ 414 (565)
.+++..... ...+++..++.++.|+++||+|||+.. +.+|+||||||+|||++.++. +||+|||+++..... ...
T Consensus 87 ~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (307)
T 2eva_A 87 YNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN 163 (307)
T ss_dssp HHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred HHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccC
Confidence 999975432 124788999999999999999999831 118999999999999998886 799999998765433 345
Q ss_pred cccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCC
Q 008431 415 LHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSG 494 (565)
Q Consensus 415 ~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 494 (565)
.+|+.|+|||++.+..++.++|||||||++|||+||+.||.... ............. .. +...
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~-~~-----~~~~----- 226 (307)
T 2eva_A 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVHNG-TR-----PPLI----- 226 (307)
T ss_dssp -CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHHHTT-CC-----CCCB-----
T ss_pred CCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHHhcC-CC-----CCcc-----
Confidence 68999999999999899999999999999999999999996321 1111111111111 11 1111
Q ss_pred HHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCCCCC
Q 008431 495 EGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNED 538 (565)
Q Consensus 495 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~~~ 538 (565)
......+.+++.+||+.||++|||+.|+++.|+.+........+
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 11123678899999999999999999999999999876544443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.74 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=206.0
Q ss_pred hccceecccCceeEEEEEE------eCCCeeEEEEeeccCc-cCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEE
Q 008431 256 ASAEVLGSGSFGSSYKAVL------LTGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 327 (565)
...+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 105 (313)
T 1t46_A 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105 (313)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEE
Confidence 3567899999999999985 2457899999975432 3456799999999999 999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC
Q 008431 328 SDFVPNGSLANLLHVRRAP-------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA 394 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~ 394 (565)
|||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETT
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEcCC
Confidence 9999999999999865421 112489999999999999999999998 99999999999999999
Q ss_pred CCcEEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcch
Q 008431 395 YEPLLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADL 467 (565)
Q Consensus 395 ~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~ 467 (565)
+.+||+|||+++...... ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... .
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~ 253 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--------V 253 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------S
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc--------c
Confidence 999999999997765432 2345678999999888889999999999999999999 999986321 1
Q ss_pred HHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
...+.......... .. +......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 254 ~~~~~~~~~~~~~~-~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 254 DSKFYKMIKEGFRM-LS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp SHHHHHHHHHTCCC-CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hhHHHHHhccCCCC-CC---------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 12222222221110 00 0112246788899999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.49 Aligned_cols=250 Identities=20% Similarity=0.344 Sum_probs=190.4
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|+. ...||+|+++... ....+.|.+|+.++++++||||+++++++ ..+..++||||++++
T Consensus 28 ~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 457899999999999974 3459999987432 23346799999999999999999999965 556789999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 105 SLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred cHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999965433 499999999999999999999998 9999999999999999999999999998765421
Q ss_pred ---ccccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 ---HAQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....+|+.|+|||++. ...++.++|||||||++|||++|+.||... .....+..........
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~~~~---- 244 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------NNRDQIIEMVGRGSLS---- 244 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC--------CCHHHHHHHHHHTSCC----
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc--------chHHHHHHHhcccccC----
Confidence 2345789999999876 567889999999999999999999999632 1112222222222111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
+.+... .......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 245 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLSKV--RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTTSS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchhhc--cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111110 01222478889999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=361.10 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=193.4
Q ss_pred ccceecccCceeEEEEEEeCC----CeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEe-cCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTG----PAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-KEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|...+. ..||||.++... ....++|.+|+.++++++||||++++++|.. ++..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 457899999999999996432 368999886432 3345789999999999999999999999765 4578999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 173 ~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 173 MKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CCCCCHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999975433 388999999999999999999998 999999999999999999999999999976532
Q ss_pred c--------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 411 E--------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 411 ~--------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
. ....+++.|+|||++.+..++.++|||||||++|||+| |.+||.... ...+...+ ....
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~~~---~~~~--- 313 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYL---LQGR--- 313 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHHHH---HTTC---
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHHHH---HcCC---
Confidence 2 12345678999999988899999999999999999999 677775321 11222211 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
....+ ......+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 314 ~~~~p--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 314 RLLQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CCCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 00011 11223678899999999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=343.87 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=200.3
Q ss_pred ccceecccCceeEEEEEEeC-CC---eeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCce-EEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLT-GP---AMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEK-LLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lv~E~ 330 (565)
..++||+|+||+||+|...+ +. .||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 45789999999999998543 33 689999875332 3456799999999999999999999999876655 999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+.+|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 105 MCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ccCCCHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999976432 489999999999999999999998 999999999999999999999999999975532
Q ss_pred c--------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 411 E--------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 411 ~--------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
. ....+++.|+|||.+.+..++.++|||||||++|||+||..|+.... ....+...+ ......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----~~~~~~~~~----~~~~~~- 247 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPFDLTHFL----AQGRRL- 247 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CGGGHHHHH----HTTCCC-
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----CHHHHHHHh----hcCCCC-
Confidence 2 23356789999999999999999999999999999999655543111 111111111 111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCCC
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDN 536 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~ 536 (565)
.. +......+.+++.+||+.||++|||+.|+++.|+++.......
T Consensus 248 ----~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 248 ----PQ-----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ----CC-----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 00 1111236788999999999999999999999999998765443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=354.03 Aligned_cols=243 Identities=19% Similarity=0.251 Sum_probs=192.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc---cCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|..+++++ +|||||++++++.+.+..|+||||+
T Consensus 13 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~ 92 (345)
T 3a8x_A 13 LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 92 (345)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCC
Confidence 4578999999999999964 688999999975422 2245688999999987 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 93 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999998654 389999999999999999999998 999999999999999999999999999976322
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||................+......... .
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~ 237 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R 237 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------C
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------C
Confidence 2345789999999999999999999999999999999999999963221111001112222222222111 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
+. ......+.+++.+||+.||++||++
T Consensus 238 ~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 IP-----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CC-----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 1112367888999999999999995
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=344.75 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=193.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|...+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 357899999999999998889999999996432 23346789999999999999999999999999999999999985
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 85 DLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 99999875432 489999999999999999999998 9999999999999999999999999998765422
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh---hc----cc--
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR---EE----WT-- 480 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~----~~-- 480 (565)
....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||... ........... .. +.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV--------SEADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHHCCCChhhchhh
Confidence 23467899999998865 45899999999999999999999999632 11111211111 00 00
Q ss_pred --CccccccccCCC------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 --GEVFDKDMRGTK------SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 --~~~~d~~~~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...+++...... ........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000111111000 00112246778999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.96 Aligned_cols=239 Identities=18% Similarity=0.215 Sum_probs=199.6
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|+.. +|+.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 4578999999999999964 7899999999743 22345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 999999998654 389999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .............. . .+.
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~-~------~~p-- 258 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA--------DQPIQIYEKIVSGK-V------RFP-- 258 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCC-C------CCC--
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC--------CCHHHHHHHHHcCC-C------CCC--
Confidence 355789999999999999999999999999999999999999962 22223332222221 1 010
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 524 (565)
......+.+++.+||+.||++||+ +.|+++
T Consensus 259 ---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 ---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111236788899999999999998 888865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=353.58 Aligned_cols=242 Identities=20% Similarity=0.246 Sum_probs=182.5
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|+.. +++.||||.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 4578999999999999965 57889999997532 35678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCccccccc-
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~~~- 411 (565)
|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 135 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 135 LFDRIVEKG-----YYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp HHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999997543 389999999999999999999998 9999999999999975 889999999999876443
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............. ....+..
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~i~~~~~--~~~~~~~- 275 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER-------GDQFMFRRILNCEY--YFISPWW- 275 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-------CHHHHHHHHHTTCC--CCCTTTT-
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc-------ccHHHHHHHHhCCC--ccCCchh-
Confidence 34568999999999999899999999999999999999999986211 11111222221111 1111111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.||++|||+.|+++
T Consensus 276 -----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 -----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112246788999999999999999999976
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=356.11 Aligned_cols=242 Identities=21% Similarity=0.299 Sum_probs=195.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++|||||+++++|.+.+..|+||||++
T Consensus 19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 4578999999999999954 6889999998642 23345688999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 99 GGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp TEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999997543 399999999999999999999998 9999999999999999999999999999876433
Q ss_pred --ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 --HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....||+.|+|||++.. ..|+.++|||||||++|||++|+.||.... ............... .
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~-~------ 237 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-----STSSKEIVHTFETTV-V------ 237 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT-----TSCHHHHHHHHHHCC-C------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhhcc-c------
Confidence 35578999999998864 458999999999999999999999996321 112222222221111 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCC-HHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWD-LREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~ 524 (565)
.. +......+.+++.+||+.||++||+ ++++.+
T Consensus 238 ~~-----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TY-----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CC-----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CC-----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 1111246788899999999999998 666653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.15 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=201.3
Q ss_pred hccceecccCceeEEEEEEe------CCCeeEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 327 (565)
...+.||+|+||+||+|... ++..||+|.+... .....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 35689999999999999962 3457999999743 233457899999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCE
Q 008431 328 SDFVPNGSLANLLHVRRAP------------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNV 389 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NI 389 (565)
|||+++|+|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NI 203 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNV 203 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGE
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhE
Confidence 9999999999999865421 012389999999999999999999998 999999999999
Q ss_pred EEcCCCCcEEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCC
Q 008431 390 LLDNAYEPLLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKG 462 (565)
Q Consensus 390 Ll~~~~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~ 462 (565)
|++.++.+||+|||+++...... ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---- 279 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---- 279 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999997654332 2345678999999888889999999999999999998 999996321
Q ss_pred CCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 463 ANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
....+.......... .. +......+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 280 ----~~~~~~~~~~~~~~~-----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 ----VDANFYKLIQNGFKM-----DQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp ----CSHHHHHHHHTTCCC-----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----cHHHHHHHHhcCCCC-----CC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 112222222222110 00 0111246788899999999999999999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=348.79 Aligned_cols=239 Identities=20% Similarity=0.273 Sum_probs=188.8
Q ss_pred ccceecccCceeEEEEEE----eCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL----LTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+..|+||
T Consensus 21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 457899999999999996 478999999997532 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 101 EYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred eCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999998654 388999999999999999999998 9999999999999999999999999998754
Q ss_pred ccc----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 409 NKE----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 409 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.. ......+........
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~~----- 238 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG--------ENRKKTIDKILKCKL----- 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTCC-----
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCCC-----
Confidence 322 344689999999999888999999999999999999999999962 222223332222210
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
.+. ......+.+++.+||+.||++|| ++.|+++
T Consensus 239 --~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 --NLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 010 11123678888999999999999 7778765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=348.06 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=197.2
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC--CCCCccceEEEEEec----CceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL--SHPNLLPLIAFYYRK----EEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~----~~~~lv~E~ 330 (565)
..+.||+|+||.||+|+. +++.||||++... ....+.+|.+++..+ +||||+++++++... ...++||||
T Consensus 41 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred EEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 468999999999999987 4889999998643 234555666666554 899999999999887 678999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC----CCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF----PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+++|+|.++++.. .+++..+..++.|++.||+|||+.+ +..+|+||||||+|||++.++.+||+|||+++
T Consensus 117 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 117 HENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 9999999999753 3899999999999999999999752 12279999999999999999999999999997
Q ss_pred cccccc--------cccccccccCCCccCCCCCCcc------hhHHHHHHHHHHHHcC----------CCCccccccCCC
Q 008431 407 IVNKEH--------AQLHMVAYKSPEFNQTDGVTRK------TDVWSLGILILELLTG----------KFPANYLAQGKG 462 (565)
Q Consensus 407 ~~~~~~--------~~~~t~~y~aPE~~~~~~~~~~------~DvwS~Gvil~el~tg----------~~p~~~~~~~~~ 462 (565)
...... ...||+.|+|||++.+..++.+ +|||||||++|||+|| +.||.......
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~- 269 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD- 269 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC-
Confidence 654321 3468999999999887766665 9999999999999999 55554322111
Q ss_pred CCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 463 ANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
. ....+........ ..+..............+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 270 --~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 270 --P-SYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp --C-CHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred --C-chhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 1 1111121111111 11111111112356677999999999999999999999999999997653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=353.80 Aligned_cols=243 Identities=19% Similarity=0.267 Sum_probs=192.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||+++|
T Consensus 11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 3578999999999999965 78899999986432 233467899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 91 ELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999886432 389999999999999999999998 9999999999999999999999999999765322
Q ss_pred ---ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ........... .... .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~---~~~~-~ 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDWKEKK---TYLN-P 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-------SHHHHHHHTTC---TTST-T
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHHhccc---ccCC-c
Confidence 24568999999999877665 77999999999999999999999632110 01111111110 0000 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~------~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 W------KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp G------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c------ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 1122367789999999999999999999764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=344.11 Aligned_cols=254 Identities=16% Similarity=0.165 Sum_probs=203.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|.. .+++.||||.+.... ..+.+.+|+..++.+ +|+|++++++++......++||||+ +|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 357899999999999995 578899999986432 344688999999999 7999999999999999999999999 99
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC-----cEEeccCCccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE-----PLLTDYALVPIVN 409 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DfGla~~~~ 409 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 91 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 91 SLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp BHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999986533 389999999999999999999998 9999999999999987776 9999999997654
Q ss_pred cc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 410 KE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 410 ~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..............
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-----ATNKQKYERIGEKK 237 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS-----CCHHHHHHHHHHHH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc-----cccHHHHHHHHhhc
Confidence 32 234578999999999999999999999999999999999999974221 11222222221111
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.... .+.+.. .....+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 238 ~~~~--~~~~~~-----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 238 QSTP--LRELCA-----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHSC--HHHHTT-----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCcc--HHHHHh-----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 0000 000100 11236888999999999999999999999999998654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=350.88 Aligned_cols=256 Identities=20% Similarity=0.305 Sum_probs=204.3
Q ss_pred hhccceecccCceeEEEEEE--------eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCce
Q 008431 255 RASAEVLGSGSFGSSYKAVL--------LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEK 324 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 324 (565)
+...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 34568899999999999986 356789999997532 23356789999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPG-----------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN 393 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~ 393 (565)
++||||+++|+|.+++......+ ...+++..++.++.|++.||.|||+. +|+||||||+|||++.
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTE 192 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECT
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccceEEEcC
Confidence 99999999999999998654311 12489999999999999999999998 9999999999999999
Q ss_pred CCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcc
Q 008431 394 AYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANAD 466 (565)
Q Consensus 394 ~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~ 466 (565)
++.+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.. ..
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~--------~~ 264 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG--------IP 264 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT--------CC
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc--------CC
Confidence 999999999999765432 22345678999999888889999999999999999999 9999862 12
Q ss_pred hHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 467 LATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
........ ....... . +......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 265 ~~~~~~~~-~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 265 VEELFKLL-KEGHRMD-----K-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHHHH-HHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHH-hcCCCCC-----C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 22222222 2211100 1 0112236788999999999999999999999999997654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.20 Aligned_cols=238 Identities=20% Similarity=0.251 Sum_probs=195.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|+.. +|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..|+||||+
T Consensus 21 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 100 (345)
T 1xjd_A 21 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 100 (345)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 4578999999999999964 68899999997532 33456788899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 101 NGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999998654 389999999999999999999998 999999999999999999999999999976432
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+............ +.
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~-------~~ 236 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--------QDEEELFHSIRMDN-------PF 236 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCC-------CC
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC--------CCHHHHHHHHHhCC-------CC
Confidence 2345789999999999999999999999999999999999999962 22222222222211 11
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLR-EAV 523 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl 523 (565)
.. ......+.+++.+||+.||++||++. |+.
T Consensus 237 ~p-----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 YP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CC-----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 11123678889999999999999997 664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=346.59 Aligned_cols=240 Identities=18% Similarity=0.224 Sum_probs=187.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc--------------------------cCHHHHHHHHHHHhcCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN--------------------------VGKEDFHEHMTRLGSLSHP 309 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~ 309 (565)
..+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|++++++++||
T Consensus 17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 96 (298)
T 2zv2_A 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96 (298)
T ss_dssp EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence 357899999999999995 4688999999864321 1135689999999999999
Q ss_pred CccceEEEEEe--cCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCC
Q 008431 310 NLLPLIAFYYR--KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSS 387 (565)
Q Consensus 310 niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~ 387 (565)
||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~ 166 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDIKPS 166 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGG
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHH
Confidence 99999999987 5678999999999999875432 2499999999999999999999998 9999999999
Q ss_pred CEEEcCCCCcEEeccCCccccccc----ccccccccccCCCccCCCC---CCcchhHHHHHHHHHHHHcCCCCccccccC
Q 008431 388 NVLLDNAYEPLLTDYALVPIVNKE----HAQLHMVAYKSPEFNQTDG---VTRKTDVWSLGILILELLTGKFPANYLAQG 460 (565)
Q Consensus 388 NILl~~~~~~kl~DfGla~~~~~~----~~~~~t~~y~aPE~~~~~~---~~~~~DvwS~Gvil~el~tg~~p~~~~~~~ 460 (565)
|||++.++.+||+|||+++..... ....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~---- 242 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD---- 242 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC----
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC----
Confidence 999999999999999999765433 3456899999999887655 37889999999999999999999962
Q ss_pred CCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 461 KGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 461 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.....+........ .. .+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 243 ----~~~~~~~~~~~~~~-~~---~~~~------~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ----ERIMCLHSKIKSQA-LE---FPDQ------PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ----SSHHHHHHHHHHCC-CC---CCSS------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----ccHHHHHHHHhccc-CC---CCCc------cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 12222222222111 10 0100 011236788899999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=344.34 Aligned_cols=250 Identities=20% Similarity=0.385 Sum_probs=204.4
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
...+.||+|+||+||+|... ++..||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred eEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 34578999999999999965 4788999998753 334678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc--
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-- 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 412 (565)
+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 95 NLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred cHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 99999986433 2489999999999999999999999 99999999999999999999999999998765332
Q ss_pred ---cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 413 ---AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 413 ---~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ........ ..... ...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--------~~~~~~~~-~~~~~-----~~~ 233 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELL-EKDYR-----MER 233 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------GGGHHHHH-HTTCC-----CCC
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-hccCC-----CCC
Confidence 2345678999999988889999999999999999999 999986321 11111111 11100 000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 234 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 234 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111224688899999999999999999999999988654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=346.69 Aligned_cols=258 Identities=19% Similarity=0.301 Sum_probs=187.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|.. .+|+.||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||++ |
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 9 QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred EeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 346899999999999995 478999999997533 3345778999999999999999999999999999999999998 6
Q ss_pred CHHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 335 SLANLLHVRRAP-GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 335 sL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
+|.+++...... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 999999764321 123489999999999999999999998 9999999999999999999999999999765432
Q ss_pred --ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc----ccC---
Q 008431 412 --HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE----WTG--- 481 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--- 481 (565)
....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+....... +..
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhHhhhhhh
Confidence 34467899999998876 4689999999999999999999999963211 11111111111100 000
Q ss_pred -ccccccccCCC--C---------CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 -EVFDKDMRGTK--S---------GEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 -~~~d~~~~~~~--~---------~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....+.+.... . .......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000000 0 0011236889999999999999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=352.40 Aligned_cols=252 Identities=15% Similarity=0.139 Sum_probs=203.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|.. .+++.||||.+.... ..+.+.+|+.+++++ +||||+++++++...+..++||||+ +|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 357899999999999995 578899999987542 234688999999999 9999999999999999999999999 99
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC-----cEEeccCCccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE-----PLLTDYALVPIVN 409 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DfGla~~~~ 409 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 90 ~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 90 SLEDLFDLCDR----TFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp BHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999986432 499999999999999999999998 9999999999999998887 9999999998653
Q ss_pred cc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 410 KE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 410 ~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKIGDTK 236 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHHHhhh
Confidence 32 24468899999999999999999999999999999999999997421 122333222222111
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.... .+.+.. . ...+.+++..||+.||.+||++.+|.+.|+++...
T Consensus 237 ~~~~--~~~~~~-----~-~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 237 RATP--IEVLCE-----N-FPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHSC--HHHHTT-----T-CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCC--HHHHhc-----c-ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0000 000000 0 11788899999999999999999999999988765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=377.35 Aligned_cols=246 Identities=21% Similarity=0.306 Sum_probs=198.7
Q ss_pred eecccCceeEEEEEEe---CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 260 VLGSGSFGSSYKAVLL---TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999997543 3456789999999999999999999999875 56999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--- 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 412 (565)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 422 L~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999975432 499999999999999999999998 99999999999999999999999999998764321
Q ss_pred ----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 413 ----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 413 ----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
...+++.|+|||++....++.++|||||||++|||+| |+.||... ...+... .+..+....
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--------~~~~~~~-~i~~~~~~~----- 559 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMA-FIEQGKRME----- 559 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CSHHHHH-HHHTTCCCC-----
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------CHHHHHH-HHHcCCCCC-----
Confidence 1234578999999988899999999999999999998 99999732 1122221 222211100
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.+......+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 560 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 560 -----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 01122347888999999999999999999999999986554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=355.20 Aligned_cols=245 Identities=17% Similarity=0.222 Sum_probs=190.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.+++.++|||||++++++.+.+..++||||+++|+
T Consensus 24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 102 (361)
T 3uc3_A 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102 (361)
T ss_dssp EEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCC
Confidence 4578999999999999965 78999999997542 334678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC--cEEeccCCcccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PLLTDYALVPIVNK--- 410 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfGla~~~~~--- 410 (565)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 103 L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 103 LYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 999997654 389999999999999999999998 9999999999999987765 99999999874332
Q ss_pred cccccccccccCCCccCCCCCCcc-hhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 411 EHAQLHMVAYKSPEFNQTDGVTRK-TDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 411 ~~~~~~t~~y~aPE~~~~~~~~~~-~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
.....||+.|+|||++.+..++.+ +|||||||++|||++|+.||..... .......+......... +.
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~---~~---- 242 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----PRDYRKTIQRILSVKYS---IP---- 242 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCCC---CC----
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhcCCCC---CC----
Confidence 234578999999999888777665 8999999999999999999974221 12223333322222110 00
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. ......+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~---~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 DD---IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TT---SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred Cc---CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 0112367889999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=374.37 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=204.3
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
...+.||+|+||+||+|.+..+..||||+++... ...++|.+|+++|++++|||||++++++.+ +..|+||||+++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 3567899999999999998888889999997543 346789999999999999999999999865 67899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 348 L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 348 LLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp HHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred HHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 9999975322 1389999999999999999999998 9999999999999999999999999999876432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....++..|+|||++....++.++|||||||++|||+| |+.||... ...+.... +..+....
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--------~~~~~~~~-i~~~~~~~------- 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQ-VERGYRMP------- 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--------CHHHHHHH-HHTTCCCC-------
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH-HHcCCCCC-------
Confidence 22345678999999888899999999999999999999 99998621 12222222 22211100
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.+......+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 485 ---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 485 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 01122246788999999999999999999999999886543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.94 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=194.9
Q ss_pred ccceecccCceeEEEEEEe-CCCe----eEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPA----MVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|... ++.. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++||||
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 4578999999999999954 5555 6677665322 233456889999999999999999999885 5678999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 96 LPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp CTTCBSHHHHHSSGG----GSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred CCCCCHHHHHHHccc----cCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999976432 388999999999999999999998 999999999999999999999999999987643
Q ss_pred c------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 E------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
. ....++..|+|||++.+..++.++|||||||++|||+| |+.||.... ..... ........ .
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~-~~~~~~~~--~ 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--------LAEVP-DLLEKGER--L 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------TTHHH-HHHHTTCB--C
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC--------HHHHH-HHHHcCCC--C
Confidence 3 22345678999999988889999999999999999999 999997321 11111 11111110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+. .....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 237 ~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 AQPQ--------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CCCT--------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCC--------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0010 1112467788899999999999999999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=340.64 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=192.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 457899999999999996 468899999987543 345678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE---cCCCCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL---DNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~ 411 (565)
+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 106 ~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 106 ELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp BHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred cHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 999998654211 12499999999999999999999998 99999999999999 45688999999999765433
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....+|+.|+|||++. ..++.++|||||||++|||++|+.||.. ................. ....
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~~---~~~~ 248 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG--------TSLEEVQQKATYKEPNY---AVEC 248 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC---CC--
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC--------CCHHHHHhhhccCCccc---cccc
Confidence 3456789999999875 5689999999999999999999999962 22222222211111100 0000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 249 --~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 --RP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --Cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1236778899999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=348.65 Aligned_cols=250 Identities=21% Similarity=0.380 Sum_probs=197.4
Q ss_pred ccceecccCceeEEEEEEeCC-----CeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTG-----PAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|..... ..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 357899999999999986432 359999987532 23355799999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 128 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 128 MENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp CTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999976433 389999999999999999999998 999999999999999999999999999977643
Q ss_pred cc-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 411 EH-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 411 ~~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
.. ...+++.|+|||++....++.++|||||||++|||++ |+.||... .......... .....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--------~~~~~~~~~~-~~~~~- 269 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--------SNHEVMKAIN-DGFRL- 269 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHH-TTCCC-
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHH-CCCcC-
Confidence 21 1234678999999988899999999999999999999 99998621 1222222221 11100
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
. .+......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 270 ----~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 270 ----P-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ----C-----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----C-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 01112246788999999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=344.35 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=197.4
Q ss_pred ccceecccCceeEEEEEEeCC----CeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEe-cCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTG----PAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-KEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|....+ ..+|+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 457899999999999985422 258888887532 2345679999999999999999999999754 5578999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 109 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 109 MKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CTTCBHHHHHHCTTC----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred CCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999975432 489999999999999999999998 999999999999999999999999999976543
Q ss_pred c--------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 411 E--------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 411 ~--------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
. ....+|+.|+|||.+.+..++.++|||||||++|||++ |.+||.... ...... .......
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~~---~~~~~~~-- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITV---YLLQGRR-- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-----TTTHHH---HHHTTCC--
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-----HHHHHH---HHhcCCC--
Confidence 2 22345678999999988899999999999999999999 556664211 111111 1111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
...+ ......+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 251 -~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 -LLQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp -CCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred -CCCC--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0000 11123688899999999999999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=341.42 Aligned_cols=252 Identities=20% Similarity=0.226 Sum_probs=193.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 3578999999999999964 688999999975332 2346789999999999999999999999999999999999975
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 -~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 86 -DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp -EHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred -CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 66666654332 399999999999999999999998 9999999999999999999999999999765432
Q ss_pred --ccccccccccCCCccCCCC-CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh---cccC---c
Q 008431 412 --HAQLHMVAYKSPEFNQTDG-VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE---EWTG---E 482 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~ 482 (565)
....+|+.|+|||++.+.. ++.++|||||||++|||++|..|+... .+....+...... .... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~-------~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-------NDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-------SSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC-------CCHHHHHHHHHHHhCCCChhhhhh
Confidence 3446789999999887665 899999999999999999998886421 1222222222211 0000 0
Q ss_pred cc-ccccc----------CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VF-DKDMR----------GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~-d~~~~----------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. .+... ...........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00000 00001122346778999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.74 Aligned_cols=243 Identities=20% Similarity=0.248 Sum_probs=196.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||+||+|+.. +++.||+|++... .....+.+.+|+.+++.++|||||+++++|.+.+..|+||||++
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 4578999999999999965 6889999998742 12334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 153 gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 153 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp TEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999753 289999999999999999999998 9999999999999999999999999999776543
Q ss_pred ----ccccccccccCCCccCCCC----CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDG----VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~----~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
....||+.|+|||++.... |+.++|||||||++|||+||+.||.. .+................
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~~- 293 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--------DSLVGTYSKIMNHKNSLT- 293 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTHHHHCC-
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC--------CChhhHHHHHHhcccccc-
Confidence 2457899999999887655 78999999999999999999999962 223333333332211000
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAER--RWDLREAVEK 525 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 525 (565)
.|.. ......+.+++.+||+.+|.+ ||+++||++.
T Consensus 294 -~p~~------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 -FPDD------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -CCTT------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -CCCc------ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0100 011236778888999999998 9999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=348.76 Aligned_cols=248 Identities=22% Similarity=0.364 Sum_probs=194.1
Q ss_pred ccceecccCceeEEEEEE-eCCCee----EEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAM----VVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|.. .+++.+ |+|.+... .....+.+.+|+.++++++||||+++++++... ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~ 97 (327)
T 3lzb_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECC
T ss_pred EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEe
Confidence 457899999999999995 455554 66666532 344567899999999999999999999999865 48899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 98 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CSSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred cCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999987543 389999999999999999999998 999999999999999999999999999987643
Q ss_pred cc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 EH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
.. ...+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+... +......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~----~~~~~~~-- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSI----LEKGERL-- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHH----HHTTCCC--
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHH----HHcCCCC--
Confidence 21 2345678999999988899999999999999999999 9999973211 111111 1111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 239 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 --------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 00111223678899999999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=352.03 Aligned_cols=239 Identities=20% Similarity=0.224 Sum_probs=196.8
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|+.. +++.||+|.++.. .....+.+.+|..++..+ +||||+++++++.+.+..|+||||+
T Consensus 24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 103 (353)
T 2i0e_A 24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 103 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence 4578999999999999965 5789999999753 234456788999999988 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 104 NGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999998654 389999999999999999999998 999999999999999999999999999976422
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+............. .
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~~-------~ 239 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--------EDEDELFQSIMEHNV-------A 239 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCC-------C
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhCCC-------C
Confidence 2345789999999999999999999999999999999999999962 222233333332211 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 524 (565)
. +......+.+++.+||+.||++||+ +.|+++
T Consensus 240 ~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 Y-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp C-----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C-----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 0111236788899999999999995 577654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.57 Aligned_cols=246 Identities=17% Similarity=0.295 Sum_probs=179.1
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.+.||+|+||+||+|... +++.||||.+... ....+.+|+.+++.+. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 368999999999999964 6889999998642 3567889999999997 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC---CcEEeccCCccccccc-
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY---EPLLTDYALVPIVNKE- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfGla~~~~~~- 411 (565)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 93 LFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp HHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999998653 399999999999999999999998 999999999999997665 8999999999765433
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ................. ...+..
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~--~~~~~~ 240 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFS--FEGEAW 240 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCC--CCSHHH
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCC--CCcccc
Confidence 344678999999999999999999999999999999999999974322111 11222222222211110 000000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.||++|||+.|+++
T Consensus 241 ------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 ------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ------cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 111246788999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=365.81 Aligned_cols=239 Identities=20% Similarity=0.237 Sum_probs=189.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+++.++||||++++++|...+..++||||++
T Consensus 152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 457899999999999995 47889999999743 23344578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-hCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK-EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
+|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 232 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 232 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp SCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999997654 38999999999999999999998 6 8999999999999999999999999999764322
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.. ............... .
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~~-------~ 367 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELILMEEI-------R 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCC-------C
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHHhCCC-------C
Confidence 345689999999999999999999999999999999999999962 222223322222211 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
.. ......+.+++.+||+.||++|| |+.|+++
T Consensus 368 ~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC-----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00 11123678889999999999999 9999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=345.22 Aligned_cols=256 Identities=21% Similarity=0.281 Sum_probs=199.6
Q ss_pred ccceecccCceeEEEEEE-----eCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-----LTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 328 (565)
..+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|+.++++++||||+++++++... ...++||
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence 457899999999999984 36789999999743 334457899999999999999999999999876 6689999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp ECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999976543 389999999999999999999998 9999999999999999999999999999766
Q ss_pred ccc-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccC------CCCCcchHHHHHHHh
Q 008431 409 NKE-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQG------KGANADLATWVNSVV 475 (565)
Q Consensus 409 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~ 475 (565)
... ....+|..|+|||++.+..++.++|||||||++|||+||..|+...... ..........+....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 433 2335677899999998888999999999999999999999986421100 000000111111111
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
..... ...+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 257 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11100 0011122246888999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=344.57 Aligned_cols=238 Identities=20% Similarity=0.197 Sum_probs=187.5
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
...++||+|+||+||+|... +++.||||++.... ......+..|+..+.++ +||||++++++|.+.+..++||||+
T Consensus 60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~ 139 (311)
T 3p1a_A 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc
Confidence 34578999999999999975 78999999986432 22234556666665554 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
+|+|.+++..... .++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 140 -~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 140 -GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp -CCBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred -CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 6799999887543 499999999999999999999998 9999999999999999999999999998766433
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..| . .+... ...+.+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~-~-~~~~~----~~~~~~ 273 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGW-Q-QLRQG----YLPPEF 273 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHH-H-HHTTT----CCCHHH
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHH-H-HHhcc----CCCccc
Confidence 23458999999998876 7999999999999999999997665411 011 1 11111 111111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 274 ~~-----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TA-----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc-----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 11246888999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=341.74 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=200.5
Q ss_pred ceecccCceeEEEEEEe---CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999853 57789999997542 33456799999999999999999999999 566799999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 95 PLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CHHHHHHhCCc----cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999975432 489999999999999999999998 9999999999999999999999999999765432
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+...... .... +
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~i~-~~~~-----~ 232 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMAFIE-QGKR-----M 232 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CTHHHHHHHH-TTCC-----C
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHh-cCCc-----C
Confidence 12345788999999888889999999999999999999 99999632 1122222211 1111 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.. +......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 233 ~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 233 EC-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp CC-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC-----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 1112246888999999999999999999999999997653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=349.81 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=201.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhc--CCCCCccceEEEEEecC----ceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGS--LSHPNLLPLIAFYYRKE----EKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~E~ 330 (565)
..+.||+|+||+||+|+. +++.||||.+... ....+.+|++++.. ++||||+++++++...+ ..++||||
T Consensus 46 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred EEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 468899999999999987 6899999998642 35678889988887 79999999999998776 78999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY--------KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH--------~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+|||++.++.+||+||
T Consensus 122 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 122 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEECTTSCEEECCC
T ss_pred cCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999753 3899999999999999999999 55 8999999999999999999999999
Q ss_pred CCccccccc--------ccccccccccCCCccCCCC------CCcchhHHHHHHHHHHHHcC----------CCCccccc
Q 008431 403 ALVPIVNKE--------HAQLHMVAYKSPEFNQTDG------VTRKTDVWSLGILILELLTG----------KFPANYLA 458 (565)
Q Consensus 403 Gla~~~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~DvwS~Gvil~el~tg----------~~p~~~~~ 458 (565)
|+++..... ....+|+.|+|||++.+.. ++.++|||||||++|||+|| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998765432 2336789999999887652 34789999999999999999 67775322
Q ss_pred cCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 459 QGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 459 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.. ......+........ ..+.+............+.+++.+||+.||++|||+.||++.|+++....
T Consensus 272 ~~---~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 272 PS---DPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CS---SCCHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cC---cccHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 21 112223322222211 11222111112356678899999999999999999999999999997653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.39 Aligned_cols=251 Identities=16% Similarity=0.219 Sum_probs=194.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCcc---CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNV---GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 4578999999999999964 6889999998754222 24678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 118 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 118 GVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999998653 389999999999999999999998 9999999999999999999999999998765433
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....+++.|+|||++.+..++.++|||||||++|||++|+.||... . ...+........... ..
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~-~~~~~~~~~~~~~~~---~~ 256 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD--------Q-LSVMGAHINQAIPRP---ST 256 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC--------H-HHHHHHHHHSCCCCG---GG
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc--------h-HHHHHHHhccCCCCc---cc
Confidence 2346789999999999889999999999999999999999999621 1 112222222211100 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHhhccC
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRW-DLREAVEKIMELKERD 533 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~~~~ 533 (565)
... .....+.+++.+||+.||++|| |++++++.|+++....
T Consensus 257 ~~~-----~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 257 VRP-----GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TST-----TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cCC-----CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 100 1112678889999999999999 9999999999886554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.86 Aligned_cols=242 Identities=21% Similarity=0.251 Sum_probs=197.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 4578999999999999964 567899999987656667889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE---cCCCCcEEeccCCccccccc-
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL---DNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~- 411 (565)
|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++......
T Consensus 93 L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 93 LFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp HHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999997654 389999999999999999999998 99999999999999 88899999999998765433
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....+|+.|+|||++.+. ++.++|||||||++|||++|+.||... ............... .......
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~--~~~~~~~ 232 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP--------TDSEVMLKIREGTFT--FPEKDWL 232 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCC--CCHHHHT
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCCCC--CCchhhh
Confidence 345688999999987654 899999999999999999999999631 122222222111100 0000000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.....+.+++.+||+.||++|||+.|+++
T Consensus 233 ------~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 233 ------NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ------TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11246788999999999999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=346.51 Aligned_cols=253 Identities=19% Similarity=0.309 Sum_probs=203.6
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 4678999999999999854 46789999987532 2334578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRA-----PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
|+++|+|.+++..... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEEcCCCeEEECcCcc
Confidence 9999999999976421 1112478999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++..... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.. .............
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--------~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQVLRFVMEG 256 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHHHHHHHHTT
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc--------CCHHHHHHHHHcC
Confidence 9765432 23345788999999888889999999999999999999 8999862 1222222222221
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
. ... . +......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 257 ~-~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 257 G-LLD-----K-----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp C-CCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred C-cCC-----C-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1 100 0 011223678899999999999999999999999988654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=345.22 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=201.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe----cCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR----KEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++.. ....++||||+
T Consensus 33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 457899999999999996 6789999999876555566789999999999999999999999973 34689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 113 KRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp TTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred CCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 999999999864322 22499999999999999999999998 9999999999999999999999999998764321
Q ss_pred -------------ccccccccccCCCccCCCC---CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh
Q 008431 412 -------------HAQLHMVAYKSPEFNQTDG---VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV 475 (565)
Q Consensus 412 -------------~~~~~t~~y~aPE~~~~~~---~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 475 (565)
....+|+.|+|||++.... ++.++|||||||++|||++|+.||....... ..+...+
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~---- 260 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVALAV---- 260 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHHHH----
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhHHh----
Confidence 1224588999999887654 6899999999999999999999996432211 1111111
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
... ...+. .......+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 261 ~~~----~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 261 QNQ----LSIPQ------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HCC------CCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hcc----CCCCc------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 110 00000 0111236888999999999999999999999999997654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=351.49 Aligned_cols=261 Identities=20% Similarity=0.275 Sum_probs=202.1
Q ss_pred ccceecccCceeEEEEEE-----eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-----LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E 329 (565)
..+.||+|+||.||+|.+ .++..||||++........+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 457899999999999984 3678899999986655556779999999999999999999999874 456899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 107 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999986443 389999999999999999999998 99999999999999999999999999997654
Q ss_pred cc-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCC------CCCcchHHHHHHHhh
Q 008431 410 KE-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGK------GANADLATWVNSVVR 476 (565)
Q Consensus 410 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~ 476 (565)
.. ....+|..|+|||++.+..++.++|||||||++|||++|+.||....... .........+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 32 22346778999999988889999999999999999999999986321100 000000011111111
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
.... ...+......+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 259 ~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 259 EGQR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred cccC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 1100 001112234688899999999999999999999999999765533
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=347.68 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=193.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCcc---CHHHHHHHHHHHhcCCCCCccceEEEEEecCce----EEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNV---GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEK----LLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----~lv~ 328 (565)
..+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++++++||||+++++++...... |+||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence 357899999999999995 57889999999754322 235789999999999999999999999876544 9999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 96 EYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp ECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999998654 389999999999999999999998 9999999999999999999999999999765
Q ss_pred ccc-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 409 NKE-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 409 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.. ................
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~- 237 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--------DSPVSVAYQHVREDPI- 237 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHCCCC-
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHhcCCCC-
Confidence 432 223578999999999998999999999999999999999999962 2222222222222111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHH-HHHHHHHhhcc
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLRE-AVEKIMELKER 532 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e-vl~~L~~i~~~ 532 (565)
.+..... .....+.+++.+||+.||++||++.+ +...+.++...
T Consensus 238 ---~~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 238 ---PPSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ---CHHHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ---CcccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0100000 11236788899999999999995554 55666666443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=339.49 Aligned_cols=249 Identities=20% Similarity=0.352 Sum_probs=202.3
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++||||+++++++. .+..++||||+++|+|
T Consensus 17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L 94 (279)
T 1qpc_A 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94 (279)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred heeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCH
Confidence 45789999999999999888889999998754 334678999999999999999999999875 5568999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 95 VDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp HHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred HHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999865321 1389999999999999999999998 9999999999999999999999999999766433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....++..|+|||++....++.++|||||||++|||++ |+.||... ...+...... .... ...
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~~~~~-~~~~-----~~~-- 231 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--------TNPEVIQNLE-RGYR-----MVR-- 231 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHH-TTCC-----CCC--
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc--------CHHHHHHHHh-cccC-----CCC--
Confidence 22345678999999888889999999999999999999 99998621 1222222221 1110 000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+......+.+++.+|++.||++|||+.++++.|+++....
T Consensus 232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 0112246888999999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.95 Aligned_cols=256 Identities=17% Similarity=0.175 Sum_probs=193.7
Q ss_pred ccceecccCceeEEEEEEe----CCCeeEEEEeeccCcc-----------CHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 008431 257 SAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNV-----------GKEDFHEHMTRLGSLSHPNLLPLIAFYYR- 320 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~- 320 (565)
..+.||+|+||+||+|... ++..+|+|++...... ....+.+|+..++.++||||+++++++..
T Consensus 41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 4578999999999999975 6788999998754221 22347788899999999999999999988
Q ss_pred ---cCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC--
Q 008431 321 ---KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-- 395 (565)
Q Consensus 321 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-- 395 (565)
....|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESSSTT
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccCCCC
Confidence 67889999999 999999987654 389999999999999999999998 999999999999998887
Q ss_pred CcEEeccCCccccccc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCC
Q 008431 396 EPLLTDYALVPIVNKE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGAN 464 (565)
Q Consensus 396 ~~kl~DfGla~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~ 464 (565)
.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... .
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~ 266 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK----D 266 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT----C
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc----c
Confidence 9999999999765322 234678999999999988999999999999999999999999963111 0
Q ss_pred cchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 465 ADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
.............. ....+....... .....+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 267 ~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAVQTAKTNLLDE-LPQSVLKWAPSG----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHHT-TTHHHHHHSCTT----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHHHHHHHhhccc-ccHHHHhhcccc----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111111 111111111100 112368888899999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.05 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=193.9
Q ss_pred hhccceecccCceeEEEEEEe----CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC-----c
Q 008431 255 RASAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE-----E 323 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 323 (565)
+...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+ .
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 345688999999999999854 33479999987432 233467999999999999999999999998754 3
Q ss_pred eEEEEeccCCCCHHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 324 KLLVSDFVPNGSLANLLHVRRA-PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 324 ~~lv~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
.++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEEeec
Confidence 5999999999999999964321 1223599999999999999999999998 9999999999999999999999999
Q ss_pred CCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHh
Q 008431 403 ALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVV 475 (565)
Q Consensus 403 Gla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 475 (565)
|+++..... ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... .........
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~ 263 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ--------NHEMYDYLL 263 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------GGGHHHHHH
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHH
Confidence 999765432 22345678999999988899999999999999999999 899986321 111222221
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
... .. .. +......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 264 ~~~-~~-----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 264 HGH-RL-----KQ-----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp TTC-CC-----CC-----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC-CC-----CC-----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 00 00 011224688899999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=362.17 Aligned_cols=246 Identities=17% Similarity=0.169 Sum_probs=196.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++..++|||||+++++|.+.+..|+|||||+
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 4578999999999999965 57889999997421 2223458899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 158 gg~L~~~l~~~~~----~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 158 GGDLLTLLSKFED----RLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp TCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHHccC----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 9999999976432 399999999999999999999998 9999999999999999999999999999765432
Q ss_pred ----ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 412 ----HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
....||+.|+|||++. ...|+.++|||||||++|||++|+.||.. .+..+.............
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~~~ 301 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHKERFQ 301 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTHHHHCC
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC--------CChhHHHHhhhhcccccc
Confidence 2347899999999876 56789999999999999999999999962 222233333322110000
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAER--RWDLREAVEK 525 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 525 (565)
.|... ......+.+++.+||..+|++ ||+++|+++.
T Consensus 302 --~p~~~-----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 302 --FPTQV-----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --CCSSC-----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --CCccc-----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 01110 011236778888999988888 9999999764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=353.69 Aligned_cols=246 Identities=13% Similarity=0.123 Sum_probs=199.5
Q ss_pred ccceecccCceeEEEEE------EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC---CCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAV------LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS---HPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||+||+|. ..+++.||+|++... ...++.+|+++++.++ |+||+++++++...+..|+|
T Consensus 69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 45789999999999993 557899999998643 4567888888888887 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-----------CCC
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-----------AYE 396 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-----------~~~ 396 (565)
|||+++|+|.+++..........++|..+..++.||+.||+|||+. +|+||||||+|||++. ++.
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999865433334599999999999999999999998 9999999999999998 899
Q ss_pred cEEeccCCcccccc------cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHH
Q 008431 397 PLLTDYALVPIVNK------EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATW 470 (565)
Q Consensus 397 ~kl~DfGla~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~ 470 (565)
+||+|||+++.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------- 292 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------- 292 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---------
Confidence 99999999965431 134568999999999999999999999999999999999999986322100
Q ss_pred HHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCC-CCHHHHHHHHHHhhccC
Q 008431 471 VNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR-WDLREAVEKIMELKERD 533 (565)
Q Consensus 471 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R-Ps~~evl~~L~~i~~~~ 533 (565)
......+.... . ...+.+++..|++.+|.+| |++.++.+.|+++....
T Consensus 293 -----------~~~~~~~~~~~-~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 -----------CKPEGLFRRLP-H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -----------EEECSCCTTCS-S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------eeechhccccC-c---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00111111111 1 2345667779999999999 58999999999887653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=355.86 Aligned_cols=193 Identities=24% Similarity=0.332 Sum_probs=169.0
Q ss_pred ccceeccc--CceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSG--SFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+| +||+||+|+.. +++.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||||+
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEcc
Confidence 45789999 99999999965 78999999997532 233467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 109 ~~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 109 AYGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp TTCBHHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred CCCCHHHHHhhhccc---CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999865322 489999999999999999999998 9999999999999999999999999987543211
Q ss_pred -----------ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 008431 412 -----------HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANY 456 (565)
Q Consensus 412 -----------~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~ 456 (565)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 22367889999999877 5799999999999999999999999963
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=339.21 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=197.4
Q ss_pred ccceecccCceeEEEEEEeCC----CeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLLTG----PAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|..... ..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCCEEEEecC
Confidence 457899999999999986532 35999998754 2334578999999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 95 PYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp TTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999976543 389999999999999999999998 9999999999999999999999999998765433
Q ss_pred -----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 -----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+ .......
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~~~~~----~~~~~~~--- 234 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDVIGVL----EKGDRLP--- 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGHHHHH----HHTCCCC---
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHHHHHH----hcCCCCC---
Confidence 22345778999999988889999999999999999998 9999863211 1121111 1111000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
. +......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 235 --~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 --K-----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp --C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --C-----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0 011123678899999999999999999999999988653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.69 Aligned_cols=245 Identities=17% Similarity=0.219 Sum_probs=187.5
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHH-hcCCCCCccceEEEEEe----cCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRL-GSLSHPNLLPLIAFYYR----KEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~lv~E~~ 331 (565)
.++||+|+||+||+|... +++.||||++.. ...+.+|+.++ +..+||||+++++++.. .+..|+||||+
T Consensus 67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred cceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 368999999999999964 688999999863 24677888887 45689999999999875 56789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCcccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIV 408 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~ 408 (565)
++|+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 142 ~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 142 DGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp CSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999976432 2499999999999999999999998 9999999999999997 789999999999865
Q ss_pred ccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 409 NKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 409 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
... ....+|+.|+|||++.+..|+.++|||||||++|||++|+.||........ ...... .+..+.. ....
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~----~i~~~~~-~~~~ 288 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKT----RIRMGQY-EFPN 288 (400)
T ss_dssp C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-CCSHHH----HHHHTCC-CCCT
T ss_pred CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-cHHHHH----HHHcCcc-cCCC
Confidence 433 345679999999999999999999999999999999999999964221110 011111 1111110 0001
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
+.. ......+.+++.+||+.||++|||+.|+++.-
T Consensus 289 ~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 289 PEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp TTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 111 11224678899999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=363.43 Aligned_cols=240 Identities=19% Similarity=0.316 Sum_probs=198.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus 20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 4578999999999999965 79999999997432 2335679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 100 GGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp SEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999996533 389999999999999999999998 9999999999999999999999999999876443
Q ss_pred --ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.. ................ .+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~----~p-- 236 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD--------DHVPTLFKKICDGIFY----TP-- 236 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC--------SSSHHHHHHHHTTCCC----CC--
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHhcCCcC----CC--
Confidence 34578999999999888765 6899999999999999999999972 2222333222222100 00
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 ------QYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1112367888999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.58 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=192.9
Q ss_pred cceecccCceeEEEEE-EeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 258 AEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
.++||+|+||+||+|. ..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 3679999999999999 457899999999866556678899999999885 79999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC---cEEeccCCccccccc-
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE---PLLTDYALVPIVNKE- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfGla~~~~~~- 411 (565)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 98 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 98 ILSHIHKRR-----HFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred HHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 999998654 389999999999999999999998 9999999999999988776 999999998764321
Q ss_pred ----------ccccccccccCCCccCC-----CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCC---cch---HHH
Q 008431 412 ----------HAQLHMVAYKSPEFNQT-----DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGAN---ADL---ATW 470 (565)
Q Consensus 412 ----------~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~---~~~---~~~ 470 (565)
....+|+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ... ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 12348899999998764 458899999999999999999999997432211000 000 011
Q ss_pred HHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 471 VNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 471 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+...+..... ....+... .....+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~i~~~~~-~~~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEGKY-EFPDKDWA------HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHCCC-CCCHHHHT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhccCc-ccCchhcc------cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1111111110 00000000 11236788999999999999999999976
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=342.39 Aligned_cols=243 Identities=21% Similarity=0.320 Sum_probs=198.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... +|..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 4678999999999999965 688999999975322 136789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC----CcEEeccCCc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY----EPLLTDYALV 405 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfGla 405 (565)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 96 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp CCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999997543 389999999999999999999998 999999999999999887 7999999999
Q ss_pred cccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
+..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.. ...............
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~i~~~~~--- 235 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANITSVSY--- 235 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHTTCC---
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhccc---
Confidence 766543 344688999999999989999999999999999999999999962 122222222221110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFFSH-----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHHTT-----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhhcc-----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011111111 1136788999999999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=336.64 Aligned_cols=241 Identities=20% Similarity=0.344 Sum_probs=192.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEe----cCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR----KEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~E 329 (565)
..+.||+|+||+||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++|||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence 346799999999999995 46788999998743 23345679999999999999999999999875 345899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--CccCCCCCCCEEEc-CCCCcEEeccCCcc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT--LPHGHLKSSNVLLD-NAYEPLLTDYALVP 406 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DfGla~ 406 (565)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++ .++.+||+|||++.
T Consensus 110 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 110 LMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999998654 389999999999999999999998 6 99999999999997 78999999999997
Q ss_pred ccccc--ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 407 IVNKE--HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 407 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
..... ....+|+.|+|||++.+ .++.++|||||||++|||++|+.||... ............. ......
T Consensus 181 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~~~~~~-~~~~~~ 251 (290)
T 1t4h_A 181 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSG-VKPASF 251 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTT-CCCGGG
T ss_pred cccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc-------CcHHHHHHHHhcc-CCcccc
Confidence 65433 34468899999998764 5899999999999999999999999631 1222222222211 111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+ .. ....+.+++.+||+.||++|||+.|+++
T Consensus 252 ~----~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 D----KV-----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----GC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----CC-----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 11 1136888999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=376.86 Aligned_cols=245 Identities=20% Similarity=0.313 Sum_probs=197.3
Q ss_pred ceecccCceeEEEEEEe---CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||+||+|.+. +++.||||+++... ....++|.+|+++|++++|||||+++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 57999999999999753 45789999997532 234578999999999999999999999985 4568999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999997543 389999999999999999999998 99999999999999999999999999998654321
Q ss_pred ------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 413 ------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 413 ------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
...+|+.|+|||++....++.++|||||||++|||+| |+.||... ...+ +...+..+....
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--------~~~~-~~~~i~~~~~~~--- 592 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSE-VTAMLEKGERMG--- 592 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHH-HHHHHHTTCCCC---
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHH-HHHHHHcCCCCC---
Confidence 2235678999999988899999999999999999999 99999631 1112 222222221110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
. +......+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 593 --~-----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 --C-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --C-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --C-----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 112224688899999999999999999999999987543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.13 Aligned_cols=256 Identities=19% Similarity=0.285 Sum_probs=196.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|.. .+|..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 457899999999999995 578999999997532 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 116 AGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp SCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 99999999753221 12489999999999999999999998 9999999999999999999999999998765433
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....+++.|+|||++....++.++|||||||++|||++|+.||... ............... .. ..
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~-~~-----~~ 258 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEQCD-YP-----PL 258 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHHTTC-SC-----CC
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc------chhHHHHHHHhhccc-CC-----CC
Confidence 2345788999999999889999999999999999999999998621 122222222222111 11 11
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.. ......+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 259 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 259 PS----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc----cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 00 111236788899999999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=350.01 Aligned_cols=269 Identities=24% Similarity=0.346 Sum_probs=195.6
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHH--HhcCCCCCccceEEEEEec-----CceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTR--LGSLSHPNLLPLIAFYYRK-----EEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~-----~~~~lv~E 329 (565)
..+.||+|+||+||+|+. +++.||||++... ....+..|.++ +..++||||+++++++... ...++|||
T Consensus 17 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred eeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 357899999999999976 7899999998643 23444444444 5568999999999876532 25689999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCC-----CCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP-----GVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
|+++|+|.+++.... .++..+..++.|++.||+|||+.+. ..+|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 93 YYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred cCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 999999999997543 6899999999999999999997621 11799999999999999999999999999
Q ss_pred ccccccc------------ccccccccccCCCccCC-------CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCc
Q 008431 405 VPIVNKE------------HAQLHMVAYKSPEFNQT-------DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANA 465 (565)
Q Consensus 405 a~~~~~~------------~~~~~t~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~ 465 (565)
++..... ....||+.|+|||++.+ ..++.++|||||||++|||+||..||...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 9765421 13358899999998876 3567799999999999999999877643221111100
Q ss_pred ch---------HHHHHHHhhhcccCccccccccCC-CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 466 DL---------ATWVNSVVREEWTGEVFDKDMRGT-KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 466 ~~---------~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
.. ............. .+.+... .........+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred hhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 00 0111111111111 1111111 11234556799999999999999999999999999999877655
Q ss_pred CCCc
Q 008431 536 NEDY 539 (565)
Q Consensus 536 ~~~~ 539 (565)
++..
T Consensus 323 ~~~~ 326 (336)
T 3g2f_A 323 NKSV 326 (336)
T ss_dssp ----
T ss_pred cccC
Confidence 4443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=353.70 Aligned_cols=238 Identities=21% Similarity=0.250 Sum_probs=186.5
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHH-HhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTR-LGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|+.. ++..||+|++.... ......+.+|..+ ++.++|||||++++++.+.+..|+||||+
T Consensus 42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 4578999999999999965 67889999997542 2233456777776 57789999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 122 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 122 NGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999998654 388999999999999999999998 999999999999999999999999999976432
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+............. .+.+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~~---~~~~- 260 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RNTAEMYDNILNKPL---QLKP- 260 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC--------SBHHHHHHHHHHSCC---CCCS-
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhccc---CCCC-
Confidence 2345789999999999999999999999999999999999999962 222333333332210 0111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAV 523 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 523 (565)
.....+.+++.+||+.||++||++.+.+
T Consensus 261 --------~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 261 --------NITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --------SSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --------CCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1123677888999999999999985433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=344.73 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=201.6
Q ss_pred ccceecccCceeEEEEEEe-CCCe--eEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPA--MVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|... ++.. +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence 4578999999999999954 5554 489988743 233456799999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 332 PNGSLANLLHVRRA-----------PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 332 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
++|+|.+++..... .....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCCeEEEc
Confidence 99999999976430 1123489999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhh
Q 008431 401 DYALVPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 401 DfGla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
|||+++..... ....+++.|+|||++....++.++|||||||++|||+| |+.||.. .......... .
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~--------~~~~~~~~~~-~ 255 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELYEKL-P 255 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHG-G
T ss_pred ccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC--------CcHHHHHHHh-h
Confidence 99998754322 23345778999999888889999999999999999998 9999962 2222222222 1
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCCC
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDN 536 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~ 536 (565)
.... ... +......+.+++.+||+.||++|||+.|+++.|+++.......
T Consensus 256 ~~~~-----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 256 QGYR-----LEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp GTCC-----CCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred cCCC-----CCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 1110 000 1112246888999999999999999999999999998765433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=336.97 Aligned_cols=240 Identities=23% Similarity=0.298 Sum_probs=195.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 4578999999999999854 56789999986421 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 93 ~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 93 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 999999998654 389999999999999999999998 9999999999999999999999999998655433
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.. ............... ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~~-------~~~- 227 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--------NTYQETYKRISRVEF-------TFP- 227 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCC-------CCC-
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC--------CcHHHHHHHHHhCCC-------CCC-
Confidence 345678999999999999999999999999999999999999962 222222222211110 010
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
......+.+++.+||+.||++|||+.|+++.
T Consensus 228 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 ----DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1112367788999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=351.19 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=201.6
Q ss_pred ccceecccCceeEEEEEEe-----CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEec--CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 328 (565)
..+.||+|+||+||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence 4578999999999988643 67889999997543 23356799999999999999999999999874 5679999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999653 289999999999999999999998 9999999999999999999999999999876
Q ss_pred ccc-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCC----CCCcch--HHHHHHHh
Q 008431 409 NKE-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGK----GANADL--ATWVNSVV 475 (565)
Q Consensus 409 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~----~~~~~~--~~~~~~~~ 475 (565)
... ....++..|+|||++.+..++.++|||||||++|||+||+.||....... ...... ...+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 432 22346778999999988889999999999999999999999986321100 000000 00011111
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
... .. ...+......+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 265 ~~~---------~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 265 ERG---------ER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HTT---------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcc---------cC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 111 00 0011122347888999999999999999999999999997764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=332.07 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=201.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence 4578999999999999965 689999999875321 236789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC----CcEEeccCCc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY----EPLLTDYALV 405 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfGla 405 (565)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 89 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 89 LVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred ecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999997643 389999999999999999999998 999999999999998877 8999999999
Q ss_pred cccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
...... ....+++.|+|||++....++.++|||||||++|||++|+.||... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~~--- 228 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE--------TKQETLTNISAVNY--- 228 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTTCC---
T ss_pred eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc--------chHHHHHHhHhccc---
Confidence 765433 2345789999999999889999999999999999999999998621 11222222111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH--HHHHhhccC
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE--KIMELKERD 533 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~~~ 533 (565)
..++.... .....+.+++.+||+.||++|||+.|+++ .++.+....
T Consensus 229 ~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 229 DFDEEYFS-----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp CCCHHHHT-----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred CCcchhcc-----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 00111100 11236788999999999999999999997 466665544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=338.24 Aligned_cols=244 Identities=20% Similarity=0.279 Sum_probs=196.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|... +|+.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 4578999999999999964 789999999986544455679999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE---cCCCCcEEeccCCccccccc-
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL---DNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~- 411 (565)
|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 93 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 93 LFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp HHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 999997654 389999999999999999999998 99999999999999 78899999999998765433
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||... ............. . .. ....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~-~-~~-~~~~-- 230 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE--------TESKLFEKIKEGY-Y-EF-ESPF-- 230 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHCC-C-CC-CTTT--
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCC-C-CC-Cccc--
Confidence 2345789999999999999999999999999999999999998621 1222222222111 1 00 0000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 231 ---WDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01122467889999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.70 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=198.6
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe---------------
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--------------- 320 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------------- 320 (565)
..+.||+|+||.||+|... +++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 4578999999999999975 78999999997532 457889999999999999999998864
Q ss_pred -cCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEE
Q 008431 321 -KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL 399 (565)
Q Consensus 321 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl 399 (565)
....++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEE
T ss_pred CcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCCCEEE
Confidence 3457999999999999999976532 2489999999999999999999998 9999999999999999999999
Q ss_pred eccCCccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 400 TDYALVPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 400 ~DfGla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||++|..|+... ..+.... .
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~~~~-~ 232 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFFTDL-R 232 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHHHHH-H
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHHHHh-h
Confidence 999998766443 3446789999999998888999999999999999999999987521 1111111 1
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.... . .. ....+.+++.+||+.||++|||+.|+++.|..++...
T Consensus 233 ~~~~----~----~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 233 DGII----S----DI-----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp TTCC----C----TT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred cccc----c----cc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1111 1 11 1135778889999999999999999999999997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=340.03 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=194.7
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEec-CceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-EEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|.. +|+.||||.++.. ...+.+.+|+.++++++||||+++++++... +..++||||+++|+
T Consensus 25 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 457899999999999986 5889999998753 3467899999999999999999999997654 47899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-ccc
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQ 414 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~ 414 (565)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 102 L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 102 LVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp HHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 9999976432 1278899999999999999999998 9999999999999999999999999998765433 234
Q ss_pred cccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 415 LHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 415 ~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
.+++.|+|||.+.+..++.++|||||||++|||+| |+.||.... ........ ..... +...
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~-~~~~~-----~~~~---- 236 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRV-EKGYK-----MDAP---- 236 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--------GGGHHHHH-TTTCC-----CCCC----
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-hcCCC-----CCCc----
Confidence 56788999999988889999999999999999998 999986321 11112111 11110 1111
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
......+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 237 -~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 237 -DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 112246788899999999999999999999999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=346.83 Aligned_cols=190 Identities=21% Similarity=0.280 Sum_probs=168.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-----CCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-----HPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|+. .+++.||||+++.. ....+.+..|+.+++++. |||||++++++...+..++||||
T Consensus 39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 117 (360)
T 3llt_A 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117 (360)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcC
Confidence 457899999999999996 57889999998642 233456788999999986 99999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-----------------
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN----------------- 393 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~----------------- 393 (565)
+ +++|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 118 ~-~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 118 L-GPSLYEIITRNNYN---GFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp C-CCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred C-CCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccccccccchhcccccc
Confidence 9 89999999865432 489999999999999999999998 9999999999999975
Q ss_pred --------CCCcEEeccCCccccccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 394 --------AYEPLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 394 --------~~~~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999865443 45578999999999999999999999999999999999999996
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.18 Aligned_cols=245 Identities=18% Similarity=0.169 Sum_probs=195.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||+||+|+.. +|+.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.+..|+||||++
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 4578999999999999964 78999999997421 2233458899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 145 gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 145 GGDLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp SCBHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999986542 389999999999999999999998 9999999999999999999999999999776433
Q ss_pred ----ccccccccccCCCccC-------CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 412 ----HAQLHMVAYKSPEFNQ-------TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~-------~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
....||+.|+|||++. ...|+.++|||||||++|||++|+.||.. .+..............
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA--------DSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTHHHH
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhcccC
Confidence 2347899999999876 45789999999999999999999999962 2222222222221100
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCC---CCHHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR---WDLREAVEK 525 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps~~evl~~ 525 (565)
...|... ......+.+++.+||. +|++| |+++|+++.
T Consensus 289 --~~~p~~~-----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 289 --LSLPLVD-----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --CCCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --cCCCccc-----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0001110 1112367888899999 99998 589998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=348.27 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=186.0
Q ss_pred hhccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEe--------cCce
Q 008431 255 RASAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYR--------KEEK 324 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--------~~~~ 324 (565)
+...++||+|+||.||+|+. .+++.||+|++........+.+.+|+.+++++. ||||+++++++.. ....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 34568999999999999995 478999999987655555678999999999996 9999999999953 2347
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--CccCCCCCCCEEEcCCCCcEEecc
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT--LPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~--ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
++||||+. |+|.+++...... ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred EEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCEEEecC
Confidence 99999996 7999998753321 2499999999999999999999998 7 999999999999999999999999
Q ss_pred CCcccccccc----------------cccccccccCCCcc---CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCC
Q 008431 403 ALVPIVNKEH----------------AQLHMVAYKSPEFN---QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGA 463 (565)
Q Consensus 403 Gla~~~~~~~----------------~~~~t~~y~aPE~~---~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~ 463 (565)
|+++...... ...+|+.|+|||++ ....++.++|||||||++|||+||+.||.....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---- 258 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK---- 258 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH----
Confidence 9997754321 23478899999987 566789999999999999999999999963211
Q ss_pred CcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 464 NADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..... .. ....... .....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 259 ----~~~~~----~~-----~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 259 ----LRIVN----GK-----YSIPPHD-----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------CCCCTTC-----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ----HHhhc----Cc-----ccCCccc-----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 01110 00 0000000 11124678889999999999999999999999997653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=346.30 Aligned_cols=269 Identities=16% Similarity=0.226 Sum_probs=195.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||++ |
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 3478999999999999965 788999999864322 222345679999999999999999999999999999999997 5
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 85 DLKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 99999876543 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc---Cccccc
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT---GEVFDK 486 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~ 486 (565)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......... ......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHhchhhhcc
Confidence 23467899999998766 5689999999999999999999999963211 1111222221111100 000000
Q ss_pred ------cccCCC-C-----CHHHHHHHHHHHhhccccCcCCCCCHHHHHH--HHHHhhccCCCCCCc
Q 008431 487 ------DMRGTK-S-----GEGEMLKLLKIGMCCCEWNAERRWDLREAVE--KIMELKERDNDNEDY 539 (565)
Q Consensus 487 ------~~~~~~-~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~~~~~~~~~ 539 (565)
...... . .......+.+++.+||+.||++|||+.|+++ .+..+........+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 298 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDT 298 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCC
Confidence 000000 0 0011246788999999999999999999987 455555443333333
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.49 Aligned_cols=267 Identities=20% Similarity=0.313 Sum_probs=209.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC--ceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE--EKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~E~~~ 332 (565)
..++||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 4578999999999999965 58999999997533 344677899999999999999999999998765 6799999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE----cCCCCcEEeccCCcccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL----DNAYEPLLTDYALVPIV 408 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfGla~~~ 408 (565)
+|+|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 93 ~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 93 CGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp TEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred CCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999764322 2389999999999999999999998 99999999999999 78888999999999876
Q ss_pred ccc---ccccccccccCCCccCC--------CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 409 NKE---HAQLHMVAYKSPEFNQT--------DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 409 ~~~---~~~~~t~~y~aPE~~~~--------~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
... ....+|+.|+|||++.. ..++.++|||||||++|||+||+.||...... ......+......
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~----~~~~~~~~~~~~~ 242 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMYKIITG 242 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT----TTCHHHHHHHHHS
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc----cchHHHHHHHhcC
Confidence 543 24468899999998754 46788999999999999999999999743221 1223333333322
Q ss_pred cccCc---c---------ccccccC-CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 478 EWTGE---V---------FDKDMRG-TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 478 ~~~~~---~---------~d~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..... . ..+.+.. ..........+.+++.+||++||++|||+.|+++.+.++....
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11100 0 0011111 1123456667889999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=334.98 Aligned_cols=244 Identities=21% Similarity=0.262 Sum_probs=197.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 3578999999999999964 68899999987532 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC---cEEeccCCcccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE---PLLTDYALVPIVNK 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfGla~~~~~ 410 (565)
|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.....
T Consensus 90 ~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 90 GELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999987654 389999999999999999999998 9999999999999986655 99999999976654
Q ss_pred c---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 E---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.. ............... ....+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~--------~~~~~~~~~~~~~~~--~~~~~~ 230 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYAQIKAGAY--DYPSPE 230 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCC--CCCTTT
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC--------CchhHHHHHHHhccc--cCCchh
Confidence 3 235688999999999999999999999999999999999999962 122222222221111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 W------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp T------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred h------cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1 1112367888999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.04 Aligned_cols=242 Identities=17% Similarity=0.285 Sum_probs=190.3
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCC--CCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSH--PNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++| |||+++++++...+..++|||| .
T Consensus 13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~ 91 (343)
T 3dbq_A 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 91 (343)
T ss_dssp EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-C
T ss_pred EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-C
Confidence 457899999999999998889999999987432 2334678999999999987 9999999999999999999994 5
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 92 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 92 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp SEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 789999998643 389999999999999999999998 999999999999997 578999999999876433
Q ss_pred -----ccccccccccCCCccCC-----------CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh
Q 008431 412 -----HAQLHMVAYKSPEFNQT-----------DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV 475 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 475 (565)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~~~~~ 234 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAII 234 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHH
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-------hhHHHHHHHHh
Confidence 23468999999998753 67899999999999999999999999631 11112222222
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
...... ... ......+.+++.+||+.||++|||+.|+++.-
T Consensus 235 ~~~~~~-----~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 235 DPNHEI-----EFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CTTSCC-----CCC-----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCccc-----CCc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111100 010 11123677889999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=335.59 Aligned_cols=241 Identities=18% Similarity=0.243 Sum_probs=195.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|... +++.||+|.+.... .....++.+|+..+..+ +||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 4578999999999999965 78999999987532 33456788999999999 99999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-------------------
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN------------------- 393 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~------------------- 393 (565)
+|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 95 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 95 GGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp TCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC--------------------
T ss_pred CCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999864321 12489999999999999999999998 9999999999999984
Q ss_pred CCCcEEeccCCcccccccccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHH
Q 008431 394 AYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVN 472 (565)
Q Consensus 394 ~~~~kl~DfGla~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 472 (565)
...+||+|||++..........+|+.|+|||++... .++.++|||||||++|||++|.+|+.. ... + .
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~--~-~ 238 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN--------GDQ--W-H 238 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS--------SHH--H-H
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc--------hhH--H-H
Confidence 447999999999887776677799999999988765 567899999999999999999987641 111 1 1
Q ss_pred HHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 473 SVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 473 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. ..... +.+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~-~~~~~-----~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 EI-RQGRL-----PRIPQ-----VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH-HTTCC-----CCCSS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HcCCC-----CCCCc-----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11 11111 11111 11236788899999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=348.80 Aligned_cols=254 Identities=21% Similarity=0.300 Sum_probs=202.1
Q ss_pred ccceecccCceeEEEEEEeC-C-----CeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLT-G-----PAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||+||+|.... + ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 45789999999999999642 2 379999987543 23456799999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEE
Q 008431 329 DFVPNGSLANLLHVRRAP---------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLL 399 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl 399 (565)
||+++|+|.+++...... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCEEEGGGEEEB
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEEECCCCeEEE
Confidence 999999999999754210 012489999999999999999999998 9999999999999999999999
Q ss_pred eccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHH
Q 008431 400 TDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVN 472 (565)
Q Consensus 400 ~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 472 (565)
+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+| |..||.... ....+.
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~~~~~ 277 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL--------VNSKFY 277 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC--------SSHHHH
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc--------hhHHHH
Confidence 999999765432 12345678999999888889999999999999999999 999986321 112222
Q ss_pred HHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 473 SVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 473 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
......... .. +......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 278 ~~~~~~~~~-----~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 278 KLVKDGYQM-----AQ-----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHTCCC-----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCC-----CC-----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 222222110 00 011123678899999999999999999999999988653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=344.65 Aligned_cols=256 Identities=20% Similarity=0.269 Sum_probs=202.6
Q ss_pred hccceecccCceeEEEEEEe------CCCeeEEEEeeccCc-cCHHHHHHHHHHHhcC-CCCCccceEEEEEecC-ceEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKE-EKLL 326 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~l 326 (565)
...+.||+|+||+||+|... +++.||||.++.... ...+.+.+|+.+++++ +||||+++++++...+ ..++
T Consensus 30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l 109 (316)
T 2xir_A 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109 (316)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence 35678999999999999842 457899999975432 3346789999999999 7999999999997755 4899
Q ss_pred EEeccCCCCHHHHHhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC
Q 008431 327 VSDFVPNGSLANLLHVRRAPG-----------QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY 395 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~ 395 (565)
||||+++|+|.+++....... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKN 185 (316)
T ss_dssp EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGG
T ss_pred EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCC
Confidence 999999999999998654210 11278999999999999999999998 999999999999999999
Q ss_pred CcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchH
Q 008431 396 EPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLA 468 (565)
Q Consensus 396 ~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~ 468 (565)
.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~ 257 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--------ID 257 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------CS
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc--------hh
Confidence 9999999999765432 23346788999999988889999999999999999998 999986321 11
Q ss_pred HHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 469 TWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
..+........... .. ......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 258 ~~~~~~~~~~~~~~-----~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 258 EEFCRRLKEGTRMR-----AP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHTCCCC-----CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCccCC-----CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 22222222221100 00 111236788899999999999999999999999987653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.21 Aligned_cols=249 Identities=21% Similarity=0.255 Sum_probs=192.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc-----CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM-----SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||+||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 468899999999999995 46788999998643 234457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCC-----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCC
Q 008431 331 VPNGSLANLLHVRRAPG-----------------------------------QPGLDWPIRLKIIKGVAKGLAYLYKEFP 375 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~-----------------------------------~~~l~~~~~~~i~~~ia~gL~ylH~~~~ 375 (565)
+++|+|.+++....... ...+++..+..++.|++.||+|||+.
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 187 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 99999999985321100 01135677889999999999999998
Q ss_pred CCCCccCCCCCCCEEEcCCC--CcEEeccCCcccccc--------cccccccccccCCCccCC--CCCCcchhHHHHHHH
Q 008431 376 GVTLPHGHLKSSNVLLDNAY--EPLLTDYALVPIVNK--------EHAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGIL 443 (565)
Q Consensus 376 ~~~ivHrDlkp~NILl~~~~--~~kl~DfGla~~~~~--------~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvi 443 (565)
+|+||||||+|||++.++ .+||+|||+++.... .....+|+.|+|||++.+ ..++.++|||||||+
T Consensus 188 --~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp --TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred --CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 999999999999998766 899999999976532 124467899999998765 678999999999999
Q ss_pred HHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 008431 444 ILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAV 523 (565)
Q Consensus 444 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 523 (565)
+|||++|+.||.. ................ ...+... .....+.+++.+||+.||++|||+.|++
T Consensus 266 l~el~~g~~pf~~--------~~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 266 LHLLLMGAVPFPG--------VNDADTISQVLNKKLC--FENPNYN------VLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHSSCSSCC--------SSHHHHHHHHHHCCCC--TTSGGGG------GSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHCCCCCCC--------CChHHHHHHHHhcccc--cCCcccc------cCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9999999999962 1222222222222111 1111111 1123678899999999999999999998
Q ss_pred HH
Q 008431 524 EK 525 (565)
Q Consensus 524 ~~ 525 (565)
+.
T Consensus 330 ~h 331 (345)
T 3hko_A 330 QH 331 (345)
T ss_dssp HS
T ss_pred cC
Confidence 73
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=335.37 Aligned_cols=240 Identities=23% Similarity=0.315 Sum_probs=177.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 457899999999999996 578999999997432 2234679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 95 NGEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp TEEHHHHHHTCSS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred CCcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999986432 489999999999999999999998 9999999999999999999999999998765432
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........ .. +...
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~----~~---~~~~ 231 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV--------KNTLNKVV----LA---DYEM 231 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC--------C-----CC----SS---CCCC
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH--------HHHHHHHh----hc---ccCC
Confidence 234678999999999888899999999999999999999999963211 01111000 00 0011
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+......+.+++.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 -----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111236788999999999999999999865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.97 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=196.6
Q ss_pred ceecccCceeEEEEEEe---CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
+.||+|+||+||+|... ++..||||.++... ....+++.+|+.+++.++||||+++++++ ..+..++||||+++
T Consensus 23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 38999999999999643 46789999987532 22356799999999999999999999999 66788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH- 412 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 412 (565)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 102 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999998643 389999999999999999999998 99999999999999999999999999987654331
Q ss_pred ------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 413 ------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 413 ------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
...+++.|+|||.+.+..++.++|||||||++|||+| |+.||... ..... ...+......
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~-~~~~~~~~~~---- 239 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEV-TAMLEKGERM---- 239 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHH-HHHHHTTCCC----
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--------CHHHH-HHHHHcCCCC----
Confidence 1234678999999888889999999999999999999 99998631 11121 1122221110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.. +......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 240 -~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 240 -GC-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -CC-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11 111224688899999999999999999999999988643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.55 Aligned_cols=234 Identities=19% Similarity=0.268 Sum_probs=194.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc--------cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN--------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||+||+|.. .+++.||||.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 457899999999999995 5788999999975321 1334678899999999999999999999999999999
Q ss_pred EeccCCC-CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 328 SDFVPNG-SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 328 ~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
|||+.+| +|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999877 9999997543 399999999999999999999998 99999999999999999999999999998
Q ss_pred ccccc---ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 407 IVNKE---HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 407 ~~~~~---~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
..... ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ..
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------------~~ 239 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------------EA 239 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------------TT
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------------hh
Confidence 76543 23468999999999888776 789999999999999999999996322110 00
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...+ . ......+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~----~---~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 AIHP----P---YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCC----S---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccCC----C---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 0112367888999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=352.69 Aligned_cols=188 Identities=24% Similarity=0.356 Sum_probs=155.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCC-CCCccceEEEEEecC--ceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKE--EKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lv~E~ 330 (565)
..+.||+|+||+||+|.. .+|+.||||++... .......+.+|+.+++++. |||||++++++...+ ..|+||||
T Consensus 13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 92 (388)
T 3oz6_A 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92 (388)
T ss_dssp EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecc
Confidence 357899999999999995 57899999998642 2334567889999999997 999999999998654 68999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
|+ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 93 ME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp CS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred cC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 97 6999999753 389999999999999999999998 999999999999999999999999999976432
Q ss_pred -------------------------cccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 411 -------------------------EHAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 411 -------------------------~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 122468899999998876 678999999999999999999999996
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.97 Aligned_cols=241 Identities=17% Similarity=0.289 Sum_probs=191.3
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCC--CCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLS--HPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|...+++.||||++.... ....+.+.+|+.++++++ |||||++++++...+..|+||| +.
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 457899999999999998789999999987432 234567999999999996 5999999999999999999999 56
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 139 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 139 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 889999998654 388999999999999999999998 999999999999995 578999999999876432
Q ss_pred -----ccccccccccCCCccCC-----------CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh
Q 008431 412 -----HAQLHMVAYKSPEFNQT-----------DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV 475 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 475 (565)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ......+....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-------~~~~~~~~~~~ 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAII 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC-------CCHHHHHHHHH
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh-------hHHHHHHHHHh
Confidence 23468999999998754 46899999999999999999999999631 11122222222
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..... ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 282 ~~~~~-----~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHE-----IEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSC-----CCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccccc-----CCCCc-----cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 21110 00101 112367888999999999999999999865
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.23 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=202.6
Q ss_pred ccceecccCceeEEEEEE-----eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecC--ceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-----LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE--EKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~E 329 (565)
..+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 467899999999999984 368899999998655555678999999999999999999999987644 7899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 125 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp CCTTCBHHHHHHHSTT----SSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999986543 389999999999999999999998 99999999999999999999999999997764
Q ss_pred ccc-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcccccc------CCCC-CcchHHHHHHHh
Q 008431 410 KEH-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQ------GKGA-NADLATWVNSVV 475 (565)
Q Consensus 410 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~------~~~~-~~~~~~~~~~~~ 475 (565)
... ...++..|+|||.+.+..++.++|||||||++|||+||+.|+..... .... .......+...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 332 23456779999998888899999999999999999999999753210 0000 000011111111
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
...... ..+......+.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 277 ~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 277 KNNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HTTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111000 00112234688899999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.25 Aligned_cols=255 Identities=15% Similarity=0.129 Sum_probs=199.6
Q ss_pred ccceecccCceeEEEEEEeC---------CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccc--------------
Q 008431 257 SAEVLGSGSFGSSYKAVLLT---------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLP-------------- 313 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-------------- 313 (565)
..+.||+|+||.||+|.... ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 45789999999999999653 789999998743 46889999999999999998
Q ss_pred -eEEEEEe-cCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE
Q 008431 314 -LIAFYYR-KEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL 391 (565)
Q Consensus 314 -l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl 391 (565)
+++++.. .+..++||||+ +|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENIFV 192 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEE
Confidence 6777776 67889999999 9999999986521 2499999999999999999999998 99999999999999
Q ss_pred cCCC--CcEEeccCCccccccc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccc
Q 008431 392 DNAY--EPLLTDYALVPIVNKE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLA 458 (565)
Q Consensus 392 ~~~~--~~kl~DfGla~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~ 458 (565)
+.++ .+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999765432 22367899999999999899999999999999999999999997432
Q ss_pred cCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 459 QGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 459 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.. ...+....... .. ......++..... .....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 273 ~~---~~~~~~~~~~~-~~-~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 273 PN---TEDIMKQKQKF-VD-KPGPFVGPCGHWI----RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TC---HHHHHHHHHHH-HH-SCCCEECTTSCEE----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cC---HHHHHHHHHhc-cC-ChhhhhhhccccC----CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 11 01111111111 11 1112211111100 11246888889999999999999999999999997664
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=339.64 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=192.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 4578999999999999965 588999999976656667889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc----c
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK----E 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~----~ 411 (565)
|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..... .
T Consensus 103 l~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 103 VDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp HHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 9999876443 389999999999999999999998 999999999999999999999999998754321 2
Q ss_pred ccccccccccCCCcc-----CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 HAQLHMVAYKSPEFN-----QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~-----~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....+|+.|+|||++ ....++.++|||||||++|||++|+.||... ............... ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~-~~~~- 244 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSDPP-TLLT- 244 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCCC-CCSS-
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC--------CHHHHHHHHhccCCc-ccCC-
Confidence 344688999999987 4677899999999999999999999998631 222222222222111 1100
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+......+.+++.+||+.||++|||+.|+++
T Consensus 245 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 -------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111236788999999999999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=338.11 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=192.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-----ccCHHHHHHHHHHHhcCC---CCCccceEEEEEecC-----
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-----NVGKEDFHEHMTRLGSLS---HPNLLPLIAFYYRKE----- 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~----- 322 (565)
..+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.++++++ ||||+++++++....
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~ 92 (308)
T 3g33_A 13 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92 (308)
T ss_dssp EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence 457899999999999994 578999999987422 122356778888777664 999999999998765
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
..++||||+. |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 93 ~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 93 KVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp EEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred eEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEEeeC
Confidence 4799999997 699999986543 2489999999999999999999998 9999999999999999999999999
Q ss_pred CCccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh--
Q 008431 403 ALVPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-- 477 (565)
Q Consensus 403 Gla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 477 (565)
|+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|++||... ............
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN--------SEADQLGKIFDLIG 236 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS--------SHHHHHHHHHHHHC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHhC
Confidence 999866433 3456789999999998889999999999999999999999999631 122222222111
Q ss_pred -----cccCccccc--cccCC-CCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 -----EWTGEVFDK--DMRGT-KSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 -----~~~~~~~d~--~~~~~-~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+......+ ..... ... ......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 011000000 00000 000 012246788999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.18 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=197.6
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|... +++.||||++... .......+.+|+.++++++|||||++++++.+.+..|+||||+++
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 4578999999999999964 7899999998642 234567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc---CCCCcEEeccCCcccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD---NAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~~~~~ 410 (565)
|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 106 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999987654 389999999999999999999998 999999999999995 456799999999986644
Q ss_pred c---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 E---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
. ....||+.|+|||++.+ .|+.++||||+||++|||++|++||.. ................. ..+.
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~~--~~~~ 245 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG--------KNEYDILKRVETGKYAF--DLPQ 245 (486)
T ss_dssp C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCCCS--CSGG
T ss_pred CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC--CCcc
Confidence 3 34568999999998875 599999999999999999999999962 12222222222221110 0111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. .....+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~------~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 WR------TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG------GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cC------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 112367889999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=357.26 Aligned_cols=243 Identities=17% Similarity=0.185 Sum_probs=186.7
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeecc---CccCHHHHHHHH---HHHhcCCCCCccceE-------EEEEecC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQM---SNVGKEDFHEHM---TRLGSLSHPNLLPLI-------AFYYRKE 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~~~~~~ 322 (565)
..+.||+|+||+||+|. ..+|+.||||++... .....+.+.+|+ +.+++++|||||+++ +++...+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 35789999999999999 467999999999743 233457789999 556666899999998 6666543
Q ss_pred -----------------ceEEEEeccCCCCHHHHHhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCC
Q 008431 323 -----------------EKLLVSDFVPNGSLANLLHVRRAPG--QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGH 383 (565)
Q Consensus 323 -----------------~~~lv~E~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrD 383 (565)
..|+||||+ +|+|.+++....... ...++|..+..++.||+.||+|||+. +|+|||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrD 231 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTY 231 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCC
Confidence 278999999 689999998643211 11245688889999999999999998 999999
Q ss_pred CCCCCEEEcCCCCcEEeccCCccccccc-ccccccccccCCCccCCC-----------CCCcchhHHHHHHHHHHHHcCC
Q 008431 384 LKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTD-----------GVTRKTDVWSLGILILELLTGK 451 (565)
Q Consensus 384 lkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~-----------~~~~~~DvwS~Gvil~el~tg~ 451 (565)
|||+|||++.++.+||+|||+++..... ....| +.|+|||++.+. .++.++|||||||++|||+||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999865443 33456 899999998877 8999999999999999999999
Q ss_pred CCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH--HHHHh
Q 008431 452 FPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE--KIMEL 529 (565)
Q Consensus 452 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i 529 (565)
.||........ ...+. +... .....+.+++.+||+.||++|||+.|+++ .++++
T Consensus 311 ~Pf~~~~~~~~-----------------~~~~~-~~~~------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 311 LPITKDAALGG-----------------SEWIF-RSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp CCC------CC-----------------SGGGG-SSCC------CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred CCCcccccccc-----------------hhhhh-hhcc------CCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 99963221100 00111 0011 11136788899999999999999999986 34444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=358.81 Aligned_cols=249 Identities=16% Similarity=0.255 Sum_probs=187.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv 327 (565)
..+.||+|+||+||+|.. .+++.||||++... .....+++.+|+.+++.++|||||++++++.... ..|+|
T Consensus 66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 457899999999999985 46889999999753 2334567899999999999999999999997553 46999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999976 57766642 288999999999999999999998 999999999999999999999999999987
Q ss_pred cccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-cc----
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-EW---- 479 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~---- 479 (565)
.... ....+|+.|+|||++.+..|+.++|||||||++|||++|+.||... +..+.+...... +.
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~--------~~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--------DYIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCSCCHH
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhcCCCCHH
Confidence 6543 3457899999999999999999999999999999999999999631 111111111110 00
Q ss_pred ------------------cC-----ccccccccCCCC--CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 ------------------TG-----EVFDKDMRGTKS--GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 ------------------~~-----~~~d~~~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. ..+...+..... .......+.+++.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000000 01124568899999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=338.56 Aligned_cols=255 Identities=20% Similarity=0.284 Sum_probs=192.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence 3578999999999999964 589999999865322 2246788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 87 TVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred chHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999887543 389999999999999999999998 9999999999999999999999999999776532
Q ss_pred --ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-----------
Q 008431 412 --HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE----------- 477 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 477 (565)
....+|..|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhccccccccccccc
Confidence 23467899999998765 6789999999999999999999999963211 1111111111100
Q ss_pred -cccCccccccccCCCC----CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 478 -EWTGEVFDKDMRGTKS----GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 478 -~~~~~~~d~~~~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+......+....... .......+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000000 01122357889999999999999999999763
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.31 Aligned_cols=240 Identities=18% Similarity=0.293 Sum_probs=190.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccC
Confidence 3578999999999999965 78999999987432 2345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 95 GGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp SCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred CCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999997654 389999999999999999999999 9999999999999999999999999998776443
Q ss_pred --ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....+++.|+|||.+.+..+ +.++|||||||++|||++|+.||.. ........... .... .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~-~~~~------~~ 230 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--------EHVPTLFKKIR-GGVF------YI 230 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-HCCC------CC
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC--------CcHHHHHHHhh-cCcc------cC
Confidence 23467889999999887765 6899999999999999999999962 12222222221 1110 00
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 P-----EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp C-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c-----hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 1112367788999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=363.60 Aligned_cols=246 Identities=22% Similarity=0.256 Sum_probs=199.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||.||+|... +|+.||+|++... .......+.+|+.+|+.++|||||++++++.+.+..|+||||++
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 3578999999999999964 7899999999742 23345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 268 gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 268 GGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp SCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999976432 2489999999999999999999998 9999999999999999999999999999876433
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..|+.++|||||||++|||++|+.||...... ... ..+........ ..+.
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~-~~i~~~i~~~~------~~~p 409 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKR-EEVERLVKEVP------EEYS 409 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCH-HHHHHHHHHCC------CCCC
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhH-HHHHHHhhccc------ccCC
Confidence 3457899999999999989999999999999999999999999732110 111 11222221110 0010
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEK 525 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 525 (565)
......+.+++.+||+.||++|| ++.||++.
T Consensus 410 -----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 -----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11123678889999999999999 78888653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=334.23 Aligned_cols=254 Identities=16% Similarity=0.179 Sum_probs=200.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEE-ecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYY-RKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|+. .+++.||||.+.... ..+++.+|+.+++.++|++++..+.++. ..+..++||||+ +|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 357899999999999995 678899999986532 2356899999999999998887777664 556789999999 89
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE---cCCCCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL---DNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~ 411 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 90 ~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 90 SLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999975433 399999999999999999999998 99999999999999 58899999999999765432
Q ss_pred -----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 412 -----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 412 -----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+....... .
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~-~ 238 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKMST-P 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHHHS-C
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--hhhhhhhcccccCC-c
Confidence 234678999999999999999999999999999999999999974322111 11111111111110 0
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.. .+.. .....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 239 ~~----~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 IE----VLCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HH----HHTT-----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hH----HHHh-----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 00 0000 11136888999999999999999999999999997664
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=342.70 Aligned_cols=253 Identities=20% Similarity=0.300 Sum_probs=198.9
Q ss_pred ccceecccCceeEEEEEE------eCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL------LTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||.||+|.. .++..||||.+... ......++.+|+.++++++||||+++++++...+..++|||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 457899999999999983 35778999999643 23345679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRAPG--QPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGl 404 (565)
|+++|+|.+++....... ...+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+|||+
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 999999999998754321 13489999999999999999999998 9999999999999984 45699999999
Q ss_pred ccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++..... ....+++.|+|||++....++.++|||||||++|||+| |+.||... ............
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~~~~~ 261 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------SNQEVLEFVTSG 261 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHHHHTT
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--------CHHHHHHHHhcC
Confidence 8654322 23456789999999888889999999999999999998 99998621 122222222111
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
. .. .. +......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 262 ~-~~-----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 G-RM-----DP-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp C-CC-----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C-CC-----CC-----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 1 10 00 011123678899999999999999999999999988654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=335.41 Aligned_cols=244 Identities=21% Similarity=0.294 Sum_probs=193.9
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 35899999999999995 46889999999876555667899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~---- 411 (565)
.+++..... ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 107 ~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 107 SALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp HHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred HHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 999986532 22477889999999999999999998 9999999999999987 899999999998765432
Q ss_pred ccccccccccCCCccCCC--CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 HAQLHMVAYKSPEFNQTD--GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....+++.|+|||++... .++.++|||||||++|||++|+.||..... ........... . ..+.+.
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-~-----~~~~~~ 248 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMF-K-----VHPEIP 248 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHH-C-----CCCCCC
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccc-c-----cccccc
Confidence 344678999999987654 388999999999999999999999963211 01111111110 0 011111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.||++|||+.|+++
T Consensus 249 -----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 -----ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112236778899999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=358.56 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=193.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|... ++..||+|++.... ......+.+|+.+++.++|||||+++++|.+....|+||||+++
T Consensus 41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 4678999999999999964 78899999987532 33467899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCcccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIVNK 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~~ 410 (565)
|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 121 g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 121 GELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999987654 389999999999999999999998 9999999999999976 45599999999977653
Q ss_pred c---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 E---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
. ....||+.|+|||++. ..|+.++||||+||++|||++|++||.. ............... ....+.
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~--~~~~~~ 260 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG--------QTDQEILRKVEKGKY--TFDSPE 260 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCC--CCCSGG
T ss_pred CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCC--CCCchh
Confidence 3 3456899999999876 4699999999999999999999999962 222223322222211 111111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
... ....+.+++.+||+.||++|||+.|+++.
T Consensus 261 ~~~------~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 261 WKN------VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GTT------SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ccc------CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111 12367888999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=333.41 Aligned_cols=239 Identities=19% Similarity=0.275 Sum_probs=197.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 4578999999999999965 57789999986421 2335679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 98 RGELYKELQKHG-----RFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 999999998654 389999999999999999999998 9999999999999999999999999998655432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.. .............. ....
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~~~~~~-------~~~~- 232 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS--------PSHTETHRRIVNVD-------LKFP- 232 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTTC-------CCCC-
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC--------CCHhHHHHHHhccc-------cCCC-
Confidence 345678999999999998999999999999999999999999962 11222222222111 0111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.||++|||+.|+++
T Consensus 233 ----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 ----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111236778999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=358.44 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=198.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..++||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++||||+.
T Consensus 30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 4578999999999999965 78999999986432 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE---cCCCCcEEeccCCccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL---DNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~ 409 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 110 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 110 GGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp SCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999997543 389999999999999999999998 99999999999999 567899999999987654
Q ss_pred cc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 410 KE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 410 ~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
.. ....||+.|+|||++.+ .++.++||||+||++|||++|++||.. ......+......... ...+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~--~~~~ 249 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG--------ANEYDILKKVEKGKYT--FELP 249 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCC--CCSG
T ss_pred cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHcCCCC--CCCc
Confidence 43 23468999999998865 699999999999999999999999962 1222222222222111 0011
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
... .....+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 250 QWK------KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGG------GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc------cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111 122367889999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=335.88 Aligned_cols=240 Identities=20% Similarity=0.284 Sum_probs=197.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 3578999999999999965 57889999987532 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 99 RRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp TCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999987654 389999999999999999999998 9999999999999999999999999998765422
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||.. ....+.......... .+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~~~-------~~ 234 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEY-------SI 234 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTTCC-------CC
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhhccC-------CC
Confidence 234678899999999888899999999999999999999999962 122222222211110 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ......+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 P-----KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp C-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred c-----cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 1112367788899999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=336.14 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=196.0
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E~~ 331 (565)
..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 89 (279)
T 2w5a_A 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89 (279)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCC
Confidence 3578999999999999964 78899999997532 3345679999999999999999999998865 46789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC-----CccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT-----LPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~-----ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
++|+|.+++...... ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 90 EGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp TTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999764321 22489999999999999999999998 6 9999999999999999999999999987
Q ss_pred cccccc----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 407 IVNKEH----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 407 ~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
...... ...+++.|+|||.+.+..++.++|||||||++|||+||+.||... ........ +..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~-i~~~~~~- 234 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELAGK-IREGKFR- 234 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHH-HHHTCCC-
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc--------CHHHHHHH-Hhhcccc-
Confidence 654332 345788999999998888999999999999999999999998632 12222222 2222111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 528 (565)
.+. ......+.+++.+||+.||++|||+.|+++.+..
T Consensus 235 ----~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 ----RIP-----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ----CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----cCC-----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111 1112367888999999999999999999886543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=346.30 Aligned_cols=245 Identities=21% Similarity=0.272 Sum_probs=195.4
Q ss_pred ccceecccCceeEEEEEE----eCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL----LTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEE
Confidence 467899999999999997 378999999986432 23456678899999999 699999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 138 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999998654 389999999999999999999998 999999999999999999999999999876
Q ss_pred cccc-----ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 408 VNKE-----HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 408 ~~~~-----~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
.... ....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ...............
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~-- 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE-- 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc----cchHHHHHHHHhccC--
Confidence 5322 23468999999998875 3578999999999999999999999963221 112222222222211
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVEKI 526 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 526 (565)
+.. +......+.+++.+||+.||++|| |+.|+++..
T Consensus 283 -----~~~-----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -----PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCC-----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011 111223677899999999999999 999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=343.17 Aligned_cols=250 Identities=16% Similarity=0.193 Sum_probs=185.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 116 (329)
T 3gbz_A 38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE- 116 (329)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-
Confidence 457899999999999985 4788999999874322 234568899999999999999999999999999999999998
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-----CCCCcEEeccCCcccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-----NAYEPLLTDYALVPIV 408 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-----~~~~~kl~DfGla~~~ 408 (565)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 117 ~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 117 NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 59999997654 389999999999999999999998 999999999999994 5556999999999765
Q ss_pred ccc----ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-ccCc
Q 008431 409 NKE----HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-WTGE 482 (565)
Q Consensus 409 ~~~----~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 482 (565)
... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||... .....+....... ....
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD--------SEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCT
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC--------CHHHHHHHHHHHhCCCch
Confidence 432 334578999999988764 5899999999999999999999999631 1112222221110 0000
Q ss_pred cc------cccc----cCC-CCCH------HHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VF------DKDM----RGT-KSGE------GEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~------d~~~----~~~-~~~~------~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. .+.. ... .... .....+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0000 000 0000 01246788999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=345.77 Aligned_cols=191 Identities=23% Similarity=0.367 Sum_probs=168.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 37 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 4578999999999999965 7889999998754 2333567999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--c
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--H 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--~ 412 (565)
+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 117 ~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 117 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999998654 3899999999999999999999841 7999999999999999999999999998755322 3
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4578999999999999999999999999999999999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.17 Aligned_cols=243 Identities=20% Similarity=0.268 Sum_probs=184.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--------ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--------NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||+||+|.. .+++.||||.+.... ......+.+|+.+|++++|||||++++++. .+..++|
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEE
Confidence 467899999999999995 467899999987432 111235889999999999999999999974 4568999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC---CCcEEeccCC
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA---YEPLLTDYAL 404 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGl 404 (565)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 218 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 99999999998886433 489999999999999999999998 99999999999999654 4599999999
Q ss_pred ccccccc---ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 405 VPIVNKE---HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 405 a~~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
++..... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... ...+...+ ...
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~~i----~~~ 360 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQI----TSG 360 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS----SCCHHHHH----HTT
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc----hHHHHHHH----hcC
Confidence 9876543 24568999999998753 6788999999999999999999999963211 11122211 111
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. ... +.... .....+.+++.+||+.||++|||+.|+++
T Consensus 361 ~~-~~~-~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KY-NFI-PEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CC-CCC-HHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-CCC-chhhc-----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 10 000 00000 11236888999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=335.23 Aligned_cols=242 Identities=23% Similarity=0.338 Sum_probs=199.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 457899999999999985 468899999997543 344678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 106 ~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 106 SALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 999998642 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+++.|+|||++.+..++.++|||||||++|||++|+.||... ........ ...... +.+..
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~-~~~~~~-----~~~~~ 241 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL--------HPMKVLFL-IPKNNP-----PTLEG 241 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHH-HHHSCC-----CCCCS
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc--------CHHHHHHH-hhcCCC-----CCCcc
Confidence 2346789999999999989999999999999999999999998631 11121111 111111 11111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
.....+.+++.+||+.||++|||+.|+++..-
T Consensus 242 -----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 242 -----NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp -----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred -----ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 11236788899999999999999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.75 Aligned_cols=240 Identities=20% Similarity=0.281 Sum_probs=197.5
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 4578999999999999965 57889999987532 2345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 125 RRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp TCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999987653 389999999999999999999998 9999999999999999999999999999765422
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.. ............... .+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~~~~~~~-------~~ 260 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEY-------SI 260 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCC-------CC
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC--------CCHHHHHHHHhcCCC-------CC
Confidence 234678999999999888899999999999999999999999962 122222222221110 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. .....+.+++.+||+.||++|||+.|+++.
T Consensus 261 ~~-----~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 PK-----HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CT-----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred Cc-----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 111357788899999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.34 Aligned_cols=243 Identities=19% Similarity=0.307 Sum_probs=195.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCcc--------CHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNV--------GKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 326 (565)
..+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|+.+++++ +||||+++++++......++
T Consensus 98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 4578999999999999975 7999999998753211 134678999999998 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 327 VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 178 v~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 999999999999998643 389999999999999999999998 99999999999999999999999999987
Q ss_pred ccccc---ccccccccccCCCccC------CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh
Q 008431 407 IVNKE---HAQLHMVAYKSPEFNQ------TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 407 ~~~~~---~~~~~t~~y~aPE~~~------~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
..... ....||+.|+|||++. ...++.++|||||||++|||+||+.||.. .............
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~--------~~~~~~~~~i~~~ 320 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH--------RRQILMLRMIMEG 320 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHT
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhC
Confidence 66533 3456899999999874 33588999999999999999999999962 1112222222111
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. . ....+.... ....+.+++.+||+.||++|||+.|+++
T Consensus 321 ~-~-~~~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 Q-Y-QFSSPEWDD------RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp C-C-CCCHHHHSS------SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C-C-CCCCccccc------CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1 011111111 1236788999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=335.54 Aligned_cols=254 Identities=17% Similarity=0.193 Sum_probs=198.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEE-EecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY-YRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|.. .+++.||||.+.... ....+.+|+.+++.++|++++..++++ ...+..++||||+ +|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 457899999999999995 578899999876432 234588999999999999888877776 4566789999999 99
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE---cCCCCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL---DNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~ 411 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 90 ~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 90 SLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999975433 399999999999999999999998 99999999999999 78999999999999765432
Q ss_pred -----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 412 -----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 412 -----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+....... .
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~-~ 238 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKMST-P 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHHHS-C
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh--hhhhhhhhcccccc-h
Confidence 234678999999999999999999999999999999999999974332111 11111111111000 0
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
.....+ .....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 239 ~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 239 IEVLCK---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHTT---------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhc---------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 000000 01136888999999999999999999999999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=345.14 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=187.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv 327 (565)
..+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+.+++.++||||+++++++...+ ..|+|
T Consensus 29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence 457899999999999996 57899999998642 2233467899999999999999999999997653 45999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+ +++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999 78999999752 389999999999999999999998 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-ccc----
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-EWT---- 480 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~---- 480 (565)
.... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||... +....+...... +..
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS--------DHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCHHH
T ss_pred cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhcCCCCHHH
Confidence 6543 34578999999998766 67999999999999999999999999631 111222111110 000
Q ss_pred ----------------CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 ----------------GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 ----------------~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+... .......+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASI--LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGT--CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHH--CCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000000 01122467889999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.95 Aligned_cols=242 Identities=19% Similarity=0.299 Sum_probs=194.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 4578999999999999965 78999999987432 334577999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 91 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 91 ELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999886432 389999999999999999999998 9999999999999999999999999998765322
Q ss_pred ---ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....+++.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ......|. ... . .. +.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~----~~~-~--~~-~~ 230 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWK----EKK-T--YL-NP 230 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHHHH----TTC-T--TS-TT
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHhh----hcc-c--cc-Cc
Confidence 23467899999999887665 77999999999999999999999732110 01111111 110 0 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. ......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 W------KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp G------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h------hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 111236778999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.96 Aligned_cols=184 Identities=20% Similarity=0.347 Sum_probs=148.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec-----CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-----EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~ 328 (565)
..++||+|+||+||+|.. .+++.||||++... .....+++.+|+.+|++++|||||++++++... ...|+||
T Consensus 57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence 457899999999999995 47899999999643 223456799999999999999999999999543 4689999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+. |+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 137 e~~~-~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 137 EIAD-SDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CCCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred eccc-cchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9984 79999997543 399999999999999999999998 9999999999999999999999999999875
Q ss_pred ccc-------------------------------ccccccccccCCCcc-CCCCCCcchhHHHHHHHHHHHHcC
Q 008431 409 NKE-------------------------------HAQLHMVAYKSPEFN-QTDGVTRKTDVWSLGILILELLTG 450 (565)
Q Consensus 409 ~~~-------------------------------~~~~~t~~y~aPE~~-~~~~~~~~~DvwS~Gvil~el~tg 450 (565)
... ....||+.|+|||++ ....|+.++|||||||++|||+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 421 223568899999975 566799999999999999999993
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.14 Aligned_cols=246 Identities=17% Similarity=0.225 Sum_probs=198.4
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|||||++++++.+.+..|+||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 468999999999999964 68999999997432 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 270 g~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 270 GDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp CBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 9999999764321 23599999999999999999999998 9999999999999999999999999999876433
Q ss_pred --ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccccc
Q 008431 412 --HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 489 (565)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||..... ............... . ..
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~----~~~~~~~~~~i~~~~-~------~~- 412 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRVLEQA-V------TY- 412 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC----CCCHHHHHHHHHHCC-C------CC-
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc----chhHHHHHHHHhhcc-c------CC-
Confidence 234789999999999999999999999999999999999999973211 112222222222211 0 00
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 008431 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDL-----REAVE 524 (565)
Q Consensus 490 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~ 524 (565)
+......+.+++.+||+.||++||++ .|+++
T Consensus 413 ----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 413 ----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11112367788899999999999965 56653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.08 Aligned_cols=243 Identities=18% Similarity=0.245 Sum_probs=191.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|... +++.||+|.+..... .+.+|++++.++ +||||+++++++.+.+..|+||||+++|
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 4578999999999999964 688999999975432 245688888887 7999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC----CCcEEeccCCcccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA----YEPLLTDYALVPIVNK 410 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~----~~~kl~DfGla~~~~~ 410 (565)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++....
T Consensus 102 ~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 102 ELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp BHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999997543 389999999999999999999998 99999999999998443 3499999999986543
Q ss_pred c----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 411 E----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 411 ~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
. ....+|+.|+|||++.+..|+.++|||||||++|||++|+.||.... ............... .. . ..
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~~~-~~-~-~~ 244 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEILARIGSGK-FS-L-SG 244 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHHHHHHHHCC-CC-C-CS
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHHHHHHccCC-cc-c-Cc
Confidence 3 24567899999999888778999999999999999999999996321 112222332222211 10 0 00
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 245 GY-----WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TT-----TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 01122367888999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=339.29 Aligned_cols=245 Identities=19% Similarity=0.258 Sum_probs=194.5
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeecc--CccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
.+.||+|+||+||+|... +++.||+|++... .......+.+|+.+++.+. ||||+++++++...+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 478999999999999965 6899999998743 2344678999999999995 69999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCcccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIVNK 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~~ 410 (565)
|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 114 ~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 114 GEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred CcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999998854322 2499999999999999999999998 9999999999999987 78999999999987654
Q ss_pred c---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 E---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
. ....+|+.|+|||++....++.++|||||||++|||++|+.||... ............. .....+.
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~--~~~~~~~ 256 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE--------DNQETYLNISQVN--VDYSEET 256 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC--CCCCTTT
T ss_pred ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CchHHHHHHHhcc--cccCchh
Confidence 3 2346899999999999999999999999999999999999999621 1122221111111 0000010
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ......+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 257 F------SSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp T------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred h------cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1 1122367888999999999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.85 Aligned_cols=247 Identities=18% Similarity=0.119 Sum_probs=177.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc---cCHHHHHHHH---HHHhcCCCCCccceE-------EEEEecC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN---VGKEDFHEHM---TRLGSLSHPNLLPLI-------AFYYRKE 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~-------~~~~~~~ 322 (565)
..+.||+|+||+||+|... +++.||||++..... ...+.+.+|+ ..|+. +||||++++ +++...+
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETT
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCC
Confidence 4578999999999999964 788999999986432 2345677784 55566 799988755 4554332
Q ss_pred -----------------ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhhCCCCCC
Q 008431 323 -----------------EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIR------LKIIKGVAKGLAYLYKEFPGVTL 379 (565)
Q Consensus 323 -----------------~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gL~ylH~~~~~~~i 379 (565)
..|+||||++ |+|.+++..... .+.+..+ ..++.||+.||+|||++ +|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~i 215 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSK----GL 215 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TE
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC----CC
Confidence 3799999999 899999986532 2455556 78889999999999998 99
Q ss_pred ccCCCCCCCEEEcCCCCcEEeccCCcccccccc-cccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 008431 380 PHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-AQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPANY 456 (565)
Q Consensus 380 vHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~~ 456 (565)
+||||||+|||++.++.+||+|||+++...... ...+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999998776554 5667799999999887 6799999999999999999999999974
Q ss_pred cccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 457 LAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
........ | ............... .........+.+++.+||+.||++|||+.|+++
T Consensus 296 ~~~~~~~~-----~-----~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGS-----W-----KRPSLRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTC-----C-----CBCCTTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccc-----h-----hhhhhhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 32211100 0 000000000000000 000122346788899999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=335.84 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=191.2
Q ss_pred ccceecccCceeEEEEEEe--CCC--eeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL--TGP--AMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|.+. ++. .||+|.++.. .....+.+.+|+.++++++||||+++++++...+ .++|||
T Consensus 22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence 4578999999999999854 233 5899988643 2234567999999999999999999999987654 899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp CCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cccCCCHHHHHHhccC----CcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999986543 389999999999999999999998 99999999999999999999999999987664
Q ss_pred ccc-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 410 KEH-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 410 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
... ...++..|+|||++.+..++.++|||||||++|||++ |+.||.. ......+..........
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------LNGSQILHKIDKEGERL 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTSCCCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc--------CCHHHHHHHHHccCCCC
Confidence 321 2345678999999888889999999999999999999 9999862 22223333222221110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+ ........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 245 ----~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 245 ----P------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ----C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----C------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 0 01112246888999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.18 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=194.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc-------------cCHHHHHHHHHHHhcCCCCCccceEEEEEecC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN-------------VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 322 (565)
..+.||+|+||+||+|... ++..||+|.+..... ...+.+.+|+.++++++|||||++++++.+..
T Consensus 40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 4578999999999999964 678999999874321 23567999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC---CcEE
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY---EPLL 399 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~---~~kl 399 (565)
..|+|||||++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999997654 399999999999999999999998 999999999999998765 6999
Q ss_pred eccCCccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 400 TDYALVPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 400 ~DfGla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
+|||+++..... ....||+.|+|||++. ..++.++||||+||++|||++|++||.. ......+.....
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~ 261 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG--------QNDQDIIKKVEK 261 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHc
Confidence 999999876543 3456899999999876 4699999999999999999999999962 222223322222
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...... .+.... ....+.+++.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~--~~~~~~------~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 GKYYFD--FNDWKN------ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCCC--HHHHTT------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCC--ccccCC------CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 211000 001111 12367889999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=340.13 Aligned_cols=250 Identities=18% Similarity=0.283 Sum_probs=191.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|.... .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 45789999999999998643 59999986432 233456889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc----
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK---- 410 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~---- 410 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 115 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 115 TLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp EHHHHTTSSCC----CCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999975432 489999999999999999999998 999999999999998 67999999999865421
Q ss_pred -----cccccccccccCCCccCC---------CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 411 -----EHAQLHMVAYKSPEFNQT---------DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 411 -----~~~~~~t~~y~aPE~~~~---------~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
.....+++.|+|||++.. ..++.++|||||||++|||++|+.||.. ...........
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~--------~~~~~~~~~~~- 256 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT--------QPAEAIIWQMG- 256 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS--------CCHHHHHHHHH-
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHhc-
Confidence 123357899999998764 4578999999999999999999999962 11222222221
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
.... +...... ....+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 257 ~~~~-----~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 257 TGMK-----PNLSQIG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp TTCC-----CCCCCSS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred cCCC-----CCCCcCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111 1111101 112577889999999999999999999999999876533
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=333.74 Aligned_cols=241 Identities=21% Similarity=0.318 Sum_probs=193.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|... +|+.||+|.+... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp EEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 4578999999999999965 5899999999753 245679999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 111 L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 111 VSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp HHHHHHHHTC----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence 9999975432 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....+++.|+|||++.+..++.++|||||||++|||++|+.||... ......... ..........
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~-~~~~~~~~~~------ 247 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI--------HPMRAIFMI-PTNPPPTFRK------ 247 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHH-HHSCCCCCSS------
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHH-hcCCCcccCC------
Confidence 3346789999999998889999999999999999999999998631 111111111 1111111100
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+......+.+++.+||+.||++|||+.|+++
T Consensus 248 --~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 --PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111236788999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.71 Aligned_cols=190 Identities=22% Similarity=0.297 Sum_probs=165.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcC------CCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL------SHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..++||+|+||+||+|... +++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++...+..++|||
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 179 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence 4578999999999999854 5889999998743 23345677888887776 67799999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC--cEEeccCCccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE--PLLTDYALVPI 407 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfGla~~ 407 (565)
|+. |+|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 180 ~~~-~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 180 LLS-MNLYELIKKNKFQ---GFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp CCC-CBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred ccC-CCHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 996 6999999865432 489999999999999999999999 9999999999999999887 99999999976
Q ss_pred cccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.... ....+|+.|+|||++.+..++.++|||||||++|||+||++||.
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp TTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 5443 35578999999999999899999999999999999999999996
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.53 Aligned_cols=252 Identities=21% Similarity=0.225 Sum_probs=192.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc-----cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN-----VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 457899999999999995 4689999999864221 1134688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+++ +|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 94 MET-DLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CSE-EHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CCC-CHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 985 89998875432 488899999999999999999998 999999999999999999999999999987643
Q ss_pred c----ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-------
Q 008431 411 E----HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE------- 478 (565)
Q Consensus 411 ~----~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 478 (565)
. ....+|+.|+|||++.+ ..++.++|||||||++|||++|.+||... .....+.......
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~--------~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--------SDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCTTT
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHHcCCCChhh
Confidence 2 24567899999998865 45899999999999999999999998621 1222222222110
Q ss_pred ccCccccccc---cCC-CCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 479 WTGEVFDKDM---RGT-KSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 479 ~~~~~~d~~~---~~~-~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
+....-.+.. ... ..+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000 000 000 1112468889999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=342.33 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=192.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc--cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN--VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 4578999999999999964 588999999865332 2245688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 109 TILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred chHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99988876433 389999999999999999999998 9999999999999999999999999999765432
Q ss_pred --ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHH----------HHhh-h
Q 008431 412 --HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVN----------SVVR-E 477 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~~-~ 477 (565)
....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+. .... .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhhhHhhhc
Confidence 344678999999988765 7899999999999999999999999632110 00000000 0000 0
Q ss_pred cccCccccccccCCCCC----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 478 EWTGEVFDKDMRGTKSG----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
........+.+...... ......+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00111111111111100 0123468899999999999999999998763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.96 Aligned_cols=199 Identities=21% Similarity=0.341 Sum_probs=155.5
Q ss_pred hHHHhhccceecccCceeEEEEEEe---CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceE
Q 008431 251 NDLLRASAEVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKL 325 (565)
Q Consensus 251 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 325 (565)
.+......++||+|+||+||+|+.. ++..||||++... .....+.+|+.+|++++|||||++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3333334568999999999999965 5789999998643 234578999999999999999999999965 56789
Q ss_pred EEEeccCCCCHHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE----cCCCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRA----PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL----DNAYEP 397 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl----~~~~~~ 397 (565)
+||||+. |+|.+++..... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCcE
Confidence 9999997 588888864321 1112489999999999999999999998 99999999999999 778999
Q ss_pred EEeccCCccccccc-------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 008431 398 LLTDYALVPIVNKE-------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANY 456 (565)
Q Consensus 398 kl~DfGla~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~ 456 (565)
||+|||+++..... ....+|+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999876432 23467899999998876 4589999999999999999999999963
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.83 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=199.0
Q ss_pred hhccceecccCceeEEEEEEeC----CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 255 RASAEVLGSGSFGSSYKAVLLT----GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 255 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
+...+.||+|+||+||+|.+.. +..||+|+++... ....+.|.+|+.++++++|||||++++++ ..+..++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceEEEEE
Confidence 3456889999999999999643 3468999886432 23346799999999999999999999998 4567899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 471 ~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 471 LCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp CCTTCBHHHHHHHTTT----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred cCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999986542 389999999999999999999998 99999999999999999999999999998764
Q ss_pred ccc-----cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 410 KEH-----AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 410 ~~~-----~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
... ...+++.|+|||++....++.++|||||||++|||++ |..||... ...+........... .
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--------~~~~~~~~i~~~~~~-~- 612 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--------KNNDVIGRIENGERL-P- 612 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHHTCCC-C-
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHcCCCC-C-
Confidence 432 2345678999999988899999999999999999997 99998631 222222222211110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
. +......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 613 ----~-----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 ----M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----C-----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1 11122467889999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.49 Aligned_cols=246 Identities=21% Similarity=0.298 Sum_probs=181.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc-cC-HHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN-VG-KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|.. .+++.||+|+++.... .. .+.+.++...++.++||||+++++++.+.+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~- 89 (290)
T 3fme_A 11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD- 89 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-
Confidence 457899999999999996 5788999999975322 22 2334455566888999999999999999999999999997
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.+++...... ...+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 90 TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 5998887653211 124999999999999999999999863 7999999999999999999999999999766443
Q ss_pred -ccccccccccCCCcc----CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 -HAQLHMVAYKSPEFN----QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~----~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....+|+.|+|||++ ....++.++|||||||++|||+||+.||... ......+.........
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~------ 232 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW-------GTPFQQLKQVVEEPSP------ 232 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC-------SCHHHHHHHHHHSCCC------
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc-------CchHHHHHHHhccCCC------
Confidence 234688999999985 5667899999999999999999999999621 1112222222222111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.... ......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 QLPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cccc----ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0100 111236788999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=348.53 Aligned_cols=189 Identities=22% Similarity=0.326 Sum_probs=161.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec-----CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-----EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~ 328 (565)
..+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+|++++||||+++++++... +..|+||
T Consensus 30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 457899999999999995 46788999999753 223356799999999999999999999999766 5689999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+. |+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 110 EIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp ECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9996 59999997533 399999999999999999999999 9999999999999999999999999999865
Q ss_pred ccc--------------------------ccccccccccCCCcc-CCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 409 NKE--------------------------HAQLHMVAYKSPEFN-QTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 409 ~~~--------------------------~~~~~t~~y~aPE~~-~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
... ....+|+.|+|||++ ....|+.++|||||||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 432 344678999999975 56679999999999999999998665553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=368.35 Aligned_cols=239 Identities=20% Similarity=0.225 Sum_probs=197.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..++||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..|+||||+
T Consensus 345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~ 424 (674)
T 3pfq_A 345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424 (674)
T ss_dssp EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence 4578999999999999954 6788999999742 234456788999999987 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc-
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK- 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 410 (565)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 425 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 425 NGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999998754 399999999999999999999998 999999999999999999999999999985322
Q ss_pred ---cccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 ---EHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ---~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||.. .+............. .
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~-------~ 560 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--------EDEDELFQSIMEHNV-------A 560 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHSSCC-------C
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhCCC-------C
Confidence 2345789999999999999999999999999999999999999962 222333333332211 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL-----REAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~ 524 (565)
+ +......+.+++.+||+.||++||++ +||.+
T Consensus 561 ~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 Y-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp C-----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred C-----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 11122467888999999999999987 66653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=335.59 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=177.8
Q ss_pred ccceecccCceeEEEEE-EeCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||.||+|. ..+++.||||.+.... ....+++.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 45789999999999998 4578999999986432 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRA---PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
+|.+++..... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 99999975211 1123489999999999999999999998 9999999999999999999999999998654322
Q ss_pred ---------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc-
Q 008431 412 ---------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT- 480 (565)
Q Consensus 412 ---------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 480 (565)
....+|+.|+|||++.. ..++.++|||||||++|||++|+.||..... .............
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP--------MKVLMLTLQNDPPS 246 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHHHHTSSCCC
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch--------hhHHHHHhccCCCc
Confidence 23357889999998765 5689999999999999999999999973211 1111111111100
Q ss_pred --CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 481 --GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 481 --~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLK-----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCC-----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhh-----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0111111111 11236788899999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.94 Aligned_cols=257 Identities=18% Similarity=0.250 Sum_probs=189.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEec--------------
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-------------- 321 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------------- 321 (565)
..+.||+|+||+||+|.. .+|+.||||++..... ...+|+++++.++|||||++++++...
T Consensus 11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 457899999999999995 5789999999875422 234799999999999999999998543
Q ss_pred ------------------------CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC
Q 008431 322 ------------------------EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377 (565)
Q Consensus 322 ------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~ 377 (565)
...++||||++ |+|.+.+...... ...+++..+..++.|++.||+|||+.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---- 160 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGFIHSL---- 160 (383)
T ss_dssp -----------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTT----
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----
Confidence 23789999998 5888887643211 12499999999999999999999998
Q ss_pred CCccCCCCCCCEEEc-CCCCcEEeccCCccccccc---ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCC
Q 008431 378 TLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVNKE---HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKF 452 (565)
Q Consensus 378 ~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~ 452 (565)
+|+||||||+|||++ .++.+||+|||+++..... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999999998 6889999999999865433 345678999999987764 58999999999999999999999
Q ss_pred CccccccCCCCCcchHHHHHHHhhh---c----------ccCccccccccCCC----CCHHHHHHHHHHHhhccccCcCC
Q 008431 453 PANYLAQGKGANADLATWVNSVVRE---E----------WTGEVFDKDMRGTK----SGEGEMLKLLKIGMCCCEWNAER 515 (565)
Q Consensus 453 p~~~~~~~~~~~~~~~~~~~~~~~~---~----------~~~~~~d~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~ 515 (565)
||... ...+.+...... . ......-+.+.... .+......+.+++.+||+.||++
T Consensus 241 pf~~~--------~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 241 LFSGE--------TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp SSCCS--------SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred CCCCC--------ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99731 111111111110 0 00000001110000 00112246889999999999999
Q ss_pred CCCHHHHHHH--HHHhhc
Q 008431 516 RWDLREAVEK--IMELKE 531 (565)
Q Consensus 516 RPs~~evl~~--L~~i~~ 531 (565)
|||+.|+++. +++++.
T Consensus 313 R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SCCHHHHHTSGGGHHHHH
T ss_pred CCCHHHHhcCHHHHHHHh
Confidence 9999999853 444443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=335.07 Aligned_cols=249 Identities=20% Similarity=0.241 Sum_probs=191.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEe--cCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYR--KEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|.. .+++.||||.+.. ...+.+.+|+.++++++ ||||+++++++.+ ....++||||++
T Consensus 40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 116 (330)
T 3nsz_A 40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116 (330)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred EEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence 457899999999999985 5788999999863 34578999999999997 9999999999987 567899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNKE 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~ 411 (565)
+++|.+++.. +++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 117 ~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 117 NTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred chhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999998752 88899999999999999999998 999999999999999776 8999999999765433
Q ss_pred ---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC------
Q 008431 412 ---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG------ 481 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 481 (565)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+.... .........
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~-~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIA-KVLGTEDLYDYIDKY 260 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHH-HHHCHHHHHHHHHHT
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHH-HhcCCchhhhHHHHh
Confidence 34567889999998776 67899999999999999999999998521100 00011100 000000000
Q ss_pred -cccccc---------------ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 -EVFDKD---------------MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 -~~~d~~---------------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...++. .............+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0000111112357889999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=340.37 Aligned_cols=249 Identities=16% Similarity=0.250 Sum_probs=185.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv 327 (565)
..+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..|+|
T Consensus 29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEE
Confidence 4578999999999999854 68899999997532 233467889999999999999999999997654 67999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||++ |+|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 109 MELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99997 588888852 288999999999999999999998 999999999999999999999999999987
Q ss_pred cccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-------
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE------- 477 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 477 (565)
.... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+......
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--------HIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHC-CCCCCHH
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCCCCHH
Confidence 6543 34568899999999999899999999999999999999999996321 11111111110
Q ss_pred ---------------ccc--C----ccccccccCCCC--CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 478 ---------------EWT--G----EVFDKDMRGTKS--GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 478 ---------------~~~--~----~~~d~~~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
... . ..+......... .......+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 0 000000000000 01224578899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=349.99 Aligned_cols=253 Identities=17% Similarity=0.195 Sum_probs=198.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCC-CccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHP-NLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..++||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++|+ +|..+..++...+..++||||+ +|
T Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 457899999999999995 5789999998765322 34588999999999875 4555555666778889999999 99
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE---cCCCCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL---DNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~ 411 (565)
+|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 sL~~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 88 SLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp BHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999975433 399999999999999999999998 99999999999999 68899999999999865433
Q ss_pred c-----------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 412 H-----------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 412 ~-----------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
. ...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~i~~~~~- 233 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----GTKKQKYEKISEKKV- 233 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----SSHHHHHHHHHHHHH-
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc-----hhHHHHHHHHhhccc-
Confidence 2 44688999999999999999999999999999999999999974321 112222222211110
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
...+...... ....+.+++..||+.||++||++.+|++.|+++...
T Consensus 234 ~~~~~~l~~~------~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 234 ATSIEALCRG------YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HSCHHHHHTT------SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccHHHHhcC------CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0000100011 123688899999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=337.56 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=192.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec--------CceE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK--------EEKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~ 325 (565)
..+.||+|+||+||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++... +..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence 457899999999999996 578999999986432 23356788999999999999999999999873 4689
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+||||+++ +|.+.+..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 101 lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp EEEECCSE-EHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCC-CHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 99999975 88888765433 399999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc--------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 406 PIVNKE--------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 406 ~~~~~~--------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
+..... ....+|+.|+|||++.+ ..++.++|||||||++|||+||++||.... .......+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLCG 246 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhC
Confidence 765321 23457899999998765 558999999999999999999999996311 0111111111111
Q ss_pred hcc---cCccccc----cc---cCCCCC-HHH------HHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 477 EEW---TGEVFDK----DM---RGTKSG-EGE------MLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 477 ~~~---~~~~~d~----~~---~~~~~~-~~~------~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
... ....-.. .+ ...... ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 100 0000000 00 000000 111 1347889999999999999999999774
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=341.94 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=186.5
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCcc-----------CHHHHHHHHHHHhcCCCCCccceEEEEEecC---
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV-----------GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE--- 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 322 (565)
..+.||+|+||.||+|...+|..||||++...... ..+.+.+|+.++++++||||+++++++...+
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence 35789999999999999888999999998642211 1267999999999999999999999996533
Q ss_pred --ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEe
Q 008431 323 --EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLT 400 (565)
Q Consensus 323 --~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 400 (565)
..|+||||++ |+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQRI----VISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cceEEEEEccCC-CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEEEcCCCCEEEE
Confidence 4799999998 689988875432 489999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccccc---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 401 DYALVPIVNKE---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 401 DfGla~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
|||+++..... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||... .....+.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--------~~~~~~~~i~~ 248 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS--------TFYNQLNKIVE 248 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHH
Confidence 99999754433 33467889999998776 67899999999999999999999999631 11122221111
Q ss_pred hccc--------------CccccccccCCCC------CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 477 EEWT--------------GEVFDKDMRGTKS------GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 477 ~~~~--------------~~~~d~~~~~~~~------~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.... ...+......... .......+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000 0000000000000 01112467889999999999999999999763
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=347.07 Aligned_cols=261 Identities=22% Similarity=0.270 Sum_probs=189.1
Q ss_pred hccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLVS 328 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 328 (565)
...++||+|+||+||+|+.. +|+.||||++.... ..+.+|+++|++++|||||+++++|.... ..++||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 34578999999999999964 68999999986532 22347999999999999999999986532 367999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-CCcEEeccCCccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-YEPLLTDYALVPI 407 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~ 407 (565)
||+++ +|.+.+...... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 133 e~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp ECCCE-EHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred hcccc-cHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 99985 677666532111 12499999999999999999999998 99999999999999965 5689999999986
Q ss_pred cccc---ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHH-------hh
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSV-------VR 476 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 476 (565)
.... ....+|+.|+|||++.+. .|+.++|||||||++|||++|++||..... ...+...+... +.
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCHHHHH
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHH
Confidence 5432 345689999999988664 799999999999999999999999963110 01111111110 00
Q ss_pred h--cccCccccccccCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhh
Q 008431 477 E--EWTGEVFDKDMRGTK----SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELK 530 (565)
Q Consensus 477 ~--~~~~~~~d~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~ 530 (565)
. ....+...+.+.... ........+.+++.+||+.||++|||+.|+++. ++++.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0 000111111111100 001112468899999999999999999999863 44443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.13 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=175.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv 327 (565)
..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...|+|
T Consensus 33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence 457899999999999985 57889999998643 223456788999999999999999999999754 457999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+||+ +++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 113 ~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 113 THLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 9999 68999988642 389999999999999999999998 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-ccc----
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-EWT---- 480 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~---- 480 (565)
.... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||... +....+...... +..
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--------DHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCSCCHHH
T ss_pred ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHhCCCCHHH
Confidence 6443 34578999999998776 67899999999999999999999999631 111212111110 000
Q ss_pred -Ccccc-------ccccCCC-CCH-----HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 -GEVFD-------KDMRGTK-SGE-----GEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 -~~~~d-------~~~~~~~-~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..+.. ..+.... ... .....+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 0000000 000 112357889999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.60 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=188.3
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc------eEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE------KLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lv~E~ 330 (565)
..++||+|+||+||+|+...+..+|+|++...... ..+|+++++.++|||||+++++|...+. .++||||
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 46789999999999999877777999998653222 2369999999999999999999976543 7899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-CCCCcEEeccCCccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVN 409 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~ 409 (565)
++++.+......... ...+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 120 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 120 VPETVYRASRHYAKL--KQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp CSEEHHHHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred cCccHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 987544333321111 12489999999999999999999998 999999999999999 79999999999998754
Q ss_pred cc---ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh---c----
Q 008431 410 KE---HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE---E---- 478 (565)
Q Consensus 410 ~~---~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---- 478 (565)
.. ....+|+.|+|||++.+. .++.++|||||||++|||++|++||... +....+...... .
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--------~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE--------SGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCHHH
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHhCCCCHHH
Confidence 32 345678999999987654 5899999999999999999999999631 111111111110 0
Q ss_pred ------ccCccccccccCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhh
Q 008431 479 ------WTGEVFDKDMRGTK----SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELK 530 (565)
Q Consensus 479 ------~~~~~~d~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~ 530 (565)
......-+...... ........+.+++.+||+.||++|||+.|+++. +++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00000001110000 001122468899999999999999999999874 44443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=328.52 Aligned_cols=243 Identities=21% Similarity=0.282 Sum_probs=195.2
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCc---------cCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN---------VGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 325 (565)
..+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.+++++. ||||+++++++...+..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 3578999999999999964 688999999874321 12356889999999996 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999998653 389999999999999999999998 9999999999999999999999999998
Q ss_pred cccccc---ccccccccccCCCccC------CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQ------TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~------~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
...... ....+++.|+|||++. ...++.++|||||||++|||++|+.||.. ............
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~ 243 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--------RKQMLMLRMIMS 243 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHH
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC--------ccHHHHHHHHhc
Confidence 765433 3346789999999864 45688999999999999999999999862 112222222222
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.... ...+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~--~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQ--FGSPEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCC--CCTTTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcc--cCcccc------cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 2110 101111 122246888999999999999999999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=332.53 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=188.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEe------cCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYR------KEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~~~~~lv~ 328 (565)
..+.||+|+||.||+|.. .+++.||+|.+... ....+.+.+|+.+++++ +||||+++++++.. .+..++||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 457899999999999996 47889999998753 33457899999999998 79999999999987 45789999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 107 e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp ECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 99999999999986432 2489999999999999999999998 9999999999999999999999999998765
Q ss_pred ccc----ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 409 NKE----HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 409 ~~~----~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
... ....+++.|+|||++. ...++.++|||||||++|||+||+.||... .............
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~- 250 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM--------HPMRALFLIPRNP- 250 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSC-
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHhhcCc-
Confidence 432 2346789999999876 567899999999999999999999998621 1111111111111
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. +...... ....+.+++.+||+.||++|||+.|+++
T Consensus 251 ~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 251 A-----PRLKSKK----WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp C-----CCCSCSC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-----ccCCccc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 1111111 1236788889999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.08 Aligned_cols=241 Identities=18% Similarity=0.305 Sum_probs=190.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC----ccCHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS----NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E 329 (565)
..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 457899999999999995 478899999997432 2335679999999999999999999999853 457899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++| |.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred hccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 99876 7777765432 2489999999999999999999998 99999999999999999999999999987653
Q ss_pred cc------ccccccccccCCCccCCCC--CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 410 KE------HAQLHMVAYKSPEFNQTDG--VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 410 ~~------~~~~~t~~y~aPE~~~~~~--~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
.. ....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.. .............. .
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~i~~~~-~- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG--------DNIYKLFENIGKGS-Y- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHCC-C-
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC--------chHHHHHHHHhcCC-C-
Confidence 21 2345789999999887643 37899999999999999999999962 22222222222111 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+.. .....+.+++.+||+.||++|||+.|+++.
T Consensus 231 -----~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -----AIPG-----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCCS-----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCCC-----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111 112367788999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=322.41 Aligned_cols=242 Identities=22% Similarity=0.308 Sum_probs=195.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 4578999999999999965 7889999998743 234567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC---CCcEEeccCCcccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA---YEPLLTDYALVPIVNK 410 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGla~~~~~ 410 (565)
++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 106 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999987654 389999999999999999999998 99999999999999754 4699999999876543
Q ss_pred c---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 411 E---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 411 ~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
. ....+++.|+|||.+.+ .++.++|||||||++|||++|+.||.. .................. .+.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~~--~~~ 245 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG--------KNEYDILKRVETGKYAFD--LPQ 245 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCCC--SGG
T ss_pred CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCCCC--chh
Confidence 3 23357889999998765 489999999999999999999999862 122222222222111100 011
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~------~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 246 WR------TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hh------hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11 11236788999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.22 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=188.3
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--------ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--------NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++...+ .++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence 4578999999999999964 67899999986422 112345889999999999999999999986554 8999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC---cEEeccCC
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE---PLLTDYAL 404 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfGl 404 (565)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 93 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 99999999999986533 489999999999999999999998 9999999999999987654 99999999
Q ss_pred ccccccc---ccccccccccCCCcc---CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 405 VPIVNKE---HAQLHMVAYKSPEFN---QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 405 a~~~~~~---~~~~~t~~y~aPE~~---~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
++..... ....+|+.|+|||++ ....++.++|||||||++|||++|+.||..... ...+...+. ..
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~----~~ 235 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQIT----SG 235 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC----SSCHHHHHH----HT
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----HHHHHHHHH----hC
Confidence 9876543 234578999999985 356789999999999999999999999963221 112222221 11
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. . ..+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~-~-~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KY-N-FIPEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC-C-CCHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc-c-cCchhhh-----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 10 0 0011100 11236788999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.09 Aligned_cols=253 Identities=17% Similarity=0.217 Sum_probs=195.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccC-----------------HHHHHHHHHHHhcCCCCCccceEEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVG-----------------KEDFHEHMTRLGSLSHPNLLPLIAFYY 319 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l~~~~~ 319 (565)
..+.||+|+||.||+|.. +++.||+|.+....... .+.+.+|+.++++++||||+++++++.
T Consensus 35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999 99999999997432111 178999999999999999999999999
Q ss_pred ecCceEEEEeccCCCCHHHH------HhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-hCCCCCCccCCCCCCCEEEc
Q 008431 320 RKEEKLLVSDFVPNGSLANL------LHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK-EFPGVTLPHGHLKSSNVLLD 392 (565)
Q Consensus 320 ~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~-~~~~~~ivHrDlkp~NILl~ 392 (565)
+.+..++||||+++|+|.++ +.... ...+++..+..++.|++.||.|||+ . +|+||||||+||+++
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNILMD 186 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGEEEC
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhEEEc
Confidence 99999999999999999988 44321 2359999999999999999999998 7 999999999999999
Q ss_pred CCCCcEEeccCCccccccc--ccccccccccCCCccCCC-CCCc-chhHHHHHHHHHHHHcCCCCccccccCCCCCcchH
Q 008431 393 NAYEPLLTDYALVPIVNKE--HAQLHMVAYKSPEFNQTD-GVTR-KTDVWSLGILILELLTGKFPANYLAQGKGANADLA 468 (565)
Q Consensus 393 ~~~~~kl~DfGla~~~~~~--~~~~~t~~y~aPE~~~~~-~~~~-~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~ 468 (565)
.++.+||+|||++...... ....++..|+|||++.+. .++. ++|||||||++|||++|+.||.... ...
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~ 259 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI-------SLV 259 (348)
T ss_dssp TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS-------CSH
T ss_pred CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC-------cHH
Confidence 9999999999999765433 345688999999998877 6666 9999999999999999999997321 112
Q ss_pred HHHHHHhhhcccCc-----cccccccC--CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 469 TWVNSVVREEWTGE-----VFDKDMRG--TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 469 ~~~~~~~~~~~~~~-----~~d~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.............. ...+.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22222221110000 00000000 0000112346788999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.48 Aligned_cols=254 Identities=17% Similarity=0.255 Sum_probs=195.9
Q ss_pred ccceecccCceeEEEEEE--eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCC------ccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL--LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN------LLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+.+++.++|+| ++++++++...+..++||
T Consensus 18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 96 (339)
T 1z57_A 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96 (339)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEE
Confidence 457899999999999986 36788999998643 233567889999998887654 999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---------------
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN--------------- 393 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~--------------- 393 (565)
||+ +++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 97 e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 97 ELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred cCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 999 8899999986542 2488999999999999999999998 9999999999999987
Q ss_pred ----CCCcEEeccCCccccccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchH
Q 008431 394 ----AYEPLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLA 468 (565)
Q Consensus 394 ----~~~~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~ 468 (565)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-----KEHL 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-----HHHH
T ss_pred ccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-----HHHH
Confidence 678999999999865543 345789999999999998999999999999999999999999963211 1111
Q ss_pred HHHHHHhhh--------cccCccc---------------------cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 469 TWVNSVVRE--------EWTGEVF---------------------DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 469 ~~~~~~~~~--------~~~~~~~---------------------d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
..+...... ....... .+..............+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111111100 0000000 00000011123445678899999999999999999
Q ss_pred HHHHH
Q 008431 520 REAVE 524 (565)
Q Consensus 520 ~evl~ 524 (565)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.93 Aligned_cols=258 Identities=19% Similarity=0.248 Sum_probs=194.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC--------CCCccceEEEEE----ecCc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS--------HPNLLPLIAFYY----RKEE 323 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~----~~~~ 323 (565)
..+.||+|+||+||+|+. .+++.||||++... ....+.+.+|+.+++.++ ||||+++++++. ....
T Consensus 41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 119 (397)
T 1wak_A 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119 (397)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred EEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence 457899999999999985 46788999998643 334567889999999885 788999999987 4557
Q ss_pred eEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC--------
Q 008431 324 KLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-------- 395 (565)
Q Consensus 324 ~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-------- 395 (565)
.++||||+ +|+|.+++..... ..+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred EEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhhhhh
Confidence 89999999 5677777665432 24999999999999999999999853 799999999999998775
Q ss_pred -----------------------------------------CcEEeccCCccccccc-ccccccccccCCCccCCCCCCc
Q 008431 396 -----------------------------------------EPLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTDGVTR 433 (565)
Q Consensus 396 -----------------------------------------~~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~ 433 (565)
.+||+|||+++..... ....+|+.|+|||++.+..++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCc
Confidence 8999999999876543 3457899999999999889999
Q ss_pred chhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh---h---------cccCccccc--cc-----------
Q 008431 434 KTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR---E---------EWTGEVFDK--DM----------- 488 (565)
Q Consensus 434 ~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~d~--~~----------- 488 (565)
++|||||||++|||+||+.||........ ..-...+..... . ......+.. .+
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEY--TRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSS--CHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCccccc--CchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 99999999999999999999974321110 001111111110 0 000000000 00
Q ss_pred -----cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 -----RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 -----~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
............+.+++.+||+.||++|||+.|+++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001123455678899999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.54 Aligned_cols=250 Identities=18% Similarity=0.242 Sum_probs=185.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEE--------------ec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYY--------------RK 321 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--------------~~ 321 (565)
..+.||+|+||.||+|... +++.||+|++........+++.+|+.++++++||||+++++++. ..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 3578999999999999965 58899999997655555678999999999999999999999874 33
Q ss_pred CceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-CCCCcEEe
Q 008431 322 EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLT 400 (565)
Q Consensus 322 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~ 400 (565)
...++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred CceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeEEEc
Confidence 56799999998 6999998642 388999999999999999999998 999999999999997 56799999
Q ss_pred ccCCccccccc-------ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHH
Q 008431 401 DYALVPIVNKE-------HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVN 472 (565)
Q Consensus 401 DfGla~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 472 (565)
|||+++..... ....++..|+|||.+.. ..++.++|||||||++|||+||+.||... .......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--------~~~~~~~ 235 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA--------HELEQMQ 235 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC--------CHHHHHH
Confidence 99999875432 23345788999997654 67899999999999999999999999632 1111121
Q ss_pred HHhhhcc-------------cCccccccccCCCCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 473 SVVREEW-------------TGEVFDKDMRGTKSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 473 ~~~~~~~-------------~~~~~d~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
....... ..............+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1111100 000000000000000 0112468889999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.66 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=191.8
Q ss_pred ccceecccCceeEEEEEE--eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcC---CCCCccceEEEEE-----ecCce
Q 008431 257 SAEVLGSGSFGSSYKAVL--LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSL---SHPNLLPLIAFYY-----RKEEK 324 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~~~~~ 324 (565)
..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++. .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 457899999999999997 467889999987432 22234567787777665 8999999999997 45678
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
++||||++ |+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred EEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEecCcc
Confidence 99999998 699999986543 2489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh----
Q 008431 405 VPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE---- 477 (565)
Q Consensus 405 a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 477 (565)
++..... ....+|..|+|||++.+..++.++|||||||++|||++|+.||... .....+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--------SDVDQLGKILDVIGLP 238 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCC
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHHHcCCC
Confidence 9876533 3456789999999998889999999999999999999999999631 111222222110
Q ss_pred ---cccCcccccc--ccC------CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 ---EWTGEVFDKD--MRG------TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ---~~~~~~~d~~--~~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+......+. ... ..........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1110000000 000 0000112246778999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.38 Aligned_cols=253 Identities=17% Similarity=0.275 Sum_probs=191.4
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEec-----CceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-----EEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~E 329 (565)
..+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++++++||||+++++++... ...|+|||
T Consensus 31 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEc
Confidence 4578999999999999954 67889999997433 23346789999999999999999999999765 36899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 997 5999999753 389999999999999999999998 99999999999999999999999999997664
Q ss_pred cc-------ccccccccccCCCccC-CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 410 KE-------HAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 410 ~~-------~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
.. ....+|+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+..........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPSQE 254 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSCCHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCCCHH
Confidence 33 2336789999999754 45589999999999999999999999963211 11111111111100000
Q ss_pred ---cccc-------cccc-CCCCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 482 ---EVFD-------KDMR-GTKSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 482 ---~~~d-------~~~~-~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...+ ..+. ....+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000 00000 0112467889999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=337.83 Aligned_cols=249 Identities=19% Similarity=0.283 Sum_probs=188.8
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCce------EEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEK------LLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~------~lv 327 (565)
..+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 4578999999999999954 68899999997532 22346789999999999999999999999876654 999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+. |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99997 688887632 389999999999999999999998 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc-c----
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW-T---- 480 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~---- 480 (565)
.... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+.+........ .
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--------DYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCCHHH
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHHhCCCcHHH
Confidence 6544 34567999999998876 67899999999999999999999999631 12222222211000 0
Q ss_pred -Ccccc-------ccccCCC-C-----CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 -GEVFD-------KDMRGTK-S-----GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 -~~~~d-------~~~~~~~-~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
..+.+ ..+.... . .......+.+++.+||+.||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 0000000 0 00112468889999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.88 Aligned_cols=254 Identities=20% Similarity=0.248 Sum_probs=179.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc-------eEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE-------KLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------~~lv~ 328 (565)
..+.||+|+||+||+|.. .++..||||++... ......+.+|++.++.++||||+++++++...+. .++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp EC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 457899999999999996 46899999998653 2334567888999999999999999999976543 78999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY--KEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALV 405 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH--~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla 405 (565)
||+++ +|.+.+...... ...+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||++
T Consensus 106 e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYYRR-QVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp ECCSC-BHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred ecccc-cHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 99986 555554432111 224889999999999999999999 66 9999999999999996 899999999999
Q ss_pred cccccc---ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc-cc
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE-WT 480 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 480 (565)
+..... ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||... .....+....+.. ..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--------~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD--------NSAGQLHEIVRVLGCP 251 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCC
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC--------ChHHHHHHHHHHcCCC
Confidence 876543 244678999999987654 4899999999999999999999999632 1111111111100 00
Q ss_pred ---------Ccccccccc---C-------CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 ---------GEVFDKDMR---G-------TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 ---------~~~~d~~~~---~-------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
....+.... . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 0 00011234578899999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.32 Aligned_cols=245 Identities=16% Similarity=0.224 Sum_probs=167.8
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe----cCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR----KEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~E~~~ 332 (565)
.++||+|+||+||+|... +++.||||++... .....+....++.++||||+++++++.. ....++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 467999999999999965 7899999998642 2222223344667899999999999976 345899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIVN 409 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~ 409 (565)
+|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 110 gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 110 GGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp TEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999986532 2499999999999999999999998 9999999999999976 4559999999997654
Q ss_pred cc--ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 410 KE--HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 410 ~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.. ....+|+.|+|||++....++.++|||||||++|||++|+.||...... .............. .....+.
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~ 256 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ-----AISPGMKRRIRLGQ-YGFPNPE 256 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------CCCTTT
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch-----hhhhhHHHhhhccc-cccCchh
Confidence 33 3456789999999998888999999999999999999999999632211 01000011110000 0000010
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ......+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 W------SEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp S------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred h------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 1122467889999999999999999999983
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.60 Aligned_cols=192 Identities=20% Similarity=0.274 Sum_probs=163.8
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CC-----CccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HP-----NLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|... +++.||||+++.. .....++.+|+.+++.++ |+ +|+++++++...+..++|||
T Consensus 58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 136 (382)
T 2vx3_A 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136 (382)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence 4578999999999999964 6788999998743 233456778888888875 44 49999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc--CCCCcEEeccCCccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD--NAYEPLLTDYALVPI 407 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfGla~~ 407 (565)
|++ |+|.+++..... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 137 ~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 137 MLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp CCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred cCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 996 599999986542 2489999999999999999999952 12899999999999994 578899999999987
Q ss_pred cccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.... ....+|+.|+|||++.+..++.++|||||||++|||+||++||.
T Consensus 211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 6543 45578999999999999999999999999999999999999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=322.03 Aligned_cols=241 Identities=20% Similarity=0.326 Sum_probs=185.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe-------------cC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-------------KE 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------------~~ 322 (565)
..+.||+|+||.||+|+. .+++.||||.+... ....+.+.+|+.++++++||||+++++++.+ .+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (303)
T 1zy4_A 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88 (303)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred hhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence 457899999999999996 47899999998643 2345678999999999999999999999865 34
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEecc
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 402 (565)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 89 TLFIQMEYCENGTLYDLIHSENL----NQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp EEEEEEECCCSCBHHHHHHHSCG----GGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEecCCCCCHHHhhhcccc----ccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEEeeC
Confidence 67999999999999999986432 378899999999999999999998 9999999999999999999999999
Q ss_pred CCccccccc------------------ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCC
Q 008431 403 ALVPIVNKE------------------HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGA 463 (565)
Q Consensus 403 Gla~~~~~~------------------~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~ 463 (565)
|+++..... ....+++.|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------ 231 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------ 231 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH------
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc------
Confidence 998765321 233578899999988754 68999999999999999998 44311
Q ss_pred CcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 464 NADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
............. ...+.+.+ .......+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~~~~~~~~---~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 -MERVNILKKLRSV---SIEFPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHHHHST---TCCCCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhHHHHHHhcccc---ccccCccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111122111111 00111111 1122346788999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.95 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=173.9
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHH-HHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMT-RLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|... +|+.||||++.... .....++.+|+. +++.++||||+++++++...+..++||||+++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 4578999999999999964 78899999997532 233445666666 77888999999999999999999999999985
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
+|.+++..........+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 8888876422111234899999999999999999999852 7999999999999999999999999999776433
Q ss_pred -ccccccccccCCCcc----CCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 -HAQLHMVAYKSPEFN----QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~----~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....+|+.|+|||++ ....++.++|||||||++|||++|+.||...... ...+. . ......+
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~----~--~~~~~~~ 248 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLT----Q--VVKGDPP 248 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------C----C--CCCSCCC
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHH----H--HhcCCCC
Confidence 233688999999988 4567899999999999999999999999632110 00000 0 0000011
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+... ........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11110 001122468889999999999999999999763
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=325.67 Aligned_cols=242 Identities=17% Similarity=0.287 Sum_probs=189.6
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCC--CCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLS--HPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++||| +.
T Consensus 32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 110 (313)
T 3cek_A 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 110 (313)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence 457899999999999998889999999997432 234567899999999997 5999999999999999999999 56
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+++ +.+||+|||+++.....
T Consensus 111 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 111 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 789999998644 389999999999999999999998 9999999999999965 88999999999876433
Q ss_pred -----ccccccccccCCCccCC-----------CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh
Q 008431 412 -----HAQLHMVAYKSPEFNQT-----------DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV 475 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 475 (565)
....+++.|+|||++.. ..++.++|||||||++|||++|+.||... ......+....
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~~~~~~~~~~ 253 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAII 253 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHH
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH-------HHHHHHHHHHH
Confidence 23457899999998765 46889999999999999999999999631 11122222222
Q ss_pred hhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 008431 476 REEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526 (565)
Q Consensus 476 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 526 (565)
..... ..... .....+.+++.+||+.||++|||+.|+++.-
T Consensus 254 ~~~~~-----~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 254 DPNHE-----IEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CTTSC-----CCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hcccc-----cCCcc-----cchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11110 00101 1123678888999999999999999998753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.28 Aligned_cols=244 Identities=17% Similarity=0.233 Sum_probs=183.4
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +|||||++++++.+.+..|+||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4689999999998877778999999998643 245678999999876 89999999999999999999999996 699
Q ss_pred HHHHhhcCCCCCC--CCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCC-------------CCcEEec
Q 008431 337 ANLLHVRRAPGQP--GLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNA-------------YEPLLTD 401 (565)
Q Consensus 337 ~~~l~~~~~~~~~--~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~-------------~~~kl~D 401 (565)
.+++......... ..++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 9999865432110 113335678999999999999998 99999999999999754 4899999
Q ss_pred cCCcccccccc--------cccccccccCCCccCC-------CCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCc
Q 008431 402 YALVPIVNKEH--------AQLHMVAYKSPEFNQT-------DGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANA 465 (565)
Q Consensus 402 fGla~~~~~~~--------~~~~t~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~ 465 (565)
||+++...... ...||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.... .
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~------~ 245 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY------S 245 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT------T
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch------h
Confidence 99998765431 2468899999998865 678999999999999999999 999986211 0
Q ss_pred chHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.. ......... .+.. ...........+.+++.+||+.||++|||+.||++
T Consensus 246 ~~----~~i~~~~~~----~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RE----SNIIRGIFS----LDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH----HHHHHTCCC----CCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH----HHHhcCCCC----cccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 111111100 0011 11112345567889999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=332.98 Aligned_cols=252 Identities=16% Similarity=0.223 Sum_probs=189.6
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEec-----CceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-----EEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~E 329 (565)
..+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++... ...++|||
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 3578999999999999964 68899999996432 23345788999999999999999999998754 57899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 997 6999998752 389999999999999999999998 99999999999999999999999999997654
Q ss_pred cc--------------ccccccccccCCCccC-CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHH
Q 008431 410 KE--------------HAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSV 474 (565)
Q Consensus 410 ~~--------------~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 474 (565)
.. ....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~ 238 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQLLLIFGI 238 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHHH
Confidence 22 1235788999999764 47789999999999999999999999963210 0001111111
Q ss_pred hhhcccC----ccccc-------cccCCC-CC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 475 VREEWTG----EVFDK-------DMRGTK-SG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 475 ~~~~~~~----~~~d~-------~~~~~~-~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....... .+..+ .+.... .. ......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1000000 00000 000000 00 012246788999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.99 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=188.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc------eEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE------KLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lv 327 (565)
..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+. .++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence 457899999999999996 468899999986532 2234678999999999999999999999987654 4999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+. |+|.+++.. .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred ecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 99997 688877632 389999999999999999999998 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc------c
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE------W 479 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~ 479 (565)
.... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||... +....+....... +
T Consensus 176 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--------DYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS--------CHHHHHHHHHHHHCBCCHHH
T ss_pred CCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHhCCCCHHH
Confidence 6543 34467899999998776 67899999999999999999999999731 1112221111100 0
Q ss_pred cCcc---------------ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 480 TGEV---------------FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 480 ~~~~---------------~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...+ ..+.+.. ........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQ--LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTT--TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHH--hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0000000 011223478889999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.02 Aligned_cols=239 Identities=15% Similarity=0.213 Sum_probs=181.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..++||+|+||+||.....+++.||||++.... ...+.+|+++++++ +|||||++++++.+.+..|+||||+. |+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 457899999999776656789999999986432 22356899999999 79999999999999999999999996 69
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-----CCCCcEEeccCCcccccc
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-----NAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-----~~~~~kl~DfGla~~~~~ 410 (565)
|.+++...... +.+..+..++.||+.||.|||+. +|+||||||+|||++ ....+||+|||+++....
T Consensus 104 L~~~l~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 104 LQEYVEQKDFA----HLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp HHHHHHSSSCC----CCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred HHHHHHhcCCC----ccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99999865432 44556778999999999999998 999999999999994 334678999999987643
Q ss_pred c-------ccccccccccCCCccC---CCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcc
Q 008431 411 E-------HAQLHMVAYKSPEFNQ---TDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEW 479 (565)
Q Consensus 411 ~-------~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (565)
. ....||+.|+|||++. ...++.++|||||||++|||+| |+.||... ........... .
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~---------~~~~~~~~~~~-~ 245 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS---------LQRQANILLGA-C 245 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST---------TTHHHHHHTTC-C
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh---------hHHHHHHHhcc-C
Confidence 2 2346899999999887 4567889999999999999999 99998521 11111111111 0
Q ss_pred cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 480 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.... ..........+.+++.+||+.||++|||+.||++
T Consensus 246 ~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDC-------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTT-------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cccc-------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 0111233445778999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=328.78 Aligned_cols=254 Identities=16% Similarity=0.229 Sum_probs=193.4
Q ss_pred ccceecccCceeEEEEEEe-CC-CeeEEEEeeccCccCHHHHHHHHHHHhcCCCCC------ccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TG-PAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN------LLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~~lv~ 328 (565)
..+.||+|+||+||+|... ++ ..||+|.++.. ....+.+.+|+.++++++|++ ++.+++++...+..++||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T 2eu9_A 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101 (355)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEE
Confidence 4578999999999999964 44 58999998643 234567889999999987766 899999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEE-----------------
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLL----------------- 391 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl----------------- 391 (565)
||+ +|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 102 e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 102 ELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred ecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecccccccccccccccc
Confidence 999 6678887765432 2489999999999999999999998 99999999999999
Q ss_pred --cCCCCcEEeccCCccccccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchH
Q 008431 392 --DNAYEPLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLA 468 (565)
Q Consensus 392 --~~~~~~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~ 468 (565)
+.++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN-----REHL 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH
T ss_pred cccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 67889999999999865443 345789999999999999999999999999999999999999963211 1111
Q ss_pred HHHHHHhhh--------cccCccc-c--------------------ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 008431 469 TWVNSVVRE--------EWTGEVF-D--------------------KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDL 519 (565)
Q Consensus 469 ~~~~~~~~~--------~~~~~~~-d--------------------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 519 (565)
..+...... ....... . +..............+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 111111100 0000000 0 0000001122345578899999999999999999
Q ss_pred HHHHH
Q 008431 520 REAVE 524 (565)
Q Consensus 520 ~evl~ 524 (565)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.21 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=175.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCcc-C-HHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNV-G-KEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||.||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++...+..++||||+ +
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 4578999999999999964 7899999999754321 2 233445556788899999999999999999999999999 5
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-hCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK-EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+.+..+...... .+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 ~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 108 TCAEKLKKRMQG----PIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred CcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhhC----CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 566666554332 38999999999999999999998 5 8999999999999999999999999998765433
Q ss_pred --ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 412 --HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
....+++.|+|||++. ...++.++|||||||++|||++|+.||... ......+.........
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~~---- 248 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-------KTDFEVLTKVLQEEPP---- 248 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHHHSCCC----
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC-------CccHHHHHHHhccCCC----
Confidence 2346789999999874 556889999999999999999999999631 1122222222222111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+.... .....+.+++.+||+.||++|||+.|+++.
T Consensus 249 --~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 --LLPGHM---GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCCSSS---CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCCccC---CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111000 112367888899999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.28 Aligned_cols=259 Identities=19% Similarity=0.248 Sum_probs=194.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-----------CCCccceEEEEEecC--
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-----------HPNLLPLIAFYYRKE-- 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~~-- 322 (565)
..+.||+|+||+||+|.. .+++.||||.+... ....+.+.+|+.++++++ ||||+++++++...+
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 101 (373)
T 1q8y_A 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101 (373)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence 457899999999999995 57889999998642 234567889999998886 899999999998654
Q ss_pred --ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc------CC
Q 008431 323 --EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD------NA 394 (565)
Q Consensus 323 --~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~------~~ 394 (565)
..++||||+ +++|.+++...... .+++..+..++.||+.||+|||+++ +|+||||||+|||++ ..
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 102 GVHVVMVFEVL-GENLLALIKKYEHR---GIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEEEEECCC-CEEHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred CceEEEEEecC-CCCHHHHHHHhhcc---CCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCCcCc
Confidence 689999999 89999999865432 3899999999999999999999853 799999999999994 44
Q ss_pred CCcEEeccCCccccccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHH
Q 008431 395 YEPLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNS 473 (565)
Q Consensus 395 ~~~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 473 (565)
+.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||........ ......+..
T Consensus 175 ~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 252 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY--TKDDDHIAQ 252 (373)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------CHHHHHHH
T ss_pred ceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc--CChHHHHHH
Confidence 57999999999876543 345789999999999988999999999999999999999999974321100 001111111
Q ss_pred Hhhh-ccc-----------Cccccc-----cc-------------cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 008431 474 VVRE-EWT-----------GEVFDK-----DM-------------RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAV 523 (565)
Q Consensus 474 ~~~~-~~~-----------~~~~d~-----~~-------------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 523 (565)
.... +.. ...++. .+ .....+......+.+++.+||+.||++|||+.|++
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 1100 000 000000 00 01112345667889999999999999999999998
Q ss_pred HH
Q 008431 524 EK 525 (565)
Q Consensus 524 ~~ 525 (565)
+.
T Consensus 333 ~h 334 (373)
T 1q8y_A 333 NH 334 (373)
T ss_dssp TC
T ss_pred hC
Confidence 73
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=328.68 Aligned_cols=233 Identities=19% Similarity=0.295 Sum_probs=190.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCcc------CHHHHHHHHHHHhcCC--CCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNV------GKEDFHEHMTRLGSLS--HPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||.||+|.. .+++.||||.+...... ..+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv 126 (320)
T 3a99_A 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126 (320)
T ss_dssp EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence 457899999999999985 57889999999753221 2345778999999996 59999999999999999999
Q ss_pred EeccCC-CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-CCCCcEEeccCCc
Q 008431 328 SDFVPN-GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALV 405 (565)
Q Consensus 328 ~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla 405 (565)
|||+.+ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||++
T Consensus 127 ~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 127 LERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999986 89999998654 389999999999999999999998 999999999999999 7899999999999
Q ss_pred cccccc--ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 406 PIVNKE--HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 406 ~~~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
+..... ....+|+.|+|||++....+ +.++|||||||++|||+||+.||.... . ..... .
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~----~~~~~---~ 260 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E----IIRGQ---V 260 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----HHHCC---C
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------h----hhccc---c
Confidence 776543 34468899999998876665 688999999999999999999986211 0 01110 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...+ .....+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 FFRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc---------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 11236788899999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=325.14 Aligned_cols=234 Identities=18% Similarity=0.250 Sum_probs=185.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc------cCHHHHHHHHHHHhcC----CCCCccceEEEEEecCceE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN------VGKEDFHEHMTRLGSL----SHPNLLPLIAFYYRKEEKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~~~~~~~~~~~ 325 (565)
..+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++.++ +||||+++++++...+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 457899999999999985 5788999999864322 1223466789998888 8999999999999999999
Q ss_pred EEEec-cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-CCCCcEEeccC
Q 008431 326 LVSDF-VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYA 403 (565)
Q Consensus 326 lv~E~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfG 403 (565)
+|||| +.+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999 78999999998654 389999999999999999999999 999999999999999 88999999999
Q ss_pred Cccccccc--ccccccccccCCCccCCCCCC-cchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 404 LVPIVNKE--HAQLHMVAYKSPEFNQTDGVT-RKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 404 la~~~~~~--~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
+++..... ....++..|+|||++....+. .++|||||||++|||++|+.||.... . ..... .
T Consensus 186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~----~~~~~-~ 250 (312)
T 2iwi_A 186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------E----ILEAE-L 250 (312)
T ss_dssp SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----HHHTC-C
T ss_pred hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------H----Hhhhc-c
Confidence 98776543 344678999999987766654 58999999999999999999986211 0 00110 0
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+ .......+.+++.+||+.||++|||+.|+++.
T Consensus 251 ------~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ------HF-----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------CC-----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CC-----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01112367888999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=348.68 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=199.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEe------cCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR------KEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~lv~ 328 (565)
..+.||+|+||+||+|.. .+|..||||.+... .....+.+.+|+.++++++||||+++++++.. .+..++||
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 457899999999999995 57899999998753 33445679999999999999999999998755 56789999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC---cEEeccCCc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE---PLLTDYALV 405 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfGla 405 (565)
||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 99999999999986442 22488999999999999999999998 9999999999999997665 899999999
Q ss_pred cccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc--
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT-- 480 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 480 (565)
+..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||... .....|..........
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~-------~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN-------WQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS-------CHHHHSSTTCC------C
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc-------cchhhhhhhhhcccchhh
Confidence 876543 2346789999999999999999999999999999999999999631 1111221111110000
Q ss_pred --Ccccc------cccc-CCCCCHHHHHHHHHHHhhccccCcCCCCCHHH-----HHHHHHHhhcc
Q 008431 481 --GEVFD------KDMR-GTKSGEGEMLKLLKIGMCCCEWNAERRWDLRE-----AVEKIMELKER 532 (565)
Q Consensus 481 --~~~~d------~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e-----vl~~L~~i~~~ 532 (565)
..... ..+. ...........+.+++.+||++||++|||+.| ..+.+..+...
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000 0000 01112345567889999999999999999988 55666666554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=352.51 Aligned_cols=235 Identities=17% Similarity=0.183 Sum_probs=189.9
Q ss_pred ccceecccCceeEEEEEEe--CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCc-----eEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL--TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE-----KLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~lv~ 328 (565)
..+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++|||||++++++...+. .|+||
T Consensus 84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 4578999999999999975 58899999986432 2334678999999999999999999999988765 69999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++++|.+++.. .++|..++.++.||+.||.|||+. +|+||||||+|||++.+ .+||+|||+++..
T Consensus 164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 99999999987743 399999999999999999999998 99999999999999886 8999999999887
Q ss_pred cccccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 409 NKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 409 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
.......||+.|+|||++.+. ++.++|||||||++|||++|.+||...... .+
T Consensus 232 ~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------------~~----- 284 (681)
T 2pzi_A 232 NSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------------------GL----- 284 (681)
T ss_dssp TCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------------------SC-----
T ss_pred ccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------------------cc-----
Confidence 766677899999999987654 489999999999999999999887621110 00
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHhh
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRW-DLREAVEKIMELK 530 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~ 530 (565)
............+.+++.+||+.||++|| +++++...|..+.
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00000011224678899999999999999 5677777776653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=310.91 Aligned_cols=229 Identities=10% Similarity=0.095 Sum_probs=177.6
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCcc---CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNV---GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||.||+|... +++.||||.+...... ..+.|.+|+..+++++||||+++++++.+.+..|+||||++
T Consensus 35 i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 114 (286)
T 3uqc_A 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIR 114 (286)
T ss_dssp EEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecC
Confidence 3478999999999999965 5889999999754322 23679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH 412 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 412 (565)
+++|.+++... .....+..++.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 115 g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 115 GGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred CCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999998531 34557888999999999999998 99999999999999999999998554
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCC
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 492 (565)
|++| ++.++|||||||++|||+||+.||.......... ... .........+....
T Consensus 175 -------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~-- 229 (286)
T 3uqc_A 175 -------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAE--------RDTAGQPIEPADID-- 229 (286)
T ss_dssp -------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-ECC--------BCTTSCBCCHHHHC--
T ss_pred -------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-HHH--------HHhccCCCChhhcc--
Confidence 4443 7899999999999999999999997432211000 000 00000000000000
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 493 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
......+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 230 --~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 230 --RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp --TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred --cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0112367889999999999999 9999999999998654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=307.58 Aligned_cols=224 Identities=16% Similarity=0.202 Sum_probs=174.1
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHH-hcCCCCCccceEEEEEe----cCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRL-GSLSHPNLLPLIAFYYR----KEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~lv~E~~ 331 (565)
.++||+|+||.||+|.. .+++.||+|.+.. ...+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 36799999999999996 5788999999863 34677888887 66799999999999987 66789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCcccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIV 408 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~ 408 (565)
++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 98 ~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 98 DGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp CSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 99999999987542 2499999999999999999999998 9999999999999998 789999999998653
Q ss_pred cccccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 409 NKEHAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 409 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
. +..++.++|||||||++|||+||+.||........ .......+.....
T Consensus 171 ~------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------------~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 171 T------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------------SPGMKTRIRMGQY 219 (299)
T ss_dssp T------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCSCCSSCTTCC
T ss_pred c------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------------hHHHHHHHhhccc
Confidence 2 24578899999999999999999999963211100 0000000000000
Q ss_pred cCCCC--CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKS--GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
. ... .......+.+++.+||+.||++|||+.|+++.
T Consensus 220 ~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 E-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp S-SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c-CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 000 00112468889999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=322.26 Aligned_cols=237 Identities=19% Similarity=0.151 Sum_probs=174.5
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCC-CCccce------------------
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSH-PNLLPL------------------ 314 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l------------------ 314 (565)
.++||+|+||+||+|.. .+|+.||||++..... ...+.|.+|+.+++.++| +|....
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 47899999999999994 5799999999873322 235789999999999987 322111
Q ss_pred ---EEEEEe-----cCceEEEEeccCCCCHHHHHhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCC
Q 008431 315 ---IAFYYR-----KEEKLLVSDFVPNGSLANLLHVRR--APGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHL 384 (565)
Q Consensus 315 ---~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDl 384 (565)
..++.. ....+++|+++ +|+|.+++.... ......++|..++.++.|++.||+|||+. +|+||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~iiHrDi 237 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL 237 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCc
Confidence 111111 12356777766 689999985221 01122478889999999999999999998 9999999
Q ss_pred CCCCEEEcCCCCcEEeccCCccccccc-ccccccccccCCCcc----------CCCCCCcchhHHHHHHHHHHHHcCCCC
Q 008431 385 KSSNVLLDNAYEPLLTDYALVPIVNKE-HAQLHMVAYKSPEFN----------QTDGVTRKTDVWSLGILILELLTGKFP 453 (565)
Q Consensus 385 kp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~----------~~~~~~~~~DvwS~Gvil~el~tg~~p 453 (565)
||+|||++.++.+||+|||+++..... ....| +.|+|||++ ....++.++|||||||++|||+||+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998776544 34456 999999988 666788999999999999999999999
Q ss_pred ccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 454 ANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
|....... ....++. .... ....+.+++.+||+.||++|||+.|+++
T Consensus 317 f~~~~~~~-----------------~~~~~~~----~~~~---~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 317 NTDDAALG-----------------GSEWIFR----SCKN---IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCTTGGGS-----------------CSGGGGS----SCCC---CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchhh-----------------hHHHHHh----hccc---CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 96322110 0011111 1111 1136888889999999999999877743
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.53 Aligned_cols=238 Identities=14% Similarity=0.171 Sum_probs=179.9
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccC--------ccCHHHHHHHHHHHhcCC---------CCCccceEEEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--------NVGKEDFHEHMTRLGSLS---------HPNLLPLIAFY 318 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~~~~ 318 (565)
...+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++ |||||++.+.+
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 4568999999999999997 78999999997542 223478899999988885 77777777765
Q ss_pred E------------------------------ecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 008431 319 Y------------------------------RKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLA 368 (565)
Q Consensus 319 ~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 368 (565)
. ..+..|+||||+++|++.+.+.. ..+++..+..++.||+.||+
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence 3 15789999999999976666532 13899999999999999999
Q ss_pred HHH-hhCCCCCCccCCCCCCCEEEcCCC--------------------CcEEeccCCcccccccccccccccccCCCccC
Q 008431 369 YLY-KEFPGVTLPHGHLKSSNVLLDNAY--------------------EPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQ 427 (565)
Q Consensus 369 ylH-~~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~t~~y~aPE~~~ 427 (565)
||| +. +|+||||||+|||++.++ .+||+|||+++.... ....||+.|+|||++.
T Consensus 176 ~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-GIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-TEEECCCCTTCSGGGC
T ss_pred HHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-CcEEEeecccChhhhc
Confidence 999 88 999999999999999887 899999999987654 3457899999999988
Q ss_pred CCCCCcchhHHHHHHH-HHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHh
Q 008431 428 TDGVTRKTDVWSLGIL-ILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGM 506 (565)
Q Consensus 428 ~~~~~~~~DvwS~Gvi-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~ 506 (565)
+.. +.++||||+|++ .+++++|..||.. ..|................ .............+.+++.
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKT-KCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSS-CCCSHHHHHHHHHHHHHHH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCc-ccchhhhhhcCHHHHHHHH
Confidence 766 899999998777 7888999999852 1122111111000000000 0000011244567899999
Q ss_pred hccccCcCCCCCHHHHH
Q 008431 507 CCCEWNAERRWDLREAV 523 (565)
Q Consensus 507 ~Cl~~~P~~RPs~~evl 523 (565)
+||+.| |+.|++
T Consensus 318 ~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 318 TMLNFS-----SATDLL 329 (336)
T ss_dssp HGGGSS-----SHHHHH
T ss_pred HHhccC-----CHHHHH
Confidence 999976 999887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=293.45 Aligned_cols=183 Identities=16% Similarity=0.123 Sum_probs=131.7
Q ss_pred ceecccCceeEEEEE-EeCCCeeEEEEeeccC----------ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEE
Q 008431 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMS----------NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 326 (565)
...+.|++|.+..++ .-.|+.+|+|.+.... ....++|.+|+++|+++ .|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456788888877766 5579999999996431 12235799999999999 69999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 327 VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
||||++||+|.++|..... ++.. +|+.||+.||+|+|++ +||||||||+|||++.++.+||+|||+|+
T Consensus 320 VMEyv~G~~L~d~i~~~~~-----l~~~---~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr 387 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEE-----IDRE---KILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIV 387 (569)
T ss_dssp EEECCCSEEHHHHHHTTCC-----CCHH---HHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred EEecCCCCcHHHHHHhCCC-----CCHH---HHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCe
Confidence 9999999999999976432 5543 5899999999999999 99999999999999999999999999998
Q ss_pred ccccc----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCc
Q 008431 407 IVNKE----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPA 454 (565)
Q Consensus 407 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~ 454 (565)
..... .+.+||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 388 ~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 388 TTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp SCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred eCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 76543 34568999999998865 4677899999999998887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-28 Score=262.19 Aligned_cols=178 Identities=15% Similarity=0.195 Sum_probs=145.6
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCcc--------CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNV--------GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
.++||+|+||+||+|. ..+..+++|+....... ..+.|.+|++++++++||||+++..++...+..|+|||
T Consensus 341 ~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 4689999999999994 46788999987542211 13458999999999999999977777778888999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|+|.+++.. +..++.|+++||.|||++ +|+||||||+|||++. .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999863 457999999999999998 9999999999999998 99999999998875
Q ss_pred cc-----------ccccccccccCCCccCC--CCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 410 KE-----------HAQLHMVAYKSPEFNQT--DGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 410 ~~-----------~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.. ....||+.|||||++.. ..|+..+|+||..+-.++-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 43 23468999999999876 568889999999999999888887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-24 Score=213.55 Aligned_cols=141 Identities=15% Similarity=0.180 Sum_probs=114.2
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCc------------------cCHHHHHHHHHHHhcCCCCCccceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN------------------VGKEDFHEHMTRLGSLSHPNLLPLIAFY 318 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~~ 318 (565)
..+.||+|+||.||+|...+|+.||+|.++.... .....+.+|+.++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 3478999999999999997789999999863211 12456899999999999 5 6666655
Q ss_pred EecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcE
Q 008431 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPL 398 (565)
Q Consensus 319 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~k 398 (565)
. .+..|+||||+++|+|.+ +. . .....++.|++.||.|||+. +|+||||||+|||++ ++.+|
T Consensus 171 ~-~~~~~lvmE~~~g~~L~~-l~---------~--~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 171 A-WEGNAVLMELIDAKELYR-VR---------V--ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp E-EETTEEEEECCCCEEGGG-CC---------C--SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE-TTEEE
T ss_pred e-ccceEEEEEecCCCcHHH-cc---------h--hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE-CCcEE
Confidence 3 456799999999999987 42 1 12457999999999999998 999999999999999 99999
Q ss_pred EeccCCcccccccccccccccccCCCccC
Q 008431 399 LTDYALVPIVNKEHAQLHMVAYKSPEFNQ 427 (565)
Q Consensus 399 l~DfGla~~~~~~~~~~~t~~y~aPE~~~ 427 (565)
|+|||+++. +..|+|||++.
T Consensus 233 l~DFG~a~~---------~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVE---------VGEEGWREILE 252 (282)
T ss_dssp ECCCTTCEE---------TTSTTHHHHHH
T ss_pred EEECCCCeE---------CCCCCHHHHHH
Confidence 999999864 33578888763
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=212.32 Aligned_cols=114 Identities=38% Similarity=0.660 Sum_probs=103.2
Q ss_pred ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEc
Q 008431 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDL 116 (565)
Q Consensus 39 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l 116 (565)
+|+.|||++|+|+|.||.. |+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|+++|.+|.. .+++|+.||+
T Consensus 633 ~L~~LdLs~N~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 633 SMMFLDMSYNMLSGYIPKE-IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp CCCEEECCSSCCBSCCCGG-GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred cccEEECcCCcccccCCHH-HhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 4778999999999999976 899999999999999999999999999999999999999999999975 6889999999
Q ss_pred ccCCCccCCCcc--ccCCCCCcccCCCCCCCCCCccccc
Q 008431 117 SYNQLVGRIPDT--LSNFDATSFQGNKGLCGKPLEACKS 153 (565)
Q Consensus 117 s~N~l~g~~p~~--~~~~~~~~~~~n~~~cg~p~~~c~~ 153 (565)
|+|+|+|.+|.. |..++..+|.||+.+||.|...|..
T Consensus 712 s~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp CSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred cCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 999999999974 6788888999999999999888854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.4e-20 Score=181.16 Aligned_cols=134 Identities=17% Similarity=0.202 Sum_probs=104.5
Q ss_pred ccceecccCceeEEEEEE-eCCCe--eEEEEeeccCcc------------------------CHHHHHHHHHHHhcCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPA--MVVKRFRQMSNV------------------------GKEDFHEHMTRLGSLSHP 309 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~ 309 (565)
..+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|+..|.++.|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 357899999999999997 78988 999987532111 013688999999999888
Q ss_pred Cc--cceEEEEEecCceEEEEeccCC-C----CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hhCCCCCCcc
Q 008431 310 NL--LPLIAFYYRKEEKLLVSDFVPN-G----SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY-KEFPGVTLPH 381 (565)
Q Consensus 310 ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH-~~~~~~~ivH 381 (565)
++ ...+++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~----givH 194 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEA----ELVH 194 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTS----CEEC
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHC----CEEe
Confidence 64 333332 467899999942 4 77776432 224467789999999999999 77 9999
Q ss_pred CCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 382 GHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 382 rDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999988 9999999998654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.73 E-value=4e-18 Score=171.40 Aligned_cols=140 Identities=36% Similarity=0.656 Sum_probs=85.9
Q ss_pred hcCCCCCCcEEEcccCcCccCCC-ccccc--ccceeecccccccccCCc----------------------chhcCCCCc
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMP-SVGKL--TLRALYLSLNKFTGEIPS----------------------DAFAGMDQL 65 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~~--~L~~L~Ls~N~l~g~ip~----------------------~~~~~l~~L 65 (565)
.|..+++|++|+|++|.|++.+| .+... .|+.|+|++|+++|.+|. ..|..+++|
T Consensus 144 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L 223 (313)
T 1ogq_A 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223 (313)
T ss_dssp GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCC
T ss_pred HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCC
Confidence 55566666666666666665554 22221 344455555544444433 335556666
Q ss_pred cEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCcc--ccCCCCCcccCCC
Q 008431 66 KKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDT--LSNFDATSFQGNK 141 (565)
Q Consensus 66 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~n~ 141 (565)
+.|+|++|++++.+|. +..+++|++|+|++|++++.+|.. .+++|+.|+|++|+|+|.+|.. +.++....+.+|+
T Consensus 224 ~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp SEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred CEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCC
Confidence 6666666666654444 556666666666666666666653 4667777777777777777764 3445566788999
Q ss_pred CCCCCCCccc
Q 008431 142 GLCGKPLEAC 151 (565)
Q Consensus 142 ~~cg~p~~~c 151 (565)
.+|+.|.+.|
T Consensus 303 ~lc~~p~~~C 312 (313)
T 1ogq_A 303 CLCGSPLPAC 312 (313)
T ss_dssp EEESTTSSCC
T ss_pred CccCCCCCCC
Confidence 9999887777
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.72 E-value=6.6e-17 Score=157.08 Aligned_cols=143 Identities=24% Similarity=0.280 Sum_probs=117.8
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|.++++|+.|+|++|.|++..|. +.. .+|+.|+|++|+|+ .+|++.|.++++|+.|+|++|+|++..
T Consensus 45 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~ 123 (251)
T 3m19_A 45 TGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLP 123 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEEcCCCcCCCcC
Confidence 345566777889999999999999999987774 333 37999999999998 678778899999999999999999877
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCC---CCCcccCCCCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNF---DATSFQGNKGLCG 145 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~---~~~~~~~n~~~cg 145 (565)
+..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|+|++..|..+..+ ....+.+|+..|.
T Consensus 124 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 124 SGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred hhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 777899999999999999999877742 67899999999999998777666544 4556788888776
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=152.06 Aligned_cols=142 Identities=25% Similarity=0.279 Sum_probs=119.8
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc--ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCccc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS--VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ 78 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ 78 (565)
|.++.||. .+ .+.++.|+|++|+|++..|. +.. .+|+.|+|++|+|+ .+++..|.++++|++|+|++|+|++.
T Consensus 21 n~l~~iP~-~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~ 96 (220)
T 2v70_A 21 QKLNKIPE-HI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENV 96 (220)
T ss_dssp SCCSSCCS-CC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcccCcc-CC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-EECHHHhCCCCCCCEEECCCCccCcc
Confidence 45567875 33 34578999999999988663 333 37999999999999 67777799999999999999999998
Q ss_pred CCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCC---CCcccCCCCCCCCC
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFD---ATSFQGNKGLCGKP 147 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~---~~~~~~n~~~cg~p 147 (565)
.|..|.++++|++|+|++|+|++..|.. .+++|+.|+|++|+|++..|..|..+. ...+.+|+..|.++
T Consensus 97 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 97 QHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 8889999999999999999999987764 689999999999999999898876554 45678998888654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.2e-16 Score=151.12 Aligned_cols=140 Identities=22% Similarity=0.302 Sum_probs=117.8
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
+..+.||.+ + .++|+.|+|++|+|++..|. +.. .+|+.|+|++|+|+ .+|+..|.++++|+.|+|++|+|++..
T Consensus 29 ~~l~~ip~~-~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~ 104 (229)
T 3e6j_A 29 KRHASVPAG-I--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLP 104 (229)
T ss_dssp SCCSSCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCcCccCCC-C--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCccC
Confidence 345678753 2 38899999999999998774 433 47999999999997 899888999999999999999999888
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCC---CCCcccCCCCCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNF---DATSFQGNKGLCGK 146 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~---~~~~~~~n~~~cg~ 146 (565)
+..|..+++|+.|+|++|+|+ .+|.. .+++|+.|+|++|+|++..+..|..+ ....+.+|+..|.+
T Consensus 105 ~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 105 SAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred hhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 888999999999999999999 45543 68999999999999998777666544 45568899988865
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-16 Score=149.73 Aligned_cols=140 Identities=25% Similarity=0.300 Sum_probs=116.8
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
....||.. +. ++|+.|+|++|+|++..+ .+... +|+.|+|++|+|+ .++++.|.++++|+.|+|++|+|+...+
T Consensus 22 ~l~~iP~~-l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 97 (220)
T 2v9t_B 22 GLTEIPTN-LP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPK 97 (220)
T ss_dssp CCSSCCSS-CC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCC-EECTTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred CcCcCCCc-cC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCC-CcCHHHhhCCcCCCEEECCCCcCCccCH
Confidence 34567753 32 689999999999998777 34433 7999999999999 5655669999999999999999997777
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCC---CCCcccCCCCCCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNF---DATSFQGNKGLCGK 146 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~---~~~~~~~n~~~cg~ 146 (565)
..|.++++|+.|+|++|++++..|.. .+++|+.|+|++|+|++..+..|..+ ....+.+|+..|.+
T Consensus 98 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 98 SLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred hHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 77899999999999999999987764 68999999999999998888776654 45568899988864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=6.8e-16 Score=151.63 Aligned_cols=126 Identities=25% Similarity=0.318 Sum_probs=75.0
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCcc-c-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-G-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
.+..+++..|.++++|++|+|++|.|+...+.. . ..+|+.|+|++|+++ .+|+..|.++++|+.|+|++|++++..|
T Consensus 48 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 126 (270)
T 2o6q_A 48 KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPP 126 (270)
T ss_dssp CCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred CCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCEEECCCCccCeeCH
Confidence 345566556777777777777777776554432 2 235666666666666 4555556666666666666666666555
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccc
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
..|.++++|++|+|++|++++..+.. .+++|+.|+|++|++++..+..|
T Consensus 127 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 177 (270)
T 2o6q_A 127 RVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAF 177 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred HHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHh
Confidence 55666666666666666666544431 35555666666665555444433
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-17 Score=170.19 Aligned_cols=135 Identities=13% Similarity=0.154 Sum_probs=94.5
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccCc--------------cCHHHH--------HHHHHHHhcCCCCCccc
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN--------------VGKEDF--------HEHMTRLGSLSHPNLLP 313 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~H~niv~ 313 (565)
.....||+|+||.||+|...+|+.||||.++.... ...... .+|...|.++.+.++.
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~- 176 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP- 176 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS-
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC-
Confidence 34678999999999999988999999998753110 011122 2355555555433322
Q ss_pred eEEEEEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC
Q 008431 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN 393 (565)
Q Consensus 314 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~ 393 (565)
....+. ....+|||||+++++|.++.. . .....++.|++.+|.|||+. +||||||||.|||+++
T Consensus 177 vp~p~~-~~~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 177 VPEPIA-QSRHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKH----GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CCCEEE-EETTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEEE
T ss_pred CCeeee-ccCceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeC
Confidence 111111 123479999999988865421 1 23456889999999999998 9999999999999987
Q ss_pred CC----------CcEEeccCCccc
Q 008431 394 AY----------EPLLTDYALVPI 407 (565)
Q Consensus 394 ~~----------~~kl~DfGla~~ 407 (565)
++ .+.|+||+-+-.
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 378999986543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-16 Score=149.11 Aligned_cols=122 Identities=25% Similarity=0.333 Sum_probs=109.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCC-cccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|..+++|+.|+|++|+|++..| .+.. .+|+.|+|++|+|+ .+|+.+|.++++|+.|+|++|+|++..
T Consensus 42 n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~ 120 (220)
T 2v9t_B 42 NTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLR 120 (220)
T ss_dssp SCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeC
Confidence 55677888889999999999999999998877 3444 47999999999999 899998999999999999999999999
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~ 124 (565)
|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++...
T Consensus 121 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 121 VDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred HHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 999999999999999999999887763 688999999999999753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.9e-16 Score=149.33 Aligned_cols=123 Identities=22% Similarity=0.326 Sum_probs=108.4
Q ss_pred ccccc-ChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 3 LMGMI-DVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 3 ~~g~i-~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
.+..+ +.+.|..+++|+.|+|++|+|++..+ .+..+ +|+.|+|++|+|+ .+|+++|.++++|++|+|++|+|++..
T Consensus 43 ~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 121 (220)
T 2v70_A 43 EFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVG 121 (220)
T ss_dssp CCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCGGGGTTCSSCCEEECTTSCCCCBC
T ss_pred cCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccC-ccCHhHhcCCcCCCEEECCCCcCCeEC
Confidence 34445 45568999999999999999998877 45444 7999999999999 678888999999999999999999999
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
|..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|.+++..+
T Consensus 122 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 122 NDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred HhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999999999999999999999987764 68899999999999987655
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=178.27 Aligned_cols=80 Identities=36% Similarity=0.563 Sum_probs=55.3
Q ss_pred CCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCCC---Cc
Q 008431 62 MDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFDA---TS 136 (565)
Q Consensus 62 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~ 136 (565)
+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|.. .+++|+.||||+|+|+|.+|..+.+++. ..
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 456677777777777777777777777777777777777777763 5677777777777777777776655443 34
Q ss_pred ccCCC
Q 008431 137 FQGNK 141 (565)
Q Consensus 137 ~~~n~ 141 (565)
+.+|+
T Consensus 711 ls~N~ 715 (768)
T 3rgz_A 711 LSNNN 715 (768)
T ss_dssp CCSSE
T ss_pred CcCCc
Confidence 45553
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-15 Score=149.78 Aligned_cols=135 Identities=23% Similarity=0.273 Sum_probs=73.6
Q ss_pred hcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQK 88 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 88 (565)
.+..+++|++|+|++|.|++..+. +.. .+|+.|+|++|+++ .+|+..|.++++|+.|+|++|++++..|..|+.+++
T Consensus 80 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 158 (272)
T 3rfs_A 80 ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTN 158 (272)
T ss_dssp GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCcc
Confidence 355555555555555555554442 222 24666666666665 444444555666666666666666555555556666
Q ss_pred CCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCC---CCCcccCCCCCCCC
Q 008431 89 LLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNF---DATSFQGNKGLCGK 146 (565)
Q Consensus 89 L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~---~~~~~~~n~~~cg~ 146 (565)
|+.|+|++|++++..+.. .+++|+.|++++|++++..|..+..+ ....+.+|+..|.+
T Consensus 159 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 159 LTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 666666666666544432 45566666666666665555444332 33345556555543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=164.02 Aligned_cols=144 Identities=24% Similarity=0.250 Sum_probs=108.5
Q ss_pred CcccccChhhcC-CCCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCccc
Q 008431 2 NLMGMIDVDTLS-RLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ 78 (565)
Q Consensus 2 n~~g~i~~~~~~-~l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ 78 (565)
|.+..++++.|. ++++|+.|+|++|+|++..+. +..+ +|+.|+|++|+|+ .+|++.|.++++|+.|+|++|+|++.
T Consensus 49 N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~ 127 (361)
T 2xot_A 49 NNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVV 127 (361)
T ss_dssp SCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCC-cCCHHHhCCCcCCCEEECCCCcccEE
Confidence 445666666676 888888888888888877663 4333 6888888888888 67777788888888888888888887
Q ss_pred CCccccCCCCCCEEeccCCcCCCCCCCC-----CCCCCCEEEcccCCCccCCCccccCCC-----CCcccCCCCCCCC
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKIPDF-----PLAHLTLLDLSYNQLVGRIPDTLSNFD-----ATSFQGNKGLCGK 146 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~~~~L~~l~ls~N~l~g~~p~~~~~~~-----~~~~~~n~~~cg~ 146 (565)
.|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|+|++..+..+..++ ...+.+|+..|.+
T Consensus 128 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 128 DRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred CHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 7888888888888888888888654432 377888888888888865555555443 3567888888864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-15 Score=142.20 Aligned_cols=121 Identities=27% Similarity=0.353 Sum_probs=97.6
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc--cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCccc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS--VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ 78 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ 78 (565)
|.++.||.. +. .+|+.|+|++|+|++..+. +..+ +|+.|+|++|+|++ ++++.|.++++|++|+|++|+|++.
T Consensus 18 ~~l~~ip~~-~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~ 93 (192)
T 1w8a_A 18 RGLKEIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIKEI 93 (192)
T ss_dssp SCCSSCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSCCCCEE
T ss_pred CCcCcCccC-CC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCC-cCHhHcCCcccCCEEECCCCcCCcc
Confidence 345677753 32 2789999999999887763 4433 69999999999985 4445688999999999999999988
Q ss_pred CCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
.|..|.++++|++|+|++|+|++.+|.. .+++|+.|+|++|++++..+
T Consensus 94 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 8888999999999999999999887764 67889999999999987665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.65 E-value=8.2e-16 Score=152.70 Aligned_cols=126 Identities=24% Similarity=0.258 Sum_probs=79.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
|.++.+++..|..+++|+.|+|++|.|++..+.....+|+.|+|++|+|+ .+|.. +.++++|++|+|++|+|++..|.
T Consensus 41 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~-~~~l~~L~~L~l~~N~l~~l~~~ 118 (290)
T 1p9a_G 41 NLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLL-GQTLPALTVLDVSFNRLTSLPLG 118 (290)
T ss_dssp SCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCC-TTTCTTCCEEECCSSCCCCCCSS
T ss_pred CcCCccCHHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchh-hccCCCCCEEECCCCcCcccCHH
Confidence 44555666678888888888888888876544322335666666666666 56653 56666666666666666665556
Q ss_pred cccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccc
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
.|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+|++..+..|
T Consensus 119 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~ 168 (290)
T 1p9a_G 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168 (290)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTT
T ss_pred HHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHh
Confidence 6666666666666666666554432 45666666666666665444333
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=141.42 Aligned_cols=129 Identities=19% Similarity=0.290 Sum_probs=109.5
Q ss_pred CcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCC
Q 008431 18 LRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN 97 (565)
Q Consensus 18 L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 97 (565)
-+.|++++|.|+..+..+. ..|+.|+|++|+|++..+..+|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 10 ~~~l~~s~~~l~~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 10 GTTVDCTGRGLKEIPRDIP-LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC-TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCEEEcCCCCcCcCccCCC-CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 3789999999975444443 389999999999994434446999999999999999999999999999999999999999
Q ss_pred cCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCC---CCcccCCCCCCCCC
Q 008431 98 SFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFD---ATSFQGNKGLCGKP 147 (565)
Q Consensus 98 ~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~---~~~~~~n~~~cg~p 147 (565)
+|++..|.. .+++|+.|+|++|+|++.+|..|..++ ...+.+|+..|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999988863 689999999999999999998876554 45678998888653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=151.43 Aligned_cols=129 Identities=22% Similarity=0.281 Sum_probs=84.4
Q ss_pred cccccChhhcCCCCCCcEEEcccCc-CccCCC-cccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNS-FDGPMP-SVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~-l~~~~p-~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
.+..+++..|..+++|+.|+|++|. +....| .+.. .+|+.|+|++|+++ .+++..|.++++|++|+|++|++++..
T Consensus 67 ~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 67 VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALP 145 (285)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCC-EECHhHhhCCcCCCEEECCCCcccccC
Confidence 3445555567777777777777776 555544 2332 35777777777777 454455777777777777777777666
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNF 132 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~ 132 (565)
+..|+++++|+.|+|++|++++..+.. .+++|+.|++++|++++..|..+..+
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 200 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCc
Confidence 666777777777777777777555432 46677777777777776666665443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.62 E-value=4.1e-16 Score=156.71 Aligned_cols=126 Identities=33% Similarity=0.612 Sum_probs=101.5
Q ss_pred ccChhhcCCCCCCcEEEccc-CcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcc
Q 008431 6 MIDVDTLSRLPGLRSLSFIN-NSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKS 82 (565)
Q Consensus 6 ~i~~~~~~~l~~L~~L~l~~-N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~ 82 (565)
.+|. .|+++++|++|+|++ |.+.+.+| .+..+ +|++|+|++|+|+|.+|.. |.++++|++|+|++|++++.+|..
T Consensus 67 ~~~~-~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~ 144 (313)
T 1ogq_A 67 PIPS-SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPS 144 (313)
T ss_dssp ECCG-GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG-GGGCTTCCEEECCSSEEESCCCGG
T ss_pred ccCh-hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHH-HhCCCCCCEEeCCCCccCCcCChH
Confidence 6764 788888888888884 88888777 44444 6888888888888777765 888888888888888888888888
Q ss_pred ccCCCCCCEEeccCCcCCCCCCCC--CCC-CCCEEEcccCCCccCCCccccCCC
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIPDF--PLA-HLTLLDLSYNQLVGRIPDTLSNFD 133 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p~~--~~~-~L~~l~ls~N~l~g~~p~~~~~~~ 133 (565)
|.++++|++|+|++|+++|.+|.. .+. +|+.|++++|+++|.+|..+..+.
T Consensus 145 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp GGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred HhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 888888888888888888877763 455 888888888888888888776543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-15 Score=140.58 Aligned_cols=140 Identities=21% Similarity=0.244 Sum_probs=115.1
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
...+|.. -.++|++|+|++|+|++..+. +.. .+|+.|+|++|+|+ .+|+..|.++++|++|+|++|+|++..+.
T Consensus 19 l~~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 94 (208)
T 2o6s_A 19 RTSVPTG---IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNG 94 (208)
T ss_dssp CSSCCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred ccCCCCC---CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECCCCcCCccCHh
Confidence 3456542 256899999999999987764 333 47999999999999 78888899999999999999999987777
Q ss_pred cccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCCCCCC
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGLCGKP 147 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~cg~p 147 (565)
.|.++++|++|+|++|++++..+.. .+++|+.|++++|++++..+..+.. +....+.+|+..|..+
T Consensus 95 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 95 VFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred HhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 8899999999999999999877753 6889999999999999877765554 4455678998887654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.9e-15 Score=138.41 Aligned_cols=125 Identities=22% Similarity=0.252 Sum_probs=106.3
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|..+++|+.|+|++|+|++..+. +. ..+|++|+|++|+|+ .+|+..|.++++|+.|+|++|+|++..
T Consensus 38 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~ 116 (208)
T 2o6s_A 38 NSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLP 116 (208)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccC
Confidence 345577777889999999999999999977664 33 347999999999999 678777899999999999999999877
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPD 127 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~ 127 (565)
+..|.++++|+.|+|++|++++..+.. .+++|+.|++++|.+.+..|.
T Consensus 117 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 117 DGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred HhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence 778899999999999999999777653 578999999999999887663
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.9e-15 Score=144.48 Aligned_cols=123 Identities=24% Similarity=0.302 Sum_probs=108.5
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|..+++|+.|+|++|+|++..+. +. ..+|+.|+|++|+|+ .+|+..|.++++|+.|+|++|+|++..
T Consensus 69 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 69 NQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccC
Confidence 455667778899999999999999999987774 33 347999999999999 788888999999999999999999888
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRI 125 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~ 125 (565)
|..|+++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 878999999999999999999877753 6789999999999998763
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.60 E-value=4.6e-15 Score=141.96 Aligned_cols=123 Identities=22% Similarity=0.279 Sum_probs=107.5
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|..+++|+.|+|++|+|+...+. +. ..+|+.|+|++|+|+ .+|+..|..+++|+.|+|++|+|+ .+
T Consensus 50 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~l 127 (229)
T 3e6j_A 50 NQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-EL 127 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SC
T ss_pred CccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-cc
Confidence 445567677899999999999999999877664 33 347999999999999 788888999999999999999999 78
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
|..+..+++|+.|+|++|+|++..+.. .+++|+.|+|++|.+++..+
T Consensus 128 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 128 PRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999999999999999999999776653 68899999999999987655
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.5e-15 Score=151.96 Aligned_cols=143 Identities=21% Similarity=0.297 Sum_probs=118.7
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cc----------ccccceeecccccccccCCcchhcCCCCccEEEc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VG----------KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~----------~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l 70 (565)
|.+..||. .|+++++|+.|+|++|++.+.+|. +. ..+|+.|+|++|+|+ .+|.. |.++++|+.|+|
T Consensus 137 n~l~~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~-l~~l~~L~~L~L 213 (328)
T 4fcg_A 137 NPLRALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS-IANLQNLKSLKI 213 (328)
T ss_dssp CCCCCCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGG-GGGCTTCCEEEE
T ss_pred CccccCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHh-hcCCCCCCEEEc
Confidence 44557875 689999999999999999888884 32 347999999999999 89976 899999999999
Q ss_pred cCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCC---CCcccCCCCCCC
Q 008431 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFD---ATSFQGNKGLCG 145 (565)
Q Consensus 71 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~---~~~~~~n~~~cg 145 (565)
++|++++ +|..|+.+++|+.|+|++|++.+.+|.. .+++|+.|+|++|++.+.+|..+.+++ ...+.+|+....
T Consensus 214 ~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 292 (328)
T 4fcg_A 214 RNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292 (328)
T ss_dssp ESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred cCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence 9999995 6778999999999999999999998874 688999999999999999998776554 445677765554
Q ss_pred CCC
Q 008431 146 KPL 148 (565)
Q Consensus 146 ~p~ 148 (565)
.|.
T Consensus 293 iP~ 295 (328)
T 4fcg_A 293 LPS 295 (328)
T ss_dssp CCG
T ss_pred ccH
Confidence 443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.5e-15 Score=144.76 Aligned_cols=125 Identities=20% Similarity=0.286 Sum_probs=110.7
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|+.+++|+.|+|++|++++..+. +.. .+|+.|+|++|+|+ .+|+..|.++++|+.|+|++|++++..
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccC-ccCHHHhccCccCCEEECCCCCcCccC
Confidence 455678877899999999999999999988774 343 47999999999999 677777999999999999999999888
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPD 127 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~ 127 (565)
|..|+++++|+.|+|++|++++..|.. .+++|+.|++++|.+.+.+|.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 888999999999999999999988763 689999999999999987763
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=9.7e-15 Score=143.32 Aligned_cols=109 Identities=26% Similarity=0.409 Sum_probs=52.0
Q ss_pred CCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEec
Q 008431 17 GLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNL 94 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 94 (565)
+|+.|+|++|+|++..+ .+... +|++|+|++|+|+ .+|+.+|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 44555555555544433 22222 4555555555554 444444455555555555555555444444455555555555
Q ss_pred cCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 95 EGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 95 ~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
++|++++..+.. .+++|+.|+|++|+|++..+
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 150 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPK 150 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCH
Confidence 555555444332 34455555555555544333
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.3e-15 Score=147.87 Aligned_cols=135 Identities=21% Similarity=0.272 Sum_probs=81.8
Q ss_pred hhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeeccccccccc-CCcchhcCCCCccEEEccCCcCcccCCccccCC
Q 008431 10 DTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGE-IPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGL 86 (565)
Q Consensus 10 ~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~-ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 86 (565)
..+..+++|+.|+|++|.+++..|. +.. .+|+.|+|++|.+++. +|. .|..+++|+.|+|++|++++..|..|.++
T Consensus 120 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 198 (306)
T 2z66_A 120 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD-IFTELRNLTFLDLSQCQLEQLSPTAFNSL 198 (306)
T ss_dssp TTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECS-CCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred hhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchh-HHhhCcCCCEEECCCCCcCCcCHHHhcCC
Confidence 3456666666666666666655553 222 2566666666666642 333 36666677777777777766666666666
Q ss_pred CCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCC----CCCcccCCCCCCC
Q 008431 87 QKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNF----DATSFQGNKGLCG 145 (565)
Q Consensus 87 ~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~----~~~~~~~n~~~cg 145 (565)
++|+.|+|++|++++..+.. .+++|+.|++++|++++..|..+..+ ....+.+|+..|.
T Consensus 199 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp TTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 77777777777766544422 45667777777777776666655443 2334566665554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=4.7e-15 Score=163.15 Aligned_cols=144 Identities=21% Similarity=0.257 Sum_probs=123.2
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCCcc--cccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV--GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
.+.++...|..+++|+.++++.|.+.+..|.. ....|+.|+|++|++.+.++++.|..+++|+.|+|++|+|++.+|.
T Consensus 433 ~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~ 512 (635)
T 4g8a_A 433 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 512 (635)
T ss_dssp ESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChH
Confidence 34455567888999999999999999887743 3347999999999876566666799999999999999999999999
Q ss_pred cccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCC----CCCcccCCCCCCCCC
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNF----DATSFQGNKGLCGKP 147 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~----~~~~~~~n~~~cg~p 147 (565)
.|.++++|++|+|++|+|++..|.. .+++|+.|+|++|+|++..|..+..+ ....+.+|++.|.+.
T Consensus 513 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 513 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred HHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999999999887763 68999999999999999999987654 345789999999764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=4.9e-15 Score=162.96 Aligned_cols=126 Identities=21% Similarity=0.294 Sum_probs=63.7
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
.+..||+++|.++++|++|+|++|+|++..|. +.. .+|++|+|++|+|+ .+|+++|.++++|++|+|++|+|++..+
T Consensus 63 ~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~ 141 (635)
T 4g8a_A 63 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLEN 141 (635)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTT
T ss_pred CCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCCh
Confidence 34445545555555555555555555554442 222 24555555555555 4555555555555555555555554444
Q ss_pred ccccCCCCCCEEeccCCcCCCC-CCCC--CCCCCCEEEcccCCCccCCCccc
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGK-IPDF--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~-~p~~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
..|+++++|++|+|++|++++. +|.. .+++|+.|++++|+|++..|..+
T Consensus 142 ~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 142 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp CCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred hhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 4555555555555555555432 2222 34555555555555555444443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-14 Score=135.35 Aligned_cols=127 Identities=21% Similarity=0.266 Sum_probs=104.0
Q ss_pred CcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCC
Q 008431 18 LRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN 97 (565)
Q Consensus 18 L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 97 (565)
-+.+++++|.|+..+..+ ...|+.|+|++|+|+ .+|. .|.++++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~~~l~~~~~~l~~ip~~~-~~~l~~L~L~~n~i~-~ip~-~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 12 DTVVRCSNKGLKVLPKGI-PRDVTELYLDGNQFT-LVPK-ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TTEEECTTSCCSSCCSCC-CTTCCEEECCSSCCC-SCCG-GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEcCCCCCCcCCCCC-CCCCCEEECCCCcCc-hhHH-HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 367899999998644333 247999999999998 8884 5899999999999999999888888999999999999999
Q ss_pred cCCCCCCCC--CCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCCCCCC
Q 008431 98 SFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGLCGKP 147 (565)
Q Consensus 98 ~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~cg~p 147 (565)
+|++..|.. .+++|+.|+|++|+|++..+..|.. +....+.+|+..|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 999887753 6789999999999999776666654 4455678898888653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.4e-14 Score=134.61 Aligned_cols=120 Identities=22% Similarity=0.279 Sum_probs=102.0
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
|.+..||.+ + .++|+.|+|++|+|+..++.+... +|+.|+|++|+|+ .+++++|.++++|+.|+|++|+|++..|
T Consensus 20 ~~l~~ip~~-~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~ 95 (193)
T 2wfh_A 20 KGLKVLPKG-I--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPP 95 (193)
T ss_dssp SCCSSCCSC-C--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CCCCcCCCC-C--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCC-EeCHhHccCCCCCCEEECCCCccCEeCH
Confidence 445678753 3 358999999999999544455444 7999999999999 6887889999999999999999999889
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRI 125 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~ 125 (565)
..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|.+....
T Consensus 96 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 96 RTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp TTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred HHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 99999999999999999999776653 6889999999999997543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.4e-14 Score=146.41 Aligned_cols=144 Identities=22% Similarity=0.302 Sum_probs=117.5
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcch--------hcCCCCccEEEccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDA--------FAGMDQLKKVHLAR 72 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~--------~~~l~~L~~L~l~~ 72 (565)
|.+..||. .|+.+++|++|+|++|.|+..++.+..+ +|+.|+|++|++.+.+|... |.++++|+.|+|++
T Consensus 114 n~l~~lp~-~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~ 192 (328)
T 4fcg_A 114 AGLMELPD-TMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192 (328)
T ss_dssp SCCCCCCS-CGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEE
T ss_pred CCccchhH-HHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcC
Confidence 34457874 7899999999999999999443355554 79999999999999999763 34599999999999
Q ss_pred CcCcccCCccccCCCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCccccCCCC---CcccCCCCCCCCC
Q 008431 73 NHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLSNFDA---TSFQGNKGLCGKP 147 (565)
Q Consensus 73 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~~cg~p 147 (565)
|+|+ .+|..|+++++|+.|+|++|++++.++.. .+++|+.|+|++|++.+.+|..+..++. ..+.+|......|
T Consensus 193 n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p 270 (328)
T 4fcg_A 193 TGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270 (328)
T ss_dssp ECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCC
T ss_pred CCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcc
Confidence 9999 89999999999999999999999765554 6889999999999999999998776554 4566665444333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-14 Score=132.62 Aligned_cols=125 Identities=22% Similarity=0.250 Sum_probs=60.3
Q ss_pred cEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCc
Q 008431 19 RSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNS 98 (565)
Q Consensus 19 ~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 98 (565)
+.+++++|+++..+..+. .+|+.|+|++|+|+ .+|+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 10 ~~l~~~~~~l~~~p~~~~-~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 10 TEIRCNSKGLTSVPTGIP-SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp TEEECCSSCCSSCCTTCC-TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEecCCCCccCCCCCC-CCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 445555555543322221 24555555555555 3444445555555555555555554444445555555555555555
Q ss_pred CCCCCCCC--CCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCCCC
Q 008431 99 FQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGLCG 145 (565)
Q Consensus 99 l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~cg 145 (565)
+++..+.. .+++|+.|++++|+|++..+..+.. +....+.+|+..|.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 55444431 3455555555555555443333322 22333445544443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-14 Score=152.55 Aligned_cols=105 Identities=23% Similarity=0.301 Sum_probs=70.1
Q ss_pred cceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcc
Q 008431 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLS 117 (565)
Q Consensus 40 L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls 117 (565)
|+.|+|++|+|+ .+|. +..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|.. .+++|+.|+|+
T Consensus 198 L~~L~L~~n~l~-~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 274 (452)
T 3zyi_A 198 LKYLNLGMCNIK-DMPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274 (452)
T ss_dssp CCEEECTTSCCS-SCCC--CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCccc-cccc--ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECC
Confidence 444444444444 3332 445556666666667777666777777778888888888877766653 56788888888
Q ss_pred cCCCccCCCccccC---CCCCcccCCCCCCCCC
Q 008431 118 YNQLVGRIPDTLSN---FDATSFQGNKGLCGKP 147 (565)
Q Consensus 118 ~N~l~g~~p~~~~~---~~~~~~~~n~~~cg~p 147 (565)
+|+|++..+..|.. +....+.+|+..|.+.
T Consensus 275 ~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 275 HNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp SSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 88888766665544 3445678888888764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.7e-14 Score=141.25 Aligned_cols=122 Identities=24% Similarity=0.246 Sum_probs=58.6
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCC-cccc-cccceeeccccc-ccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGK-LTLRALYLSLNK-FTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~-~~L~~L~Ls~N~-l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
..++++.|..+++|+.|+|++|.+++..| .+.. .+|+.|+|++|+ ++ .+++..|.++++|++|+|++|++++..|.
T Consensus 45 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 123 (285)
T 1ozn_A 45 SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPG 123 (285)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred CccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHh
Confidence 33444445555555555555555554433 2222 245555555554 33 34333455555555555555555544455
Q ss_pred cccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCc
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPD 127 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~ 127 (565)
.|.++++|++|+|++|++++..+.. .+++|+.|++++|++++..+.
T Consensus 124 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred HhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 5555555555555555555443331 344555555555555544333
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.4e-15 Score=148.20 Aligned_cols=138 Identities=24% Similarity=0.261 Sum_probs=85.1
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccC---CCcc--c-ccccceeecccccccccCCc---chhcCCCCccEEEccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGP---MPSV--G-KLTLRALYLSLNKFTGEIPS---DAFAGMDQLKKVHLARN 73 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~---~p~~--~-~~~L~~L~Ls~N~l~g~ip~---~~~~~l~~L~~L~l~~N 73 (565)
.+..+++..|+.+++|++|+|++|++.+. .+.. . ..+|++|+|++|+|+ .+|. ..+.++++|++|+|++|
T Consensus 156 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N 234 (310)
T 4glp_A 156 HSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHN 234 (310)
T ss_dssp SSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTS
T ss_pred CcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCC
Confidence 34455555666677777777777766541 1111 1 225777777777765 3332 23566677777777777
Q ss_pred cCcccCCccccCC---CCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCcc-CCCccccCCCCCcccCCCC
Q 008431 74 HFSGQIPKSLAGL---QKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG-RIPDTLSNFDATSFQGNKG 142 (565)
Q Consensus 74 ~l~g~~p~~~~~l---~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g-~~p~~~~~~~~~~~~~n~~ 142 (565)
+|++.+|..+..+ ++|++|+|++|+|+ .+|....++|+.|+|++|+|++ +.+..+.++....+.+|+.
T Consensus 235 ~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l 306 (310)
T 4glp_A 235 SLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPF 306 (310)
T ss_dssp CCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCSCCCTTSCCCCSCEECSSTTT
T ss_pred CCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCCCchhhhCCCccEEECcCCCC
Confidence 7777667666665 47777777777777 4454434677777777777776 4445555555666666653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=142.12 Aligned_cols=145 Identities=19% Similarity=0.213 Sum_probs=100.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCccc-
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ- 78 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~- 78 (565)
|.+..+++..|..+++|+.|+|++|.|++..+. +.. .+|+.|+|++|+++ .+++..|..+++|++|+|++|++++.
T Consensus 62 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~ 140 (276)
T 2z62_A 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFK 140 (276)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCC
T ss_pred CcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCccceec
Confidence 445567777788888888888888888877653 333 36888888888887 45555577888888888888888763
Q ss_pred CCccccCCCCCCEEeccCCcCCCCCCCC-----------------------------CCCCCCEEEcccCCCccCCCccc
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKIPDF-----------------------------PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~-----------------------------~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
+|..|+++++|+.|+|++|++++..+.. ...+|+.|++++|+|++..+..+
T Consensus 141 l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 220 (276)
T 2z62_A 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIF 220 (276)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTT
T ss_pred CchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHh
Confidence 5778888888888888888877654321 12357777777777776555444
Q ss_pred cCC---CCCcccCCCCCCCCC
Q 008431 130 SNF---DATSFQGNKGLCGKP 147 (565)
Q Consensus 130 ~~~---~~~~~~~n~~~cg~p 147 (565)
..+ ....+.+|+..|.++
T Consensus 221 ~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 221 DRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp TTCCSCCEEECCSSCBCCCTT
T ss_pred cccccccEEEccCCcccccCC
Confidence 433 344567777777654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=9.3e-15 Score=160.31 Aligned_cols=138 Identities=19% Similarity=0.171 Sum_probs=88.9
Q ss_pred hhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCC
Q 008431 10 DTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQ 87 (565)
Q Consensus 10 ~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 87 (565)
..|..+++|+.|+|++|.+++.+|. +.. .+|+.|+|++|++++.+++..|.++++|+.|+|++|++++..|..|.+++
T Consensus 418 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 497 (606)
T 3vq2_A 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497 (606)
T ss_dssp TTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccc
Confidence 4566666666666666666665552 322 25777777777777543333467777777777777777777777777777
Q ss_pred CCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccC----CCCCcccCCCCCCCCCC
Q 008431 88 KLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN----FDATSFQGNKGLCGKPL 148 (565)
Q Consensus 88 ~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~----~~~~~~~~n~~~cg~p~ 148 (565)
+|+.|+|++|++++.+|.. .+++|+.|++++|+|+ .+|..+.. +....+.+|+..|.++.
T Consensus 498 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 7777777777777765553 4667777777777776 45544443 33345677777776543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.3e-14 Score=150.96 Aligned_cols=143 Identities=24% Similarity=0.281 Sum_probs=101.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cc--------------------------ccccceeecccccccccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VG--------------------------KLTLRALYLSLNKFTGEI 54 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~--------------------------~~~L~~L~Ls~N~l~g~i 54 (565)
|.+..++++.|..+++|+.|+|++|.|+...+. +. ..+|+.|+|++|+|+ .+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc
Confidence 445567776777888888888888877654431 11 124666666666666 56
Q ss_pred CcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccC-
Q 008431 55 PSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN- 131 (565)
Q Consensus 55 p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~- 131 (565)
|. +..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+|++..+..|..
T Consensus 201 ~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 201 PN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC--CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc--cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 63 666777777777777777777788888888888888888888766653 5788888999999888777666554
Q ss_pred --CCCCcccCCCCCCCCC
Q 008431 132 --FDATSFQGNKGLCGKP 147 (565)
Q Consensus 132 --~~~~~~~~n~~~cg~p 147 (565)
+....+.+|+..|.+.
T Consensus 279 ~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 279 HHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TTCCEEECCSSCEECSST
T ss_pred cCCCEEEcCCCCccCCCC
Confidence 4455678898888764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.9e-14 Score=157.57 Aligned_cols=138 Identities=19% Similarity=0.219 Sum_probs=110.7
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.++.+|+..|..+++|+.|+|++|.|++.+| .+..+ +|+.|+|++|.|+ .+|+..|+++++|+.|+|++|.|++..
T Consensus 61 ~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~ 139 (597)
T 3oja_B 61 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLP 139 (597)
T ss_dssp CEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC-CCCHHHHcCCCCCCEEEeeCCCCCCCC
Confidence 44577888778889999999999999988777 45444 6999999999998 466677889999999999999998766
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCCCCcccCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGN 140 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 140 (565)
|..|+++++|++|+|++|.+++..|.. .+++|+.|+|++|+|++..+..+.++....+.+|
T Consensus 140 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 140 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp TTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred HHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 666789999999999999999887763 6788999999999998766566666655555555
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.52 E-value=6.8e-14 Score=128.02 Aligned_cols=120 Identities=19% Similarity=0.213 Sum_probs=102.9
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
.+..+|.. -.++|+.|+|++|+|++..+. +.. .+|+.|+|++|+|+ .+|+..|.++++|+.|+|++|+|++..+
T Consensus 18 ~l~~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 93 (177)
T 2o6r_A 18 GLTSVPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSLPN 93 (177)
T ss_dssp CCSSCCTT---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCccCCCC---CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEEECCCCCccccCH
Confidence 34567643 247899999999999987764 343 47999999999999 7888889999999999999999998888
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|++++..|
T Consensus 94 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 94 GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred HHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88999999999999999999776653 58899999999999998766
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=4.4e-14 Score=128.47 Aligned_cols=108 Identities=21% Similarity=0.222 Sum_probs=91.4
Q ss_pred CCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccC
Q 008431 17 GLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEG 96 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 96 (565)
..+.|++++|.|+..+..+. ..|+.|+|++|+|+ .++++.|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 10 ~~~~l~~s~n~l~~ip~~~~-~~l~~L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 10 SGTTVDCSGKSLASVPTGIP-TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp ETTEEECTTSCCSSCCSCCC-TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCEEEeCCCCcCccCccCC-CCCcEEEcCCCcCC-ccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 46789999999997544443 57999999999999 56666799999999999999999988888889999999999999
Q ss_pred CcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 97 NSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 97 N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
|+|++..+.. .+++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999877753 68899999999999875543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.52 E-value=5.7e-14 Score=139.34 Aligned_cols=141 Identities=26% Similarity=0.322 Sum_probs=116.8
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
|.+..+++ .+.+++|+.|+|++|+|+..+..+.. .+|+.|+|++|+|+ .+|++.|.++++|+.|+|++|+|++..+
T Consensus 65 n~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~ 141 (290)
T 1p9a_G 65 AELTKLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPP 141 (290)
T ss_dssp SCCCEEEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCT
T ss_pred CccCcccC--CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEECCCCCCCccCh
Confidence 34455654 37899999999999999965444433 47999999999999 7888889999999999999999998888
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCCCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGLCGK 146 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~cg~ 146 (565)
..|..+++|+.|+|++|+|++..+.. .+++|+.|+|++|+|+ .+|..+.. +....+.+|+..|.+
T Consensus 142 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred hhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 88999999999999999999766653 5899999999999999 56665443 444567899998864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.8e-14 Score=141.76 Aligned_cols=114 Identities=20% Similarity=0.210 Sum_probs=69.6
Q ss_pred CCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEec
Q 008431 17 GLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNL 94 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 94 (565)
+|+.|+|++|.|++..+ .+... +|+.|+|++|+++ .+++..|.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 56666666666665554 33322 5666666666666 455555666666666666666666666666666666666666
Q ss_pred cCCcCCCCCCC--CCCCCCCEEEcccCCCccC-CCccccC
Q 008431 95 EGNSFQGKIPD--FPLAHLTLLDLSYNQLVGR-IPDTLSN 131 (565)
Q Consensus 95 ~~N~l~g~~p~--~~~~~L~~l~ls~N~l~g~-~p~~~~~ 131 (565)
++|++++..+. ..+++|+.|++++|++++. +|..+.+
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~ 147 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGG
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhcc
Confidence 66666655442 1456666666666666652 4555443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=4.5e-14 Score=149.17 Aligned_cols=133 Identities=23% Similarity=0.282 Sum_probs=112.4
Q ss_pred CCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEE
Q 008431 15 LPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQL 92 (565)
Q Consensus 15 l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 92 (565)
.++|+.|+|++|.+++.+|. +..+ +|+.|+|++|++++ +++..|.++++|+.|+|++|++++..|..|.++++|++|
T Consensus 274 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 352 (455)
T 3v47_A 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK-IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVL 352 (455)
T ss_dssp TSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEE
T ss_pred ccCceEEEecCccccccchhhcccCCCCCEEECCCCcccc-cChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEE
Confidence 36899999999999988774 4433 79999999999994 555569999999999999999998889999999999999
Q ss_pred eccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCCCCCCC
Q 008431 93 NLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGLCGKPL 148 (565)
Q Consensus 93 ~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~cg~p~ 148 (565)
+|++|++++..|.. .+++|+.|+|++|+|++..+..+.. +....+.+|+..|.+|.
T Consensus 353 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 353 DLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 99999999887764 6899999999999999876665554 45567889999888763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.50 E-value=9.2e-15 Score=161.22 Aligned_cols=135 Identities=21% Similarity=0.335 Sum_probs=114.0
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccC-----------------CC-ccc--cc-ccceeecccccccccCCcchhc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGP-----------------MP-SVG--KL-TLRALYLSLNKFTGEIPSDAFA 60 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~-----------------~p-~~~--~~-~L~~L~Ls~N~l~g~ip~~~~~ 60 (565)
++.| ||. .|+++++|++|+|++|.|+|. +| .++ .+ +|++|+|++|+++|.+|.. |.
T Consensus 194 ~l~~-ip~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~-l~ 270 (636)
T 4eco_A 194 NITF-VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF-LK 270 (636)
T ss_dssp EEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTT-TT
T ss_pred CCcc-CCH-HHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHH-Hh
Confidence 3445 885 799999999999999999994 55 555 44 7999999999999999965 99
Q ss_pred CCCCccEEEccCCc-Ccc-cCCccccCC------CCCCEEeccCCcCCCCCCC--C--CCCCCCEEEcccCCCccCCCcc
Q 008431 61 GMDQLKKVHLARNH-FSG-QIPKSLAGL------QKLLQLNLEGNSFQGKIPD--F--PLAHLTLLDLSYNQLVGRIPDT 128 (565)
Q Consensus 61 ~l~~L~~L~l~~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~g~~p~--~--~~~~L~~l~ls~N~l~g~~p~~ 128 (565)
++++|+.|+|++|+ ++| .+|..++++ ++|+.|+|++|+++ .+|. . .+++|+.|++++|+++|.+| .
T Consensus 271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~ 348 (636)
T 4eco_A 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-A 348 (636)
T ss_dssp TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-C
T ss_pred cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-h
Confidence 99999999999998 999 899999887 99999999999999 6776 2 78899999999999999999 6
Q ss_pred ccCC---CCCcccCCC
Q 008431 129 LSNF---DATSFQGNK 141 (565)
Q Consensus 129 ~~~~---~~~~~~~n~ 141 (565)
+..+ ....+.+|.
T Consensus 349 ~~~l~~L~~L~L~~N~ 364 (636)
T 4eco_A 349 FGSEIKLASLNLAYNQ 364 (636)
T ss_dssp CEEEEEESEEECCSSE
T ss_pred hCCCCCCCEEECCCCc
Confidence 6433 334455553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.1e-14 Score=142.86 Aligned_cols=124 Identities=24% Similarity=0.210 Sum_probs=66.9
Q ss_pred CCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccC--Ccc-hhcCCCCccEEEccCCcCcc--cCC-ccccCCC
Q 008431 16 PGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEI--PSD-AFAGMDQLKKVHLARNHFSG--QIP-KSLAGLQ 87 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~i--p~~-~~~~l~~L~~L~l~~N~l~g--~~p-~~~~~l~ 87 (565)
++|++|+|++|+|++..| .+..+ +|+.|+|++|+++|.+ |+. .|.++++|++|+|++|+|++ .++ ..+.+++
T Consensus 149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~ 228 (312)
T 1wwl_A 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228 (312)
T ss_dssp TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC
T ss_pred CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC
Confidence 666666666666666554 33332 5666666666665442 222 12566666666666666652 112 2334556
Q ss_pred CCCEEeccCCcCCCCCCCC---CCCCCCEEEcccCCCccCCCcccc-CCCCCcccCC
Q 008431 88 KLLQLNLEGNSFQGKIPDF---PLAHLTLLDLSYNQLVGRIPDTLS-NFDATSFQGN 140 (565)
Q Consensus 88 ~L~~L~l~~N~l~g~~p~~---~~~~L~~l~ls~N~l~g~~p~~~~-~~~~~~~~~n 140 (565)
+|+.|+|++|++++.+|.. .+++|+.|+|++|+|+ .+|..+. ++....+.+|
T Consensus 229 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N 284 (312)
T 1wwl_A 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYN 284 (312)
T ss_dssp CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEEEEEECCSS
T ss_pred CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCceEEECCCC
Confidence 6666666666666655321 3456666666666666 4554432 2333344444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.7e-14 Score=150.06 Aligned_cols=126 Identities=23% Similarity=0.314 Sum_probs=78.4
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
.+..++++.|.++++|+.|+|++|.+++..| .+..+ +|++|+|++|+|+ .+|+++|.++++|++|+|++|++++..|
T Consensus 43 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 121 (477)
T 2id5_A 43 RIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLD 121 (477)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECT
T ss_pred ccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEECCCCccccCCh
Confidence 3444555566666666666666666666555 23332 5666666666666 5666666666666666766666666666
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccc
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
..|.++++|+.|+|++|.+++..|.. .+++|+.|+|++|++++..+..+
T Consensus 122 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 172 (477)
T 2id5_A 122 YMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEAL 172 (477)
T ss_dssp TTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHH
T ss_pred hHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHh
Confidence 66666666666666666666555542 45666666666666665444333
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=9.1e-14 Score=146.80 Aligned_cols=118 Identities=25% Similarity=0.268 Sum_probs=74.5
Q ss_pred ChhhcCCCCCCcEEEcccCcCccCCC-cccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccC
Q 008431 8 DVDTLSRLPGLRSLSFINNSFDGPMP-SVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAG 85 (565)
Q Consensus 8 ~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 85 (565)
++..|+.+++|+.|+|++|.+++..| .+.. .+|+.|+|++|+++ .+++..|.++++|++|+|++|++++..|..|.+
T Consensus 291 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 369 (455)
T 3v47_A 291 LKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG 369 (455)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECGGGGTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred chhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccC-CcChhHhcCcccCCEEECCCCcccccChhhccc
Confidence 34456666667777777776666555 3332 25666777766665 444445666666777777777666666666666
Q ss_pred CCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 86 LQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 86 l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
+++|++|+|++|++++..+.. .+++|+.|++++|++++.+|
T Consensus 370 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 370 LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 666777777777666544432 45666667777776666665
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.8e-14 Score=164.19 Aligned_cols=136 Identities=27% Similarity=0.347 Sum_probs=118.3
Q ss_pred cCCCCCCcEEEcccCcCccCCCc--c-cccccceeecccccccc----cCCcchhcCCCCccEEEccCCcCcccCCcccc
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPS--V-GKLTLRALYLSLNKFTG----EIPSDAFAGMDQLKKVHLARNHFSGQIPKSLA 84 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~--~-~~~~L~~L~Ls~N~l~g----~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 84 (565)
+.++++|+.|+|++|+|++..+. . ...+|+.|+|++|.+++ .++++.|.++++|+.|+|++|+|++.+|..|.
T Consensus 422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 501 (844)
T 3j0a_A 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501 (844)
T ss_dssp HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence 55899999999999999976553 2 23479999999999973 23345689999999999999999999999999
Q ss_pred CCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccccCCCCCcccCCCCCCCCC
Q 008431 85 GLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGLCGKP 147 (565)
Q Consensus 85 ~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~~~cg~p 147 (565)
++++|+.|+|++|+|++..|....++|+.|+|++|+|++.+|..+.++....+.+|+..|.++
T Consensus 502 ~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp SCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred chhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 999999999999999988777655899999999999999999999988888999999999654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.49 E-value=7e-14 Score=144.74 Aligned_cols=137 Identities=19% Similarity=0.219 Sum_probs=84.1
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
.++.+|+..|..+++|+.|+|++|.+++..+ .+..+ +|++|+|++|+++ .+|++.|.++++|++|+|++|+++...+
T Consensus 56 ~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~ 134 (390)
T 3o6n_A 56 TMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPR 134 (390)
T ss_dssp EESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred chhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEEECCCCccCcCCH
Confidence 3455666556667777777777777766555 33333 5777777777776 4555556677777777777777764444
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCCCCcccCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGN 140 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 140 (565)
..|.++++|++|+|++|++++..|.. .+++|+.|++++|++++.....+.++....+.+|
T Consensus 135 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp TTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred HHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 44566777777777777776655542 4566777777777776544344444444444443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.4e-14 Score=142.66 Aligned_cols=136 Identities=23% Similarity=0.167 Sum_probs=110.4
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCcc---cccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV---GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
.+..||.. + .+.|+.|+|++|+|++..+.. ...+|+.|+|++|+|+ .+|+++|.++++|+.|+|++|+|++..
T Consensus 29 ~l~~iP~~-~--~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~ 104 (361)
T 2xot_A 29 QLPNVPQS-L--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLD 104 (361)
T ss_dssp CCSSCCSS-C--CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcCccCcc-C--CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEEECCCCcCCcCC
Confidence 34567753 3 245899999999999887743 3447999999999999 678778999999999999999999888
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccc------cCCCCCcccCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTL------SNFDATSFQGNKG 142 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~------~~~~~~~~~~n~~ 142 (565)
+..|.++++|+.|+|++|++++..|.. .+++|+.|+|++|+|++..+..| .++..+.+.+|..
T Consensus 105 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 105 EFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred HHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 889999999999999999999877763 68999999999999997555443 3344455666653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.3e-14 Score=131.18 Aligned_cols=110 Identities=15% Similarity=0.224 Sum_probs=61.6
Q ss_pred cCCCCCCcEEEcccCcCccCCCccc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCC
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 90 (565)
+..+++|+.|+|++|.++.. +.+. ..+|+.|+|++|++++..|.. |..+++|+.|+|++|++++..|..|+.+++|+
T Consensus 62 l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~ 139 (197)
T 4ezg_A 62 IEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPN-LSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139 (197)
T ss_dssp GGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCC-CTTCTTCCEEECCSSBCBGGGHHHHTTCSSCC
T ss_pred HhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChh-hcCCCCCCEEEecCCccCcHhHHHHhhCCCCC
Confidence 55566666666666655432 2222 224666666666666444443 56666666666666666655566666666666
Q ss_pred EEeccCCcCCCCCCCC-CCCCCCEEEcccCCCcc
Q 008431 91 QLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 91 ~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g 123 (565)
.|+|++|++.+.+|.. .+++|+.|++++|++++
T Consensus 140 ~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 140 SIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp EEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC
T ss_pred EEEccCCCCccccHhhcCCCCCCEEECCCCCCcC
Confidence 6666666522233322 45566666666666654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-13 Score=125.84 Aligned_cols=104 Identities=19% Similarity=0.229 Sum_probs=85.0
Q ss_pred CcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCC
Q 008431 18 LRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN 97 (565)
Q Consensus 18 L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 97 (565)
-+.+++++|.|+..++.+. ..|+.|+|++|+|+ .++++.|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 14 ~~~l~~~~n~l~~iP~~~~-~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP-TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC-TTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcEEEeCCCCCCccCCCcC-CCCcEEEeCCCCcc-ccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 4688999999975444443 57899999999998 565566899999999999999999877777889999999999999
Q ss_pred cCCCCCCC-C-CCCCCCEEEcccCCCcc
Q 008431 98 SFQGKIPD-F-PLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 98 ~l~g~~p~-~-~~~~L~~l~ls~N~l~g 123 (565)
+|++..+. + .+++|+.|+|++|++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 99977665 2 57889999999998864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.4e-14 Score=149.07 Aligned_cols=142 Identities=23% Similarity=0.242 Sum_probs=107.5
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCCc--------------------------ccccccceeecccccccccCCcc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMPS--------------------------VGKLTLRALYLSLNKFTGEIPSD 57 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~--------------------------~~~~~L~~L~Ls~N~l~g~ip~~ 57 (565)
+..+++..|..+++|+.|+|++|.+.+..+. ....+|+.|+|++|+|+ .+|..
T Consensus 164 l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~ 242 (477)
T 2id5_A 164 LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242 (477)
T ss_dssp CSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-SCCHH
T ss_pred CcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-ccCHH
Confidence 4455555566666666666666666543331 11226788888888888 78877
Q ss_pred hhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCcccc---CC
Q 008431 58 AFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLS---NF 132 (565)
Q Consensus 58 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~---~~ 132 (565)
.|.++++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|.. .+++|+.|+|++|+|++..+..|. ++
T Consensus 243 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 322 (477)
T 2id5_A 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322 (477)
T ss_dssp HHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGC
T ss_pred HhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCccc
Confidence 7899999999999999999888888999999999999999999887764 678999999999999987766654 44
Q ss_pred CCCcccCCCCCCCC
Q 008431 133 DATSFQGNKGLCGK 146 (565)
Q Consensus 133 ~~~~~~~n~~~cg~ 146 (565)
....+.+|+..|.+
T Consensus 323 ~~L~l~~N~l~c~c 336 (477)
T 2id5_A 323 ETLILDSNPLACDC 336 (477)
T ss_dssp CEEECCSSCEECSG
T ss_pred CEEEccCCCccCcc
Confidence 55678888888764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.6e-13 Score=144.97 Aligned_cols=120 Identities=26% Similarity=0.270 Sum_probs=76.2
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCC-cccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..++++.|.++++|+.|+|++|.|++..| .+.. .+|++|+|++|+|+ .+|++.|.++++|++|+|++|+|+...
T Consensus 85 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~ 163 (452)
T 3zyi_A 85 NNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIP 163 (452)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEEC
T ss_pred CcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeC
Confidence 34455666778888888888888888887665 3333 36888888888887 677777777888888888888777655
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC---CCCCCCEEEcccCCCc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~ls~N~l~ 122 (565)
+..|.++++|+.|+|++|+..+.++.. .+.+|+.|+|++|+|+
T Consensus 164 ~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209 (452)
T ss_dssp TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred HhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence 555555555555555553332233321 3444444444444444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=2e-13 Score=143.73 Aligned_cols=120 Identities=24% Similarity=0.288 Sum_probs=69.4
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCC-cccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|.++++|+.|+|++|.|++..+ .+.. .+|+.|+|++|+|+ .+|++.|.++++|+.|+|++|+|+...
T Consensus 74 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~ 152 (440)
T 3zyj_A 74 NQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIP 152 (440)
T ss_dssp CCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEEC
T ss_pred CcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccC
Confidence 34455565667777777777777777766554 2322 35777777777776 566666666777777777777666555
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC---CCCCCCEEEcccCCCc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF---PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~ls~N~l~ 122 (565)
+..|.++++|+.|+|++|+..+.++.. .+++|+.|+|++|+|+
T Consensus 153 ~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred HHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 555555555555555553333333321 3444444444444444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.47 E-value=4.1e-14 Score=150.84 Aligned_cols=138 Identities=25% Similarity=0.196 Sum_probs=84.4
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceee-------------------------------------
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALY------------------------------------- 44 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~------------------------------------- 44 (565)
|.+..++++.|+.+++|+.|+|++|.|++.+|.....+|+.|+
T Consensus 44 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~ 123 (487)
T 3oja_A 44 NPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKK 123 (487)
T ss_dssp SCCCCCCGGGGTTCTTCCEEECTTSCCEEEEECTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCE
T ss_pred CcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcccccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCC
Confidence 3455677778888888888888888888655521122344444
Q ss_pred ---cccccccccCCcchhcCCCCccEEEccCCcCcccCCcccc-CCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCC
Q 008431 45 ---LSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLA-GLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQ 120 (565)
Q Consensus 45 ---Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~ 120 (565)
|++|+|++. ++..|+++++|+.|+|++|.|++.+|..|. ++++|+.|+|++|.|++..+...+++|+.|+|++|+
T Consensus 124 ~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~ 202 (487)
T 3oja_A 124 NIYLANNKITML-RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNK 202 (487)
T ss_dssp EEECCSSCCCSG-GGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSC
T ss_pred EEECCCCCCCCC-CchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCC
Confidence 444444422 223356666777777777777766666665 567777777777777766444456777777777777
Q ss_pred CccCCCcccc---CCCCCcccCCC
Q 008431 121 LVGRIPDTLS---NFDATSFQGNK 141 (565)
Q Consensus 121 l~g~~p~~~~---~~~~~~~~~n~ 141 (565)
|++..|. +. ++....+.+|.
T Consensus 203 l~~~~~~-~~~l~~L~~L~Ls~N~ 225 (487)
T 3oja_A 203 LAFMGPE-FQSAAGVTWISLRNNK 225 (487)
T ss_dssp CCEECGG-GGGGTTCSEEECTTSC
T ss_pred CCCCCHh-HcCCCCccEEEecCCc
Confidence 7765443 33 33334455553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=153.25 Aligned_cols=141 Identities=18% Similarity=0.183 Sum_probs=109.9
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccC--------CcchhcCCCCccEEEccCCc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEI--------PSDAFAGMDQLKKVHLARNH 74 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~i--------p~~~~~~l~~L~~L~l~~N~ 74 (565)
+.+| ..|..+++|+.|+|++|+|++.+|. +.. .+|+.|+|++|++++ + |...|.++++|+.|+|++|+
T Consensus 470 ~~~p-~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 547 (680)
T 1ziw_A 470 DSSP-SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR-LWKHANPGGPIYFLKGLSHLHILNLESNG 547 (680)
T ss_dssp TCSS-CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGG-GGSTTSTTSCCCTTTTCTTCCEEECCSSC
T ss_pred ccCC-cccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccc-cchhhccCCcchhhcCCCCCCEEECCCCC
Confidence 3444 4678888888888888888877664 333 368899999998884 3 22237888899999999999
Q ss_pred CcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCcc----ccCCCCCcccCCCCCCCCC
Q 008431 75 FSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDT----LSNFDATSFQGNKGLCGKP 147 (565)
Q Consensus 75 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~----~~~~~~~~~~~n~~~cg~p 147 (565)
|+...+..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+|++..|.. +.++....+.+|+..|.++
T Consensus 548 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 98555557899999999999999999766653 6789999999999999877764 4567777889999999865
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=9.7e-14 Score=141.69 Aligned_cols=127 Identities=23% Similarity=0.309 Sum_probs=88.6
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
....||.+ +. ++|+.|+|++|+|++..+ .+... +|+.|+|++|+++ .++++.|.++++|++|+|++|++++..+
T Consensus 42 ~l~~iP~~-~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 117 (353)
T 2z80_A 42 SLNSIPSG-LT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSS 117 (353)
T ss_dssp TCSSCCTT-CC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCSSCCH
T ss_pred Cccccccc-cc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC-ccCHhhcCCCCCCCEEECCCCcCCcCCH
Confidence 34566643 22 478888888888887665 34333 6888888888888 4555568888888888888888886555
Q ss_pred ccccCCCCCCEEeccCCcCCCCCC-C-C-CCCCCCEEEcccC-CCccCCCccccCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIP-D-F-PLAHLTLLDLSYN-QLVGRIPDTLSNFD 133 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p-~-~-~~~~L~~l~ls~N-~l~g~~p~~~~~~~ 133 (565)
..|+++++|++|+|++|++++..+ . + .+++|+.|++++| .+++..|..+.+++
T Consensus 118 ~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 174 (353)
T 2z80_A 118 SWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174 (353)
T ss_dssp HHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred hHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCC
Confidence 557888888888888888885444 1 2 5778888888888 46655566665544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=2.8e-13 Score=136.87 Aligned_cols=123 Identities=24% Similarity=0.288 Sum_probs=63.8
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCcc--CCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG--PMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSG 77 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~--~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g 77 (565)
|.+..+++..|.++++|+.|+|++|.+.. ..+ .+..+ +|+.|+|++|+++ .+|...+ ++|+.|+|++|++++
T Consensus 131 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~~ 206 (330)
T 1xku_A 131 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITK 206 (330)
T ss_dssp SCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC---TTCSEEECTTSCCCE
T ss_pred CcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc---ccCCEEECCCCcCCc
Confidence 34455666667777777777777777752 333 22222 4555555555555 4444321 445555555555555
Q ss_pred cCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccc
Q 008431 78 QIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 78 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
..|..|.++++|+.|+|++|++++..+.. .+++|+.|++++|+|+ .+|..+
T Consensus 207 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 259 (330)
T 1xku_A 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259 (330)
T ss_dssp ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhh
Confidence 44555555555555555555555444321 3445555555555554 344433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=150.38 Aligned_cols=142 Identities=20% Similarity=0.250 Sum_probs=106.2
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCC--cccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCc-ccCC
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMP--SVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS-GQIP 80 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~-g~~p 80 (565)
..+++. +..+++|+.|+|++|.+.+..| .+.. .+|+.|+|++|++++.+| ..|.++++|+.|+|++|.++ +.+|
T Consensus 386 ~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~p 463 (570)
T 2z63_A 386 ITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLP 463 (570)
T ss_dssp EEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCT-TTTTTCTTCCEEECTTCEEGGGEEC
T ss_pred cccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccch-hhhhcCCcCcEEECcCCcCccccch
Confidence 345543 6777788888888887777655 2322 368888888888885444 45888888888888888887 5788
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCC---CCcccCCCCCCCCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFD---ATSFQGNKGLCGKPL 148 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~---~~~~~~n~~~cg~p~ 148 (565)
..|..+++|+.|+|++|++++..|.. .+++|+.|++++|++++..|..+.+++ ...+.+|+..|.+|.
T Consensus 464 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred hhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 88888888888888888888876753 578888888888888887777665444 456788888887654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.47 E-value=8.5e-14 Score=133.89 Aligned_cols=135 Identities=13% Similarity=0.167 Sum_probs=110.1
Q ss_pred ccccChhhcCCCCCCcEEEccc-CcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCcc---EEEccCC-cCc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFIN-NSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLK---KVHLARN-HFS 76 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~-N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~---~L~l~~N-~l~ 76 (565)
++.|++..|.++++|+.|+|++ |.|++..+. +.. .+|+.|+|++|+|+ .+|. |..+++|+ .|+|++| +++
T Consensus 68 l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~--~~~l~~L~~L~~L~l~~N~~l~ 144 (239)
T 2xwt_C 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD--LTKVYSTDIFFILEITDNPYMT 144 (239)
T ss_dssp CCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC--CTTCCBCCSEEEEEEESCTTCC
T ss_pred cceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc--cccccccccccEEECCCCcchh
Confidence 6788888899999999999998 999987763 333 47999999999999 4886 88888888 9999999 999
Q ss_pred ccCCccccCCCCCC-EEeccCCcCCCCCCCC--CCCCCCEEEcccCC-CccCCCccccCC-C---CCcccCCCC
Q 008431 77 GQIPKSLAGLQKLL-QLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQ-LVGRIPDTLSNF-D---ATSFQGNKG 142 (565)
Q Consensus 77 g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~-l~g~~p~~~~~~-~---~~~~~~n~~ 142 (565)
+..+..|.++++|+ .|+|++|+++ .+|.. ...+|+.|++++|+ +++..+..|..+ + ...+.+|..
T Consensus 145 ~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l 217 (239)
T 2xwt_C 145 SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217 (239)
T ss_dssp EECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCC
T ss_pred hcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcc
Confidence 87778899999999 9999999999 45542 34789999999995 987767766554 3 345666654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.9e-14 Score=139.31 Aligned_cols=144 Identities=19% Similarity=0.234 Sum_probs=112.9
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCcc-CCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDG-PMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~-~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
.+..+++..|..+++|+.|+|++|.+++ .+| .+... +|+.|+|++|+|++ +++..|..+++|+.|+|++|++++..
T Consensus 137 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp CCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred cCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCC-cCHHHhcCCCCCCEEECCCCccCccC
Confidence 3445566789999999999999999987 445 34443 79999999999995 55556999999999999999999888
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CC-CCCCEEEcccCCCccCCC-----ccccCCCCCcccCCCCCCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PL-AHLTLLDLSYNQLVGRIP-----DTLSNFDATSFQGNKGLCGKP 147 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~-~~L~~l~ls~N~l~g~~p-----~~~~~~~~~~~~~n~~~cg~p 147 (565)
+..|..+++|+.|+|++|++++..|.. .+ ++|+.|+|++|++++..+ .++..........+...|..|
T Consensus 216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 888999999999999999999988864 44 589999999999987643 233333333334445556544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=149.76 Aligned_cols=100 Identities=17% Similarity=0.224 Sum_probs=89.3
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|+.+++|+.|+|++|.|++.+|. ++.+ +|++|+|++|.|+ .+|+.+|.++++|+.|+|++|.|++..
T Consensus 85 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~ 163 (597)
T 3oja_B 85 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIE 163 (597)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCC
Confidence 445667777899999999999999999998884 3444 7999999999999 789888999999999999999999999
Q ss_pred CccccCCCCCCEEeccCCcCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGK 102 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~ 102 (565)
|..|+++++|+.|+|++|.+++.
T Consensus 164 ~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 164 DDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp TTTTTTCTTCCEEECTTSCCSBC
T ss_pred hhhhhcCCcCcEEECcCCCCCCc
Confidence 99999999999999999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=151.53 Aligned_cols=128 Identities=23% Similarity=0.258 Sum_probs=80.4
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCc--ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcc---c
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPS--VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSG---Q 78 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g---~ 78 (565)
..+++..|..+++|+.|+|++|.+++..|. +.. .+|+.|+|++|.+++. ++..|.++++|++|+|++|++++ .
T Consensus 389 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~ 467 (606)
T 3t6q_A 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS-SEQLFDGLPALQHLNLQGNHFPKGNIQ 467 (606)
T ss_dssp EEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTT-CTTTTTTCTTCCEEECTTCBCGGGEEC
T ss_pred CcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCc-CHHHHhCCCCCCEEECCCCCCCccccc
Confidence 344455677777777777777777765542 222 2577777777777643 33446667777777777777665 2
Q ss_pred CCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCC
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFD 133 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~ 133 (565)
.+..+..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..|..+.++.
T Consensus 468 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 524 (606)
T 3t6q_A 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524 (606)
T ss_dssp SSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCC
T ss_pred cchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccc
Confidence 2345666677777777777776665543 456667777777776666666655444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.45 E-value=5.5e-14 Score=156.93 Aligned_cols=121 Identities=22% Similarity=0.308 Sum_probs=101.1
Q ss_pred cChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccC
Q 008431 7 IDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAG 85 (565)
Q Consensus 7 i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 85 (565)
++++.|..++.|+.|+|++|.|....+.+..+ .|+.|+|++|+|+ .||.. |.+|++|+.|+|++|+|+ .+|..|++
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAE-IKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGG-GGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChh-hhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 55678999999999999999999554455444 7999999999999 89976 899999999999999999 78999999
Q ss_pred CCCCCEEeccCCcCCCCCCC-C-CCCCCCEEEcccCCCccCCCccccC
Q 008431 86 LQKLLQLNLEGNSFQGKIPD-F-PLAHLTLLDLSYNQLVGRIPDTLSN 131 (565)
Q Consensus 86 l~~L~~L~l~~N~l~g~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~ 131 (565)
|++|++|+|++|.|+ .+|. + .+++|+.|+|++|+|+|.+|..+..
T Consensus 292 l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp GTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred CCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 999999999999998 5555 3 6899999999999999998887643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=149.74 Aligned_cols=123 Identities=21% Similarity=0.317 Sum_probs=57.7
Q ss_pred ccChhhcCCCCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 6 MIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 6 ~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
.+++..|+++++|++|+|++|.+++..|. +..+ +|++|+|++|+++ .++++.|.++++|++|+|++|.+++..|..|
T Consensus 46 ~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~ 124 (606)
T 3vq2_A 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ-SFSPGSFSGLTSLENLVAVETKLASLESFPI 124 (606)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-CCCTTSSTTCTTCCEEECTTSCCCCSSSSCC
T ss_pred EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc-ccChhhcCCcccCCEEEccCCcccccccccc
Confidence 34444455555555555555555544442 2222 3555555555554 2322335555555555555555554444445
Q ss_pred cCCCCCCEEeccCCcCCC-CCCCC--CCCCCCEEEcccCCCccCCCccc
Q 008431 84 AGLQKLLQLNLEGNSFQG-KIPDF--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g-~~p~~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
+++++|++|+|++|++++ .+|.. .+++|+.|++++|++++..|..+
T Consensus 125 ~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence 555555555555555543 22331 34455555555555554444433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.5e-14 Score=159.41 Aligned_cols=131 Identities=20% Similarity=0.260 Sum_probs=108.1
Q ss_pred cChhhcCCCCCCcEEEcccCcCcc-----------------CCC-ccc--cc-ccceeecccccccccCCcchhcCCCCc
Q 008431 7 IDVDTLSRLPGLRSLSFINNSFDG-----------------PMP-SVG--KL-TLRALYLSLNKFTGEIPSDAFAGMDQL 65 (565)
Q Consensus 7 i~~~~~~~l~~L~~L~l~~N~l~~-----------------~~p-~~~--~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L 65 (565)
||. .|++|++|+.|+|++|+|+| .+| .++ .+ +|+.|+|++|++.|.+|.. |.++++|
T Consensus 440 IP~-~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~-l~~L~~L 517 (876)
T 4ecn_A 440 ISK-AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF-LYDLPEL 517 (876)
T ss_dssp ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGG-GGGCSSC
T ss_pred hhH-HHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHH-HhCCCCC
Confidence 885 79999999999999999999 255 554 44 7999999999999999965 8999999
Q ss_pred cEEEccCCc-Ccc-cCCccccCCC-------CCCEEeccCCcCCCCCCC--C--CCCCCCEEEcccCCCccCCCccccCC
Q 008431 66 KKVHLARNH-FSG-QIPKSLAGLQ-------KLLQLNLEGNSFQGKIPD--F--PLAHLTLLDLSYNQLVGRIPDTLSNF 132 (565)
Q Consensus 66 ~~L~l~~N~-l~g-~~p~~~~~l~-------~L~~L~l~~N~l~g~~p~--~--~~~~L~~l~ls~N~l~g~~p~~~~~~ 132 (565)
+.|+|++|+ |+| .+|..+++++ +|+.|+|++|+|+ .+|. . .+++|+.|+|++|+|+ .+| .|.++
T Consensus 518 ~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L 594 (876)
T 4ecn_A 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTN 594 (876)
T ss_dssp CEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTT
T ss_pred CEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCC
Confidence 999999998 998 8898776665 9999999999999 6776 2 7889999999999998 788 66554
Q ss_pred CC---CcccCCCC
Q 008431 133 DA---TSFQGNKG 142 (565)
Q Consensus 133 ~~---~~~~~n~~ 142 (565)
+. ..+.+|..
T Consensus 595 ~~L~~L~Ls~N~l 607 (876)
T 4ecn_A 595 VKLTDLKLDYNQI 607 (876)
T ss_dssp SEESEEECCSSCC
T ss_pred CcceEEECcCCcc
Confidence 43 34556643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.7e-13 Score=147.42 Aligned_cols=134 Identities=22% Similarity=0.287 Sum_probs=76.0
Q ss_pred hhcCCCCCCcEEEcccCcCccCC--C-cccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccC
Q 008431 10 DTLSRLPGLRSLSFINNSFDGPM--P-SVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAG 85 (565)
Q Consensus 10 ~~~~~l~~L~~L~l~~N~l~~~~--p-~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 85 (565)
..|+++++|+.|+|++|+|++.. | .+.. .+|+.|+|++|++++.+|.+.|.++++|+.|+|++|++++.+|..+.
T Consensus 371 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~- 449 (562)
T 3a79_B 371 QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449 (562)
T ss_dssp TTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-
T ss_pred hhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-
Confidence 35566666666666666666422 2 1222 24666666666666546665566666666666666666655555443
Q ss_pred CCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCcc-ccCC---CCCcccCCCCCCCC
Q 008431 86 LQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDT-LSNF---DATSFQGNKGLCGK 146 (565)
Q Consensus 86 l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~-~~~~---~~~~~~~n~~~cg~ 146 (565)
++|+.|+|++|+++...+.. .+++|+.|+|++|+|++ +|.. +..+ ....+.+|+..|.+
T Consensus 450 -~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 450 -PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp -TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred -CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 56666666666666322222 45667777777777763 4433 4333 33456667666654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=150.41 Aligned_cols=131 Identities=22% Similarity=0.237 Sum_probs=99.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|+++++|++|+|++|.+++..|. +..+ +|++|+|++|++++ +++..|.++++|++|+|++|++++..
T Consensus 43 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~l~ 121 (606)
T 3t6q_A 43 NVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSID 121 (606)
T ss_dssp CCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSE-ECTTTTSSCTTCCEEECTTSCCSCGG
T ss_pred CccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccc-cChhhhcccccccEeeccccCcccCC
Confidence 445566667788888888888888888877663 4433 68888888888884 44445888888888888888888766
Q ss_pred CccccCCCCCCEEeccCCcCCCC-CCCC-CCCCCCEEEcccCCCccCCCccccCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGK-IPDF-PLAHLTLLDLSYNQLVGRIPDTLSNFD 133 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~-~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~ 133 (565)
|..|+++++|++|+|++|++++. +|.. .+++|+.|++++|++++..|..+..+.
T Consensus 122 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 177 (606)
T 3t6q_A 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177 (606)
T ss_dssp GSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTT
T ss_pred cchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhc
Confidence 77888888888888888888874 3443 578888888888888877776665544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=7.1e-14 Score=149.02 Aligned_cols=129 Identities=26% Similarity=0.277 Sum_probs=106.1
Q ss_pred CCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 14 RLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
.+++|+.|+|++|.|++..| .++.+ +|+.|+|++|+|++.+|...+..+++|+.|+|++|.|++..+ +..+++|+.
T Consensus 118 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~ 195 (487)
T 3oja_A 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKT 195 (487)
T ss_dssp CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCE
T ss_pred ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCE
Confidence 46889999999999998877 44443 799999999999987777644589999999999999997633 446999999
Q ss_pred EeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCCCC
Q 008431 92 LNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGLCG 145 (565)
Q Consensus 92 L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~cg 145 (565)
|+|++|+|++.+|.+ .+++|+.|+|++|+|++ +|..+.. +....+.+|+..|+
T Consensus 196 L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 196 LDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp EECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred EECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 999999999877765 67899999999999997 5665544 44556788887775
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.44 E-value=2.1e-13 Score=123.59 Aligned_cols=117 Identities=21% Similarity=0.275 Sum_probs=96.4
Q ss_pred CCCCCcEEEcccCcCc-cCCCcc-ccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCC
Q 008431 14 RLPGLRSLSFINNSFD-GPMPSV-GKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~-~~~p~~-~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 90 (565)
..++|+.|+|++|.++ +.+|.. ... +|+.|+|++|.|++ + ..|..+++|++|+|++|++++.+|..+.++++|+
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-C--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-h--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 4578999999999998 677743 333 79999999999994 5 4489999999999999999988899888899999
Q ss_pred EEeccCCcCCCCC--CCC-CCCCCCEEEcccCCCccCCC---ccccCCC
Q 008431 91 QLNLEGNSFQGKI--PDF-PLAHLTLLDLSYNQLVGRIP---DTLSNFD 133 (565)
Q Consensus 91 ~L~l~~N~l~g~~--p~~-~~~~L~~l~ls~N~l~g~~p---~~~~~~~ 133 (565)
.|+|++|++++.. +.. .+++|+.|++++|++++..+ ..+..++
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~ 147 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLP 147 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCS
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCc
Confidence 9999999999754 232 68899999999999997665 3444444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-13 Score=125.00 Aligned_cols=116 Identities=24% Similarity=0.201 Sum_probs=98.7
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC-Ccc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI-PKS 82 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~-p~~ 82 (565)
+.+|. .+..+++|+.|+|++|.|++. +.+..+ +|+.|+|++|++++.+| ..+..+++|+.|+|++|+|++.. +..
T Consensus 39 ~~i~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 115 (168)
T 2ell_A 39 GKIEG-LTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLD-MLAEKLPNLTHLNLSGNKLKDISTLEP 115 (168)
T ss_dssp TBCSS-CCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCC-HHHHHCTTCCEEECBSSSCCSSGGGGG
T ss_pred hhHHH-HHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHH-HHHhhCCCCCEEeccCCccCcchhHHH
Confidence 47875 588999999999999999987 555444 79999999999996565 45788999999999999999642 278
Q ss_pred ccCCCCCCEEeccCCcCCCCCC----C-CCCCCCCEEEcccCCCcc
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIP----D-FPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p----~-~~~~~L~~l~ls~N~l~g 123 (565)
|..+++|+.|+|++|.+++..+ . ..+++|+.|++++|.+..
T Consensus 116 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 116 LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp GSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred HhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 9999999999999999998766 2 268999999999999863
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.9e-13 Score=152.03 Aligned_cols=125 Identities=22% Similarity=0.273 Sum_probs=82.3
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
.+..+++..|+++++|++|+|++|.+++..|. +.. .+|+.|+|++|+|+ .+|+++|.++++|++|+|++|++++..|
T Consensus 36 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~ 114 (680)
T 1ziw_A 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKN 114 (680)
T ss_dssp CCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCS
T ss_pred CCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccCh
Confidence 34455655666777777777777777666553 222 25777777777776 5666667777777777777777776666
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCcc
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDT 128 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~ 128 (565)
..|+++++|++|+|++|.+++..|.. .+++|+.|++++|++++..|..
T Consensus 115 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 164 (680)
T 1ziw_A 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164 (680)
T ss_dssp CTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHH
T ss_pred hHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHH
Confidence 66777777777777777777665553 5667777777777776655543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.9e-13 Score=147.92 Aligned_cols=110 Identities=25% Similarity=0.354 Sum_probs=64.1
Q ss_pred CCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEe
Q 008431 16 PGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 93 (565)
++|+.|+|++|.+++..| .+..+ +|++|+|++|+++ .+++++|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcC-ccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 456666666666666554 23332 4666666666666 34444466666666666666666665555566666666666
Q ss_pred ccCCcCCCC-CCC-C-CCCCCCEEEcccCCCccCCC
Q 008431 94 LEGNSFQGK-IPD-F-PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 94 l~~N~l~g~-~p~-~-~~~~L~~l~ls~N~l~g~~p 126 (565)
|++|++++. .|. + .+++|+.|++++|++.+.+|
T Consensus 105 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~ 140 (549)
T 2z81_A 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140 (549)
T ss_dssp CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred CCCCcccccchhhhhhccCCccEEECCCCccccccC
Confidence 666666642 222 1 45566666666666433333
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.1e-13 Score=131.18 Aligned_cols=124 Identities=14% Similarity=0.292 Sum_probs=95.5
Q ss_pred CCCcEEEcccCcCccCCC-cccc-cccceeeccccc-ccccCCcchhcCCCCccEEEccC-CcCcccCCccccCCCCCCE
Q 008431 16 PGLRSLSFINNSFDGPMP-SVGK-LTLRALYLSLNK-FTGEIPSDAFAGMDQLKKVHLAR-NHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p-~~~~-~~L~~L~Ls~N~-l~g~ip~~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~ 91 (565)
++|+.|+|++|+|++..+ .+.. .+|+.|+|++|+ ++ .+|+.+|.++++|++|+|++ |+|++..|..|.++++|+.
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 378889999999887776 3433 368899999997 77 67877788889999999988 8888777788888899999
Q ss_pred EeccCCcCCCCCCCC-CCCCCC---EEEcccC-CCccCCCccccCCC----CCcccCCC
Q 008431 92 LNLEGNSFQGKIPDF-PLAHLT---LLDLSYN-QLVGRIPDTLSNFD----ATSFQGNK 141 (565)
Q Consensus 92 L~l~~N~l~g~~p~~-~~~~L~---~l~ls~N-~l~g~~p~~~~~~~----~~~~~~n~ 141 (565)
|+|++|++++ +|.+ .+.+|+ .|++++| ++++..+..|.++. ...+.+|.
T Consensus 110 L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~ 167 (239)
T 2xwt_C 110 LGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG 167 (239)
T ss_dssp EEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCC
T ss_pred EeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCC
Confidence 9999998887 4543 566776 8999998 88877666666554 34455654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.5e-13 Score=147.74 Aligned_cols=86 Identities=23% Similarity=0.342 Sum_probs=41.5
Q ss_pred ccceeecccccccccCCcchh-cCCCCccEEEccCCcCcccCCccccCCCCCCEEec------cCCcCCCCCCCC--CCC
Q 008431 39 TLRALYLSLNKFTGEIPSDAF-AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNL------EGNSFQGKIPDF--PLA 109 (565)
Q Consensus 39 ~L~~L~Ls~N~l~g~ip~~~~-~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l------~~N~l~g~~p~~--~~~ 109 (565)
+|+.|+|++|+|+ .+|...+ ..+++|+.|+|++|+|++ +|..+.++++|+.|+| ++|++.+.+|.. .++
T Consensus 489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 4555555555555 4554322 245555555555555554 4555555555555555 334444444432 344
Q ss_pred CCCEEEcccCCCccCCCc
Q 008431 110 HLTLLDLSYNQLVGRIPD 127 (565)
Q Consensus 110 ~L~~l~ls~N~l~g~~p~ 127 (565)
+|+.|+|++|+| +.+|.
T Consensus 567 ~L~~L~Ls~N~l-~~ip~ 583 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNE 583 (636)
T ss_dssp SCCEEECCSSCC-CBCCS
T ss_pred CCCEEECCCCcC-CccCH
Confidence 555555555555 34443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.43 E-value=9.8e-14 Score=123.08 Aligned_cols=110 Identities=23% Similarity=0.267 Sum_probs=93.9
Q ss_pred CCCCCcEEEcccCcCc-cCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCC
Q 008431 14 RLPGLRSLSFINNSFD-GPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~-~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 90 (565)
..++|+.|++++|.++ +.+|. +... +|+.|+|++|+|++ + ..|..+++|+.|+|++|++++.+|..+..+++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 91 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-I--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCC-C--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCC-c--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCC
Confidence 4578999999999998 66774 3333 79999999999994 4 4589999999999999999988999999999999
Q ss_pred EEeccCCcCCCCC--CC-CCCCCCCEEEcccCCCccCCC
Q 008431 91 QLNLEGNSFQGKI--PD-FPLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 91 ~L~l~~N~l~g~~--p~-~~~~~L~~l~ls~N~l~g~~p 126 (565)
.|+|++|++++.. +. ..+++|+.|++++|++++..+
T Consensus 92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 9999999999742 22 268899999999999998766
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.9e-13 Score=147.01 Aligned_cols=114 Identities=25% Similarity=0.378 Sum_probs=67.3
Q ss_pred CCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccc--cCCcchhcCCCCccEEEccCCcCcccCCc-cccCCC
Q 008431 13 SRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTG--EIPSDAFAGMDQLKKVHLARNHFSGQIPK-SLAGLQ 87 (565)
Q Consensus 13 ~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~ 87 (565)
..+++|+.|+|++|.+++.+| .+..+ +|+.|+|++|++++ .+|. .|.++++|+.|+|++|.+++.+|. .|..++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~ 399 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE-MTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHH-HHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchH-HHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence 566667777777777766554 33322 56666666666663 2332 366666666666666666664444 356666
Q ss_pred CCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCcc
Q 008431 88 KLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDT 128 (565)
Q Consensus 88 ~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~ 128 (565)
+|+.|+|++|++++.+|....++|+.|++++|+|+ .+|..
T Consensus 400 ~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~ 439 (520)
T 2z7x_B 400 SLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQ 439 (520)
T ss_dssp TCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGG
T ss_pred cCCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchh
Confidence 66666666666665555432255666666666665 44543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.1e-13 Score=138.94 Aligned_cols=107 Identities=21% Similarity=0.253 Sum_probs=56.0
Q ss_pred CCCCCcEEEcccCcCccCCCc-c--c-ccccceeecccccccccCCcchhcCC-----CCccEEEccCCcCcccCCcccc
Q 008431 14 RLPGLRSLSFINNSFDGPMPS-V--G-KLTLRALYLSLNKFTGEIPSDAFAGM-----DQLKKVHLARNHFSGQIPKSLA 84 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~~~~p~-~--~-~~~L~~L~Ls~N~l~g~ip~~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~ 84 (565)
++++|++|+|++|.+++.+|. + . ..+|+.|+|++|+|++. |. .|..+ ++|++|+|++|++++..|..|+
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~ 170 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR 170 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhc
Confidence 455566666666666555542 1 2 22455666666665533 42 24444 5556666666666555555555
Q ss_pred CCCCCCEEeccCCcCCCCCC---C---CCCCCCCEEEcccCCCc
Q 008431 85 GLQKLLQLNLEGNSFQGKIP---D---FPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 85 ~l~~L~~L~l~~N~l~g~~p---~---~~~~~L~~l~ls~N~l~ 122 (565)
++++|++|+|++|+++|.++ . ..+++|+.|++++|+|+
T Consensus 171 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 55566666666665554311 1 13455555555555554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.42 E-value=5.4e-13 Score=134.91 Aligned_cols=123 Identities=27% Similarity=0.329 Sum_probs=71.6
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCcc--CCC-cccccccceeecccccccccCCcchhcCCCCccEEEccCCcCccc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDG--PMP-SVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ 78 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~--~~p-~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ 78 (565)
|.++.+++..|..+++|+.|+|++|.++. ..| .+...+|+.|+|++|+++ .+|...+ ++|+.|+|++|.+++.
T Consensus 133 n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~ 208 (332)
T 2ft3_A 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNKIQAI 208 (332)
T ss_dssp SCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCS-SCCSSSC---SSCSCCBCCSSCCCCC
T ss_pred CccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCC-ccCcccc---CCCCEEECCCCcCCcc
Confidence 44567777778889999999999998863 444 233335566666666655 3554322 4555555555555555
Q ss_pred CCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccc
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
.|..|.++++|+.|+|++|++++..+.. .+++|+.|++++|+|+ .+|..+
T Consensus 209 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 260 (332)
T 2ft3_A 209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260 (332)
T ss_dssp CTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred CHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence 5555555555555555555555544432 3455555555555555 444433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1.4e-13 Score=122.16 Aligned_cols=111 Identities=24% Similarity=0.240 Sum_probs=94.4
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCccc-CCcc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ-IPKS 82 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~-~p~~ 82 (565)
+.+|. .+..+++|+.|+|++|.|++. +.+... +|+.|+|++|++++.+|. .+..+++|++|+|++|++++. .|..
T Consensus 32 ~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~ls~N~i~~~~~~~~ 108 (149)
T 2je0_A 32 GKLEG-LTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEV-LAEKCPNLTHLNLSGNKIKDLSTIEP 108 (149)
T ss_dssp TBCCS-CCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHH-HHHHCTTCCEEECTTSCCCSHHHHGG
T ss_pred hHHHH-HHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHH-HhhhCCCCCEEECCCCcCCChHHHHH
Confidence 47875 789999999999999999987 555444 799999999999966664 578899999999999999974 4588
Q ss_pred ccCCCCCCEEeccCCcCCCCCC---C--CCCCCCCEEEccc
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIP---D--FPLAHLTLLDLSY 118 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p---~--~~~~~L~~l~ls~ 118 (565)
+..+++|+.|++++|.+++..+ . ..+++|+.||+++
T Consensus 109 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 109 LKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp GGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred HhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999999999999998766 2 2688999999874
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.3e-12 Score=132.00 Aligned_cols=117 Identities=21% Similarity=0.363 Sum_probs=69.0
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|+++++|++|+|++|.+++..| .+..+ +|++|+|++|+|+ .+|...+ ++|++|++++|++++..
T Consensus 62 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~ 137 (330)
T 1xku_A 62 NKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVR 137 (330)
T ss_dssp SCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBC
T ss_pred CcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc---ccccEEECCCCcccccC
Confidence 44556666678888888888888888887655 34333 5777777777776 5665432 45555566555555555
Q ss_pred CccccCCCCCCEEeccCCcCCC--CCCCC--CCCCCCEEEcccCCCc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQG--KIPDF--PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g--~~p~~--~~~~L~~l~ls~N~l~ 122 (565)
+..|.++++|+.|+|++|.++. ..+.. .+++|+.|++++|+++
T Consensus 138 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp HHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred HhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 5555555555555555555542 22221 3444555555555544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.3e-13 Score=146.64 Aligned_cols=122 Identities=23% Similarity=0.328 Sum_probs=58.9
Q ss_pred ccChhhcCCCCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 6 MIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 6 ~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
.+++..|.++++|++|+|++|++++..|. +..+ +|++|+|++|+++ .+|++.|.++++|++|+|++|++++..+..|
T Consensus 42 ~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~ 120 (570)
T 2z63_A 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPI 120 (570)
T ss_dssp EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTSCCCCSTTCSC
T ss_pred ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC-ccCHhhhcCccccccccccccccccCCCccc
Confidence 34444455555555555555555544432 2222 4555555555555 3443445555555555555555554333345
Q ss_pred cCCCCCCEEeccCCcCCC-CCCCC--CCCCCCEEEcccCCCccCCCcc
Q 008431 84 AGLQKLLQLNLEGNSFQG-KIPDF--PLAHLTLLDLSYNQLVGRIPDT 128 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g-~~p~~--~~~~L~~l~ls~N~l~g~~p~~ 128 (565)
+++++|++|+|++|.+++ .+|.. .+++|+.|++++|++++..|..
T Consensus 121 ~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (570)
T 2z63_A 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (570)
T ss_dssp TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred cccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence 555555555555555554 22332 3455555555555555444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.41 E-value=9.5e-13 Score=133.11 Aligned_cols=135 Identities=24% Similarity=0.348 Sum_probs=95.3
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..++++.|.++++|+.|+|++|.+++..| .+..+ +|++|+|++|+++ .+|...+ ++|++|+|++|++++..
T Consensus 64 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~ 139 (332)
T 2ft3_A 64 NDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVP 139 (332)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCC
T ss_pred CcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccC
Confidence 44566777788889999999999999988766 34433 6888888888888 7887644 67888888888888766
Q ss_pred CccccCCCCCCEEeccCCcCCC--CCCCC--CCCCCCEEEcccCCCccCCCccccCCCCCcccCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQG--KIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNK 141 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g--~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~ 141 (565)
+..|.++++|+.|+|++|.++. ..|.. .+ +|+.|++++|++++.....+.++....+.+|.
T Consensus 140 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~ 204 (332)
T 2ft3_A 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLPETLNELHLDHNK 204 (332)
T ss_dssp SGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSC
T ss_pred HhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCccccCCCCEEECCCCc
Confidence 6778888888888888888863 44432 23 67777777777765322223344444555553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=6e-13 Score=123.97 Aligned_cols=111 Identities=18% Similarity=0.190 Sum_probs=91.4
Q ss_pred hcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQK 88 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 88 (565)
.+..+++|+.|+|++|.+++..| .+..+ +|+.|+|++|++++..|. .|..+++|+.|+|++|.+.+.+| .+..+++
T Consensus 83 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~ 160 (197)
T 4ezg_A 83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT-KINTLPKVNSIDLSYNGAITDIM-PLKTLPE 160 (197)
T ss_dssp GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHH-HHTTCSSCCEEECCSCTBCCCCG-GGGGCSS
T ss_pred hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHH-HHhhCCCCCEEEccCCCCccccH-hhcCCCC
Confidence 68899999999999999998544 45444 799999999999976665 48999999999999998334566 6999999
Q ss_pred CCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 89 LLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 89 L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
|+.|+|++|++++..+-..+++|+.|++++|++.+
T Consensus 161 L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 161 LKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred CCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99999999999975533478999999999999864
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-13 Score=136.07 Aligned_cols=123 Identities=24% Similarity=0.165 Sum_probs=69.8
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccc-----------------------------
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTG----------------------------- 52 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g----------------------------- 52 (565)
|.+..++++.|..+++|+.|+|++|.+++.+|.....+|+.|+|++|+|++
T Consensus 44 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~ 123 (317)
T 3o53_A 44 NPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKK 123 (317)
T ss_dssp SCCCCCCHHHHTTCTTCCEEECTTSCCEEEEEETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCE
T ss_pred CccCcCCHHHhhCCCcCCEEECCCCcCCcchhhhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCC
Confidence 344556666778888888888888888765442112234444444444432
Q ss_pred ----------cCCcchhcCCCCccEEEccCCcCcccCCcccc-CCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCC
Q 008431 53 ----------EIPSDAFAGMDQLKKVHLARNHFSGQIPKSLA-GLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121 (565)
Q Consensus 53 ----------~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l 121 (565)
.+++..|..+++|+.|+|++|.+++..|..+. .+++|++|+|++|++++..+...+++|+.|+|++|+|
T Consensus 124 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l 203 (317)
T 3o53_A 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKL 203 (317)
T ss_dssp EEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCC
T ss_pred EEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcC
Confidence 22333355555666666666666655555442 4566666666666665543333456666666666666
Q ss_pred ccC
Q 008431 122 VGR 124 (565)
Q Consensus 122 ~g~ 124 (565)
++.
T Consensus 204 ~~l 206 (317)
T 3o53_A 204 AFM 206 (317)
T ss_dssp CEE
T ss_pred Ccc
Confidence 643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=6.4e-13 Score=143.87 Aligned_cols=105 Identities=23% Similarity=0.294 Sum_probs=75.5
Q ss_pred CCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEecc
Q 008431 17 GLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLE 95 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 95 (565)
.|+.|+|++|.|++. |.++.+ +|+.|+|++|+|+ .||.. |+++++|+.|+|++|+|++ +| .|+++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~l-p~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCCC-cCccccccCcEeecCccccc-ccchh-hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 467777777777763 444443 5777777777777 77764 7777777777777777775 56 67777777777777
Q ss_pred CCcCCCCC-CCC--CCCCCCEEEcccCCCccCCC
Q 008431 96 GNSFQGKI-PDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 96 ~N~l~g~~-p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
+|+|++.. |.. .+++|+.|+|++|+|++.+|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 77777765 543 56777777777777776655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.39 E-value=9.5e-13 Score=119.59 Aligned_cols=100 Identities=20% Similarity=0.315 Sum_probs=86.6
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..||.. + .++|+.|+|++|+|++..|. +..+ +|+.|+|++|+|+ .+|+++|.++++|+.|+|++|+|++..
T Consensus 19 n~l~~ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~ 94 (170)
T 3g39_A 19 KSLASVPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLKSIP 94 (170)
T ss_dssp SCCSSCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCcCccCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEECCCCccCEeC
Confidence 455678753 3 37899999999999998874 4444 7999999999999 788888999999999999999999888
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPD 105 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~ 105 (565)
|..|.++++|+.|+|++|.+++..+.
T Consensus 95 ~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 95 RGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp TTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred HHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 88899999999999999999976653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=8e-13 Score=143.06 Aligned_cols=131 Identities=18% Similarity=0.251 Sum_probs=85.2
Q ss_pred cCCCCCCcEEEcccCcCccCCC---ccc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc----
Q 008431 12 LSRLPGLRSLSFINNSFDGPMP---SVG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL---- 83 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p---~~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~---- 83 (565)
++.+++|+.|+|++|+|++..+ .+. ..+|+.|+|++|+|+ .+|.. +..+++|+.|+|++|+|++ +|..+
T Consensus 357 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~~~~L~~L~Ls~N~l~~-l~~~~~~~L 433 (549)
T 2z81_A 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS-CQWPEKMRFLNLSSTGIRV-VKTCIPQTL 433 (549)
T ss_dssp TTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSC-CCCCTTCCEEECTTSCCSC-CCTTSCTTC
T ss_pred hhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChh-hcccccccEEECCCCCccc-ccchhcCCc
Confidence 5667777777777777765432 122 225777777777776 56654 5666666666666666652 22221
Q ss_pred --------------cCCCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCccccCC---CCCcccCCCCCCC
Q 008431 84 --------------AGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLSNF---DATSFQGNKGLCG 145 (565)
Q Consensus 84 --------------~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~---~~~~~~~n~~~cg 145 (565)
.++++|++|+|++|+|+ .+|.. .+++|+.|+|++|+|++.+|..+..+ ....+.+|+..|.
T Consensus 434 ~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 434 EVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp SEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred eEEECCCCChhhhcccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 36777888888888887 44443 56788888888888888777665543 4456778887775
Q ss_pred C
Q 008431 146 K 146 (565)
Q Consensus 146 ~ 146 (565)
+
T Consensus 513 ~ 513 (549)
T 2z81_A 513 C 513 (549)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=9.8e-13 Score=119.99 Aligned_cols=99 Identities=23% Similarity=0.367 Sum_probs=85.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.++.||.. + .++|+.|+|++|+|++.+|. +..+ +|+.|+|++|+|+ .+|+++|.++++|+.|+|++|+|++..
T Consensus 22 n~l~~iP~~-~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~l~~l~ 97 (174)
T 2r9u_A 22 IRLASVPAG-I--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKSIP 97 (174)
T ss_dssp SCCSSCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCCccCCC-c--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECCCCccceeC
Confidence 556788863 3 38899999999999998884 4444 7999999999999 689888999999999999999999877
Q ss_pred CccccCCCCCCEEeccCCcCCCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIP 104 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p 104 (565)
+..|..+++|+.|+|++|.+....+
T Consensus 98 ~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 98 RGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp TTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred HHHhccccCCCEEEeCCCCcccccc
Confidence 7779999999999999999997654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.3e-12 Score=135.25 Aligned_cols=120 Identities=18% Similarity=0.215 Sum_probs=105.7
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|..+++|+.|+|++|.+++.+|. +..+ +|+.|+|++|+|+ .+|+.+|.++++|++|+|++|++++..
T Consensus 79 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccC
Confidence 445677878899999999999999999998875 4444 7999999999999 899988999999999999999999988
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
|..|.++++|+.|+|++|++++. +...+++|+.|++++|.+++
T Consensus 158 ~~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 158 DDTFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp TTTTSSCTTCCEEECCSSCCSBC-CGGGCTTCSEEECCSSCCSE
T ss_pred hhhccCCCCCCEEECCCCcCCcc-ccccccccceeecccccccc
Confidence 99999999999999999999965 43457889999999998875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=148.91 Aligned_cols=108 Identities=26% Similarity=0.250 Sum_probs=46.1
Q ss_pred CCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEe
Q 008431 16 PGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 93 (565)
++|+.|+|++|.|++..| .+..+ .|++|+|++|.+.+.|++++|.++++|+.|+|++|.+++..|..|+++++|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 344444444444444333 22222 3444444444333344333444444444444444444444444444444444444
Q ss_pred ccCCcCCCCCCC---C-CCCCCCEEEcccCCCcc
Q 008431 94 LEGNSFQGKIPD---F-PLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 94 l~~N~l~g~~p~---~-~~~~L~~l~ls~N~l~g 123 (565)
|++|.+++.+|. + .+++|+.|+|++|++++
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~ 137 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS 137 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccc
Confidence 444444443222 1 33444444444444443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=130.07 Aligned_cols=112 Identities=25% Similarity=0.357 Sum_probs=74.7
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
..++ .+..+++|+.|+|++|.+++..+ +.. .+|+.|+|++|+++ .+| .|..+++|+.|+|++|++++ +|. +
T Consensus 54 ~~l~--~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~-~~~--~~~~l~~L~~L~l~~n~l~~-~~~-l 125 (308)
T 1h6u_A 54 TTIE--GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLK-NVS--AIAGLQSIKTLDLTSTQITD-VTP-L 125 (308)
T ss_dssp CCCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCS-CCG--GGTTCTTCCEEECTTSCCCC-CGG-G
T ss_pred cCch--hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCC-Cch--hhcCCCCCCEEECCCCCCCC-chh-h
Confidence 3454 36677777888888877776555 333 35777777777777 344 26777777777777777775 333 6
Q ss_pred cCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccC
Q 008431 84 AGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~ 124 (565)
..+++|+.|+|++|++++..+-..+++|+.|++++|++++.
T Consensus 126 ~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~ 166 (308)
T 1h6u_A 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL 166 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred cCCCCCCEEECCCCccCcCccccCCCCccEEEccCCcCCCC
Confidence 77777777777777777655433566777777777777653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.1e-12 Score=145.87 Aligned_cols=120 Identities=16% Similarity=0.218 Sum_probs=60.8
Q ss_pred ccChhhcCCCCCCcEEEcccCcCccCCCccc-cc--------ccceeecccccccccCCcchh-cCCCCccEEEccCCcC
Q 008431 6 MIDVDTLSRLPGLRSLSFINNSFDGPMPSVG-KL--------TLRALYLSLNKFTGEIPSDAF-AGMDQLKKVHLARNHF 75 (565)
Q Consensus 6 ~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~--------~L~~L~Ls~N~l~g~ip~~~~-~~l~~L~~L~l~~N~l 75 (565)
.+|...+..+++|+.|+|++|+|+..++... .. +|+.|+|++|+|+ .||...+ ..+++|+.|+|++|+|
T Consensus 687 ~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L 765 (876)
T 4ecn_A 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF 765 (876)
T ss_dssp SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCC
T ss_pred ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCC
Confidence 4444444455555555555555552222211 10 4555555555555 5554422 2555555555555555
Q ss_pred cccCCccccCCCCCCEEeccC------CcCCCCCCCC--CCCCCCEEEcccCCCccCCCcc
Q 008431 76 SGQIPKSLAGLQKLLQLNLEG------NSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDT 128 (565)
Q Consensus 76 ~g~~p~~~~~l~~L~~L~l~~------N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~ 128 (565)
++ +|..+.++++|+.|+|++ |++.+.+|.. .+++|+.|+|++|+| +.+|..
T Consensus 766 ~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~ 824 (876)
T 4ecn_A 766 SS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK 824 (876)
T ss_dssp SS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC
T ss_pred Cc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh
Confidence 54 455555555555555543 4555555542 355555555555555 445543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.1e-13 Score=135.36 Aligned_cols=116 Identities=17% Similarity=0.150 Sum_probs=68.1
Q ss_pred CCCCCCcEEEcccCcCccCCCccc------ccccceeecccccccccCCcchhcCCCCccEEEccCCcCccc--C--Ccc
Q 008431 13 SRLPGLRSLSFINNSFDGPMPSVG------KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ--I--PKS 82 (565)
Q Consensus 13 ~~l~~L~~L~l~~N~l~~~~p~~~------~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~--~--p~~ 82 (565)
..+++|+.|+|++|.+++..+.+. ..+|+.|+|++|+++ .+|+..|.++++|++|+|++|++.+. + +..
T Consensus 114 ~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 192 (310)
T 4glp_A 114 ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSP-AFSCEQVRAFPALTSLDLSDNPGLGERGLMAALC 192 (310)
T ss_dssp CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSC-CCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSC
T ss_pred ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcc-hhhHHHhccCCCCCEEECCCCCCccchhhhHHHh
Confidence 666666666777666666544221 225666777777666 34444566666677777777766542 1 122
Q ss_pred ccCCCCCCEEeccCCcCCCCCCC-----CCCCCCCEEEcccCCCccCCCccc
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIPD-----FPLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p~-----~~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
++.+++|++|+|++|+++...+. ..+++|+.|+|++|+|++..|..+
T Consensus 193 ~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~ 244 (310)
T 4glp_A 193 PHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSA 244 (310)
T ss_dssp TTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCC
T ss_pred hhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhH
Confidence 35566666666666666532211 134667777777777776666544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.36 E-value=7.4e-13 Score=120.97 Aligned_cols=112 Identities=20% Similarity=0.165 Sum_probs=92.9
Q ss_pred hcCCCCCCcEEEcccCcCccCCCccc-cc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMPSVG-KL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQK 88 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p~~~-~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 88 (565)
.+.++++|+.|+|++|+|+.. |.+. .. +|+.|+|++|+|++ ++ .|..+++|++|+|++|+|++..|..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~-~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD--GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC--CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCc-cc--ccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 466789999999999999964 6443 33 79999999999995 53 4899999999999999999766666799999
Q ss_pred CCEEeccCCcCCCCCC--CC-CCCCCCEEEcccCCCccCCCc
Q 008431 89 LLQLNLEGNSFQGKIP--DF-PLAHLTLLDLSYNQLVGRIPD 127 (565)
Q Consensus 89 L~~L~l~~N~l~g~~p--~~-~~~~L~~l~ls~N~l~g~~p~ 127 (565)
|++|+|++|+++...+ .. .+++|+.|++++|+++. +|.
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~ 130 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKH 130 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STT
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCC-cHh
Confidence 9999999999975333 22 68899999999999984 454
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=141.60 Aligned_cols=104 Identities=26% Similarity=0.308 Sum_probs=48.9
Q ss_pred CCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEe
Q 008431 16 PGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 93 (565)
++|+.|+|++|.|++..| .+... +|+.|+|++|+|+ .+++++|.++++|++|+|++|+|+ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCC-cCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 445555555555554443 22222 4555555555555 233333555555555555555554 34433 455555555
Q ss_pred ccCCcCCCC-CCCC--CCCCCCEEEcccCCCcc
Q 008431 94 LEGNSFQGK-IPDF--PLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 94 l~~N~l~g~-~p~~--~~~~L~~l~ls~N~l~g 123 (565)
|++|++++. +|.. .+++|+.|++++|++++
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 555555442 2221 34455555555555443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.6e-13 Score=141.88 Aligned_cols=103 Identities=23% Similarity=0.261 Sum_probs=47.7
Q ss_pred CCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEe
Q 008431 16 PGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 93 (565)
++|+.|+|++|.+++.+| .+... +|++|+|++|+|++ ++++.|.++++|++|+|++|+|+ .+|.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCE-EEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCC-cChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 445555555555554443 22222 35555555555552 22233555555555555555554 23433 445555555
Q ss_pred ccCCcCCC-CCCCC--CCCCCCEEEcccCCCc
Q 008431 94 LEGNSFQG-KIPDF--PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 94 l~~N~l~g-~~p~~--~~~~L~~l~ls~N~l~ 122 (565)
|++|++++ .+|.. .+++|+.|++++|+++
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~ 128 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCC
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccc
Confidence 55555544 23321 3444445555444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-12 Score=129.30 Aligned_cols=128 Identities=24% Similarity=0.338 Sum_probs=95.8
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
.+..++ .+..+++|+.|+|++|++++..+ +.. .+|+.|+|++|+++ .+|. +..+++|+.|+|++|++++. .
T Consensus 57 ~i~~~~--~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~L~~n~i~~~--~ 128 (291)
T 1h6t_A 57 DIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK-DLSS--LKDLKKLKSLSLEHNGISDI--N 128 (291)
T ss_dssp CCCCCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CGGG--GTTCTTCCEEECTTSCCCCC--G
T ss_pred CcccCh--hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCC-CChh--hccCCCCCEEECCCCcCCCC--h
Confidence 344554 37788999999999999988666 433 36899999999988 4553 88889999999999998863 4
Q ss_pred cccCCCCCCEEeccCCcCCCCCCC-CCCCCCCEEEcccCCCccCCCccccCC---CCCcccCCC
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPD-FPLAHLTLLDLSYNQLVGRIPDTLSNF---DATSFQGNK 141 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~l~ls~N~l~g~~p~~~~~~---~~~~~~~n~ 141 (565)
.+..+++|+.|+|++|++++. +. ..+++|+.|++++|++++..| +..+ ....+.+|.
T Consensus 129 ~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 129 GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred hhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 688888999999999988876 33 367888999999998887654 4333 334455654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-12 Score=131.02 Aligned_cols=133 Identities=23% Similarity=0.347 Sum_probs=103.0
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
|.+..+++ +..+++|+.|+|++|.+++. +.+.. .+|+.|+|++|+++ .+|+ +..+++|+.|+|++|++++..+
T Consensus 73 n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~~~ 146 (308)
T 1h6u_A 73 NQITDLAP--LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQIT-DVTP--LAGLSNLQVLYLDLNQITNISP 146 (308)
T ss_dssp SCCCCCGG--GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCC-CCGG--GTTCTTCCEEECCSSCCCCCGG
T ss_pred CcCCCChh--HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCC-Cchh--hcCCCCCCEEECCCCccCcCcc
Confidence 34556664 88999999999999999875 44443 37999999999998 4664 8899999999999999986544
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCC-ccccCCCCCcccCCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP-DTLSNFDATSFQGNKG 142 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p-~~~~~~~~~~~~~n~~ 142 (565)
+..+++|+.|+|++|++++..+-..+++|+.|++++|++++..+ ..+.++....+.+|..
T Consensus 147 --l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l 207 (308)
T 1h6u_A 147 --LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQI 207 (308)
T ss_dssp --GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred --ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCcc
Confidence 88999999999999999976664478899999999999986544 1233444455666653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-13 Score=154.28 Aligned_cols=127 Identities=23% Similarity=0.279 Sum_probs=104.2
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..||.. +..+++|+.|+|++|.|+ .+| .+..+ +|+.|+|++|+|+ .||.. |.+|++|+.|+|++|.|+ .+
T Consensus 234 n~l~~l~~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~L~~N~l~-~l 308 (727)
T 4b8c_D 234 LQIFNISAN-IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAE-LGSCFQLKYFYFFDNMVT-TL 308 (727)
T ss_dssp SCCSCCCGG-GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSS-GGGGTTCSEEECCSSCCC-CC
T ss_pred CCCCCCChh-hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChh-hcCCCCCCEEECCCCCCC-cc
Confidence 455688864 558999999999999999 555 56555 7999999999999 89976 899999999999999997 78
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCCC--C-CCCCEEEcccCCCccCCCccccCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDFP--L-AHLTLLDLSYNQLVGRIPDTLSNFD 133 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~~--~-~~L~~l~ls~N~l~g~~p~~~~~~~ 133 (565)
|..|++|++|+.|+|++|.|++.+|... + ..+..|+|++|.++|.+|..+..+.
T Consensus 309 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~ 365 (727)
T 4b8c_D 309 PWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE 365 (727)
T ss_dssp CSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred ChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence 9999999999999999999999888641 1 1233588999999999998876554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.3e-12 Score=124.72 Aligned_cols=105 Identities=19% Similarity=0.316 Sum_probs=52.5
Q ss_pred cCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCC
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 90 (565)
+..+++|+.|++++|.|+.. |.+..+ +|+.|+|++|+|+ .+|+ |.++++|+.|+|++|++++ +|... . ++|+
T Consensus 37 ~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~L~~N~i~-~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~ 109 (263)
T 1xeu_A 37 QKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQIS-DLSP--LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLS 109 (263)
T ss_dssp HHHHTTCSEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCC
T ss_pred hhhcCcCcEEECcCCCcccc-hHHhhCCCCCEEECCCCccC-CChh--hccCCCCCEEECCCCccCC-cCccc-c-Cccc
Confidence 34455555556655555532 233222 4555555555555 3443 5555555555555555554 33221 1 5555
Q ss_pred EEeccCCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 91 QLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 91 ~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
.|+|++|++++...-..+++|+.|++++|+|++
T Consensus 110 ~L~L~~N~l~~~~~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 110 RLFLDNNELRDTDSLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp EEECCSSCCSBSGGGTTCTTCCEEECTTSCCCB
T ss_pred EEEccCCccCCChhhcCcccccEEECCCCcCCC
Confidence 555555555543211244555555555555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.1e-12 Score=126.02 Aligned_cols=132 Identities=19% Similarity=0.285 Sum_probs=104.2
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
|.+..++ .+..+++|+.|+|++|+|++..+ +.. .+|+.|+|++|+|+ .+|. +.. ++|+.|+|++|++++ +|
T Consensus 51 n~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~-~l~~--~~~-~~L~~L~L~~N~l~~-~~ 122 (263)
T 1xeu_A 51 SNIQSLA--GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK-NLNG--IPS-ACLSRLFLDNNELRD-TD 122 (263)
T ss_dssp SCCCCCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCS-CCTT--CCC-SSCCEEECCSSCCSB-SG
T ss_pred CCcccch--HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccC-CcCc--ccc-CcccEEEccCCccCC-Ch
Confidence 3455676 58889999999999999998776 443 37999999999999 5775 334 899999999999996 44
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGLC 144 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~c 144 (565)
.+..+++|+.|+|++|++++..+-..+++|+.|++++|++++. ..+.. +....+.+|+..+
T Consensus 123 -~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 123 -SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp -GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred -hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 5999999999999999999764333789999999999999976 33443 3444566775444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.33 E-value=7e-13 Score=121.15 Aligned_cols=115 Identities=19% Similarity=0.262 Sum_probs=95.1
Q ss_pred cccccChhhcCCCC-CCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLP-GLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
.+..+|. +..+. +|+.|+|++|.|++. +.+..+ +|+.|+|++|+|+ .+|+..|.++++|+.|+|++|+|+ .+|
T Consensus 30 ~l~~i~~--~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~ 104 (176)
T 1a9n_A 30 KIPVIEN--LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELG 104 (176)
T ss_dssp CCCSCCC--GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGG
T ss_pred CCchhHH--hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCC-cch
Confidence 3445642 44454 999999999999986 555444 7999999999999 688887899999999999999996 577
Q ss_pred c--cccCCCCCCEEeccCCcCCCCCCC----C-CCCCCCEEEcccCCCc
Q 008431 81 K--SLAGLQKLLQLNLEGNSFQGKIPD----F-PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 81 ~--~~~~l~~L~~L~l~~N~l~g~~p~----~-~~~~L~~l~ls~N~l~ 122 (565)
. .+..+++|+.|+|++|.++...+. . .+++|+.||+++|.+.
T Consensus 105 ~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 105 DLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp GGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred hhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 6 899999999999999999854432 2 6889999999999875
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.9e-12 Score=129.71 Aligned_cols=105 Identities=22% Similarity=0.185 Sum_probs=51.6
Q ss_pred CCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEecc
Q 008431 16 PGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLE 95 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 95 (565)
+.....++++|.++..+..+. .+|+.|+|++|+++ .+|++.|.++++|+.|+|++|++++..|..|.++++|++|+|+
T Consensus 31 ~~~~~c~~~~~~l~~iP~~~~-~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 31 DRNGICKGSSGSLNSIPSGLT-EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp CTTSEEECCSTTCSSCCTTCC-TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCeEeeCCCCCccccccccc-ccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 333445555555553322221 24555555555555 3444445555555555555555555445555555555555555
Q ss_pred CCcCCCCCCC--CCCCCCCEEEcccCCCc
Q 008431 96 GNSFQGKIPD--FPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 96 ~N~l~g~~p~--~~~~~L~~l~ls~N~l~ 122 (565)
+|++++..+. ..+++|+.|++++|+++
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 137 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYK 137 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCS
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCc
Confidence 5555543332 13455555555555555
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=131.02 Aligned_cols=129 Identities=26% Similarity=0.282 Sum_probs=101.6
Q ss_pred CCCCCcEEEcccCcCccCCC-cccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 14 RLPGLRSLSFINNSFDGPMP-SVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~~~~p-~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
.+++|+.|+|++|++++..| .+.. .+|+.|+|++|++++..|...+..+++|++|+|++|++++. |. ...+++|+.
T Consensus 118 ~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~ 195 (317)
T 3o53_A 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKT 195 (317)
T ss_dssp CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCE
T ss_pred ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCE
Confidence 46789999999999998766 3433 37999999999999655555446899999999999999965 43 345899999
Q ss_pred EeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCCCC
Q 008431 92 LNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGLCG 145 (565)
Q Consensus 92 L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~cg 145 (565)
|+|++|++++..+.+ .+++|+.|++++|+|++ +|..+.. +....+.+|+..|+
T Consensus 196 L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 196 LDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp EECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred EECCCCcCCcchhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 999999999876654 67899999999999995 5666644 44456778876654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.32 E-value=4.4e-12 Score=125.75 Aligned_cols=106 Identities=25% Similarity=0.326 Sum_probs=66.2
Q ss_pred CCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 13 SRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 13 ~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
..+++|+.|++++|.+... +.+..+ +|+.|+|++|+++ .+++ +.++++|+.|+|++|++++ +| .+..+++|+.
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLT-DIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccC-CCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 3456677777777776654 333332 5777777777776 3443 6667777777777777764 33 3667777777
Q ss_pred EeccCCcCCCCCCCCCCCCCCEEEcccCCCccC
Q 008431 92 LNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 92 L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~ 124 (565)
|+|++|++++...-..+++|+.|++++|++++.
T Consensus 117 L~L~~n~i~~~~~l~~l~~L~~L~l~~n~l~~~ 149 (291)
T 1h6t_A 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDI 149 (291)
T ss_dssp EECTTSCCCCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred EECCCCcCCCChhhcCCCCCCEEEccCCcCCcc
Confidence 777777776542112566677777777777654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.32 E-value=3.4e-12 Score=139.06 Aligned_cols=129 Identities=24% Similarity=0.332 Sum_probs=94.7
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcc
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKS 82 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~ 82 (565)
.+..++ .|..|++|+.|+|++|.|++..|.....+|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++ + ..
T Consensus 54 ~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~-~l~--~l~~l~~L~~L~Ls~N~l~~-l-~~ 126 (605)
T 1m9s_A 54 DIKSVQ--GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK-DLS--SLKDLKKLKSLSLEHNGISD-I-NG 126 (605)
T ss_dssp CCCCCT--TGGGCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCC-CCT--TSTTCTTCCEEECTTSCCCC-C-GG
T ss_pred CCCCCh--HHccCCCCCEEEeeCCCCCCChhhccCCCCCEEECcCCCCC-CCh--hhccCCCCCEEEecCCCCCC-C-cc
Confidence 344554 47888999999999999988666223336888899998888 455 37888888888888888885 3 35
Q ss_pred ccCCCCCCEEeccCCcCCCCCCC-CCCCCCCEEEcccCCCccCCCccccC---CCCCcccCCC
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIPD-FPLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNK 141 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~ 141 (565)
+..|++|+.|+|++|+|++. +. ..+++|+.|+|++|+|++..| +.. +..+.+.+|.
T Consensus 127 l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 127 LVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp GGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred ccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 78888888888888888876 33 367888888888888887665 433 3334455553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3e-12 Score=138.64 Aligned_cols=110 Identities=21% Similarity=0.253 Sum_probs=95.1
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC-
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI- 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~- 79 (565)
|.+..||. |+.+++|+.|+|++|.|+..++.++.+ +|+.|+|++|+|++ || .|+++++|+.|+|++|+|++.+
T Consensus 451 n~l~~lp~--~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp--~l~~l~~L~~L~Ls~N~l~~~~~ 525 (567)
T 1dce_A 451 KDLTVLCH--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD--GVANLPRLQELLLCNNRLQQSAA 525 (567)
T ss_dssp SCCSSCCC--GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG--GGTTCSSCCEEECCSSCCCSSST
T ss_pred CCCCCCcC--ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc--ccCCCCCCcEEECCCCCCCCCCC
Confidence 45566874 899999999999999999443355555 79999999999995 88 4999999999999999999887
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC-----CCCCCCEEEc
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF-----PLAHLTLLDL 116 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~~~~L~~l~l 116 (565)
|..|+++++|+.|+|++|.|++.+|.. .+++|+.|++
T Consensus 526 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp TGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred cHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 999999999999999999999988764 3789999875
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=4.9e-12 Score=128.62 Aligned_cols=104 Identities=18% Similarity=0.206 Sum_probs=87.7
Q ss_pred cEEEcccC-cCccCCCccccc-ccceeeccc-ccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEecc
Q 008431 19 RSLSFINN-SFDGPMPSVGKL-TLRALYLSL-NKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLE 95 (565)
Q Consensus 19 ~~L~l~~N-~l~~~~p~~~~~-~L~~L~Ls~-N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 95 (565)
..+++++| +|++.++ +... +|+.|+|++ |+|+ .+|++.|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCC-CcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35788888 8987555 6544 699999996 9998 6777779999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCC-CCCCCCEEEcccCCCccC
Q 008431 96 GNSFQGKIPDF-PLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 96 ~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~ 124 (565)
+|+|++..+.. ....|+.|+|++|.|...
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 99999776653 333499999999999754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.5e-11 Score=132.79 Aligned_cols=118 Identities=22% Similarity=0.356 Sum_probs=69.9
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcccc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLA 84 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 84 (565)
+.||.. + +++|+.|+|++|+|+. +| ....+|+.|+|++|+|++ ||. |.+ +|+.|+|++|+|++ +|.
T Consensus 72 ~~lp~~-l--~~~L~~L~Ls~N~l~~-ip-~~l~~L~~L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~-lp~--- 137 (571)
T 3cvr_A 72 SSLPDN-L--PPQITVLEITQNALIS-LP-ELPASLEYLDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM-LPE--- 137 (571)
T ss_dssp SCCCSC-C--CTTCSEEECCSSCCSC-CC-CCCTTCCEEECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC-CCC---
T ss_pred CccCHh-H--cCCCCEEECcCCCCcc-cc-cccCCCCEEEccCCCCCC-cch--hhc--CCCEEECCCCcCCC-CCC---
Confidence 346653 2 2567777777777773 44 222357777777777774 665 433 67777777777765 554
Q ss_pred CCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccc-cCCCCCcccCC
Q 008431 85 GLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTL-SNFDATSFQGN 140 (565)
Q Consensus 85 ~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~-~~~~~~~~~~n 140 (565)
.+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. | .++....+.+|
T Consensus 138 ~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-lp~-l~~~L~~L~Ls~N 190 (571)
T 3cvr_A 138 LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-LPE-LPESLEALDVSTN 190 (571)
T ss_dssp CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSS
T ss_pred cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-cch-hhCCCCEEECcCC
Confidence 45667777777777765 443 45666666666666665 444 3 23333344444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=7.7e-12 Score=121.87 Aligned_cols=137 Identities=15% Similarity=0.029 Sum_probs=105.8
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCCCCHH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNGSLA 337 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 337 (565)
..++.|+++.||++.. .+..+++|............+.+|+.+++.+. |..+.++++++...+..|+||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 4567788899999874 46889999987532233456889999999885 667889999998888899999999999998
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC-------------------------------------------
Q 008431 338 NLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF------------------------------------------- 374 (565)
Q Consensus 338 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~------------------------------------------- 374 (565)
+.+. +......++.+++++|+.||+.-
T Consensus 99 ~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 7631 11223478899999999999810
Q ss_pred ------------CCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 375 ------------PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 375 ------------~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
.+..++|+|++|.|||++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999876566799998764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.5e-11 Score=132.61 Aligned_cols=112 Identities=19% Similarity=0.327 Sum_probs=74.4
Q ss_pred CCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccC
Q 008431 17 GLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEG 96 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 96 (565)
+|+.|+|++|.|++.++.+. .+|+.|+|++|+|+ .|| . .+++|+.|+|++|+|++ +|. |.+ +|+.|+|++
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~-~~L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP-PQITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC-TTCSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred CccEEEeCCCCCCccCHhHc-CCCCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence 67777777777776333332 45777777777777 677 2 35677777777777776 665 554 777777777
Q ss_pred CcCCCCCCCCCCCCCCEEEcccCCCccCCCccccCCCCCcccCCC
Q 008431 97 NSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNK 141 (565)
Q Consensus 97 N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~ 141 (565)
|+|++ +|. .+++|+.|+|++|+|++ +|..+.++....+.+|.
T Consensus 130 N~l~~-lp~-~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 130 NQLTM-LPE-LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQ 171 (571)
T ss_dssp SCCSC-CCC-CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred CcCCC-CCC-cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCC
Confidence 77776 444 56777777777777776 55545555555566664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.27 E-value=7.1e-12 Score=127.29 Aligned_cols=133 Identities=23% Similarity=0.261 Sum_probs=92.9
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
+..+++ +..+++|+.|++++|.+++..+.....+|+.|+|++|+++ .+|+ +..+++|++|+|++|.+++ + ..+
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~ 261 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKIT-DLSP--LANLSQLTWLEIGTNQISD-I-NAV 261 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-C-GGG
T ss_pred cccccc--ccCCCccceeecccCCCCCCchhhcCCcCCEEEccCCccC-CCcc--hhcCCCCCEEECCCCccCC-C-hhH
Confidence 344543 6778888888888888877655223336888888888887 4554 7778888888888888875 3 357
Q ss_pred cCCCCCCEEeccCCcCCCCCCC-CCCCCCCEEEcccCCCccCCCccccCCC---CCcccCCCCCC
Q 008431 84 AGLQKLLQLNLEGNSFQGKIPD-FPLAHLTLLDLSYNQLVGRIPDTLSNFD---ATSFQGNKGLC 144 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~l~ls~N~l~g~~p~~~~~~~---~~~~~~n~~~c 144 (565)
..+++|+.|++++|++++. |. ..+++|+.|++++|++++..|..+..++ ...+.+|+...
T Consensus 262 ~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 262 KDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp TTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred hcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 7888888888888888764 33 2567888888888888777766554433 34566665443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.27 E-value=9e-12 Score=131.58 Aligned_cols=127 Identities=16% Similarity=0.119 Sum_probs=92.4
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcc
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKS 82 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~ 82 (565)
.++.+ .++.+++|+.|+|++|+|++. |.....+|+.|+|++|+|++ ++ +..+++|+.|+|++|+|++ +|
T Consensus 160 ~~~~~---~~~~l~~L~~L~ls~n~l~~l-~l~~l~~L~~L~l~~N~l~~-~~---l~~l~~L~~L~Ls~N~l~~-ip-- 228 (457)
T 3bz5_A 160 KITKL---DVTPQTQLTTLDCSFNKITEL-DVSQNKLLNRLNCDTNNITK-LD---LNQNIQLTFLDCSSNKLTE-ID-- 228 (457)
T ss_dssp CCCCC---CCTTCTTCCEEECCSSCCCCC-CCTTCTTCCEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSC-CC--
T ss_pred ccccc---ccccCCcCCEEECCCCcccee-ccccCCCCCEEECcCCcCCe-ec---cccCCCCCEEECcCCcccc-cC--
Confidence 45555 377899999999999999984 42233479999999999984 43 7888999999999999997 66
Q ss_pred ccCCCCCCEEeccCCcCCCCCCCCCCC----------CCCEEEcccCCCccCCCc-cccCCCCCcccCCC
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIPDFPLA----------HLTLLDLSYNQLVGRIPD-TLSNFDATSFQGNK 141 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p~~~~~----------~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~n~ 141 (565)
++.+++|+.|+|++|++++..+. .++ +|+.|++++|.+.|.+|. .+.++....+.+|+
T Consensus 229 ~~~l~~L~~L~l~~N~l~~~~~~-~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~ 297 (457)
T 3bz5_A 229 VTPLTQLTYFDCSVNPLTELDVS-TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNT 297 (457)
T ss_dssp CTTCTTCSEEECCSSCCSCCCCT-TCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCT
T ss_pred ccccCCCCEEEeeCCcCCCcCHH-HCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCc
Confidence 88899999999999999986543 233 445556666666665553 23444555555554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.26 E-value=5.8e-12 Score=127.96 Aligned_cols=125 Identities=26% Similarity=0.338 Sum_probs=102.3
Q ss_pred cCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
+..+++|+.|+|++|.+++..+.....+|+.|+|++|+++ .++ .+..+++|+.|+|++|++++. ..+..+++|+.
T Consensus 217 ~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~-~~~--~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~ 291 (347)
T 4fmz_A 217 VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS-DIN--AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNS 291 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCCccC-CCh--hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCE
Confidence 7889999999999999998666333347999999999998 454 488999999999999999864 45889999999
Q ss_pred EeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC-ccccCCCCCcccCCC
Q 008431 92 LNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP-DTLSNFDATSFQGNK 141 (565)
Q Consensus 92 L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p-~~~~~~~~~~~~~n~ 141 (565)
|+|++|++++..|.. .+++|+.|++++|++++..| ..+.++....+.+|+
T Consensus 292 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp EECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred EECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhc
Confidence 999999999877763 68899999999999998777 334455556667764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-11 Score=134.47 Aligned_cols=130 Identities=27% Similarity=0.323 Sum_probs=103.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
|.+..+++ |..|++|+.|+|++|.|++. |.+..+ +|+.|+|++|+|+ .+|. +..|++|+.|+|++|+|++.
T Consensus 75 N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~-~l~~--l~~l~~L~~L~Ls~N~l~~l-- 146 (605)
T 1m9s_A 75 NKLTDIKP--LTNLKNLGWLFLDENKIKDL-SSLKDLKKLKSLSLEHNGIS-DING--LVHLPQLESLYLGNNKITDI-- 146 (605)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCCC-TTSTTCTTCCEEECTTSCCC-CCGG--GGGCTTCSEEECCSSCCCCC--
T ss_pred CCCCCChh--hccCCCCCEEECcCCCCCCC-hhhccCCCCCEEEecCCCCC-CCcc--ccCCCccCEEECCCCccCCc--
Confidence 33455654 88999999999999999974 445444 7999999999998 4553 88999999999999999975
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccccC---CCCCcccCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNK 141 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~ 141 (565)
..|..+++|+.|+|++|+|++..|-..+++|+.|+|++|+|++. | .+.. +..+.+.+|+
T Consensus 147 ~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 147 TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQE 208 (605)
T ss_dssp GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEE
T ss_pred hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCc
Confidence 67899999999999999999888855789999999999999874 3 3443 4444556664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=130.29 Aligned_cols=133 Identities=22% Similarity=0.248 Sum_probs=103.9
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
+..+++ +..+++|+.|+|++|.+++..+.....+|+.|+|++|++++ +++ +..+++|+.|+|++|++++..| +
T Consensus 255 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~L~~n~l~~~~~--~ 327 (466)
T 1o6v_A 255 ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED-ISP--ISNLKNLTYLTLYFNNISDISP--V 327 (466)
T ss_dssp CCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSC-CGG--GGGCTTCSEEECCSSCCSCCGG--G
T ss_pred cccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcCCCcccC-chh--hcCCCCCCEEECcCCcCCCchh--h
Confidence 344543 88999999999999999987663334479999999999994 554 7889999999999999998766 7
Q ss_pred cCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCc-cccCCCCCcccCCCCC
Q 008431 84 AGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPD-TLSNFDATSFQGNKGL 143 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~n~~~ 143 (565)
..+++|+.|++++|++++...-..+++|+.|++++|++++..|- .+.++....+.+|+..
T Consensus 328 ~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 328 SSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWT 388 (466)
T ss_dssp GGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEE
T ss_pred ccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCccc
Confidence 89999999999999999863334789999999999999988771 1233334455666543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.23 E-value=5.5e-11 Score=125.53 Aligned_cols=104 Identities=23% Similarity=0.194 Sum_probs=64.0
Q ss_pred cCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
++.+++|+.|+|++|+|++. +.....+|+.|+|++|++.+.++ +..+++|+.|+|++|++++ +| ++.+++|+.
T Consensus 123 ~~~l~~L~~L~l~~N~l~~l-~l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~ 195 (457)
T 3bz5_A 123 VSQNPLLTYLNCARNTLTEI-DVSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNR 195 (457)
T ss_dssp CTTCTTCCEEECTTSCCSCC-CCTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCE
T ss_pred CCCCCcCCEEECCCCcccee-ccccCCcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCE
Confidence 67788888888888888874 32222356666666665544553 5556666666666666665 34 556666666
Q ss_pred EeccCCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 92 LNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 92 L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
|++++|++++. +-..+++|+.|++++|+|++
T Consensus 196 L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 196 LNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp EECCSSCCSCC-CCTTCTTCSEEECCSSCCSC
T ss_pred EECcCCcCCee-ccccCCCCCEEECcCCcccc
Confidence 66666666653 33345566666666666655
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.23 E-value=2.3e-11 Score=128.84 Aligned_cols=126 Identities=27% Similarity=0.335 Sum_probs=104.7
Q ss_pred hcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL 90 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 90 (565)
.+..+++|+.|+|++|.+++..|.....+|+.|+|++|+++ .+|+ +..+++|+.|+|++|++++..| +..+++|+
T Consensus 238 ~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 312 (466)
T 1o6v_A 238 TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQIS-NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLT 312 (466)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCS
T ss_pred hhhcCCCCCEEECCCCccccchhhhcCCCCCEEECCCCccC-cccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCC
Confidence 57889999999999999998776334447999999999999 4554 8899999999999999997555 88999999
Q ss_pred EEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccccC---CCCCcccCCCCC
Q 008431 91 QLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSN---FDATSFQGNKGL 143 (565)
Q Consensus 91 ~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~---~~~~~~~~n~~~ 143 (565)
.|+|++|++++..|...+++|+.|++++|++++. ..+.+ +....+.+|...
T Consensus 313 ~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 313 YLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp EEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred EEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccC
Confidence 9999999999988866789999999999999975 23443 444456666543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.8e-11 Score=124.46 Aligned_cols=97 Identities=23% Similarity=0.267 Sum_probs=83.7
Q ss_pred cccccChhhcCCCCCCcEEEccc-CcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFIN-NSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~-N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
.+..||. |..+++|+.|+|++ |.|++.+| .+..+ +|+.|+|++|+|+| +|+++|.+|++|+.|+|++|+|++..
T Consensus 20 ~l~~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~ 96 (347)
T 2ifg_A 20 ALDSLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRLNLSFNALESLS 96 (347)
T ss_dssp CCTTTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEEECCSSCCSCCC
T ss_pred CCCccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce-eCHHHhcCCcCCCEEeCCCCccceeC
Confidence 4567986 99999999999996 99999887 35444 79999999999995 66677999999999999999999877
Q ss_pred CccccCCCCCCEEeccCCcCCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKI 103 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~ 103 (565)
|..|..+. |+.|+|++|.|....
T Consensus 97 ~~~~~~~~-L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 97 WKTVQGLS-LQELVLSGNPLHCSC 119 (347)
T ss_dssp STTTCSCC-CCEEECCSSCCCCCG
T ss_pred HHHcccCC-ceEEEeeCCCccCCC
Confidence 77777776 999999999998643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.22 E-value=7.5e-14 Score=130.24 Aligned_cols=112 Identities=24% Similarity=0.283 Sum_probs=74.7
Q ss_pred hcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKL 89 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 89 (565)
.|..+++|+.|+|++|.|++ +|.+..+ +|+.|+|++|+|+ .+|. .+..+++|+.|+|++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~-~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIEN-LDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSS-HHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccc-hhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 56677777777777777776 4444333 5777777777777 6665 35556777777777777775 44 46777777
Q ss_pred CEEeccCCcCCCCCC--C-CCCCCCCEEEcccCCCccCCCc
Q 008431 90 LQLNLEGNSFQGKIP--D-FPLAHLTLLDLSYNQLVGRIPD 127 (565)
Q Consensus 90 ~~L~l~~N~l~g~~p--~-~~~~~L~~l~ls~N~l~g~~p~ 127 (565)
+.|+|++|++++..+ . ..+++|+.|++++|++++.+|.
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 777777777775332 1 2566777777777777665543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.20 E-value=8.8e-11 Score=123.86 Aligned_cols=100 Identities=23% Similarity=0.373 Sum_probs=53.6
Q ss_pred CCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEec
Q 008431 16 PGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNL 94 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 94 (565)
++|++|+|++|++++ +|.+..+ +|++|+|++|+++ .+|.. ..+|++|+|++|++++ +| .|+++++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~-~lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCc-ccCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 456666666666665 3443333 4666666666665 35532 1356666666666654 44 3556666666666
Q ss_pred cCCcCCCCCCCCCCCCCCEEEcccCCCccCCC
Q 008431 95 EGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 95 ~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p 126 (565)
++|++++ +|.. ..+|+.|++++|+++ .+|
T Consensus 203 ~~N~l~~-l~~~-~~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 203 DNNSLKK-LPDL-PLSLESIVAGNNILE-ELP 231 (454)
T ss_dssp CSSCCSS-CCCC-CTTCCEEECCSSCCS-SCC
T ss_pred CCCcCCc-CCCC-cCcccEEECcCCcCC-ccc
Confidence 6666654 2322 135555555555555 344
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.14 E-value=8.4e-11 Score=119.70 Aligned_cols=137 Identities=20% Similarity=0.245 Sum_probs=96.0
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc--ccccccceeeccc-ccccccCCcchhcCCC-CccEEEccCCcCcc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS--VGKLTLRALYLSL-NKFTGEIPSDAFAGMD-QLKKVHLARNHFSG 77 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~~L~~L~Ls~-N~l~g~ip~~~~~~l~-~L~~L~l~~N~l~g 77 (565)
|.+..|+++.|..+++|+.|++++|+|++..+. ....++..|++++ |++. .+|...|.++. .|+.|+|++|+|+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccchhhcchhhhhhccccccccC
Confidence 445567777788888888888888888766552 2333566777755 4565 67777777765 58889999999985
Q ss_pred cCCccccCCCCCCEEeccC-CcCCCCCCC-C--CCCCCCEEEcccCCCccCCCccccCCCCCcccCCC
Q 008431 78 QIPKSLAGLQKLLQLNLEG-NSFQGKIPD-F--PLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNK 141 (565)
Q Consensus 78 ~~p~~~~~l~~L~~L~l~~-N~l~g~~p~-~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~ 141 (565)
+|.......+|..|++++ |.++ .+|. . .+++|+.|||++|+|+...+..+.++......++.
T Consensus 169 -i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 169 -IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234 (350)
T ss_dssp -ECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT
T ss_pred -CChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC
Confidence 444444567788999876 4555 4554 2 67889999999999987666667777666554443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=7.5e-11 Score=114.36 Aligned_cols=132 Identities=14% Similarity=0.139 Sum_probs=96.7
Q ss_pred eec-ccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCC--ccceEEEEEecCceEEEEeccCCCCH
Q 008431 260 VLG-SGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN--LLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 260 ~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.++ .|..+.||+....+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55669999998767888999987543 2346788999998886545 45688888777788999999999887
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF------------------------------------------ 374 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~------------------------------------------ 374 (565)
. .. . .. ...++.+++..|+.||+..
T Consensus 103 ~--~~---~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 103 L--SS---H-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp T--TS---C-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred C--cC---c-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 4 11 0 11 2356777778888887631
Q ss_pred ------------CCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 375 ------------PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 375 ------------~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
.+..++|+|++|.|||++++..+.|+|||.+..
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 012389999999999998876677999998643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.10 E-value=5.2e-10 Score=117.96 Aligned_cols=98 Identities=23% Similarity=0.372 Sum_probs=62.3
Q ss_pred CCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEec
Q 008431 15 LPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNL 94 (565)
Q Consensus 15 l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 94 (565)
.++|+.|+|++|.+++ +|.. ..+|+.|+|++|+++ .+|.. .++|++|+|++|++++ +| .|+++++|++|++
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~-~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPEL-PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCC-CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred cCCCCEEEccCCcCCc-cccc-cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 3577888888888877 4432 135777777777776 34431 1567777777777765 55 4677777777777
Q ss_pred cCCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 95 EGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 95 ~~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
++|++++ +|.. ..+|+.|++++|++++
T Consensus 161 ~~N~l~~-lp~~-~~~L~~L~L~~n~l~~ 187 (454)
T 1jl5_A 161 DNNSLKK-LPDL-PPSLEFIAAGNNQLEE 187 (454)
T ss_dssp CSSCCSC-CCCC-CTTCCEEECCSSCCSS
T ss_pred CCCcCcc-cCCC-cccccEEECcCCcCCc
Confidence 7777765 3432 2466677777776665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.09 E-value=4.4e-10 Score=122.66 Aligned_cols=121 Identities=22% Similarity=0.200 Sum_probs=82.5
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcc
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKS 82 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~ 82 (565)
.+..||.. +. ++|+.|+|++|+|+..++ ...+|+.|+|++|+|+ .||. .+++|+.|+|++|+|++ +|.
T Consensus 51 ~L~~lp~~-l~--~~L~~L~L~~N~l~~lp~--~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~- 118 (622)
T 3g06_A 51 GLTTLPDC-LP--AHITTLVIPDNNLTSLPA--LPPELRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLTH-LPA- 118 (622)
T ss_dssp CCSCCCSC-CC--TTCSEEEECSCCCSCCCC--CCTTCCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCCC-CCC-
T ss_pred CcCccChh-hC--CCCcEEEecCCCCCCCCC--cCCCCCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCCC-CCC-
Confidence 34567753 33 688888888888885433 3347888888888888 6776 56788888888888885 454
Q ss_pred ccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccccCCCCCcccCC
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGN 140 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 140 (565)
.+++|+.|+|++|++++ +|. .+++|+.|+|++|+|++ +|..+.++....+.+|
T Consensus 119 --~l~~L~~L~L~~N~l~~-lp~-~l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N 171 (622)
T 3g06_A 119 --LPSGLCKLWIFGNQLTS-LPV-LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNN 171 (622)
T ss_dssp --CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred --CCCCcCEEECCCCCCCc-CCC-CCCCCCEEECcCCcCCC-cCCccCCCCEEECCCC
Confidence 55778888888888876 333 24777888888887775 3444444444444444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.09 E-value=5.7e-10 Score=121.79 Aligned_cols=90 Identities=26% Similarity=0.314 Sum_probs=46.5
Q ss_pred ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEccc
Q 008431 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSY 118 (565)
Q Consensus 39 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~ 118 (565)
+|+.|+|++|+|+ .+|.. +++|+.|++++|.|+ .+|.. +++|+.|+|++|+|++ +| ..+++|+.|+|++
T Consensus 182 ~L~~L~Ls~N~l~-~l~~~----~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp-~~l~~L~~L~Ls~ 250 (622)
T 3g06_A 182 GLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP-VLPSELKELMVSG 250 (622)
T ss_dssp TCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC-CCCTTCCEEECCS
T ss_pred CCcEEECCCCCCC-CCCCc----cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC-CCCCcCcEEECCC
Confidence 4666777777766 45542 245555555555555 23332 2455555555555554 33 2335555555555
Q ss_pred CCCccCCCccccCCCCCcccCC
Q 008431 119 NQLVGRIPDTLSNFDATSFQGN 140 (565)
Q Consensus 119 N~l~g~~p~~~~~~~~~~~~~n 140 (565)
|+|+. +|..+.++....+.+|
T Consensus 251 N~L~~-lp~~~~~L~~L~Ls~N 271 (622)
T 3g06_A 251 NRLTS-LPMLPSGLLSLSVYRN 271 (622)
T ss_dssp SCCSC-CCCCCTTCCEEECCSS
T ss_pred CCCCc-CCcccccCcEEeCCCC
Confidence 55552 3334444444444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.4e-10 Score=118.04 Aligned_cols=127 Identities=16% Similarity=0.127 Sum_probs=98.8
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccE-EEccCCcCcccC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKK-VHLARNHFSGQI 79 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~-L~l~~N~l~g~~ 79 (565)
-+.+||.+ + .++|+.|+|++|+|+...+. +.. .+|+.|+|++|++.+.||.++|.++++|.+ +.++.|+|+...
T Consensus 20 ~Lt~iP~~-l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~ 96 (350)
T 4ay9_X 20 KVTEIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYIN 96 (350)
T ss_dssp TCCSCCTT-C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEEC
T ss_pred CCCccCcC-c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccC
Confidence 34578753 3 36899999999999977663 443 479999999999987899999999998775 667789999888
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEccc-CCCccCCCccccCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSY-NQLVGRIPDTLSNF 132 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~-N~l~g~~p~~~~~~ 132 (565)
|..|.++++|++|++++|++++..+.. ...++..|++++ |++....+..|..+
T Consensus 97 ~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~ 152 (350)
T 4ay9_X 97 PEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152 (350)
T ss_dssp TTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred chhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhc
Confidence 999999999999999999999766653 345567788765 56665555555443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.00 E-value=8.9e-11 Score=120.07 Aligned_cols=138 Identities=22% Similarity=0.228 Sum_probs=95.4
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCC----c-c-ccc-ccceeecccccccccCCcchhcCC-----CCccEEE
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMP----S-V-GKL-TLRALYLSLNKFTGEIPSDAFAGM-----DQLKKVH 69 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p----~-~-~~~-~L~~L~Ls~N~l~g~ip~~~~~~l-----~~L~~L~ 69 (565)
++.|.+| ..+...++|+.|+|++|.|++..+ . + ... +|+.|+|++|+|++..+ ..|..+ ++|++|+
T Consensus 9 ~~~~~~~-~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~-~~l~~~l~~~~~~L~~L~ 86 (362)
T 3goz_A 9 PGSNPVE-EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNS-DELVQILAAIPANVTSLN 86 (362)
T ss_dssp TTCCHHH-HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCH-HHHHHHHHTSCTTCCEEE
T ss_pred cchHHHH-HHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHH-HHHHHHHhccCCCccEEE
Confidence 3455555 456666679999999999987665 1 1 223 69999999999985433 345554 8899999
Q ss_pred ccCCcCcccCCccccC----C-CCCCEEeccCCcCCCCCCCC------C-CCCCCEEEcccCCCccCCCccc--------
Q 008431 70 LARNHFSGQIPKSLAG----L-QKLLQLNLEGNSFQGKIPDF------P-LAHLTLLDLSYNQLVGRIPDTL-------- 129 (565)
Q Consensus 70 l~~N~l~g~~p~~~~~----l-~~L~~L~l~~N~l~g~~p~~------~-~~~L~~l~ls~N~l~g~~p~~~-------- 129 (565)
|++|.+++..+..+.. + ++|+.|+|++|++++..+.. . ..+|+.|+|++|+|+...+..+
T Consensus 87 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~ 166 (362)
T 3goz_A 87 LSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166 (362)
T ss_dssp CCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSC
T ss_pred CcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCC
Confidence 9999998777765443 4 88999999999988655431 2 3589999999999885433322
Q ss_pred cCCCCCcccCCC
Q 008431 130 SNFDATSFQGNK 141 (565)
Q Consensus 130 ~~~~~~~~~~n~ 141 (565)
.++....+.+|.
T Consensus 167 ~~L~~L~Ls~n~ 178 (362)
T 3goz_A 167 ANVNSLNLRGNN 178 (362)
T ss_dssp TTCCEEECTTSC
T ss_pred ccccEeeecCCC
Confidence 244445555654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=7.3e-10 Score=113.11 Aligned_cols=142 Identities=15% Similarity=0.198 Sum_probs=104.1
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEee--ccC-ccCHHHHHHHHHHHhcCC--CCCccceEEEEEec---CceEEEEec
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR--QMS-NVGKEDFHEHMTRLGSLS--HPNLLPLIAFYYRK---EEKLLVSDF 330 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~E~ 330 (565)
+.++.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 57899999999998864 4678888765 322 122456888999999887 44578888888765 348999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP----------------------------------- 375 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~----------------------------------- 375 (565)
++|..+.+.. ...++...+..++.+++..|+.||+.-.
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9987764311 1237788889999999999999997310
Q ss_pred -------------------CCCCccCCCCCCCEEEcCCCC--cEEeccCCcccc
Q 008431 376 -------------------GVTLPHGHLKSSNVLLDNAYE--PLLTDYALVPIV 408 (565)
Q Consensus 376 -------------------~~~ivHrDlkp~NILl~~~~~--~kl~DfGla~~~ 408 (565)
+..++|+|++|.|||++.++. +.|.||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 236899999999999987653 689999988653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.97 E-value=2e-12 Score=120.50 Aligned_cols=125 Identities=22% Similarity=0.312 Sum_probs=99.2
Q ss_pred cCCCCCCcEEEcccCcCccCCCc-------cccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPS-------VGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~-------~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
+.....++.++|+.|.|+|.+|. +... .|+.|+|++|+|++ +| .|.++++|+.|+|++|+++ .+|..+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~-~l~~~~ 89 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLD 89 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcc-cccchh
Confidence 45567888999999999998874 3333 69999999999994 88 4899999999999999999 688888
Q ss_pred cCCCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCC-cccc---CCCCCcccCCC
Q 008431 84 AGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIP-DTLS---NFDATSFQGNK 141 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p-~~~~---~~~~~~~~~n~ 141 (565)
..+++|+.|+|++|++++. |.. .+++|+.|++++|++++..+ ..+. ++....+.+|+
T Consensus 90 ~~~~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 90 AVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp HHHHHCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred hcCCcCCEEECcCCcCCcC-CccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 8889999999999999974 443 57899999999999985332 2333 33344455554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.96 E-value=1e-10 Score=119.58 Aligned_cols=125 Identities=22% Similarity=0.257 Sum_probs=73.5
Q ss_pred cccccCh----hhcCCCC-CCcEEEcccCcCccCCC-cccc------cccceeecccccccccCCcc---hhcCC-CCcc
Q 008431 3 LMGMIDV----DTLSRLP-GLRSLSFINNSFDGPMP-SVGK------LTLRALYLSLNKFTGEIPSD---AFAGM-DQLK 66 (565)
Q Consensus 3 ~~g~i~~----~~~~~l~-~L~~L~l~~N~l~~~~p-~~~~------~~L~~L~Ls~N~l~g~ip~~---~~~~l-~~L~ 66 (565)
.++.++. +.|..++ +|+.|+|++|.|++..+ .+.. .+|+.|+|++|+|++..+.. .+..+ ++|+
T Consensus 33 ~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~ 112 (362)
T 3goz_A 33 NLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTIT 112 (362)
T ss_dssp CGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred CCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCcc
Confidence 3445554 5566666 67777777777776544 2222 35777777777776433321 13333 6777
Q ss_pred EEEccCCcCcccCCcccc----C-CCCCCEEeccCCcCCCCCCCC------CC-CCCCEEEcccCCCccCCCc
Q 008431 67 KVHLARNHFSGQIPKSLA----G-LQKLLQLNLEGNSFQGKIPDF------PL-AHLTLLDLSYNQLVGRIPD 127 (565)
Q Consensus 67 ~L~l~~N~l~g~~p~~~~----~-l~~L~~L~l~~N~l~g~~p~~------~~-~~L~~l~ls~N~l~g~~p~ 127 (565)
+|+|++|+|++..+..+. . .++|++|+|++|+++...+.. .+ .+|+.|+|++|+|++..+.
T Consensus 113 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~ 185 (362)
T 3goz_A 113 VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCA 185 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH
T ss_pred EEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHH
Confidence 777777777665554433 2 257777777777776432211 22 3677777777777665543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.95 E-value=3.4e-11 Score=124.30 Aligned_cols=114 Identities=25% Similarity=0.334 Sum_probs=70.1
Q ss_pred hcCCCCCCcEEEcccCcCccCCC-cccc--------------cccceeeccccccc-ccCCc--chhcCCCCccEEEccC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMP-SVGK--------------LTLRALYLSLNKFT-GEIPS--DAFAGMDQLKKVHLAR 72 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~--------------~~L~~L~Ls~N~l~-g~ip~--~~~~~l~~L~~L~l~~ 72 (565)
.+..+++|+.|+|++|.|+...+ .+.. .+|+.|+|++|+|+ +.+|. ..|..+++|++|+|++
T Consensus 117 ~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~ 196 (386)
T 2ca6_A 117 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 196 (386)
T ss_dssp HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCS
T ss_pred HHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcC
Confidence 56677788888888887764322 1111 36777777777776 33442 2355666777777777
Q ss_pred CcCc--c---cCCccccCCCCCCEEeccCCcCC----CCCCCC--CCCCCCEEEcccCCCccC
Q 008431 73 NHFS--G---QIPKSLAGLQKLLQLNLEGNSFQ----GKIPDF--PLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 73 N~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~--~~~~L~~l~ls~N~l~g~ 124 (565)
|+|+ | .+|..+..+++|+.|+|++|.++ +.+|.. .+++|+.|+|++|+|++.
T Consensus 197 n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 197 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp SCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred CCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 7776 2 34446666777777777777764 333321 456677777777776654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=4.6e-10 Score=111.81 Aligned_cols=182 Identities=17% Similarity=0.162 Sum_probs=120.3
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCC--ccceEEEEEecC---ceEEEEeccC
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPN--LLPLIAFYYRKE---EKLLVSDFVP 332 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~E~~~ 332 (565)
+.++.|.+..||+.. ..+++|..... .....+.+|..+|+.+. +.. +.+.+.+....+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 468999999999763 56888886432 23567889999998874 332 334444332322 3489999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF-------------------------------------- 374 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~-------------------------------------- 374 (565)
|.+|.+.... .++...+..++.+++..|+.||+.-
T Consensus 100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9888754321 2677778888889998888888610
Q ss_pred ----------------CCCCCccCCCCCCCEEEcC--CCCcEEeccCCcccccccccccccc----------------cc
Q 008431 375 ----------------PGVTLPHGHLKSSNVLLDN--AYEPLLTDYALVPIVNKEHAQLHMV----------------AY 420 (565)
Q Consensus 375 ----------------~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~t~----------------~y 420 (565)
.+..++|+|++|.||++++ ...+.|+||+.+............. .|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1135799999999999988 5567899999876543221100000 12
Q ss_pred --cC-CCccCCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 008431 421 --KS-PEFNQTDGVTRKTDVWSLGILILELLTGKFPAN 455 (565)
Q Consensus 421 --~a-PE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~ 455 (565)
.. |+... ......+.|++|.++|++.+|..+|.
T Consensus 253 ~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 11110 01123588999999999999998864
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.93 E-value=8.5e-11 Score=121.31 Aligned_cols=128 Identities=22% Similarity=0.312 Sum_probs=101.1
Q ss_pred CCCcEEEcccCcCc-cCCCc----ccc-cccceeeccccccccc----CCcchhcCCCCccEEEccCCcCc----ccCCc
Q 008431 16 PGLRSLSFINNSFD-GPMPS----VGK-LTLRALYLSLNKFTGE----IPSDAFAGMDQLKKVHLARNHFS----GQIPK 81 (565)
Q Consensus 16 ~~L~~L~l~~N~l~-~~~p~----~~~-~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~l~~N~l~----g~~p~ 81 (565)
++|+.|+|++|+|+ +.+|. +.. .+|+.|+|++|+|+.. +.+..+..+++|+.|+|++|.|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 89999999999998 44443 222 3799999999999821 22324788999999999999996 67899
Q ss_pred cccCCCCCCEEeccCCcCCCC----CCC----CCCCCCCEEEcccCCCcc----CCCccc----cCCCCCcccCCCCC
Q 008431 82 SLAGLQKLLQLNLEGNSFQGK----IPD----FPLAHLTLLDLSYNQLVG----RIPDTL----SNFDATSFQGNKGL 143 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~----~p~----~~~~~L~~l~ls~N~l~g----~~p~~~----~~~~~~~~~~n~~~ 143 (565)
.+..+++|+.|+|++|.+++. +|. ..+++|+.|+|++|++++ .+|..+ .++....+.+|+..
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 999999999999999999875 333 237899999999999998 477654 45666677777644
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.7e-10 Score=116.35 Aligned_cols=114 Identities=21% Similarity=0.318 Sum_probs=86.1
Q ss_pred hhcCCC--CCCcEEEcccCcCccCCCcccc-cccceeeccccccccc-CCcchhcCCCCccEEEccCCcCcccCCccccC
Q 008431 10 DTLSRL--PGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGE-IPSDAFAGMDQLKKVHLARNHFSGQIPKSLAG 85 (565)
Q Consensus 10 ~~~~~l--~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~-ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 85 (565)
..+..+ ++|+.|++++|.+.+.++.... .+|+.|+|++|.+++. +|. .+..+++|++|+|++|.+++..|..++.
T Consensus 62 ~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~l~~ 140 (336)
T 2ast_B 62 DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG-ILSQCSKLQNLSLEGLRLSDPIVNTLAK 140 (336)
T ss_dssp HHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHH-HHTTBCCCSEEECTTCBCCHHHHHHHTT
T ss_pred HHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHH-HHhhCCCCCEEeCcCcccCHHHHHHHhc
Confidence 344455 7888888888888887775443 3688888888888755 554 4788888888888888888888888888
Q ss_pred CCCCCEEeccCC-cCCCC-CCCC--CCCCCCEEEcccC-CCccC
Q 008431 86 LQKLLQLNLEGN-SFQGK-IPDF--PLAHLTLLDLSYN-QLVGR 124 (565)
Q Consensus 86 l~~L~~L~l~~N-~l~g~-~p~~--~~~~L~~l~ls~N-~l~g~ 124 (565)
+++|++|+|++| .+++. ++.. .+++|+.|++++| .+++.
T Consensus 141 ~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~ 184 (336)
T 2ast_B 141 NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK 184 (336)
T ss_dssp CTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH
T ss_pred CCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH
Confidence 888888888888 67652 3432 5678888888888 87753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-10 Score=117.68 Aligned_cols=129 Identities=18% Similarity=0.193 Sum_probs=84.9
Q ss_pred cCCCCCCcEEEcccCcCccC-CCc-cc-ccccceeecccccccccCCcchhcCCCCccEEEccCC-cCccc-CCccccCC
Q 008431 12 LSRLPGLRSLSFINNSFDGP-MPS-VG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARN-HFSGQ-IPKSLAGL 86 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~-~p~-~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l 86 (565)
+..+++|+.|+|++|.+++. +|. +. ..+|+.|+|++|++++.+|.. +..+++|++|+|++| .+++. +|..+.++
T Consensus 89 ~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~-l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~ 167 (336)
T 2ast_B 89 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT-LAKNSNLVRLNLSGCSGFSEFALQTLLSSC 167 (336)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHH-HTTCTTCSEEECTTCBSCCHHHHHHHHHHC
T ss_pred hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHH-HhcCCCCCEEECCCCCCCCHHHHHHHHhcC
Confidence 55788888888888888754 442 22 236888888888887666653 777888888888888 67753 66667778
Q ss_pred CCCCEEeccCC-cCCCC-CCCC--CCC-CCCEEEcccC--CCc-cCCCccc---cCCCCCcccCCC
Q 008431 87 QKLLQLNLEGN-SFQGK-IPDF--PLA-HLTLLDLSYN--QLV-GRIPDTL---SNFDATSFQGNK 141 (565)
Q Consensus 87 ~~L~~L~l~~N-~l~g~-~p~~--~~~-~L~~l~ls~N--~l~-g~~p~~~---~~~~~~~~~~n~ 141 (565)
++|+.|+|++| .+++. ++.. .++ +|+.|++++| .++ +.+|..+ .++....+.+|.
T Consensus 168 ~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~ 233 (336)
T 2ast_B 168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 233 (336)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence 88888888888 77753 2321 455 7777777777 444 3333332 334444445543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.89 E-value=4.2e-09 Score=106.07 Aligned_cols=92 Identities=20% Similarity=0.137 Sum_probs=74.6
Q ss_pred ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCC-EEeccCCcCCCCCCCC--CCCCCCEEE
Q 008431 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLL-QLNLEGNSFQGKIPDF--PLAHLTLLD 115 (565)
Q Consensus 39 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~--~~~~L~~l~ 115 (565)
+|+.|+|++|+++ .||+.+|.++++|+.|+|++| ++..-+.+|.++.+|+ .|+|.+ +++...+.. .+.+|+.|+
T Consensus 227 ~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 227 NLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 6889999999998 899999999999999999988 7777788899999999 999988 666444432 678999999
Q ss_pred cccCCCccCCCccccCCC
Q 008431 116 LSYNQLVGRIPDTLSNFD 133 (565)
Q Consensus 116 ls~N~l~g~~p~~~~~~~ 133 (565)
+++|+++..-+.+|.+..
T Consensus 304 l~~n~i~~I~~~aF~~~~ 321 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGV 321 (329)
T ss_dssp ECSSCCCEECTTTTCTTC
T ss_pred eCCCccCccchhhhcCCc
Confidence 999988866566665443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.67 E-value=9e-10 Score=116.16 Aligned_cols=132 Identities=20% Similarity=0.178 Sum_probs=94.0
Q ss_pred hhcCCCCCCcEEEcccCcCccC----CC-ccc-ccccceeecccccccccCCcc----hhcCCCCccEEEccCCcCccc-
Q 008431 10 DTLSRLPGLRSLSFINNSFDGP----MP-SVG-KLTLRALYLSLNKFTGEIPSD----AFAGMDQLKKVHLARNHFSGQ- 78 (565)
Q Consensus 10 ~~~~~l~~L~~L~l~~N~l~~~----~p-~~~-~~~L~~L~Ls~N~l~g~ip~~----~~~~l~~L~~L~l~~N~l~g~- 78 (565)
..+..+++|+.|+|++|.++.. ++ .+. ..+|+.|+|++|.+++..+.. .....++|+.|+|++|.+++.
T Consensus 250 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 329 (461)
T 1z7x_W 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH
Confidence 3445688999999999999863 23 222 236999999999987432221 122346899999999999865
Q ss_pred ---CCccccCCCCCCEEeccCCcCCCCCCCC-------CCCCCCEEEcccCCCcc----CCCccc---cCCCCCcccCCC
Q 008431 79 ---IPKSLAGLQKLLQLNLEGNSFQGKIPDF-------PLAHLTLLDLSYNQLVG----RIPDTL---SNFDATSFQGNK 141 (565)
Q Consensus 79 ---~p~~~~~l~~L~~L~l~~N~l~g~~p~~-------~~~~L~~l~ls~N~l~g----~~p~~~---~~~~~~~~~~n~ 141 (565)
+|..+..+++|+.|+|++|.+++..+.. ..++|+.|++++|++++ .+|..+ .++....+.+|+
T Consensus 330 ~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 330 CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 5677788899999999999887643321 25689999999999985 566554 345555666764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.57 E-value=2.8e-09 Score=112.35 Aligned_cols=114 Identities=20% Similarity=0.258 Sum_probs=83.5
Q ss_pred cCCCCCCcEEEcccCcCccC----CCc-cc-ccccceeecccccccccCCcchhcCCC----CccEEEccCCcCcc----
Q 008431 12 LSRLPGLRSLSFINNSFDGP----MPS-VG-KLTLRALYLSLNKFTGEIPSDAFAGMD----QLKKVHLARNHFSG---- 77 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~----~p~-~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~----~L~~L~l~~N~l~g---- 77 (565)
+..+++|+.|+|++|.++.. ++. +. ..+|+.|+|++|+++...+...+..+. +|++|+|++|+++.
T Consensus 24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~ 103 (461)
T 1z7x_W 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 103 (461)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence 56788899999999988742 221 22 236899999999887544444455566 69999999999883
Q ss_pred cCCccccCCCCCCEEeccCCcCCCCCCC-------CCCCCCCEEEcccCCCccCC
Q 008431 78 QIPKSLAGLQKLLQLNLEGNSFQGKIPD-------FPLAHLTLLDLSYNQLVGRI 125 (565)
Q Consensus 78 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~-------~~~~~L~~l~ls~N~l~g~~ 125 (565)
.+|..|..+++|++|+|++|.+++..+. ....+|+.|++++|++++..
T Consensus 104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158 (461)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence 5688888899999999999988753322 13457999999999887643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.45 E-value=3.5e-07 Score=91.89 Aligned_cols=63 Identities=11% Similarity=0.083 Sum_probs=35.7
Q ss_pred ccChhhcCC--------CCCCcEEEcccCcCccCCC-cc-cccccceeecccccccccCCcchhcCCCCccEEEc
Q 008431 6 MIDVDTLSR--------LPGLRSLSFINNSFDGPMP-SV-GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHL 70 (565)
Q Consensus 6 ~i~~~~~~~--------l~~L~~L~l~~N~l~~~~p-~~-~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l 70 (565)
+||..+|.+ +++|+.|+|++ +++...+ .+ +..+|+.|+|++|.++ .|++++|.++.++..+.+
T Consensus 83 ~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~ 155 (329)
T 3sb4_A 83 FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPL 155 (329)
T ss_dssp EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECT
T ss_pred ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecC
Confidence 466666666 77777777776 5654333 22 2235777777777665 555555555444444433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.44 E-value=1.2e-08 Score=98.69 Aligned_cols=84 Identities=20% Similarity=0.215 Sum_probs=61.8
Q ss_pred eecccccccccCCc---chhcCCCCccEEEccCCcCcc--cCCccccCCCCCCEEeccCCcCCCCCCCCCCC--CCCEEE
Q 008431 43 LYLSLNKFTGEIPS---DAFAGMDQLKKVHLARNHFSG--QIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLA--HLTLLD 115 (565)
Q Consensus 43 L~Ls~N~l~g~ip~---~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~--~L~~l~ 115 (565)
++++.|+.. .++. .+..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.-.-..+. +|+.|+
T Consensus 148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~ 226 (267)
T 3rw6_A 148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW 226 (267)
T ss_dssp CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEE
T ss_pred ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEE
Confidence 778888543 3331 123567889999999999987 55677788999999999999998752211223 899999
Q ss_pred cccCCCccCCCc
Q 008431 116 LSYNQLVGRIPD 127 (565)
Q Consensus 116 ls~N~l~g~~p~ 127 (565)
|++|.+++.+|.
T Consensus 227 L~~Npl~~~~~~ 238 (267)
T 3rw6_A 227 LDGNSLCDTFRD 238 (267)
T ss_dssp CTTSTTGGGCSS
T ss_pred ccCCcCccccCc
Confidence 999999887763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.39 E-value=6.7e-09 Score=106.33 Aligned_cols=107 Identities=20% Similarity=0.207 Sum_probs=55.9
Q ss_pred CCCcEEEcccCcCccCCC-ccc--ccccceeecccccccccCCcchh-----cCCCCccEEEccCCcCcc----cCCccc
Q 008431 16 PGLRSLSFINNSFDGPMP-SVG--KLTLRALYLSLNKFTGEIPSDAF-----AGMDQLKKVHLARNHFSG----QIPKSL 83 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p-~~~--~~~L~~L~Ls~N~l~g~ip~~~~-----~~l~~L~~L~l~~N~l~g----~~p~~~ 83 (565)
++|+.|+|++|.|+.... .+. ..+|+.|+|++|+|+.. ....+ ...++|++|+|++|.|+. .++..+
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~-~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L 179 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPE-ACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHH-HHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHH-HHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence 466666666666643211 111 12466666666666522 11112 234566677777776653 233444
Q ss_pred cCCCCCCEEeccCCcCCCCC----CC--CCCCCCCEEEcccCCCcc
Q 008431 84 AGLQKLLQLNLEGNSFQGKI----PD--FPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g~~----p~--~~~~~L~~l~ls~N~l~g 123 (565)
..+++|++|+|++|.|+..- +. ...++|+.|+|++|.|+.
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 55666777777777665321 11 123466777777776653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.38 E-value=2.3e-08 Score=102.31 Aligned_cols=110 Identities=21% Similarity=0.252 Sum_probs=83.2
Q ss_pred CCCCCcEEEcccCcCccCCC-cc------cccccceeeccccccccc----CCcchhcCCCCccEEEccCCcCccc----
Q 008431 14 RLPGLRSLSFINNSFDGPMP-SV------GKLTLRALYLSLNKFTGE----IPSDAFAGMDQLKKVHLARNHFSGQ---- 78 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~~~~p-~~------~~~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~---- 78 (565)
.+++|+.|+|++|.|+.... .+ ...+|+.|+|++|.|+.. ++ .++..+++|++|+|++|.|+..
T Consensus 124 ~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~-~~L~~~~~L~~L~Ls~N~l~~~g~~~ 202 (372)
T 3un9_A 124 VFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLM-EGLAGNTSVTHLSLLHTGLGDEGLEL 202 (372)
T ss_dssp HHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHH-HHHHTCSSCCEEECTTSSCHHHHHHH
T ss_pred HHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHH-HHHhcCCCcCEEeCCCCCCCcHHHHH
Confidence 35689999999999974322 11 134699999999999731 22 2357789999999999999752
Q ss_pred CCccccCCCCCCEEeccCCcCCCCCCC----C--CCCCCCEEEcccCCCccC
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKIPD----F--PLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~p~----~--~~~~L~~l~ls~N~l~g~ 124 (565)
++..+...++|+.|+|++|.++..-.. . ..++|+.|+|++|.|+..
T Consensus 203 L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 203 LAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 356678888999999999999753211 1 357899999999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.5e-06 Score=84.69 Aligned_cols=136 Identities=15% Similarity=0.067 Sum_probs=92.6
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCC---CccceEEEEE-ecCceEEEEeccCCC
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHP---NLLPLIAFYY-RKEEKLLVSDFVPNG 334 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~E~~~~g 334 (565)
+.++.|....||+. |..+++|.... ......+.+|..+|+.+.+. .+.+.+.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46788888899987 67788888532 22346789999999998753 2456666664 344578999999998
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF---------------------------------------- 374 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~---------------------------------------- 374 (565)
.+.+.... .++...+..++.+++..|+.||+..
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 87663211 1344455555555555555555321
Q ss_pred ----------------CCCCCccCCCCCCCEEEcC---CCC-cEEeccCCccc
Q 008431 375 ----------------PGVTLPHGHLKSSNVLLDN---AYE-PLLTDYALVPI 407 (565)
Q Consensus 375 ----------------~~~~ivHrDlkp~NILl~~---~~~-~kl~DfGla~~ 407 (565)
.+..++|+|++|.|||++. ++. ..|.||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2225699999999999987 455 47999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.5e-06 Score=82.84 Aligned_cols=136 Identities=20% Similarity=0.234 Sum_probs=92.4
Q ss_pred eecccCce-eEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 260 VLGSGSFG-SSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 260 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+..|..| .||+.... ++..+++|.-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987744 4567888876532 3456888999888774 22366788888888899999999999888
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE------------------------------------------- 373 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~------------------------------------------- 373 (565)
.+...... .....++.+++..|+-||..
T Consensus 108 ~~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 76543211 12233445555555555531
Q ss_pred --------C---CCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 374 --------F---PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 374 --------~---~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
. .+..++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1 112378999999999999877677999987643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.30 E-value=1.7e-07 Score=90.58 Aligned_cols=75 Identities=29% Similarity=0.385 Sum_probs=56.7
Q ss_pred cccceeecccccccc--cCCcchhcCCCCccEEEccCCcCcccCCccccCCC--CCCEEeccCCcCCCCCCCC-------
Q 008431 38 LTLRALYLSLNKFTG--EIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQ--KLLQLNLEGNSFQGKIPDF------- 106 (565)
Q Consensus 38 ~~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~~p~~------- 106 (565)
..|+.|+||+|+|++ .+|. .+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|+.
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~-~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSS-IVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTT-HHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccchh-HHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 368999999999985 4443 467889999999999999865 3344444 8999999999998877741
Q ss_pred --CCCCCCEEE
Q 008431 107 --PLAHLTLLD 115 (565)
Q Consensus 107 --~~~~L~~l~ 115 (565)
.+++|+.||
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 467788776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.20 E-value=1.9e-07 Score=101.55 Aligned_cols=128 Identities=13% Similarity=0.118 Sum_probs=77.8
Q ss_pred CCCCCCcEEEcccCcCccCCC-ccc--ccccceeecc----cccccccCCcc-----hhcCCCCccEEEccCC--cCccc
Q 008431 13 SRLPGLRSLSFINNSFDGPMP-SVG--KLTLRALYLS----LNKFTGEIPSD-----AFAGMDQLKKVHLARN--HFSGQ 78 (565)
Q Consensus 13 ~~l~~L~~L~l~~N~l~~~~p-~~~--~~~L~~L~Ls----~N~l~g~ip~~-----~~~~l~~L~~L~l~~N--~l~g~ 78 (565)
..+++|+.|+|+.|.+++..+ .+. ..+|+.|+|+ .|++++ .|.+ .+.++++|+.|+|+++ .+++.
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~-~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~ 453 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD-LPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDL 453 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSS-CCCHHHHHHHHHHCTTCCEEEEECCGGGCCHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccC-chHHHHHHHHHHhCCCCCEEEEecCCCCccHH
Confidence 357888888888888876443 222 2358888885 677774 2221 2556777888888643 35555
Q ss_pred CCccccC-CCCCCEEeccCCcCCCC-CCC--CCCCCCCEEEcccCCCccCC-Cc---cccCCCCCcccCCC
Q 008431 79 IPKSLAG-LQKLLQLNLEGNSFQGK-IPD--FPLAHLTLLDLSYNQLVGRI-PD---TLSNFDATSFQGNK 141 (565)
Q Consensus 79 ~p~~~~~-l~~L~~L~l~~N~l~g~-~p~--~~~~~L~~l~ls~N~l~g~~-p~---~~~~~~~~~~~~n~ 141 (565)
.+..++. +++|+.|+|++|.+++. ++. ..+++|+.|+|++|.+++.. +. .+.++....+.+|.
T Consensus 454 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 454 GLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 5444443 67788888888877652 222 24677888888888775432 22 13344555556654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=2e-06 Score=87.23 Aligned_cols=79 Identities=5% Similarity=-0.021 Sum_probs=53.5
Q ss_pred cee-cccCceeEEEEEEe-------CCCeeEEEEeeccC---ccCHHHHHHHHHHHhcCCC---CCccceEEEEEec---
Q 008431 259 EVL-GSGSFGSSYKAVLL-------TGPAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSH---PNLLPLIAFYYRK--- 321 (565)
Q Consensus 259 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~--- 321 (565)
+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 88889999988754 26678888765322 1123457788888887742 2466777776554
Q ss_pred CceEEEEeccCCCCHH
Q 008431 322 EEKLLVSDFVPNGSLA 337 (565)
Q Consensus 322 ~~~~lv~E~~~~gsL~ 337 (565)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999886543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.10 E-value=3.7e-07 Score=83.57 Aligned_cols=111 Identities=13% Similarity=0.228 Sum_probs=81.6
Q ss_pred hcCCCCCCcEEEcccC-cCccCC----C-cc-cccccceeeccccccccc----CCcchhcCCCCccEEEccCCcCccc-
Q 008431 11 TLSRLPGLRSLSFINN-SFDGPM----P-SV-GKLTLRALYLSLNKFTGE----IPSDAFAGMDQLKKVHLARNHFSGQ- 78 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N-~l~~~~----p-~~-~~~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~- 78 (565)
.+...+.|+.|+|++| .|...- . .+ ...+|+.|+|++|+|+.. |. +++...+.|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~-~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA-EMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHH-HHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHH-HHHHhCCCcCEEECcCCcCCHHH
Confidence 4667889999999999 887321 1 11 123699999999998732 22 2355568899999999999853
Q ss_pred ---CCccccCCCCCCEEec--cCCcCCCCCCC----C--CCCCCCEEEcccCCCc
Q 008431 79 ---IPKSLAGLQKLLQLNL--EGNSFQGKIPD----F--PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 79 ---~p~~~~~l~~L~~L~l--~~N~l~g~~p~----~--~~~~L~~l~ls~N~l~ 122 (565)
+...+...++|++|+| ++|.++..-.. . ..++|+.|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4566788889999999 88998743211 1 3478999999999874
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.09 E-value=1e-05 Score=83.37 Aligned_cols=112 Identities=14% Similarity=0.153 Sum_probs=50.6
Q ss_pred ccChhhcCCCCCCcEEEcccCcCccCCC-cccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcccc
Q 008431 6 MIDVDTLSRLPGLRSLSFINNSFDGPMP-SVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLA 84 (565)
Q Consensus 6 ~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 84 (565)
.|+..+|.++++|+.++|++|+++.... .+...+|+.+.|..| ++ .|+..+|.++++|+.++|..| ++..-..+|.
T Consensus 170 ~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~ 246 (401)
T 4fdw_A 170 QLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFR 246 (401)
T ss_dssp EECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTT
T ss_pred EehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCccccccc
Confidence 3444455555555555555555543322 122234555555422 44 455555555555555555443 3333344444
Q ss_pred CCCCCCEEeccCCcCCCCCCC--CCCCCCCEEEcccCCCc
Q 008431 85 GLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 85 ~l~~L~~L~l~~N~l~g~~p~--~~~~~L~~l~ls~N~l~ 122 (565)
+ .+|+.+.|. |.++...+. ..+.+|+.+++.+|.+.
T Consensus 247 ~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 247 E-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp T-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred c-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 4 445555552 223322111 13455566665555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.03 E-value=1.4e-05 Score=82.34 Aligned_cols=78 Identities=24% Similarity=0.225 Sum_probs=37.7
Q ss_pred ccceeecccccccccCCcchhcCCCCccEEEccCCcCc-----ccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCC
Q 008431 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS-----GQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHL 111 (565)
Q Consensus 39 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L 111 (565)
+|+.+.| .|+++ .|+..+|.++++|+.++|.+|.+. ...+.+|.+|++|+.++|.+ .++..-... .+.+|
T Consensus 249 ~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L 325 (401)
T 4fdw_A 249 GITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKV 325 (401)
T ss_dssp CCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSC
T ss_pred CccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCc
Confidence 4555555 23344 455555555555555555555443 23344555555555555552 233221111 34555
Q ss_pred CEEEcccC
Q 008431 112 TLLDLSYN 119 (565)
Q Consensus 112 ~~l~ls~N 119 (565)
+.++|..|
T Consensus 326 ~~l~lp~~ 333 (401)
T 4fdw_A 326 TQLTIPAN 333 (401)
T ss_dssp CEEEECTT
T ss_pred cEEEECcc
Confidence 55555433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.00 E-value=2.7e-07 Score=100.41 Aligned_cols=114 Identities=17% Similarity=0.168 Sum_probs=79.4
Q ss_pred CCCCCcEEEcccCcCccCCC-cccc---cccceeeccccc-ccc-cCCcchhcCCCCccEEEccCCcCccc----CCccc
Q 008431 14 RLPGLRSLSFINNSFDGPMP-SVGK---LTLRALYLSLNK-FTG-EIPSDAFAGMDQLKKVHLARNHFSGQ----IPKSL 83 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~~~~p-~~~~---~~L~~L~Ls~N~-l~g-~ip~~~~~~l~~L~~L~l~~N~l~g~----~p~~~ 83 (565)
.+++|+.|+|++|.+++..+ .+.. .+|+.|+|++|. ++. .++ ....++++|++|+|++|.+++. ++..+
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~ 188 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLL-SIVTHCRKIKTLLMEESSFSEKDGKWLHELA 188 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHH-HHHHHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHH-HHHhhCCCCCEEECccccccCcchhHHHHHH
Confidence 67888899999888775443 2322 238889988876 221 111 2234788999999999988765 44556
Q ss_pred cCCCCCCEEeccCCcCCCCCCC----C--CCCCCCEEEcccCCCccCCCccc
Q 008431 84 AGLQKLLQLNLEGNSFQGKIPD----F--PLAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g~~p~----~--~~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
.++++|+.|+|++|.+++..+. . .+++|+.|++++|.+.+ +|..+
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~ 239 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFF 239 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHH
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHH
Confidence 7788999999999998743221 1 46889999999998876 44433
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=3.3e-05 Score=79.48 Aligned_cols=75 Identities=12% Similarity=0.157 Sum_probs=49.8
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeeccCc-------cCHHHHHHHHHHHhcCCC--CCcc-ceEEEEEecCceEE
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSN-------VGKEDFHEHMTRLGSLSH--PNLL-PLIAFYYRKEEKLL 326 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~niv-~l~~~~~~~~~~~l 326 (565)
.+.||.|.++.||++... ++..+++|....... ...+.+..|.++++.+.. |..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999743 567899997653211 234567888888887642 3444 44433 4566789
Q ss_pred EEeccCCC
Q 008431 327 VSDFVPNG 334 (565)
Q Consensus 327 v~E~~~~g 334 (565)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=5.4e-05 Score=75.88 Aligned_cols=143 Identities=17% Similarity=0.194 Sum_probs=78.9
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcC-----CCCCccceE-E--EEEecCceEEEEec
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSL-----SHPNLLPLI-A--FYYRKEEKLLVSDF 330 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~-~--~~~~~~~~~lv~E~ 330 (565)
+.|+.|..+.||+....+| .+++|..... ..++..|..+++.+ ..|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999886554 4888887641 23344455544443 234444311 1 12345678999999
Q ss_pred cCCCCHH--------------HHHhhcCCCC--C-------CCCCHHHHH------------------------------
Q 008431 331 VPNGSLA--------------NLLHVRRAPG--Q-------PGLDWPIRL------------------------------ 357 (565)
Q Consensus 331 ~~~gsL~--------------~~l~~~~~~~--~-------~~l~~~~~~------------------------------ 357 (565)
++|..+. ..++...... . ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 1122111100 0 012343210
Q ss_pred -HHHHHHHHHHHHHHh--------h-CCCCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 358 -KIIKGVAKGLAYLYK--------E-FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 358 -~i~~~ia~gL~ylH~--------~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
.+...+..++.+|+. . ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446667763 1 013379999999999999878889999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00014 Score=71.17 Aligned_cols=73 Identities=15% Similarity=0.205 Sum_probs=54.0
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCC---CccceEEEEEecCceEEEEeccCCCC
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHP---NLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
+.+|.|..+.||+....+|+.+++|+...........|..|...|+.+.-. -+.+++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 568999999999999999999999987654444445688899988877422 23444443 24579999998764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.74 E-value=4.2e-06 Score=90.85 Aligned_cols=125 Identities=11% Similarity=0.107 Sum_probs=85.8
Q ss_pred CCCCCcEEEcccCcCccCCC-ccc--ccccceeecc--c----ccccccCCcc-----hhcCCCCccEEEccCCcCcccC
Q 008431 14 RLPGLRSLSFINNSFDGPMP-SVG--KLTLRALYLS--L----NKFTGEIPSD-----AFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~~~~p-~~~--~~~L~~L~Ls--~----N~l~g~ip~~-----~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
.+++|+.|.++.|.+++... .+. ..+|+.|+|+ + |+++ ..|.+ .+.++++|+.|+|++ .+++..
T Consensus 370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~ 447 (594)
T 2p1m_B 370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV 447 (594)
T ss_dssp HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence 47899999999999986544 232 3479999998 4 6666 33322 256788999999977 677665
Q ss_pred CccccC-CCCCCEEeccCCcCCCCCCC---CCCCCCCEEEcccCCCccCCCc----cccCCCCCcccCC
Q 008431 80 PKSLAG-LQKLLQLNLEGNSFQGKIPD---FPLAHLTLLDLSYNQLVGRIPD----TLSNFDATSFQGN 140 (565)
Q Consensus 80 p~~~~~-l~~L~~L~l~~N~l~g~~p~---~~~~~L~~l~ls~N~l~g~~p~----~~~~~~~~~~~~n 140 (565)
+..++. +++|+.|+|++|.+++..+. ..+++|+.|+|++|.+++..+. .+.++....+.+|
T Consensus 448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~ 516 (594)
T 2p1m_B 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC 516 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESS
T ss_pred HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCC
Confidence 566665 88899999999998654332 1468899999999998643322 2334444555554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.65 E-value=1.6e-05 Score=86.24 Aligned_cols=111 Identities=17% Similarity=0.206 Sum_probs=63.2
Q ss_pred hhcCCCCCCcEEEcccCcCc---cCCCc------------c--cccccceeecccccccccCCcchhcCCCCccEEEccC
Q 008431 10 DTLSRLPGLRSLSFINNSFD---GPMPS------------V--GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLAR 72 (565)
Q Consensus 10 ~~~~~l~~L~~L~l~~N~l~---~~~p~------------~--~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~ 72 (565)
..+..+++|+.|+|++|... +..|. + ...+|+.|+|++|.+++..+......+++|+.|+|++
T Consensus 60 ~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~ 139 (594)
T 2p1m_B 60 TVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSS 139 (594)
T ss_dssp HHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEES
T ss_pred HHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCC
Confidence 34556677777777776532 11110 0 1125777777777776554443222567777777777
Q ss_pred C-cCccc-CCccccCCCCCCEEeccCCcCCCCCCCC------CCCCCCEEEcccCC
Q 008431 73 N-HFSGQ-IPKSLAGLQKLLQLNLEGNSFQGKIPDF------PLAHLTLLDLSYNQ 120 (565)
Q Consensus 73 N-~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~------~~~~L~~l~ls~N~ 120 (565)
| .++.. ++..+.++++|++|+|++|.+++..+.. .+++|+.|++++|.
T Consensus 140 ~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 140 CEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA 195 (594)
T ss_dssp CEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC
T ss_pred cCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC
Confidence 7 44422 4444456777777777777765533221 35567777777765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00019 Score=71.08 Aligned_cols=74 Identities=15% Similarity=0.095 Sum_probs=58.1
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC---CCCccceEEEEEecCceEEEEeccCCCC
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS---HPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
+.|+.|.+..+|+... ++..+++|..... ....|..|...|+.+. ...+.+.+.++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 5689999999999875 5678888887542 3567888988888774 2467788888877788999999999875
Q ss_pred H
Q 008431 336 L 336 (565)
Q Consensus 336 L 336 (565)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00049 Score=71.26 Aligned_cols=74 Identities=15% Similarity=0.106 Sum_probs=48.1
Q ss_pred CCCccCCCCCCCEEEcCCCCcEEeccCCcccccccccc---c--ccccccCCCccCCC---CCCcchhHHHHHHHHHHHH
Q 008431 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQ---L--HMVAYKSPEFNQTD---GVTRKTDVWSLGILILELL 448 (565)
Q Consensus 377 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~---~--~t~~y~aPE~~~~~---~~~~~~DvwS~Gvil~el~ 448 (565)
..++|+|++|.|||++.++ +++.||+.+......... . -...|.+|+..... .-....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3799999999999998776 999999988654322111 0 11346666654321 1122345567888888887
Q ss_pred cCC
Q 008431 449 TGK 451 (565)
Q Consensus 449 tg~ 451 (565)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.45 E-value=2e-05 Score=71.94 Aligned_cols=89 Identities=16% Similarity=0.237 Sum_probs=66.9
Q ss_pred hcCCCCCCcEEEcccCcCccCCC-----cc-cccccceeeccccccccc----CCcchhcCCCCccEEEc--cCCcCccc
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMP-----SV-GKLTLRALYLSLNKFTGE----IPSDAFAGMDQLKKVHL--ARNHFSGQ 78 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p-----~~-~~~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~l--~~N~l~g~ 78 (565)
.+...++|+.|+|++|.|...-. .+ ...+|+.|+|++|.|+.. +. +++...+.|++|+| ++|.|+..
T Consensus 60 ~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~-~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 60 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV-EALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH-HGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH-HHHHhCCCceEEEecCCCCCCCHH
Confidence 45677899999999999973211 11 123699999999999742 22 23666789999999 88999753
Q ss_pred ----CCccccCCCCCCEEeccCCcCC
Q 008431 79 ----IPKSLAGLQKLLQLNLEGNSFQ 100 (565)
Q Consensus 79 ----~p~~~~~l~~L~~L~l~~N~l~ 100 (565)
+...+...++|+.|+|++|.+.
T Consensus 139 g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 139 VEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3445666789999999999875
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00018 Score=61.42 Aligned_cols=57 Identities=19% Similarity=0.297 Sum_probs=37.3
Q ss_pred ceeeccccccc-ccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCC
Q 008431 41 RALYLSLNKFT-GEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100 (565)
Q Consensus 41 ~~L~Ls~N~l~-g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 100 (565)
..++.+++.|+ ..+|.+ +. .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~-lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTA-FP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSC-CC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCC-CC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 35667777665 346644 22 35777777777777666666777777777777777765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.39 E-value=5.9e-05 Score=76.42 Aligned_cols=110 Identities=15% Similarity=0.181 Sum_probs=48.8
Q ss_pred cCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchh--cCCCCccEEEccC--CcCccc-----CCcc
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAF--AGMDQLKKVHLAR--NHFSGQ-----IPKS 82 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~--~~l~~L~~L~l~~--N~l~g~-----~p~~ 82 (565)
+..+|+|+.|+|++|.-. .++.+...+|+.|+|..|.++..... .+ ..+++|+.|+|+. |...|. +...
T Consensus 168 l~~~P~L~~L~L~g~~~l-~l~~~~~~~L~~L~L~~~~l~~~~l~-~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~ 245 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNL-SIGKKPRPNLKSLEIISGGLPDSVVE-DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245 (362)
T ss_dssp HHTCTTCCEEEEECCBTC-BCCSCBCTTCSEEEEECSBCCHHHHH-HHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG
T ss_pred HhcCCCCcEEEEeCCCCc-eeccccCCCCcEEEEecCCCChHHHH-HHHHccCCCCcEEEEeccccccccchhHHHHHHH
Confidence 344556666666555211 11222233566666665554321111 12 1456666666542 211111 0111
Q ss_pred c--cCCCCCCEEeccCCcCCCCCCC-----CCCCCCCEEEcccCCCcc
Q 008431 83 L--AGLQKLLQLNLEGNSFQGKIPD-----FPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 83 ~--~~l~~L~~L~l~~N~l~g~~p~-----~~~~~L~~l~ls~N~l~g 123 (565)
+ ..+++|+.|+|++|.++...+. ..+++|+.|+|+.|.|+.
T Consensus 246 l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp SCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred HhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 2 2355666666666665432111 124556666666666553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.34 E-value=5.1e-05 Score=76.88 Aligned_cols=107 Identities=18% Similarity=0.326 Sum_probs=74.5
Q ss_pred CCCCcEEEcccCcCccCCC-cc---cccccceeeccc--cccccc-----CCcchh--cCCCCccEEEccCCcCcccCCc
Q 008431 15 LPGLRSLSFINNSFDGPMP-SV---GKLTLRALYLSL--NKFTGE-----IPSDAF--AGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 15 l~~L~~L~l~~N~l~~~~p-~~---~~~~L~~L~Ls~--N~l~g~-----ip~~~~--~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
+++|+.|+|..|.++...- .+ ...+|+.|+|+. |...|. +.+ .+ ..+++|+.|+|.+|.++...+.
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~-~l~~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP-LFSKDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG-GSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH-HHhcCCCCCcCEEeCCCCCCchHHHH
Confidence 7899999999988763211 12 234799999864 332222 111 12 2478999999999999754444
Q ss_pred ccc---CCCCCCEEeccCCcCCCC----CCCC--CCCCCCEEEcccCCCc
Q 008431 82 SLA---GLQKLLQLNLEGNSFQGK----IPDF--PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 82 ~~~---~l~~L~~L~l~~N~l~g~----~p~~--~~~~L~~l~ls~N~l~ 122 (565)
.+. .+++|+.|+|+.|.++.. ++.. .+++|+.|+|++|.|+
T Consensus 271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 443 478999999999999863 2221 4689999999999886
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00033 Score=59.66 Aligned_cols=56 Identities=18% Similarity=0.329 Sum_probs=32.6
Q ss_pred EEEcccCcCc-cCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCc
Q 008431 20 SLSFINNSFD-GPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFS 76 (565)
Q Consensus 20 ~L~l~~N~l~-~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~ 76 (565)
.++.+++.|+ ..+|.....+|+.|+|++|+|+ .||.++|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 5566666665 2333222234666666666666 566666666666666666666553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0017 Score=64.50 Aligned_cols=144 Identities=17% Similarity=0.134 Sum_probs=80.8
Q ss_pred eecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCC--ccceEEE-----EEecCceEEEEeccC
Q 008431 260 VLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPN--LLPLIAF-----YYRKEEKLLVSDFVP 332 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lv~E~~~ 332 (565)
.++ |....||+....+|+.+++|..... ....+.+..|..+++.+.... +.+.+.. ....+..+++|||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 7788999887667778999988632 123556777887777664212 3333332 122455688999998
Q ss_pred CCCHH-----H------H---HhhcCC--C--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhhC-
Q 008431 333 NGSLA-----N------L---LHVRRA--P--GQPGLDWPIR----LKI---------------IKGVAKGLAYLYKEF- 374 (565)
Q Consensus 333 ~gsL~-----~------~---l~~~~~--~--~~~~l~~~~~----~~i---------------~~~ia~gL~ylH~~~- 374 (565)
|..+. . . ++.... . ....+++... ..+ ...+...+..+....
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 74321 1 1 111110 0 0112232211 001 111122233343322
Q ss_pred --CCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 375 --PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 375 --~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
.+..++|+|+++.|||++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999998 4 899999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0015 Score=64.74 Aligned_cols=145 Identities=15% Similarity=0.200 Sum_probs=79.2
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-----CCCccceE-E--EEEecCceEEEEec
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-----HPNLLPLI-A--FYYRKEEKLLVSDF 330 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lv~E~ 330 (565)
+.|+.|....+|+....+| .+++|..... ...+.+..|+.+++.+. -|.++... | +....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577888889999887555 6788887642 12345566777666553 23333210 1 11224567899999
Q ss_pred cCCCCHH--------------HHHhhcCCC-CCC---C---CCHHHHHH------------HHHHHHHHHHHHHhhCC--
Q 008431 331 VPNGSLA--------------NLLHVRRAP-GQP---G---LDWPIRLK------------IIKGVAKGLAYLYKEFP-- 375 (565)
Q Consensus 331 ~~~gsL~--------------~~l~~~~~~-~~~---~---l~~~~~~~------------i~~~ia~gL~ylH~~~~-- 375 (565)
++|..+. ..++..... ... . ..|..... +...+...++++....+
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 9875421 012211110 000 0 12332111 01124455666664422
Q ss_pred -CCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 376 -GVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 376 -~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+..++|+|+.+.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3468999999999999887656899998764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0017 Score=66.48 Aligned_cols=112 Identities=20% Similarity=0.332 Sum_probs=82.2
Q ss_pred cccChhhcCCCCCCcEEEcccCcCc-cCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFD-GPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
..|...+|.+++.|+.+.+.++..+ |.-.......|+.+.+. +.++ .|+..+|.++.+|+.++|..| ++..-..+|
T Consensus 254 ~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF 330 (394)
T 4gt6_A 254 ARIETHAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAF 330 (394)
T ss_dssp EEECTTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred eEcccceeeecccccEEecccccceecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence 3455677888999999998766543 11111233468888886 5677 789999999999999999765 665567789
Q ss_pred cCCCCCCEEeccCCcCCCCCCC---CCCCCCCEEEcccCCC
Q 008431 84 AGLQKLLQLNLEGNSFQGKIPD---FPLAHLTLLDLSYNQL 121 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g~~p~---~~~~~L~~l~ls~N~l 121 (565)
.++.+|+.+.|..| ++ .++. ..+.+|+.+++.+|..
T Consensus 331 ~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 331 AGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred hCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 99999999999755 55 3443 2678999999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0039 Score=62.13 Aligned_cols=144 Identities=13% Similarity=0.075 Sum_probs=71.2
Q ss_pred ceecccCcee-EEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCC--CCccceEEEEEecCceEEEEeccCCCC
Q 008431 259 EVLGSGSFGS-SYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH--PNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 259 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
+.|+.|+... +|+....++..+++|....... +.+..|+.+++.+.. -.+.+++.+. .+.-+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcc
Confidence 3455554443 6666543366777765443211 234455665555532 2244566553 233478999998777
Q ss_pred HHHHHhhcC---------------------CCCCCCCCHHHHH--------------------HHHHHHHHHHHHHHhh-
Q 008431 336 LANLLHVRR---------------------APGQPGLDWPIRL--------------------KIIKGVAKGLAYLYKE- 373 (565)
Q Consensus 336 L~~~l~~~~---------------------~~~~~~l~~~~~~--------------------~i~~~ia~gL~ylH~~- 373 (565)
+.+++.... ....+.++..... .....+...+..+...
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 765543211 0001112211100 0001112223333221
Q ss_pred -CCCCCCccCCCCCCCEEEcCC----CCcEEeccCCccc
Q 008431 374 -FPGVTLPHGHLKSSNVLLDNA----YEPLLTDYALVPI 407 (565)
Q Consensus 374 -~~~~~ivHrDlkp~NILl~~~----~~~kl~DfGla~~ 407 (565)
..+..++|+|+.+.|||++.+ ..+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123468999999999999874 6789999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0033 Score=61.71 Aligned_cols=140 Identities=9% Similarity=0.058 Sum_probs=73.6
Q ss_pred ceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCc-cceEEEEEecCceEEEEecc-CCCCH
Q 008431 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL-LPLIAFYYRKEEKLLVSDFV-PNGSL 336 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~E~~-~~gsL 336 (565)
+.|+.|....+|+. ..+++|........ .....+|+..++.+....+ .+++++ +.+.-++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56888999999998 56888877543211 1123457776666543233 344443 445568999999 55443
Q ss_pred HH------------------HHhhcCCCCCCCCC-HHHHHHHHH--------------HHHHHHHHHH----hhCCCCCC
Q 008431 337 AN------------------LLHVRRAPGQPGLD-WPIRLKIIK--------------GVAKGLAYLY----KEFPGVTL 379 (565)
Q Consensus 337 ~~------------------~l~~~~~~~~~~l~-~~~~~~i~~--------------~ia~gL~ylH----~~~~~~~i 379 (565)
.. .+|........... +.....+.. .+...+..+. ....+..+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 11111110000011 111111111 1111122221 11223358
Q ss_pred ccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 380 PHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 380 vHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+|+|+.+.||+ ..++.+.++||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5667789999987654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0015 Score=66.90 Aligned_cols=112 Identities=17% Similarity=0.232 Sum_probs=77.4
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCC-ccc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMP-SVG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKS 82 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~ 82 (565)
..|...+|.++++|+.+.+. +.++.... .+. ..+|+.++|..| ++ .|...+|.++.+|+.+.|..+ ++-.-..+
T Consensus 277 ~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~~I~~~a 352 (394)
T 4gt6_A 277 VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VTKIPESA 352 (394)
T ss_dssp CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CCBCCGGG
T ss_pred ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cCEEhHhH
Confidence 35677789999999999996 44543322 233 347999999865 77 899999999999999999765 76556789
Q ss_pred ccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCC
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l 121 (565)
|.++++|+.+++.+|.... -......+|+.+.+..|.+
T Consensus 353 F~~C~~L~~i~~~~~~~~~-~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 353 FSNCTALNNIEYSGSRSQW-NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp GTTCTTCCEEEESSCHHHH-HTCBCCCCC----------
T ss_pred hhCCCCCCEEEECCceeeh-hhhhccCCCCEEEeCCCCE
Confidence 9999999999999986542 1123567788888877755
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.005 Score=63.77 Aligned_cols=70 Identities=10% Similarity=0.142 Sum_probs=47.5
Q ss_pred ceecccCceeEEEEEEeC--------CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCc-cceEEEEEecCceEEEEe
Q 008431 259 EVLGSGSFGSSYKAVLLT--------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL-LPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~E 329 (565)
+.|+.|....||+....+ +..+++|..... ...+.+.+|..+++.+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 568888889999998753 467888876331 122566789888887754344 56666542 2 38999
Q ss_pred ccCCC
Q 008431 330 FVPNG 334 (565)
Q Consensus 330 ~~~~g 334 (565)
|++|.
T Consensus 153 ~l~G~ 157 (429)
T 1nw1_A 153 YIPSR 157 (429)
T ss_dssp CCCEE
T ss_pred EeCCc
Confidence 99863
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0062 Score=61.77 Aligned_cols=56 Identities=20% Similarity=0.277 Sum_probs=30.3
Q ss_pred ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccC
Q 008431 39 TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEG 96 (565)
Q Consensus 39 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 96 (565)
.|+.+.+..+ ++ .|+..+|.++++|+.+.+.+|.++..-+.+|.++.+|+.+.|..
T Consensus 264 ~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 264 ALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp TCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCT
T ss_pred hhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCc
Confidence 3555555432 33 45555556666666666655555544455555666666665543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0056 Score=62.59 Aligned_cols=24 Identities=21% Similarity=0.246 Sum_probs=17.1
Q ss_pred ccChhhcCCCCCCcEEEcccCcCc
Q 008431 6 MIDVDTLSRLPGLRSLSFINNSFD 29 (565)
Q Consensus 6 ~i~~~~~~~l~~L~~L~l~~N~l~ 29 (565)
.|+...|..+..|+.+.+..|..+
T Consensus 243 ~i~~~~f~~~~~l~~~~~~~~~~~ 266 (394)
T 4fs7_A 243 ELGKSVFYGCTDLESISIQNNKLR 266 (394)
T ss_dssp EECSSTTTTCSSCCEEEECCTTCE
T ss_pred ecccccccccccceeEEcCCCcce
Confidence 455567778888888888776543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.01 Score=60.22 Aligned_cols=143 Identities=15% Similarity=0.199 Sum_probs=80.9
Q ss_pred ceecccCceeEEEEEEeC--------CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCc-cceEEEEEecCceEEEEe
Q 008431 259 EVLGSGSFGSSYKAVLLT--------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL-LPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~E 329 (565)
+.+..|....+|+....+ +..+++|..... ......+.+|..+++.+.-.++ .++++++. + .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 457778888999988642 467888875332 2245667789988877742223 45665543 2 29999
Q ss_pred ccCCCCHH--------------HH---HhhcCCCCCCCC--CHHHHHHHHHHHH-------------------HHHHHHH
Q 008431 330 FVPNGSLA--------------NL---LHVRRAPGQPGL--DWPIRLKIIKGVA-------------------KGLAYLY 371 (565)
Q Consensus 330 ~~~~gsL~--------------~~---l~~~~~~~~~~l--~~~~~~~i~~~ia-------------------~gL~ylH 371 (565)
|++|..|. +. |+.......... -|....++..++. ..+.+|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99875442 11 111111111112 2444444444332 2344443
Q ss_pred hh----CCCCCCccCCCCCCCEEEcCC----CCcEEeccCCcc
Q 008431 372 KE----FPGVTLPHGHLKSSNVLLDNA----YEPLLTDYALVP 406 (565)
Q Consensus 372 ~~----~~~~~ivHrDlkp~NILl~~~----~~~kl~DfGla~ 406 (565)
.. ..+..++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 32 223468999999999999876 688999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0024 Score=64.69 Aligned_cols=72 Identities=7% Similarity=0.098 Sum_probs=41.4
Q ss_pred ceecccCceeEEEEEEeC---------CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCc-cceEEEEEecCceEEEE
Q 008431 259 EVLGSGSFGSSYKAVLLT---------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL-LPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~ 328 (565)
+.++.|....+|+....+ +..+++|........ ......|..+++.+...++ .++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 467788888999988654 267777776432111 1123567777776643333 3565443 247899
Q ss_pred eccCCCC
Q 008431 329 DFVPNGS 335 (565)
Q Consensus 329 E~~~~gs 335 (565)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.027 Score=58.65 Aligned_cols=73 Identities=10% Similarity=0.155 Sum_probs=45.2
Q ss_pred ceecccCceeEEEEEEeC-CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCc-cceEEEEEecCceEEEEeccCCCCH
Q 008431 259 EVLGSGSFGSSYKAVLLT-GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL-LPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
+.|+.|-...+|+....+ +..+++|........ .-.-.+|..+++.+...++ .++++++ .+ .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 568888889999998754 467778776432111 1112578888888865555 4666665 22 359999987443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0012 Score=59.16 Aligned_cols=84 Identities=20% Similarity=0.272 Sum_probs=53.6
Q ss_pred cccccceeecccccccccCCcchhcCCCCccEEEccCCc-CcccCCccccCC----CCCCEEeccCCc-CCCC--CCCCC
Q 008431 36 GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNH-FSGQIPKSLAGL----QKLLQLNLEGNS-FQGK--IPDFP 107 (565)
Q Consensus 36 ~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~--~p~~~ 107 (565)
....|+.||||++.++. .--..+.++++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++. +|.. ..-..
T Consensus 59 ~~~~L~~LDLs~~~Itd-~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~ 137 (176)
T 3e4g_A 59 DKYKIQAIDATDSCIMS-IGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHH 137 (176)
T ss_dssp TCCCEEEEEEESCCCCG-GGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGG
T ss_pred CCceEeEEeCcCCCccH-HHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhc
Confidence 34568888888888763 222336778888888888874 654322334443 368888888864 5521 00024
Q ss_pred CCCCCEEEcccCC
Q 008431 108 LAHLTLLDLSYNQ 120 (565)
Q Consensus 108 ~~~L~~l~ls~N~ 120 (565)
+++|+.|+|++..
T Consensus 138 ~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 138 FRNLKYLFLSDLP 150 (176)
T ss_dssp CTTCCEEEEESCT
T ss_pred CCCCCEEECCCCC
Confidence 6788888888764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.28 E-value=0.081 Score=48.57 Aligned_cols=103 Identities=13% Similarity=0.027 Sum_probs=66.8
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccccc
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHA 413 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 413 (565)
-+|.++|..+.. ++++.+++.++.|.+.+|.-+-..-. . ..+=+-|..|++..+|.+...+ ..+
T Consensus 33 vSL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~--~-~~~i~~~~~i~l~~dG~V~f~~-~~s-------- 96 (229)
T 2yle_A 33 LSLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQ--P-RHRVRSAAQIRVWRDGAVTLAP-AAD-------- 96 (229)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTC--C-CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhccc--C-CceecCCcceEEecCCceeccc-ccc--------
Confidence 389999988765 39999999999999999876622100 1 1223346889999999888764 111
Q ss_pred ccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 008431 414 QLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453 (565)
Q Consensus 414 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p 453 (565)
......+.|||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 97 ~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 97 DAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 11223567888763 3456788899999999998874444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.006 Score=62.32 Aligned_cols=108 Identities=17% Similarity=0.135 Sum_probs=82.5
Q ss_pred ccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccC
Q 008431 6 MIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAG 85 (565)
Q Consensus 6 ~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 85 (565)
.|+...|..+..|+.+.+..+.+.. .......+|+.+.+..| ++ .|+..+|.++++|+.++|..+ ++-.-..+|.+
T Consensus 266 ~i~~~~F~~~~~l~~~~~~~~~i~~-~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 341 (394)
T 4fs7_A 266 RIGGSLFYNCSGLKKVIYGSVIVPE-KTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRG 341 (394)
T ss_dssp EECSCTTTTCTTCCEEEECSSEECT-TTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTT
T ss_pred eeeccccccccccceeccCceeecc-ccccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-ccEEhHHhccC
Confidence 4666778899999999887765432 11223347899999755 67 799999999999999999755 77566789999
Q ss_pred CCCCCEEeccCCcCCCCCCC---CCCCCCCEEEcccC
Q 008431 86 LQKLLQLNLEGNSFQGKIPD---FPLAHLTLLDLSYN 119 (565)
Q Consensus 86 l~~L~~L~l~~N~l~g~~p~---~~~~~L~~l~ls~N 119 (565)
+.+|+.++|..| ++. ++. ..+.+|+.+++..|
T Consensus 342 c~~L~~i~lp~~-l~~-I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 342 CTSLSNINFPLS-LRK-IGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CTTCCEECCCTT-CCE-ECTTTBTTCTTCCEEEEEGG
T ss_pred CCCCCEEEECcc-ccE-ehHHHhhCCCCCCEEEECCC
Confidence 999999999877 553 433 26789999998765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0025 Score=56.93 Aligned_cols=91 Identities=8% Similarity=0.105 Sum_probs=60.6
Q ss_pred ccChhhcCCCCCCcEEEcccCcCccC-CCcc-cccccceeeccccc-ccccCCcchhcCC----CCccEEEccCCc-Ccc
Q 008431 6 MIDVDTLSRLPGLRSLSFINNSFDGP-MPSV-GKLTLRALYLSLNK-FTGEIPSDAFAGM----DQLKKVHLARNH-FSG 77 (565)
Q Consensus 6 ~i~~~~~~~l~~L~~L~l~~N~l~~~-~p~~-~~~~L~~L~Ls~N~-l~g~ip~~~~~~l----~~L~~L~l~~N~-l~g 77 (565)
.+|......+ .|+.|||+++.++.. +..+ +..+|+.|+|+++. ++.. --..+..+ ++|+.|+|+++. ++.
T Consensus 52 ~LP~~~~~~~-~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~-gL~~L~~~~~~~~~L~~L~Ls~C~~ITD 129 (176)
T 3e4g_A 52 HLPTGPLDKY-KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDG-CLERLSQLENLQKSMLEMEIISCGNVTD 129 (176)
T ss_dssp GSCCCSTTCC-CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHH-HHHHHHTCHHHHHHCCEEEEESCTTCCH
T ss_pred cCCcccCCCc-eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHH-HHHHHHhcccccCCCCEEEcCCCCcCCH
Confidence 4554333333 699999999998632 2223 33379999999985 5521 11124443 369999999974 774
Q ss_pred cCCccccCCCCCCEEeccCCc
Q 008431 78 QIPKSLAGLQKLLQLNLEGNS 98 (565)
Q Consensus 78 ~~p~~~~~l~~L~~L~l~~N~ 98 (565)
.-=..+..+++|+.|+|++..
T Consensus 130 ~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 130 KGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHHHGGGCTTCCEEEEESCT
T ss_pred HHHHHHhcCCCCCEEECCCCC
Confidence 323357789999999999874
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.012 Score=59.66 Aligned_cols=88 Identities=14% Similarity=0.144 Sum_probs=62.0
Q ss_pred cChhhcCCCCCCcEEEcccCcCccCCC-cc-cccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcccc
Q 008431 7 IDVDTLSRLPGLRSLSFINNSFDGPMP-SV-GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLA 84 (565)
Q Consensus 7 i~~~~~~~l~~L~~L~l~~N~l~~~~p-~~-~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 84 (565)
|+..+|.++.+|+.+.+..+ +..... .+ +..+|+.+.+.+|.++ .|+..+|.++.+|+.+.|..| ++-.-..+|.
T Consensus 254 I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 330 (379)
T 4h09_A 254 IGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFK 330 (379)
T ss_dssp ECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred eCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhh
Confidence 34444555555555555433 221111 12 2347999999999998 899999999999999999765 7655577899
Q ss_pred CCCCCCEEeccCC
Q 008431 85 GLQKLLQLNLEGN 97 (565)
Q Consensus 85 ~l~~L~~L~l~~N 97 (565)
++++|+.+.+..|
T Consensus 331 ~C~~L~~i~ip~~ 343 (379)
T 4h09_A 331 NCKALSTISYPKS 343 (379)
T ss_dssp TCTTCCCCCCCTT
T ss_pred CCCCCCEEEECCc
Confidence 9999999888654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.03 Score=55.87 Aligned_cols=31 Identities=23% Similarity=0.322 Sum_probs=26.9
Q ss_pred CCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 377 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
..++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999878899999987644
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0018 Score=58.98 Aligned_cols=84 Identities=8% Similarity=0.141 Sum_probs=38.6
Q ss_pred CCCCCcEEEcccC-cCccC--CC---cc-cccccceeecccccccccCC---cchhcCCCCccEEEccCCcCccc----C
Q 008431 14 RLPGLRSLSFINN-SFDGP--MP---SV-GKLTLRALYLSLNKFTGEIP---SDAFAGMDQLKKVHLARNHFSGQ----I 79 (565)
Q Consensus 14 ~l~~L~~L~l~~N-~l~~~--~p---~~-~~~~L~~L~Ls~N~l~g~ip---~~~~~~l~~L~~L~l~~N~l~g~----~ 79 (565)
+-+.|+.|+|++| .|... .. .+ ....|+.|+|++|+|...-- .+++..-+.|++|+|++|.|+.. +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3455666666664 55311 00 01 12246666666666651100 01122235566666666666521 1
Q ss_pred CccccCCCCCCEEeccCC
Q 008431 80 PKSLAGLQKLLQLNLEGN 97 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N 97 (565)
-..+..-+.|+.|+|++|
T Consensus 119 a~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHTTTTCCCSEEECCCC
T ss_pred HHHHhhCCceeEEECCCC
Confidence 222333445666666543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.07 E-value=0.15 Score=52.31 Aligned_cols=143 Identities=15% Similarity=0.229 Sum_probs=81.2
Q ss_pred ceecccCceeEEEEEEeC--------CCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCc-cceEEEEEecCceEEEEe
Q 008431 259 EVLGSGSFGSSYKAVLLT--------GPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL-LPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~E 329 (565)
+.+..|-...+|+....+ +..++++....... ..-...+|..+++.+.-.++ .++++.+ .-++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 467778888999998653 57788887543221 11123567777776642233 4555432 2378999
Q ss_pred ccCCCCHH--------------HH---HhhcCC-----C---CCCCCCHHHHHHHHHH-------------------HHH
Q 008431 330 FVPNGSLA--------------NL---LHVRRA-----P---GQPGLDWPIRLKIIKG-------------------VAK 365 (565)
Q Consensus 330 ~~~~gsL~--------------~~---l~~~~~-----~---~~~~l~~~~~~~i~~~-------------------ia~ 365 (565)
|++|..|. +. +|.... . .....-|..+.++..+ +..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 99986531 11 111100 0 1111124443333322 223
Q ss_pred HHHHHHhhC--------------------CCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 366 GLAYLYKEF--------------------PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 366 gL~ylH~~~--------------------~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
.+.+|.+.. .+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 444544221 1235789999999999 7888999999987643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=92.74 E-value=0.031 Score=50.84 Aligned_cols=89 Identities=12% Similarity=0.158 Sum_probs=57.3
Q ss_pred hcCCCCCCcEEEcccCcCcc--CCC--c-c-cccccceeecccccccccCC---cchhcCCCCccEEEccCCc---Ccc-
Q 008431 11 TLSRLPGLRSLSFINNSFDG--PMP--S-V-GKLTLRALYLSLNKFTGEIP---SDAFAGMDQLKKVHLARNH---FSG- 77 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~--~~p--~-~-~~~~L~~L~Ls~N~l~g~ip---~~~~~~l~~L~~L~l~~N~---l~g- 77 (565)
.+..-+.|+.|+|++|+|.. ... . + ...+|+.|+|++|+|+..-- .+++..-+.|++|+|++|. +..
T Consensus 65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~ 144 (197)
T 1pgv_A 65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQ 144 (197)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHH
T ss_pred HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHH
Confidence 45566789999999999973 222 1 1 23369999999999973210 0123444679999998763 332
Q ss_pred ---cCCccccCCCCCCEEeccCCcC
Q 008431 78 ---QIPKSLAGLQKLLQLNLEGNSF 99 (565)
Q Consensus 78 ---~~p~~~~~l~~L~~L~l~~N~l 99 (565)
.+-..+..-++|..|+|+.|..
T Consensus 145 g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 145 VEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHHhCCCcCeEeccCCCc
Confidence 1333455556777777776653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.21 E-value=0.5 Score=43.22 Aligned_cols=120 Identities=12% Similarity=0.118 Sum_probs=81.6
Q ss_pred CCCCCccceEEEEEecCceEEEEeccCCC-CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCC
Q 008431 306 LSHPNLLPLIAFYYRKEEKLLVSDFVPNG-SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHL 384 (565)
Q Consensus 306 l~H~niv~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDl 384 (565)
-.||+++.. .+-.+.+.+.+.++.-+.+ ++.. ++ .++...+++++.+|+.-..+++. -+|--+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik--------~~~~~eKlr~l~ni~~l~~~~~~------r~tf~L 105 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK--------SFTKNEKLRYLLNIKNLEEVNRT------RYTFVL 105 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG--------GSCHHHHHHHHHHGGGGGGGGGS------SEECCC
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH--------hcCHHHHHHHHHHHHHHHHHhcC------ceEEEE
Confidence 368888876 4555666666666654422 2222 22 27778999999999887765553 347778
Q ss_pred CCCCEEEcCCCCcEEeccCCcccccccccccccccccCCCccCCCCCCcchhHH-HHHHHHHHHHcCCCCccccccC
Q 008431 385 KSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVW-SLGILILELLTGKFPANYLAQG 460 (565)
Q Consensus 385 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw-S~Gvil~el~tg~~p~~~~~~~ 460 (565)
.|+||+++.++.+++.-.|+... ++|. .. ..-|-| .+=|++..+++++..|+..-.+
T Consensus 106 ~P~NL~f~~~~~p~i~~RGik~~-------------l~P~-----~~-~ee~fL~qyKAliiall~~K~~Fe~l~~G 163 (215)
T 4ann_A 106 APDELFFTRDGLPIAKTRGLQNV-------------VDPL-----PV-SEAEFLTRYKALVICAFNEKQSFDALVEG 163 (215)
T ss_dssp SGGGEEECTTSCEEESCCEETTT-------------BSCC-----CC-CHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred ecceEEEcCCCCEEEEEccCccC-------------CCCC-----CC-CHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence 99999999999999988876432 2232 11 233444 6888999999999999754443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.45 E-value=0.12 Score=53.73 Aligned_cols=59 Identities=10% Similarity=0.043 Sum_probs=17.3
Q ss_pred ceecccCceeEEEEEEeC-CCeeEE------EEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 008431 259 EVLGSGSFGSSYKAVLLT-GPAMVV------KRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR 320 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 320 (565)
+.|| ||.||+|.+.. ...||| |..+... ......|.+|..+++.++|||+++.+++...
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4565 99999999653 467888 7665422 2234568899999999999999999887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.11 E-value=3 Score=38.15 Aligned_cols=115 Identities=11% Similarity=0.114 Sum_probs=77.9
Q ss_pred CCCCccceEEEEEecCceEEEEeccCCC-CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhhCCCCCCccCCC
Q 008431 307 SHPNLLPLIAFYYRKEEKLLVSDFVPNG-SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLA-YLYKEFPGVTLPHGHL 384 (565)
Q Consensus 307 ~H~niv~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~-ylH~~~~~~~ivHrDl 384 (565)
.||++ -..+-.+++.+.+.++.-+++ ++. .++ .++...+++++.+|+.-.. +++. -+|--+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~--------~~~~~eKlrll~nl~~L~~~~~~~------r~tf~l 110 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR--------KTTLLSRIRAAIHLVSKVKHHSAR------RLIFIV 110 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH--------TSCHHHHHHHHHHHHHHHSSCCSS------SEECCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH--------hcCHHHHHHHHHHHHHHHHHhhhC------ceeEEE
Confidence 57777 233345666777777765443 343 333 2777889999888877665 4443 457778
Q ss_pred CCCCEEEcCCCCcEEeccCCcccccccccccccccccCCCccCCCCCCcchhHH-HHHHHHHHHHcCCCCcccc
Q 008431 385 KSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTDGVTRKTDVW-SLGILILELLTGKFPANYL 457 (565)
Q Consensus 385 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw-S~Gvil~el~tg~~p~~~~ 457 (565)
.|+||++|.++.+++.-.|+-.. ++|.- ....|-| .+=|++..++.++..|+..
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~~~-------------lpP~e------~~ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVKES-------------LPPDE------WDDERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp CGGGEEECTTCCEEESCCEETTT-------------BSSCS------CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred eCceEEEeCCCcEEEEEcCCccc-------------CCCCC------CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 89999999999999998886432 34431 1233444 6888999999999888643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 565 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-40 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-32 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-32 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-22 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-22 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-17 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-41
Identities = 52/282 (18%), Positives = 111/282 (39%), Gaps = 32/282 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+ +GSGSFG+ YK A+ + + + F + L H N+L + +
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+ +V+ + SL + LH+ + + I + A+G+ YL+ +
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH--AKSI- 125
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPEF---NQTD 429
H LKS+N+ L + D+ L + ++ + + +PE +
Sbjct: 126 -IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 430 GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489
+ ++DV++ GI++ EL+TG+ P +N + + +V + D+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRGY----LSPDLS 232
Query: 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531
+S + +K ++ C + + R + + I L
Sbjct: 233 KVRSNCPKAMK--RLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 8e-41
Identities = 57/278 (20%), Positives = 107/278 (38%), Gaps = 32/278 (11%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+ +GSG FG + L + +K R+ + +EDF E + LSHP L+ L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
+ LV +F+ +G L++ L +R L + V +G+AYL +
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEEA----C 121
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----VAYKSPEFNQTDGVTR 433
+ H L + N L+ ++D+ + V + V + SPE +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 434 KTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493
K+DVWS G+L+ E+ + +N+++ +++ R
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYE----NRSNSEVVEDISTGFRLYKP------------- 224
Query: 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531
+ +I C + E R + ++ E+ E
Sbjct: 225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 7e-40
Identities = 54/300 (18%), Positives = 104/300 (34%), Gaps = 32/300 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
E +G G FG ++ G + VK F + + L H N+L IA
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 319 YRKEEKL----LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ LVSD+ +GSL + L+ + + +K+ A GLA+L+ E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 375 PGVT----LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA--------YKS 422
G + H LKS N+L+ + D L + + + Y +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 423 PEFNQTD------GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADL--ATWVNSV 474
PE ++ D++++G++ E+ + DL +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 475 VREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDN 534
+R+ + ++ + + KI C N R + + +L +++
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 57/315 (18%), Positives = 116/315 (36%), Gaps = 37/315 (11%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
LG+G+ G +K +G M K ++ + + L + P ++
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+Y E + + + GSL +L + I K+ V KGL YL ++
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM--VAYKSPEFNQTDGVTRK 434
+ H +K SN+L+++ E L D+ + + A + +Y SPE Q + +
Sbjct: 127 M---HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 435 TDVWSLGILILELLTGKFP----------ANYLAQGKGANADLATWVNSVVREEWTGEVF 484
+D+WS+G+ ++E+ G++P + Q +G A+ + R + +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 485 DKDMRGTKSGEGEMLK--------------LLKIGMCCCEWNAERRWDLREAVEKIMELK 530
+ ++ C N R DL++ + +K
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF-IK 302
Query: 531 ERDNDNEDYSSYASE 545
D + D++ +
Sbjct: 303 RSDAEEVDFAGWLCS 317
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-36
Identities = 53/274 (19%), Positives = 102/274 (37%), Gaps = 30/274 (10%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+ +G G FG G + VK + ++ + F + + L H NL+ L+
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 319 YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
++ L +V++++ GSL + L R G+ L LK V + + YL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---- 122
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-VAYKSPEFNQTDGVTRKTD 436
H L + NVL+ ++D+ L + + V + +PE + + K+D
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 437 VWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEG 496
VWS GIL+ E+ + + D+ V + +
Sbjct: 183 VWSFGILLWEIYSFGRVPYP----RIPLKDVVPRVEKGYKMDAPDGCPP----------- 227
Query: 497 EMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530
+ ++ C +A R + E++ +K
Sbjct: 228 ---AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-36
Identities = 55/291 (18%), Positives = 107/291 (36%), Gaps = 39/291 (13%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRL 303
RE +L E LG+G FG + + VK +Q ++ + F +
Sbjct: 11 PRETLKLV-------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLM 62
Query: 304 GSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGV 363
L H L+ L A +E ++++++ NGSL + L P L L + +
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQI 118
Query: 364 AKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----V 418
A+G+A++ + H L+++N+L+ + + D+ L ++ +
Sbjct: 119 AEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 419 AYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478
+ +PE T K+DVWS GIL+ E++T N ++ + R
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQNLERGYRMV 230
Query: 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529
+ +L ++ C + E R + +
Sbjct: 231 RPDNCPE--------------ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-36
Identities = 52/277 (18%), Positives = 109/277 (39%), Gaps = 34/277 (12%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
+ LG+G FG + +K ++ ++ +++F E + +LSH L+ L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
++ ++++++ NG L N L R L++ K V + + YL +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESK----Q 120
Query: 379 LPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----VAYKSPEFNQTDGVTR 433
H L + N L+++ ++D+ L V + + V + PE +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 434 KTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492
K+D+W+ G+L+ E+ + GK P N++ A + +R +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERF-----TNSETAEHIAQGLRLYRPHLASE------- 228
Query: 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529
K+ I C A+ R + + I+++
Sbjct: 229 -------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 9e-35
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 11/205 (5%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+G+GS+G K G +V K M+ K+ + L L HPN++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 316 AFYYRKEEKLL--VSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY-K 372
+ L V ++ G LA+++ Q LD L+++ + L + +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRR 128
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV----AYKSPEFNQT 428
G T+ H LK +NV LD L D+ L I+N + + Y SPE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 429 DGVTRKTDVWSLGILILELLTGKFP 453
K+D+WSLG L+ EL P
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-34
Identities = 55/286 (19%), Positives = 93/286 (32%), Gaps = 39/286 (13%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRL 303
RE L LG G FG + + +K + + E F + +
Sbjct: 15 PRESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVM 66
Query: 304 GSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGV 363
L H L+ L A E +V++++ GSL + L P + + +
Sbjct: 67 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQI 122
Query: 364 AKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-----V 418
A G+AY+ + H L+++N+L+ + D+ L ++ +
Sbjct: 123 ASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 419 AYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478
+ +PE T K+DVWS GIL+ EL T N ++ V R
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP----GMVNREVLDQVERGYRMP 234
Query: 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
E + L + C E R
Sbjct: 235 CPPECPE--------------SLHDLMCQCWRKEPEERPTFEYLQA 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 57/312 (18%), Positives = 105/312 (33%), Gaps = 43/312 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGP---AMVVKRFRQM-SNVGKEDFHEHMTRLGSLS-HPNLLP 313
+V+G G+FG KA + +KR ++ S DF + L L HPN++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVR-----------RAPGQPGLDWPIRLKIIKG 362
L+ + L ++ P+G+L + L L L
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 363 VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV---A 419
VA+G+ YL ++ H L + N+L+ Y + D+ L +
Sbjct: 136 VARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 191
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW 479
+ + E T +DVWS G+L+ E+++ A+L + R E
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEKLPQGYRLEK 247
Query: 480 TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDY 539
D ++ + C R + + + + E +
Sbjct: 248 PLNCDD--------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 293
Query: 540 SSYASEDYVYSS 551
+ Y E + Y+
Sbjct: 294 TLY--EKFTYAG 303
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 2e-33
Identities = 56/332 (16%), Positives = 106/332 (31%), Gaps = 64/332 (19%)
Query: 232 NDEISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLL------TGPAMVVKRF 285
N ++ L + R E +G G+FG ++A + VK
Sbjct: 2 NPKLLSLEY---PRNNIEYV-------RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML 51
Query: 286 R-QMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRR 344
+ + S + DF + +PN++ L+ + L+ +++ G L L
Sbjct: 52 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 111
Query: 345 -------------------APGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLK 385
+PG P L +L I + VA G+AYL + H L
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLA 167
Query: 386 SSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPEFNQTDGVTRKTDVWS 439
+ N L+ + D+ L + + + PE + T ++DVW+
Sbjct: 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227
Query: 440 LGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEML 499
G+++ E+ + Y A+ ++ +V E L
Sbjct: 228 YGVVLWEIFSYGLQPYY----GMAHEEVIYYVRDGNILACP--------------ENCPL 269
Query: 500 KLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531
+L + C R + + E
Sbjct: 270 ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (316), Expect = 4e-33
Identities = 54/301 (17%), Positives = 116/301 (38%), Gaps = 39/301 (12%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR 302
+R + LG G +G Y+ V + VK + + E+F +
Sbjct: 15 ERTDITMK-------HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66
Query: 303 LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKG 362
+ + HPNL+ L+ R+ ++++F+ G+L + L + + + L +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQ 123
Query: 363 VAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH-----M 417
++ + YL K+ H L + N L+ + + D+ L ++ + H
Sbjct: 124 ISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 418 VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE 477
+ + +PE + + K+DVW+ G+L+ E+ T +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDL 222
Query: 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNE 537
E+ +KD R + EG K+ ++ C +WN R E + + + + ++
Sbjct: 223 SQVYELLEKDYRMERP-EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
Query: 538 D 538
+
Sbjct: 282 E 282
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 5e-33
Identities = 69/306 (22%), Positives = 116/306 (37%), Gaps = 53/306 (17%)
Query: 259 EVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVGK-EDFHEHMTRLGSLSHPNLLP 313
EV+G G FG Y LL VK +++++G+ F + SHPN+L
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 314 LIAFYYRKEEK-LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L+ R E L+V ++ +G L N + + VAKG+ +L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM--------VAYKSPE 424
+ H L + N +LD + + D+ L + + V + + E
Sbjct: 149 K----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484
QT T K+DVWS G+L+ EL+T P + T ++
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--------------------DVNTFDIT 244
Query: 485 DKDMRGTKSGEGEML--KLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDYSSY 542
++G + + E L ++ + C AE R E V +I + +S++
Sbjct: 245 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI---------FSTF 295
Query: 543 ASEDYV 548
E YV
Sbjct: 296 IGEHYV 301
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 6e-33
Identities = 43/200 (21%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E +G G+ G+ Y A+ + TG + +++ KE + + +PN++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
Y +E +V +++ GSL +++ + +D + + + L +L+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSN---- 135
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTDGVTR 433
+ H +KS N+LL LTD+ + E ++ + + +PE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 434 KTDVWSLGILILELLTGKFP 453
K D+WSLGI+ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 47/205 (22%), Positives = 80/205 (39%), Gaps = 18/205 (8%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
LG G+FG YKA T K S ED+ + L S HPN++ L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+Y + ++ +F G++ ++ P L + K L YL+ +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYLHDN--KI 131
Query: 378 TLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEF-----NQT 428
H LK+ N+L + L D+ + + + + +PE ++
Sbjct: 132 I--HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 429 DGVTRKTDVWSLGILILELLTGKFP 453
K DVWSLGI ++E+ + P
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 52/297 (17%), Positives = 118/297 (39%), Gaps = 39/297 (13%)
Query: 259 EVLGSGSFGSSYKAVLLTGP-----AMVVKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLL 312
+V+G+G FG YK +L T + +K + + + DF +G SH N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L + + +++++++ NG+L L + + +++G+A G+ YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-------VAYKSPEF 425
H L + N+L+++ ++D+ L ++ + + + + +PE
Sbjct: 129 M----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 426 NQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485
T +DVWS GI++ E++T + + +N ++ +N R
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYW----ELSNHEVMKAINDGFRLPTP----- 235
Query: 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDYSSY 542
+ ++ M C + RR + V + +L + + + +
Sbjct: 236 ---------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 1e-32
Identities = 52/291 (17%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 259 EVLGSGSFGSSYKAVLL----TGPAMVVKRFR-QMSNVGKEDFHEHMTRLGSLSHPNLLP 313
+V+G+G FG L + +K + + + DF + +G HPN++
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L + +++++F+ NGSL + L + +++G+A G+ YL
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLADM 147
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA---------YKSPE 424
H L + N+L+++ ++D+ L + + + + + +PE
Sbjct: 148 ----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 425 FNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483
Q T +DVWS GI++ E+++ G+ P + N D+ + R +
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----TNQDVINAIEQDYRLPPPMDC 258
Query: 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDN 534
L ++ + C + + R + V + ++ N
Sbjct: 259 PS--------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 2e-32
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 23/227 (10%)
Query: 234 EISKLHFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVG 292
++++L F ++ ++F +G GSFG+ Y A + + +K+
Sbjct: 3 DVAELFFKDDPEKLFSD-------LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55
Query: 293 KEDFHEHMTR---LGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQP 349
E + + + L L HPN + Y R+ LV ++ + L ++
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----- 110
Query: 350 GLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409
L + G +GLAYL+ + H +K+ N+LL L D+ I+
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 410 KEHAQLHMVAYKSPEFNQTDG---VTRKTDVWSLGILILELLTGKFP 453
++ + + +PE K DVWSLGI +EL K P
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 124 bits (311), Expect = 6e-32
Identities = 45/201 (22%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E LG+G+FG ++ TG K KE + + + L HP L+ L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+ E +++ +F+ G L + + ++ ++ V KGL ++++
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHEN---- 143
Query: 378 TLPHGHLKSSNVLL--DNAYEPLLTDYALVPIVNKEHA---QLHMVAYKSPEFNQTDGVT 432
H LK N++ + E L D+ L ++ + + + +PE + V
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 433 RKTDVWSLGILILELLTGKFP 453
TD+WS+G+L LL+G P
Sbjct: 204 YYTDMWSVGVLSYILLSGLSP 224
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 56/295 (18%), Positives = 109/295 (36%), Gaps = 46/295 (15%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLL---TGPAMVVKRFRQMSNVG-KEDFHEH 299
R+ + D+ LG G+FGS + V + +K +Q + E+
Sbjct: 6 KRDNLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 59
Query: 300 MTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKI 359
+ L +P ++ LI + E +LV + G L L +R + ++
Sbjct: 60 AQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAEL 114
Query: 360 IKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-- 417
+ V+ G+ YL E H L + NVLL N + ++D+ L + + +
Sbjct: 115 LHQVSMGMKYL--EEKNFV--HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 418 -----VAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWV 471
+ + +PE + ++DVWS G+ + E L+ G+ P + ++ ++
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGPEVMAFI 225
Query: 472 NSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKI 526
R E E +L + C + E R D +++
Sbjct: 226 EQGKRMECPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 60/273 (21%), Positives = 97/273 (35%), Gaps = 37/273 (13%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
LG G FG+ Y A + + +K + + + K + R L HPN+L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L +++ L+ ++ P G++ L D I +A L+Y + +
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHSK 125
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM--VAYKSPEFNQTDGV 431
V H +K N+LL +A E + D+ + Y PE +
Sbjct: 126 --RVI--HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 432 TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491
K D+WSLG+L E L GK P + R E+T F +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFT---FPDFV--- 227
Query: 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
L+ + N +R LRE +E
Sbjct: 228 ---TEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-31
Identities = 50/276 (18%), Positives = 107/276 (38%), Gaps = 35/276 (12%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRF--RQMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+G GSF + YK + T + R+++ ++ F E L L HPN++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 316 AFYY----RKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ K+ +LV++ + +G+L L + + + + + KGL +L+
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLH 129
Query: 372 KEFPGVTLPHGHLKSSNVLLDNA-YEPLLTDYALVPIVNKEHAQLHM--VAYKSPEFNQT 428
+ H LK N+ + + D L + A+ + + +PE +
Sbjct: 130 TR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186
Query: 429 DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488
+ DV++ G+ +LE+ T ++P A + V S V+ +V ++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
+ +I C N + R+ +++ +
Sbjct: 243 K-------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 122 bits (306), Expect = 3e-31
Identities = 59/272 (21%), Positives = 111/272 (40%), Gaps = 30/272 (11%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
E LGSG+FG ++ V TG V K + K ++ + L HP L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+ K E +L+ +F+ G L + + + + ++ +GL ++++ +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMHEH--SI 148
Query: 378 TLPHGHLKSSNVLLDNAYEPL--LTDYALVPIVNKEHAQLHMVA---YKSPEFNQTDGVT 432
H +K N++ + + D+ L +N + A + +PE + V
Sbjct: 149 V--HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 433 RKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTK 492
TD+W++G+L LL+G P A D + +V R +W FD+D +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPF--------AGEDDLETLQNVKRCDWE---FDEDAFSSV 255
Query: 493 SGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
S E +K + +R + +A+E
Sbjct: 256 S--PEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 55/321 (17%), Positives = 112/321 (34%), Gaps = 49/321 (15%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVL------LTGPAMVVKRFRQMSNVG-KEDF 296
RE ++ LG GSFG Y+ V + +K + +++ + +F
Sbjct: 18 AREKITMS-------RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF 70
Query: 297 HEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRR-----APGQPGL 351
+ + + +++ L+ + + L++ + + G L + L R P
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 352 DWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411
+++ +A G+AYL H L + N ++ + + D+ + + +
Sbjct: 131 SLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 412 HAQLHM------VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANA 465
V + SPE + T +DVWS G+++ E+ T N
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NE 242
Query: 466 DLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525
+ +V + D L ++ C ++N + R E +
Sbjct: 243 QVLRFVMEGGLLDKPDNCPD--------------MLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 526 IMELKERDNDNEDYSSYASED 546
I E E + S Y SE+
Sbjct: 289 IKEEME--PGFREVSFYYSEE 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 2e-30
Identities = 58/322 (18%), Positives = 117/322 (36%), Gaps = 44/322 (13%)
Query: 259 EVLGSGSFGSSYKAVLL-----TGPAMVVKRFRQ-MSNVGKEDFHEHMTRLGSLSHPNLL 312
+VLGSG+FG+ YK + + + +K R+ S ++ + + S+ +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L+ +L+ +P G L + + + L +AKG+ YL
Sbjct: 75 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNYLED 129
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPEFN 426
H L + NVL+ +TD+ L ++ E + H + + + E
Sbjct: 130 RRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486
T ++DVWS G+ + EL+T +++++ + R
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLPQP------ 235
Query: 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE-----RDNDNEDYSS 541
+ + I + C +A+ R RE + + ++ ++
Sbjct: 236 --------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
Query: 542 YASEDYVYSSRAMTDEDFSFSV 563
S RA+ DE+ V
Sbjct: 288 LPSPTDSNFYRALMDEEDMDDV 309
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 2e-30
Identities = 57/313 (18%), Positives = 104/313 (33%), Gaps = 60/313 (19%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVG-KEDF 296
RE E +VLGSG+FG A + VK ++ ++ +E
Sbjct: 35 PRENLEFG-------KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL 87
Query: 297 HEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAP--------- 346
+ + L SH N++ L+ L+ ++ G L N L +R
Sbjct: 88 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147
Query: 347 ---------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEP 397
L + L VAKG+ +L H L + NVL+ +
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCV--HRDLAARNVLVTHGKVV 203
Query: 398 LLTDYALVPIVNKEHAQLHM------VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGK 451
+ D+ L + + + V + +PE T K+DVWS GIL+ E+ +
Sbjct: 204 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
Query: 452 FPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEW 511
G +A+ + + + + + ++ I C +
Sbjct: 264 VNPY---PGIPVDANFYKLIQNGFKMDQPFYATE--------------EIYIIMQSCWAF 306
Query: 512 NAERRWDLREAVE 524
++ +R
Sbjct: 307 DSRKRPSFPNLTS 319
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-30
Identities = 58/313 (18%), Positives = 108/313 (34%), Gaps = 55/313 (17%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVG-KEDF 296
R + LG+G+FG +A + VK + +++ +E
Sbjct: 21 PRNRLSFG-------KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73
Query: 297 HEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRR----------- 344
+ L L H N++ L+ L+++++ G L N L +R
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 345 --APGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402
+ LD L VAKG+A+L + H L + N+LL + + D+
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGRITKICDF 189
Query: 403 ALVPIVNKEHAQLHM------VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANY 456
L + + + V + +PE T ++DVWS GI + EL +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 457 LAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR 516
G ++ + R S E ++ I C + + +R
Sbjct: 250 ---GMPVDSKFYKMIKEGFRML--------------SPEHAPAEMYDIMKTCWDADPLKR 292
Query: 517 WDLREAVEKIMEL 529
++ V+ I +
Sbjct: 293 PTFKQIVQLIEKQ 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-30
Identities = 61/311 (19%), Positives = 110/311 (35%), Gaps = 53/311 (17%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLL---TGPAMVVKRFRQ--MSNVGKEDFHE 298
DR++ L D + LGSG+FG+ K + VK + K++
Sbjct: 4 DRKLLTLED------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 57
Query: 299 HMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
+ L +P ++ +I E +LV + G L L R + ++
Sbjct: 58 EANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIE 111
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM- 417
++ V+ G+ YL + H L + NVLL + ++D+ L + +
Sbjct: 112 LVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 418 ------VAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATW 470
V + +PE + K+DVWS G+L+ E + G+ P
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----------------- 210
Query: 471 VNSVVREEWTGEVFDKDMRGTKSG--EGEMLKLLKIGMCCCEWNAERRWDLREAVEKIME 528
R EV +G + G G ++ + C ++ E R ++
Sbjct: 211 ----YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
Query: 529 LKERDNDNEDY 539
D NE +
Sbjct: 267 YYY-DVVNEGH 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-29
Identities = 49/275 (17%), Positives = 93/275 (33%), Gaps = 35/275 (12%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVG-KEDFHEHMTRLGSLSHPNLLPLIA 316
+ LG G++G AV T A+ VK V E+ + + L+H N++
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+ L ++ G L + + G+ P + + G+ YL+
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPEFNQTDG 430
H +K N+LLD ++D+ L + + + + + Y +PE +
Sbjct: 126 ----HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 431 V-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMR 489
DVWS GI++ +L G+ Q + + + W ++
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGEL---PWDQPSDSCQEYSDWKEKKTYLNPWKKIDS---- 234
Query: 490 GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
L LL N R + + +
Sbjct: 235 -------APLALLH---KILVENPSARITIPDIKK 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 9e-29
Identities = 39/200 (19%), Positives = 82/200 (41%), Gaps = 13/200 (6%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFY 318
E LG G FG ++ V + + +F ++ + + ++ L H N+L L +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 319 YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVT 378
EE +++ +F+ + ++ L+ + + V + L +L+
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEALQFLHSH----N 122
Query: 379 LPHGHLKSSNVLLDNAYEPL--LTDYALVPIVNKEHAQLHMV---AYKSPEFNQTDGVTR 433
+ H ++ N++ + ++ + + Y +PE +Q D V+
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 434 KTDVWSLGILILELLTGKFP 453
TD+WSLG L+ LL+G P
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 1e-28
Identities = 52/301 (17%), Positives = 102/301 (33%), Gaps = 44/301 (14%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVG-KEDFHE 298
RE EL +G G FG ++ + + A+ +K + ++ +E F +
Sbjct: 5 QRERIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 57
Query: 299 HMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLK 358
+ HP+++ LI + ++ + G L + L VR+ LD +
Sbjct: 58 EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYS----LDLASLIL 112
Query: 359 IIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM- 417
++ LAYL + H + + NVL+ + L D+ L +
Sbjct: 113 YAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168
Query: 418 ----VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNS 473
+ + +PE T +DVW G+ + E+L + N D+ + +
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVIGRIEN 224
Query: 474 VVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533
R L + C ++ RR E ++ + E +
Sbjct: 225 GERLPMPPNCPP--------------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
Query: 534 N 534
Sbjct: 271 K 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-28
Identities = 53/287 (18%), Positives = 101/287 (35%), Gaps = 42/287 (14%)
Query: 259 EVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPN 310
E LG GSFG + ++ VK + + + + + R + SL H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 311 LLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
L+ L K+ V++ P GSL + L + + VA+G+ YL
Sbjct: 73 LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYL 127
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-------VAYKSP 423
+ H L + N+LL + D+ L+ + + M A+ +P
Sbjct: 128 ESKR----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 424 EFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483
E +T + +D W G+ + E+ T + + ++ + +E GE
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKE---GER 233
Query: 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530
+ E + + + C E R + ++E +
Sbjct: 234 LPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 5e-28
Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 21/206 (10%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
++LG GSF + A L T +K ++ KE+ ++TR + L HP +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L + E+ + NG L + D + L YL+ +
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM------VAYKSPEFNQ 427
+ H LK N+LL+ +TD+ +++ E Q Y SPE
Sbjct: 128 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP 453
+ +D+W+LG +I +L+ G P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (275), Expect = 1e-27
Identities = 40/211 (18%), Positives = 84/211 (39%), Gaps = 26/211 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
E+LG G + A L + VK R F+ R +L+HP ++
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 314 LIAFYYRKEEKL----LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
+ + +V ++V +L +++H + +++I + L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNF 126
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-------VAYKS 422
++ + H +K +N+++ + D+ + + + Y S
Sbjct: 127 SHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 423 PEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
PE + D V ++DV+SLG ++ E+LTG+ P
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 4e-27
Identities = 53/274 (19%), Positives = 101/274 (36%), Gaps = 33/274 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKED-FHEHMTRLGSLSHPNLLPLIA 316
+VLG+G+F A T + +K + + GKE + L + HPN++ L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
Y L+ V G L + + + ++I V + YL+
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG-- 127
Query: 377 VTLPHGHLKSSNVLLDNAYE---PLLTDYALVPIVNKEHAQLHMV---AYKSPEFNQTDG 430
+ H LK N+L + E +++D+ L + + Y +PE
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 431 VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490
++ D WS+G++ LL G P + + A +++ E+ FD
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFY--------DENDAKLFEQILKAEYE---FDSPYWD 234
Query: 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
S + + E + E+R+ +A++
Sbjct: 235 DISDSAKDF-IRH----LMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 8e-27
Identities = 44/204 (21%), Positives = 75/204 (36%), Gaps = 18/204 (8%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
++LG GSFG + A T +K ++ + +D M + HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+ + KE V +++ G L + D + GL +L+
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS- 121
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTD 429
G+ + LK N+LLD + D+ + A+ + Y +PE
Sbjct: 122 -KGIV--YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 430 GVTRKTDVWSLGILILELLTGKFP 453
D WS G+L+ E+L G+ P
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 5e-26
Identities = 55/316 (17%), Positives = 102/316 (32%), Gaps = 59/316 (18%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLL--------TGPAMVVKRFR-QMSNVGKE 294
R+ L + LG G+FG A + + VK + +
Sbjct: 11 PRDRLVLG-------KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63
Query: 295 DFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPG--- 350
D M + + H N++ L+ + ++ ++ G+L L RR PG
Sbjct: 64 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 351 --------LDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDY 402
L + VA+G+ YL + H L + NVL+ + D+
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDNVMKIADF 179
Query: 403 ALVPIVNKEHAQLHM------VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANY 456
L ++ V + +PE T ++DVWS G+L+ E+ T
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239
Query: 457 LAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERR 516
+L + R + + +L + C +R
Sbjct: 240 ----GVPVEELFKLLKEGHRMDKPSNCTN--------------ELYMMMRDCWHAVPSQR 281
Query: 517 WDLREAV---EKIMEL 529
++ V ++I+ L
Sbjct: 282 PTFKQLVEDLDRIVAL 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 104 bits (261), Expect = 1e-25
Identities = 45/215 (20%), Positives = 79/215 (36%), Gaps = 29/215 (13%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFR---------QMSNVGKEDFHEHMTRLGSLS- 307
E+LG G + + T VK + +E + + L +S
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 308 HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGL 367
HPN++ L Y LV D + G L + L + L KI++ + + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVI 123
Query: 368 AYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV--------- 418
L+K + H LK N+LLD+ LTD+ ++ +
Sbjct: 124 CALHKL--NIV--HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 419 AYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ + G ++ D+WS G+++ LL G P
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-25
Identities = 52/314 (16%), Positives = 101/314 (32%), Gaps = 54/314 (17%)
Query: 244 DREMFELNDLLRASAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSNVG-KEDF 296
R+ +L + LG G+FG +A T + VK ++ +
Sbjct: 11 PRDRLKLG-------KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 63
Query: 297 HEHMTRLGSLSHPNLLPLIAFYYRKEEK--LLVSDFVPNGSLANLLHVRRAPGQPG---- 350
+ L + H + + K +++ +F G+L+ L +R P
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 351 -------LDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYA 403
L + VAKG+ +L H L + N+LL + D+
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFG 179
Query: 404 LVPIVNKEHAQLHM------VAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYL 457
L + K+ + + + +PE T ++DVWS G+L+ E+ +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP- 238
Query: 458 AQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW 517
+ ++E D ++ + + C +R
Sbjct: 239 ------GVKIDEEFCRRLKEGTRMRAPDYTTP----------EMYQTMLDCWHGEPSQRP 282
Query: 518 DLREAVEKIMELKE 531
E VE + L +
Sbjct: 283 TFSELVEHLGNLLQ 296
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 103 bits (258), Expect = 1e-24
Identities = 40/205 (19%), Positives = 76/205 (37%), Gaps = 19/205 (9%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKED------FHEHMTRLGSLSHPNL 311
++G G FG Y TG +K + K+ ++ + + P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ + ++ ++ + D + G L L + GL +++
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILGLEHMH 124
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--HAQLHMVAYKSPEFNQTD 429
F + + LK +N+LLD ++D L +K+ HA + Y +PE Q
Sbjct: 125 NRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 430 -GVTRKTDVWSLGILILELLTGKFP 453
D +SLG ++ +LL G P
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 2e-24
Identities = 49/201 (24%), Positives = 79/201 (39%), Gaps = 16/201 (7%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
LG+GSFG + G +K ++ V + EH L ++HP ++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
+ + ++ ++ D++ G L +LL + P+ V L YL+
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLHS- 122
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQL-HMVAYKSPEFNQTDGVT 432
+ + LK N+LLD +TD+ V L Y +PE T
Sbjct: 123 -KDII--YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 433 RKTDVWSLGILILELLTGKFP 453
+ D WS GILI E+L G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 3e-24
Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
E +G G++G YKA LTG + +K+ R + ++ L L+HPN++ L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 316 AFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFP 375
+ + + LV +F+ +L A G+ P+ + + +GLA+ +
Sbjct: 68 DVIHTENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----HAQLHMVAYKSPE-FNQTDG 430
+ H LK N+L++ L D+ L ++ + Y++PE
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 431 VTRKTDVWSLGILILELLTGKFP 453
+ D+WSLG + E++T +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-24
Identities = 66/292 (22%), Positives = 107/292 (36%), Gaps = 41/292 (14%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+V+G+GSFG Y+A L +G + +K+ Q K + + + L H N++ L F
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 318 YYRKEEK------LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+Y EK LV D+VP H RA L + + + LAY++
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMYQLFRSLAYIH 139
Query: 372 KEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVNKE---HAQLHMVAYKSP-EFN 426
+ H +K N+LLD + L D+ + + + + Y++P
Sbjct: 140 SF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP---ANYLAQGKGANADLATWVNSVVRE------ 477
T DVWS G ++ ELL G+ + + Q L T +RE
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 478 -----EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
+ + K R E + L E+ R EA
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEA--IALCS---RLLEYTPTARLTPLEACA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-24
Identities = 40/206 (19%), Positives = 75/206 (36%), Gaps = 22/206 (10%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+VLG G G + T +K + +E E R P+++ ++
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE--VELHWRA--SQCPHIVRIVDV 73
Query: 318 Y---YRKEEKL-LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
Y Y + L +V + + G L + + R G +I+K + + + YL+
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYA------LVPIVNKEHAQLHMVAYKSPEFNQ 427
+ H +K N+L + + N + Y +PE
Sbjct: 131 ----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP 453
+ + D+WSLG+++ LL G P
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 2e-23
Identities = 46/206 (22%), Positives = 75/206 (36%), Gaps = 20/206 (9%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR-----LGSLSHPNLL 312
+ LG G F + YKA T + +K+ + +D L LSHPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 313 PLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
L+ + K LV DF+ + L + +GL YL++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPE-FNQ 427
+ H LK +N+LLD L D+ L + Y++PE
Sbjct: 119 HWIL----HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP 453
D+W++G ++ ELL
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.8 bits (240), Expect = 8e-23
Identities = 43/296 (14%), Positives = 80/296 (27%), Gaps = 37/296 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+GSGSFG Y + G + +K H + +P I +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+ + ++ + SL +L + L + + + Y++ +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSK---- 122
Query: 378 TLPHGHLKSSNVL---LDNAYEPLLTDYALVPIVNKEHAQLHM-----------VAYKSP 423
H +K N L + D+ L H+ Y S
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 424 EFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483
+ +R+ D+ SLG +++ G P A ++
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG---------LKAATKRQKYERISEKKM 233
Query: 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDY 539
K E L C + + D + L R + DY
Sbjct: 234 STPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.3 bits (236), Expect = 2e-22
Identities = 48/282 (17%), Positives = 100/282 (35%), Gaps = 25/282 (8%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR--QMSNVGKEDFHEHMTRLGSLSHPNLLPLIA 316
E +G G++G YKA G +K+ R + ++ L L H N++ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 317 FYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPG 376
+ K+ +LV + + L GL+ + + G+AY +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD---- 118
Query: 377 VTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----HAQLHMVAYKSPE-FNQTDGV 431
+ H LK N+L++ E + D+ L ++ + Y++P+ +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 432 TRKTDVWSLGILILELLTGKFP---ANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488
+ D+WS+G + E++ G + Q L T + +D +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 489 RGTKSGEGEML------KLLKIGMCCCEWNAERRWDLREAVE 524
+ E + + + + +R ++A+E
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 2e-22
Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFR------QMSNVGKEDFHEHMTRLGSLSHPNL 311
E LGSG F K TG K + V +ED ++ L + HPN+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLY 371
+ L Y K + +L+ + V G L + L + L + +K + G+ YL+
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH 130
Query: 372 KEFPGVTLPHGHLKSSNVLLDNAYEPL----LTDYALVPIVNKEHAQLHMV---AYKSPE 424
+ H LK N++L + P + D+ L ++ + ++ + +PE
Sbjct: 131 SLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ + + D+WS+G++ LL+G P
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 3e-22
Identities = 44/291 (15%), Positives = 103/291 (35%), Gaps = 35/291 (12%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVG-KEDFHEHMTRLGSLSHPNLLPLIA 316
+G G++G A + + +K+ + + + L H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 317 FY----YRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYK 372
+ + + + + L LL + L + + +GL Y++
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHS 127
Query: 373 EFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH-------MVAYKSPE- 424
+ H LK SN+LL+ + + D+ L + + +H Y++PE
Sbjct: 128 A----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 425 FNQTDGVTRKTDVWSLGILILELLTGKFP---ANYLAQGKGANADLATWVNSVVREEWTG 481
+ G T+ D+WS+G ++ E+L+ + +YL Q L + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 482 EVFDKDMRGTKSGEGEMLKLLK--------IGMCCCEWNAERRWDLREAVE 524
+ + + + +L + +N +R ++ +A+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 3e-22
Identities = 49/287 (17%), Positives = 97/287 (33%), Gaps = 28/287 (9%)
Query: 259 EVLGSGSFGSSYKAVLL--TGPAMVVKRFRQMSNVGKEDFH-----EHMTRLGSLSHPNL 311
+G G++G +KA L G + +KR R + + L + HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 312 LPLIAFYYRKEEKLLVSDFVPNGSLAN-LLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
+ L + + L +PG+ ++ + +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV---AYKSPEFNQ 427
+ + H LK N+L+ ++ + L D+ L I + + A +V Y++PE
Sbjct: 133 HSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 188
Query: 428 TDGVTRKTDVWSLGILILELLTGKFP----------ANYLAQGKGANADLATWVNSVVRE 477
D+WS+G + E+ K L + ++ R+
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524
+ + + + LL C +N +R A+
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALS 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.5 bits (234), Expect = 5e-22
Identities = 43/300 (14%), Positives = 90/300 (30%), Gaps = 43/300 (14%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF 317
+G GSFG ++ LL + +K + S+ + L+ +P + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGV 377
+ ++ ++ + SL +LL + K + + +++ +
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHE--KSL 122
Query: 378 TLPHGHLKSSNVLLDNAYEPL-----LTDYALVPIVNKEHAQLHM-----------VAYK 421
+ +K N L+ + D+ +V + H+ Y
Sbjct: 123 V--YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 422 SPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481
S + +R+ D+ +LG + + L G P L + + E G
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-----------KAATNKQKYERIG 229
Query: 482 EVFDKDMRGTKSGE--GEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDNDNEDY 539
E E K + + D ++ ER N ED
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 6e-22
Identities = 43/209 (20%), Positives = 78/209 (37%), Gaps = 23/209 (11%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR-------LGSLS--H 308
+LGSG FGS Y + + + +K + + + TR L +S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 309 PNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLA 368
++ L+ ++ R + +L+ + R L + V + +
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVR 124
Query: 369 YLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVNKEHAQLHM--VAYKSPEF 425
+ + GV H +K N+L+D N E L D+ ++ Y PE+
Sbjct: 125 HCHNC--GVL--HRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 426 NQTDGV-TRKTDVWSLGILILELLTGKFP 453
+ R VWSLGIL+ +++ G P
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.9 bits (230), Expect = 3e-21
Identities = 44/201 (21%), Positives = 73/201 (36%), Gaps = 16/201 (7%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
+ LG+GSFG +G +K + V K EH L +++ P L+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L + +V ++V G + + L P + YL+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLH-MVAYKSPEFNQTDGVT 432
+ + LK N+L+D +TD+ V L +PE + G
Sbjct: 161 --DLI--YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 433 RKTDVWSLGILILELLTGKFP 453
+ D W+LG+LI E+ G P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 44/220 (20%), Positives = 91/220 (41%), Gaps = 11/220 (5%)
Query: 239 HFVNNDREMFELNDLLRASAEVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKED 295
+ + +E+ + R + +GSG++G+ AV TG + +K+ + S + +
Sbjct: 5 YRQEVTKTAWEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 296 FHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPI 355
+ + L + H N++ L+ + E +DF + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDR 122
Query: 356 RLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH-AQ 414
++ + KGL Y++ H LK N+ ++ E + D+ L + E
Sbjct: 123 IQFLVYQMLKGLRYIHAAGI----IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 178
Query: 415 LHMVAYKSPE-FNQTDGVTRKTDVWSLGILILELLTGKFP 453
+ Y++PE T+ D+WS+G ++ E++TGK
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 4e-20
Identities = 43/204 (21%), Positives = 75/204 (36%), Gaps = 19/204 (9%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
++LG G+FG TG +K R+ + +D H L + HP L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L + + V ++ G L L + + L YL+
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS- 123
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA----YKSPEFNQTD 429
V + +K N++LD +TD+ L + A + Y +PE + +
Sbjct: 124 -RDV--VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 430 GVTRKTDVWSLGILILELLTGKFP 453
R D W LG+++ E++ G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 2e-19
Identities = 47/286 (16%), Positives = 85/286 (29%), Gaps = 31/286 (10%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
E +G G++G+ +KA T + +KR R + E R L L H N++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVR 65
Query: 314 LIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKE 373
L + ++ LV +F D I + + KGL + +
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSR 120
Query: 374 FPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVA-----YKSPEFNQT 428
+ H LK N+L++ E L ++ L
Sbjct: 121 ----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 429 DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488
+ D+WS G + EL P + + + E+W D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 489 RGTKSGEGEMLKLLKIGMC----------CCEWNAERRWDLREAVE 524
+ + + + N +R EA++
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 7e-19
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 259 EVLGSGSFGSSYKAVLL----TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSH-P 309
+VLG+G++G + + TG +K ++ + V K EH L + P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 310 NLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
L+ L + + + L+ D++ G L L R + + L +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEH 144
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMVAYKSPEFNQTD 429
L+K G+ + +K N+LLD+ +LTD+ L + + + E+ D
Sbjct: 145 LHK--LGII--YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 430 -------GVTRKTDVWSLGILILELLTGKFP 453
G + D WSLG+L+ ELLTG P
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 83.7 bits (206), Expect = 3e-18
Identities = 43/204 (21%), Positives = 74/204 (36%), Gaps = 24/204 (11%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIA 316
LG G + ++A+ + +VVK + V K+ + L +L PN++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 317 FYYRKEEKL--LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF 374
+ LV + V N L L + + K L Y +
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM- 148
Query: 375 PGVTLPHGHLKSSNVLLDNAYEPL-LTDYALVPIVNKEHAQLHMV---AYKSPEFNQTD- 429
+ H +K NV++D+ + L L D+ L + V +K PE
Sbjct: 149 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 430 GVTRKTDVWSLGILILELLTGKFP 453
D+WSLG ++ ++ K P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 2e-17
Identities = 44/214 (20%), Positives = 74/214 (34%), Gaps = 23/214 (10%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQMSNVGKEDF-----------HEHMTRLGSL 306
LG G F + + A ++ + +K R V E T+ S+
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 307 SHPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKG 366
++L L+ + K + V NLL + + G+ +I K + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 367 LAYLYKEFPGVTLPHGHLKSSNVLLDNAYEP-------LLTDYALVPIVNKEHAQLHMVA 419
L Y+++ + H +K NVL++ P + +
Sbjct: 138 LDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 420 YKSPEFNQTDGVTRKTDVWSLGILILELLTGKFP 453
Y+SPE D+WS LI EL+TG F
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 3e-17
Identities = 43/205 (20%), Positives = 85/205 (41%), Gaps = 20/205 (9%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+GSG++GS A TG + VK+ + S + + + + L + H N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 316 AFYYRKE-----EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYL 370
+ + + + L N++ ++ L +I + +GL Y+
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYI 137
Query: 371 YKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-VAYKSPEFNQTD 429
+ + H LK SN+ ++ E + D+ L + E Y++PE
Sbjct: 138 HSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 430 G-VTRKTDVWSLGILILELLTGKFP 453
+ D+WS+G ++ ELLTG+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 4e-17
Identities = 54/300 (18%), Positives = 99/300 (33%), Gaps = 45/300 (15%)
Query: 259 EVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTR----LGSLSHPNLLP 313
+G G+FG +KA TG + +K+ + KE F R L L H N++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVN 73
Query: 314 LIAFYYRKEEK--------LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAK 365
LI K LV DF + L +V ++++ +
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLN 128
Query: 366 GLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHM-------- 417
GL Y+++ + H +K++NVL+ L D+ L +
Sbjct: 129 GLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 418 VAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGK--FPANYLAQGKGANADLATWVNSV 474
+ Y+ PE + D+W G ++ E+ T N + L +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 475 VREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMC----------CCEWNAERRWDLREAVE 524
V + + K + ++ LK + + +R D +A+
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 32/207 (15%), Positives = 77/207 (37%), Gaps = 24/207 (11%)
Query: 259 EVLGSGSFGSSYKAV-LLTGPAMVVKRFRQ--MSNVGKEDFHEHMTRLGSLSHPNLLPLI 315
+ +GSG+ G A + + +K+ + + + + + + ++H N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 316 AFYYRK------EEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAY 369
+ + ++ LV + + + D ++ + G+ +
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134
Query: 370 LYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQLHMV---AYKSPEFN 426
L+ H LK SN+++ + + D+ L V Y++PE
Sbjct: 135 LHSAGII----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 427 QTDGVTRKTDVWSLGILILELLTGKFP 453
G D+WS+G ++ E++ K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.7 bits (174), Expect = 3e-14
Identities = 25/83 (30%), Positives = 34/83 (40%), Gaps = 20/83 (24%)
Query: 69 HLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDT 128
L N G +P+ L L+ L LN+ N+ G+IP
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG--------------------N 289
Query: 129 LSNFDATSFQGNKGLCGKPLEAC 151
L FD +++ NK LCG PL AC
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 16/58 (27%), Positives = 23/58 (39%), Gaps = 4/58 (6%)
Query: 25 NNSFDGPMP-SVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80
NN G +P + +L L +L +S N GEIP + + A N P
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 14/55 (25%), Positives = 22/55 (40%), Gaps = 2/55 (3%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIP 55
+ G + L++L L SL+ N+ G +P G L + NK P
Sbjct: 255 RIYGTLP-QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 1e-12
Identities = 26/119 (21%), Positives = 44/119 (36%), Gaps = 5/119 (4%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFA 60
+ + ++ L+ L L +L N + P L L L N + P +
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP---VS 326
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119
+ +L+++ A N S SLA L + L+ N P L +T L L+
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.7 bits (151), Expect = 3e-11
Identities = 30/139 (21%), Positives = 46/139 (33%), Gaps = 23/139 (16%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAF-------- 59
D+ TL+ L L L NN P G L L L N+ + P
Sbjct: 233 DIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 60 -----------AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-P 107
+ + L + L N+ S P ++ L KL +L N +
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLAN 349
Query: 108 LAHLTLLDLSYNQLVGRIP 126
L ++ L +NQ+ P
Sbjct: 350 LTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 29/126 (23%), Positives = 43/126 (34%), Gaps = 5/126 (3%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFA 60
+ D+ L+ L L L +N L +L + N+ + P
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP---LG 216
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQ 120
+ L ++ L N +LA L L L+L N P L LT L L NQ
Sbjct: 217 ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQ 274
Query: 121 LVGRIP 126
+ P
Sbjct: 275 ISNISP 280
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.5 bits (138), Expect = 3e-10
Identities = 28/204 (13%), Positives = 58/204 (28%), Gaps = 34/204 (16%)
Query: 259 EVLGSGSFGSSYKAVLLTGPAMVVKRFR----------QMSNVGKEDFHEHMTRLGSLSH 308
+++G G + + VVK + + + G F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 309 PNLLPL----IAFYYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVA 364
L L + Y E ++ + + + +++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKE------------LYRVRVENPDEVLDMIL 113
Query: 365 KGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEHAQ--LHMVAYKS 422
+ +A Y + HG L NVL+ + D+ V +E + L
Sbjct: 114 EEVAKFYHRG----IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNI 168
Query: 423 PEFNQTDGVTRKTDVWSLGILILE 446
+ + D+ S IL+
Sbjct: 169 ITYFSRTY-RTEKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 30/134 (22%), Positives = 49/134 (36%), Gaps = 5/134 (3%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFA 60
N + I + L L L N +P TL+ L + N+ T + F
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITK-VRKSVFN 121
Query: 61 GMDQLKKVHL--ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSY 118
G++Q+ V L SG + G++KL + + + IP LT L L
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDG 180
Query: 119 NQLVGRIPDTLSNF 132
N++ +L
Sbjct: 181 NKITKVDAASLKGL 194
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 26/119 (21%), Positives = 38/119 (31%), Gaps = 8/119 (6%)
Query: 30 GPM-PSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQK 88
GP+ P + LR + S ++P D + L N + L+
Sbjct: 1 GPVCPFRCQCHLRVVQCSDLGLE-KVPKDLPP---DTALLDLQNNKITEIKDGDFKNLKN 56
Query: 89 LLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQLVGRIPDTLSNFDATSFQGNKGLCG 145
L L L N P PL L L LS NQL +P+ + +
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 26/150 (17%), Positives = 44/150 (29%), Gaps = 6/150 (4%)
Query: 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSV-GKLT-LRALYLSLNKFTGEIPSDAF 59
N + I L L +L INN P L L LYLS N+ E+P
Sbjct: 41 NKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP 99
Query: 60 AGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLS 117
+ +L+ + L +++L G + L+ + ++
Sbjct: 100 KTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 158
Query: 118 YNQLVGRIPDTLSNFDATSFQGNKGLCGKP 147
+ + GNK
Sbjct: 159 DTNITTIPQGLPPSLTELHLDGNKITKVDA 188
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.8 bits (117), Expect = 3e-07
Identities = 38/148 (25%), Positives = 56/148 (37%), Gaps = 5/148 (3%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDG-PMPSVGKLT-LRALYLSLNKFTGEIPSDA 58
N + + DT L L L N P + L L L L N+ P A
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP-HA 196
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPL-AHLTLLDLS 117
F + +L ++L N+ S ++LA L+ L L L N + PL A L S
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGS 256
Query: 118 YNQLVGRIPDTLSNFDATSFQGNKGLCG 145
+++ +P L+ D N L G
Sbjct: 257 SSEVPCSLPQRLAGRDLKRLAAND-LQG 283
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 11/94 (11%)
Query: 38 LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ----IPKSLAGLQKLLQLN 93
L +++L + + + ++ + Q + V L + I +L L +LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 94 LEGNSFQGKIPDF-------PLAHLTLLDLSYNQ 120
L N P + L L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 1e-04
Identities = 17/91 (18%), Positives = 30/91 (32%), Gaps = 12/91 (13%)
Query: 39 TLRALYLSLNKFTGEIPS---DAFAGMDQLKKVHLARNHFSGQIPKSLA-GLQ----KLL 90
LR L+L+ + S L+++ L+ N L ++ L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 91 QLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
QL L + ++ D L L+ L
Sbjct: 430 QLVLYDIYWSEEMEDR----LQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 1e-04
Identities = 15/82 (18%), Positives = 22/82 (26%), Gaps = 11/82 (13%)
Query: 59 FAGMDQLKKVHLARNHFSGQ----IPKSLAGLQKLLQLNLEGNSFQGKIPDF-------P 107
L+ + LA S + +L L +L+L N P
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 108 LAHLTLLDLSYNQLVGRIPDTL 129
L L L + D L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 4e-06
Identities = 22/108 (20%), Positives = 39/108 (36%), Gaps = 4/108 (3%)
Query: 8 DVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK 67
+ L +L + L +N P++ L R L + D A + +L++
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPALAAL--RCLEVLQASDNALENVDGVANLPRLQE 69
Query: 68 VHLARNHF-SGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLL 114
+ L N + L +L+ LNL+GNS +L
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 1e-04
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 19 RSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSG 77
R L + + +L + L LS N+ P+ A + L+ + + N
Sbjct: 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPPA--LAALRCLEVLQASDNAL-- 55
Query: 78 QIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLA---HLTLLDLSYNQLVG 123
+ +A L +L +L L N Q PL L LL+L N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 15/71 (21%), Positives = 31/71 (43%), Gaps = 7/71 (9%)
Query: 62 MDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQL 121
L++++++ N ++P L++L N ++P+ P +L L + YN L
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELP-QNLKQLHVEYNPL 336
Query: 122 VGRIPDTLSNF 132
PD +
Sbjct: 337 RE-FPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 19/93 (20%), Positives = 31/93 (33%), Gaps = 9/93 (9%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFA 60
+N P L L+ NN + L L S N E+P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPR--LERLIASFNHLA-EVPEL--- 322
Query: 61 GMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93
LK++H+ N + P ++ L++N
Sbjct: 323 -PQNLKQLHVEYNPLR-EFPDIPESVED-LRMN 352
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 2e-05
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 3/62 (4%)
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSY 118
A + +L + N S P LA L L++++L+ N P ++L ++ L+
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT- 225
Query: 119 NQ 120
NQ
Sbjct: 226 NQ 227
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.2 bits (92), Expect = 2e-04
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 24/104 (23%)
Query: 48 NKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKL------------------ 89
EI + F G+ QLK ++L N S +P S L L
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 90 -----LQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDT 128
+ +L G + + P + + + DL +++ ++
Sbjct: 147 FAEWLRKKSLNGGAARCGAPS-KVRDVQIKDLPHSEFKCSSENS 189
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 6e-04
Identities = 12/55 (21%), Positives = 20/55 (36%), Gaps = 3/55 (5%)
Query: 50 FTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIP 104
E+P+D F G + ++R L L+KL + K+P
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 239
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.001
Identities = 25/126 (19%), Positives = 41/126 (32%), Gaps = 11/126 (8%)
Query: 1 MNLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLT-LRALYLSLNKFTG-EIPSDA 58
++L G+ L L+ ++ + L +L LS N+ + S
Sbjct: 27 LDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSI 86
Query: 59 FAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFP---------LA 109
LK ++L+ N + KL +L L+GNS D
Sbjct: 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFP 146
Query: 110 HLTLLD 115
L LD
Sbjct: 147 KLLRLD 152
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.001
Identities = 14/48 (29%), Positives = 20/48 (41%), Gaps = 1/48 (2%)
Query: 53 EIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQ 100
E+P+ G++ L + L N IPK G L L GN +
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.003
Identities = 18/82 (21%), Positives = 27/82 (32%), Gaps = 5/82 (6%)
Query: 31 PMPSVGKLT-LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKL 89
P+ V K+ + T +P D +HL+ N +L +L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLPKD---TTILHLSENLLYTFSLATLMPYTRL 57
Query: 90 LQLNLEGNSFQGKIPDFPLAHL 111
QLNL+ D L L
Sbjct: 58 TQLNLDRAELTKLQVDGTLPVL 79
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 10/64 (15%), Positives = 23/64 (35%), Gaps = 5/64 (7%)
Query: 38 LTLRALYLSLNKFTGE----IPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLN 93
+ L+ L L N+ + + + M L + L N F + + ++++
Sbjct: 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTR 331
Query: 94 LEGN 97
G
Sbjct: 332 GRGE 335
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 565 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.61 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.61 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.61 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.6 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.38 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.36 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.34 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.32 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.3 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.22 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.2 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.16 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.11 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.1 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.07 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.03 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.02 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.98 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.8 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.77 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.23 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.21 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.99 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.74 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.72 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.69 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.86 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.84 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.47 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.1 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 92.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.22 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=421.40 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=198.0
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|++.++..||||+++.. ....++|.+|++++++++|||||+++|+|..++..++||||+++|+|
T Consensus 9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 34689999999999999988889999999753 44567899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
.+++..... .++|..++.++.|||.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 88 SDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp HHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred HHHhhcccc----CCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999876543 489999999999999999999998 9999999999999999999999999999876433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcC-CCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTG-KFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|+|||++.+..|+.++|||||||++|||+|+ ++||.. ....+.+.... .+. ....|
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--------~~~~~~~~~i~-~~~--~~~~p---- 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDIS-TGF--RLYKP---- 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--------CCHHHHHHHHH-HTC--CCCCC----
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--------CCHHHHHHHHH-hcC--CCCCc----
Confidence 234578899999999999999999999999999999995 555541 22222222222 211 11111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
......+.+++.+||+.||++||||+||++.|+++.+
T Consensus 225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122467889999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=421.65 Aligned_cols=250 Identities=20% Similarity=0.338 Sum_probs=198.1
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|++. ..||||+++.. .....+.|.+|+.+|++++|||||++++++. .+..++|||||++|
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGS 88 (276)
T ss_dssp CCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred EEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence 4578999999999999753 46999998743 2344578999999999999999999999874 45789999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++...+. .++|..++.++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 89 SLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999976443 399999999999999999999998 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 ---HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....||+.|||||++.+ ..|+.++|||||||++|||+||+.||... .....+......+.. .
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~--------~~~~~~~~~~~~~~~----~ 228 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------NNRDQIIFMVGRGYL----S 228 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC--------CCHHHHHHHHHHTSC----C
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC--------ChHHHHHHHHhcCCC----C
Confidence 23468999999998754 45899999999999999999999999632 122222222222211 1
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
|.+.... ......+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 229 p~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 229 PDLSKVR--SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCGGGSC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Ccchhcc--ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111110 1122468889999999999999999999999998875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-53 Score=411.14 Aligned_cols=239 Identities=23% Similarity=0.300 Sum_probs=201.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++|||||++++++.+++..|+|||||+
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4678999999999999964 7889999998642 23446779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 90 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred CCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999998654 399999999999999999999998 9999999999999999999999999999876543
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.. .+..+.......... .+.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~-------~~p- 224 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--------NTYQETYKRISRVEF-------TFP- 224 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTTCC-------CCC-
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCC-------CCC-
Confidence 345789999999999999999999999999999999999999962 222233332222211 111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.||++|||++|+++
T Consensus 225 ----~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 ----DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111236778889999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-53 Score=420.96 Aligned_cols=248 Identities=20% Similarity=0.378 Sum_probs=193.7
Q ss_pred ccceecccCceeEEEEEEe-CCC---eeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGP---AMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..++||+|+||+||+|.+. +++ .||||++... .....++|.+|+++|++++|||||+++|+|.+++..++|||||
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence 3578999999999999964 333 5888887643 3344568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .++|..++.++.|||+||.|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 110 ~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 110 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp TTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999876443 499999999999999999999998 9999999999999999999999999999876433
Q ss_pred c---------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 412 H---------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 412 ~---------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
. ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||... ...+.+.........
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--------~~~~~~~~i~~~~~~- 252 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------TNQDVINAIEQDYRL- 252 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTTCCC-
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCCC-
Confidence 1 1246789999999999999999999999999999998 89998631 222222222221110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
+.+......+.+++.+||+.||++||||.||++.|+++..
T Consensus 253 ----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 ----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0011223467889999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-53 Score=417.03 Aligned_cols=249 Identities=20% Similarity=0.378 Sum_probs=205.0
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|++++|||||+++++|.+.+..++|||||++|+
T Consensus 21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 4578999999999999965 6888999998754 3456789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc---
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH--- 412 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 412 (565)
|.+++..... ..++|..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 100 LLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp HHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred hHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 9999976433 2499999999999999999999998 99999999999999999999999999998765432
Q ss_pred --cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 --AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 --~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...+++.|+|||++.+..|+.++|||||||++|||++|..|+.. ..+.... ...+..+.. +..
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~-------~~~~~~~-~~~i~~~~~-----~~~-- 237 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQV-YELLEKDYR-----MER-- 237 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST-------TCCHHHH-HHHHHTTCC-----CCC--
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-------cchHHHH-HHHHhcCCC-----CCC--
Confidence 23467889999999999999999999999999999997776541 1122222 222222211 111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
+......+.+++.+||+.||++||||+||++.|+.+..
T Consensus 238 ---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 238 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11222468889999999999999999999999988754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=414.09 Aligned_cols=241 Identities=20% Similarity=0.315 Sum_probs=201.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+|||||++|+
T Consensus 24 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp SCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 347899999999999994 5799999999986655667889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred HHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 99988653 389999999999999999999998 9999999999999999999999999999876433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||.. ......+.......... ...
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~--------~~~~~~~~~~~~~~~~~-~~~------ 238 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN--------ENPLRALYLIATNGTPE-LQN------ 238 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHHCSCC-CSS------
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC--------CCHHHHHHHHHhCCCCC-CCC------
Confidence 345689999999999999999999999999999999999999962 12222233332222111 100
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+......+.+++.+||+.||++|||+.|+++
T Consensus 239 --~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 --PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112246788899999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=415.21 Aligned_cols=247 Identities=20% Similarity=0.323 Sum_probs=200.3
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|.+.++..||||+++.. ....++|.+|+.++++++|||||+++|++. ++..++||||+++|+|
T Consensus 17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94 (272)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred EeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcH
Confidence 45789999999999999988889999999754 345678999999999999999999999874 5678999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
.+++..... ..++|..++.++.||++||.|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 95 ~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 95 VDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp HHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred HHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 998765432 2389999999999999999999998 9999999999999999999999999999876533
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....+|+.|||||++....++.++|||||||++|||+||..|+.. .....+..... ..+.. +..
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~-------~~~~~~~~~~i-~~~~~-----~~~--- 231 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP-------GMTNPEVIQNL-ERGYR-----MVR--- 231 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHHHHH-HTTCC-----CCC---
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC-------CCCHHHHHHHH-HhcCC-----CCC---
Confidence 234578899999999888999999999999999999996555431 11222222222 22110 011
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELK 530 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 530 (565)
+......+.+++.+||+.||++||||+||++.|+++-
T Consensus 232 --p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1112236788999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=406.20 Aligned_cols=245 Identities=20% Similarity=0.357 Sum_probs=205.0
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|+++++..||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 45789999999999999988889999999864 34567899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccccc----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKEH---- 412 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 412 (565)
.+++..... .+++..+.+++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 87 LNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp HHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred HHhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999876543 389999999999999999999998 99999999999999999999999999998654332
Q ss_pred -cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 413 -AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 413 -~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
...+|+.|+|||++....++.++|||||||++|||+| |+.||... ...+. ...+..+. ....|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--------~~~~~-~~~i~~~~--~~~~p---- 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSET-AEHIAQGL--RLYRP---- 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHH-HHHHHTTC--CCCCC----
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--------CHHHH-HHHHHhCC--CCCCc----
Confidence 3457889999999999999999999999999999998 89998632 22222 22222221 11111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
......+.+++.+||+.||++|||++|+++.|.+|
T Consensus 224 ----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11224688899999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=414.11 Aligned_cols=243 Identities=22% Similarity=0.312 Sum_probs=200.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|+. .++..||||++........+.|.+|+++|++++|||||++++++.+.+..|+|||||++|+
T Consensus 16 i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 457899999999999996 4788999999987666667789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 L~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 96 VDAVMLELER----PLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp HHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999876543 399999999999999999999998 9999999999999999999999999999765432
Q ss_pred ccccccccccCCCccC-----CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 HAQLHMVAYKSPEFNQ-----TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....||+.|||||++. ...|+.++|||||||++|||+||+.||... ...+.+......... ..
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~--------~~~~~~~~i~~~~~~-~~--- 235 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--------NPMRVLLKIAKSEPP-TL--- 235 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS--------CGGGHHHHHHHSCCC-CC---
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC--------CHHHHHHHHHcCCCC-CC---
Confidence 3567899999999873 456899999999999999999999999632 112222222222111 11
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
..+......+.+++.+||+.||++|||++|+++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122246788899999999999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-52 Score=404.96 Aligned_cols=242 Identities=19% Similarity=0.341 Sum_probs=193.0
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEe----cCceEEEEec
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR----KEEKLLVSDF 330 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~E~ 330 (565)
.++||+|+||+||+|... ++..||+|++... .....+.|.+|+++|++++|||||++++++.+ +...|+||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 357999999999999964 6889999998753 23345679999999999999999999999875 2457999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc-CCCCcEEeccCCccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD-NAYEPLLTDYALVPIVN 409 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~ 409 (565)
+++|+|.+++.... .+++..+..++.||++||+|||++.+ +|+||||||+|||++ +++.+||+|||+++...
T Consensus 94 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~--~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTP--PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSS--CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCC--CEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999998654 38999999999999999999999811 399999999999996 57899999999998755
Q ss_pred cc--ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 410 KE--HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 410 ~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
.. ....||+.|||||++.+ .|+.++|||||||++|||+||+.||... ......... +..+.... .
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-------~~~~~~~~~-i~~~~~~~----~ 233 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRR-VTSGVKPA----S 233 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHH-HTTTCCCG----G
T ss_pred CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-------ccHHHHHHH-HHcCCCCc----c
Confidence 43 34578999999998865 5999999999999999999999999621 122222222 22211111 1
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.... ....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~-----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDKV-----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcc-----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111 1235778899999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=410.92 Aligned_cols=242 Identities=19% Similarity=0.258 Sum_probs=193.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||||++|
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 457899999999999996 478999999997532 233457999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 89 ~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 89 ELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999986433 499999999999999999999998 9999999999999999999999999999876422
Q ss_pred ---ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....||+.|||||++.+..+ +.++||||+||++|||+||++||.... ............... .+.
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~-------~~~~~~~~~~~~~~~----~~~ 228 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-------DSCQEYSDWKEKKTY----LNP 228 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS-------TTSHHHHHHHTTCTT----STT
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCCCC----CCc
Confidence 34568999999999887776 578999999999999999999996321 111111111111100 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. ......+.+++.+||+.||++|||++|+++
T Consensus 229 ~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 W------KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp G------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 111236778889999999999999999854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=410.68 Aligned_cols=244 Identities=21% Similarity=0.310 Sum_probs=198.5
Q ss_pred eecccCceeEEEEEEe---CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 260 VLGSGSFGSSYKAVLL---TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 260 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
+||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..|+|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999853 34579999997543 3345789999999999999999999999864 56899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc----
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE---- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~---- 411 (565)
|.+++...+. .+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 95 LHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp HHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999865433 499999999999999999999998 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....+|+.|+|||++....++.++|||||||++|||+| |+.||... ...+... .+..+... .
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~--------~~~~~~~-~i~~~~~~-----~ 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMA-FIEQGKRM-----E 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CTHHHHH-HHHTTCCC-----C
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC--------CHHHHHH-HHHcCCCC-----C
Confidence 23357889999999988899999999999999999998 99999732 1122222 22222111 1
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
. +......+.+++.+||+.||++||||.+|++.|+.+..
T Consensus 233 ~-----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 C-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp C-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 11222467889999999999999999999999987754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=408.13 Aligned_cols=249 Identities=20% Similarity=0.375 Sum_probs=197.0
Q ss_pred cceecccCceeEEEEEEeCC-----CeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLLTG-----PAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
.++||+|+||+||+|.+... ..||||++... ......+|.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 47899999999999996543 36999998743 2334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
.+|++.+++..... .++|..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 92 ENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp TTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999998876543 499999999999999999999998 9999999999999999999999999999876432
Q ss_pred -------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccc
Q 008431 412 -------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVF 484 (565)
Q Consensus 412 -------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (565)
....||+.|||||++....++.++|||||||++|||+||..|+.. .....+.+.. +..+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~-------~~~~~~~~~~-i~~~~~---- 231 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKA-INDGFR---- 231 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT-------TCCHHHHHHH-HHTTCC----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc-------cCCHHHHHHH-HhccCC----
Confidence 123468899999999999999999999999999999997666531 1122222222 222111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 485 DKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 485 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
+. .+......+.+++.+||+.||++||||.||++.|+++...
T Consensus 232 -~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 -LP-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -CC-----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CC-----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 00 1112234688899999999999999999999999988754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=408.31 Aligned_cols=242 Identities=20% Similarity=0.315 Sum_probs=195.4
Q ss_pred ceecccCceeEEEEEEeC---CCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 259 EVLGSGSFGSSYKAVLLT---GPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
++||+|+||+||+|.+.. ++.||||+++... ....++|.+|+++|++++|||||+++|+|. .+..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 579999999999998653 4579999996432 233568999999999999999999999985 4567999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
|+|.++++... .++|..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999998644 399999999999999999999998 9999999999999999999999999999865432
Q ss_pred -----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 -----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....||+.|||||++....++.++|||||||++|||+| |+.||... ...+. ...+..+...
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--------~~~~~-~~~i~~~~~~---- 229 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEV-TAMLEKGERM---- 229 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHH-HHHHHTTCCC----
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--------CHHHH-HHHHHcCCCC----
Confidence 12357889999999988899999999999999999998 89999631 12222 2222222111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
.. +......+.+++.+||+.||++|||++||++.|+..
T Consensus 230 -~~-----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 -GC-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -CC-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CC-----CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 01 111224678899999999999999999999998875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=409.00 Aligned_cols=248 Identities=24% Similarity=0.279 Sum_probs=188.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEe--cCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--KEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ .+..|+|||||
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 457899999999999995 578999999987532 3335679999999999999999999999975 45689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC-CCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF-PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~-~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
++|+|.+++...... ...+++..++.++.|++.||+|||+.. ...+|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 88 EGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp TTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 999999999753221 124999999999999999999999872 112499999999999999999999999999987654
Q ss_pred c----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 411 E----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 411 ~----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
. ....||+.|||||++.+..|+.++|||||||++|||+||+.||.. .+..+..... ..+....
T Consensus 167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~--------~~~~~~~~~i-~~~~~~~---- 233 (269)
T d2java1 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA--------FSQKELAGKI-REGKFRR---- 233 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHH-HHTCCCC----
T ss_pred CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC--------CCHHHHHHHH-HcCCCCC----
Confidence 3 345689999999999999999999999999999999999999962 2222222222 2221111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
+. ......+.+++.+||+.||++|||+.|+++
T Consensus 234 -~~-----~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -IP-----YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CC-----cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 111236788889999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-52 Score=416.55 Aligned_cols=192 Identities=23% Similarity=0.356 Sum_probs=170.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|.+.+..|+|||||++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 457899999999999996 478899999997532 333567999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--c
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--H 412 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--~ 412 (565)
+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++++||+|||+|+..... .
T Consensus 90 ~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 161 (322)
T d1s9ja_ 90 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161 (322)
T ss_dssp EHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred cHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence 9999998654 3899999999999999999999731 7999999999999999999999999999876433 4
Q ss_pred cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 008431 413 AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANY 456 (565)
Q Consensus 413 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~ 456 (565)
+..||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 56899999999999999999999999999999999999999963
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-51 Score=408.54 Aligned_cols=242 Identities=21% Similarity=0.265 Sum_probs=199.9
Q ss_pred hccceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 256 ASAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
...+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 18 ~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 97 (309)
T d1u5ra_ 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEec
Confidence 3457899999999999995 5788999999975432 22356899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 98 LGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp SEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred CCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999987766543 399999999999999999999998 9999999999999999999999999999988777
Q ss_pred ccccccccccCCCccCC---CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 HAQLHMVAYKSPEFNQT---DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.. ....+.+........ +.+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~--------~~~~~~~~~i~~~~~------~~~ 234 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQNES------PAL 234 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSCC------CCC
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCCC------CCC
Confidence 78899999999998754 4689999999999999999999999962 122222222222211 111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
... .....+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 QSG----HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC----CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111 11236788889999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=414.15 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=198.7
Q ss_pred ccceecccCceeEEEEEEeC-CC-----eeEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLT-GP-----AMVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~-~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..++||+|+||+||+|+... ++ .||||++... .......|.+|+.+|.++ +|||||+++++|.+.+..|+||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 56899999999999999653 22 5899988643 334456899999999998 8999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEE
Q 008431 329 DFVPNGSLANLLHVRRAP------------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVL 390 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NIL 390 (565)
|||++|+|.++++..+.. ....++|..++.++.||++||+|||++ +||||||||+|||
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHRDlKp~Nil 196 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVL 196 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCchhccc
Confidence 999999999999865421 113489999999999999999999998 9999999999999
Q ss_pred EcCCCCcEEeccCCcccccccc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCC
Q 008431 391 LDNAYEPLLTDYALVPIVNKEH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGA 463 (565)
Q Consensus 391 l~~~~~~kl~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~ 463 (565)
++.++.+||+|||+|+...... ...+|+.|||||++....|+.++|||||||++|||+| |++||....
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~----- 271 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP----- 271 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-----
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC-----
Confidence 9999999999999998765432 3356899999999999999999999999999999998 899996321
Q ss_pred CcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 008431 464 NADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIM 527 (565)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 527 (565)
....+...+..+.. +.. +......+.+++.+||+.||++||||+||++.|.
T Consensus 272 ---~~~~~~~~~~~~~~-----~~~-----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 ---VDANFYKLIQNGFK-----MDQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ---CSHHHHHHHHTTCC-----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHHHHHhcCCC-----CCC-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11222223332211 011 1112246888999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=401.19 Aligned_cols=250 Identities=20% Similarity=0.295 Sum_probs=199.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCCH
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
..+.||+|+||+||+|+..++..||||+++.. ....+.|.+|+.++++++|||||+++|+|. .+..++||||+++|+|
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 55789999999999999988889999999754 445678999999999999999999999984 5678999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-----
Q 008431 337 ANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE----- 411 (565)
Q Consensus 337 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~----- 411 (565)
..++..... ..++|..++.++.||+.||+|||+. +|+||||||+|||+|.++.+||+|||+++.....
T Consensus 99 ~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 99 LDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp HHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 999875432 1499999999999999999999998 9999999999999999999999999999876433
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....+|+.|+|||++....++.++|||||||++|||+||..|+.. .....+.+..... +.. +..
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~-------~~~~~~~~~~i~~-~~~-----~~~--- 235 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-------GMVNREVLDQVER-GYR-----MPC--- 235 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHHHHHHT-TCC-----CCC---
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC-------CCCHHHHHHHHHh-cCC-----CCC---
Confidence 234578999999999999999999999999999999997666542 1222222222221 111 011
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
+......+.+++.+||+.||++||||++|+++|++.....
T Consensus 236 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1122246888999999999999999999999999876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=403.67 Aligned_cols=240 Identities=20% Similarity=0.285 Sum_probs=199.4
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+|||||+
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 457899999999999996 57899999998742 23445779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 92 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999988654 399999999999999999999998 9999999999999999999999999999876432
Q ss_pred -----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 412 -----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
....||+.|||||++.+..|+.++||||+||++|||+||+.||.. .+.............
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~~~~~------- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--------GNEYLIFQKIIKLEY------- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHTTCC-------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC--------cCHHHHHHHHHcCCC-------
Confidence 234689999999999999999999999999999999999999962 122222222222211
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+. ......+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 DFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCC-----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111 1112367889999999999999999997654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-50 Score=404.45 Aligned_cols=244 Identities=20% Similarity=0.282 Sum_probs=185.1
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+.+|++++|||||++++++.+++..|+|||||++|
T Consensus 13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 4578999999999999964 78999999997533 233456889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc---CCCCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD---NAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~~~~~~ 411 (565)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 93 ~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 93 ELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp BHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred cHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999997543 399999999999999999999998 999999999999994 5789999999999876543
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.. ....+........... .+...
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~~~~~~---~~~~~ 232 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD--------ENDAKLFEQILKAEYE---FDSPY 232 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHTTCCC---CCTTT
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC--------CCHHHHHHHHhccCCC---CCCcc
Confidence 345789999999999999999999999999999999999999962 1222222222222111 00000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.......+.+++.+||+.||++|||++|+++.
T Consensus 233 -----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 233 -----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01112367889999999999999999999763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=397.69 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=194.7
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEe-cCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR-KEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||.||+|.+ .|..||||+++.. ...++|.+|++++++++|||||+++|+|.+ .+..++||||+++|+
T Consensus 11 ~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 457899999999999998 5788999999653 346789999999999999999999999965 456899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-ccc
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-HAQ 414 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~ 414 (565)
|.+++...... .++|..+++++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++..... ...
T Consensus 88 L~~~l~~~~~~---~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 88 LVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp HHHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhcCCC---CCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 99999764321 389999999999999999999998 9999999999999999999999999999876543 344
Q ss_pred cccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCCCC
Q 008431 415 LHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGTKS 493 (565)
Q Consensus 415 ~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 493 (565)
.++..|+|||++.+..++.++|||||||++|||+| |++||.... ...+..++ ..+.. +...
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~i----~~~~~-----~~~~---- 222 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRV----EKGYK-----MDAP---- 222 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHHH----TTTCC-----CCCC----
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHH----HcCCC-----CCCC----
Confidence 67889999999988999999999999999999998 788876321 12232222 11111 1111
Q ss_pred CHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 494 GEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 494 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
......+.+++.+||+.||++||||.|++++|++++..
T Consensus 223 -~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 223 -DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 11224678899999999999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-50 Score=402.42 Aligned_cols=252 Identities=20% Similarity=0.301 Sum_probs=203.1
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccCc-cCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMSN-VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|+.. ++..||||+++.... ...++|.+|+++|++++||||++++++|...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 4578999999999999964 346899999875332 335679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEE
Q 008431 330 FVPNGSLANLLHVRRA-------------------PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVL 390 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NIL 390 (565)
|+++|+|.++++.... .....++|..++.++.|++.||+|||+. +||||||||+|||
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ivHrDlKp~NIL 172 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCL 172 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----CeEeeEEcccceE
Confidence 9999999999975322 1123489999999999999999999998 9999999999999
Q ss_pred EcCCCCcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCC-CCccccccCCCC
Q 008431 391 LDNAYEPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGK-FPANYLAQGKGA 463 (565)
Q Consensus 391 l~~~~~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~-~p~~~~~~~~~~ 463 (565)
+|.++.+||+|||+++..... ....+++.|+|||++....|+.++|||||||++|||++|. +||..
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~------- 245 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG------- 245 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-------
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-------
Confidence 999999999999999765432 2345678999999999999999999999999999999986 56652
Q ss_pred CcchHHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 464 NADLATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
.+..+.... +..+.... . +......+.+++.+||+.||++||||.||++.|+++.+
T Consensus 246 -~~~~e~~~~-v~~~~~~~-----~-----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 246 -MAHEEVIYY-VRDGNILA-----C-----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -SCHHHHHHH-HHTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -CCHHHHHHH-HHcCCCCC-----C-----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222222222 22221111 1 11222468889999999999999999999999999863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-50 Score=408.71 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=202.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+|||||++|+
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 457899999999999996 4789999999976555556789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc--CCCCcEEeccCCccccccc--
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD--NAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfGla~~~~~~-- 411 (565)
|.+++..... .+++..+..++.||+.||.|||++ +||||||||+|||++ .++.+||+|||+++.....
T Consensus 110 L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 110 LFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp HHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999965432 399999999999999999999998 999999999999995 4678999999999876543
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....||+.|||||++.+..|+.++||||+||++|||+||+.||.. .+..+.+.......... ..+...
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~--~~~~~~- 250 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG--------ENDDETLRNVKSCDWNM--DDSAFS- 250 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCCCS--CCGGGG-
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC--Cccccc-
Confidence 345789999999999999999999999999999999999999962 22333333333322110 011111
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.....+.+++.+||+.||++|||++|+++.
T Consensus 251 -----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 -----GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112367888999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=396.55 Aligned_cols=248 Identities=20% Similarity=0.334 Sum_probs=191.8
Q ss_pred ccceecccCceeEEEEEEeC----CCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVLLT----GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|++.. +..||||+++... ....+.|.+|+.+|++++|||||+++|++. ++..|+||||+
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 45789999999999998643 3468888886432 333567999999999999999999999985 56789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 90 TLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp TTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cCCcHHhhhhccCC----CCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999998876543 489999999999999999999998 9999999999999999999999999999876432
Q ss_pred -----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 412 -----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 412 -----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
....+|+.|+|||++....|+.++|||||||++|||+| |++||..... ..+. .... .+...
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~---~~i~-~~~~~---- 228 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVI---GRIE-NGERL---- 228 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHH---HHHH-TTCCC----
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHH---HHHH-cCCCC----
Confidence 23356889999999999999999999999999999998 8999873221 1122 2211 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.. +......+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 229 -~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 -PM-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC-----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01 111224688899999999999999999999999988653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=400.65 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=201.4
Q ss_pred cceecccCceeEEEEEEeCC----CeeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEec-CceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLLTG----PAMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-EEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~E~~ 331 (565)
.++||+|+||+||+|.+..+ ..||||+++.. .....++|.+|+++|++++|||||+++|++.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 25899999743 334457899999999999999999999998764 5789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... .+++..++.++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999876543 378899999999999999999998 9999999999999999999999999999875432
Q ss_pred --------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 412 --------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 412 --------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
....+|+.|+|||.+....++.++|||||||++|||+||..||..... ..++..++ ... .. .
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----~~~~~~~i---~~g-~~--~ 253 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYL---LQG-RR--L 253 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHH---HTT-CC--C
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----HHHHHHHH---HcC-CC--C
Confidence 123578899999999999999999999999999999998888753111 11222222 211 11 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCCC
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDND 535 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 535 (565)
..| ......+.+++.+||+.||++||||.||++.|+++......
T Consensus 254 ~~p--------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 254 LQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCc--------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 111 11223678899999999999999999999999999876433
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.2e-50 Score=406.21 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=201.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|+|||||++|+
T Consensus 33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 457899999999999995 5799999999986555556788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc--CCCCcEEeccCCccccccc--
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD--NAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfGla~~~~~~-- 411 (565)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 113 L~~~~~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 113 LFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp HHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9988764432 499999999999999999999998 999999999999998 6789999999999877544
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+|+.|+|||++.+..|+.++||||+||++|||+||+.||.. .+....+......... ..+...
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~~---~~~~~~- 252 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--------EDDLETLQNVKRCDWE---FDEDAF- 252 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHCCCC---CCSSTT-
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC---CCcccc-
Confidence 345789999999999999999999999999999999999999962 2222333332222111 011110
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
......+.+++.+||+.||++|||+.|+++
T Consensus 253 ----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 ----SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111236788999999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=394.50 Aligned_cols=243 Identities=20% Similarity=0.324 Sum_probs=198.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC------ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS------NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|+.+|++++|||||+++++|.+.+..|+|||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457899999999999996 578999999986422 1235789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC----CcEEeccCCc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY----EPLLTDYALV 405 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfGla 405 (565)
||++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+|++|||++
T Consensus 94 ~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 94 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999998654 399999999999999999999998 999999999999998776 4999999999
Q ss_pred cccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
+..... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ....+...........
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~~~~~~-- 234 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANVSAVNYE-- 234 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHTTCCC--
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC--------CCHHHHHHHHHhcCCC--
Confidence 876533 345788999999999999999999999999999999999999962 1222222222221110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
. .+.... .....+.+++.+||+.||++|||++|+++
T Consensus 235 ~-~~~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 F-EDEYFS-----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-CHHHHT-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-CchhcC-----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 11236778999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=401.80 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=199.1
Q ss_pred cceecccCceeEEEEEEeCCCeeEEEEeeccCccCHHHHH--HHHHHHhcCCCCCccceEEEEEecC----ceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFH--EHMTRLGSLSHPNLLPLIAFYYRKE----EKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~E~~ 331 (565)
.+.||+|+||+||+|++ +|+.||||+++.. ..+++. .|+..+..++|||||+++++|.+.+ ..|+|||||
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 46899999999999986 7889999998643 233444 4555567789999999999998764 579999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC----CCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF----PGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
++|+|.++++.. .++|..++.++.|+|.||+|+|+.. +..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 84 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999753 3899999999999999999999742 234899999999999999999999999999987
Q ss_pred cccc--------ccccccccccCCCccCCCC------CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCc------ch
Q 008431 408 VNKE--------HAQLHMVAYKSPEFNQTDG------VTRKTDVWSLGILILELLTGKFPANYLAQGKGANA------DL 467 (565)
Q Consensus 408 ~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~------~~ 467 (565)
.... ....||+.|+|||++.... ++.++|||||||++|||+||..|+........... ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6432 2346899999999876542 57899999999999999999988753222111100 11
Q ss_pred HHHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 468 ATWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
.......... +..+|.+.......+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 238 ~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 238 VEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1222222222 122333322222234566789999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=399.80 Aligned_cols=247 Identities=22% Similarity=0.384 Sum_probs=196.5
Q ss_pred ccceecccCceeEEEEEEe-CCC----eeEEEEeecc-CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGP----AMVVKRFRQM-SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 330 (565)
..++||+|+||+||+|.+. +|+ .||+|+++.. .....++|.+|+.++++++|||||+++|+|.+ +..++++||
T Consensus 13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~ 91 (317)
T d1xkka_ 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQL 91 (317)
T ss_dssp EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEe
Confidence 4579999999999999854 454 5888888643 34456789999999999999999999999976 467889999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+.+|+|.+++..... .++|..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 92 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp CTTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred ccCCccccccccccc----CCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 999999999876543 499999999999999999999998 999999999999999999999999999987643
Q ss_pred cc------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccCcc
Q 008431 411 EH------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTGEV 483 (565)
Q Consensus 411 ~~------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (565)
.. ...||+.|+|||++.+..|+.++|||||||++|||+| |++||.... ...+.. .+..+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~----~i~~~~~~-- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISS----ILEKGERL-- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHH----HHHHTCCC--
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHH----HHHcCCCC--
Confidence 32 2356899999999999999999999999999999999 788986321 111222 22221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 484 FDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 484 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
..+......+.+++.+||+.||++|||+.||++.|..+..
T Consensus 233 --------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 0011223468889999999999999999999999988754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=396.63 Aligned_cols=239 Identities=19% Similarity=0.242 Sum_probs=200.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..|+|||||+
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence 457899999999999995 57999999999743 23346779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++...+. +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 gg~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 89 GGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp TCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999987653 89999999999999999999999 9999999999999999999999999999865432
Q ss_pred ---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccc
Q 008431 412 ---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDM 488 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 488 (565)
...+||+.|+|||++.+..|+.++||||+||++|||++|++||.. .+............ . .+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~--------~~~~~~~~~i~~~~-~------~~ 224 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHERLFELILMEE-I------RF 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCC-C------CC
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC--------cCHHHHHHHHhcCC-C------CC
Confidence 345789999999999999999999999999999999999999962 22223332222221 1 11
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 008431 489 RGTKSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVE 524 (565)
Q Consensus 489 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 524 (565)
. ......+.+++.+||+.||++||+ ++|+++
T Consensus 225 p-----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 P-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C-----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 111235778899999999999994 888876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-49 Score=395.73 Aligned_cols=239 Identities=21% Similarity=0.273 Sum_probs=200.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.+.+..|+|||||+
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 457899999999999996 57899999999742 23446789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|..++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 88 GGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp SCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred Ccccccccccccc-----ccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999999886543 88899999999999999999998 9999999999999999999999999999876544
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|||||++.+..|+.++||||+||++|||+||+.||.. .+............. .+.+
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~--------~~~~~~~~~i~~~~~---~~p~----- 222 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD--------SNTMKTYEKILNAEL---RFPP----- 222 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHCCC---CCCT-----
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC--------cCHHHHHHHHHcCCC---CCCC-----
Confidence 456799999999999999999999999999999999999999962 223333333332211 0111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
.....+.+++.+||+.||.+|| |++|+++
T Consensus 223 ----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 223 ----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1123577888999999999996 8999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=394.73 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=200.6
Q ss_pred cceecccCceeEEEEEEe-CCC--eeEEEEeecc-CccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEEeccC
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGP--AMVVKRFRQM-SNVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
.++||+|+||+||+|++. +|. .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 578999999999999965 444 4778887643 334566899999999998 79999999999999999999999999
Q ss_pred CCCHHHHHhhcC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEec
Q 008431 333 NGSLANLLHVRR-----------APGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTD 401 (565)
Q Consensus 333 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 401 (565)
+|+|.++++... ......++|..+..++.|||.||.|+|+. +|+||||||+|||++.++.+||+|
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCceEEcc
Confidence 999999997542 11223599999999999999999999998 999999999999999999999999
Q ss_pred cCCccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCC-CCccccccCCCCCcchHHHHHHHhhh
Q 008431 402 YALVPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGK-FPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 402 fGla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
||+++..... ....+|..|+|||.+....|+.++|||||||++|||++|. +||.. ....+...... .
T Consensus 171 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~--------~~~~~~~~~i~-~ 241 (309)
T d1fvra_ 171 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELYEKLP-Q 241 (309)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHGG-G
T ss_pred ccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC--------CCHHHHHHHHH-h
Confidence 9999765443 2345789999999999999999999999999999999976 45642 22333332222 2
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccCC
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERDN 534 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 534 (565)
+.. +.. +......+.+++.+||+.||++||||.||++.|+++.+...
T Consensus 242 ~~~-----~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 242 GYR-----LEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp TCC-----CCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCC-----CCC-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 111 111 11222468888999999999999999999999999986543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-49 Score=386.71 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=198.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc---cCHHHHHHHHHHHhcCCCCCccceEEEEEecCc----eEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN---VGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEE----KLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~lv~ 328 (565)
..+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|+++++.++|||||++++++...+. .|+||
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence 457899999999999995 5789999999975332 224579999999999999999999999987543 78999
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++..+++|||.++..
T Consensus 91 E~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp ECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhhhhh
Confidence 9999999999987654 399999999999999999999998 9999999999999999999999999998654
Q ss_pred ccc-------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 409 NKE-------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 409 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
... ....||+.|||||++.+..|+.++|||||||++|||+||++||.. ....+............
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--------DSPVSVAYQHVREDPIP 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHCCCCC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC--------cCHHHHHHHHHhcCCCC
Confidence 322 234689999999999999999999999999999999999999962 22233333333332111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHhhc
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-DLREAVEKIMELKE 531 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~~ 531 (565)
+..... .....+.+++.+||+.||++|| |++|+.+.|.++..
T Consensus 234 ----~~~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 ----PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ----GGGTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ----Cchhcc----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 111001 1123678888999999999999 89999999998863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=393.78 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=192.4
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEec-CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRK-EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lv 327 (565)
..+.||+|+||+||+|... +++.||||+++... ....+.+.+|+..+.++ +|+|||.+++++... +..++|
T Consensus 17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 4678999999999999954 23579999987432 33456788888888776 689999999998765 468999
Q ss_pred EeccCCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC
Q 008431 328 SDFVPNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE 396 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~ 396 (565)
||||++|+|.++++..... ....++|..++.++.||++||.|||++ +||||||||+|||++.++.
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGC
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCcCCccceeECCCCc
Confidence 9999999999999764321 112489999999999999999999998 9999999999999999999
Q ss_pred cEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCC-CCccccccCCCCCcchHH
Q 008431 397 PLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGK-FPANYLAQGKGANADLAT 469 (565)
Q Consensus 397 ~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~ 469 (565)
+||+|||+|+..... ....||+.|||||++.+..++.++|||||||++|||+||. +||.. .....
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~--------~~~~~ 244 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--------VKIDE 244 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCCSH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC--------CCHHH
Confidence 999999999865432 2346889999999999999999999999999999999974 56752 12223
Q ss_pred HHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 470 WVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 470 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
.+...+..+.... . +......+.+++.+||+.||++||||.||+++|+++.+
T Consensus 245 ~~~~~~~~~~~~~-----~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 245 EFCRRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCC-----C-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 3333333332111 1 11122367889999999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=390.13 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=191.5
Q ss_pred ccceecccCceeEEEEEEeC--C--CeeEEEEeeccC---ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLLT--G--PAMVVKRFRQMS---NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|++.. + ..||||++.... ....++|.+|+.+|++++|||||+++|+|.+ +..++|||
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeee
Confidence 45789999999999998542 2 368999986432 2334689999999999999999999999965 57789999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
|+++|++.+++..... .+++..++.++.|||.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp CCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999998876543 399999999999999999999998 99999999999999999999999999998764
Q ss_pred ccc-------cccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchHHHHHHHhhhcccC
Q 008431 410 KEH-------AQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLATWVNSVVREEWTG 481 (565)
Q Consensus 410 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (565)
... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.. .+..+.+....+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~--------~~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------LNGSQILHKIDKEGERL 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTSCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC--------cCHHHHHHHHHhCCCCC
Confidence 331 2245778999999999999999999999999999998 8999962 22333333333332111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 008431 482 EVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMEL 529 (565)
Q Consensus 482 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 529 (565)
. . +......+.+++.+||+.||++||||.||++.|++.
T Consensus 235 ~-----~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 P-----R-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----C-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 0 111123678899999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=390.02 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=198.9
Q ss_pred ccceecccCceeEEEEEEeC--------CCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEE
Q 008431 257 SAEVLGSGSFGSSYKAVLLT--------GPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 326 (565)
..+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.+++..++
T Consensus 17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence 45789999999999998532 2369999997543 33456789999999888 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC
Q 008431 327 VSDFVPNGSLANLLHVRRAP-----------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY 395 (565)
Q Consensus 327 v~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~ 395 (565)
|||||++|+|.+++...... ....+++..++.++.||+.||+|||+. +||||||||+|||++.++
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTC
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecccceeecCCC
Confidence 99999999999999865421 123589999999999999999999999 999999999999999999
Q ss_pred CcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchH
Q 008431 396 EPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLA 468 (565)
Q Consensus 396 ~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~ 468 (565)
.+||+|||+++..... ....+++.|+|||++..+.|+.++|||||||++|||+| |.+||.. ....
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~--------~~~~ 244 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPVE 244 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC--------CCHH
Confidence 9999999999876543 22457889999999999999999999999999999998 6888762 1121
Q ss_pred HHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 469 TWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
.+...+..+... .. +......+.+++.+||+.||++||||.||++.|+++.+
T Consensus 245 -~~~~~i~~~~~~-----~~-----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 -ELFKLLKEGHRM-----DK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHHTTCCC-----CC-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCC-----CC-----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 222222222111 11 11122368889999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=389.44 Aligned_cols=254 Identities=19% Similarity=0.299 Sum_probs=205.7
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..+.||+|+||+||+|.+. ++..||||+++... ......|.+|+.++++++|||||+++++|..++..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999863 35789999997532 2334569999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 330 FVPNGSLANLLHVRRA-----PGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
|+++|+|.+++...+. .....++|..+..++.|+|+||.|||++ +|+||||||+|||++.++++||+|||+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999875321 1123479999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCC-CCccccccCCCCCcchHHHHHHHhhh
Q 008431 405 VPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGK-FPANYLAQGKGANADLATWVNSVVRE 477 (565)
Q Consensus 405 a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 477 (565)
++..... ....+|+.|+|||.+.+..++.++|||||||++|||+||. +||.. ....++.......
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQVLRFVMEG 251 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHHHHHHHHTT
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHHhC
Confidence 9876433 2335789999999999999999999999999999999985 66642 3334444333322
Q ss_pred cccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 478 EWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 478 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
. ... . +......+.+++.+||+.||++||||.||++.|++..+..
T Consensus 252 ~-~~~-----~-----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 252 G-LLD-----K-----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp C-CCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred C-CCC-----C-----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1 111 0 1112246888999999999999999999999998876644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=391.25 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=203.7
Q ss_pred ccceecccCceeEEEEEEe------CCCeeEEEEeeccC-ccCHHHHHHHHHHHhcC-CCCCccceEEEEEecCceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL------TGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSL-SHPNLLPLIAFYYRKEEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 328 (565)
..++||+|+||+||+|++. +++.||||+++... .....+|.+|+.+++++ +|||||+++++|.+.+..++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 4678999999999999863 44689999997533 33456799999999999 6999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC
Q 008431 329 DFVPNGSLANLLHVRRAP-------------GQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY 395 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~ 395 (565)
|||++|+|.++++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGR 182 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETTT
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccccccccccccC
Confidence 999999999999865421 123589999999999999999999999 999999999999999999
Q ss_pred CcEEeccCCccccccc------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHc-CCCCccccccCCCCCcchH
Q 008431 396 EPLLTDYALVPIVNKE------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLT-GKFPANYLAQGKGANADLA 468 (565)
Q Consensus 396 ~~kl~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~ 468 (565)
.+|++|||+++..... ....+|+.|+|||++....++.++|||||||++|||+| |.+||.. ....
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~--------~~~~ 254 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------MPVD 254 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--------CCSS
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC--------CCHH
Confidence 9999999999876433 23467899999999999999999999999999999999 5555542 1122
Q ss_pred HHHHHHhhhcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhcc
Q 008431 469 TWVNSVVREEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKER 532 (565)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 532 (565)
..+...+..+... .. +......+.+++.+||+.||++||||.||+++|+++...
T Consensus 255 ~~~~~~i~~~~~~-----~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SKFYKMIKEGFRM-----LS-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHTCCC-----CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCC-----CC-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 2222333332111 00 111224688899999999999999999999999987544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-48 Score=393.81 Aligned_cols=239 Identities=18% Similarity=0.209 Sum_probs=200.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+.+..++||||+.
T Consensus 45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence 457899999999999996 47999999998642 23445679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
+|+|.+++.... .+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 125 ~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 999999998654 399999999999999999999998 9999999999999999999999999999877543
Q ss_pred ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccCC
Q 008431 412 HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRGT 491 (565)
Q Consensus 412 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 491 (565)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.. .+............. ..
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~--------~~~~~~~~~i~~~~~-------~~--- 257 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA--------DQPIQIYEKIVSGKV-------RF--- 257 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCC-------CC---
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC--------cCHHHHHHHHhcCCC-------CC---
Confidence 456799999999999999999999999999999999999999962 222333333222211 00
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 492 KSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 492 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
+......+.+++.+||+.||++|+ |++|+++
T Consensus 258 --p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 --PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011123678888999999999994 8999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-48 Score=380.13 Aligned_cols=243 Identities=21% Similarity=0.282 Sum_probs=196.9
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCcc---------CHHHHHHHHHHHhcCC-CCCccceEEEEEecCceE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNV---------GKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 325 (565)
..+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++ |||||++++++.+++..|
T Consensus 7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 86 (277)
T d1phka_ 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 86 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence 457899999999999996 57889999999753221 1246889999999997 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+|||||++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999998654 399999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc---ccccccccccCCCccC------CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 406 PIVNKE---HAQLHMVAYKSPEFNQ------TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 406 ~~~~~~---~~~~~t~~y~aPE~~~------~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
+..... ....||+.|+|||++. ...++.++||||+||++|||+||+.||.. ............
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~--------~~~~~~~~~i~~ 229 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--------RKQMLMLRMIMS 229 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHH
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC--------CCHHHHHHHHHh
Confidence 876543 3456899999999764 34578999999999999999999999972 122222222222
Q ss_pred hcccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 477 EEWTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 477 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
... ....+.. ......+.+++.+||+.||++|||+.||++
T Consensus 230 ~~~--~~~~~~~------~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNY--QFGSPEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCC--CCCTTTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCC--CCCCccc------ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 211 1111111 122246888999999999999999999854
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=388.18 Aligned_cols=243 Identities=19% Similarity=0.282 Sum_probs=198.5
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNGS 335 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 335 (565)
..+.||+|+||+||+|... +++.||||.++.. ......+.+|+++|+.++|||||++++++.+++..|+|||||++|+
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 4578999999999999964 6889999999754 2334568899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC--CCCcEEeccCCccccccc--
Q 008431 336 LANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN--AYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 336 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~-- 411 (565)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 88 L~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 88 IFERINTSAF----ELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 9999975432 389999999999999999999998 9999999999999984 458999999999876543
Q ss_pred -ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccccccC
Q 008431 412 -HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKDMRG 490 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 490 (565)
....+|+.|+|||...+..|+.++||||+||++|||++|+.||.. ....+.+......... ++.....
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~--------~~~~~~~~~i~~~~~~---~~~~~~~ 228 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--------ETNQQIIENIMNAEYT---FDEEAFK 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCC---CCHHHHT
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC---CChhhcc
Confidence 345678999999999999999999999999999999999999962 2223333333322211 0100000
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 491 TKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 491 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.....+.+++.+||+.||++|||+.|+++
T Consensus 229 -----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 -----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01135788999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.6e-48 Score=392.90 Aligned_cols=242 Identities=19% Similarity=0.228 Sum_probs=192.0
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC---ccCHHHHHH---HHHHHhcCCCCCccceEEEEEecCceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS---NVGKEDFHE---HMTRLGSLSHPNLLPLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 329 (565)
..++||+|+||+||+|+.. +|+.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..|+|||
T Consensus 8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE 87 (364)
T d1omwa3 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87 (364)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEE
Confidence 4578999999999999964 78999999986421 122233444 4777888899999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVN 409 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 409 (565)
||++|+|.+++.... .+++..+..++.||+.||.|||+. +||||||||+|||++.++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 88 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp CCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred ecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999998654 388999999999999999999998 99999999999999999999999999998765
Q ss_pred cc--ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCccccc
Q 008431 410 KE--HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDK 486 (565)
Q Consensus 410 ~~--~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (565)
.. ....||+.|+|||++.. ..|+.++|||||||++|||+||+.||.... ...... +....... ..
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~-~~~~~~~~------~~ 226 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHE-IDRMTLTM------AV 226 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC-----SSCHHH-HHHHSSSC------CC
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC-----HHHHHH-HHHhcccC------CC
Confidence 43 34579999999998864 568999999999999999999999996321 111111 11111110 00
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 008431 487 DMRGTKSGEGEMLKLLKIGMCCCEWNAERRWD-----LREAVE 524 (565)
Q Consensus 487 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 524 (565)
... ......+.+++.+||+.||++||| ++|+++
T Consensus 227 ~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCC-----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCC-----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 110 111236788899999999999999 688865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=388.31 Aligned_cols=239 Identities=20% Similarity=0.259 Sum_probs=195.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc---CccCHHHHHHHHHHHh-cCCCCCccceEEEEEecCceEEEEecc
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM---SNVGKEDFHEHMTRLG-SLSHPNLLPLIAFYYRKEEKLLVSDFV 331 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv~E~~ 331 (565)
..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+..|..++. .++|||||++++++.+++..|+|||||
T Consensus 6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~ 85 (320)
T d1xjda_ 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85 (320)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence 457899999999999996 47899999999742 2344566777777765 689999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 411 (565)
++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~g~L~~~i~~~~~-----~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 86 NGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp TTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999986553 89999999999999999999999 9999999999999999999999999999865432
Q ss_pred ----ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccccc
Q 008431 412 ----HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFDKD 487 (565)
Q Consensus 412 ----~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (565)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||.. .+..+..... .... +.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i-~~~~------~~ 221 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--------QDEEELFHSI-RMDN------PF 221 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHH-HHCC------CC
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC--------CCHHHHHHHH-HcCC------CC
Confidence 345789999999999999999999999999999999999999962 2222222222 2211 11
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 008431 488 MRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLR-EAVE 524 (565)
Q Consensus 488 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl~ 524 (565)
.. ......+.+++.+||+.||++|||+. |+++
T Consensus 222 ~p-----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC-----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 11123678889999999999999995 6753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=386.65 Aligned_cols=252 Identities=21% Similarity=0.201 Sum_probs=189.3
Q ss_pred ceecccCceeEEEEEE-eCCCeeEEEEeeccCcc-----CHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccC
Q 008431 259 EVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNV-----GKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVP 332 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 332 (565)
++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++..|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6899999999999995 57899999998643221 13468999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc-
Q 008431 333 NGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE- 411 (565)
Q Consensus 333 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~- 411 (565)
++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88776655422 2388899999999999999999998 9999999999999999999999999999776543
Q ss_pred ---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc--
Q 008431 412 ---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD-- 485 (565)
Q Consensus 412 ---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 485 (565)
....+|+.|+|||++.. ..|+.++|||||||++|||+||++||.... ..+....+.............+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-----~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-----HHHHHHHHHHhcCCCChhhccchh
Confidence 24468999999998764 468999999999999999999999996211 1111111111111100000000
Q ss_pred -----ccccCC-CCCH-----HHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 486 -----KDMRGT-KSGE-----GEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 486 -----~~~~~~-~~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...... ..+. .....+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 0000 11246888999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=390.83 Aligned_cols=244 Identities=16% Similarity=0.227 Sum_probs=190.7
Q ss_pred cceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhc-CCCCCccceEEEEEe----cCceEEEEecc
Q 008431 258 AEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGS-LSHPNLLPLIAFYYR----KEEKLLVSDFV 331 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~~lv~E~~ 331 (565)
.++||+|+||+||+|+. .+++.||||+++. ...+.+|+.++.+ .+|||||+++++|.+ +...|+|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 35799999999999995 5789999999864 3567889988655 589999999999875 35689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC---CCCcEEeccCCcccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN---AYEPLLTDYALVPIV 408 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~ 408 (565)
+||+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 92 ~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 92 DGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp CSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccceeeec
Confidence 99999999975432 2499999999999999999999998 9999999999999985 567999999999866
Q ss_pred ccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCcccc
Q 008431 409 NKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGEVFD 485 (565)
Q Consensus 409 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (565)
... ....||+.|||||++.+..|+.++|||||||++|||+||++||..... ......+....... ..
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~-----~~~~~~~~~~i~~~---~~-- 234 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMG---QY-- 234 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC-----C--------CCCSC---SS--
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH-----HHHHHHHHHHHhcC---CC--
Confidence 443 355789999999999999999999999999999999999999973221 11111111111100 00
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 486 KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 235 -~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -EFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -SCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 00001223468889999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=375.82 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=191.3
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|+||||+.+
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence 347899999999999995 579999999996432 23457899999999999999999999999999999999999976
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++.+++..... ..+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 -~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 86 -DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp -EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred -chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 45555543322 2499999999999999999999998 9999999999999999999999999999766433
Q ss_pred --ccccccccccCCCccCCCC-CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-cccCccccc-
Q 008431 412 --HAQLHMVAYKSPEFNQTDG-VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-EWTGEVFDK- 486 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~- 486 (565)
....+|+.|+|||.+.... ++.++||||+||++|||++|+.||... +-...+...... +...+...+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~--------~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--------SEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC--------CHHHHHHHHHHhcCCCchhhccc
Confidence 3447899999999866655 578999999999999999999999621 111111111111 000000000
Q ss_pred -----cc----cCCC-CC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 487 -----DM----RGTK-SG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 487 -----~~----~~~~-~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.. .... .. ......+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0000 00 0112467888999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=374.21 Aligned_cols=233 Identities=19% Similarity=0.290 Sum_probs=189.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCc------cCHHHHHHHHHHHhcCC--CCCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSN------VGKEDFHEHMTRLGSLS--HPNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv 327 (565)
..++||+|+||+||+|+. .+|+.||||++..... ....++.+|+.+|++++ |||||++++++.+.+..++|
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv 87 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87 (273)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence 457899999999999995 5789999999874321 12234778999999987 89999999999999999999
Q ss_pred EeccCC-CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-CCCcEEeccCCc
Q 008431 328 SDFVPN-GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-AYEPLLTDYALV 405 (565)
Q Consensus 328 ~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla 405 (565)
|||+.+ +++.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 88 ~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccccc
Confidence 999976 68888887654 399999999999999999999998 9999999999999985 479999999999
Q ss_pred cccccc--ccccccccccCCCccCCCCC-CcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccCc
Q 008431 406 PIVNKE--HAQLHMVAYKSPEFNQTDGV-TRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTGE 482 (565)
Q Consensus 406 ~~~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (565)
+..... ....||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ...... .
T Consensus 159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~~---~ 221 (273)
T d1xwsa_ 159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRGQ---V 221 (273)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHCC---C
T ss_pred eecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhcc---c
Confidence 865543 45578999999998877665 577999999999999999999996211 011110 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 483 VFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 483 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
.+.+.+ ...+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~---------s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 FFRQRV---------SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCSSCC---------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCC---------CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111111 136788889999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-46 Score=370.61 Aligned_cols=251 Identities=19% Similarity=0.275 Sum_probs=192.8
Q ss_pred ccceecccCceeEEEEEEeCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..++||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..+++|||+.++
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhh
Confidence 357899999999999999899999999996532 333578999999999999999999999999999999999999887
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc---
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE--- 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~--- 411 (565)
.+..+..... .+++..+..++.||+.||+|||+. +||||||||+|||++.++.+|++|||++......
T Consensus 86 ~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 86 LKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp HHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred hHHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 7776654332 499999999999999999999998 9999999999999999999999999998765433
Q ss_pred -ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh---hc----ccC-
Q 008431 412 -HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR---EE----WTG- 481 (565)
Q Consensus 412 -~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~- 481 (565)
....+++.|+|||.+.. ..++.++||||+||++|||++|+.||... ...+....... .. +..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~--------~~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV--------SEADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC--------CHHHHHHHHHHhhCCCChhhccch
Confidence 33457889999998765 45799999999999999999999999632 11111111111 00 000
Q ss_pred ---ccccccccCC------CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 ---EVFDKDMRGT------KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 ---~~~d~~~~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...+...... .........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 000111246788999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=370.89 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=188.4
Q ss_pred ccceecccCceeEEEEEE-eC-CCeeEEEEeecc--CccCHHHHHHHHHHHhcC---CCCCccceEEEEEe-----cCce
Q 008431 257 SAEVLGSGSFGSSYKAVL-LT-GPAMVVKRFRQM--SNVGKEDFHEHMTRLGSL---SHPNLLPLIAFYYR-----KEEK 324 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~~~ 324 (565)
..+.||+|+||+||+|+. .+ ++.||||+++.. .......+.+|+.+|+.+ +|||||+++++|.. ....
T Consensus 11 i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~ 90 (305)
T d1blxa_ 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 90 (305)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred EEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceE
Confidence 457899999999999996 34 557899998643 222344567787776655 89999999999864 2367
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCC
Q 008431 325 LLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYAL 404 (565)
Q Consensus 325 ~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 404 (565)
+++|||+++|++........ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 91 TLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred EEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecchhh
Confidence 99999999877765544332 2489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh----
Q 008431 405 VPIVNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE---- 477 (565)
Q Consensus 405 a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 477 (565)
++..... ....||+.|+|||++.+..|+.++||||+||++|||+||++||... +..+.+......
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--------SDVDQLGKILDVIGLP 234 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCC
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHhhCCC
Confidence 8765433 4567899999999999999999999999999999999999999631 111112211110
Q ss_pred ---cccCcccccc--cc-CCC-----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 478 ---EWTGEVFDKD--MR-GTK-----SGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 478 ---~~~~~~~d~~--~~-~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+......+. .. ... ........+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0100000000 00 000 001112357788999999999999999998763
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=370.03 Aligned_cols=258 Identities=22% Similarity=0.272 Sum_probs=188.7
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEEEe
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLVSD 329 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv~E 329 (565)
..++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|++++|||||+++++|... ...|+|||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 347899999999999996 4789999999975432 234799999999999999999998653 24689999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCcccc
Q 008431 330 FVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIV 408 (565)
Q Consensus 330 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~ 408 (565)
||++|.+..+.+.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 100 y~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp CCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred ccCCccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9987644444332211 12499999999999999999999998 999999999999999765 8999999999876
Q ss_pred ccc---ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-------
Q 008431 409 NKE---HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE------- 477 (565)
Q Consensus 409 ~~~---~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 477 (565)
... ....||..|+|||.+.+ ..|+.++||||+||++|||++|++||.... ...........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~--------~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--------GVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS--------HHHHHHHHHHHHCCCCHH
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC--------HHHHHHHHHHHhCCChHH
Confidence 433 34578899999997654 578999999999999999999999996321 11111111100
Q ss_pred ---cccCcccc---ccccCC----CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHhhcc
Q 008431 478 ---EWTGEVFD---KDMRGT----KSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMELKER 532 (565)
Q Consensus 478 ---~~~~~~~d---~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~ 532 (565)
.......+ +..... .........+.+++.+||+.||++|||+.|+++. +++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 00000000 000000 0001122367888999999999999999999863 6666543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=360.59 Aligned_cols=255 Identities=19% Similarity=0.226 Sum_probs=187.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeecc--CccCHHHHHHHHHHHhcCCCCCccceEEEEEe--------cCceE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQM--SNVGKEDFHEHMTRLGSLSHPNLLPLIAFYYR--------KEEKL 325 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~~~~~ 325 (565)
..+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.. .+..|
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 347899999999999996 57999999998643 33445779999999999999999999999865 34579
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCc
Q 008431 326 LVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALV 405 (565)
Q Consensus 326 lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 405 (565)
+||||+.++.+..+.... ..++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 94 iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp EEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeeccee
Confidence 999999887666443322 2488999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc--------ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhh
Q 008431 406 PIVNKE--------HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVR 476 (565)
Q Consensus 406 ~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 476 (565)
+..... ....||+.|+|||++.+. .|+.++||||+||++|||++|++||.... .......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-----~~~~~~~i~~~~~ 239 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLCG 239 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-----HHHHHHHHHHhcC
Confidence 765422 234689999999987654 68999999999999999999999996211 0111111111111
Q ss_pred hcc---cCcccc----cc---ccCCCCCH-HH------HHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 477 EEW---TGEVFD----KD---MRGTKSGE-GE------MLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 477 ~~~---~~~~~d----~~---~~~~~~~~-~~------~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
... ...... .. ........ .. ...+.+++.+||++||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 100 000000 00 00001011 11 2346789999999999999999999753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=365.97 Aligned_cols=254 Identities=17% Similarity=0.246 Sum_probs=187.0
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC-ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC----ceEEEEec
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS-NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE----EKLLVSDF 330 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~E~ 330 (565)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 457899999999999995 589999999997533 233567899999999999999999999997653 23555667
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccccc
Q 008431 331 VPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNK 410 (565)
Q Consensus 331 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 410 (565)
+.+|+|.+++... .+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 92 LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 7799999999753 389999999999999999999998 999999999999999999999999999976543
Q ss_pred c-------ccccccccccCCCccC-CCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcccC-
Q 008431 411 E-------HAQLHMVAYKSPEFNQ-TDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWTG- 481 (565)
Q Consensus 411 ~-------~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 481 (565)
. ....||+.|+|||++. ...++.++||||+||++|||++|+.||..... .+...............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPSQED 236 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHHHHhhhccCCChhh
Confidence 2 2345789999999874 45678999999999999999999999963110 01111111111000000
Q ss_pred ----------ccccccccCCCCCH-----HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 482 ----------EVFDKDMRGTKSGE-----GEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 482 ----------~~~d~~~~~~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
............+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000 111357889999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=365.08 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=187.8
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecC------ceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKE------EKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv 327 (565)
..+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+ ..|+|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 346899999999999995 579999999997432 233467899999999999999999999997654 46999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+ +++|..+.+.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++.
T Consensus 102 ~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred Eecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccceec
Confidence 9999 56888887642 399999999999999999999998 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCCCccCC-CCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhh-cc-----
Q 008431 408 VNKE-HAQLHMVAYKSPEFNQT-DGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVRE-EW----- 479 (565)
Q Consensus 408 ~~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~----- 479 (565)
.... ....+|+.|+|||++.+ ..++.++||||+||++|||++|++||.... -...+...... ..
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--------HLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCCCCHHH
T ss_pred cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC--------hHHHHHHHHhccCCCcHHH
Confidence 6554 45678999999998765 457899999999999999999999996321 11111110000 00
Q ss_pred ---------------cCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHh
Q 008431 480 ---------------TGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK--IMEL 529 (565)
Q Consensus 480 ---------------~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 529 (565)
..+.....+... .......+.+++.+||+.||++|||+.|+++. ++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASI--LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGT--CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHh--ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000000000 01112357789999999999999999999874 5544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-44 Score=353.72 Aligned_cols=252 Identities=19% Similarity=0.207 Sum_probs=195.5
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEecCceEEEEeccCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRKEEKLLVSDFVPN 333 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 333 (565)
..+.||+|+||+||+|+. .+++.||||+++... ....+++.+|+.+|+.++|||||+++++|.+.+..++|+||+.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 347899999999999995 578899999997432 23357899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccccccc--
Q 008431 334 GSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIVNKE-- 411 (565)
Q Consensus 334 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~-- 411 (565)
++|..++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 86 ~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 86 DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99988876543 388999999999999999999998 9999999999999999999999999999876543
Q ss_pred --ccccccccccCCCccCCCC-CCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc-------cC
Q 008431 412 --HAQLHMVAYKSPEFNQTDG-VTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW-------TG 481 (565)
Q Consensus 412 --~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 481 (565)
....+++.|+|||.+.... ++.++||||+||++|||++|+.||.. ..+..+.+........ ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-------GNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-------CSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC-------CCCHHHHHHHHHhhcCCCChhhhhh
Confidence 2334678899999876654 68999999999999999999999752 1223333332221100 00
Q ss_pred --cccc----ccc----cCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 482 --EVFD----KDM----RGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 482 --~~~d----~~~----~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
...+ +.. ............+.+++.+||++||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000 000001122246778899999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-44 Score=355.61 Aligned_cols=252 Identities=15% Similarity=0.173 Sum_probs=190.6
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCccceEEE-EEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLLPLIAF-YYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~-~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|+. .+|+.||||.+.... ..+++.+|+++++.++|+|+|..++. +.+.+..++||||+ +|
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~ 87 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 87 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence 457899999999999995 568899999887532 23468899999999988876666555 46677889999999 56
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEc---CCCCcEEeccCCccccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLD---NAYEPLLTDYALVPIVNKE 411 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~~~~~~ 411 (565)
++.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+|+.....
T Consensus 88 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 88 SLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp BHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred chhhhhhhccC----CCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 77777655433 499999999999999999999998 999999999999975 4567999999999876432
Q ss_pred -----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 412 -----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 412 -----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
....||+.|||||.+.+..++.++|||||||++|||+||+.||......... .....+....... .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~--~ 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMST--P 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHS--C
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhcccCCC--C
Confidence 2346899999999999999999999999999999999999999743221110 1111111111100 0
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhc
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKE 531 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 531 (565)
.+.+.. .....+.+++..|++.+|++||++.++.+.|+.+..
T Consensus 237 ----~~~~~~-----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 ----IEVLCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHHTT-----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----hhHhcc-----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 001101 112367888899999999999999999999988744
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=357.85 Aligned_cols=243 Identities=21% Similarity=0.258 Sum_probs=192.5
Q ss_pred ccceecccCceeEEEEEEe----CCCeeEEEEeecc----CccCHHHHHHHHHHHhcCCC-CCccceEEEEEecCceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL----TGPAMVVKRFRQM----SNVGKEDFHEHMTRLGSLSH-PNLLPLIAFYYRKEEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv 327 (565)
..+.||+|+||+||+|+.. +|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+....++|
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 4578999999999999852 4789999998642 22345678899999999977 8999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
|||+.+|+|.+++..... ++...+..++.|++.||.|+|+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp ECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999987653 77889999999999999999998 999999999999999999999999999976
Q ss_pred cccc-----ccccccccccCCCccCCC--CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhccc
Q 008431 408 VNKE-----HAQLHMVAYKSPEFNQTD--GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEWT 480 (565)
Q Consensus 408 ~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (565)
.... ....+++.|+|||.+... .++.++||||+||+||||+||+.||..... ......+........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~-----~~~~~~i~~~~~~~~- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE-----KNSQAEISRRILKSE- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS-----CCCHHHHHHHHHHCC-
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcccCC-
Confidence 5432 345678999999987654 468899999999999999999999974321 122222221111110
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 008431 481 GEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRW-----DLREAVE 524 (565)
Q Consensus 481 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 524 (565)
+.+ +......+.+++.+||++||++|| |++|+++
T Consensus 253 -----~~~-----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -----PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCC-----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011 111224678888999999999999 4788864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-43 Score=349.98 Aligned_cols=254 Identities=16% Similarity=0.162 Sum_probs=198.6
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccCccCHHHHHHHHHHHhcCCC-CCccceEEEEEecCceEEEEeccCCC
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSH-PNLLPLIAFYYRKEEKLLVSDFVPNG 334 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~E~~~~g 334 (565)
..+.||+|+||+||+|+.. +|+.||||.+.... ..+.+.+|++.++.++| +|++.+++++......++||||+ +|
T Consensus 9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~ 85 (293)
T d1csna_ 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence 4578999999999999954 68899999886432 23457888999999876 89999999999999999999999 68
Q ss_pred CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcC-----CCCcEEeccCCccccc
Q 008431 335 SLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDN-----AYEPLLTDYALVPIVN 409 (565)
Q Consensus 335 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DfGla~~~~ 409 (565)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 86 ~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 86 SLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp BHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHhhcc----chhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999876543 389999999999999999999998 9999999999999974 5679999999998654
Q ss_pred cc-----------ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhc
Q 008431 410 KE-----------HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREE 478 (565)
Q Consensus 410 ~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (565)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||..... ..............
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~-----~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-----ATNKQKYERIGEKK 232 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS-----CCHHHHHHHHHHHH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc-----hhHHHHHHHHHhcc
Confidence 22 234689999999999999999999999999999999999999963221 11222222111111
Q ss_pred ccCccccccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhccC
Q 008431 479 WTGEVFDKDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEKIMELKERD 533 (565)
Q Consensus 479 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 533 (565)
... ..+.+.. .....+.+++..|++.+|++||+++.+.+.|+++....
T Consensus 233 ~~~--~~~~l~~-----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 233 QST--PLRELCA-----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHS--CHHHHTT-----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCC--ChHHhcC-----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 000 0011101 01135778888999999999999999999998876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.6e-43 Score=354.15 Aligned_cols=250 Identities=20% Similarity=0.245 Sum_probs=188.4
Q ss_pred hccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEec--CceEEEEecc
Q 008431 256 ASAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRK--EEKLLVSDFV 331 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~E~~ 331 (565)
...++||+|+||+||+|+. .+|+.||||+++. ...+++.+|+++|++++ ||||+++++++... ...++|||||
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 3567899999999999996 5789999999864 33567899999999995 99999999999854 4689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCC-CcEEeccCCcccccc
Q 008431 332 PNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAY-EPLLTDYALVPIVNK 410 (565)
Q Consensus 332 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~ 410 (565)
++|+|..+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 115 ~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 115 NNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred CCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999976532 389999999999999999999998 999999999999998655 589999999987654
Q ss_pred c---ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHh---------hh
Q 008431 411 E---HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVV---------RE 477 (565)
Q Consensus 411 ~---~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~ 477 (565)
. ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ......+.... ..
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~----~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH----HHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh----HHHHHHHHHHHCCchhhhhhhh
Confidence 3 345678999999987654 5799999999999999999999998632110 00000011100 00
Q ss_pred ccc------Ccccc-------ccccCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 478 EWT------GEVFD-------KDMRGTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 478 ~~~------~~~~d-------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
... ..... ...............+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000 000000011112246788999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=355.61 Aligned_cols=249 Identities=16% Similarity=0.248 Sum_probs=182.7
Q ss_pred ccceecccCceeEEEEEEe-CCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec------CceEEE
Q 008431 257 SAEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK------EEKLLV 327 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv 327 (565)
..++||+|+||+||+|+.. +|+.||||++.... .....++.+|+.++++++|||||+++++|... ...|+|
T Consensus 21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 3478999999999999964 79999999997532 23345789999999999999999999999643 578999
Q ss_pred EeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 328 SDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 328 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
||||.++ +.+.+.. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++.
T Consensus 101 ~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 101 MELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EeccchH-HHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhhhc
Confidence 9999765 4444431 389999999999999999999999 999999999999999999999999999876
Q ss_pred cccc---ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHH----------
Q 008431 408 VNKE---HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSV---------- 474 (565)
Q Consensus 408 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 474 (565)
.... ....+|+.|+|||++.+..+++++||||+||++|||++|++||... +........
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~--------~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--------DYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCHH
T ss_pred cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC--------CHHHHHHHHHHhccCCCHH
Confidence 5443 3456889999999999999999999999999999999999999621 111111111
Q ss_pred ------------hhhccc-C-----ccccccccCCCC--CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 475 ------------VREEWT-G-----EVFDKDMRGTKS--GEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 475 ------------~~~~~~-~-----~~~d~~~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
...... . ............ .......+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111000 0 000001101110 12234568899999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=356.23 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=187.1
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccC--ccCHHHHHHHHHHHhcCCCCCccceEEEEEec-----CceEEEE
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMS--NVGKEDFHEHMTRLGSLSHPNLLPLIAFYYRK-----EEKLLVS 328 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~ 328 (565)
..+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++|||||++++++... ...++++
T Consensus 22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 457899999999999995 579999999997432 23345789999999999999999999998643 3457778
Q ss_pred eccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCcEEeccCCcccc
Q 008431 329 DFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEPLLTDYALVPIV 408 (565)
Q Consensus 329 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 408 (565)
||+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++...
T Consensus 102 ~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhccc
Confidence 888899999998642 399999999999999999999998 9999999999999999999999999999776
Q ss_pred ccc-ccccccccccCCCccCCC-CCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHHHhhhcc-cC-cc-
Q 008431 409 NKE-HAQLHMVAYKSPEFNQTD-GVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNSVVREEW-TG-EV- 483 (565)
Q Consensus 409 ~~~-~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~- 483 (565)
... ....||+.|+|||..... .++.++||||+||++|||++|++||... +............. .. +.
T Consensus 172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~--------~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--------DHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhcCCCChHHh
Confidence 543 456788999999976654 5689999999999999999999999621 11111111111000 00 00
Q ss_pred ----------ccccccCC-CCC-----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 008431 484 ----------FDKDMRGT-KSG-----EGEMLKLLKIGMCCCEWNAERRWDLREAVE 524 (565)
Q Consensus 484 ----------~d~~~~~~-~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 524 (565)
....+... ... ......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000 000 011235778999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-38 Score=322.53 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=184.2
Q ss_pred ccceecccCceeEEEEEE-eCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-----------CCCccceEEEEEec--C
Q 008431 257 SAEVLGSGSFGSSYKAVL-LTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-----------HPNLLPLIAFYYRK--E 322 (565)
Q Consensus 257 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~--~ 322 (565)
..++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.++++++ |+|||++++++... .
T Consensus 17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 95 (362)
T d1q8ya_ 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 95 (362)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence 457999999999999996 57899999999753 223467788998888775 57899999988654 4
Q ss_pred ceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCC------
Q 008431 323 EKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYE------ 396 (565)
Q Consensus 323 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~------ 396 (565)
..+++|+++..+........... ...+++..+..++.||+.||+|||+.. +|+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence 56677777655443322222221 234889999999999999999999831 8999999999999986653
Q ss_pred cEEeccCCccccccc-ccccccccccCCCccCCCCCCcchhHHHHHHHHHHHHcCCCCccccccCCCCCcchHHHHHH--
Q 008431 397 PLLTDYALVPIVNKE-HAQLHMVAYKSPEFNQTDGVTRKTDVWSLGILILELLTGKFPANYLAQGKGANADLATWVNS-- 473 (565)
Q Consensus 397 ~kl~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 473 (565)
+|++|||.+...... ....+|+.|+|||++....++.++||||+||+++||++|+.||........ ..........
T Consensus 171 ~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~-~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY-TKDDDHIAQIIE 249 (362)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CHHHHHHHHHH
T ss_pred eeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc-cchhHHHHHHHH
Confidence 899999998765443 456789999999999899999999999999999999999999974321111 0111111110
Q ss_pred Hhh--------hc-ccCcccc-----cccc-------------CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 008431 474 VVR--------EE-WTGEVFD-----KDMR-------------GTKSGEGEMLKLLKIGMCCCEWNAERRWDLREAVEK 525 (565)
Q Consensus 474 ~~~--------~~-~~~~~~d-----~~~~-------------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 525 (565)
.+. .. ......+ ..+. ...........+.+++.+||++||.+|||++|+++.
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 00 0000000 0000 111234566789999999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.9e-24 Score=199.25 Aligned_cols=163 Identities=15% Similarity=0.144 Sum_probs=120.4
Q ss_pred hccceecccCceeEEEEEEeCCCeeEEEEeeccCc-----c-------------CHHHHHHHHHHHhcCCCCCccceEEE
Q 008431 256 ASAEVLGSGSFGSSYKAVLLTGPAMVVKRFRQMSN-----V-------------GKEDFHEHMTRLGSLSHPNLLPLIAF 317 (565)
Q Consensus 256 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~-------------~~~~~~~E~~~l~~l~H~niv~l~~~ 317 (565)
+..+.||+|+||+||+|...+|+.||||.++.... . ....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34689999999999999988999999998753110 0 01234568889999999999988765
Q ss_pred EEecCceEEEEeccCCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCCCCCCEEEcCCCCc
Q 008431 318 YYRKEEKLLVSDFVPNGSLANLLHVRRAPGQPGLDWPIRLKIIKGVAKGLAYLYKEFPGVTLPHGHLKSSNVLLDNAYEP 397 (565)
Q Consensus 318 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~~~~~ivHrDlkp~NILl~~~~~~ 397 (565)
. ..+++|||++++.+.+ +++.....++.|++.||+|||+. +|+||||||+|||++++ .+
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETT-EE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCC-CE
Confidence 3 3479999998765432 44455678999999999999998 99999999999999865 58
Q ss_pred EEeccCCcccccccccccccccccC------CCccCCCCCCcchhHHHHHHHH
Q 008431 398 LLTDYALVPIVNKEHAQLHMVAYKS------PEFNQTDGVTRKTDVWSLGILI 444 (565)
Q Consensus 398 kl~DfGla~~~~~~~~~~~t~~y~a------PE~~~~~~~~~~~DvwS~Gvil 444 (565)
+|+|||+|......... .|.. .+++ .+.|+.++|+||..--+
T Consensus 142 ~liDFG~a~~~~~~~~~----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWR----EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHH----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcH----HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999998765433211 0110 0111 25678899999986443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.74 E-value=1.1e-18 Score=173.13 Aligned_cols=70 Identities=39% Similarity=0.707 Sum_probs=56.1
Q ss_pred ccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCcc--ccCCCCCcccCCCCCCCCCCcccc
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDT--LSNFDATSFQGNKGLCGKPLEACK 152 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~n~~~cg~p~~~c~ 152 (565)
++.+++|+.|+|++|+|+|.+|.. .+++|+.|+|++|+|+|.+|.. +.++....+.||+.+||.|+++|.
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence 455667778888888888888764 5788899999999999888863 456677788999999999988883
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.61 E-value=1.8e-16 Score=145.27 Aligned_cols=120 Identities=26% Similarity=0.289 Sum_probs=102.4
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCC--ccc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMP--SVG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
...+||.+ + .+++++|+|++|+|++.++ .+. ..+|+.|+|++|+++ .++++.|..+++|+.|+|++|+|+...
T Consensus 19 ~L~~iP~~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~-~~~~~~~~~~~~L~~L~Ls~N~l~~l~ 94 (192)
T d1w8aa_ 19 GLKEIPRD-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEIS 94 (192)
T ss_dssp CCSSCCSC-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSCCCCEEC
T ss_pred CcCccCCC-C--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc-cccccccccccccceeeeccccccccC
Confidence 34578864 3 2689999999999987665 233 347999999999999 677778999999999999999999988
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
|.+|.++++|++|+|++|+|++..|+. .+.+|+.|+|++|.+.+..+
T Consensus 95 ~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 95 NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred HHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 999999999999999999999888764 68999999999999976443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.61 E-value=1.5e-15 Score=138.90 Aligned_cols=129 Identities=19% Similarity=0.290 Sum_probs=112.0
Q ss_pred CCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccC
Q 008431 17 GLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEG 96 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 96 (565)
..+.++.++|+|+..++.+. ..+++|+|++|+|++.++...|.++++|+.|+|++|++.+..+..|..+++|++|+|++
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp-~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIP-LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCC-TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCEEEEeCCCcCccCCCCC-CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 35689999999996554543 57999999999998778888899999999999999999999999999999999999999
Q ss_pred CcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCCC---CCcccCCCCCCCC
Q 008431 97 NSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNFD---ATSFQGNKGLCGK 146 (565)
Q Consensus 97 N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~---~~~~~~n~~~cg~ 146 (565)
|+|++..|.. .+++|+.|+|++|+|++..|..|..+. ...+.+|+..|.+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 9999877763 689999999999999998888876655 4467888887764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=2.1e-15 Score=145.44 Aligned_cols=142 Identities=24% Similarity=0.231 Sum_probs=92.8
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccE--------------
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKK-------------- 67 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~-------------- 67 (565)
|.+..||++.|.++++|+.|+|++|+|+...+.....+|+.|+|++|+|+ .+|.. |.++++|+.
T Consensus 41 N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls~N~l~-~~~~~-~~~l~~L~~L~l~~~~~~~~~~~ 118 (266)
T d1p9ag_ 41 NLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLL-GQTLPALTVLDVSFNRLTSLPLG 118 (266)
T ss_dssp SCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCC-TTTCTTCCEEECCSSCCCCCCSS
T ss_pred CcCCCcCHHHhhcccccccccccccccccccccccccccccccccccccc-ccccc-cccccccccccccccccceeecc
Confidence 55667777788888888888888888875433222335777777777766 33332 444444444
Q ss_pred ----------EEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccC---C
Q 008431 68 ----------VHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSN---F 132 (565)
Q Consensus 68 ----------L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~---~ 132 (565)
|++++|.++...+..+..+++|+.|++++|+|++..+.. .+++|+.|+|++|+|+ .+|..+.. +
T Consensus 119 ~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L 197 (266)
T d1p9ag_ 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197 (266)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCC
T ss_pred ccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCC
Confidence 444455555445555666777777777777777666553 5678888888888887 66665433 3
Q ss_pred CCCcccCCCCCCCC
Q 008431 133 DATSFQGNKGLCGK 146 (565)
Q Consensus 133 ~~~~~~~n~~~cg~ 146 (565)
....+.||++.|.+
T Consensus 198 ~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 198 PFAFLHGNPWLCNC 211 (266)
T ss_dssp SEEECCSCCBCCSG
T ss_pred CEEEecCCCCCCCc
Confidence 44567788888864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.2e-15 Score=148.58 Aligned_cols=144 Identities=24% Similarity=0.307 Sum_probs=125.3
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCc-cc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~ 79 (565)
|.+..+++..|.++++|+.|+|++|.+....+. .. ..+|+.+++++|+|+ .||+++|..+++|+.|+|++|+|++..
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccc
Confidence 456778888999999999999999999876653 33 336999999999999 788888999999999999999999988
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCCccccCC---CCCcccCCCCCCCC
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIPDTLSNF---DATSFQGNKGLCGK 146 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~---~~~~~~~n~~~cg~ 146 (565)
|..|.++++|+.|++++|++++..|.. .+++|+.|++++|++++..|..|.++ ....+.+|+..|.+
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 999999999999999999999988874 67899999999999999888777654 44567899988864
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.49 E-value=1.5e-14 Score=142.64 Aligned_cols=121 Identities=34% Similarity=0.656 Sum_probs=63.7
Q ss_pred hcCCCCCCcEEEccc-CcCccCCC-ccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCC
Q 008431 11 TLSRLPGLRSLSFIN-NSFDGPMP-SVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQ 87 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~-N~l~~~~p-~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 87 (565)
.+++|++|++|+|++ |+|+|.+| .++.+ +|++|+|++|+|+|..| ..+..+..|+.+++++|.+.+.+|..|++++
T Consensus 71 ~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~-~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~ 149 (313)
T d1ogqa_ 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP-DFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149 (313)
T ss_dssp GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC-GGGGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred HHhcCccccccccccccccccccccccccccccchhhhcccccccccc-ccccchhhhcccccccccccccCchhhccCc
Confidence 455555555555554 55555555 33333 45555555555554333 2355555555555555555555555555555
Q ss_pred CCCEEeccCCcCCCCCCCC--CCCC-CCEEEcccCCCccCCCccccCC
Q 008431 88 KLLQLNLEGNSFQGKIPDF--PLAH-LTLLDLSYNQLVGRIPDTLSNF 132 (565)
Q Consensus 88 ~L~~L~l~~N~l~g~~p~~--~~~~-L~~l~ls~N~l~g~~p~~~~~~ 132 (565)
.|+.+++++|.++|.+|.. .+.. ++.+++++|+++|..|..+.++
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l 197 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC
T ss_pred ccceeecccccccccccccccccccccccccccccccccccccccccc
Confidence 5555555555555555542 2222 3555555555555555544433
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=1.2e-13 Score=116.35 Aligned_cols=100 Identities=24% Similarity=0.322 Sum_probs=84.7
Q ss_pred cEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCC
Q 008431 19 RSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGN 97 (565)
Q Consensus 19 ~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 97 (565)
+.|+|++|+|+.. +.+..+ .|++|+|++|+|+ .+|+. |..+++|+.|++++|+|+. +| .++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~-~lp~~-~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccC-cchhh-hhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 5799999999854 445444 7999999999999 79875 8899999999999999995 55 4899999999999999
Q ss_pred cCCCCCCC---CCCCCCCEEEcccCCCcc
Q 008431 98 SFQGKIPD---FPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 98 ~l~g~~p~---~~~~~L~~l~ls~N~l~g 123 (565)
+++....- ..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 99865432 267899999999999974
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=4e-13 Score=130.40 Aligned_cols=123 Identities=23% Similarity=0.332 Sum_probs=107.9
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
....++...+..+++|+.+++++|+|++.++. +.. ..|+.|+|++|+|+ .+|+++|.++++|+.|++++|++++..|
T Consensus 116 ~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~-~l~~~~f~~l~~L~~l~l~~N~l~~i~~ 194 (284)
T d1ozna_ 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (284)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred ccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccc-ccchhhhccccccchhhhhhccccccCh
Confidence 34456777788899999999999999987764 333 36999999999999 6888889999999999999999999999
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEcccCCCccCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ls~N~l~g~~p 126 (565)
..|.++++|++|++++|++++..|.. .+.+|+.|+|++|.+.+..+
T Consensus 195 ~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999999999999999999877753 68899999999999987554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=3.2e-13 Score=119.42 Aligned_cols=110 Identities=18% Similarity=0.088 Sum_probs=91.1
Q ss_pred hcCCCCCCcEEEcccCcCccCCCccc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMPSVG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKL 89 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p~~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 89 (565)
.|.++.+|+.|+|++|+|+....... ...|+.|+||+|+|+ .++. |..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~~--~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG--FPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EECC--CCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccCC--cccCcchhhhhcccccccCCCcccccccccc
Confidence 36788899999999999987633222 337999999999999 7863 8999999999999999997667777889999
Q ss_pred CEEeccCCcCCCCCC--C-CCCCCCCEEEcccCCCcc
Q 008431 90 LQLNLEGNSFQGKIP--D-FPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 90 ~~L~l~~N~l~g~~p--~-~~~~~L~~l~ls~N~l~g 123 (565)
+.|+|++|+++.... . ..+++|+.|++++|+++.
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCcccc
Confidence 999999999985322 1 267899999999999864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=2.7e-12 Score=123.15 Aligned_cols=118 Identities=26% Similarity=0.294 Sum_probs=91.5
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccc-------------------------ccccceeecccccccccCCc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVG-------------------------KLTLRALYLSLNKFTGEIPS 56 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-------------------------~~~L~~L~Ls~N~l~g~ip~ 56 (565)
|.+..||. ++.+++|+.|+|++|+|++..+.+. ..+++.|++++|.++ .+|+
T Consensus 65 N~l~~l~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~ 141 (266)
T d1p9ag_ 65 AELTKLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPP 141 (266)
T ss_dssp SCCCEEEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCT
T ss_pred cccccccc--ccccccccccccccccccccccccccccccccccccccccceeeccccccccccccccccccccc-eecc
Confidence 33445543 4567777777777777664333211 124667777788887 7888
Q ss_pred chhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCC--CCCCCCCEEEcccCCCcc
Q 008431 57 DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD--FPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 57 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~~L~~l~ls~N~l~g 123 (565)
..|..+++|+.|++++|+|++..|..|..+++|++|+|++|+|+ .+|. +.+.+|+.|+|++|.+..
T Consensus 142 ~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 88899999999999999999988899999999999999999999 5654 368899999999999864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=3.7e-12 Score=111.61 Aligned_cols=108 Identities=18% Similarity=0.177 Sum_probs=90.0
Q ss_pred CCCCCcEEEcccCcCccCCCcccc-cccceeeccccc-ccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 14 RLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNK-FTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 14 ~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~-l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
.+...+.++.+++.+...+..+.. .+|+.|+|++|+ |+ .|++++|.++++|+.|+|++|+|+...|.+|.++++|++
T Consensus 6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCccCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 445567799999998866555543 379999998775 88 899889999999999999999999888999999999999
Q ss_pred EeccCCcCCCCCCCC-CCCCCCEEEcccCCCc
Q 008431 92 LNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 92 L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~ 122 (565)
|+|++|+|+...+.. ...+|+.|+|++|.+.
T Consensus 85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhccccccccccCCCccc
Confidence 999999999655553 4457999999999885
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.30 E-value=3.6e-12 Score=107.06 Aligned_cols=108 Identities=21% Similarity=0.281 Sum_probs=86.1
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccC-
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQI- 79 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~- 79 (565)
|.+..++ .+..+++|++|+|++|.|+..++.+..+ +|+.|++++|+|+ .+|. |..+++|++|++++|+|+...
T Consensus 8 n~l~~l~--~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~N~i~~~~~ 82 (124)
T d1dcea3 8 KDLTVLC--HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCNNRLQQSAA 82 (124)
T ss_dssp SCCSSCC--CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSSCCCSSST
T ss_pred CCCCCCc--ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccCc--cccccccCeEECCCCccCCCCC
Confidence 4455676 3889999999999999999765556544 7999999999999 6763 899999999999999998543
Q ss_pred CccccCCCCCCEEeccCCcCCCCCCCC-----CCCCCCEE
Q 008431 80 PKSLAGLQKLLQLNLEGNSFQGKIPDF-----PLAHLTLL 114 (565)
Q Consensus 80 p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~~~~L~~l 114 (565)
...++.+++|+.|++++|.++...... .+++|+.|
T Consensus 83 ~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 83 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp TGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred chhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 357899999999999999998543211 35666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=6.2e-12 Score=110.92 Aligned_cols=110 Identities=17% Similarity=0.266 Sum_probs=90.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
|.+..|+ +.+..+++|+.|+|++|.|+.. +.+.. .+|+.|+|++|+|+ .+|+..|..+++|+.|+|++|+|+. ++
T Consensus 28 n~I~~i~-~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~~-~~ 103 (162)
T d1a9na_ 28 YKIPVIE-NLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVE-LG 103 (162)
T ss_dssp SCCCSCC-CGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCC-GG
T ss_pred CCCCccC-ccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCccccccccccccceeccccccc-cc
Confidence 5667886 4677899999999999999964 44443 37999999999999 7888888899999999999999984 44
Q ss_pred --ccccCCCCCCEEeccCCcCCCCCCC------CCCCCCCEEEc
Q 008431 81 --KSLAGLQKLLQLNLEGNSFQGKIPD------FPLAHLTLLDL 116 (565)
Q Consensus 81 --~~~~~l~~L~~L~l~~N~l~g~~p~------~~~~~L~~l~l 116 (565)
..+..+++|+.|++++|.++. .|. ..+++|+.||.
T Consensus 104 ~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 104 DLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp GGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred cccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence 468899999999999999985 343 14788998873
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=2e-11 Score=111.54 Aligned_cols=107 Identities=23% Similarity=0.325 Sum_probs=58.5
Q ss_pred cCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
+..+++|++|+|++|+|++..|.....+|+.|++++|.+. .+|. +.+++.|+.|++++|.+... ..+..+++|+.
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~ 132 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIA-DITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNR 132 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred cccCCCcCcCccccccccCcccccCCcccccccccccccc-cccc--cccccccccccccccccccc--cccchhhhhHH
Confidence 4556666666666666665433212224666666666655 4442 55566666666666655532 23555666666
Q ss_pred EeccCCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 92 LNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 92 L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
|++++|++....+-..+.+|+.|++++|++++
T Consensus 133 L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp EECCSSCCCCCGGGTTCTTCSEEECCSSCCCC
T ss_pred hhhhhhhhcccccccccccccccccccccccC
Confidence 66666666532212245566666666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=2.3e-11 Score=112.18 Aligned_cols=125 Identities=26% Similarity=0.335 Sum_probs=76.9
Q ss_pred cCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCE
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQ 91 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 91 (565)
+..+++|+.|+|++|.|++..|.....+|+.|+|++|+|+ .+|. +.++++|+.|++++|.+.. + ..+..++.|+.
T Consensus 64 l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~ 138 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK-DLSS--LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLES 138 (210)
T ss_dssp GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CGGG--GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCE
T ss_pred HhhCCCCCEEeCCCccccCccccccCcccccccccccccc-cccc--ccccccccccccccccccc-c-ccccccccccc
Confidence 5567777777777777776443222335777777777777 4552 6667777777777777652 2 24666677777
Q ss_pred EeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCC-ccccCCCCCcccCCC
Q 008431 92 LNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIP-DTLSNFDATSFQGNK 141 (565)
Q Consensus 92 L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p-~~~~~~~~~~~~~n~ 141 (565)
+++++|.+++..+...+++|+.+++++|++++..| ..+.++....+.+|.
T Consensus 139 l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNH 189 (210)
T ss_dssp EECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccccccccccccccccCCCCCCEEECCCCC
Confidence 77777776654433456777788888887775332 122333344455553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.20 E-value=4.5e-11 Score=116.74 Aligned_cols=134 Identities=19% Similarity=0.182 Sum_probs=106.0
Q ss_pred hhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCC
Q 008431 9 VDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQK 88 (565)
Q Consensus 9 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 88 (565)
...|..+++|+.+++++|.++.. |.....+|+.|++++|.+++..+ ..|.+++.++.|++++|.+++..|..|.++++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~l-~~~~~~~L~~L~l~~n~~~~~~~-~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~ 220 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITTI-PQGLPPSLTELHLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCSC-CSSCCTTCSEEECTTSCCCEECT-GGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred ccccccccccCccccccCCcccc-CcccCCccCEEECCCCcCCCCCh-hHhhcccccccccccccccccccccccccccc
Confidence 34677899999999999998853 43334579999999999996555 56999999999999999999988999999999
Q ss_pred CCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccCCCcccc---------CCCCCcccCCCCCC
Q 008431 89 LLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGRIPDTLS---------NFDATSFQGNKGLC 144 (565)
Q Consensus 89 L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~---------~~~~~~~~~n~~~c 144 (565)
|++|+|++|+|+...+.. .+++|+.|+|++|+|+..-+..|. ++....+.||+..+
T Consensus 221 L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 221 LRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ceeeecccccccccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 999999999999653333 689999999999999864433432 23334566776543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.16 E-value=7.8e-11 Score=107.52 Aligned_cols=115 Identities=30% Similarity=0.375 Sum_probs=94.5
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCc
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPK 81 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~ 81 (565)
|.+..+++ ++++++|+.|++++|.+....+......|+.|++++|.+. .++ .+..+++|+.|++++|++.. +|
T Consensus 72 N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~~~~~-~~~--~~~~l~~L~~L~l~~n~l~~-~~- 144 (199)
T d2omxa2 72 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT-DID--PLKNLTNLNRLELSSNTISD-IS- 144 (199)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEECCSSCCC-CCG--GGTTCTTCSEEECCSSCCCC-CG-
T ss_pred ccccCccc--ccCCcccccccccccccccccccccccccccccccccccc-ccc--ccchhhhhHHhhhhhhhhcc-cc-
Confidence 33445553 8899999999999999886443223347999999999988 444 27889999999999999984 44
Q ss_pred cccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 82 SLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 82 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
.+..+++|+.|++++|++++..+-..+++|+.|++++|+++.
T Consensus 145 ~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 145 ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred cccccccccccccccccccCCccccCCCCCCEEECCCCCCCC
Confidence 588999999999999999976554578999999999999985
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=8.8e-11 Score=108.15 Aligned_cols=122 Identities=27% Similarity=0.315 Sum_probs=97.9
Q ss_pred CcccccChhhcCCCCCCcEEEcccCcCccCCCccc-ccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC
Q 008431 2 NLMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP 80 (565)
Q Consensus 2 n~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p 80 (565)
|.+..+++ ++.+++|+.|++++|+|++. |.+. ..+|+.|++++|.+. .++. +.+++.|+.+++++|.+++ +
T Consensus 78 n~i~~l~~--~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~l~~~~~~-~~~~--l~~l~~l~~l~~~~n~l~~--~ 149 (210)
T d1h6ta2 78 NKLTDIKP--LANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGIS-DING--LVHLPQLESLYLGNNKITD--I 149 (210)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCC--C
T ss_pred ccccCccc--cccCcccccccccccccccc-cccccccccccccccccccc-cccc--ccccccccccccccccccc--c
Confidence 33455653 78999999999999999874 4443 347999999999987 5653 8889999999999999985 3
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccCCCccccCCC
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGRIPDTLSNFD 133 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 133 (565)
..+..+++|+.+++++|++++..+-..+++|+.|+|++|+|+. +| .+.+++
T Consensus 150 ~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~ 200 (210)
T d1h6ta2 150 TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLK 200 (210)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCT
T ss_pred ccccccccccccccccccccccccccCCCCCCEEECCCCCCCC-Ch-hhcCCC
Confidence 4578899999999999999976554578999999999999984 44 344443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.11 E-value=1.5e-10 Score=112.94 Aligned_cols=113 Identities=20% Similarity=0.237 Sum_probs=93.9
Q ss_pred cccChhhcCCCCCCcEEEcccCcCccCCCc-ccc-cccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCcc
Q 008431 5 GMIDVDTLSRLPGLRSLSFINNSFDGPMPS-VGK-LTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKS 82 (565)
Q Consensus 5 g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~ 82 (565)
..+|.. .+++|+.|++++|.+++..+. +.. ..++.|++++|.++ .+++..|.++++|++|+|++|+|+ .+|..
T Consensus 163 ~~l~~~---~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~-~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~ 237 (305)
T d1xkua_ 163 TTIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGG 237 (305)
T ss_dssp CSCCSS---CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC-EECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred cccCcc---cCCccCEEECCCCcCCCCChhHhhcccccccccccccccc-ccccccccccccceeeeccccccc-ccccc
Confidence 445532 367899999999999987773 333 36999999999999 677778999999999999999998 67889
Q ss_pred ccCCCCCCEEeccCCcCCCCCCCC--------CCCCCCEEEcccCCCc
Q 008431 83 LAGLQKLLQLNLEGNSFQGKIPDF--------PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 83 ~~~l~~L~~L~l~~N~l~g~~p~~--------~~~~L~~l~ls~N~l~ 122 (565)
|.++++|++|+|++|+|+...... .+.+|+.|+|++|+++
T Consensus 238 l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 999999999999999999643221 3578999999999985
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=1.1e-10 Score=101.98 Aligned_cols=105 Identities=20% Similarity=0.258 Sum_probs=88.3
Q ss_pred cceeecccccccccCCcchhcCCCCccEEEccCC-cCcccCCccccCCCCCCEEeccCCcCCCCCCCC--CCCCCCEEEc
Q 008431 40 LRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARN-HFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF--PLAHLTLLDL 116 (565)
Q Consensus 40 L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l 116 (565)
...+++++|.++ .+|.. +.++++|++|+|++| .|+...+.+|.++++|+.|+|++|+|+...|.. .+++|+.|+|
T Consensus 10 ~~~l~c~~~~~~-~~p~~-l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSCEECCSSCCC-TTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCeEEecCCCCc-cCccc-ccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 567899999998 78876 888999999999876 599777888999999999999999999877763 7899999999
Q ss_pred ccCCCccCCCccccC--CCCCcccCCCCCCCC
Q 008431 117 SYNQLVGRIPDTLSN--FDATSFQGNKGLCGK 146 (565)
Q Consensus 117 s~N~l~g~~p~~~~~--~~~~~~~~n~~~cg~ 146 (565)
++|+|+...+..|.. +....+.+|+..|.+
T Consensus 88 s~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred cCCCCcccChhhhccccccccccCCCcccCCc
Confidence 999999666666653 345678899988864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.07 E-value=1.4e-10 Score=116.57 Aligned_cols=110 Identities=25% Similarity=0.360 Sum_probs=60.7
Q ss_pred hcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCc--------------------chhcCCCCccEEEc
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPS--------------------DAFAGMDQLKKVHL 70 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~--------------------~~~~~l~~L~~L~l 70 (565)
.+..+++|+.|++++|.+++..+.....+|+.|++++|++++ +++ ..+..+++++.|+|
T Consensus 236 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~-~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~l 314 (384)
T d2omza2 236 TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTL 314 (384)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEEC
T ss_pred hhhcccccchhccccCccCCCCcccccccCCEeeccCcccCC-CCccccccccccccccccccccccccchhcccCeEEC
Confidence 466777888888888888775553344467777777777763 332 01334445555555
Q ss_pred cCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCC-CCCCCCEEEcccCCCccC
Q 008431 71 ARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDF-PLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 71 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~ls~N~l~g~ 124 (565)
++|++++..| +..+++|++|+|++|++++. +.. .+++|+.|++++|+|++.
T Consensus 315 s~n~l~~l~~--l~~l~~L~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 315 YFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCCBC
T ss_pred CCCCCCCCcc--cccCCCCCEEECCCCCCCCC-hhHcCCCCCCEEECCCCcCCCC
Confidence 5555554321 44555555555555555532 221 345555555555555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.03 E-value=1.4e-12 Score=119.20 Aligned_cols=110 Identities=25% Similarity=0.267 Sum_probs=83.0
Q ss_pred hhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCC
Q 008431 10 DTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQK 88 (565)
Q Consensus 10 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 88 (565)
..|+.|++|+.|+|++|+|+.. +.+..+ +|+.|+|++|+|+ .+|. .+..+++|++|++++|+++. ++ .+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~-~i~~-~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIEN-LDAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC-SCSS-HHHHHHHCCEEECSEEECCC-HH-HHHHHHH
T ss_pred hHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccc-cccc-cccccccccccccccccccc-cc-ccccccc
Confidence 4577888999999999988854 444433 6899999999988 7774 35556778999999998884 33 4778888
Q ss_pred CCEEeccCCcCCCCCC--C-CCCCCCCEEEcccCCCccC
Q 008431 89 LLQLNLEGNSFQGKIP--D-FPLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 89 L~~L~l~~N~l~g~~p--~-~~~~~L~~l~ls~N~l~g~ 124 (565)
|+.|+|++|+++.... . ..+++|+.|+|++|+++..
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 9999999998875321 1 2678899999999987643
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.02 E-value=2.6e-10 Score=114.50 Aligned_cols=103 Identities=26% Similarity=0.333 Sum_probs=85.2
Q ss_pred cCCCCCCcEEEcccCcCccCCCc---------------------c-cccccceeecccccccccCCcchhcCCCCccEEE
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPS---------------------V-GKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVH 69 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~---------------------~-~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~ 69 (565)
++.+++|+.|++++|.+++..+. + ....++.|+|++|+|++ +++ +..+++|++|+
T Consensus 259 ~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~-l~~--l~~l~~L~~L~ 335 (384)
T d2omza2 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-ISP--VSSLTKLQRLF 335 (384)
T ss_dssp GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSC-CGG--GGGCTTCCEEE
T ss_pred ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCC-Ccc--cccCCCCCEEE
Confidence 67788888888888888754331 1 11257899999999994 553 78899999999
Q ss_pred ccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccC
Q 008431 70 LARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYN 119 (565)
Q Consensus 70 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N 119 (565)
|++|+|++ +| .|+++++|++|+|++|++++..|-..+++|+.|+|++|
T Consensus 336 L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 336 FANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 99999985 55 69999999999999999998877667899999999998
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.98 E-value=7.8e-10 Score=102.88 Aligned_cols=110 Identities=23% Similarity=0.354 Sum_probs=68.4
Q ss_pred cCCCCCCcEEEcccCcCccCCCcccc-cccceeecccccccccCC-------------------cchhcCCCCccEEEcc
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGK-LTLRALYLSLNKFTGEIP-------------------SDAFAGMDQLKKVHLA 71 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~-~~L~~L~Ls~N~l~g~ip-------------------~~~~~~l~~L~~L~l~ 71 (565)
+..+++|+.|++++|.++. ++.+.. ..|+.|++++|.+.+..+ ...+.++++|+.|+++
T Consensus 81 l~~l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~ 159 (227)
T d1h6ua2 81 LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIG 159 (227)
T ss_dssp GTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccchhccccchhhhhchhhhhchhhhhcccccccccccc
Confidence 5666677777777666653 222222 235555555554432100 0125567778888888
Q ss_pred CCcCcccCCccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCccC
Q 008431 72 RNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 72 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g~ 124 (565)
+|.+++.. .|+++++|+.|+|++|++++..+-..+++|+.|+|++|+|+..
T Consensus 160 ~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 160 NAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp SSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBC
T ss_pred ccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCCCC
Confidence 88876432 3778888888888888887644333677888888888888754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.95 E-value=1.4e-09 Score=101.04 Aligned_cols=109 Identities=24% Similarity=0.342 Sum_probs=64.1
Q ss_pred cCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC-----------
Q 008431 12 LSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP----------- 80 (565)
Q Consensus 12 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p----------- 80 (565)
+..+++|+.|+|++|++++..|......|++|++++|.++ .++. +.++++|+.|++++|...+..+
T Consensus 59 l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n~~~-~i~~--l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~ 135 (227)
T d1h6ua2 59 VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLK-NVSA--IAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCS-CCGG--GTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEE
T ss_pred HhcCCCCcEeecCCceeecccccccccccccccccccccc-cccc--ccccccccccccccccccccchhccccchhhhh
Confidence 5667777777777777766544323335777777777766 5542 5666777777777666553222
Q ss_pred ---------ccccCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCcc
Q 008431 81 ---------KSLAGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 81 ---------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~g 123 (565)
..+.++++|+.|++++|.++...+-..+++|+.|+|++|++++
T Consensus 136 ~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187 (227)
T ss_dssp CCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred chhhhhchhhhhccccccccccccccccccchhhcccccceecccCCCccCC
Confidence 1234445556666666655543333345666666666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.83 E-value=4.2e-09 Score=98.60 Aligned_cols=114 Identities=14% Similarity=0.128 Sum_probs=72.7
Q ss_pred CCCcEEEcccCcCccCCCc-cc-ccccceeecccccccccCCcchhcCCCCccEEEcc-CCcCcccCCccccCCCCCCEE
Q 008431 16 PGLRSLSFINNSFDGPMPS-VG-KLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLA-RNHFSGQIPKSLAGLQKLLQL 92 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p~-~~-~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~-~N~l~g~~p~~~~~l~~L~~L 92 (565)
+++++|+|++|+|+...+. +. ..+|++|+|++|.+...+|+.+|.+++.+++|.+. .|++....+..|.++++|+.|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 3677777777777765542 33 33677777777777666777777777777777765 366766667777777777777
Q ss_pred eccCCcCCCCCCCCC---CCCCCEEEcccCCCccCCCccc
Q 008431 93 NLEGNSFQGKIPDFP---LAHLTLLDLSYNQLVGRIPDTL 129 (565)
Q Consensus 93 ~l~~N~l~g~~p~~~---~~~L~~l~ls~N~l~g~~p~~~ 129 (565)
++++|+++...+... +..+..+..+++++....+..+
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~ 148 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSS
T ss_pred ccchhhhccccccccccccccccccccccccccccccccc
Confidence 777777765433322 3344445555666654333333
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.80 E-value=7.4e-09 Score=96.87 Aligned_cols=130 Identities=16% Similarity=0.163 Sum_probs=86.7
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCCc--cccc-ccceeecccccccccCCcchhcCCC-CccEEEccCCcCcccC
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMPS--VGKL-TLRALYLSLNKFTGEIPSDAFAGMD-QLKKVHLARNHFSGQI 79 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~-~L~~L~l~~N~l~g~~ 79 (565)
+..++++.|.++++|+.|++++|.+....+. .... .+..+..+++++. .++...|.+++ .++.|++++|+++...
T Consensus 91 l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~i~~~~~~~~~~~l~~L~l~~n~l~~i~ 169 (242)
T d1xwdc1 91 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQEIH 169 (242)
T ss_dssp CCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCCCEEC
T ss_pred ccccccccccccccccccccchhhhcccccccccccccccccccccccccc-cccccccccccccceeeecccccccccc
Confidence 3455666777888888888888887754432 1122 3555566666776 67766677765 7888899999998655
Q ss_pred CccccCCCCCCE-EeccCCcCCCCCCC-C-CCCCCCEEEcccCCCccCCCccccCCCCC
Q 008431 80 PKSLAGLQKLLQ-LNLEGNSFQGKIPD-F-PLAHLTLLDLSYNQLVGRIPDTLSNFDAT 135 (565)
Q Consensus 80 p~~~~~l~~L~~-L~l~~N~l~g~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~~ 135 (565)
+..|. ..++.. +++++|+++...+. + .+++|+.|+|++|+|+...+..|.++...
T Consensus 170 ~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 227 (242)
T d1xwdc1 170 NCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 227 (242)
T ss_dssp TTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEE
T ss_pred ccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccc
Confidence 54444 445444 46788888854443 2 57899999999999985544556665544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.77 E-value=6.2e-11 Score=108.02 Aligned_cols=108 Identities=26% Similarity=0.308 Sum_probs=84.8
Q ss_pred cccccChhhcCCCCCCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCC-
Q 008431 3 LMGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIP- 80 (565)
Q Consensus 3 ~~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p- 80 (565)
.+..|+ .|..|++|+.|+|++|.|+...+..... +|+.|++++|+|+ .++. +..+++|+.|+|++|+|+....
T Consensus 59 ~I~~i~--~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~L~~N~i~~~~~~ 133 (198)
T d1m9la_ 59 NIEKIS--SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLSG--IEKLVNLRVLYMSNNKITNWGEI 133 (198)
T ss_dssp EESCCC--CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHHH--HHHHHHSSEEEESEEECCCHHHH
T ss_pred CCCCcc--cccCCccccChhhccccccccccccccccccccccccccccc-cccc--ccccccccccccccchhcccccc
Confidence 345665 3788999999999999998643333333 6999999999999 5653 7889999999999999985322
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCCC------------CCCCCCEEE
Q 008431 81 KSLAGLQKLLQLNLEGNSFQGKIPDF------------PLAHLTLLD 115 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N~l~g~~p~~------------~~~~L~~l~ 115 (565)
..|..+++|+.|+|++|.++...+.. .+++|+.||
T Consensus 134 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 134 DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 46899999999999999987655542 367788876
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.62 E-value=7.8e-08 Score=94.49 Aligned_cols=98 Identities=20% Similarity=0.239 Sum_probs=78.7
Q ss_pred CCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEecc
Q 008431 16 PGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLE 95 (565)
Q Consensus 16 ~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 95 (565)
.+|+.|+|++|.|+. +|.. ...|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.. .+.|++|+|+
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~-~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL-PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC-CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred cCCCEEEeCCCCCCC-CCCC-CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 368999999999986 4543 247999999999999 89864 468999999999998 45532 1469999999
Q ss_pred CCcCCCCCCCCCCCCCCEEEcccCCCccC
Q 008431 96 GNSFQGKIPDFPLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 96 ~N~l~g~~p~~~~~~L~~l~ls~N~l~g~ 124 (565)
+|.++...+...+++|+.|++++|.++..
T Consensus 107 ~n~l~~lp~~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 107 NNQLEKLPELQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp SSCCSSCCCCTTCTTCCEEECCSSCCSCC
T ss_pred ccccccccchhhhccceeecccccccccc
Confidence 99999654444789999999999998754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.23 E-value=1.7e-06 Score=81.23 Aligned_cols=132 Identities=15% Similarity=0.051 Sum_probs=87.7
Q ss_pred CceeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCC-CCCccceEEEEEecCceEEEEeccCCCCHHHHHhhc
Q 008431 265 SFGSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLS-HPNLLPLIAFYYRKEEKLLVSDFVPNGSLANLLHVR 343 (565)
Q Consensus 265 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~ 343 (565)
+.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.++...+..++||++++|.++.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468998763 56677888876554444556788888877664 323567788888888899999999998876543210
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC-------------------------------------------------
Q 008431 344 RAPGQPGLDWPIRLKIIKGVAKGLAYLYKEF------------------------------------------------- 374 (565)
Q Consensus 344 ~~~~~~~l~~~~~~~i~~~ia~gL~ylH~~~------------------------------------------------- 374 (565)
. ....++.++++.++.||+..
T Consensus 105 -------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 105 -------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp -------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred -------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 1 12223444444444454321
Q ss_pred ----C--CCCCccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 375 ----P--GVTLPHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 375 ----~--~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
+ +..++|+|+.|.|||++++...-|.||+.+..
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0 12378999999999999876667999987643
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.21 E-value=8.5e-06 Score=79.35 Aligned_cols=104 Identities=20% Similarity=0.307 Sum_probs=79.1
Q ss_pred ccccChhhcCCCCCCcEEEcccCcCccCCCcccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccc
Q 008431 4 MGMIDVDTLSRLPGLRSLSFINNSFDGPMPSVGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSL 83 (565)
Q Consensus 4 ~g~i~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 83 (565)
+++||. .+++|++|+|++|+|+. +|.. ..+|+.|++++|+++ .|+. +. +.|++|+|++|.+. .+|. +
T Consensus 50 L~~lp~----~~~~L~~L~Ls~N~l~~-lp~~-~~~L~~L~l~~n~l~-~l~~--lp--~~L~~L~L~~n~l~-~lp~-~ 116 (353)
T d1jl5a_ 50 LSSLPE----LPPHLESLVASCNSLTE-LPEL-PQSLKSLLVDNNNLK-ALSD--LP--PLLEYLGVSNNQLE-KLPE-L 116 (353)
T ss_dssp CSCCCS----CCTTCSEEECCSSCCSS-CCCC-CTTCCEEECCSSCCS-CCCS--CC--TTCCEEECCSSCCS-SCCC-C
T ss_pred CCCCCC----CCCCCCEEECCCCCCcc-cccc-hhhhhhhhhhhcccc-hhhh--hc--cccccccccccccc-cccc-h
Confidence 456773 25789999999999994 4543 237999999999998 6763 22 46999999999998 5675 6
Q ss_pred cCCCCCCEEeccCCcCCCCCCCCCCCCCCEEEcccCCCc
Q 008431 84 AGLQKLLQLNLEGNSFQGKIPDFPLAHLTLLDLSYNQLV 122 (565)
Q Consensus 84 ~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~ls~N~l~ 122 (565)
+.+++|+.|++++|.++...+. ...+..+++..+...
T Consensus 117 ~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~~ 153 (353)
T d1jl5a_ 117 QNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQLE 153 (353)
T ss_dssp TTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCS
T ss_pred hhhccceeeccccccccccccc--cccccchhhcccccc
Confidence 8899999999999999865442 345666666665543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.99 E-value=8.9e-07 Score=76.98 Aligned_cols=81 Identities=26% Similarity=0.261 Sum_probs=62.9
Q ss_pred cccceeecccccccccCCc--chhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCcCCCCCCC---------C
Q 008431 38 LTLRALYLSLNKFTGEIPS--DAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEGNSFQGKIPD---------F 106 (565)
Q Consensus 38 ~~L~~L~Ls~N~l~g~ip~--~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~---------~ 106 (565)
..|+.|+||+|+|+ .++. ..+..+++|+.|+|++|+++...+-.+.....|+.|+|++|.++..... .
T Consensus 65 ~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~ 143 (162)
T d1koha1 65 PELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143 (162)
T ss_dssp TTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred CCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence 36999999999998 5652 4577899999999999999964444555566899999999999876653 1
Q ss_pred CCCCCCEEEcccCCC
Q 008431 107 PLAHLTLLDLSYNQL 121 (565)
Q Consensus 107 ~~~~L~~l~ls~N~l 121 (565)
.+++|+.|| ++.+
T Consensus 144 ~~P~L~~LD--g~~v 156 (162)
T d1koha1 144 RFPKLLRLD--GHEL 156 (162)
T ss_dssp TSTTCCEET--TEEC
T ss_pred HCCCCCEEC--cCCC
Confidence 478899886 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=9.3e-07 Score=76.85 Aligned_cols=105 Identities=17% Similarity=0.109 Sum_probs=74.4
Q ss_pred CCcEEEcccCcCccCCCccccc-ccceeecccccccccCCcchhcCCCCccEEEccCCcCccc--CCccccCCCCCCEEe
Q 008431 17 GLRSLSFINNSFDGPMPSVGKL-TLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQ--IPKSLAGLQKLLQLN 93 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~p~~~~~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~ 93 (565)
.++.|+++++... +.+... .+..|++++|..+ .+ ..++..+++|++|+|++|+|+.. ++..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~---~~l~~~~~~~~l~~~~~~~~-~l-~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD---PDLVAQNIDVVLNRRSSMAA-TL-RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC---TTTTTTTCCCCTTSHHHHHH-HH-HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC---chhhhccchhhcchhhhHhh-hh-HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4566777766533 222222 3455666666554 44 34577899999999999999864 345678899999999
Q ss_pred ccCCcCCCCCCC--CCCCCCCEEEcccCCCccCCC
Q 008431 94 LEGNSFQGKIPD--FPLAHLTLLDLSYNQLVGRIP 126 (565)
Q Consensus 94 l~~N~l~g~~p~--~~~~~L~~l~ls~N~l~g~~p 126 (565)
|++|.++...+- .....|+.|++++|+++....
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 999999964432 144579999999999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=2.2e-05 Score=73.03 Aligned_cols=144 Identities=15% Similarity=0.155 Sum_probs=83.3
Q ss_pred eecccCc-eeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCC--CccceEEEEEecCceEEEEeccCCCCH
Q 008431 260 VLGSGSF-GSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHP--NLLPLIAFYYRKEEKLLVSDFVPNGSL 336 (565)
Q Consensus 260 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~lv~E~~~~gsL 336 (565)
.+..|.. +.||+....++..+++|...... ...+..|...++.+... .+.+++.+..+.+..++||||++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 57899887778888888765432 23466777777665432 356678887788889999999987554
Q ss_pred HH--------------HHhhcCCC--CCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhhCC---
Q 008431 337 AN--------------LLHVRRAP--GQPGL--DWPIRLKII--------------------KGVAKGLAYLYKEFP--- 375 (565)
Q Consensus 337 ~~--------------~l~~~~~~--~~~~l--~~~~~~~i~--------------------~~ia~gL~ylH~~~~--- 375 (565)
.+ .+...... ...++ .+.....-. ......+..+....+
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 21 11111000 00001 111000000 011223344443321
Q ss_pred CCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 376 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+..++|+|+.|.|||++++..+-|+||+.+.
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999987667899998764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.74 E-value=2.2e-06 Score=84.09 Aligned_cols=130 Identities=19% Similarity=0.229 Sum_probs=86.1
Q ss_pred CCCCCCcEEEcccCcCccCCC-c----cc-ccccceeeccccccccc----CCcchhcCCCCccEEEccCCcCccc----
Q 008431 13 SRLPGLRSLSFINNSFDGPMP-S----VG-KLTLRALYLSLNKFTGE----IPSDAFAGMDQLKKVHLARNHFSGQ---- 78 (565)
Q Consensus 13 ~~l~~L~~L~l~~N~l~~~~p-~----~~-~~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~---- 78 (565)
...+.|+.|++++|.++..-. . +. ...|+.|+|++|+++.. +-...+..+++|+.|+|++|.|+..
T Consensus 155 ~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~ 234 (344)
T d2ca6a1 155 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 234 (344)
T ss_dssp HTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH
T ss_pred ccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccc
Confidence 356789999999998863211 1 11 22689999999988632 1123366778899999999988632
Q ss_pred CCccccCCCCCCEEeccCCcCCCCC--------CCCCCCCCCEEEcccCCCccCC----Ccc----ccCCCCCcccCCCC
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKI--------PDFPLAHLTLLDLSYNQLVGRI----PDT----LSNFDATSFQGNKG 142 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~--------p~~~~~~L~~l~ls~N~l~g~~----p~~----~~~~~~~~~~~n~~ 142 (565)
+...+..+++|++|+|++|.+++.- .......|+.|++++|+|+..- ... ..++....+.||..
T Consensus 235 L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred ccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 4456778899999999999987531 1123467999999999986421 111 22445556666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=4.4e-06 Score=79.63 Aligned_cols=102 Identities=20% Similarity=0.268 Sum_probs=73.8
Q ss_pred CcEEEcccCcCccCCCc-ccccccceeecccccccccCCcchhcCCCCccEEEccCCcCcccCCccccCCCCCCEEeccC
Q 008431 18 LRSLSFINNSFDGPMPS-VGKLTLRALYLSLNKFTGEIPSDAFAGMDQLKKVHLARNHFSGQIPKSLAGLQKLLQLNLEG 96 (565)
Q Consensus 18 L~~L~l~~N~l~~~~p~-~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 96 (565)
+..+.++.+.+..++.. ....+|++|||+++.++.......+..+++|++|+|+++.+++..+..++.+++|+.|+|++
T Consensus 25 ~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred ceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 44555555555443332 23347999999999887554455688899999999999999888888899999999999998
Q ss_pred C-cCCCC-CCC--CCCCCCCEEEcccC
Q 008431 97 N-SFQGK-IPD--FPLAHLTLLDLSYN 119 (565)
Q Consensus 97 N-~l~g~-~p~--~~~~~L~~l~ls~N 119 (565)
+ .++.. +.. ..+++|+.|+++++
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred cccccccccchhhHHHHhccccccccc
Confidence 4 55521 111 14688999999885
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.72 E-value=3.3e-06 Score=85.50 Aligned_cols=110 Identities=21% Similarity=0.176 Sum_probs=56.9
Q ss_pred CCCCCCcEEEcccCcCccCCC-c------ccccccceeecccccccccCCc---chhcCCCCccEEEccCCcCccc----
Q 008431 13 SRLPGLRSLSFINNSFDGPMP-S------VGKLTLRALYLSLNKFTGEIPS---DAFAGMDQLKKVHLARNHFSGQ---- 78 (565)
Q Consensus 13 ~~l~~L~~L~l~~N~l~~~~p-~------~~~~~L~~L~Ls~N~l~g~ip~---~~~~~l~~L~~L~l~~N~l~g~---- 78 (565)
...+.++.+++++|.++.... . .....|+.+++++|.++..-.. .++....+|++|+|++|+|+..
T Consensus 280 ~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~ 359 (460)
T d1z7xw1 280 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 359 (460)
T ss_dssp HHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred cccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccch
Confidence 345667777777776652111 0 0112466667776666532111 1233445677777777766532
Q ss_pred CCcccc-CCCCCCEEeccCCcCCCC----CCCC--CCCCCCEEEcccCCCc
Q 008431 79 IPKSLA-GLQKLLQLNLEGNSFQGK----IPDF--PLAHLTLLDLSYNQLV 122 (565)
Q Consensus 79 ~p~~~~-~l~~L~~L~l~~N~l~g~----~p~~--~~~~L~~l~ls~N~l~ 122 (565)
++..+. ..+.|++|+|++|.|+.. ++.. ..++|+.|+|++|+|+
T Consensus 360 l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred hhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 222232 345567777777766532 1110 2456677777777665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.69 E-value=1.4e-06 Score=88.23 Aligned_cols=106 Identities=20% Similarity=0.201 Sum_probs=76.1
Q ss_pred CCcEEEcccCcCccCC-Cc-ccc-cccceeecccccccc----cCCcchhcCCCCccEEEccCCcCccc----CCcccc-
Q 008431 17 GLRSLSFINNSFDGPM-PS-VGK-LTLRALYLSLNKFTG----EIPSDAFAGMDQLKKVHLARNHFSGQ----IPKSLA- 84 (565)
Q Consensus 17 ~L~~L~l~~N~l~~~~-p~-~~~-~~L~~L~Ls~N~l~g----~ip~~~~~~l~~L~~L~l~~N~l~g~----~p~~~~- 84 (565)
+|+.||++.|+++... .. +.. .+|+.|+|++|.|+- .|+ .++..+++|++|||++|.|+.. +...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~-~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS-SALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHH-HHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHH-HHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 6899999999998631 11 222 268999999998872 222 2467889999999999998621 222232
Q ss_pred CCCCCCEEeccCCcCCCCC----CC--CCCCCCCEEEcccCCCcc
Q 008431 85 GLQKLLQLNLEGNSFQGKI----PD--FPLAHLTLLDLSYNQLVG 123 (565)
Q Consensus 85 ~l~~L~~L~l~~N~l~g~~----p~--~~~~~L~~l~ls~N~l~g 123 (565)
...+|+.|+|++|+++..- +. ..+++|+.|++++|+++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 2357999999999997531 21 256899999999999864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.63 E-value=8.5e-06 Score=79.72 Aligned_cols=114 Identities=23% Similarity=0.230 Sum_probs=81.4
Q ss_pred hcCCCCCCcEEEcccCcCccCC--------Cc-------ccccccceeecccccccccCC---cchhcCCCCccEEEccC
Q 008431 11 TLSRLPGLRSLSFINNSFDGPM--------PS-------VGKLTLRALYLSLNKFTGEIP---SDAFAGMDQLKKVHLAR 72 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~--------p~-------~~~~~L~~L~Ls~N~l~g~ip---~~~~~~l~~L~~L~l~~ 72 (565)
.+...++|+.|+|++|.|...- .. .....|+.|.++.|+++..-- ..++.....|+.|+|++
T Consensus 116 ~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~ 195 (344)
T d2ca6a1 116 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 195 (344)
T ss_dssp HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCS
T ss_pred hhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccc
Confidence 3457889999999999985210 00 112368999999998862111 12355678999999999
Q ss_pred CcCccc-----CCccccCCCCCCEEeccCCcCCCCC----CC--CCCCCCCEEEcccCCCccC
Q 008431 73 NHFSGQ-----IPKSLAGLQKLLQLNLEGNSFQGKI----PD--FPLAHLTLLDLSYNQLVGR 124 (565)
Q Consensus 73 N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~~----p~--~~~~~L~~l~ls~N~l~g~ 124 (565)
|+++.. +...+..+++|+.|+|++|.++..- .. ...++|+.|+|++|.|++.
T Consensus 196 n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 196 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp SCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred ccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence 998732 3445778899999999999986321 11 1468899999999998753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.47 E-value=2.5e-05 Score=74.12 Aligned_cols=122 Identities=18% Similarity=0.248 Sum_probs=76.0
Q ss_pred hhcCCCCCCcEEEcccC-cCccC-CCcc--cccccceeecccc-ccccc-CCcchhcCCCCccEEEccCC--cCcc-cCC
Q 008431 10 DTLSRLPGLRSLSFINN-SFDGP-MPSV--GKLTLRALYLSLN-KFTGE-IPSDAFAGMDQLKKVHLARN--HFSG-QIP 80 (565)
Q Consensus 10 ~~~~~l~~L~~L~l~~N-~l~~~-~p~~--~~~~L~~L~Ls~N-~l~g~-ip~~~~~~l~~L~~L~l~~N--~l~g-~~p 80 (565)
..++.+++|+.|+|+++ .++.. +..+ ...+|+.|+|+++ +++.. ++.......++|+.|++++. .++. .+.
T Consensus 89 ~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~ 168 (284)
T d2astb2 89 NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 168 (284)
T ss_dssp HHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHH
T ss_pred HHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccc
Confidence 35778999999999984 56521 1111 2236999999984 45422 22222233478999999864 3442 233
Q ss_pred ccccCCCCCCEEeccCC-cCCCCCCC--CCCCCCCEEEccc-CCCccCCCccccC
Q 008431 81 KSLAGLQKLLQLNLEGN-SFQGKIPD--FPLAHLTLLDLSY-NQLVGRIPDTLSN 131 (565)
Q Consensus 81 ~~~~~l~~L~~L~l~~N-~l~g~~p~--~~~~~L~~l~ls~-N~l~g~~p~~~~~ 131 (565)
..+.++++|+.|+|++| .+++.... ..+++|+.|+|++ +.++......+++
T Consensus 169 ~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~ 223 (284)
T d2astb2 169 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223 (284)
T ss_dssp HHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG
T ss_pred ccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhc
Confidence 44567889999999886 46644333 2578899999998 4666443333433
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.34 E-value=0.00054 Score=67.76 Aligned_cols=76 Identities=11% Similarity=0.073 Sum_probs=48.2
Q ss_pred cceecccCceeEEEEEEe-CCCeeEEEEeecc-------CccCHHHHHHHHHHHhcCC-C--CCccceEEEEEecCceEE
Q 008431 258 AEVLGSGSFGSSYKAVLL-TGPAMVVKRFRQM-------SNVGKEDFHEHMTRLGSLS-H--PNLLPLIAFYYRKEEKLL 326 (565)
Q Consensus 258 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~l 326 (565)
.+.||.|....||+.... +++.++||.-... -....++...|.+.|+.+. + ..+.+++. .+.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 356899999999999854 4678888865321 1123345566877776552 2 23445554 35667889
Q ss_pred EEeccCCCC
Q 008431 327 VSDFVPNGS 335 (565)
Q Consensus 327 v~E~~~~gs 335 (565)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.86 E-value=0.0023 Score=61.30 Aligned_cols=138 Identities=14% Similarity=0.161 Sum_probs=77.7
Q ss_pred eeEEEEEEeCCCeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCc-----cce--EEEEEecCceEEEEeccCCCCH---
Q 008431 267 GSSYKAVLLTGPAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNL-----LPL--IAFYYRKEEKLLVSDFVPNGSL--- 336 (565)
Q Consensus 267 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~l--~~~~~~~~~~~lv~E~~~~gsL--- 336 (565)
-.||+....+|..+++|..+.. ....+++..|...+..|....+ +.. -..+...+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 3799999989999999987643 3346778888888777642222 111 1122345667889999876322
Q ss_pred --HHH---------Hhh----cCCCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHhhC---CCCCC
Q 008431 337 --ANL---------LHV----RRAPGQPGLDWP-------------------IRLKIIKGVAKGLAYLYKEF---PGVTL 379 (565)
Q Consensus 337 --~~~---------l~~----~~~~~~~~l~~~-------------------~~~~i~~~ia~gL~ylH~~~---~~~~i 379 (565)
..+ ++. ........+++. .+..+...+...++.+.... .+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 110 111 111111112221 11112222333344443322 23468
Q ss_pred ccCCCCCCCEEEcCCCCcEEeccCCccc
Q 008431 380 PHGHLKSSNVLLDNAYEPLLTDYALVPI 407 (565)
Q Consensus 380 vHrDlkp~NILl~~~~~~kl~DfGla~~ 407 (565)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899987653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.84 E-value=0.0002 Score=61.76 Aligned_cols=109 Identities=8% Similarity=0.112 Sum_probs=69.9
Q ss_pred CCCCCCcEEEcccC-cCccC--CC---cc-cccccceeecccccccccCC---cchhcCCCCccEEEccCCcCccc----
Q 008431 13 SRLPGLRSLSFINN-SFDGP--MP---SV-GKLTLRALYLSLNKFTGEIP---SDAFAGMDQLKKVHLARNHFSGQ---- 78 (565)
Q Consensus 13 ~~l~~L~~L~l~~N-~l~~~--~p---~~-~~~~L~~L~Ls~N~l~g~ip---~~~~~~l~~L~~L~l~~N~l~g~---- 78 (565)
.+.+.|+.|+|+++ .++.. .+ .+ ....|+.|+|++|.|+..-. .+++...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45688999999874 46421 11 11 12359999999998862211 12345568899999999988742
Q ss_pred CCccccCCCCCCEEeccCCcCCCCCCC----C-----CCCCCCEEEcccCCC
Q 008431 79 IPKSLAGLQKLLQLNLEGNSFQGKIPD----F-----PLAHLTLLDLSYNQL 121 (565)
Q Consensus 79 ~p~~~~~l~~L~~L~l~~N~l~g~~p~----~-----~~~~L~~l~ls~N~l 121 (565)
+-..+...++|+.|+|++|.+...-.. . ..++|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 222456678899999998876632111 0 246788888876643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.69 E-value=0.0017 Score=55.73 Aligned_cols=89 Identities=13% Similarity=0.117 Sum_probs=62.6
Q ss_pred hcCCCCCCcEEEcccCcCcc--CCC---ccc-ccccceeecccccccccCC---cchhcCCCCccEEEccCCcCccc---
Q 008431 11 TLSRLPGLRSLSFINNSFDG--PMP---SVG-KLTLRALYLSLNKFTGEIP---SDAFAGMDQLKKVHLARNHFSGQ--- 78 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~--~~p---~~~-~~~L~~L~Ls~N~l~g~ip---~~~~~~l~~L~~L~l~~N~l~g~--- 78 (565)
.+...+.|+.|+|++|.+.. ... .+. ...|+.|+|++|.|+..-- ..++...+.|++|+|++|++...
T Consensus 39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~ 118 (167)
T d1pgva_ 39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQ 118 (167)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHH
T ss_pred HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHH
Confidence 45677889999999999973 222 111 2369999999999874211 12355668899999999976532
Q ss_pred ----CCccccCCCCCCEEeccCCcC
Q 008431 79 ----IPKSLAGLQKLLQLNLEGNSF 99 (565)
Q Consensus 79 ----~p~~~~~l~~L~~L~l~~N~l 99 (565)
+...+...++|+.|+++.+..
T Consensus 119 ~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 119 VEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHHhCCCccEeeCcCCCc
Confidence 334456678999999987653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.47 E-value=0.014 Score=57.22 Aligned_cols=71 Identities=10% Similarity=0.116 Sum_probs=45.3
Q ss_pred ceecccCceeEEEEEEeCC--------CeeEEEEeeccCccCHHHHHHHHHHHhcCCCCCcc-ceEEEEEecCceEEEEe
Q 008431 259 EVLGSGSFGSSYKAVLLTG--------PAMVVKRFRQMSNVGKEDFHEHMTRLGSLSHPNLL-PLIAFYYRKEEKLLVSD 329 (565)
Q Consensus 259 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~E 329 (565)
+.|+.|-.-.+|+....++ ..|.++... . ........+|..+++.+.-.+++ ++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 5688888889999987543 234444433 2 22334556788888877533444 6676652 268999
Q ss_pred ccCCCC
Q 008431 330 FVPNGS 335 (565)
Q Consensus 330 ~~~~gs 335 (565)
|++|..
T Consensus 122 fi~g~~ 127 (395)
T d1nw1a_ 122 YIPSRP 127 (395)
T ss_dssp CCCEEE
T ss_pred Eecccc
Confidence 998643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.10 E-value=0.0037 Score=53.28 Aligned_cols=110 Identities=12% Similarity=0.217 Sum_probs=70.7
Q ss_pred cCCCCCCcEEEccc-CcCcc--CCC---cc-cccccceeecccccccccCC---cchhcCCCCccEEEccCCcCccc---
Q 008431 12 LSRLPGLRSLSFIN-NSFDG--PMP---SV-GKLTLRALYLSLNKFTGEIP---SDAFAGMDQLKKVHLARNHFSGQ--- 78 (565)
Q Consensus 12 ~~~l~~L~~L~l~~-N~l~~--~~p---~~-~~~~L~~L~Ls~N~l~g~ip---~~~~~~l~~L~~L~l~~N~l~g~--- 78 (565)
..+.+.|+.|+|++ |.++. ..+ .+ ....|+.|+|++|.++..-- .+++...+.|+.|++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 45678999999997 55652 111 11 23369999999998863211 12355678899999999988632
Q ss_pred -CCccccCCCCCCEEec--cCCcCCCCC----CC--CCCCCCCEEEcccCCC
Q 008431 79 -IPKSLAGLQKLLQLNL--EGNSFQGKI----PD--FPLAHLTLLDLSYNQL 121 (565)
Q Consensus 79 -~p~~~~~l~~L~~L~l--~~N~l~g~~----p~--~~~~~L~~l~ls~N~l 121 (565)
+-..+...++|+.++| ++|.+.... .. ...++|+.|+++.|..
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2345677788887555 456664211 00 0357888998877754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.40 E-value=0.0095 Score=50.57 Aligned_cols=89 Identities=16% Similarity=0.216 Sum_probs=61.5
Q ss_pred hcCCCCCCcEEEcccCcCccCCC-c----c-cccccceeecccccccccCCc---chhcCCCCccEEEc--cCCcCcc--
Q 008431 11 TLSRLPGLRSLSFINNSFDGPMP-S----V-GKLTLRALYLSLNKFTGEIPS---DAFAGMDQLKKVHL--ARNHFSG-- 77 (565)
Q Consensus 11 ~~~~l~~L~~L~l~~N~l~~~~p-~----~-~~~~L~~L~Ls~N~l~g~ip~---~~~~~l~~L~~L~l--~~N~l~g-- 77 (565)
.+...+.|+.|+|++|.++...- . + ....++.|++++|.++..--. +++...++|+.++| ++|.+..
T Consensus 41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~ 120 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV 120 (166)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH
T ss_pred HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHH
Confidence 34578899999999999874211 1 1 123699999999998633111 23566788988666 4677753
Q ss_pred --cCCccccCCCCCCEEeccCCcC
Q 008431 78 --QIPKSLAGLQKLLQLNLEGNSF 99 (565)
Q Consensus 78 --~~p~~~~~l~~L~~L~l~~N~l 99 (565)
.+-..+...++|+.|+++.|..
T Consensus 121 ~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 121 EMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHhCCCcCEEeCcCCCC
Confidence 3445567789999999987754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.22 E-value=0.062 Score=50.35 Aligned_cols=31 Identities=19% Similarity=0.139 Sum_probs=27.0
Q ss_pred CCCCccCCCCCCCEEEcCCCCcEEeccCCcc
Q 008431 376 GVTLPHGHLKSSNVLLDNAYEPLLTDYALVP 406 (565)
Q Consensus 376 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 406 (565)
+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3479999999999999988777899999764
|